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Intrahepatic Cholestasis of Pregnancy (ICP) is a liver disease that affects approximately 1% 
pregnancies in the United Kingdom. ICP is characterised by an increase in maternal serum bile acids (BA), 
as well as a change in bile acid composition, whereby the increase in primary bile acids, taurocholic acid 
(TC) and taurochenodeoxycholic acid (TCDCA) is most pronounced. ICP is characterised by maternal 
symptoms and can be complicated by adverse events for the fetus, the latter of which occur more 
commonly in pregnancies complicated by high maternal serum bile acid levels. 
 
Adverse events that may complicate ICP pregnancies include spontaneous preterm labour, fetal 
distress, fetal heart arrhythmia and even intrauterine death in the third term of pregnancy. The aetiology 
of the fetal death is still poorly understood and is thought to occur suddenly. This thesis aims to 
investigate the effect of bile acids on the models of the human fetal heart and elucidate the mechanism 
of action of the protective role of UDCA. In addition, interaction between cardiomyocytes and fibroblasts 
will be investigated. 
 
Potential mechanisms of protection against bile acid induced fetal arrhythmia were investigated in 
different fetal heart models. The different models of the fetal heart will be described first, which include 
previously used models and a novel model using cells isolated from human fetal tissue. The effect of bile 
acids on these models will be described subsequently, with the focus on prevention of TC induced 
arrhythmias using Ursodeoxycholic acid (UDCA) and NorUrsodeoxycholic acid (NorUDCA). Human fetal 
heart tissue was obtained from terminations of pregnancy and for the first time beating cardiomyocytes 
were obtained. Characterisation of cardiac markers such as α-Actinin in these cells shows that there are 
similarities between neonatal rat, human fetal cardiomyocytes and the induced pluripotent stem cell- 
derived cardiomyocytes (iPS-CM) from Cellular Dynamics (CDI). Upon addition of TC to human fetal 
cardiomyocytes and CDI adverse effects occurred, including decreased spontaneous beating and 
prolongation of calcium transients and action potentials. Both UDCA and NorUDCA were not toxic to 
neonatal rat cardiomyocytes and fibroblasts, as used in the model and prevented TC-induced adverse 
effects. It was previously shown that there was a transient appearance of myofibroblasts and that these 
myofibroblasts play a role in TC induced arrhythmias. This thesis investigates role of fibroblasts and 
myofibroblasts in bile acid mediated arrhythmias. Addition of TC to human fetal and neonatal rat 
fibroblasts led to further depolarisation of these cells which could potentially depolarise connected 
cardiomyocytes. UDCA and NorUDCA on the other hand hyperpolarised these cells, which may be a 
potential mechanism of the protection seen in the models. UDCA and NorUDCA may act via modulation 
of the Sulfonylurea Receptor (SUR), a subunit of the ATP-sensitive inward rectifying potassium channel 
(KATP channel). This channel is involved in the regulation of the membrane potential of the cell. The 
interaction between cardiomyocytes and fibroblasts and the role of gap junctions in this was also 
investigated. 
ABSTRACT 
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Maternal symptoms include pruritus of the skin. Pruritus is defined as itching without a visible rash, 
which can become very severe in women with ICP. The pruritus usually resolves quickly after delivery of 
the baby. In addition, high bile acid levels are associated with increased risk of spontaneous preterm 
labour. The mechanism by which bile acids induce spontaneous preterm labour is not well understood 
and this thesis aims to further elucidate bile acid associated receptors and labour associated proteins 
expression levels. Expression levels of nuclear and membrane-bound bile acid receptors were 
investigated in myometrium tissue of labouring and non-labouring patients at term. FXR, one of the main 
nuclear bile acid receptors was not expressed. LXRα, LXRβ, PPARα and PPARγ were expressed as were the 
bile acid G-protein coupled receptor TGR5 and muscarinic receptor M5, while some muscarinic receptors 
(M1, M3 and M4) were not. It is difficult to obtain human myometrial tissue from earlier gestation, as the 
tissue is obtained from caesarean sections usually of non-labouring term pregnancies. This makes studies 
into the causes of preterm labour more difficult, especially those where high bile acid levels are involved, 
as it is often not possible to obtain consent for tissue collection from patients undergoing an emergency 
caesarean section due to difficulties whilst in term or preterm labour. Therefore other models could help 
elucidate the mechanisms behind early labour. For this reason novel protocols using a combinatory 
method called CombiCult (Plasticell) were developed which led to the differentiation of human 
embryonic (ES) and induced pluripotent stem (iPS) cells into myometrial smooth muscle cells (SMCs) in 
collaboration with Plasticell and these protocols will be described in this thesis. 
 
The work presented in this thesis provides new insight into the effect of bile acids on the fetal heart, 
with the focus on the development of novel cellular models of the human heart. The characterisation of 
human fetal cardiomyocytes and CDI was carried out using immunofluorescence staining of cardiac 
markers, which show changes upon maturation of the heart. Both the CDI and human fetal 
cardiomyocytes show an immature phenotype of these markers, similar to the neonatal rat 
cardiomyocytes. Optical recording of human fetal cardiomyocytes containing naturally occurring 
myofibroblasts showed that, similar to the neonatal rat model of the fetal heart, TC leads to calcium 
transient duration prolongation which can be prevented by UDCA. It was shown that Cx43 is involved in 
this interaction and that the cardiomyocytes and myofibroblasts are functionally coupled by GJs. 
Furthermore, work presented in this thesis provides further insight into the expression bile acid receptors 
in the myometrium, by providing evidence of the expression of various bile acid sensitive receptors, 
including the GPCR TGR5. Finally, for the first time, novel protocols were developed for the 
differentiation of myometrial smooth muscle cells. 
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Intrahepatic Cholestasis of Pregnancy (ICP) is a liver disease prevalent in 1 in 200 pregnancies in 
the United Kingdom. ICP is characterised by an increased concentration of maternal serum bile acids 
(BA) and a change in bile acid composition, whereby the increase in the primary conjugated bile 
acids, taurocholic acid (TC) and taurochenodeoxycholic acid (TCDCA), are most pronounced. ICP is 
characterised by maternal symptoms of pruritus (itch without a rash) and poor pregnancy outcomes. 
Poor pregnancy outcomes occur more commonly in pregnancies complicated by high maternal 
serum bile acid levels (Geenes, Lövgren-Sandblom, Benthin, et al., 2014; Glantz, Marschall & 
Mattsson, 2004). 
 
Poor pregnancy outcome includes spontaneous preterm labour, fetal distress, fetal heart 
arrhythmia, spontaneous preterm labour and intrauterine death in the third term of pregnancy 
(Geenes & Williamson, 2009; Geenes, Lövgren-Sandblom, Benthin, et al., 2014; Glantz, Marschall & 
Mattsson, 2004; Geenes, Chappell, Seed, et al., 2013). The aetiology of the fetal death is still poorly 
understood, but is thought to occur suddenly. Maternal symptoms usually resolve quickly after 
delivery of the baby (Geenes & Williamson, 2009; Geenes, Lövgren-Sandblom, Benthin, et al., 2014; 
Geenes, Chappell, Seed, et al., 2013). 
 
In this thesis, bile acid effects that lead to adverse pregnancy outcomes were investigated. The 
potentially protection of Ursodeoxycholic and NorUrsodeoxycholic acid against bile acid induced 
arrhythmia was investigated in human models of the fetal heart. The increased risk of bile acid 
associated spontaneous preterm labour was investigated using myometrial tissue and cells. 
 
Different models of the fetal heart will be described first and the effect of bile acids on these 
models will be described. For the first time, it was possible to obtain beating cardiomyocytes from 
human fetal tissue. This allowed for the comparison of the previously used neonatal rat model with 
human fetal models. The importance of further investigation into the role of fibroblasts in bile acid 
mediated arrhythmias and the interaction between cardiomyocytes and fibroblasts and the role of 
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gap junctions will be explored subsequently. Finally, the effect of bile acids on the myometrium was 
investigated to elucidate molecular pathways which are influenced by bile acids that can induce 
preterm labour. In addition, novel protocols to differentiate human embryonic (ES) and induced 
pluripotent stem (iPS) cells into myometrial smooth muscle cells (SMCs) generated in conjunction 
with Plasticell will be described. 
 
 
 
 
 
 
Intrahepatic cholestasis of pregnancy (ICP), also known as Obstetric Cholestasis (OC), is a 
pregnancy related disease first described in the 1950s as severe pruritus with or without jaundice, 
which resolves completely after delivery and with a high incidence of recurrence in subsequent 
pregnancies, although in 1883 a case was described by Ahfeld as ‘recurrent jaundice in pregnancy’ 
which resolved after delivery, but he did not mention pruritus (Reyes, 1982). ICP patients generally 
present late second to third trimester with pruritus and with abnormal liver function tests with 
elevated serum bile acids, in the absence of other liver disease, although cases have been reported 
of early onset in the first trimester (Brites, Rodrigues, Cardoso, et al., 1998). The aetiology of ICP is 
still poorly understood and is thought to be multifactorial, potentially due to the effect of 
reproductive hormones and their metabolites on bile acid signalling in genetically predisposed 
individuals (Geenes & Williamson, 2009; Lammert, Marschall, Glantz, et al., 2000; Chen, Vasilenko, 
Song, et al., 2015; Abu-Hayyeh, Martinez-Becerra, Sheikh Abdul Kadir, et al., 2010; Abu-Hayyeh, 
Papacleovoulou, Lövgren-Sandblom, et al., 2013; Abu-Hayyeh & Williamson, 2015, 2014). 
 
The incidence of ICP varies with geographical location and ethnicity. In addition seasonal 
differences have been described, with a higher prevalence during winter months in a number of 
countries. It is most commonly found in South America, especially in Chile, where an overall 
incidence of 10% was originally described, with an even higher incidence of 27% in women of 
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Araucanian Indian descent (Reyes, 1982). More recently the incidence was described to have 
decreased to approximately 1.5 – 4% of pregnancies in Chile. There is also a high incidence in 
Sweden and other Baltic countries (Geenes & Williamson, 2009; Reyes, 1982). North America, Asia 
and Australia show lower prevalence, with as few as 1 in 1000 to 1 in 10 000 cases (Reyes, 2008). In 
the UK the incidence rate is about 1 in 150-200 pregnancies (Geenes & Williamson, 2009; Reyes, 
2008). 
 
In addition to differences in geographical location and seasonality, there is an increased incidence 
seen in twin pregnancies (20-22%) and following in vitro fertilisation (2.7% vs. 1%) (Koivurova et al., 
2002, Rioseco et al., 1994, Gonzalez et al., 1989). There is a high chance of ICP in subsequent 
pregnancies, with pruritus starting at an earlier gestation (Williamson et al., 2004). Evaluation of first 
degree family members showed an increased incidence of intrahepatic cholestasis if family members 
have the disease (Eloranta et al., 2001, Reyes, 1982). A percentage of women with a history of 
intrahepatic cholestasis also showed cyclical or contraceptive-induced pruritus, whereby some 
women experienced pruritus after use of the contraceptive pill, whilst others experienced pruritus 
around the time of ovulation (day 14) or just before or during menstruation (Williamson et al., 
2004). 
 
The effects of ICP can be divided into adverse effects for the mother and for the fetus. ICP can 
have profound effects on the wellbeing of the mother, as the pruritus can become very severe and it 
may be difficult to alleviate, although these problems are not generally life threatening. There is also 
an increased chance of spontaneous preterm labour and problems associated with this. The adverse 
effects for the fetus may be life threatening, as they include fetal heart arrhythmias and intrauterine 
death. Recently a large case-control study was published which compared severe cases of ICP with 
controls. In this study it was shown that there was an increased risk of stillbirths in women with  
severe ICP (10/664; 1.5% versus 11/2205; 0.5%; adjusted Odds Ratio [OR] 2.58, 95% Confidence 
Interval [CI] 1.03 to 6.49, P = 0.044) and in neonates admitted to the neonatal unit (80/654; 12% 
versus 123/2192; 5.6%; adjusted OR 2.68, 95% CI 1.97 to 3.65) (Geenes, Chappell, Seed, et al., 2013). 
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1.3.1 MATERNAL SYMPTOMS 
 
 
Symptoms usually start in the third trimester, with women presenting with pruritus of the 
extremities. Pruritus is defined as an unpleasant sensation that evokes the desire to scratch but 
without any dermatological features such as rash. The most commonly affected area is the palms of 
the hands and soles of the feet, although it may be generalised (Geenes & Williamson, 2009). 
 
Pruritus often develops from 30 weeks and worsens as pregnancy progresses to full term, 
although cases of early onset ICP with pruritus starting as early as 8 weeks of gestation have been 
described (Johnston, Stephenson & Nageotte, 2014; Brites, Rodrigues, Cardoso, et al., 1998).  
Women suffering from ICP may also suffer from general discomfort including anorexia, malaise and 
abdominal pain. Dark urine and steatorrhea may occur (Geenes & Williamson, 2009). An increased 
incidence of postpartum haemorrhage has also been reported which may be due to Vitamin K 
deficiency. Vitamin K is a fat soluble vitamin whose absorption is dependent on sufficient bile salt 
secretion in the gut in order to promote micelle formation. Therefore Vitamin K deficiency may 
occur in severe or prolonged cholestasis cases. Administration of Vitamin K supplements may 
protect against postpartum haemorrhage (Reid et al., 1976). In almost all cases, maternal symptoms 
resolve spontaneously within a few weeks after delivery. 
 
ICP is also associated with an 1 – 2% increase in incidence of spontaneous preterm labour, but  
the mechanisms of how increased bile acid levels lead to induction of preterm labour are not well 
understood (Geenes & Williamson, 2009; Geenes, Lövgren-Sandblom, Benthin, et al., 2014; Glantz, 
Marschall & Mattsson, 2004). Labour is associated with contractions of the myometrium, which 
leads to the expulsion of the fetus. In this thesis expression of bile acid receptors in the myometrium 
was investigated and the effect of bile acids on contraction of myometrial tissues. 
1.3 CLINICAL FEATURES 
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1.3.2 FETAL CONSEQUENCES OF  ICP 
 
 
Fetal complications of ICP include intrapartum fetal distress, heart arrhythmia and intrauterine 
death in the third term of pregnancy, often occurring around week 37-39. Fetal distress is indicated 
by meconium staining of the amniotic fluid or by reduced umbilical cord blood pH measurements. 
Intrauterine death is thought to occur suddenly, as there is no evidence of preceding utero-placental 
insufficiency. The fetal autopsy is usually normal, potentially showing signs of acute anoxia, but no 
intrauterine growth retardation (Geenes & Williamson, 2009, Pusl & Beuers, 2007, Reid et al., 1976). 
 
The aetiology of the fetal complications and fetal death is still poorly understood. It is difficult to 
research as the acquisition of human fetal heart samples is not feasible for most cases. It is thought 
that fetal complications arise due to the effects of bile acids which cross the placenta and 
subsequently accumulate in the fetus to a toxic level compared to fetuses during normal pregnancy 
(Geenes, Lövgren-Sandblom, Benthin, et al., 2014). However, reduced heart rate variability and an 
abnormal fetal heart rate (less than 100 bpm or greater than 180 bpm) have been observed in some 
studies of ICP pregnancies. Normal fetal heart rate is defined as 100 – 180 beats a minute. 
Pathological fetal tachycardia is described as an elevated heart rate over 180 bpm, whilst 
bradycardia is a decrease in heart rate below 100 bpm. Furthermore, fetal atrial flutter has been 
reported in ICP (Shand, Dickinson & D'Orsogna, 2008, Al Inizi, Gupta & Gale, 2006). 
 
Our current knowledge of bile acid induced arrhythmias is based on neonatal rat heart models 
and it is difficult to know how much can be extrapolated into the clinic. This thesis will describe the 
effects of bile acids in human models of the fetal heart by using commercially available human 
induced pluripotent stem cell derived cardiomyocytes (iPS-CM) and human fetal tissue. 
Page | 30  
 
 
Diagnosis of ICP is based on occurrence of pruritus in association with raised serum bile acid 
levels. Liver transaminases are usually also raised. ICP is a diagnosis of exclusion so it is important to 
exclude other possible causes of these symptoms, e.g. associated pre-eclampsia, acute fatty liver of 
pregnancy, acute viral hepatitis or other causes of biliary obstruction. 
 
 
 
 
 
1.4.1 BILE ACID ABNORMALITIES 
 
 
During an uncomplicated pregnancy only a minimal rise in total serum bile acid levels is detected 
with progressing gestation. The fetus synthesises bile acids from 12 weeks of gestation which 
increases as the fetus matures, these bile acids are subsequently exported via the placenta to the 
maternal circulation. The majority of bile acids in the circulation of fetuses from ICP pregnancies are 
conjugates of cholic acid (CA), taurocholic acid (TC) and glycocholic acid (GC) and chenodeoxycholic 
acid (CDCA), glycochenodeoxycholic acid (GCDCA), as measured by umbilical cord samples (Geenes, 
Lövgren-Sandblom, Benthin, et al., 2014). The ratio of primary bile acids (CA : CDCA)  in  these 
samples was also increased to 1.89 in untreated ICP samples compared to control (0.78), whilst 
maternal Ursodeoxycholic acid (UDCA) treatment led to a decrease in the ratio to 0.81 (Geenes, 
Lövgren-Sandblom, Benthin, et al., 2014). A proportion of these bile acids are ‘unusual bile acids’, 
such as unsaturated ketonic bile acids and 1β-hydroxylated bile acids (Seki, Matsushita, Kimura, et 
al., 2011; Geenes, Lövgren-Sandblom, Benthin, et al., 2014). These bile acids are in large part 
transferred to the maternal circulation, from where they are excreted in the urine, although a small 
amount is also excreted into the amniotic fluid (Seki, Matsushita, Kimura, et al., 2011; Geenes, 
Lövgren-Sandblom, Benthin, et al., 2014). Maternal serum of healthy pregnant women, on the other 
hand contains mostly low levels of primary and secondary bile acids, similar to healthy non-pregnant 
control serum (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). In maternal serum from ICP 
pregnancies there is a significant increase in total bile acid levels compared to control serum and 
1.4 BIOCHEMICAL FEATURES 
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UDCA treatment leads to a significant reduction in total bile acid levels compared to the levels in 
untreated ICP serum (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). The majority of bile acids 
elevated in ICP pregnancies were conjugates of CA (TC and GC) and CDCA (TCDCA  and  GCDCA), 
which increased significantly compared to control serum (Geenes, Lövgren-Sandblom, Benthin, et  
al., 2014). UDCA treatment led to a significant decrease in total serum bile acids in the maternal 
serum, mainly due to a significant reduction of conjugated CA and CDCA (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014). The ratio of primary bile acids (CA : CDCA) was increased in 
untreated ICP pregnancies to 3.26, compared to control (1.00) whilst UDCA treatment let to a 
decrease (1.95), mainly due to an increase in unconjugated and conjugated UDCA (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014). UDCA treatment also affected the bile acid pool with respect to 
ratios between unconjugated and taurine and glycine conjugated bile acids. In control serum, there 
are roughly equal amounts of these three pools of bile acids. These ratios become altered in ICP due 
to the large increases of mainly conjugated bile acids. UDCA treatment leads to the reduction of the 
unconjugated and taurine conjugated proportions whilst the glycine conjugates were proportionally 
increased, mainly due to a significant increase in glycine-conjugated UDCA (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014). 
 
The main bile acids in their urine on the other hand are the ‘unusual’ bile acids, which most likely 
come from the fetus. The composition of the main bile acids in the urine changed after birth and 
becomes mostly primary bile acids, similar to healthy non-pregnant control samples (Seki, 
Matsushita, Kimura, et al., 2011). 
 
It has been shown that bile acids are transferred across the placenta in rat and sheep models 
(Macias, Pascual, Bravo, et al., 2000; Sewell, Hardy, Smallwood, et al., 1982, 1980). In the sheep 
studies by Sewell et al., radiolabelled CA in the form of Sodium [14C]-cholic acid was injected either 
intravenously in the mother or in the portal vein of the fetus to study the maternal-to-fetal and fetal-
to-maternal transfer of bile acids respectively. The radiolabelled CA in the maternal bile acid pool 
was found to be present mostly in the conjugated form of [14C]-TC. In addition, no radiolabelled 
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CA or TC was found in the fetus after 6-9 days, indicating that there was little or no placental transfer 
of [14C]-TC to the fetus. In fetal-to-maternal experiments, [14C]-TC was found to be present in the 
maternal pool after 3-4 days, indicating that there is fetal excretion of bile acids via the placenta 
(Sewell, Hardy, Smallwood, et al., 1980). This indicates that under normal circumstances negligible 
amounts bile acids are transferred across the placenta to the fetus. Little data on the transfer of bile 
acids across the human placenta is available and our knowledge of the molecular pathways for bile 
acid transport across placental tissue is still limited (Cui, Liu, Men, et al., 2009; Geenes, Dixon, 
Chambers, et al., 2011; Patel, Weerasekera, Hitchins, et al., 2003; Serrano, Macias, Briz, et al., 2007; 
Xu, Ke & Xing, 2008), although indirect evidence is becoming more available, by carrying out 
concurrent measurements of bile acid levels in matched maternal and umbilical cord serum 
(Colombo, Roda, Roda, et al., 1985; Itoh, Onishi, Isobe, et al., 1982; Geenes, Lövgren-Sandblom, 
Benthin, et al., 2014). These studies provide evidence that there is a trans-placental gradient from 
fetus to mother that facilitates excretion of toxic bile acids from the fetal circulation into maternal 
serum in normal pregnancies, thereby regulating fetal steroid homeostasis (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014; Sewell, Hardy, Smallwood, et al., 1980). If the bile acid levels in the 
maternal serum pass a threshold value, the maternal-fetal bile acid gradient is reversed, resulting in 
elevated bile acid concentrations in the fetal blood (Geenes, Lövgren-Sandblom, Benthin, et al., 
2014). This increase in maternal serum bile acids prevents the export of fetal bile acids, which leads 
to an increase in the bile acids in the fetal circulation due to the accumulation of these fetal bile 
acids and associated risk to the wellbeing of the fetus (Geenes & Williamson, 2009; Geenes, Lim, 
Bowman, et al., 2011; Geenes, Lövgren-Sandblom, Benthin, et al., 2014). 
 
Bile acid levels increase slightly with increasing gestation even in normal pregnancies, compared 
to non-pregnant women. Previous research indicates that this slight increase is normal and not 
harmful to the baby. However, the serum bile acid concentration in women suffering from ICP 
increase markedly. This leads to a classification of the severity of the disease along a scale based on 
bile acid level (Glantz, Marschall & Mattsson, 2004). Maternal serum bile acid concentrations of 10 
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µmol/L and below are considered normal. 40 µmol/L and higher is classed as severe ICP and serum 
bile acids above this level are associated with adverse pregnancy outcomes (Geenes & Williamson, 
2009). These women often receive active treatment, whilst women with mild disease (bile acids 
between 10 and 40 µmol/L) may receive treatment at the discretion of the treating gynaecologist 
and depending on other factors including previous pregnancies with ICP and genetic predisposition 
(Geenes & Williamson, 2009; Geenes, Chappell, Seed, et al., 2013; Glantz, Marschall & Mattsson, 
2004). 
 
 
 
 
 
1.5.1 BILE ACID SYNTHESIS 
 
 
Diagnosis of ICP is mainly based on the fact that the mother presents with pruritus and has 
increased levels of serum bile acids. Bile acids (BA) are steroid molecules with detergent properties 
which contain up to 3 hydroxyl groups. 500 mg bile acids is synthesized de novo daily from 
cholesterol in a complex multi-enzymatic process. Mammalian bile acids are C24-5β-bile acids 
(cholanoic acid), consisting of a total of four carbon rings, three 6-carbon rings and single 5-carbon 
ring. The process of cholesterol conversion into bile acids includes hydroxylation, saturation of the 
C5-C6 double bond, epimerization of the 3-hydroxyl group and the removal of a 3-carbon unit from 
the side chain by oxidative cleavage (Chiang, 2013). 
 
Bile acids can be produced via two pathways, via the neutral or classical pathway and via the 
alternative or acidic pathway, see Figure 1.1. The relative contribution of each of these pathways 
differs between species. In the human, only a small portion of bile acids are produced via the 
alternative pathway under normal circumstances, although this may change in cholestatic patients 
where the alternative pathway may become the major route for bile acid synthesis (Monte, Marin, 
Antelo, et al., 2009). The major difference between the pathways is the order in which the 
conversion of cholesterol into bile acids occurs. In the classical pathway only neutral steroids 
are produced as intermediate metabolites and steroid ring modifications occur first, followed by 
1.5 BILE ACIDS 
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the side-chain cleavage, whilst in the alterative pathway acidic intermediate metabolites are 
formed as the steroid ring modifications are preceded by the side chain cleavage (Chiang, 2013; 
Monte, Marin, Antelo, et al., 2009). The neutral pathway is the major pathway for production of 
newly synthesised bile acids in human and mice and is present only in the liver. 
 
Bile  acid  synthesis  in  the  classical  pathway  is  initiated  by  the  microsomal  cytochrome  P-
450 enzyme, cholesterol 7α-hydroxylase (CYP7A1) which converts cholesterol into 7α-
hydroxycholesterol. CYP7A1 is the rate-limiting enzyme in this pathway. 7α-hydroxycholesterol is 
then converted via multiple intermediates into primary bile acids CA and CDCA in human, whilst in 
mice CDCA is rapidly converted into muricholic acid (MCA). 7α-hydroxycholesterol is converted to 
7α-hydroxy-4-cholesten-3-one by 3β-hydroxy-Δ5-C27-steroid dehydrogenase/isomerase (HSD3B7). 
The relative CA/CDCA and CA/MCA ratio is determined by sterol 12α-hydroxylase (CYP8B1) activity, 
which hydroxylases 7α-hydroxy-4-cholesten-3-one at the C-12 position (Monte, Marin, Antelo, et al., 
2009). CYP8B1 is required for the synthesis of CA without this modification the final product is CDCA 
(or MCA). The subsequent steps are independent of CYP8B1 modification and involve the same 
enzymes for both the trajectories leading to the production of CA and CDCA (or MCA). Reduction of 
the double bond by Δ4–3-oxosteroid-5β-reductase (AKR1D1) and 3α-hydroxysteroid dehydrogenase 
(AKR1C4) leads to the generation of the CA and CDCA precursors 5β-cholestan-3α,7α,12α-triol and 
5β-cholestan-3α,7α-diol, respectively. The next step is oxidization of the side-chain by the 
introduction of a hydroxyl group to the C-27 position by mitochondrial sterol 27-hydroxylase 
(CYP27A1). The hydroxyl group is subsequently oxidized to an aldehyde and further modified to a 
carboxylic acid. This leads to the production of 3α,7α,12α-trihydroxy-5β-cholestanoic acid (THCA) 
and 3α,7α-dihydroxy-5β- cholestanoic acid (DHCA), the CA and CDCA precursor respectively. Bile 
acid CoA synthetase (BACS) or very long chain acyl CoA synthetase (VLCS) then activate these 
precursors to their coenzyme A-esters. 
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FIGURE 1.1. BILE ACID SYNTHESIS PATHWAYS 
 
The classical and alternative pathways for bile acid synthesis in the liver. Bile acid synthesis from 
cholesterol is initiated by cholesterol 7α-hydroxylase (CYP7A1) and in the mitochondria by sterol 27- 
hydroxylase (CYP27A1) for the classical and alternative pathways respectively. The CA : CDCA ratio is 
regulated subsequently by sterol 12α-hydroxylase (CYP8B1) activity. 
25OH-C: 27-hydroxycholesterol; 27OH-C: 27-hydroxycholesterol; StAR D1: steroidogenic acute 
regulatory protein D1; SULT2B1b: hydroxycholesterol sulfotransferase 2B1b; CYP7B1: oxysterol 7α- 
hydroxylase; AKR1C4: 3α-hydroxysteroid dehydrogenase; AKR1D1: Δ4–3-oxosteroid-5β-reductase; 
AMACR: Alpha methylacyl-CoA racemase; BAAT: Bile acid CoA: Amino acid N-acyltransferase; BACS: 
Bile acid CoA synthetase; BCOX: Branched- chain acyl CoA oxidase; BDP: D-bifunctional protein 
hydratase; CYP27A1: Sterol 27-hydroxylase; CYP7A1: Cholesterol 7α-hydroxylase; CYP8B1: Sterol 
12α-hydroxylase; HSD3B7: 3β-hydroxy-Δ5-C27-steroid dehydrogenase/ isomerase; SCPx: Sterol 
carrier protein X; VLCS: Very long-chain acyl CoA synthetase; ER: Endoplasmic reticulum. Adapted 
from (Hylemon, Zhou, Pandak, et al., 2009; Monte, Marin, Antelo, et al., 2009). 
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Finally, the side chain is shortened of the resulting cholestanoyl-CoAs by β-oxidation which leads to 
the end product of CA and CDCA (Monte, Marin, Antelo, et al., 2009). Under normal circumstances 
there are very low levels of unconjugated bile acid. The majority of bile acids is conjugated with 
glycine or taurine at the end terminal side-chain carboxylic acid by the enzyme bile acid CoA: amino 
acid N-acyltransferase (BAAT) (Monte, Marin, Antelo, et al., 2009). 
 
The initiation of the alternative pathway is not liver specific, as the initial enzymes sterol 27-
hydroxylase (CYP27A1) and oxysterol 7α-hydroxylase (CYP7B1) are expressed in various tissues. This 
pathway is initiated by the oxidation of cholesterol to 27-hydroxycholesterol by CYP27A1, which is 
subsequently converted into 7α,27-dihydroxycholesterol by CYP7B1. These oxidized sterols are 
subsequently transported to the liver for further conversion into bile acids. Unlike the classical 
pathway, the main bile acid formed is CDCA (Monte, Marin, Antelo, et al., 2009). 
 
The bile acids CA and CDCA are synthesized in the hepatocytes of the liver, these bile acids are 
also known as primary bile acids, see also Figure 1.2. They are conjugated with the amino acids 
glycine or taurine in a ratio of approximately 3 : 1 to increase solubility under physiological 
circumstances, before secretion into the bile canaliculi and subsequently storage as one of the 
components of bile in the gall bladder. In addition to bile acids, bile is also composed of bilirubin, 
cholesterol and phosphatidylcholine. When a meal is ingested, bile and therefore bile acids are 
released into the duodenum by contraction of the gallbladder. This is triggered by the release of 
cholecystokinin secreted from the duodenum (Pols, Noriega, Nomura, et al., 2011b). 
 
In the ileum and colon primary bile acids are metabolised by bacteria into secondary bile acids. 
Secondary bile acids produced from CA and CDCA by bacterial 7-dehydroxylation are deoxycholic 
acid (DCA) and lithocholic acid (LCA) respectively. LCA is subsequently conjugated with glycine or 
taurine and sulphated at the C3 position, which is then secreted in the bile, but is not absorbed as 
efficiently as the other bile acids and is subsequently eliminated via the faeces. The bile acid 
Ursodeoxycholic acid (UDCA) is formed by bacterial epimerisation and hepatic metabolism of   CDCA 
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and is only detected in trace amounts in human (van Mil, Houwen & Klomp, 2005, Hofmann, 1999). 
The bile acid pool in mice consists of mostly of MCA and CA, whilst in human the majority of bile 
acids are CA and CDCA, with DCA making up approximately 10% of the total pool. Due to the toxic 
nature of LCA, it is eliminated rapidly. Due to structural differences bile acids differ in 
hydrophobicity, with UDCA being the least hydrophobic and therefore the most hydrophilic and LCA 
the most hydrophobic. The order of hydrophobicity is LCA > DCA > CDCA > CA > UDCA. Unconjugated 
bile acids are more hydrophobic than glycine-conjugated and taurine-conjugated bile acids are the 
most hydrophilic (Monte, Marin, Antelo, et al., 2009). 
 
After a meal is ingested, the bile acids are secreted from the bile duct into the duodenum, where 
they serve as emulsifiers of cholesterol and solubilize other dietary lipids to promote their 
absorption. From the duodenum they are resorbed and transported back to the liver. The 
continuous cycle of secretion, absorption and resecretion is called the enterohepatic circulation. 
Approximately 95% of bile acids are efficiently circulated. A small percentage of bile acids enter the 
colon, from where the bile acids are excreted or enter the systemic circulation. 
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FIGURE 1.2. CHEMICAL STRUCTURE OF BILE ACIDS 
 
Primary bile acids are formed from Cholesterol in the liver, whilst secondary bile acids are produced 
from the primary precursors by bacterial 7-dehydroxylation (Deoxycholic acid and Lithocholic acid). 
The bile acid Ursodeoxycholic acid is only found in trace elements in bile and is formed by 
epimerisation of the 7α-hydroxyl groups in CDCA to 7β-hydroxyl groups at C7. All bile acids exist 
more commonly in taurine or glycine conjugated form. A generic structure of conjugated bile salts is 
shown in the bottom left-hand side, R: OH or H group; X: glycine or taurine conjugates. Adapted 
from (Hofmann, 1999; Russell, 2009). 
NorUrsodeoxycholic acid is produced synthetically by removal of one of the side chain groups of 
Ursodeoxycholic acid, and is not naturally modified in the body, although synthetic conjugation of 
NorUrsodeoxycholic acid is possible (Fickert, Wagner, Marschall, et al., 2006). 
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1.5.2 BILE ACID FUNCTION AND RECEPTOR  INTERACTIONS 
 
 
The role of bile acids in facilitating lipid absorption (including the lipid-soluble vitamins A, D, E  
and K) and cholesterol homeostasis has long been investigated (Russell, 2009; Pols, Noriega,  
Nomura, et al., 2011b). Bile acid production and secretion from the hepatocytes is under tight 
regulation to prevent accumulation of bile acids in the hepatocyte, where they would have a 
cytotoxic effect. After uptake by the Na+/Taurocholate Cotransporter (NTCP) or Organic Anion 
Transporting Protein 2 (OATP2), bile acids bind to nuclear hormone receptors, such as the nuclear 
Farnesoid X receptor (FXR), Pregnane X receptor (PXR), Peroxisome proliferator-activated receptor 
(PPAR) and Vitamin D receptor (VDR), which leads to regulation of bile acid synthesis and secretion 
(Zollner & Trauner, 2009). 
 
FXR regulates the expression of bile acid transporters and is required for maintenance of the 
enterohepatic circulation (Milona et al., 2010, Trauner & Boyer, 2003). FXR directly induces the gene 
expression of hepatic bile acid efflux transporters including the Bile Salt Export Pump (ABCB11 or 
BSEP) and ATP-binding cassette B4 (ABCB4 or MDR3 in human, Mdr2 in mouse) and indirectly 
negatively regulates the gene expression of CYP7A1, via SHP (Short heterodimer partner). CYP7A1 is 
the rate limiting enzyme in bile acid synthesis, leading to a reduction in bile acid production. Genetic 
variants of the FXR, ABCB11 and ABCB4 genes have been implicated in predisposition to ICP (Dixon 
et al., 2009, Van Mil et al., 2007, Wasmuth et al., 2007, Dixon et al., 2000). 
 
In addition to the role bile acids play in lipid absorption and cholesterol homeostasis, evidence is 
accumulating that bile acids function as signalling molecules in other tissues and are important for 
regulating cardiovascular function (Thomas, Auwerx & Schoonjans, 2008). 
 
With regard to the tissues of relevance to the work presented in this thesis, FXR may be 
expressed in cardiomyocytes (CMs) at low levels; however evidence suggests that it is not involved in 
cardiomyocyte bile acid signalling. Sheikh Abdul Kadir et al. (2010) found that upon treatment with 
TC the receptor does not undergo nuclear translocation and treatment with the FXR receptor agonist 
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GW4064 had no effect on contraction, thereby indicating that FXR does not mediate bile acid 
induced arrhythmia in the heart (Sheikh Abdul Kadir et al., 2010). Little is known about the 
expression levels and function of FXR and other nuclear receptors in the myometrium. 
 
In addition to nuclear receptors, bile acids are also able to activate a G-protein-coupled receptor 
(GPCR) called TGR5. TGR5 expression levels vary greatly between tissues, high expression of TGR5 is 
observed in the intestine, spleen and gall bladder (Li, Holmstrom, Kir, et al., 2011; Wang, Chen, Yu, et 
al., 2011; Pols, Noriega, Nomura, et al., 2011b, 2011a). Moderate levels of expression can be found 
in the liver, brain muscle, brown adipose tissues (BAT) and monocytes as well as in the heart (de 
Aguiar Vallim, Edwards, Vallim, et al., 2009; Keitel, Görg, Bidmon, et al., 2010; Khurana, Raufman & 
Pallone, 2011; Desai, Shabier, Coss-Bu, et al., 2014; Desai, Shabier, Taylor, et al., 2010; Desai, Eblimit, 
Thevananther, et al., 2014; Desai & Penny, 2013). TGR5 activation by bile acids regulates nitric oxide 
production in endothelial cells through activation of the cyclic-AMP-dependent endothelial nitric 
oxide synthase, whilst in muscle and BAT cells TGR5 activation results in an increase in cAMP and 
subsequent activation of type 2 thyroid hormone deiodinase (D2), which leads to a change in glucose 
homeostasis. D2 activation leads to the conversion of inactive T4 into the active thyroid hormone T3. 
In entero-endocrine L cells of the intestine TGR5 activation leads to the stimulation of incretin 
glucagon-like peptide-1 (GLP-1) secretion (Thomas, Auwerx & Schoonjans, 2008). 
 
Expression of TGR5 in cardiomyocytes was previously thought to be very low, although a pilot 
study in our lab indicates that in the model of a fetal heart TGR5 may be involved in arrhythmicity of 
contraction in cardiomyocytes upon stimulation with oleanolic acid (OA), CDCA or LCA and 
stimulation with bile acids leads to cAMP production in neonatal rat cardiomyocytes [Unpublished 
Data]. The expression level of TGR5 in human cardiomyocytes and fibroblasts has not been explored. 
 
The muscarinic M2 receptor on the other hand was shown to be expressed in both neonatal and 
adult cardiomyocytes. The bile acid TC functions as a partial agonist of this receptor. TC was shown 
to reduce the rate of contraction in neonatal cardiomyocytes and had an arrhythmogenic effect on 
cardiomyocyte beating, as indicated by calcium desynchronization in TC treated cells (Sheikh Abdul 
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Kadir et al., 2010). This was shown to be through a partial inhibitory effect on intracellular cyclic 
adenosine monophosphate (cAMP) levels due to specific muscarinic M2 receptor activation. The 
functional M2 receptor agonist carbachol has a more potent effect on cAMP levels in comparison to 
TC, it was therefore postulated that TC is a partial agonist, as TC reduced cAMP levels by 
approximately 30% in comparison with baseline activity. The effect of TC was shown to be 
dependent on the Gi-proteins and was blocked by the selective M2 receptor antagonist 
methoctramine. Furthermore, siRNA knockdown of the M2 receptor abolished the effect of TC on 
contraction. In addition it was shown that knockdown of the M2 receptor protected against the 
arrhythmogenic effect of TC (Sheikh Abdul Kadir et al., 2010). 
 
UDCA was previously shown to be effective in preventing TC-induced arrhythmias, but the 
mechanism of action is unclear and whether UDCA also signals through bile acid receptors in the 
heart remains unknown (Miragoli, Kadir, Sheppard, et al., 2011). 
 
How bile acids induce preterm labour is still not well understood. Previously the expression levels 
of bile acid receptors and downstream proteins have been investigated in the placenta of normal 
and ICP pregnancies, as well tissue morphology (Geenes, Dixon, Chambers, et al., 2011; Geenes, Lim, 
Bowman, et al., 2011). They found that elevated bile acid levels were associated with morphological 
abnormalities of the placenta (Geenes, Lim, Bowman, et al., 2011). These findings were replicated in 
an in vitro model and where UDCA protected against these changes in morphology (Geenes, Lim, 
Bowman, et al., 2011). The low expression levels of FXR and its downstream targets BSEP and SHP 
found in both normal and ICP placentas indicate that these changes may be mediated via other 
pathways (Geenes, Dixon, Chambers, et al., 2011; Geenes, Lim, Bowman, et al., 2011). But there has 
been very little in depth analysis of human myometrial tissue. 
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FIGURE 1.3. STRUCTURE OF URSODEOXYCHOLIC ACID AND MODIFICATION TO NorURSODEOXYCHOLIC ACID 
 
 
 
 
 
 
 
1.5.3 URSODEOXYCHOLIC ACID & NorURSODEOXYCHOLIC ACID 
URSODEOXYCHOLIC ACID 
 
Asian traditional medicine has long used bear bile as a ‘cure-all’. Compared to human bile, bear 
bile is more hydrophilic as it contains a larger proportion of UDCA. Many studies now have shown 
that UDCA has potential beneficial effects on a variety of cholestatic diseases including liver  
disorders and ICP (Solá, Amaral, Aranha, et al., 2006; Miragoli, Kadir, Sheppard, et al., 2011; Gurung, 
Williamson, Chappell, et al., 2009; Geenes, Chappell, Seed, et al., 2013). 
 
Cholestatic liver disorders like Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis 
(PSC) are characterised by chronic liver injury due to impaired bile acid secretion. Impaired secretion 
leads to intrahepatic accumulation of hydrophobic bile acids, which together with inflammation 
leads the development of fibrosis and cirrhosis and to bile duct and liver injury, liver failure and 
portal hypertension (Moustafa, Fickert, Magnes, et al., 2012; Fickert, Pollheimer, Silbert, et al., 2013; 
Chiang, 2013). The severity of liver injury has been found to be correlated to the ratio of toxic, 
hydrophobic bile acids to less toxic bile acids such as UDCA (Schmucker, Ohta, Kanai, et al., 1990; 
Denk, Maitz, Wimmer, et al., 2010). 
 
UDCA protects the liver and bile duct by reducing the toxicity of the relatively hydrophobic bile 
acid pool. It has been shown to protect bile duct cholangiocytes, as well as stimulating bile acid 
secretion from the  liver  and bile  duct.  UDCA has  been  shown  to  improve  both biochemical and 
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histological parameters in PBC and is currently the only approved treatment, UDCA treatment slows 
down the progression to cirrhosis and normalises life expectancy in a majority of patients (Denk, 
Maitz, Wimmer, et al., 2010; Anon, 2009). In PSC the long term benefits are unclear, although 
markers of long term prognosis improved after UDCA treatment in pilot trials (Denk, Maitz, Wimmer, 
et al., 2010; Anon, 2009). 
 
Although the exact mechanism of action in the liver of UDCA remains unknown, mechanisms for 
the activation of PXR and target genes inducing the detoxification of bile acids as well as stimulation 
of bile acid secretion via posttranscriptional activation have been stipulated (Denk, Maitz, Wimmer, 
et al., 2010; Chiang, 2013; Beuers, 2006). 
 
UDCA is already in use to reduce pruritus in women with ICP, although it is currently not 
specifically licenced for use during pregnancy, a pilot study shows no adverse effects for the mother 
or the pregnancy and a reduction in pruritus of the mother (Chappell, Gurung, Seed, et al., 2012; 
Geenes, Chappell, Seed, et al., 2013). They also found a reduction in meconium stained amniotic 
fluid, which may indicate a potentially beneficial effect for the fetus (Chappell, Gurung, Seed, et al., 
2012). This may be due to the protection of the fetus via UDCA associated protection against 
arrhythmia, as beneficial effects of UDCA on the fetal heart has previously been shown in our group 
using neonatal rat cardiomyocytes and fibroblasts (Miragoli, Kadir, Sheppard, et al., 2011). 
 
In a clinical trial for patients with chronic heart failure, patients were treated with UDCA to assess 
whether it could improve endothelial function and reduce inflammation. They found that UDCA was 
well tolerated and that its use improved peripheral blood flow and improved markers of liver 
function, although no improvement was found in exercise tests (Von Haehling, Schefold, Jankowska, 
et al., 2012; Tousoulis, Papageorgiou & Stefanadis, 2012; Sinisalo, Vanhanen, Pajunen, et al., 1999). 
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NorURSODEOXYCHOLIC ACID 
 
 
Emerging studies indicate that NorUrsodeoxycholic acid (NorUDCA) may be more effective than 
UDCA at reduction of progression of certain liver diseases (Fickert, Wagner, Marschall, et al., 2006; 
Fickert, Pollheimer, Silbert, et al., 2013; Halilbasic, Fiorotto, Fickert, et al., 2009). ‘Nor’ indicates the 
elimination of one methylene group from a side chain of the parental structure, as defined by the 
IUPAC Compendium of Chemical Terminology (A.D. McNaught and A. Wilkinson, 1997). NorUDCA is 
a C-23 homolog of UDCA and is also referred to as 24-NorUDCA, as the side chain was shortened by 
eliminating the C-24 group thereby producing the C-23 homolog, see Figure 1.2 and 1.3 (Chiang, 
2013; Fickert, Wagner, Marschall, et al., 2006; Denk, Maitz, Wimmer, et al., 2010). Only trace 
amounts of C23 bile acids can be found in the human bile and these bile acids have different 
pharmacokinetic properties compared to C24 bile acids (Denk, Maitz, Wimmer, et al., 2010). These 
bile acids are poorly conjugated with glycine or taurine in the liver, with NorUDCA unable to be 
modified naturally, although synthetic conjugates of NorUDCA have now been generated (Halilbasic, 
Fiorotto, Fickert, et al., 2009). NorUDCA is a hypercholeretic bile acid which is secreted into bile, 
passively reabsorbed by cholangiocytes and subsequently returned to the liver. This cholehepatic 
shunting leads to increased bile flow induced by unconjugated or non-charged bile acids (such as 
NorUDCA). Cholehepatic shunting by passive absorption of NorUDCA induced the generation of 
bicarbonate molecules in bile, which leads to an increase of bicarbonate secretion as well as 
increased bile flow (Denk, Maitz, Wimmer, et al., 2010). 
 
In a mouse model of PSC, the targeted deletion of multidrug resistance protein 2, also known as 
ATP-binding cassette B4 (MRD2 / ABCB4 -/-) leads to the development of a sclerosing cholangitis-
like phenotype. Fickert et al. (2006) found that NorUDCA had a significantly higher effect in 
comparison to unconjugated UDCA at treating this phenotype (Fickert, Wagner, Marschall, et al., 
2006; Denk, Maitz, Wimmer, et al., 2010). In this model, NorUDCA induced increased bile flow, 
improved bile acid hydrophobicity and induced bile acid detoxification pathways (Fickert, Wagner, 
Marschall, et al., 2006; Denk,  Maitz,  Wimmer, et  al.,  2010).  NorUDCA was also shown to  reduce 
inflammation and fibrosis by inhibition of myofibroblast (MFB) proliferation (Fickert, Wagner, 
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Marschall, et al., 2006; Halilbasic, Fiorotto, Fickert, et al., 2009). 
 
In further hepatic studies, using primary human hepatocytes UDCA was found to be toxic at lower 
concentrations (150 µM) compared to NorUDCA (2 mM). This may be due to the fact that in 
hepatocytes UDCA induces depletion of hepatocellular ATP at lower doses, which leads to a higher 
degree of apoptosis. ATP depletion may be due to natural formation of coenzyme A thioester 
formation of UDCA as well as glycine/taurine conjugation, processes which require ATP. NorUDCA on 
the contrary cannot be conjugated and forms fewer thioesters, inducing less ATP depletion and 
apoptosis. This may be one of the differential mechanisms leading to lower cytotoxicity of NorUDCA 
(Fickert, Pollheimer, Silbert, et al., 2013). Clinical trials of NorUDCA for PBC and PSC are underway in 
Europe (Denk, Maitz, Wimmer, et al., 2010; Fickert, Pollheimer, Silbert, et al., 2013). 
 
The protective effect of UDCA in the neonatal rat model of the fetal heart was found to be due to 
hyperpolarisation of the fibroblasts used in the model. This led to the question; is NorUDCA, shown 
to be effective against fibrosis by targeting fibroblasts, more beneficial for the fetus than UDCA. 
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1.6.1 DEVELOPMENT OF THE  HEART 
 
 
EARLY EMBRYONIC HEART DEVELOPMENT 
 
 
To understand the mechanisms behind fetal arrhythmias it is important to consider the 
development of the heart and the environment it develops in. Cardiogenesis, or the development of 
the embryonic heart, occurs early in gestation and the heart is the first organ to reach a functional 
state (Webster & Abela, 2007; Xin, Olson & Bassel-Duby, 2013; Tam, Parameswaran, Kinder, et al., 
1997; Buckingham, Meilhac & Zaffran, 2005).  The human heart starts to beat during the fourth  
week of gestation, with the circulation of blood starting a few days later (Webster & Abela, 2007; 
Buckingham, Meilhac & Zaffran, 2005). The heart, even as it is still developing, is essential for the 
distribution of nutrients and oxygen in the developing embryo (Webster & Abela, 2007; Buckingham, 
Meilhac & Zaffran, 2005). 
 
During embryonic development the single layered blastula is reorganized into three germ layers, 
the ectoderm (the outer layer), mesoderm and endoderm (inner layer), this tree-layered structure is 
called the gastrula. The mesoderm, or middle layer, is formed from the anterior primitive streak and 
can be divided into three components: the paraxial, intermediate and lateral plate mesoderm. The 
heart and vascular system are derived from the lateral plate mesoderm (Garcia-Martinez & 
Schoenwolf, 1993; Schoenwolf & Garcia-Martinez, 1995; Tam, Parameswaran, Kinder, et al., 1997; 
Xin, Olson & Bassel-Duby, 2013). 
 
Induction of myocardium formation is mediated by BMP (Bone morphogenetic protein) produced 
by the endoderm (Xin, Olson & Bassel-Duby, 2013). In the mouse embryo, cardiac progenitor cells 
migrate as early as embryonic day 6.5 (E6.5) in an anterior-lateral direction to an area under  the 
head folds. Here they form two cell populations on either side of the midline, see Figure 1.4. (Garcia- 
Martinez & Schoenwolf, 1993; Schoenwolf & Garcia-Martinez, 1995; Tam, Parameswaran, Kinder, et 
al., 1997; Xin, Olson & Bassel-Duby, 2013; Buckingham, Meilhac & Zaffran, 2005; Srivastava, 2006). 
1.6 FETAL DEVELOPMENT OF THE  HEART 
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The primary heart field is formed by cardiac progenitor cells migrating from the anterior lateral plate 
mesoderm, these cardiac progenitor cells form a crescent at E7.5 in mouse, corresponding to week 2 
in human embryos (Srivastava, 2006; Xin, Olson & Bassel-Duby, 2013). 
 
This crescent then forms a scaffold for the secondary heart field to migrate to. The secondary 
heart field is formed by cells from the pharyngeal mesoderm located medial and anterior to the 
cardiac crescent (Xin, Olson & Bassel-Duby, 2013; Srivastava, 2006). Ultimately the primary heart 
field cells give rise to the left ventricle and both atria, while the second heart field also contributes to 
both atria, the right ventricle and outflow tract (Xin, Olson & Bassel-Duby, 2013). By E8.0 (or 3 
weeks) a linear heart tube has formed at the ventral midline from migrating primary heart field cells 
from the cardiac crescent. This heart tube consists of an exterior layer of myocardial cells and an 
interior layer of endocardial cells (Srivastava, 2006). Cells from the secondary heart field 
subsequently migrate to the anterior and posterior ends of the heart tube, becoming the arterial and 
venous pole respectively (Xin, Olson & Bassel-Duby, 2013; Srivastava, 2006). 
 
The heart tube then loops to the right due to uneven growth and remodelling. By E8.5 the 
primitive ventricles and atria are formed (Xin, Olson & Bassel-Duby, 2013; Srivastava, 2006). By E10.5 
the developing ventricles have moved forward and downward, whilst the atria move upward. This 
allows for the correct positioning of the developing chambers. Heart maturation occurs from 
approximately day 28 – day 50 in human development and up to E15 in mice. Maturation includes 
the formation of septa between the left and right ventricles and atria and the formation of the  
valves (Xin, Olson & Bassel-Duby, 2013; Srivastava, 2006). 
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FIGURE 1.4. DEVELOPMENTAL STAGES OF THE MAMMALIAN  HEART 
 
a) Development of the human heart. Oblique view and schematic representation of the cardiac 
developmental stages of the human heart at approximate gestational days. 
V: ventricle; A: atrium, LV: left ventricle; LA: left atrium; RA: right atrium; AS: aortic sac; Ao: aorta; 
PA: pulmonary artery; RSCA: right subclavian artery; LSCA: left subclavian artery; RCA: right carotid 
artery; LCA: left carotid artery; DA: ductus arteriosus. 
b) Development of the mouse heart. Schematic representations of cardiac development 
approximately equivalent to human gestation. Ex stands for embryonic days. 
First panel (a. and b.): Primary heart field cardiac progenitors form a crescent in the anterior embryo 
on either side of the midline, with secondary heart field progenitors migrating medial and anterior  
to the primary heart field. 
Second panel (a. and b.): Formation of a linear heart tube along the ventral midline by migrating 
primary heart field cells, the early formation of right ventricle (RV) and atria (A) by migrating 
secondary heart field cells and (b.) the looping of the heart tube due to uneven growth and 
remodelling, allowing for the formation of the primitive ventricles and atria. 
Third panel: Formation of the outflow tract and bilateral symmetric aortic arch arteries (III, IV, VI) by 
cardiac neural crest cells. 
Fourth panel: Development of the atrioventricular valves (AVV) and septation of the ventricles and 
atria lead to the formation of a four-chambered heart. Based on: (Srivastava, 2006; Xin, Olson & 
Bassel-Duby, 2013) 
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CHANGES IN THE HEART DURING FETAL AND NEONATAL  DEVELOPMENT 
 
 
The heart is comprised of what is generally known as a myocyte population, comprised of the 
cardiomyocytes and non-myocyte population, which includes endothelial cells, vascular smooth 
muscle cells, cardiac fibroblasts (FBs) and various immune cells (Banerjee, Fuseler, Price, et al., 2007; 
Xin, Olson & Bassel-Duby, 2013). Together these cells make up the atria and ventricles and are all 
necessary for the intricate balance that allows for the correct function of the heart. 
 
Changes in cell number or cell type have profound effects on the structural, mechanical, electrical 
and biochemical properties and can lead to cardiac dysfunction and heart disease (Xin, Olson & 
Bassel-Duby, 2013). The heart would be unable to function without the myocardium,  the  
contracting cardiomyocytes, but endothelial cells lining the blood vessels and making up the cardiac 
valves as well as the endocardium are equally essential, as are vascular smooth muscle cells of the 
coronary arteries and vasculature (Xin, Olson & Bassel-Duby, 2013). 
 
Cardiac fibroblasts are necessary for maintenance of the structural integrity of the heart and 
specialised cardiomyocytes; pacemaker cells in the sinoatrial (SA) node and atrioventricular (AV) 
node and cardiac cells in the Purkinje fibres are essential for the generation and propagation of 
electrical impulses which lead to the uniform contraction of the heart (Xin, Olson & Bassel-Duby, 
2013). 
 
The myocyte – non-myocyte ratio differs during development, in early life and in the adult heart, 
see also Table 1.1. It also differs between species. In the adult mouse heart the majority of cells are 
myocytes (55%) with fibroblasts making up 27% of the non-myocyte population, whilst the adult rat 
heart consists of only 30% myocyte, with fibroblasts making up 67% of the remaining 70% (Banerjee, 
Fuseler, Price, et al., 2007; Krenning, Zeisberg & Kalluri, 2010; Vliegen, van der Laarse, Cornelisse, et 
al., 1991). The ratio does not only differ between species, it also changes during development [Table 
1.1]. 
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Banerjee et al. (2007) did a comprehensive study of the different cell populations in the 
developing heart of both rats and mice, summarised in Table 1.1 (Banerjee, Fuseler, Price, et al., 
2007). In the rat heart, early neonatal hearts (day 1) consist mostly of myocytes (62%), with 
fibroblasts making up most of the remainder (30%). These ratios had changed significantly by day 15, 
where populations are more similar to the adult populations described previously, with myocytes 
making up only 30% and fibroblasts making up 64% of the remaining non-myocytes (Banerjee, 
Fuseler, Price, et al., 2007). 
 
In murine hearts there are large fluctuations of cardiac cell populations in the late developmental 
stages of the fetus and early neonatal stages. The myocyte populations fluctuates between 65% 
(E18) and 78% (day 5 post-natal), to 62% at day 15, this is a significantly larger population compared 
to the myocyte population observed in adult mice. Fibroblast populations fluctuate also, from 14% 
(E18), to 10% shortly after birth (day 1), to 14% by day 5 and 18% by day 15 (Banerjee, Fuseler, Price, 
et al., 2007). These fluctuations may partially be due to the dynamics of the growth of the heart. The 
majority of studies indicated that these early neonatal growth fluctuations in the different cell 
populations are due to different factors, with the non-myocyte populations increases due to 
increased cell number, while increases in the myocyte population are mostly due to hypertrophy of 
existing myocytes, although some proliferation was observed (Banerjee, Fuseler, Price, et al., 2007). 
TABLE 1.1. FLUCTUATIONS OF CELL POPULATIONS IN THE RODENT   HEART 
 
At the end of development and during the first few weeks after birth there are large 
fluctuations in the myocyte and non-myocyte populations of the rodent heart. The 
percentage cardiomyocytes / fibroblasts changes upto 15 days after birth, when it 
approximates levels of adult hearts. Based on: (Banerjee, Fuseler, Price, et al., 2007). 
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The cardiovascular system and more specifically the myocardium, undergoes many structural and 
functional changes during in-utero development and whilst switching from fetal to neonatal 
circulation. After birth, the ductus arteriosus and foramen ovale close and the blood flow to the left 
ventricle increases due to pulmonary circulation, this leads to changes in pressure and volume of the 
heart and ultimately leads to an increase of the overall size (Banerjee, Fuseler, Price, et al., 2007; 
Tiemann, Weyer, Djoufack, et al., 2003; Jurko, 2004). Taken together, this suggests that these 
temporal and spatial changes in cell populations are due to dynamic changes of chemical, electrical 
and biomechanical nature (Banerjee, Fuseler, Price, et al., 2007). Taken together, this suggests that 
these temporal and spatial changes in cell populations are due to dynamic changes of chemical, 
electrical and biomechanical nature (Banerjee, Fuseler, Price, et al., 2007). 
 
 
 
 
 
THE ROLE OF HYPOXIA IN HEART  DEVELOPMENT 
 
 
During the organogenic period of embryonic development many developing areas undergo  
partial hypoxia, as indicated by the hypoxia marker pimonidazole. These hypoxic areas change 
depending upon the age of the fetus (Webster & Abela, 2007). Pimonizadole also co-localises with 
cardiac developmental markers including vascular endothelial growth factor (VEGF) and hypoxia 
inducible factor (HIF-1α). It can therefore be speculated that the relative state of chronic hypoxia in 
which the human heart develops is necessary for the normal development of the cardiovascular 
system (Webster & Abela, 2007). Clancy et al. (2007) showed that hypoxia is thought to contribute 
to differentiation of human fetal cardiac fibroblasts into myofibroblasts in vitro (Clancy et al., 2007). 
A study by Miragoli et al. (2011) showed that myofibroblasts transiently appear in human fetal 
ventricular tissue during the second and third trimester of gestation, which may have an influence  
on ICP-related fetal heart arrhythmia and sudden fetal death which is thought to occur abruptly and 
at late gestation (Miragoli et al., 2011). 
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1.7.1 FIBROBLAST TRANSFORMATION TO  MYOFIBROBLASTS 
 
 
The transformation of cardiac fibroblasts to myofibroblasts also occurs in ischemic, fibrotic and 
infarcted adult hearts. In healthy hearts, interstitial cardiac fibroblasts are responsible for collagen 
synthesis and other extracellular matrix (ECM) proteins to provide a mechanical scaffolding for the 
cardiomyocytes which facilitates the synchronous contraction of the heart (Miragoli, Gaudesius & 
Rohr, 2006; Gaudesius, Miragoli, Thomas, et al., 2003; Biernacka & Frangogiannis, 2011; Rohr, 2009; 
McAnulty, 2007; Camelliti, Borg & Kohl, 2005). Fibroblast function is under tight regulation as excess 
deposition of collagen can lead to fibrosis and arrhythmias. But fibroblasts are much more than just 
ECM producers, they can detect changes in their microenvironment by sensing mechanical (stretch) 
or biochemical (cytokines, growth factors) changes and can modulate this environment by excretion 
of cytokines and growth factors and therefore are integral in the maintenance of cardiac mechanical, 
biochemical and electrical function (Krenning, Zeisberg & Kalluri, 2010). 
 
Identification, characterisation, labelling and specific targeting of cardiac fibroblasts in vivo is 
complicated by the fact that there is no truly specific marker of cardiac fibroblasts (Camelliti, Borg & 
Kohl, 2005; Krenning, Zeisberg & Kalluri, 2010). The most often used marker is Vimentin. Vimentin 
antibodies stain the abundant intermediate filaments in fibroblasts and also those found in vascular 
endothelial cells and neurons. Because of size and morphological differences between these cell 
types it is possible to differentiate between the large fibroblasts which have extensive cytoplasm and 
other cell types (Camelliti, Borg & Kohl, 2005). A more specific cardiac fibroblast marker is the 
collagen receptor discoidin domain receptor 2 (DDR2). This receptor tyrosine kinase is involved in 
the conversion of environmental stimuli into cellular responses, which include changes in 
morphology, differentiation, migration and growth (Camelliti, Borg & Kohl, 2005). DDR2 is found on 
mesenchymal cells and leukocytes, but in the heart only cardiac fibroblasts express this receptor 
(Camelliti, Borg & Kohl, 2005). 
1.7 FIBROBLASTS &  MYOFIBROBLASTS 
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After an infarct or ischemic event, especially in the scar region where the injury occurred and in 
the surrounding infarct border zone, interstitial fibroblasts are replaced by or switch to 
myofibroblasts, characterized by expression of αSmooth Muscle Actin (αSMA). These myofibroblasts 
are implicated in the initial formation of the scar and subsequent border zone / scar expansion 
(Miragoli et al. 2006; Gaudesius et al. 2003; Biernacka & Frangogiannis 2011; Rohr 2009; McAnulty 
2007; O’Quinn et al. 2011). The border zone is the area surrounding the scar where there is 
infiltration of myofibroblasts but there are still cardiomyocytes surviving, in contrast to the scar area 
where very few cardiomyocytes survive due to necrosis (O’Quinn, Palatinus, Harris, et al., 2011). This 
transformation or infiltration of myofibroblasts is thought to be triggered by a multitude of signals 
including local inflammatory reactions, mechanical stress and various cytokines and biochemical 
factors (Rohr, 2009). Numerous factors have been implicated in myofibroblast activation, phenotype 
and function, including transforming growth factor β1 (TGF-β1), basic fibroblast growth factor 
(bFGF), insulin-like growth factors (IGF), angiotensin II and catecholamines (Rohr, 2009; Manabe, 
Shindo & Nagai, 2002). Myofibroblasts have a low resting membrane potential, which can be 
modulated by axial stretch, hypoxia and humoral activity (Chilton, Giles & Smith, 2007, Kamkin et al., 
2005, Kamkin et al., 2003). Myofibroblasts are thought to contribute to the arrhythmogenesis that 
occurs in diseased hearts, by structural remodelling of the heart. There are two components to 
structural remodelling, the fibrotic and electrical component which both contribute to arrhythmias. 
Fibrosis, or the excess deposition of ECM leads to disruption of the three-dimensional network of 
electrically coupled cardiomyocytes (Miragoli, Gaudesius & Rohr, 2006; Gaudesius, Miragoli, 
Thomas, et al., 2003; Biernacka & Frangogiannis, 2011; Rohr, 2009; McAnulty, 2007; Camelliti, Borg 
& Kohl, 2005; O’Quinn, Palatinus, Harris, et al., 2011). These collagenous depositions separate 
bundles of cardiomyocytes, which reduces their electrical coupling and leads to disruption of 
synchronous electrical activation and leads to uneven conduction and even conduction block of 
electrical impulses. Heterogeneity in conduction around an area of fibrosis or conduction block can 
predispose to re-entry formation and therefore arrhythmias (Deb & Ubil, 2014). The other 
component of structural remodelling is related to cardiomyocyte electrophysiology and is a result of 
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changes in expression and function of ion channels, receptors and calcium handling proteins 
associated with excitation-contraction coupling, as well as modification in gap junction (GJ) function 
and location (Rohr, 2009). In addition, myofibroblasts are also capable of establishing heterocellular 
gap junctions with cardiomyocytes, which results in the modulation of cardiomyocyte 
electrophysiology and lead to development of arrhythmia in vitro (Miragoli, Salvarani & Rohr, 2007, 
Miragoli, Gaudesius & Rohr, 2006, Gaudesius et al., 2003). 
 
 
 
 
 
1.7.2 CARDIOMYOCYTE –  (MYO)FIBROBLAST INTERACTIONS 
 
 
Healthy adult cardiomyocytes are coupled end to end at the intercalated discs by gap junctions 
(GJ) (Rhett & Gourdie, 2012). This direct coupling allows for the conduction of action potentials 
between cells, propagating through the tissue and therefore ensures rhythmic contraction of the 
heart. In diseased hearts adverse remodelling of gap junctions occur. Especially in the border zone 
surrounding the scar where there is a loss of gap junctions at the intercalated discs and increased 
expression of the gap junctional protein connexin43 (Cx43) at the lateral domains of the sarcolemma 
(O’Quinn, Palatinus, Harris, et al., 2011). In vitro studies are often carried out using rat neonatal 
cardiomyocytes (CM) and myofibroblasts (MFB) (Miragoli, Gaudesius & Rohr, 2006; Miragoli, 
Salvarani & Rohr, 2007; Gaudesius, Miragoli, Thomas, et al., 2003). These studies have shown that 
fibroblasts sporadically interspersed between cardiomyocytes synchronized spontaneous 
contractions of cardiomyocytes, but that high infiltration of fibroblasts can lead to conduction 
slowing due to relative cardiomyocyte membrane potential depolarisation (Hyde, Blondel, Matter, et 
al., 1969; Miragoli, Gaudesius & Rohr, 2006; Rohr, 2009). This is due to heterocellular gap junctions 
formed between cardiomyocytes and myofibroblasts (Rohr, 2009; Miragoli, Gaudesius & Rohr,  
2006). 
 
Myofibroblasts were found to express two type of connexions, Cx43 and Cx45, with which they 
can establish contacts between myofibroblasts and with cardiomyocytes (Miragoli, Gaudesius & 
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Rohr, 2006; Rohr, 2009; Li, Sun, Chen, et al., 2009). These homo- or heterocellular contacts between 
cardiomyocytes and myofibroblasts consist of gap junctions which are aggregates of two connected 
hexamers of connexins (Cx43, Cx45 or Cx40) called hemichannels which together form an intercellar 
connexon channel through which signals are propagated between the two connected cells (Rhett & 
Gourdie, 2012). The most common connexin expressed in the heart is Cx43, although Cx40 and Cx45 
are also expressed during development and in specific tissues (the atria, AV node). There are a 
number of other proteins also associated with Cx43 which help regulate gap junction size and Cx43 
channel formation. Cx43 hemichannels are recruited from the edge of the GJ which is called the 
perinexus to form new channels (Gaietta, Deerinck, Adams, et al., 2002; Rhett & Gourdie, 2012). One 
of the associated regulatory proteins is the membrane associated guanylate kinase (MAGUK) 
scaffolding protein Zonula occludens-1 (ZO-1). ZO-1 colocalises with Cx43 preferentially in the 
perinexus and regulates GJ size by interacting with Cx43 (Rhett, Jourdan & Gourdie, 2011; Rhett & 
Gourdie, 2012). ZO-1 is part of the MAGUK family of adaptor proteins which are regulators of 
channel properties, including clustering and trafficking of channels and signalling properties. ZO-1 
and other MAGUKs have an amino-terminal protein-protein binding domain which is called Post- 
synaptic-density/Disks-large/ZO-1 or PDZ domain, for the MAGUKs that have one or more of these 
motifs in their sequence. A complementary 4 amino acid (AA) PDZ-binding domain sequence was 
found at the carboxyl terminus (CT) of Cx43, although for stable binding the last 19 AAs of Cx43 are 
needed (Sorgen, Duffy, Sahoo, et al., 2004; Rhett & Gourdie, 2012). Modulation of Cx43 by ZO-1 
leads to changes in GJs and therefore can lead to changes in interaction between cardiomyocytes 
and fibroblasts. This may lead to modification of electrical conduction and cardiomyocyte 
electrophysiology. 
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The exact mechanisms through which bile acids induce arrhythmias in the fetal heart remain 
unclear although cardiomyocyte studies have shown that bile acids can affect the heart in these 
models. Previous studies demonstrated that the bile acid TC can alter the rate and rhythm of 
cardiomyocyte contraction in both single cells and in a monolayer, as well as causing abnormal Ca2+ 
dynamics of single cells (Gorelik et al., 2002, Williamson et al., 2001). Miragoli et al. (2011) 
subsequently showed that TC induces arrhythmia in a heterocellular fetal heart model consisting of a 
monolayer of rat neonatal cardiomyocytes coated with a layer of myofibroblasts (Miragoli, Kadir, 
Sheppard, et al., 2011). The main characteristics of arrhythmia induced by TC were a reduction of 
the contraction rate, decreased amplitude of contraction, calcium overload, irregularity of 
contraction within a beating cell and desynchronization of a network of cardiomyocytes. 
 
Rainer et al. (2013) showed that bile acids, especially TC can also induce arrhythmias in adult 
myocardium, while UDCA does not induce arrhythmias (Rainer, Primessnig, Harenkamp, et  al., 
2013). High concentrations of TC, associated with cholestasis, can lead to arrhythmias in human 
adult atria. In addition, patients with atrial fibrillation have lower levels of UDCA conjugates and 
higher levels of other bile acids (Rainer, Primessnig, Harenkamp, et al., 2013). 
 
Taken together with the data from neonatal rat models of ICP, this indicates that high levels of 
arrhythmogenic bile acids and low levels of the protective UDCA may lead to an environment that 
increases the risk of arrhythmic events (Rainer, Primessnig, Harenkamp, et al., 2013). 
 
Current treatment of ICP includes the use of UDCA to reduce the maternal symptoms by lowering 
maternal serum bile acid concentration and reducing pruritus. Geenes et al. (2014) showed that 
UDCA treatment of ICP pregnancies led to reduced total serum bile acid levels in both the maternal 
blood and fetal cord blood samples (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). UDCA also 
normalised the bile acid pool to profiles similar to control pregnancies and although bile acid   levels 
1.8 EFFECT OF BILE ACIDS ON THE HEART AND THERAPEUTIC   ASPECTS 
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remained relatively high in cord samples compared to control pregnancies, UDCA did improve the 
maternal-to-fetal bile acid gradient (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). 
 
The effects of UDCA on the fetus are still under investigation. Geenes et al. (2014) showed that 
UDCA crosses the placenta and potentially into the fetal compartment, as in UDCA treated ICP 
pregnancies 0.6 – 2.60 µmol/L UDCA was measured in cord blood samples (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014). 
 
Miragoli et al. (2011) showed that UDCA can also protect against the arrhythmic properties of TC 
in a model of the fetal heart using rat neonatal cardiomyocytes (CMs) and myofibroblasts (MFBs), if 
incubated simultaneously with TC. The study found that co-incubation of UDCA with TC abolishes  
the arrhythmic effect of TC in a rat model of the fetal heart (Miragoli et al., 2011). Conduction 
velocity was shown to be increased upon treatment with UDCA in a rat model of the fetal heart 
(neonatal rat CMs and MFBs), but did not change in a rat model of the maternal heart (CMs only). 
This is thought to occur through hyperpolarisation of the membrane potential in myofibroblasts, 
which allows for better signal conduction between cardiomyocytes, as it was shown that 
myofibroblast infiltration interferes with conduction velocity in a monolayer of cardiomyocytes with 
myofibroblasts seeded on top (Gaudesius, Miragoli, Thomas, et al., 2003; Miragoli, Gaudesius & 
Rohr, 2006; Miragoli, Kadir, Sheppard, et al., 2011). This indicates that myofibroblasts may be 
involved in fetal ICP-induced arrhythmia and sudden fetal death and that the protection by UDCA is 
through myofibroblast membrane potential modulation. UDCA causes hyperpolarisation in 
myofibroblasts, possibly through an increase in potassium conductance, via direct binding of UDCA  
to sulfonylurea receptor expressed on myofibroblasts (Miragoli et al., 2011, Benamer et al., 2009). 
These receptors are associated with modulation of potassium conductance. 
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1.8.1 ATP-SENSITIVE POTASSIUM CHANNELS 
 
 
A number of ion channels and currents have been described in populations of fibroblasts and 
myofibroblasts (Li, Sun, Chen, et al., 2009; Benamer, Maati, Demolombe, et al., 2009; Vasquez, 
Benamer & Morley, 2011). Li et al. (2009) did a large study into the presence of different ion  
currents and expression levels of ion channels in populations of human cardiac fibroblasts and 
compared these with cardiomyocytes (Li, Sun, Chen, et al., 2009), although in this study they did not 
differentiate between fibroblast populations. They found a number of sodium (INa), calcium (BKCa), 
chloride (ICl,vol) and potassium (IKir, IKdr, Ito) currents and expression of associated ion channels. They 
also found differences in distribution and properties of these channels in fibroblasts when compared 
to cardiomyocytes (Li, Sun, Chen, et al., 2009). Other studies described multiple potassium currents 
in rat ventricular fibroblasts, including an inward rectifier (IKir) and delayed rectifier (IKdr) potassium 
current (Li, Sun, Chen, et al., 2009; Benamer, Maati, Demolombe, et al., 2009). 
 
A recent study has demonstrated that the membrane potential of isolated fibroblasts can be 
regulated by K+ current (Chilton, Ohya, Freed, et al., 2005; Shibukawa, Chilton, Maccannell, et al., 
2005). One of the mediators of the inward rectifying current is the ATP-sensitive inward rectifying 
potassium channel (KATP channel). KATP channels are well established pharmacological targets that 
control cellular energy production through alteration of electrical properties of the membrane of the 
cell. KATP channels consist of a hetero-octamer of different combinations of the pore-forming and 
regulatory subunits [Figure 1.5]. The pore-forming subunit consists of potassium inward-rectifying 
channel subtype Kir6.x (either Kir6.1 or Kir6.2), which consists of two transmembrane domains (M1 
and M2) and cytoplasmic amino-terminal (NT) and C-terminal (CT) domains, which together form an 
interface for ATP to bind (Hund & Mohler, 2011). The regulatory subunit is comprised of sulfonylurea 
receptors (SUR1, SUR2A or SUR2B), which are members of the ATP-binding cassette membrane 
protein family (Hund & Mohler, 2011). SURs consist of three transmembrane domains (TMD0, TMD1 
and TMD2), of which TMD0 and a cytoplasmic linker (L0) interact with Kir6.x. In addition two 
nucleotide   binding   folds   (NBF1   and   NBF2)   contain   binding   sites   for  magnesium-adenosine 
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nucleotides (Mg2+ADP/ATP) (Hund & Mohler, 2011; Seino & Miki, 2003). Different combinations of 
these subunits lead to distinct pharmacological and electrophysiological properties of the channel 
(Benamer, Maati, Demolombe, et al., 2009; Hund & Mohler, 2011; Benamer, Vasquez, Mahoney, et 
al., 2013). KATP channels can be activated by KATP channel openers pinacidil, P1075, diazoxide and 
nicorandil. Pinacidil is indicated in the management of hypertension, as it induces vasorelaxation 
(Lange, Löffler-Walz, Englert, et al., 2002). Pinacidil and P1075 act on the sulphonylurea receptor 
subunits (SUR) of the KATP channel, which enhances the ability of SURs to bind and hydrolyse MgATP. 
KATP channels are inhibited by intracellular ATP as well as the sulfonylurea drugs glibenclamide and 
tolbutamide (Hund & Mohler, 2011; Benamer, Maati, Demolombe, et al., 2009; Benamer, Vasquez, 
Mahoney, et al., 2013; Lange, Löffler-Walz, Englert, et al., 2002). KATP channel activity is also  
regulated by other factors including phospholipids, pH, the cytoskeleton and phosphorylation by 
protein kinases A (PKA) and C (PKC) (Hund & Mohler, 2011). 
 
KATP channels are important sensors of cellular metabolic state, changes that lead to modulation 
of electrophysiological functions, such as membrane excitability, resting membrane potential and 
action potential. KATP channel activity is regulated by intracellular nucleotides (Hund & Mohler, 2011; 
Seino & Miki, 2003; Benamer, Maati, Demolombe, et al., 2009). Under normal physiological 
circumstances glucose metabolism leads to sufficient cytoplasmic levels of ATP. ATP, in the absence 
of Mg2+, binds to its binding pocket at the interface of the NT and CT of the Kir6.x subunit and inhibits 
the opening of the channel (Benamer, Maati, Demolombe, et al., 2009; Hund & Mohler, 2011; 
Benamer, Vasquez, Mahoney, et al., 2013). As the Kir6.x pore is a tetrameric structure, each KATP 
channel has 4 regulatory sites. SURx on the other hand is activated by both Mg2+ADP and Mg2+ATP, 
which activates the channel and decreases the IC50 of ATP binding to the Kir6.x subunits and the 
regulation of KATP channel drug sensitivity (Hund & Mohler, 2011). Various factors, such as exercise, 
increased cardiac work load, hypoxia, ischemia or cardiac disease can lead to changes in cardiac 
metabolism, causing the intracellular ADP levels to rise and the ATP/ADP ratio to decrease. The 
decreased level of ATP leads to the activation of the KATP  channel and efflux of potassium ions.   This 
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leads to membrane hyperpolarisation, action potential shortening and suppression of electrical 
activity in order to preserve energy (Benamer, Maati, Demolombe, et al., 2009; Hund & Mohler, 
2011; Benamer, Vasquez, Mahoney, et al., 2013). 
 
Expression levels of KATP channel subunits in fibroblasts and myofibroblasts in healthy and 
infarcted hearts were characterised by Benamer et al. (Benamer, Maati, Demolombe, et al., 2009; 
Benamer, Vasquez, Mahoney, et al., 2013). They showed that Kir6.1 and SUR2 were the most 
abundantly expressed in fibroblasts and their expression increased over time in culture, potentially 
due to the differentiation of fibroblasts into myofibroblasts (Benamer, Maati, Demolombe, et al., 
2009). 
 
Changes in expression level and increased activation of fibroblasts KATP channels in infarcted 
hearts, especially in the scar and border zone, may play an important role in cardiomyocyte 
physiology (Benamer, Vasquez, Mahoney, et al., 2013). Fibroblasts and myofibroblasts are relatively 
depolarised, i.e. have a less negative membrane potential, compared to cardiomyocytes. When 
coupled to cardiomyocytes, these cells have a depolarising effect on resting membrane potential of 
cardiomyocytes, which can lead to partial sodium channel inactivation and increased chances of 
early afterdepolarisations (EAD) (Benamer, Vasquez, Mahoney, et al., 2013; Nguyen, Xie, Garfinkel, 
et al., 2012). In their study, Benamer et al. (2013) showed that in fibroblasts from normal hearts or 
the remote regions, away from the scar, in infarcted heart KATP currents were not present, but 
functional KATP channels were expressed in the scar and border zone region of the infarct (Benamer, 
Vasquez, Mahoney, et al., 2013). Activation of KATP channels, by for example pinacidil leads to KATP 
channel opening causing potassium efflux, which in turn hyperpolarizes the cell membrane (Lange, 
Löffler-Walz, Englert, et al., 2002). It is thought that activation of fibroblast KATP current would  
reduce the depolarizing effect on coupled cardiomyocytes, which would subsequently prevent early 
after depolarisations. Therefore this may lead to modulation of cardiomyocyte electrophysiological 
characteristics, including repolarisation properties and excitability and therefore can modulate 
conduction velocity and arrhythmogenic substrates in the scar tissue. 
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FIGURE 1.5. STRUCTURE OF AN ATP-SENSITIVE POTASSIUM  CHANNEL 
 
 
ATP-sensitive potassium channel (KATp channel) consists of a hetero-octameric structure of two 
subunits. The pore is formed by 4 potassium inward-rectifying channel 6.1 or 6.2 subunits (Kir6.x), 
and the mantle is formed by 4 sulfonylurea receptors, SUR1, SUR2A or SUR2B (SURx). 
a. The membrane structure of the KATp channel subunits Kir6.x and SURx. The Kir6.x proteins have 2 
transmembrane domains. The SURx proteins have 3 transmembrane domains (TMD0, TMD1 and 
TMD2) consisting of 5, 5, 6 membrane spanning regions respectively as well as two nucleotide 
binding folds (NBF1/2). TMD0 is thought to interact with the Kir6.x subunits. 
b. The assembled channel structure. The inner pore formed by the Kir6.1 or Kir 6.2 and the outer 
regulatory mantle formed by SUR1 or SUR2A/B. 
Adapted from: (Seino & Miki, 2003; Hund & Mohler, 2011). 
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1.9.1 EARLY DEVELOPMENT OF THE FEMALE REPRODUCTIVE  TRACT 
 
 
The uterus, including the myometrium also develops from the mesoderm. The myometrium is the 
contracting muscle of the uterus. Rhythmic contractions of the myometrium at term lead to the 
expulsion of the fetus from the uterus. Development of the uterus and the myometrium begins early 
on in fetal life and continues when the fetus is born, only reaching maturity during puberty. From  
the time of puberty, the uterus goes through a monthly renewal cycle, the menstrual cycle, which 
prepares the uterus for implantation in case an egg is fertilised. 
 
In mammals, the urogenital system is derived from the intermediate mesoderm. The female 
reproductive tract (FRT), which includes the oviduct, uterus, cervix and vagina, develops from the 
paramesonephric or Müllerian duct. The human genital tract develops undifferentiated up to the 9th 
week of gestation (around day E9 in mouse development), with both the mesonephric (also known  
as Wolffian) and paramesonephric ducts developing in parallel (Yin & Ma, 2005; Sajjad, 2010; Kurita, 
2011). Subsequently only one of these develops into either the FRT or male genitals depending on 
the presence of a Y chromosome or an additional X chromosome (Yin & Ma, 2005; Sajjad, 2010; 
Kurita, 2011). A number of genes have been described that are necessary for the correct 
development of the FRT (Yin & Ma, 2005; Miller & Sassoon, 1998; Sassoon, 1999; Baker, Hardy,  
Zhou, et al., 1996). 
 
The Wnt family of genes are homologues to the Drosophilla gene Wingless and are necessary in 
many developmental processes including FRT development (Yin & Ma, 2005; Miller & Sassoon, 1998; 
Sassoon, 1999). Three members of the Wnt family, Wnt4, Wnt5a and Wnt7 are all highly expressed 
during the early development of the FRT as well as in adults (Sassoon, 1999). Wnt4 null females have 
no FRT due to the lack of paramesonephric duct formation, indicating that Wnt4 is essential for 
initiation of FRT formation (Yin & Ma, 2005; Miller & Sassoon, 1998; Sassoon, 1999). Later on in 
development, Wnt7a  expression is  essential  in  the  differentiation of  different organs  of  the FRT. 
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Wnt7a deficiency leads to abnormal uterus morphology and absence of the oviducts (Yin & Ma, 
2005; Miller & Sassoon, 1998; Sassoon, 1999). Further analysis showed that there was reduced 
expression of Hoxa10 and Hoxa11, indicating that Wnt7a is essential in maintaining uterine 
expression of these genes, which are both essential for the correct development of the uterus (Yin & 
Ma, 2005). Wnt7a is also implicated in radial axial patterning of the myometrium, as this is highly 
disorganized in Wnt7a deficient females compared to wild type (Yin & Ma, 2005; Miller & Sassoon, 
1998; Sassoon, 1999). There is an increase in the amount and thickness of the myometrium in these 
mice, which is exacerbated with age (Sassoon, 1999). Wnt5a is also essential in uterine 
development, as Wnt5a null females have coiled and shortened uteri compared to wild type animals 
(Sassoon, 1999; Yin & Ma, 2005; Curtis, Clark, Myers, et al., 1999; Lubahn, Moyer, Golding, et al., 
1993; Miller & Sassoon, 1998). Wnt family members can signal through canonical and noncanonical 
signalling pathways. In the developing uterus Wnt7a can activate the canonical β-catenin pathway 
(Xavier & Allard, 2003; Arango, Szotek, Manganaro, et al., 2005). Arango et al. (2005) showed that in 
the absence of β-catenin, the myometrium is progressively replaced by adipocytes. This is thought to 
be due to changes in the myogenic precursor cells that prevent correct commitment to myometrial 
smooth muscle cells, which then differentiate into adipocytes instead. This phenotypic switch from 
myometrial smooth muscle cells to adipocytes may be due to perturbation of the Wnt signalling 
pathway or due to the disruption of cell-to-cell junctions (Arango, Szotek, Manganaro, et al., 2005). 
β-catenin is essential for the formation of adherens junctions, linking cadherins to the cytoskeleton 
(Arango, Szotek, Manganaro, et al., 2005; Nelson & Nusse, 2004). Loss of β-catenin may lead to Rho- 
GTPase activity and activation of adipocyte specific promotors leading to formation of adipocytes 
(Charrasse, Meriane, Comunale, et al., 2002; Arango, Szotek, Manganaro, et al., 2005). 
 
IGF1 and several IGF-binding proteins have been characterised in the developing rodent uterus 
(Yin & Ma, 2005; Baker, Hardy, Zhou, et al., 1996). These proteins have multifunctional roles in the 
regulation  of  numerous  biological  processes  (Yin  &  Ma,  2005).  IGF1  loss  in  mice  leads  to    an 
Page | 64  
underdeveloped uterine phenotype, indicating that it plays a critical role in the growth and 
differentiation of the developing uterus (Yin & Ma, 2005). 
 
Abnormal exposure to hormones during neonatal uterine development can lead to abnormalities 
in uterine adenogenesis, or in the process of endometrial gland development (Yin & Ma, 2005). Early 
neonatal exposure to progestin leads to complete abolishment of uterine adenogenesis, which is 
thought to be due to suppression of Estrogen receptor-α (ERα) expression (Gray, Bartol, Tarleton, et 
al., 2001; Yin & Ma, 2005). ERα null mice females develop a reduced number of endometrial glands, 
indicating that ERα is most likely involved in gland differentiation, rather than initiation (Yin & Ma, 
2005; Curtis, Clark, Myers, et al., 1999; Lubahn, Moyer, Golding, et al., 1993). 
 
 
 
 
 
1.9.2 PREGNANCY RELATED UTERINE CHANGES 
 
 
During pregnancy many physiological and biochemical changes occur in the uterus. The process 
leading to the delivery of the fetus from the uterus, or parturition, is a result of a complex interplay 
between maternal and fetal factors. During early pregnancy the uterus grows to accommodate the 
growing fetus, whilst remaining quiescent to prevent miscarriage (Terzidou, 2009, 2007; Challis, 
Matthews, Gibb, et al., 2000). During late pregnancy further changes occur to prepare the uterus for 
labour. Labour occurs after activation of a number of proteins collectively known as contraction- 
associated proteins (CAPs). CAPs include cell signalling proteins, gap junctional proteins such  as 
Cx43, hormone receptors (Oxytocin and prostanoid receptors) and enzymes associated with 
prostaglandin synthesis (Terzidou, 2009, 2007; Challis, Matthews, Gibb, et al., 2000). Cell signalling 
proteins mediate the uterine response that lead to myometrial contractions after receptor activation 
by various labour inducing agents (Terzidou, 2009). 
 
Parturition can be divided into a number of phases. The first phase is the developing stage that 
allows  for  the  maintenance  of  pregnancy  by  uterine  quiescence.  A  critical  mediator  of uterine 
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quiescence is Progesterone. Progesterone allows for the embryo to be implanted by endometrial 
development during early gestation. Subsequently, it mediates pregnancy by promoting uterine 
quiescence by myometrial relaxation. Uterine quiescence is maintained via multiple signalling 
pathways that lead to increased concentrations of intracellular cAMP (cyclic adenosine 
monophosphate) or cGMP (cyclic guanosine monophosphate), which inhibit the release of 
intracellular calcium needed for the initiation of myometrial contractions (Terzidou, 2009, 2007). 
 
One mediator of uterine quiescence is Progesterone. This is produced by the corpus luteum in  
the first trimester of human pregnancy and after luteal regression the placenta takes over. In many 
mammals, including rodents, there is a drop in Progesterone levels at term which lead to the 
induction of labour. In human pregnancy the circulating levels of Progesterone remain high and 
labour is initiated by functional withdrawal of Progesterone by changes in myometrial  smooth 
muscle cell responsiveness to Progesterone (Tan, Yi, Rote, et al., 2012; Terzidou, 2009, 2007). 
Progesterone signalling through Progesterone receptor-B (PR-B) leads to increased expression of 
inhibitor-κBα (IκBα). IκBα in turn represses nuclear factor-κB transcription factor (NF-κB) function 
and inhibits basal and lipopolysaccharide-induced proinflammatory gene expression. At the onset of 
labour there is an increase in Progesterone receptor-A (PR-A). PR-A inhibits these anti-inflammatory 
effects of PR-B and induces expression of a number of proinflammatory genes including PTGS2, IL8, 
IL1A and PTX3 in response to Progesterone (Tan, Yi, Rote, et al., 2012; Terzidou, 2009, 2007). 
 
The next stage of parturition is the activation phase. Increasing levels of Estrogen and 
corticotrophin-releasing hormone (CRH) in conjunction with increasing mechanical stretch leads to 
the activation of the myometrium and the fetal membrane by upregulation of CAPs. The 
myometrium expresses CRH receptors which associate with cAMP based second messenger systems. 
CRH binding to CRHR1α leads to dissociation of the Gα subunit and increased levels of  cAMP 
inducing uterine relaxation. At term, changes in CRH receptor subtype leads to activation of the Gq 
pathway, protein kinase C activation and contractile pathways (Terzidou, 2009). In addition CRH 
induces  increased prostaglandin synthesis  and upregulation of  cyclo-oxygenase type-2  (COX2),    a 
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prostaglandin synthetic enzyme (Terzidou, 2009). This leads to the stimulation phase, which 
resembles an inflammatory response. During the third trimester CAPs are upregulated, whilst in the 
last two to three weeks before the onset of labour a number of inflammatory mediators such as 
cytokines, especially interleukins and prostaglandins become upregulated. These cytokines, Oxytocin 
and prostaglandins activate an inflammatory-like response and stimulate the uterus in preparation 
for labour (Terzidou, 2009, 2007). During the final phase, the uterus undergoes involution after the 
delivery of the fetus and the placenta due to removal of the hormonal and mechanical signals of 
pregnancy and labour as well as changes in hormone receptor subtypes (Terzidou, 2009). 
 
Myometrial tissue samples can only be obtained from caesarean sections, after consent is 
obtained. This shrinks the pool of available tissue, as usually only patients undergoing elective 
caesarean sections at term whilst not in labour can be consented beforehand. These are often 
patients with normal, uncomplicated pregnancies who have previously had a caesarean section or 
have one for breech presentation of the fetus. This makes obtaining tissue from other groups, such 
as preterm (non)-labour and term samples as well as samples from ICP pregnancies more difficult. 
ICP pregnancies are often actively managed to prevent adverse events and are often induced around 
week 37, or if there are concerns earlier. As these deliveries occur vaginally, or after induction as an 
emergency section, obtaining prior consent is difficult due to the urgency of delivery. It is therefore 
of use to develop other methods of obtaining myometrial smooth muscle cells. Part of this thesis 
explores the possibility of obtaining protocols of human ES or iPS cells that are differentiated into 
myometrial smooth muscle cells of different maturity, which could mimic different gestations. These 
cells could be useful mostly for drug studies, as they would not be in the mechanical and chemical 
environment of the tissue. But they could be used for toxicity or developmental drug studies into 
prevention of preterm labour induced by ICP or other mechanisms such as infection. 
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1.9.3 EFFECT OF BILE ACIDS ON THE   MYOMETRIUM 
 
 
Sheep studies have demonstrated that acute cholic acid administration leads to preterm delivery 
in around 20% of animals, whereas chronic intravenous administration of cholic acid to the fetal 
circulation resulted in preterm delivery in 100% of the animals (Campos, Guerra & Israel, 1986). This 
was achieved by placing plastic catheters in maternal and fetal vessels and in the amniotic cavity, 
after recovery either cholic acid (1.6 mumoles/min) or a 5% dextrose solution was infused (Campos, 
Guerra & Israel, 1986). There is an increased chance of spontaneous premature labour in ICP, but 
little is known about the effect of bile acids on the myometrium and whether any of the described in 
section 1.5.2 or other bile acid receptors influence the contractility of myometrial cells (Glantz, 
Marschall & Mattsson, 2004; Geenes, Lövgren-Sandblom, Benthin, et al., 2014; Geenes & 
Williamson, 2009). Labour results from the activation of CAPs which convert the myometrium from a 
quiescent to a contractile state. Previous studies by Germain et al. (2003) showed that bile acids 
increase the sensitivity of myometrial cells to Oxytocin by increasing expression and response of the 
Oxytocin receptor in myometrial cells. This led to a reduction in the Oxytocin level required to  
induce contraction in myometrial strips incubated in cholic acid in comparison to control strips 
(Germain et al., 2003). There is currently limited knowledge about the expression levels of bile acid 
associated nuclear receptors or GPCRs in the myometrium and whether these influence the timing  
of labour. 
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I hypothesise that raised serum bile acids in the mother and fetus can lead to abnormal 
contractions in the myometrial tissue of the uterus of the mother as well as in the fetal heart. This 
could potentially lead to preterm labour and fetal arrhythmias and fetal death. 
 
To investigate the causes of abnormal contractions this hypothesis was split into subhypotheses: 
 
 
I hypothesise that raised serum bile acids in the maternal and therefore fetal, circulation cause 
arrhythmia in the fetal heart which can lead to sudden intrauterine death of the fetus. I also 
hypothesise that fetal arrhythmia is due to the arrhythmic influence of bile acids on the transiently 
appearing fibroblasts in the fetal heart and that UDCA and its derivatives prevent arrhythmia  
through hyperpolarisation of the fibroblast membrane potential. 
 
I hypothesise that raised maternal serum bile acids lead to spontaneous premature labour 
through induction of contractions in the myometrium or by signalling via pathways that alter 
myometrial contractility. 
1.10 HYPOTHESES 
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1.10.1 AIMS 
 
 
This project consists of the following objectives: 
 
 
1. To investigate the effects of bile acids on the fetal heart using human and rat models and  
the effect of possible protective reagents such as UDCA and derivatives, including the 
chemically altered derivative of UDCA, NorUDCA. 
 
2. To further investigate the role of fibroblasts in UDCA protection and the mechanism of 
action of UDCA and channels involved. 
 
3. To investigate the interaction between cardiomyocytes and fibroblasts, whether functional 
contacts and gap junctions are formed between both cell types and the effect of Connexin43 
modulation and hypoxia on this contact. 
 
4. To investigate the effect of bile acids on myometrial contractility and to establish whether 
bile acid receptors are expressed in myometrium or whether bile acid effects on myometrial 
function are mediated through other labour associated proteins. 
 
5. To develop a model of myometrial smooth muscle cells differentiated from human iPS- 
derived Stem Cells and Embryonic Stem Cells, which can potentially be differentiated into 
different stages of pregnancy and/or labour. 
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CHAPTER 2: MATERIALS AND  METHODS 
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2.1.1 DRUGS 
 
Bile Acids  Concentration Stock solution Supplier 
Glycocholic acid GC 0.1 mM  Sigma 
Glycochenodeoxycholic acid GCDCA 0.1 mM  Sigma 
NorUrsodeoxycholic acid NorUDCA 10 nM - 0.1 mM 1 mM in DMSO Courtesy of Prof. Trauner 
Taurocholic acid TC 0.1 mM - 0.5 mM Sigma 
Taurochenodeoxycholic acid TCDCA 0.1 mM  Sigma 
Ursodeoxycholic acid UDCA 10 nM - 0.1 mM 1 mM in EtOH Sigma 
Other Drugs  Concentration Stock solution Supplier 
Interleukin 1β IL1β 1 ng/ mL 5 µg/mL  
Oxytocin [Syntho] OT 10 nM – 100 nM 10 µM  
Potassium Chloride KCl 60 mM 3 M VWR 
P1075*  10 µM 100 mM in EtOH Tocris 
Glibenclamide  5 µM 1 mM Sigma 
* N-cyano-N'-(1,1-dimethylpropyl)-N"-3-pyridylguanidine   
 
 
 
 
2.1.2 IMMUNOFLUORESCENCE MICROSCOPY 
 
Blocking Buffer (20 mL)  Final Concentration Supplier 
BSA 1 g 5% Fisher 
Tween-20 50 µL 0.05% Sigma 
Horse Serum 4 mL 20% Invitrogen 
1xPBS 16 L   
 
 
10x PBS (1 L) – pH 7.4  Final Concentration Supplier 
Sodium Chloride NaCl 136.9 mM 80 g Sigma 
Potassium Chloride KCl 26.8 mM 2 g Sigma 
Potassium Phosphate KH2PO4 – pH 7.2 17.63 mM 2.4 g Sigma 
Sodium Phosphate 
ddH2O 
Na2HPO4 – pH 7.2 10 mM 14.4 g 
1 L 
Sigma 
1x PBS (500 mL)    
10x PBS  50 mL  
ddH2O  450 mL  
    
2.1.3 QRT-PCR    
 
SybrGreen MasterMix Sigma 
Primers Invitrogen, Sigma 
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2.1.4 SDS GEL AND WESTERN BLOTTING SOLUTIONS 
REAGENTS 
PageRuler Prestained Protein Ladder; range of 10 – 170 kDa Thermo Fisher Scientific 
Immobilon-P Transfer membranes Millipore 
 
 
10% Gel x2  Resolving Stacking Supplier 
dH2O  7.9 mL 4.3 mL  
30% Acrylamide mix  6.7 mL 1.3 mL Sigma 
1.5 M Tris  pH 8.8  5 mL -  
0.5 M Tris  pH 6.8  - 2 mL  
10% SDS  200 µL 40 µL Fisher 
10% Ammonium Per Sulfate [APS]  200 µL 80 µL  
N,N,N′,N′-Tetramethylethylenediamine [TEMED] 8 µL 8 µL Sigma 
3x Loading dye Stock Solution   Supplier 
dH2O  3 mL   
10% SDS 10% 3 mL  Fisher 
Glycerol  3 mL  Sigma 
DTT 2 M 50 µL  BDH 
Brilliant Blue G 5% Until Blue  
 
 
BUFFERS 
 
10x SDS Page Buffer (2 L)   Final Concentration Supplier 
TrisBase  60.6 g  Sigma 
Glycine  288.4 g  Sigma 
SDS 20% 100 mL 1% Fisher 
dH2O  2 L   
1x SDS Page Buffer (1 L)     
SDS Buffer 10x 100 mL 1x  
dH2O  900 mL   
 
10x Transfer Buffer (1 L) 
   
Final Concentration 
 
Supplier 
TrisBase  30.27 g 0.25 M Sigma 
Glycine  144.0 g 1.92 M Sigma 
dH2O  1 L   
1x Transfer Buffer (2 L)     
Methanol  400 mL  Fisher 
TB 10x 200 mL 1x  
dH2O  1400 mL   
Precool before use 
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10x TBS-T (1 L) - pH 7.6   Final Concentration Supplier 
TrisBase  24.2 g 200 mM Sigma 
Sodium Chloride NaCl 80 g 1.36 M Sigma 
dH2O  1 L   
 
1x TBS-T (1L) 
    
TBS-T 10x 100 mL 1x  
dH2O  900 mL   
5% Milk     
TBS-T 1x 50 mL   
Skim milk powder  2.5 g 5% Fluka 
1% Milk     
5% Milk  10 mL   
TBS-T  40 mL   
 
 
 
 
2.1.5 KITS 
 
RNeasy Mini Kit  + RNase-Free DNase set Qiagen 
Advantage RT-for-PCR Kit Clontech Laboratories 
Neonatal Heart Dissociation Kit for rat Miltenyi Biotec. 
BCA Protein Assay Kit Pierce, ThermoScientific 
 
 
 
2.1.6 SOFTWARE 
 
Ariadne Plasticell 
BV_Analyse version 11.08 Scimedia USA Ltd., USA 
CellTrack 1.1 Open Source software from Ohio State University1 
Clampex v8 and 10 Molecular Devices, USA 
COPAS software Union Biometrica 
FACSDIVA software BD Biosciences 
FIJI Vale Lab 
Graphpad Prism v5.0 Graphpad Software Inc. 
MiCAM ULTIMA Acquisition Software Scimedia USA Ltd., USA 
Matlab vR2014 Mathworks 
PowerLab Chart 5 software ADInstruments Ltd., Oxfordshire, UK 
SDS 2.4 Applied Biosystems, Life Technologies 
1(Sacan, Ferhatosmanoglu & Coskun, 2008) 
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2.2.1 ISOLATION AND CELL CULTURE REAGENTS 
NEONATAL AND FETAL CULTURES (RAT, MOUSE,  HUMAN) 
 
 
 
 
 
 
 
 
 
 
SOLUTIONS FOR ADULT HUMAN AND RAT CARDIOMYOCYTE AND FIBROBLAST   ISOLATION 
 
Enzyme free solutions as below, without NTA and an addition of 7.5 µL CaCl2 / L as needed 
 
Low calcium solutions 
Human 
 
Final Concentration 
 
Supplier 
Glucose  20 mM Sigma 
Magnesium Sulfate MgSO4 5 mM BDH-GPR 
Pyruvate  5 mM Sigma 
Potassium Chloride KCl 5.4 mM Sigma 
Sodium Chloride NaCl 120 mM BDH-AnalaR 
Taurine  20 mM Sigma 
2[4-(2-hydroxyethyl)-1-piperazinyl]-ethane sulphonic acid HEPES 10 mM Sigma 
Nitrilotriacetic acid NTA 5 mM  
ddH2O  1 l  
Additional for Rat:    
Calcium Chloride CaCl2 12-14 µM  
 
 
 
 
ADULT HUMAN AND RAT CARDIOMYOCYTE  CULTURES 
 
 
Adult Cell culture medium Final Concentration Supplier 
Medium 199 + Phenol Red  500 mL Invitrogen 
Bovine Serum Albumin  1 g  
Taurine  0.331 g  
Penicillin / Streptomycin (Pen/Strep) 1% 5 mL  
Creatine  0.33 g  
Carnitine  0.161 g  
Ascorbic Acid 1% 0.5 mL Sigma 
2.2 MATERIALS FOR THE INVESTIGATION OF THE FETAL AND ADULT   HEART 
Cell Culture Medium 10% and 5% Final Concentration  Supplier 
Medium 199 + HBSS + Phenol Red    
Neonatal Calf Serum [NCS] 10% or 5% 10 or 5 mL Sigma 
L-Gutamine 1% 0.5 mL Sigma 
Penicillin / Streptomycin (Pen/Strep) 0.5% 0.5 mL PAA 
Vitamin B12 1% 0.5 mL Sigma 
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HUMAN ADULT AND ADULT RAT  FIBROBLASTS 
 
Cell Culture Medium – For Culture Final Concentration Supplier 
Dulbecco's Eagle Medium [DMEM] + Glutamax  40 mL Invitrogen 
Fetal Calf Serum [FCS] 20% 9 mL Sigma 
L-Glutamine 1% 0.5 mL Sigma 
AB/AM 1% 0.5 mL Sigma 
0.25% Trypsin-EDTA Invitrogen   
Dulbecco’s Phosphate Buffered Saline [D-PBS] Invitrogen   
 
 
OTHER CULTURE REAGENTS 
 
Cell culture Reagents Supplier 
(-) Epinephrine Sigma 
5-bromo-2’-deoxyuridine (BrdU) Sigma 
Ascorbic acid (Vitamin C) – Cell Culture Tested Sigma 
Collagen VI (from human placenta) Sigma 
L-Glutamine PAA 
Neonatal Calf Serum (NCS) PAA / Biosera 
Neonatal Heart Dissociation Kit for rat/mouse Miltenyi Biotec 
Pancreatin Sigma 
Penicillin / Streptomycin (Pen/Strep) PAA 
Trypsin 10x PAA 
Vitamin B12 Sigma 
Laminin I from mouse Trevigen 
Hank’s Balanced Salts Solution with Phenol Red [HBSS+] Gibco, Invitrogen 
Hank’s Balanced Salts Solution without Phenol Red [HBSS-] Gibco, Invitrogen 
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acid 
 
2.2.2 BUFFERS AND DYES 
 
 
BUFFER FOR SCANNING ION CONDUCTANCE  MICROSCOPY 
 
 
FRET buffer – 2 L  Final Concentration Supplier 
Sodium Chloride NaCL 16.83 g 144 mM Sigma 
Potassium Chloride KCl 0.746 g 5 mM Sigma 
Magnesium Chloride MgCL2 2 mL 1 mM Sigma 
2[4-(2-hydroxyethyl)-1-piperazinyl]-ethane sulphonic acid HEPES 4.76 g 10 mM VWR 
dH2O  2 L up to 2 L  
pH 7.4 (add 8 mL of 1M NaOH) 
 
 
 
 
IMPALEMENT 
 
 
External solution – HBSS- 2x  500 mL [as above] Final Concentration Supplier 
HBSS -  500 mL Invitrogen 
Neonatal Calf Serum [NCS] 1% 5 mL PAA 
Internal solution Supplier   
3 M KCl VWR   
 
 
OPTICAL RECORDING 
 
HBSS – (1 L) – non sterile  Final Concentration Supplier 
Hanks Balanced Salts (Powder) without phenol red HBS - 9.7 g Sigma 
Sodium Bicarbonate 
2[4-(2-hydroxyethyl)-1-piperazinyl]-ethane sulphonic 
NaHCO3 4.16 mM 0.35 g Sigma 
HEPES 10 mM 2.38 g VWR 
dH2O 1 L up to 1 L 
 
pH to 7.4, osmolity 290-320 
 
Fluorescence Dyes Supplier 
Bis – (1,3 – dibutylbarbituric acid)trimethine oxonol [DiBAC4(3)] Biotium 
Di-8-Anepps VWR, Enzo Life Sciences 
Fluo4 acetoxymethyester [Fluo4AM] Invitrogen 
Vybrant DiI Invitrogen 
Wheat Germ Agglutinin-Alexa Fluor488 conjugated [WGA-488] Invitrogen 
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2.3.1 CELL CULTURE MEDIA 
HUMAN MYOMETRIAL CULTURES 
 
 
 
 
 
 
 
Cell Culture Medium – For Culture Final Concentration Supplier 
Dulbecco's Eagle Medium [DMEM] + Glutamax + Phenol Red 500 mL Invitrogen 
Fetal Calf Serum [FCS] or [DCC-FCS] 10% 50 mL Sigma 
Antibiotic/Antimycotic (AB/AM) 1% 5 mL Sigma 
Cell Culture Medium – For treatment Final Concentration Supplier 
Dulbecco's Eagle Medium [DMEM] - Phenol Red 500 mL Sigma 
DCC - Fetal Calf Serum [DCC-FCS] 1% 5 mL Sigma 
Antibiotic/Antimycotic (AB/AM) 1% 5 mL Sigma 
L-Glutamine 1% 5 mL Invitrogen 
Dextran coated Charcoal stripped serum [DCC-FCS]   
Fetal Calf Serum [FCS] 500 mL Sigma 
Charcoal, activated 208.16 mM 1.25 g Sigma 
Dextran T70 0.25 g/L 0.125 g Pharmacia 
0.25% Trypsin-EDTA Invitrogen   
 
 
 
2.3.2 BUFFERS 
 
 
KREBS (1 L) – pH 7.4  Final Concentration Supplier 
D-Glucose  11.1 mM 2 g Sigma 
Magnesium Sulfate [Anhydrous] MgSO4 1.17 mM 0.141 g BDH-GPR 
Potassium Phosphate Monobasic KH2PO4 1.18 mM 0.16 g Sigma 
Potassium Chloride KCl 4.69 mM 0.35 g Sigma 
Sodium Chloride NaCl 118.1 mM 6.9 g BDH-AnalaR 
Calcium Chloride Dihydrate CaCl2·2H2O 2.53 mM 0.373 g Sigma 
Sodium Bicarbonate NaHCO3 25 mM 2.1 g Sigma 
ddH2O   1 L  
2.3 MATERIALS FOR THE INVESTIGATION OF THE  MYOMETRIUM 
Collagenase Solution (40 mL) Final Concentration Supplier 
Collagenase IA  0.01 g Sigma 
Collagenase XI  0.01 g Sigma 
Bovine Serum Albumin [BSA]  0.2 g Sigma 
Dulbecco's Eagle Medium [DMEM] 50% 20 mL Sigma 
Dulbecco's Eagle Medium Nutrient Mixture F12 Ham [DMEM-F12 Ham] 50% 20 mL Sigma 
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2.4.1 RNA ISOLATION AND QRT-PCR 
RNA ISOLATION 
 
Cells from experiments were frozen in 350 µL RLT buffer until RNA extraction according to the 
Qiagen RNAeasy protocol. Snap-frozen tissue samples were kept on dry ice and small pieces of tissue 
were transferred to plastic vials for homogenisation. The homogenizer was cleaned before and after 
use and in between sample homogenisation with dH2O and 70% ethanol (70% ethanol, 30% dH2O). 
350 µL RLT buffer (Qiagen) containing 10 µL β-merceptoethanol was added to the tissue pieces and 
the mixture was homogenised using the homogenizer. Debris was spun down using a centrifuge at 
low speed (<1000g) for 10 minutes. RNA was subsequently extracted using the  RNAeasy  protocol 
and diluted in DEPC-treated water (Qiagen). RNA content was measured using the Nanodrop 
ND1000. Measurements were taken using the RNA-40 setting after the system was blanked using 
DEPC-treated water. RNA was stored at -80°C. 
 
 
 
 
 
QRT-PCR 
 
 
cDNA was prepared using the Advantage RT-for-PCR protocol and kit (Clontech). The RNA was 
defrosted on ice and all subsequent preparations were carried out on ice. 0.5 µg of RNA was used for 
each reaction and made up to 6.25 µL with DEPC treated water before addition of 0.5 µL of random 
hexamer primer (Clontech). The mixture was heated for 2 minutes at 70°C and placed on ice. 3.25 µL 
Mastermix containing per reaction 2 µL Reaction Buffer, 0.5 µL dNTP Mix [10 mM each], 0.25 µL 
recombinant RNase Inhibitor and 0.5 µL MMLV Reverse transcriptase was added, the contents mixed 
and incubated at 42°C for 1h, followed by 5 minutes at 95°C. 40 µL of DEPC treated water was  
added, to a final volume of 50 µL and the tubes were stored at -20°C until needed. 
2.4 METHODS 
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All qRT-PCR reactions were carried out in triplicate (samples) or duplicate (no template control). 
Each reaction consisted of 1 µL cDNA, 4 µL of 2x Sybrgreen Mastermix (Sigma), 0.16 µL forward and 
reverse primers to a final concentration of 0.2 µM of each primer, made up to 8 µL total volume with 
DEPC water. All primer sequences are described in Table 2.1. The qPCR experiments were carried out 
in a 384 well plate setup (ABI Prism, Applied Biosystems). An ABI 7900HT real time PCR machine was 
used, cycling as follows: at 95°C for 10 minutes and then 40 cycles of 95°C for 15s and 60°C for 30- 
60s. The data was then saved and analysed using the SDS 2.4 program. 
 
 
 
 
 
 
TABLE 2.1. PRIMER SEQUENCES 
 
 
Target name Forward Sequence Reverse Sequence 
hL19 CCAACTCCCGTCAGCAGATC CAGGTGTTTTTCCGGCATC 
hFXR AGGATTTCAGACTTTGGACCATGA TGCCCAGACGGAAGTTTCTTATT 
hLXRα GACACCTACATGCGTCGCAA TGTTCTTCTGACAGGACACACTCC 
hLXRβ CAAGAGGCCGCAGGACCAGC ACAGAGCTCAGCGTGCGCAG 
hPPARα TACAGACCAGTAGCTTGGAG ATTTCTTGCAGGAACTCTTCAG 
hPPARγ TCCATTCACAAGAACAGATCCAG CACTTTGATTGCACTTTGGTACTC 
hPXR ATCATGGCTATGCTCACCGAG CCTGTGATGCCGAACAACTC 
hVDR GCCCACCATAAGACCTACGA ACTTGACTTCAGCAGTACGA 
hCAR AGAGCTGATCCGGACACTCCT GGAGGCCTAAACTGCACAAACT 
hCHRM1 CGTCCGGGACTTTTAGCCTT TTCACCAGGGCACCCAATTT 
hCHRM2 CCATACAATGTCATGGTGCTC GATGTAACAAAGCCAGTAACCA 
hCHRM3 AGCGCCTTCTCTCTGCTTTT GCCCTTTTCCCTCTGTCTCC 
hCHRM4 GTACATCATCAAGGGCTACTGG GATGAGAAGGTTCATGACGGAG 
hCHRM5 CCAAACTACCTTCTGTCTCCA TTACCACCAATCGGAATTATAGG 
hTGR5 GCTTCTTCCTGAGCCTACTG GAGAGGAAGGAGAAGTTGGG 
hOTR GATGGGAAGGGTGGT CAAGGACCCCAGCATTTGTT 
hCOX2 TGTGCAACACTTGAGTGGCT ACTTTCTGTACTGCGGGTGG 
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2.4.2 PROTEIN ISOLATION AND WESTERN BLOTTING 
PROTEIN ISOLATION 
 
Cells were grown and treated as needed before washing in PBS and extraction using lysis buffer 
containing phosphatase and protease inhibitors. Cell lysates were sonicated and centrifuged at 10 
000 RPM for 10 minutes at 4°C to remove cell debris. Protein concentration was determined using 
the BCA protein assay kit [Pierce]. BSA standards were prepared ranging from 0 – 2000 µg/ml. The 
BCA reagents were prepared in a 50:1 ratio of reagent A and B. 100 µL of the mixture was added to 
each well in a 96 well plate, after which 12.5 µL of standards or samples was added in duplicate. 
Plates were incubated at 37°C for 30 minutes and the absorbance at 562 nm was measured. 
 
 
 
 
 
SDS PAGE AND WESTERN BLOTTING 
 
 
Gels were made between a spacer plate and cover plate by placing the plates in the holder after 
cleaning each plate with EtOH. The resolving gel was prepared for the number of gels as required. 
The Resolving gel mix was pipetted between the glass plates and allowed to set before the stacking 
gel was added. A 15 or 10 well comb was placed in the stacking gel and the wells were allowed to set 
before use. Gels were run in running buffer with 2 gels per tank. 20 to 50 µg protein was aliquoted 
and loading dye was added so that all wells would contain equal volumes. PageRuler plus ladders 
were run on either side with a stronger ladder in the first well (5 µL) and weaker in the last (2 µL). 
Gels were run at 90 V until the ladder started to resolve, when the voltage was increased to 130 V. 
The blue edge was allowed to run until the end of the plate. 
 
Protein was transferred to membranes (Millipore) using a wet transfer tank. One gel was 
transferred per holder, whereby gel and membrane were placed between filter paper and sponges.  
A holder containing ice was also added to cool the transfer. Transfers were allowed to run for 90 
min. 
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When the transfer was complete, membranes were removed and activated in Methanol before 
either being used or dried between filter paper before future use. 
 
Before blotting, membranes were activated by methanol. Membranes were washed and blocked 
in 5% milk for 1h, after which membranes were washed for 10 min, 5 min and 5 min. Membranes 
were incubated overnight in primary antibody [Table 2.2], washed as before and incubated for 2h in 
secondary antibody [Table 2.3]. Afterward the blots were visualized using the ECL system (Pierce, 
Thermo-Fisher). Blots were exposed to autoradiographic X-ray film as well as imaged on the 
Chemiluminescence imager (GE LAS4000; GE Healthcare) and bands were quantified with ImageJ 
software and normalised again GAPDH. 
 
 
 
 
 
2.4.3 IMMUNOFLUORESCENCE MICROSCOPY 
 
 
Cells were plated on glass coverslips as described previously and fixed either in 4% PFA for 20 
minutes or in ice-cold Methanol for 5 – 10 minutes in the freezer. Coverslips were subsequently 
washed and stored in PBS. Coverslips were transferred to the top row of a 6 well plate containing  
PBS as needed, blocked in Blocking Buffer for 30 – 60 minutes by inverting the coverslip (cells down) 
onto a small drop of Blocking Buffer on Parafilm. Primary antibodies were prepared in Blocking 
Buffer at dilutions according to Table 2.2, negative controls were incubated in Blocking Buffer. 
Coverslips were placed subsequently on a small drop of antibody and incubated either for 2h at RT  
or overnight at 4°C [Table 2.2]. Subsequently coverslips were washed 3x in 2 mL of PBS for 20 
minutes each time. In the meantime secondary antibodies were prepared at a 1: 400 dilution 
together with DAPI (Molekula) at 1:1000 [Table 2.3]. All coverslips were incubated for 1-2h at RT, 
washed as before and mounted on glass slides (Thermo-Fisher) using mounting solution 
(Vectashield). 
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TABLE 2.2. ANTIBODY DILUTIONS FOR PRIMARY  ANTIBODIES 
 
 
Primary antibodies 
Name Species IF Dilution Incubation Time WB dilution Company Code Notes 
Vimentin Chicken 1 : 5000 2h [RT] – O/N [4°C] - Thermo Scientific PA1 - 16759  
Alpha Smooth muscle actin (αSMA) Rabbit 1 : 200 2h [RT] – O/N [4°C] 1 : 1000 Abcam ab5694 Rodent* 
Alpha Actinin Mouse 1 : 1000 2h [RT] – O/N [4°C] - Sigma A7811  
Connexin 43 Rabbit 1 : 2000 2h [RT] – O/N [4°C]  Sigma c6219  
Connexin 43 Mouse 1 : 1500  - Chemicon (Millipore) mab3068  
Caveolin 3 Mouse 1 : 100 2h [RT] – O/N [4°C] - BD Transductions 610421  
Troponin T Rabbit 1 : 2000 2h [RT] – O/N [4°C] - Abcam   
Junctophilin-2 Goat 1 : 200 - 400 O/N [4°C] - Santa Cruz sc51313 PFA 
Calsequestrin-2 Goat 1 : 100 - 200 O/N [4°C] - Santa Cruz sc16576 Methanol 
Ryanodine Receptor Rabbit 1 : 100 - 200 2h [RT] – O/N [4°C] - Sigma HPA020028  
Alpha Smooth muscle actin (αSMA) Mouse 1:1000 2h [RT] – O/N [4°C] 1 : 1000 DAKO  Human* 
Streptavidin 488 - 1 : 2000 2h [RT] - Invitrogen S32354  
TGR5 Rabbit 1: 100 – 200 2h [RT] – O/N [4°C] - Courtesy of Prof Nigel Bunnett Methanol 
Kir6.1 Goat 1 : 200 O/N [4°C]  Santa Cruz   
Kir6.2 Goat 1 : 200 O/N [4°C]  Santa Cruz   
SUR1 Goat 1 : 200 O/N [4°C]  Santa Cruz   
SUR2 Goat 1 : 200 O/N [4°C]  Santa Cruz   
Estrogen Receptor alpha (ERα) Rabbit 1 : 100 O/N [4°C] - Santa Cruz   
Oxytocin  Receptor (OTR) (C-20) Goat 1 : 50 -  1 : 100 O/N [4°C]  Santa Cruz sc-8102  
COX2 (C-20) Goat -  1 : 2000 Santa Cruz sc-1745  
GAPDH Rabbit -  1 : 1000    
β-Actin Mouse -  1 : 50 000    
* The Abcam rabbit αSMA antibody works best for rodent fibroblasts; the DAKO mouse monoclonal αSMA antibody was raised against the human αSMA and 
works therefore best for human fibroblasts 
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TABLE 2.3. ANTIBODY DILUTIONS FOR SECONDARY  ANTIBODIES 
 
Secondary antibodies 
Immunofluorescence 
All antibodies were diluted 1:400; all secondary antibodies were Alexa-Fluor antibodies obtained from Invitrogen 
 
Goat-anti-Chicken 568 
Donkey anti-Goat 488 
Donkey anti-Goat 546 
Donkey-anti-Mouse 488 
Donkey-anti-Mouse 546 
Goat-anti-Mouse 647 
Donkey-anti-Rabbit 488 
 
Donkey-anti-Rabbit 546 
Goat-anti-Rabbit 647 
 
 
 
Western Blotting  Dilution 
Donkey anti-Goat IgG-HRP Santa Cruz 1 : 2000 
Donkey-anti-Mouse IgG-HRP Santa Cruz 1 : 250 000 
Donkey-anti-Rabbit-FITC Santa Cruz 1 : 1000 
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2.4.4 STATISTICAL ANALYSIS 
 
 
Statistical analysis for all data was carried out using Graphpad Prism 5 or Microsoft Office Excel. 
Data are shown as Mean + Standard Error of the Mean (SEM), unless otherwise stated. The number 
of replicate dishes, isolations of rat neonatal cells, different vials of CDI or tissue samples in case of 
human tissue is indicated by ‘n’ as described in the figure legend and text. All data was tested for 
normality using the Komogorov-Smirnov test and if it passed the normality test (i.e. the data has a 
Gaussian distribution) the data was tested by parametric tests, if not, non-parametric equivalents 
were used. A p-value of p ≤ 0.05 (*), p ≤ 0.01 (**) or p ≤ 0.001 (***) is deemed significant. 
 
Results were analysed using a Student’s t-test or the non-parametric equivalent, Mann-Whitney 
U-test for comparison between two categories, for example the myometrial strip contraction. For 
the analysis of more than two categories, One-way Analysis of Variance (One-way ANOVA) with 
post-tests using the Bonferonni correction or non-parametric equivalent Kruskall-Wallis ANOVA with 
the Dunns correction were used. All data with multiple categories were analysed using these tests, 
including PCR work, Optical recording, motility experiments using SICM and impalement work. 
 
A Two-way Analysis of Variance (Two-way ANOVA) and post-tests using the Bonferonni  
correction was used for the DiBAC4(3) experiments and for the analysis of time differences of the 
myometrial strip contraction. 
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2.5.1 MODELS OF THE FETAL AND ADULT  HEART 
 
Human fetal cardiomyocytes and fibroblasts were isolated from tissues obtained from fetuses 
aged 12 – 17 weeks terminated due to genetic abnormalities (Trisomy 13, 18 and 21). During this 
PhD 5 hearts were obtained from which cells were isolated successfully [Table 2.4]. These cells were 
used for optical mapping, electrophyosiology and immunofluorescence studies. 
 
A number of models of the fetal and adult heart were used. Human models of the fetal heart 
were developed in order to reduce the number of animals used and to avoid using neonatal rat 
cardiomyocytes and fibroblasts derived from newborn rats. As these cells were derived from a 
different species with different gestations and different heart development and which at least for a 
postnatal day experienced a different environment than the fetus. Two novel models of the human 
fetal heart were developed and these were compared to the previously described neonatal rat 
models of the fetal/maternal heart, consisting of cardiomyocytes and fibroblasts or cardiomyocytes 
only respectively. For the first time we obtained beating cardiomyocytes from human fetal tissues 
from terminations of pregnancy due to scan or genetic abnormalities [detailed in table 2.4]. These 
cells were subsequently used for optical recording and immunofluorescence microscopy  
experiments (Chapter 3). In addition, fibroblasts isolated from the same tissues and the effect of bile 
acids on these was further investigated (Chapter 4). There are however, some limitations associated 
with the tissue obtained from these fetuses, as there could potentially be structural abnormalities of 
the heart due to the genetic anomalies; in addition trisomy 13, 18 and 21 are known to cause an 
increased risk of heart defects and congenital heart disease (Yates, Hoffman, Shepherd, et al., 2011; 
Costello, Weiderhold, Louis, et al., 2015; Meyer, Liu, Gilboa, et al., 2015; Stoll, Dott, Alembik, et al., 
2015). However, the work obtained with these cells would still bring valuable knowledge  with 
regards to the effect of bile acids on human fetal cells. Therefore, human cardiomyocytes derived 
from induced pluripotent stem cells were used (CDI) to model human fetal-like heart cells (Chapter 
3), although these cells are reprogrammed from stem cells and are not necessarily the same as  fetal 
2.5 METHODS FOR THE INVESTIGATION OF THE FETAL AND ADULT   HEART 
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cells, they are structurally and functionally immature and more similar to the human fetal and 
neonatal cells described here than to adult cardiomyocytes. Finally, the neonatal heart models were 
used to expand upon the research first published in 2011 by Miragoli et al. (Miragoli, Kadir, 
Sheppard, et al., 2011) and these models were used to compare the human models to. Investigation 
into the relative maturity of these fetal and neonatal cells was carried out, for which human adult 
cardiomyocytes were also used. 
 
UDCA was previously shown to affect neonatal rat myofibroblasts (Miragoli, Kadir, Sheppard, et 
al., 2011). This research was expanded upon in the investigation of the effect of bile acids on human 
fetal and neonatal rat myofibroblasts (Chapter 4). In addition, myofibroblasts affect cardiomyocytes 
via gap junctional coupling. Therefore the interaction between neonatal rat cardiomyocytes and 
fibroblasts was further investigated (Chapter 5). Finally, it was hypothesised that UDCA may not only 
have a hyperpolarising effect on fetal fibroblasts, but may have a protective role in adult cardiac 
disease. Therefore, adult rat fibroblasts isolated from hearts from myocardial infarction rats (MI) as 
well as sham control rats and adult human fibroblasts isolated from hearts of dilated or ischemic 
(DCM/ICM respectively) patients were used to investigate whether UDCA could be used as a 
potential therapeutic agent in cardiac disease. 
 
 
 
 
 
TABLE 2.4. HUMAN FETAL  SAMPLES 
 
Human fetal samples were obtained from surgical terminations of pregnancy due to scan or 
genetic abnormalities detailed in the table below. Fetuses were between 12 and 17 weeks (wks) 
of gestation. 
 
Human fetal samples 
Sample name Gestation Notes 
2 13 wks Trisomy 13 
3 13 wks Trisomy 18 
4 16 + 6 wks Trisomy 21, isolated as atrial and ventricular cells 
5 14 + 4 wks Trisomy 13, scan abnormalities 
6 14 + 4 wks Trisomy 21 
7 16 + 5 wks Chromosomal deletion 12q1-2, hydrops 
8 12+5 wks Scan abnormalities in lower abdomen 
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2.5.2 ISOLATION AND CELL CULTURE OF PRIMARY RAT CARDIAC   CELLS 
 
 
ISOLATION OF NEONATAL RAT VENTRICULAR CARDIOMYOCYTES AND  MYOFIBROBLASTS 
 
 
Neonatal rat ventricular cardiomyocytes (CM) and myofibroblasts (MFB) were isolated from 1-2 
day old Sprague-Dawley rats. Newborns were sedated and culled by decapitation. The hearts were 
subsequently excised, the atria removed and the cells dissociated using a GentleMACS Dissociator 
(MACS, Mitenyi Biotec) according to the protocol for neonatal hearts 
(www.miltenyibiotec.com/protocols). To inhibit further digestion 10% Medium was added, which 
consisted of Medium 199 + Hanks Balanced Salts (M199 + HBSS) supplemented with 10% Neonatal 
Calf Serum (NCS), 1% L-Glutamine (v/v), 1% Vitamin B12 (v/v) and 0.5% penicillin/streptomycin 
(Pen/Strep). Cells were pelleted by centrifugation for 5 minutes at 1000 RPM and resuspended in 
10% Medium. The  cells  were  passed  through  a  cell  strainer  (70  µm)  and  were  preplated  in  
T75 flasks for 1h at 37°C and 1% CO2 to separate the CM from the MFB. After preplating, cells were 
collected,  counted  and  cultured  at  the  required  density  on  laminin-coated  glass  coverslips     
(22 cm2, 18 cm2 or 13 cm2) or in 35 mm culture dishes. The subsequent day cells were washed and 
cultured in 5% medium (supplemented M199 containing 5% NCS). CM were allowed to mature for 2- 
3 days, to allow for the formation of synchronously beating networks. 
 
 
 
 
 
HEART MODELS USING NEONATAL RAT VENTRICULAR CARDIOMYOCYTES AND 
 
MYOFIBROBLASTS 
 
 
Different models of the heart were used for this project. A confluent monolayer of 
cardiomyocytes is used as a model of the maternal or healthy adult heart. In addition a model of the 
fetal heart had been developed previously in this lab, which consists of a confluent monolayer of  
CM, with MFB seeded on top (Miragoli et al., 2011). MFB were allowed to differentiate into 
myofibroblasts for one week before use. 8 day old MFB were detached from the culture flasks using 
an enzyme solution containing 20% Pancreatin (Sigma) and 0.5 mL Trypsin (PAA) dissolved in 10   mL 
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HBSS (Invitrogen). After the 30 minute incubation at 35°C and 1% CO2, cells were collected, 
centrifuged and resuspended in 5% medium. MFB were subsequently seeded on the day after 
isolation at the required density on top of the CM. Unattached cells were removed one hour after 
seeding. For contact experiments, MFB were incubated with 5-10 µL Vybrant DiI or WGA-488 (Wheat 
Germ Agglutinin) / 1 million cells for 20 minutes at 35°C and 1% CO2 before seeding onto the CM. 
 
 
 
 
 
ISOLATION  OF  ADULT  RAT  CARDIOMYOCYTES  AND  FIBROBLASTS  FROM  CONTROL    AND 
 
MYOCARDIAL INFARCTION RATS 
 
 
The adult rat work was in accordance to the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). A rat 
model of Myocardial Infarction (MI) was used for further elucidation of the mechanism of action of 
UDCA and its potential application in adult cardiac disease. For this, male adult Sprague-Dawley rats 
(250–300 g) were anaesthetized and underwent proximal coronary ligation to induce chronic 
myocardial infarction and were allowed to recover for 16 weeks to induce heart failure. Time 
matched control animals not having undergone surgery were used as control. Sixteen weeks later, in 
vivo PV analysis was performed before the hearts were explanted, weighed and prepared for cell 
isolation as described below (Lyon, MacLeod, Zhang, et al., 2009). I am grateful to Dr. Markus Sikkel, 
Dr. Adam Mills and Dr. Catherine Mansfield for the surgery of the MI rats. 
 
The isolation of cardiomyocytes and fibroblasts from the MI and time matched control hearts was 
carried out as previously described (Lewis, Gong, Brown, et al., 2004; Gorelik, Yang, Zhang, et al., 
2006). The animals were humanely killed using cervical dislocation and the heart was rapidly excised 
and placed in ice-cold KREBS solutions which was oxygenated with 95% O2  / 5% CO2  (119 mM  NaCl, 
4.7 mM KCl, 0.94 mM MgSO4, 1.2 mM KH2PO4, 25 mM NaHCO3, 11.5 mM glucose and 1 mM   CaCl2, 
 
pH 7.4). The heart was then placed on a Langendorff perfusion system and perfused with the low 
calcium (Ca2+) solution oxygenated by 100% O2  (120 mM NaCl, 5.4 mM KCl, 5 mM MgSO4, 5 mM 
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pyruvate, 20 mM glucose, 20 mM taurine, 10 mM HEPES, 5 mM nitrilotriacetic acid (NTA) and 12–   
14 mmol/L calcium, pH 6.95). Subsequently the enzyme solution (as low calcium solution, but 
without NTA) containing 200 µM Ca2+, 1 mg/mL collagenase and 0.6 mg/mL hyaluronidase was 
perfused over the heart for 10 minutes. The ventricles and atria were then separated for separate 
isolation. The right ventricle was separated from the left ventricle and septum and was discarded. 
The left ventricle and septum was chopped into small pieces with scissors and placed in enzyme 
solution. This was shaken at 35°C oxygenated at 100% O2 for 5 minutes and the solution containing 
the heart pieces was subsequently strained using a gauze with a mesh size of 300 µm. This was 
repeated for another 5 minutes incubation and the solution was centrifuged at 400 g for 1 minute. 
The supernatant contained the fibroblasts, whilst the pellet contained the cardiomyocytes. The 
supernatant was removed and respun at 1000 g for 10 minutes to pellet the fibroblasts. The 
supernatant was removed and the pellet resuspended in DMEM containing 10% FBS, L-Glutamine, 
AB/AM and plated in T25 flasks. The fibroblasts were kept at 37°C and 5% CO2. I am grateful to Mr. 
Peter O'Gara for the preparation of adult rat ventricular cardiomyocytes and fibroblasts. 
 
 
 
 
 
2.5.3 ISOLATION AND CELL CULTURE OF PRIMARY HUMAN CARDIAC   CELLS 
 
 
ISOLATION AND CULTURE OF HUMAN FETAL CARDIOMYOCYTES AND   FIBROBLASTS 
 
 
Fetal hearts were obtained from Surgical terminations of pregnancy (STOP) after prior consent of 
the mother using the Biobank ethical approval (registration number WHC CW 14 006). Tissue of 
fetuses between 8 and 16 wks was obtained from theatre after the procedure and placed on ice. 
Cardiac tissue was identified and separated from the remains and placed in cold PBS with AB/AM. 
The remaining tissue was returned to the theatre for disposal according to the NHS trust guidelines. 
Aorta and other attached tissue was removed and the atrial and ventricular tissues were minced to 
small pieces in PBS with AB/AM. Cardiomyocytes and fibroblasts were isolated using solutions from 
the neonatal heart kit for mouse / rat (Miltenyi Biotec). Minced tissue was placed in the C-tube of 
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the kit, the PBS removed and the solutions of the kit added. The isolation method was then followed 
as described in the protocol (www.miltenyibiotec.com/protocols). Fibroblasts were separated from 
the cardiomyocytes by preplating for 1 – 2 h at 37°C. Cardiomyocytes were counted and plated for 
different experiments, including for optical recording experiments, beating experiments and 
transfection for FRET. Fetal Cardiomyocytes were cultured at 37°C and 1% CO2 in M199 + 10% NCS, 
1% L-Glutamine, 1% AB/AM and 1% Vitamin B12 (v/v). 
 
Fetal Fibroblasts were cultured in M199 + 10% NCS as described above until confluency and were 
subsequently passaged using 0.25% Trypsin-EDTA. Cells were plated as needed for experiments on 
coverslips for staining, in wells for RNA/Protein extraction and together with CDI for the fetal heart 
model. Treatment with Hypoxia was carried out at 37°C and 1% CO2 and 8% O2. 
 
 
 
 
 
ISOLATION AND CULTURE OF HUMAN ADULT  FIBROBLASTS 
 
 
Adult fibroblasts were obtained from multiple sources after prior consent for donation of cardiac 
tissue. Atrial fibroblasts were obtained from atrial appendixes of patients with atrial fibrillation (AF) 
or sinus rhythm (SR) after cardiomyocyte isolation. Ventricular fibroblasts were obtained from left 
ventricular tissue of patients undergoing mitral valve replacement with no cardiac failure (control) or 
from the apex of the heart after transplant, of patients with ischemic or dilated cardiomyopathy  
(ICM or DCM respectively). Ventricular fibroblasts were obtained from the supernatant after 
cardiomyocyte isolation and after explants. Tissue was minced in Low calcium solution, after which it 
was digested first in 3.6 mg/ml Protease XIV (Sigma) and subsequently in 10 mg/mL Collagenase V 
(Sigma). Fibroblasts were obtained from cardiomyocyte isolation after each isolation step, by 
retaining the supernatant after separation from the cardiomyocytes. The supernatant was then spun 
for 7 minutes at 1100 g, the liquid removed and the pellet resuspended in DMEM containing 10% 
FCS, 1% AB/AM and 1% L-Glutamine. Cells were plated in 1 – 2 wells of a 6 well plate or 1 T25 
depending on the size of the pellet. The medium was changed 2h after plating and the subsequent 
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day, after which the medium was changed every other day and the cells were passaged upon 
confluency. Explants were prepared from small pieces of tissue. A piece of tissue was washed in PBS 
and cut into 1 by 1 cm pieces in PBS. These small pieces were then transferred to fibronectin coated 
6 cm dishes (Corning) containing 1 mL medium. After 2h 1 mL of medium was gently added to the 
dish to prevent dislodging of the tissue pieces. The subsequent day the medium was replaced and 
then every other day. Tissue pieces were removed before passaging when the dish was confluent. 
 
 
 
 
 
2.5.4 CULTURE    OF     HUMAN    iPS-DERIVED    CARDIOMYOCYTES    FROM     CELLULAR 
 
DYNAMICS 
 
 
Commercially available human iPS-derived cardiomyocytes (CDI) were obtained from Cellular 
Dynamics International. Cells arrived frozen in cryovials and were kept in liquid nitrogen storage  
until needed. A vial was defrosted as needed, the number of viable cells were calculated based on 
the plating efficiency and survivability and plated using this value. The CDI cells were defrosted 
gently by incubating for 3 minutes at 37°C in a water bath, after which the 1 mL containing the cells 
was transferred slowly to a falcon. 1 mL of plating medium (Cellular Dynamics International) was 
added to the cryovial, to rinse out any remaining CDI. This was then added slowly to the CDI. 8 mL 
was subsequently added slowly with gentle mixing to the CDI to make up a total volume of 10 mL. 
CDI were plated at different densities depending on experiments and placed in the incubator at 37°C 
and 5% CO2 for 2 days in plating medium before changing to maintenance medium containing 1% 
Pen/Strep [Cellular Dynamics]. Medium was changed every other day until the CDI were used for 
experiments. The CDI were allowed to mature for at least 10 days, the optimal window of use was 10 
– 14 days. Both a maternal model (CDI only) and fetal model were used. The fetal model contained 
CDI and additionally the day before experiments human fibroblasts from human fetal origin were 
plated on top. In order to differentiate between fibroblasts and CDI, the fibroblasts were incubated 
with  the  fluorescent  dye  Vybrant  DiI  [Invitrogen].  Fetal  fibroblasts  were  detached  the  flask  by 
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incubation with 0.25% Trypsin-EDTA for 5 minutes, resuspended in DMEM and spun for 5 minutes at 
1000g. The supernatant was removed and 1 mL HBSS / 1 million cells was added. 1 mL was retained 
and incubated with 5 µL DiI for 20 minutes at 37°C and 5% CO2. Cells were washed with 5 mL HBSS 
before repelleting and resuspension into serum free medium (Adult CM medium). Approximately 
6000 cells were added to the CDI and incubated overnight in the incubator. The next day the cells 
were used for experiments. 
Page | 93  
 
2.5.5 OPTICAL RECORDING 
 
 
Coverslips were incubated for 20 minutes in 1 mL of medium containing 20 mM Fluo4 
acetoxymethyester [Fluo4 AM] (Invitrogen) or in 1 mL HBSS- containing 1 µM di-8-Anepps for 5-10 
minutes (Invitrogen). Non-sterile HBSS [HBSS-] was used for experiments, which was prepared by 
addition of a vial of Phenol Red Free Hanks Balanced Salts (Sigma), 0.35 g/L Sodium Bicarbonate 
(Sigma) and 2.38 g/L HEPES (VWR) to 1L dH2 O. After incubation the coverslip was washed in HBSS- 
and mounted on a holder. The holder was then mounted on an inverted microscope (Nikon Eclipse 
TI) with a MICAM Ultima Camera for optical recording. Different filters were used for imaging with 
FLuo4 AM, di-8-Anepps and to visualise DiI stained Fibroblasts [TRITC– Ex 540/25, DM 565, BA 
605/55]. Cells were allowed to adapt before control videos were taken using the imaging software of 
the Micam Ultima from Brainvision, Scimedia (Japan). The duration of the videos taken for UDCA and 
NorUDCA experiments was 0.5s, images were taken at a frame rate of 1 frame/ms. A number of 
recordings were taken before the perfused solution was changed to different drugs dissolved in 
HBSS-. UDCA and NorUDCA were perfused at three different concentrations, 10 nM, 100 nM and 1 
µM, TC was perfused at 100 µM. After each experiment, HBSS- was perfused over the cells to 
confirm reversibility of the drugs. The duration of the videos taken for treatment with 0.1 mM TC  
and TC in combination with UDCA or NorUDCA was 4 – 8s with a frame rate of 1 – 2 frames / ms. 
Analysis of the data was carried out using BV_Analyse v11.08 (Brainvision, Scimedia) [Figure 2.2] or 
Matlab. Example videos are provided as Supplementary Material on the DVD. 
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FIGURE 2.1. ANALYSIS OF CALCIUM TRANSIENTS OBTAINED BY OPTICAL   RECORDING 
 
Each video of 512 ms (0.5 s) was analysed for duration, time-to-peak, propagation and max 
amplitude. 
The image on the left is the actual video, calcium fluorescence ranges from grey to red, whereby  
grey signifies very low amounts of calcium and red very high amounts. The red, green, blue and  
black squares signify specific points. The time-to-peak is the duration until the max amplitude is 
reached, while the full duration is taken as the time to reach the background level of fluorescence. 
Propagation is measured from left to right (the direction from the stimulus). In this case propagation 
was measured from the red to black points. Example videos are provided on the DVD. 
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2.5.6 MEASUREMENT OF MEMBRANE POTENTIAL OF  FIBROBLASTS 
 
 
 
MEASUREMENT OF MEMBRANE POTENTIAL USING A VOLTAGE SENSITIVE   DYE 
 
 
8 day old MFB were seeded at 10 000 cells per well in a 96 well plate format, leaving 4 wells 
empty for background measurements. In addition to Background measurements, where no cells 
were seeded, but the dye was loaded for measurement, Blank measurements were taken, cells were 
seeded in these wells, but only clear HBSS was added. A row of wells was also designated ‘control’, 
where dye was added to the cells, but no additional drug. These measurements were taken as a 
baseline to which the treatments were compared to. Two drugs were taken as control treatments,  
as Potassium Chloride (KCl) is known to depolarize cells, while P1075 (N-cyano-N'-(1,1- 
dimethylpropyl)-N''-3-pyridylguanidine) is known to hyperpolarize cells, as this is a potent KATP 
channel opener, binding with high affinity to SUR2A/2B (Lange, Löffler-Walz, Englert, et al., 2002). 
The DiBAC4(3) dye was prepared at a 5 µM concentration in clear HBSS. Drugs were either added at 
the same time as the DiBAC4(3) dye (chronic) or directly before measurement (acute). Drugs were 
diluted to the final concentration in DiBAC4(3) for chronic treatment (UDCA, NorUDCA and 
TauroUDCA at 10nM, 100nM and 1 µM) or in a small volume for later addition for acute treatment 
(10µM P1075, 60 mM KCl and 0.2 or 0.5 mM TC). Medium was taken off the cells and the cells were 
stained for 30 minutes before measurement. To the ‘control’ and ‘background’ wells 100 µL 
DiBAC4(3) was added, to wells for chronic treatment 100 µL DiBAC4(3) containing the drugs was 
added. 100 µL of clear HBSS was added to 4 wells for ‘blank’ readings. Wells for acute treatment 
were loaded with 80 µL of dye and a subsequent 20 µL containing the concentrated drug was added 
to the appropriate final concentration before the plate was mounted on the reader. 
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MEASUREMENT OF MEMBRANE POTENTIAL USING  IMPALEMENT 
 
 
Impalement was carried out on a Nikon Eclipse TE300 using Axopatch 2b with Clampex 8.0 to 
record resting membrane potential. Neonatal rat, human fetal, adult rat and human adult fibroblasts 
were maintained on the system with HBSS- containing 1% NCS. Cells were impaled by sharp 
nanopipettes containing 3M KCl and 10s recordings were taken. Resting membrane potential was 
averaged each trace. After control traces were taken, the solution was changed to 0.2 mM TC, 1 µM 
UDCA or 1 µM NorUDCA and cells were allowed to adjust before subsequent traces were taken. 
After experiments with TC, 0.2 mM TC together with 1µM UDCA or 1 µM NorUDCA was added to 
record UDCA or NorUDCA induced changes in membrane potential. 
 
 
 
 
 
2.5.7 RADIOLIGAND BINDING 
 
 
Neonatal rat and Human adult fibroblasts from cardiac explants or cardiomyocyte isolations were 
cultured until sufficient cell numbers were reached. Cells were washed in PBS, detached by Trypsin- 
Pancreatin or Trypsin-EDTA for rat and human FB respectively, before centrifugation  and  were 
frozen at -80˚C until use. Cells were homogenized and cell debris was collected by centrifugation for 
10 minutes at 1700g. The supernatant was then ultracentrifuged for 30 minutes at 50 000g. The 
pellet containing the cell membranes was carefully resuspended in the assay buffer. 10 – 20 µg 
protein was incubated for 2h at 37˚C in 200 µl assay buffer containing 20 mmol/L TRIS, 100 mmol/L 
NaCl, 1 mmol/L EDTA (pH 7.6), together with 0.1-1 nmol/L [3H]-Glibenclamide (PerkinElmer) and 
increasing concentrations of unlabeled UDCA or NorUDCA ranging from 1-5 to 1000 µmol/L. 
Reactions were terminated by vacuum filtration through GF/F glass fibre filters (Millipore, Germany) 
before bound radioactivity was measured. 
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2.5.8 SCANNING ION CONDUCTANCE MICROSCOPY  (SICM) 
 
 
Scanning Ion Conductance Microscopy (SICM) was used to image the contact area between cells 
or cell morphology and topography. SICM is a non-contact method of imaging the topography of 
intact cells (Miragoli, Moshkov, Novak, et al., 2011; Nikolaev, Moshkov, Lyon, et al., 2010). This can 
be achieved by scanning the surface of the cell using a nanopipette filled with electrolyte and an 
electrode connected to a feedback mechanism that also receives information from a ground 
electrode placed in the bath. Using the ion current as a feedback mechanism the distance between 
the pipette tip and sample can be maintained, since there is a drop in current when the pipette 
approaches the cell surface. This enables high resolution scans of varying size to be generated of the 
surface area of cells in the dish. 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2.2. SCHEMATIC OF SCANNING ION 
CONDUCTANCE MICROSCOPY 
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2.6.1 CELL CULTURE OF HUMAN PRIMARY  UTERINE TISSUE 
PATIENT SELECTION 
 
Approval from the ethics committee was granted for the studies performed (REC 3357 for 
myometrium, RREC 2002-6283 for amnion) and patients gave informed consent before the  
collection of tissue samples. Myometrial biopsies were taken from the upper part of the incision in 
the lower segment of the uterus of women undergoing an elective caesarean section for breech 
presentation or previous caesarean section (labour -) or during an emergency section after labour 
started (labour +) for both uncomplicated and ICP pregnancies. Biopsies from uncomplicated 
pregnancies were used for primary cell culture or snap-frozen. Biopsies from ICP pregnancies were 
snap-frozen. Placentas of both uncomplicated and ICP pregnancies, from labouring and non- 
labouring women were retained. From the placenta, the fetal membranes were taken, whereby part 
of the amnion (membrane on fetal side) was separated from the chorion (maternal side) and these 
samples were subsequently snap-frozen. All snap-frozen material was stored at -80°C before use for 
either RNA or protein extraction. 
 
 
 
 
 
PREPARATION OF PRIMARY MYOMETRIAL  CULTURE 
 
 
Myometrial cultures were prepared from most of the biopsy and a small piece was snap-frozen. 
Biopsies were dissected into very small pieces and digested in a solution of 0.25 mg/mL Collagenase 
IA, 0.25 mg/mL Collagenase XI and 5 mg/mL Bovine Serum Albumin (BSA) in 50% Dulbecco’s 
modified Eagle’s Medium (DMEM) and 50% DMEM-F12 Ham, for 45 minutes at 37°C and 5% CO2 
with agitation every 15 minutes. After 45 minutes the digestion was inhibited by addition of DMEM 
supplemented with 10% fetal calf serum (FCS). The cell suspension was passed through a 70 µm cell 
strainer 
(BD Falcon) and collected by centrifugation for5 minutes at 1000 RPM. Cells were grown in full 
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DMEM medium containing 10% FCS and 1% antibiotic / antimycotic solution (AB/AM) in an  
incubator at 37°C and 5% CO2. Cells were grown for two types of experiments. Cells were grown 
either in 2 T25 flasks (Corning) for passage experiments until passage 4 or for treatment at   passage 
4. Cells were passaged upon confluency. For passage experiments, 1 T25 was washed in PBS and 
frozen in 350 µL RLT-buffer. The other flask was washed and trypsinized in 0.25% Trypsin-EDTA for 5 
minutes, before inhibition by full medium. Cells were pelleted, resuspended and split into 2 new  
T25. 
 
At passage 4, 1 flask was kept in full medium and 1 flask was serum-starved in 1% Dextran coated 
Charcoal stripped serum (DCC-FCS) overnight. DCC-FCS was prepared by adding 1.25 g charcoal   and 
0.125 g dextran to a new bottle of FCS. The mixture was incubated at 56°C for 2 hours, mixed 
regularly before filtering, aliquoting and storage at -20°C. Both flasks were washed and frozen in RLT- 
buffer. For treatments, cells were harvested as above and subsequently cultured in larger flasks to 
increase cell number. Passage 4 cells were plated into 6 well dishes in DMEM containing 10% DCC- 
FCS and 1% AB/AM. Upon confluency, the medium was removed and the cells serum-starved by 
addition of DMEM without Phenol Red containing 1% DCC-FCS overnight before treatment the 
following day. 100 µM TC or TCDCA was added for overnight treatment or for 10h, 6h, 1h, 15 min, 5 
min or no BA (control). 
 
 
 
 
 
2.6.2 MYOMETRIAL CONTRACTION USING A  CONTRACTILITY  MACHINE 
 
 
Myometrial strips were prepared from a small part of the biopsy, avoiding blood vessels. The 
tissue was divided into 8 – 10 strips of about 3 mm by 6 mm, which were then mounted in the 
chambers of a contractility machine (DMT). Treatments were subsequently carried out according to 
the protocol in Figure 2.1. Chambers contained preheated KREBS solution which was prepared 
according to Sigma manual K3753 for a KREBS solution containing 2000 mg/L D-Glucose dissolved in 
dH2O. The strips were incubated at 37°C with 5% CO2  and stretched to a tension of 3.5 g after 
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whichhey were allowed to adapt to the KREBS solution for 1 hour to allow for the initiation of 
contractions. After 1 hour the KREBS solution was replaced with fresh preheated KREBS solution. 
Subsequently every 30 minutes the KREBS was changed to maintain fresh conditions. The KREBS was 
changed 2-3 times (1 - 1.5h) to establish contractions before recordings started. After establishment, 
the contractions were recorded via the PowerLab Chart 5 software (AD Instruments Ltd., 
Oxfordshire, UK). Drugs were added upon change of KREBS solution. After the first 30 minutes of 
spontaneous (control) contractions, drugs were added to half of the strips, whilst the other strips 
acted as vehicle controls. Treatments included a dose response curve of doses between 20 µM and 
100 µM Taurocholic acid (TC) whereby the dose was increased every 30 minutes. To the final 
treatment 10 nM Oxytocin (OT) was added to each of the treated and untreated strips, to confirm 
that the strip was still alive and capable of contracting in addition to assessing whether TC influences 
OT induced contractions. Contractions upon Oxytocin induction were recorded for another 15 
minutes to observe changes in contraction after bile acid treatment. A number of parameters were 
analysed using Chartlab (v5.5.6), in order to assess whether TC has an influence on contractions. The 
area under the curve (AUC) and total AUC were analysed, to assess the total work done by the strip, 
as well as the amplitude or strength of contractions, duration of each contraction and the rate of 
contraction. The contractions were normalized to initial spontaneous contractions to account for 
natural degeneration over time of the tissue. Treated samples were then compared to the control 
measurements to determine whether there are any effects of different bile acid treatment on the 
contractions. 
 
 
 
FIGURE 2.3. TREATMENT PROTOCOL FOR THE CONTRACTION OF MYOMETRIAL   STRIPS 
 
A dose response curve was carried out using doses between 20 µM and 100 µM taurocholic acid (TC) 
whereby the dose was increased every 30 minutes. As the final treatment 10 nM Oxytocin (OT) was 
added to each of the treated and untreated strips, to confirm the strip was able to contract. 
Additionally it was possible to assess whether TC influences OT induced contractions. All treatments 
and controls were normalised to spontaneous contractions, after which the treatment was 
compared to control as well as any differences over time. 
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2.6.3 COMBICULT 
 
 
CombiCult (Plasticell) is a combinatorial method using small porous beads which allows for 
screening of a large number of different combinations of media and soluble factors to obtain the 
optimal conditions for directing stem cell differentiation to the cell type of interest (Tarunina, 
Hernandez, Johnson, et al., 2014). Human embryonic or iPS derived stem cells are seeded on the 
beads at a density of 100-200 cells per bead, after which the beads are exposed to 10,000 
(10x10x10x10) different combinations of differentiation media in 4 stages of differentiation. The 
media consists of serum-free media and small molecules that are either known from other protocols 
in the literature to induce differentiation into the desired cell type or are needed in normal 
development of the cell type. The large number of combinations allows for the screening for novel 
protocols as well as optimisation of any existing protocols (Tarunina, Hernandez, Johnson, et al., 
2014). Analysis of the resulting pathways is carried out using Ariadne (Plasticell), which provided 
information on common pathways that would lead to the formulation of specific protocols. In this 
project the aim was to differentiate human stem cells into myometrial smooth muscle cells. The 
specific methodology and results are described in Chapter 6. 
 
 
 
FIGURE 2.4. EXAMPLES OF COMBICULT  BEADS 
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CHAPTER 3: CHARACTERISATION AND MODELLING THE FETAL  HEART 
Page | 103  
 
 
 
 
 
This chapter describes the work carried out using human and rat models of the fetal heart. The 
first aim was to characterise these models and subsequently to investigate the effects of bile acids  
on the fetal heart using human and rat models, and the effect of possible protective reagents such  
as UDCA and derivatives, including the chemically altered derivative of UDCA, NorUDCA. 
 
The first section of this chapter describes the characteristics of human fetal cardiomyocytes  
(CMs) isolated from human fetuses aged 12 – 17 weeks, neonatal rat cardiomyocytes and the human 
iPS-derived cardiomyocytes from CDI. A number of cardiac markers were used to compare the 
various cardiomyocytes. In addition, the localisation of the GPCR TGR5 was carried out in the 
cardiomyocytes and fibroblasts from neonatal rat, human fetal and human adult origin. 
 
The second section of the chapter describes the functional work using different fetal  heart 
models and the effect of bile acids on human, neonatal and iPS-derived cardiomyocytes. 
 
 
FIGURE 3.1. IMAGE OF A HUMAN FETAL CARDIOMYOCYTE 
CULTURE WITH INTERSPERSED FIBROBLASTS 
 
Bright field image of human fetal cardiomyocytes and fibroblasts. 
Images from Video 1 [human fetal CMs] shown in the companion 
DVD. Scale bar: 100 µm. 
CHAPTER 3: CHARACTERISATION AND MODELLING THE FETAL  HEART 
Page | 104  
 
 
Due to the difficulty in obtaining and isolating cells from human fetal hearts previous research in 
our lab focused on neonatal rat models of the fetal heart. Gorelik et al. (2006) previously isolated 
human fetal cardiomyocytes from aborted fetuses of 9 – 12 weeks of gestation with no known 
pathology (Gorelik, Patel, Ng’andwe, et al., 2006). These cells were used to investigate gene 
expression of bile acid transporters and changes after TC incubation (Gorelik, Patel, Ng’andwe, et al., 
2006). The transient appearance of myofibroblasts in the fetal heart during development led to the 
adaptation of the model to a fetal heart model consisting of neonatal rat fibroblasts and 
cardiomyocytes (Miragoli, Kadir, Sheppard, et al., 2011). In addition, human iPS-derived or ES- 
derived cardiomyocytes are often used as a model of adult cardiomyocytes, but these cells are said 
to be structurally and functionally relatively immature and fetal-like when compared to human adult 
cardiomyocytes. The gene expression characteristics of iPS-derived cardiomyocytes are often more 
reminiscent of developing cardiomyocytes, with immature structural phenotypes and 
electrophysiological properties and calcium transients more similar to developing cardiomyocytes 
than adult cardiomyocytes (Rao, Prodromakis, Kolker, et al., 2013; Gai, Leung, Costantino, et al., 
2009; Gherghiceanu, Barad, Novak, et al., 2011; Itzhaki, Rapoport, Huber, et al., 2011; Ma, Guo, 
Fiene, et al., 2011; Zhang, Wilson, Soerens, et al., 2009). Previously, mouse Embryonic Stem cells at 
three different stages of maturation, as well human Embryonic Stem Cells of two stages of 
maturation were used for the investigation of TC induced arrhythmias in these cells (Kadir, Ali, 
Mioulane, et al., 2009). The iPS-derived cardiomyocytes from CDI (iCell Cardiomyocytes, from  
Cellular Dynamics international) are used as a model of the fetal heart as these properties make 
them a suitable model of the immature human fetal cardiomyocytes. 
 
It was possible for the first time in our lab, to obtain beating cardiomyocytes from human fetal 
tissues from fetuses aged 12 – 17 weeks terminated due to scan or genetic abnormalities [Table 2.4], 
including a number of samples with trisomy 13, 18 or 21 [Figure 3.1, Video 1 and 2 as Supplementary 
Materials on  the DVD].  There are  however, some  limitations associated with the  tissue   obtained 
3.1 INTRODUCTION 
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from these fetuses, as there could potentially be structural abnormalities of the heart due to the 
genetic anomalies; in addition trisomy 13, 18 and 21 are known to cause an increased risk of heart 
defects and congenital heart disease (Yates, Hoffman, Shepherd, et al., 2011; Costello, Weiderhold, 
Louis, et al., 2015; Meyer, Liu, Gilboa, et al., 2015; Stoll, Dott, Alembik, et al., 2015). However, the 
work obtained with these cells would still bring valuable knowledge with regards to the effect of bile 
acids on human fetal cells. In future we hope to obtain tissues without abnormalities for further 
research, although these tissues are generally of lower gestation. These tissues of lower gestation 
may have other limitations, as previously no beating cells were obtained from these hearts, although 
this could be due to age or isolation method (Gorelik, Patel, Ng’andwe, et al., 2006). In addition, fetal 
death occurs usually late term; cells obtained from early gestations would be much less developed 
and more immature. 
 
The first section of this chapter describes a comprehensive comparison of human fetal, neonatal 
rat and human iPS-derived cardiomyocytes. The iPS-derived cardiomyocytes will be referred to as 
CDI and Axiogenesis (iPS-cardiomyocytes from Axiogenesis). Human adult cardiomyocytes were used 
to compare the relative maturity of the various cell types to, as most markers were chosen for their 
changes in localisation and organisation during the maturation of the heart. The cellular topography 
of CDI, human fetal and neonatal rat cardiomyocytes was also compared to human adult 
cardiomyocytes using scanning ion conductance microscopy (SICM). The cell topography of the 
human adult (and adult rat) cardiomyocyte is well organised and structured and has been described 
previously by our group (Nikolaev, Moshkov, Lyon, et al., 2010; Gorelik, Yang, Zhang, et al., 2006). A 
number of cardiac markers were used to compare the various cardiomyocytes. In addition, the 
localisation of the GPCR TGR5 was carried out in the cardiomyocytes and fibroblasts from neonatal 
rat, human fetal and human adult origin. The second part of the chapter describes the functional 
work using different fetal heart models and the effect of bile acids on human, neonatal and iPS- 
derived cardiomyocytes. 
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3.2.1 THE HUMAN FETAL HEART 
 
 
Human fetal cardiomyocytes and fibroblasts were isolated from tissues obtained from fetuses 
aged 12 – 17 weeks terminated due to genetic abnormalities (Trisomy 13, 18 and 21). During this 
PhD 5 hearts were obtained from which cells were isolated successfully [Table 2.4]. These cells were 
used for optical mapping and immunofluorescence studies. 
 
 
 
 
 
3.2.2 MODELS OF THE FETAL  HEART 
 
 
Different models of the heart were used for this project. A confluent monolayer of neonatal rat 
cardiomyocytes is used as a model of the maternal or healthy adult heart. In addition a model of the 
fetal heart had been developed previously in this lab, which consists of a confluent monolayer of 
neonatal rat cardiomyocyte, with neonatal rat myofibroblasts seeded on top (Miragoli et al., 2011). 
The work with the CDI presented here was carried out with a confluent monolayer of CDI only. 
Finally, the human fetal cardiomyocytes were plated as single cultures, but due to the natural 
infiltration of human fetal fibroblasts this model was actually also a co-culture of the two cell types. 
 
 
 
 
3.2.3 SCANNING ION CONDUCTANCE MICROSCOPY 
 
 
Scanning Ion Conductance Microscopy (SICM) was used to image the T-tubular structure  of 
human adult control cardiomyocytes and the whole cell morphology of neonatal rat, human fetal 
cardiomyocytes and CDI. SICM is a non-contact method of imaging the topography of intact cells 
(Miragoli, Moshkov, Novak, et al., 2011; Nikolaev, Moshkov, Lyon, et al., 2010). This can be achieved 
by scanning the surface of the cell using a nanopipette filled with electrolyte and an electrode 
connected to a feedback mechanism that also receives information from a ground electrode placed 
in the bath. Using the ion current as a feedback mechanism the distance between the pipette tip and 
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Page | 107  
sample can be maintained, since there is a drop in current when the pipette approaches the cell 
surface. This enables high resolution scans of varying size to be generated of the surface area of cells 
in the dish. A large scan (50 – 80 x 50 - 80) was carried out to visualise the whole cardiomyocyte. 
High resolution scan of 10 x 10 µm of the cell topography of human adult control cardiomyocytes 
was carried out to visualise the Z-grooves, T-tubules and crests. 
 
 
 
 
 
3.2.4 IMMUNOFLUORESCENCE MICROSCOPY 
 
 
Immunofluorescence  staining  was  carried  out  as  described  in  Chapter  2  with  markers     for 
 
cardiomyocytes (α-Actinin,    Junctophillin 2, Caveolin 3 (Cav3), cardiac Troponin T and Calsequestrin 
 
2) and fibroblasts (αSMA and Vimentin), to visualise the gap junctional coupling Connexin43 (Cx43) 
was used and to further investigate bile acid receptors staining was carried out for TGR5 using an 
antibody kindly provided by Professor Nigel Bunnett (Poole, Godfrey, Cattaruzza, et al., 2010). 
 
 
 
 
3.2.5 BEATING EXPERIMENTS 
 
 
Neonatal rat, human fetal cardiomyocytes and CDI form spontaneously beating cells and  
networks of cells when plated and left in culture for a few days. This allows for the assessment of the 
effect of bile acids on spontaneous beating rate, the protocol is shown below. The number of beats 
was calculated per minute at baseline and after subsequent treatment with 0.1 mM TC and 0.1 mM 
TC in combination with 1 µM UDCA or NorUDCA. 
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3.2.6 OPTICAL RECORDING OF CALCIUM TRANSIENTS AND ACTION   POTENTIALS 
 
 
Optical recording was carried out to visualise the calcium ion release and reuptake during a 
contraction or action potential that induces contractions. Coverslips were incubated for 20 minutes 
in 1 mL of medium containing 20 mM Fluo4 acetoxymethyester [Fluo4 AM] for calcium recordings 
(Invitrogen) or in 1 mL HBSS- containing 1µM di-8-Anepps for 5-10 minutes for action potentials 
(Invitrogen). Non-sterile HBSS [HBSS-] was used for experiments; HBSS- was prepared by addition of 
a vial of Phenol Red Free Hanks Balanced Salts (Sigma), 0.35 g/L Sodium Bicarbonate (Sigma) and 
2.38 g/L HEPES (VWR) to 1L dH2O. After incubation the coverslip was washed in HBSS- and mounted 
on a holder. The holder was then mounted on an inverted microscope (Nikon Eclipse TI) with a 
MICAM Ultima Camera for optical recording. Different filters were used for imaging with FLuo4 AM, 
di-8-Anepps and to visualise DiI stained fibroblasts. Cells were allowed to adapt before control  
videos were taken using the imaging software of the Micam Ultima from Brainvision, Scimedia 
(Japan). The duration of the videos taken for UDCA and NorUDCA experiments was 0.5s, images 
were taken at a frame rate of 1 frame/ms. A number of recordings were taken before the perfused 
solution was changed to different drugs dissolved in HBSS-, as shown in the protocol below. UDCA 
and NorUDCA were perfused at three different concentrations, 10 nM, 100 nM and 1 µM, TC was 
perfused at 100 µM, the treatment protocol is shown below. After each experiment, HBSS- was 
perfused over the cells to confirm reversibility of the drugs. The duration of the videos taken for 
treatment with 0.1 mM TC and TC in combination with 1 µM UDCA or NorUDCA was 4 – 8s with a 
frame rate of 1 – 2 frames / ms. Analysis of the data was carried out using BV_Analyse v11.08 
(Brainvision, Scimedia) or Matlab. Examples of videos are shown in the Supplementary Materials on 
the DVD, showing calcium activation and propagation across the monolayer. 
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3.3.1 CELL  TOPOGRAPHY  OF  THE  NEONATAL  RAT,  HUMAN  FETAL  CARDIOMYOCYTES 
 
AND CDI 
 
 
A striking difference between adult cardiomyocytes and the other cell types is the general cell 
shape and volume. Adult cardiomyocytes are generally large, rectangular and more box-like, ‘rod- 
shaped’, with well organised sarcomeric Z-line striations, also called Z-grooves in which the 
transverse tubules (T-tubules) reside and crests between these Z-grooves (Gorelik, Yang, Zhang, et 
al., 2006). 
 
T-tubules are invaginations of the sarcolemma which facilitate the fast signalling of electrical 
signalling via their close association with adjacent sarcoplasmic reticulum, together the T-tubule and 
sarcoplasmic reticulum form a dyadic junction, or dyad (Brette & Orchard, 2003). The sarcoplasmic 
reticulum regulates contraction by controlling intracellular calcium ion levels. It releases stored 
calcium ions (Ca2+) during contraction and subsequently stores Ca2+ during relaxation (Imanaka- 
Yoshida, Amitani, Ioshii, et al., 1996). This well organised structure with the different microdomains, 
including dyads, caveolae and the contraction machinery is critical for the correct functioning of the 
cell and facilitates the fast signalling within the cell necessary for the synchronous contraction of the 
heart. CDI, human fetal and neonatal rat cardiomyocytes are much less well organised internally and 
on the surface, have a more round or star-shaped morphology and are generally much smaller. The 
heart continues to develop after the baby or rodent is born. It takes weeks or months, depending on 
the species, before the cardiomyocytes reach their final size and morphology as well as internal 
organisation in microdomains (Chen, Guo, Zhang, et al., 2013; Reynolds, Chiang, Wang, et al., 2013; 
Forbes, Hawkey & Sperelakis, 1984). 
 
The size, topography and morphology of neonatal rat cardiomyocytes, CDI and human fetal 
cardiomyocytes were compared to each other and the adult human cardiomyocytes. The size 
difference between cardiomyocyte from different origin is rather striking, even though there are 
3.3 CHARACTERISATION OF  CARDIOMYOCYTES 
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multiple types of human cardiomyocytes, the adult cardiomyocyte is much larger than either CDI or 
human fetal cardiomyocytes. The CDI and human fetal cardiomyocytes seem similar in size, although 
there are large variations in cell size within the same cell type. Generally, the neonatal rat 
cardiomyocytes are smaller, as can be expected due to the difference in size of the animal versus 
human. The neonatal rat, human fetal cardiomyocytes and CDI have a more similar morphology to 
each other than to adult rat or human cardiomyocytes. They are more often ‘fried egg’ shaped or  
star shaped and have a larger depth compared to fibroblasts which are relatively flat and spread out. 
The cell topography of the adult rat and human adult cardiomyocyte has been resolved by SICM 
previously (Nikolaev, Moshkov, Lyon, et al., 2010; Gorelik, Yang, Zhang, et al., 2006). These cells have 
a well-structured topography, with well-defined crests, Z-grooves and T-tubules [Figure 3.2a] 
(Gorelik, Yang, Zhang, et al., 2006). These cells are rod-shaped with an overall length of 
approximately 100 μm and depth of up to 25 μm. As can be seen in Figure 3.2 the human fetal 
cardiomyocytes (b), CDI (c) and neonatal rat cardiomyocytes (d) do not have the regular topography 
observed in human adult cardiomyocytes, the human fetal and neonatal rat cardiomyocytes have 
not yet developed the crests or Z-grooves nor T-tubules and are much smaller [Figure 3.2b-d]. 
 
The size of the whole human fetal hearts differed depending on gestation (gestations ranged 
between 12 and 16 + 6 weeks) and possibly due to differences in genetic background (all samples 
were obtained from fetuses with either Trisomy 13, 18 or 21) [personal observation]. The size 
(length) of a neonatal rat heart was approximately 5 mm, whilst the fetal hearts were slightly larger, 
more similar to the size of an adult rat or mouse heart (adult rat heart length is approximately 2 cm). 
This is potentially due to the difference in size of the different species, as well as the difference in  
the duration of pregnancy and development of the fetus. The fetal hearts were between 1 and 2 cm 
long, compared to a length of approximately 12 cm of an adult heart. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.2. REPRESENTATIVE SICM SCANS OF THE TOPOGRAPHY OF   CARDIOMYOCYTES 
Cardiomyocytes were plated as described previously and incubated in FRET buffer. 
a) SICM scans of 10 x 10 μm were carried out to resolve the well-organised structure of a 
human adult control CM. These CMs are approximately 100 μm and have a height of 
approximately 25 μm. To scan the total area of this CM is beyond the scope of the SICM microscope. 
b) Neonatal rat CMs are relatively small and ellipse shape and are 20 to 30 μm in length with a height of 5 – 10 μm. 
No topographical structures are visible in a high resolution 13x13 μm scan. c) Human fetal CMs were scanned to visualise 
their topography. They have a round or elongated shape and are 50 to 80 μm in length with a height of 5 – 10 μm. d) CDI 
are generally round in shape with a large nucleus in the middle, CDI are 50 to 100 μm in diameter or length with a height 
of 5 – 10 μm. No topographical structures are visible in a high resolution 15x15 μm scan. Scans reproduced with 
permission of Dr. Jose Sanchez-Alonso (Human adult) and Dr. Claire Poulet (CDI). 
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3.3.2 CARDIAC MARKERS OF  CARDIOMYOCYTES 
 
 
The localisation of cardiac markers was assessed in various types of cardiomyocytes using 
immunofluorescence. Neonatal rat, human fetal and iPS-derived cardiomyocytes from CDI and 
Axiogenesis were compared to human adult cardiomyocytes from transplant tissue. 
 
For the purpose of this thesis a variety of cardiac markers were chosen. These cardiac markers 
 
were α-Actinin [Figure 3.3, 3.4, 3.5 and 3.9], Junctophillin 2 [Figure 3.4 and 3.5], Caveolin 3 (Cav3) 
 
[Figure 3.6 and 3.7], cardiac Troponin T [Figure 3.7 and 3.8], Connexin43 (Cx43) [Figure 3.9] and 
Calsequestrin 2 [Figure 3.10], although no immunofluorescence staining of the human fetal 
cardiomyocytes was carried out for Calsequestrin 2 and cardiac Troponin T, due to insufficient 
samples. α-Actinin and cardiac Troponin T were often used as a marker to visualise the shape of the 
cell. These proteins are well-organised in the adult cardiomyocytes. These patterns are not yet 
established in (human) fetal and (rat) neonatal cardiomyocytes and nor in the CDI. 
 
α-Actinin is an actin-binding protein which plays a key role in the formation and maintenance of 
Z-lines in a cardiomyocyte. It is therefore an important marker for the maturity  of  the 
cardiomyocyte, as organisation of the t-tubular system along the z-lines becomes progressively 
structured during maturation of cardiomyocytes after birth. In human adult cardiomyocytes α- 
Actinin forms a well-organised, striated pattern along the Z-lines of the cardiomyocyte [Figure 3.3c]. 
In CDI [Figure 3.3a], human fetal [Figure 3.3b] and neonatal rat cardiomyocytes [Figure 3.3d] α- 
Actinin distribution is not so well organised yet and it forms more of a random pattern and although 
there are meandering striated tracks visible these are not organised along the length of the cell nor 
parallel to each other. In the human fetal and neonatal rat cardiomyocytes the maturation of the 
heart after birth includes the re-organisation of the Z-lines and therefore α-Actinin into the well- 
structured state of the adult cardiomyocyte. 
 
 
 
 
 
 
 
Page | 112 
  
 
FIGURE 3.3. LOCALISATION OF αACTININ IN  CARDIOMYOCYTES 
 
 
α-Actinin (mouse 488 or 546) is an actin-binding protein which plays a key role in the formation and maintenance of Z-lines in a 
cardiomyocyte. Therefore, in human adult cardiomyocytes (CMs), α-Actinin forms a well-organised, striated pattern along the Z-lines of the 
cardiomyocyte (c). In CDI (a), human fetal (b) and neonatal rat CMs (d) α-Actinin distribution is not so well arranged yet and it forms 
disorganised pattern, and although there are meandering striated tracks visible these are not organised along the length of the cell nor 
parallel to each other. Scale bar: 20 µm (a, b, d). In c) scale bar: 50 µm (left) or 20 µm (middle, right). 
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Junctophillin 2 plays a critical role in maintaining the space between the plasma membrane and 
the sarcoplasmic reticulum allowing for fast signalling upon influx of calcium ions. Human adult 
cardiomyocytes have high expression levels of Junctophillin 2, which is localised in the dyads, a 
microdomain of the cardiomyocyte consisting of a T-tubule and adjacent sarcoplasmic reticulum 
[Figure 3.5b]. The close proximity of these allows for the rapid transmission of the excitatory signals 
that leads to the contraction of the cardiomyocyte. Neonatal rat [Figure 3.4 a], human fetal 
cardiomyocytes [Figure 3.4b] and CDI [Figure 3.5a] also express Junctophillin 2 but this is not 
organised. The organisation and localisation of Junctophillin 2 continues to mature after birth with 
the development of the t-tubular system, therefore, Junctophillin 2 is a marker for maturity of 
cardiomyocytes (Chen, Guo, Zhang, et al., 2013; Reynolds, Chiang, Wang, et al., 2013). 
 
Cav3 is localised along the sarcolemma of the cardiomyocytes, where it forms caveolae, which 
are invaginations of the cell membrane (Wright, Nikolaev, O’Hara, et al., 2014; Galbiati, Engelman, 
Volonte, et al., 2001; Al-Qusairi & Laporte, 2011; Ziman, Gómez-Viquez, Bloch, et al., 2010).  
Caveolae allow for the close association of a number of receptors, including the β2 adrenergic 
receptor, channels, such as the L-type Calcium channel and regulatory proteins, such as CAM kinase 
(Wright, Nikolaev, O’Hara, et al., 2014). Cav3 is important for cell signalling and expression and is 
thought to play a role in the formation of T-tubules during development (Ziman, Gómez-Viquez, 
Bloch, et al., 2010). In adult cardiomyocytes Cav3 has a clear striated pattern with increased 
localisation at the cell membrane [Figure 3.6d], whilst in the human fetal [Figure 3.6a], neonatal rat 
[Figure 3.6b] and CDI [Figure 3.6c and 3.7] this pattern is not as clear. Not all CDI cells seem to 
express it in equal amounts, as there are CDI with and without Cav3 in Figure 3.7. In human fetal 
cardiomyocytes [Figure 3.6a] the density of Cav3 does not seem always equally distributed within 
the cell, some cells have to have larger aggregation of Cav3 near the centre of the cells, whilst in 
other the density seems reasonably evenly distributed. 
Page | 115  
 
FIGURE 3.4. LOCALISATION OF JUNCTOPHILLIN 2 IN NEONATAL RAT AND HUMAN FETAL 
CARDIOMYOCYTES 
 
Junctophillin 2 (goat 488) plays a critical role in maintaining the space between the plasma 
membrane and the sarcoplasmic reticulum allowing for fast signalling upon influx of calcium ions. 
Neonatal rat (a) and human fetal cardiomyocytes (CMs) (b) express Junctophillin 2, although 
expression and organisation of Junctophillin 2 increases with maturity of the CMs making it a good 
marker to assess maturity of CMs. α-Actinin (mouse 546) was used as a positive control to visualise 
the cell shape. Scale bar: 20 µm a) and b) (top and middle) or b) 25 µm (bottom). 
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FIGURE 3.5. LOCALISATION OF JUNCTOPHILLIN 2 IN CDI AND HUMAN ADULT   CARDIOMYOCYTES 
 
Junctophillin 2 (goat 488 or 546) plays a critical role in maintaining the space between the plasma 
membrane and the sarcoplasmic reticulum allowing for fast signalling upon influx of calcium ions. CDI (a) 
express Junctophillin 2. Maturation of Junctophillin-2 organisation occurs after birth and continues as the 
cells mature to adult cardiomyocytes (CMs). b) Human adult CMs have well-structured Junctophillin-2 
organisation necessary for the transmission of the excitation signals. 
α-Actinin (mouse 488 or 546) or cardiac Troponin T (rabbit 546) was used as a positive control to  
visualise the cell shape. Scale bar: 20 µm. 
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FIGURE 3.6. LOCALISATION OF CAVEOLIN 3 IN HUMAN FETAL, HUMAN ADULT AND NEONATAL RAT CARDIOMYOCYTES AND CDI 
 
Caveolin 3 (Cav3) is localised along the sarcolemma of the cardiomyocytes (CMs), where it forms caveolae, which are invaginations of the cell membrane. 
Caveolae allow for the close association of a number of receptors, including the β2 adrenergic receptor, L-type Calcium channels and regulatory proteins. It 
is important for cell signalling. In adult CMs CAV3 (d) has a clear striated pattern with increased localisation at the cell membrane (d), whilst in the human 
fetal (a)], neonatal rat (b) and CDI (c) this pattern is not as clear. Human adult images reproduced with permission of Dr. Claire Poulet. Scale bar: 20 µm. 
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FIGURE 3.7. LOCALISATION OF CAVEOLIN 3 IN   CDI 
 
Caveolin 3 (Cav3, mouse 488) is localised along the sarcolemma of the cardiomyocytes (CMs), where it forms caveolae 
together with a variety of other proteins. It is important for cell signalling. In adult CMs it has a clear striated pattern 
whilst in CDI this pattern is not as clear. In CDI the expression of Cav3 seems to be cell density depended, as not all CDI 
cells seem to express it.  In the bottom panel only one cell seems to express Cav3 at the membrane. Cardiac Troponin  
T (rabbit 546) was used to visualise the shape of the CDI. Scale bar: 20 µm. 
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Cardiac Troponin T is part of the troponin-tropomyosin complex and is essential for contraction  
of the cardiomyocyte. It is highly expressed in adult cardiomyocytes [Figure 3.8c], CDI [Figure 3.8a] 
and neonatal rat cardiomyocytes [Figure 3.8b] and is therefore a good marker to use as a positive 
control whilst antibody testing or as a marker for cell morphology, to identify the size and shape of 
the cell. 
 
Cx43 is an important gap junctional protein, which allows for cell-cell coupling and 
communication between cells. In adult cardiomyocytes the majority of Cx43 is localised at the 
intercalated disc between two cells, although CM – FB coupling is also possible. Cx43 is located along 
the edges of the cardiomyocytes, where they form gap junctions with other cells. Due to the more 
round morphology of the human fetal [Figure 3.9a], neonatal rat cardiomyocytes [Figure 3.9b] and 
CDI [Figure 3.9c], Cx43 is localised around the whole cell, not just at opposite edges like in adult 
cardiomyocytes. In subsequent chapters the interaction between cardiomyocytes and fibroblasts  
and the involvement of CM - FB coupling is explored further (Chapter 5). 
 
Finally, Calsequestrin 2 is a calcium-binding protein of the sarcoplasmic reticulum and is 
expressed in CDI [Figure 3.10a] and neonatal rat cardiomyocytes [Figure 3.10b] as well as in adult 
cardiomyocytes [Figure 3.10c]. The sarcoplasmic reticulum regulates the levels of cytoplasmic Ca2+ in 
the cardiomyocytes, it releases calcium upon activation of the Ryanodine Receptor, whilst 
Calsequestrin 2 functions as a calcium storing protein (Ioshii, Imanaka-Yoshida & Yoshida, 1994). 
During cardiomyocyte development there is a switch from Calreticulin, a functional homologue of 
Calsequestrin, to Calsequestrin (Imanaka-Yoshida, Amitani, Ioshii, et al., 1996). This is due to the 
development from endoplasmic reticulum storage of Ca2+ facilitated by Calreticulin to   sarcoplasmic 
reticulum storage of Ca2+ facilitated by Calsequestrin (Imanaka-Yoshida, Amitani, Ioshii, et al., 1996). 
 
This makes Calsequestrin a potential marker for fetal cardiac development. 
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FIGURE 3.8. LOCALISATION OF CARDIAC TROPONIN   
T IN CARDIOMYOCYTES 
 
Cardiac Troponin T (rabbit 488 or 546) is part of the 
troponin-tropomyosin complex and is essential for 
contraction of the cardiomyocyte (CM). It is highly 
expressed in adult CMs (c), CDI (a) and neonatal rat CMs 
(b). Scale bar: 20 µm. 
  
 
FIGURE 3.9. LOCALISATION OF CONNEXIN43 IN HUMAN FETAL, NEONATAL RAT CARDIOMYOCYTES AND   CDI 
 
Connexin43 (Cx43) is an important gap junctional protein, which allows for cell-cell coupling and communication between cells. In adult CMs the majority 
of Cx43 is localised at the intercalated disc between two cells, although CM – FB coupling is also possible. Cx43 is located along the edges of the CMs, 
where they form gap junctions with other cells. Due to the more round morphology of the human fetal (a), neonatal rat CMs (b) and CDI (c), Cx43 is 
localised around the whole cell, not just at opposite edges like in adult CMs. α-Actinin (mouse 546) was used to visualise the shape of the human fetal 
CMs, whilst Cx43 is shown in green (rabbit 488) (b). Cx43 is shown in red (rabbit 546) in b) and c). Scale bar: 20 µm. Page | 121 
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FIGURE 3.10. LOCALISATION OF CALSEQUESTRIN 2 IN  CARDIOMYOCYTES 
 
Calsequestrin 2 (rabbit 488 in a) or 546 in b)) is a calcium-binding protein of the 
sarcoplasmic reticulum and is expressed in CDI (a) and neonatal rat cardiomyocytes 
(CMs) (b) as well as in adult CMs (c). α-Actinin (mouse 488 in a) or 546 in b)) was used as 
a control for staining and to visualise the cell shape. Scale bar: 20 µm (a,b), or 50 µm (c). 
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Many bile acid receptors have now been described, including FXR, the Muscarinic receptors and 
TGR5. It was previously shown that FXR, even though it is expressed in neonatal cardiomyocytes, is 
probably not involved in bile acid signalling in the neonatal rat cardiomyocyte (Kadir, Miragoli, Abu- 
Hayyeh, et al., 2010). 
 
Previously, expression of the Muscarinic M2 receptor was observed in neonatal rat 
cardiomyocytes and that M2 is involved in TC induced arrhythmias (Kadir, Miragoli, Abu-Hayyeh, et 
al., 2010). But, no TGR5 was detected with the antibody used [Antibody from Dr. Keitel], but this  
may be due to specificity of the antibody (Keitel, Cupisti, Ullmer, et al., 2009; Keitel, Ullmer & 
Häussinger, 2010; Kadir, Miragoli, Abu-Hayyeh, et al., 2010). Using a new antibody kindly provided to 
us by Prof. Nigel Bunnett, TGR5 was detected in neonatal rat cardiomyocytes (Poole, Godfrey, 
Cattaruzza, et al., 2010). Therefore, characterisation of TGR5 in neonatal rat, human fetal and adult 
rat cardiomyocytes as well as iPS-derived cardiomyocytes was carried out using this antibody. 
 
Miragoli et al. (2011) showed the necessity of investigating the influence of bile acids and 
potentially the expression of bile acid receptors in fibroblasts, not only cardiomyocytes (Miragoli, 
Kadir, Sheppard, et al., 2011). There is little know about the expression and localisation of bile acid 
receptors in cardiac fibroblasts. Therefore TGR5 protein localisation in neonatal rat, human fetal and 
human adult fibroblasts was carried out. 
3.4 BILE ACID RECEPTORS IN CARDIOMYOCYTES &   FIBROBLASTS 
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3.4.1 TGR5 IN CARDIOMYOCYTES &   FIBROBLASTS 
 
 
Prof. Nigel Bunnett’s rabbit antibody was used for all TGR5 staining shown, it will be in future 
referred to as NB antibody, whilst the Secondary only (Alexa-Fluor488 donkey-anti-rabbit) was used 
as a negative control. Figures are representative images of TGR5 and DAPI. In contrast to  the 
antibody used previously by Sheik Abdul Kadir et al. (2010), this antibody did detect TGR5 in the 
neonatal rat cardiomyocytes and fibroblasts [Appendix A1] (Kadir, Miragoli, Abu-Hayyeh, et al., 
2010). In addition, in our lab expression of TGR5 RNA was shown in both neonatal rat 
cardiomyocytes and fibroblasts, although the expression level was very low [unpublished data].  
TGR5 was also detected in human fetal cardiomyocytes and fibroblasts [Appendix A1]. TGR5 was  
also detected in both the iPS-derived cardiomyocytes from CDI and Axiogenesis [Figure 3.11a and 
3.11b respectively], but was interestingly, was not detected in the adult rat cardiomyocytes [Figure 
3.12]. Interestingly, TGR5 was detected in human adult fibroblasts from dilated cardiomyopathy, in 
contrast to the adult cardiomyocytes [Figure 3.13]. 
 
TGR5 was not assessed previously in neonatal rat fibroblasts. For the first time, TGR5 was 
detected in neonatal rat and human fetal fibroblasts [Figures 3.14a and 3.14b respectively]. These 
findings may be of import to the studies whether TGR5 is involved in bile acid signalling in the heart 
and this is currently under investigation in our group [unpublished data]. 
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a) CDI b) Axiogenesis-CM 
 
FIGURE 3.11. TGR5 WAS ALSO DETECTED IN THE IPS-DERIVED CMS: CDI AND AXIOGENESIS 
CARDIOMYOCYTES 
 
a) Localisation of TGR5 in cultured iPS-derived cardiomyocytes (CMs) from CDI. Scale bar: 20 µm 
(bottom) and 15 µm (top 2 sets). CDI also appear to express TGR5. 
b) TGR5 was detected in cultured iPS-derived CMs from Axiogenesis. Scale bar: 50 µm. 
Both CDI and Axiogenesis cardiomyocytes were fixed in methanol before staining with the NB 
antibody provided by Prof. Nigel Bunnett (rabbit; secondary: donkey-anti-rabbit-488). 
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FIGURE 3.12. TGR5 WAS NOT DETECTED IN 
ADULT RAT CARDIOMYOCYTES 
 
TGR5 was not detected in cultured adult rat 
cardiomyocytes (CMs. Adult rat CMs were cultured 
as described previously and fixed in Methanol 
before staining with: a) the NB antibody provided  
by Prof. Nigel Bunnett (rabbit; secondary: donkey- 
anti-rabbit-488) scale bars: 50 µm (top) and 10 µm 
(bottom). b) The negative control of an adult rat 
cardiomyocyte stained with secondary  antibody 
only (donkey-anti-rabbit-488). Scale bar: 50 µm. 
TGR5 expression was shown for the first time in   adult 
human fibroblasts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.13. TGR5 IN HUMAN ADULT 
FIBROBLASTS 
 
TGR5 was detected in cultured human adult  
fibroblasts (FBs) from a patient with dilated 
cardiomyopathy. Human adult FBs were cultured as 
described previously and fixed in Methanol before 
staining with the NB antibody provided by Prof. Nigel 
Bunnett (rabbit; secondary: donkey-anti-rabbit-488). 
Scale bar: 20 µm. 
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a) Neonatal Rat Fibroblasts b) Human Fetal Fibroblasts 
 
FIGURE 3.14. FOR THE FIRST TIME, TGR5 WAS DETECTED IN NEONATAL RAT AND HUMAN 
FETAL FIBROBLASTS 
 
a) The localisation of TGR5 in neonatal rat fibroblasts (FBs) was shown for the first time. 
b) The localisation of TGR5 in human fetal FBs was shown for the first time. 
FBs were cultured as described previously and fixed in Methanol before staining with the NB 
antibody provided by Prof. Nigel Bunnett (rabbit; secondary: donkey-anti-rabbit-488). Scale bar:   20 
µm. 
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For the work presented in the next section, a number of different models of the fetal heart were 
used. Firstly, a neonatal rat model of the fetal heart was used, consisting of neonatal rat CMs + 
MFBs, based on previous work carried out in our group (Miragoli, Kadir, Sheppard, et al., 2011). 
Subsequently a human model of the fetal heart using iPS-derived cardiomyocytes from CDI was 
developed, in the first instance consisting of CDI only, but will in future also be investigated in co- 
culture with human fetal fibroblasts from fetal tissues. Finally, a human fetal model using human 
fetal cardiomyocytes and fibroblasts was used. For this, cardiomyocytes were plated, but due to 
natural ‘contamination’ of fibroblasts, a co-culture model was prepared. 
 
The interaction between cardiomyocytes and myofibroblasts in these models was characterised  
in the first instance, to confirm that there were both cardiomyocytes and fibroblasts in the culture 
and that these interacted via GJs with each other. Figure 3.15 shows the interaction between CDI 
only [Figure 3.15a top], CDI + human fetal fibroblasts [Figure 3.15a bottom], human fetal 
cardiomyocytes + fibroblasts [Figure 3.15b] and neonatal rat cardiomyocytes + myofibroblasts 
[Figure 3.15c]. 
3.5 MODELS OF THE FETAL  HEART 
  
 
FIGURE 3.15. INTERACTION BETWEEN CARDIOMYOCYTES AND  FIBROBLASTS 
 
 
The culture models used in this project were characterised by staining for cardiomyocytes (CMs, αActinin), fibroblasts (FBs, Vimentin, αSMA) and 
Connexin43. a) CDI make functional gap junctions when cultured alone (top) and with human fetal FBs (bottom). Scale bar: 10, 5, 10 µm 
respectively from top to bottom. b) When plating human fetal CMs there is a contamination with FBs, which proliferate are interspersed  
between the CMs. Human fetal CMs and FBs make functional gap junctions. Scale bar: 20 µm. c) Neonatal rat CMs and FBs cultured together 
form clusters of cells. Scale 50 µm. 
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The exact mechanisms through which bile acids induce arrhythmias in the human fetal heart 
remain unclear although a number of studies using neonatal rat cardiomyocytes have shown that 
bile acids can affect the heart in these models. Previous studies demonstrated that the bile acid TC 
can alter the rate and rhythm of cardiomyocyte contraction in both single cells and in a monolayer, 
as well as causing abnormal Ca2+ dynamics of single cells (Gorelik et al., 2002, Williamson et al., 
2001). 
 
But cardiomyocytes are not the only cells in the heart, fibroblasts make up a large proportion of 
cells during development and may therefore also be affected by bile acids (Banerjee, Fuseler, Price, 
et al., 2007). Miragoli et al. (2011) showed that there was a transient appearance of αSMA positive 
myofibroblasts with increasing gestation, with increasing myofibroblast density as pregnancy 
progresses [Figure 3.16] (Miragoli, Kadir, Sheppard, et al., 2011). This led to the adaptation of the 
neonatal rat heart model to the fetal heart model consisting of neonatal rat cardiomyocytes coated 
with neonatal rat myofibroblasts, which will also be used in this thesis. A neonatal rat cardiomyocyte 
only model was used to simulate the maternal heart (Miragoli, Kadir, Sheppard, et al., 2011). Using 
these models, Miragoli et al. (2011) showed that TC induces arrhythmia only in the fetal heart model 
(CM + MFB) (Miragoli et al., 2011). The main characteristics of arrhythmia induced by TC were a 
reduction of the contraction rate, decreased amplitude of contraction, calcium overload, irregularity 
of contraction within a beating cell and desynchronization of a network of cardiomyocytes (Miragoli, 
Kadir, Sheppard, et al., 2011; Williamson, Gorelik, Eaton, et al., 2001; Gorelik, Harding, Shevchuk, et 
al., 2002; Sheikh Abdul Kadir, Miragoli, Abu-Hayyeh, et al., 2010). 
 
Miragoli et al. (2011) showed that UDCA can protect against these arrhythmic properties of TC, if 
incubated simultaneously with TC in the neonatal rat model of the fetal heart. The study found that 
co-incubation of UDCA with TC abolishes the arrhythmic effect of TC in the fetal heart model 
(Miragoli et al., 2011). Conduction velocity was shown to be increased upon treatment with UDCA in 
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the fetal heart model (CMs + MFBs), but did not change in the maternal heart (CMs only) (Miragoli, 
Kadir, Sheppard, et al., 2011). 
 
The protective effect of UDCA in the neonatal rat model was shown to be due to the 
hyperpolarisation of myofibroblasts (Miragoli, Kadir, Sheppard, et al., 2011). This led to the question 
whether NorUDCA, shown to be effective against fibrosis by targeting fibroblasts, may be more 
beneficial for the fetus than UDCA. This question will be addressed in the subsequent sections of this 
chapter. 
 
Following on from previous neonatal rat work, the fetal heart model has been expanded upon 
using human cardiomyocytes and fibroblasts, in the form of the human iPS-derived cardiomyocyte 
cell line CDI and primary isolated human fetal cardiomyocytes and fibroblasts from fetal hearts of 
fetuses obtained from surgical terminations of pregnancy (gestation 12 – 17 wks) terminated due to 
genetic abnormalities, which are the subject of the final sections of this chapter. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.16. TRANSIENT APPEARANCE OF MYOFIBROBLASTS IN THE HUMAN FETAL   HEART 
 
a) Top: Immunohistochemistry of αSmooth Muscle Actin (αSMA) was used to identify cardiac myofibroblasts (MFBs) in human ventricular tissue from 
fetuses of various gestations. In second trimester tissues scattered MFBs can be seen (in dark brown), with increased density of αSMA positive areas  
during the third trimester. These disappeared after birth, as the only αSMA positive areas in the postnatal heart were smooth muscle cells lining the blood 
vessels. Scale bar: 100 µm. Bottom: High magnification images show MFBs in contact with neighbouring cardiomyocytes. Scale bar: 10 µm. b) Analysis of 
the MFB density. A transient increment of MFB density can be seen with increasing gestation. MFB density was analysed from fixed preparations of fetal 
hearts from different gestations, 10 random locations were analysed per heart (Mean ± Standard Deviation). c) Staining of an infarcted human heart, 
abundant MFB presence can be seen as indicated by the αSMA staining. Scale bar: 100 µm. Page | 132 
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Ursodeoxycholic acid or UDCA has been in use as treatment for ICP for a few years now and is 
undergoing currently in clinical trials for ICP as well as adult heart disease, but the effects of UDCA  
on the fetus are still under investigation. Geenes et al. (2014) showed that in ICP pregnancies  
treated with UDCA 0.6 – 2.60 µmol/L UDCA was measured in cord blood samples (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014). 
 
Miragoli et al. also used UDCA (100 nM) for prevention of arrhythmias in the fetal heart model 
(Miragoli, Kadir, Sheppard, et al., 2011). But the toxicity of UDCA in neonatal rat cardiomyocytes and 
myofibroblast has not yet been investigated, nor has the effect of NorUDCA been investigated in 
neonatal rat cardiomyocytes and myofibroblasts. 
 
Optical recording of calcium transients and action potentials was carried out. Excitation leads to 
action potentials of the cardiomyocyte, which can be visualised by a voltage sensitive dye. After 
excitation of the cardiomyocyte and the initiation of an action potential, internal calcium is  
mobilised which results in a calcium transient and subsequently activates contraction machinery 
which leads to cardiomyocyte contraction. Changes in action potentials and calcium transients can 
provide insight into cardiomyocyte electrophysiological and calcium abnormalities and therefore  
into arrhythmias. 
3.7 THE EFFECT OF UDCA AND NORUDCA ON THE NEONATAL RAT    MODELS 
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3.7.1 THE EFFECT OF UDCA AND NORUDCA ON NEONATAL RAT    CARDIOMYOCYTES 
 
 
Miragoli et al. (2011) previously used preplated neonatal rat cardiomyocytes on their own as a 
model for the maternal heart (Miragoli, Kadir, Sheppard, et al., 2011). To investigate whether UDCA 
or NorUDCA had any toxic effect on the maternal heart model, optical recording of Calcium 
transients using Fluo4 was carried out. 
 
No significant difference was found between the calcium transient duration (90%) of baseline 
HBSS- control (333.0 ms ± 8.4; n = 66 recordings, i = 6 isolations, p > 0.05) and the increasing 
concentrations of UDCA used: : 10 nM (389.3 ms ± 22.6; n = 7, i = 2), 100 nM (338.2 ms ± 12.7; n =  
28, i = 2) and 1 μM (345.0 ms ± 19.0; n = 10, i = 2) [Figure 3.17a], as analysed by a One-Way ANOVA 
with post-tests. This indicated that UDCA would not be toxic for cardiomyocytes at the levels used 
here and levels found to cross the placenta in ICP pregnancies treated with UDCA (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014). In addition, UDCA has no lasting negative effects, as it can be 
washed out, as measured by the calcium transient duration of control solution after the incubation 
of UDCA (372.0 ms ± 25.89; n = 10, i = 2 isolations, p > 0.05) when compared to control. 
 
In addition, time to peak was not affected in the cardiomyocytes only cultures [Figure 3.17c] after 
treatment with 10 nM (80.1 ms ± 7.0), 100 nM (89.9 ms ± 7.5) or 1 µM UDCA (78.0 ms ± 6.6) 
compared to control (79.4 ms ± 2.9; p > 0.05). 
 
NorUDCA was also shown to reduce inflammation and fibrosis by inhibition of myofibroblast 
(MFB) proliferation (Fickert et al., 2006). NorUDCA was kindly provided by Prof. Michael Trauner in 
order to compare UDCA with NorUDCA. No significant difference was found between the calcium 
transient duration (90%) of baseline HBSS- control (444.2 ms ± 8.23; n = 15, i = 2 p > 0.05) and the 
increasing concentrations of NorUDCA used: 10 nM (474.8 ms ± 11.18; n = 5, i = 2), 100 nM (414.9  
ms ± 9.32; n = 5, i = 2) and 1 µM (465.0 ms ± 7.45; n = 9, i = 2) [Figure 3.17b], as analysed by a One- 
Way ANOVA with post-tests. This indicated that NorUDCA would also not be toxic for  
cardiomyocytes at the levels used here. In addition, NorUDCA has no lasting effects negative effects, 
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as it can be washed out, as measured by the calcium transient duration of control solution after the 
incubation of UDCA (462.0 ms ± 10.60; n = 7, i = 2, p > 0.05) when compared to control. 
 
To ensure any changes in duration over time were not due to bleaching of the cells, the changing 
of solutions or the time on the system, a set of recordings was carried out with control HBSS- 
solutions which were changed as it would when a treatment was carried out [Figure 3.17c]. No 
significant differences in the calcium transient duration (90%) of baseline control (329.4 ms ± 19.57; 
n = 6, i = 2, p > 0.05) and Time matched control (308.0 ms ± 10.33; n = 11, i = 2) was found. This 
indicated that there was no effect from the system on any subsequent treatments carried out. 
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FIGURE 3.17. UDCA AND NorUDCA DO NOT AFFECT CALCIUM TRANSIENTS OF  NEONATAL  
RAT CARDIOMYOCYTES 
 
Cardiomyocytes (CMs) were seeded on 22 cm coverslips. After 4 days in culture the Calcium duration 
was assessed under control conditions (vehicle, 35°C) and after increasing concentrations of a) 
Ursodeoxycholic acid (UDCA) or b) NorUrsodeoxycholic acid (NorUDCA) treatment. c) As a time and 
perfusion control; control recordings were carried out, after which the vehicle was reperfused over 
CMs as it would be changed for treatments. No significant differences was found between the first 
set of recordings and second. Treatment with either UDCA (a) or NorUDCA (b) does not significantly 
affect calcium duration of neonatal rat CMs, nor time to peak (c). Calcium was recorded using the 
dye Fluo4 AM and videos of 0.5s were recorded for control (vehicle), treatment (10 nM, 100 nM or 1 
µM) with UDCA or NorUDCA and wash-out (vehicle) to show that any effect was reversible. No 
significant difference in treatment with UDCA or NorUDCA was found compared to control, as 
analysed with a One-way ANOVA and post-tests (values represented as MEAN ± SEM). N represents 
the number of traces for each treatment category; multiple isolations were used per category. 
This indicates that UDCA and NorUDCA are not toxic to cardiomyocytes at the concentrations used. 
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3.7.2 THE EFFECT OF  UDCA AND NORUDCA ON  NEONATAL RAT CARDIOMYOCYTES   AND 
 
MYOFIBROBLASTS 
 
 
Miragoli et al. (2011) previously used neonatal rat cardiomyocytes and myofibroblasts as a model 
for the fetal heart (Miragoli, Kadir, Sheppard, et al., 2011). To investigate whether UDCA or  
NorUDCA had any toxic effect on the fetal heart model, optical recording of calcium transients using 
Fluo4 was carried out. 
 
No significant difference was found between the calcium transient duration (90%) of baseline 
control (382.7 ms ± 7.3; n = 77, i = 6, p > 0.05) and the increasing concentrations of UDCA used: 10 
nM (394.3 ms ± 5.4; n = 71, i = 2), 100 nM (337.4 ms ± 11.0; n = 35, i = 2), 1 μM (407.6 ms ± 4.0; n = 
38, i = 2) and 100 µM UDCA (444.1 ms ± 3.1; n = 6, i = 2) [Figure 3.18a], as analysed by a One-Way 
ANOVA with post-tests. This indicated that UDCA would not be toxic to cardiomyocytes and 
myofibroblasts at the levels used here and levels found to cross the placenta in ICP pregnancies 
treated with UDCA (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). 
 
In addition, time to peak was not affected neither in the co-cultures [Figure 3.18c] after 
treatment with 10 nM (47.5 ms ± 1.2), 100 nM (48.7 ms ± 2.0) or 1 µM UDCA (48.0 ms ± 1.8) 
compared to control (48.2 ms ± 2.1; p > 0.05). 
 
Finally, no significant difference was measured in the total calcium amplitude (ΔF/F0 ) in the co- 
cultures [Figure 3.18d] after treatment with 10 nM (57.2 a.u. ± 1.7), 100 nM (43.4 a.u. ± 1.6) or 1 µM 
UDCA (53.9 a.u. ± 1.9) compared to control (53.2 a.u. ± 2.6; p > 0.05). 
 
 
No significant difference was found between the calcium transient duration (90%) of baseline 
control (402.9 ms ± .3.19; n = 69, i = 6, p > 0.05) and the increasing concentrations of NorUDCA used: 
10 nM (385.0 ms ± 4.82; n = 35, i = 2), 100 nM (393.7 ms ± 6.09; n = 35, i = 2) and 1 µM (402.2 ms ± 
4.68; n = 33, i = 2) [Figure 3.18b], as analysed by a One-Way ANOVA with post-tests. This indicated 
that NorUDCA would also not be toxic for cardiomyocytes at the levels used here. 
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These results are important, as a small amount of UDCA crosses the placenta in women with ICP 
pregnancies treated with UDCA (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). In addition, if 
UDCA or NorUDCA was to be developed as a treatment against bile acid arrhythmias in the fetus, 
toxicity of either UDCA or NorUDCA would endanger the fetus further and would therefore be 
unusable as a treatment. 
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FIGURE 3.18. UDCA AND NorUDCA DO NOT AFFECT CALCIUM TRANSIENTS OF  
NEONATAL RAT CARDIOMYOCYTES WHEN CULTURED WITH  MYOFIBROBLASTS 
 
Cardiomyocytes (CMs) were seeded on 22 cm coverslips and after 24h topped with  
myofibroblasts (MFBs). After 4 days in culture the Calcium duration was assessed under control 
conditions (vehicle, 35°C) and after increasing concentrations of a) Ursodeoxycholic acid (UDCA) 
or b) NorUrsodeoxycholic acid (NorUDCA) treatment. 
Treatment with either UDCA (a) or NorUDCA (b) does not significantly affect calcium duration of 
neonatal rat CMs when cultured with MFBs. UDCA also did not affect time to peak (c) or 
amplitude (ΔF/F0,d). Calcium was recorded using the dye Fluo4 AM and videos of 0.5s were 
recorded for control (vehicle), treatment (10 nM, 100 nM or 1 µM) with UDCA or NorUDCA and 
wash-out (vehicle) to show that any effect was reversible. No significant difference in treatment 
with UDCA or NorUDCA was found compared to control, as analysed with a One-way ANOVA and 
post-tests (values represented as MEAN ± SEM). N represents the number of traces for each 
treatment category; multiple isolations were used per category. 
This indicates that UDCA and NorUDCA are not toxic to cardiomyocytes and myofibroblasts at the 
concentrations used. 
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3.8.1 TC INDUCED PROLONGATION OF CALCIUM TRANSIENTS IS ATTENUATED BY    UDCA 
 
AND NORUDCA IN THE NEONATAL RAT MODEL OF THE FETAL    HEART 
 
 
Miragoli et al. (2011) previously showed that UDCA attenuated TC induced conduction velocity 
slowing and prevented TC induced re-entries in the fetal heart model (Miragoli, Kadir, Sheppard, et 
al., 2011). To expand upon this work, the effect of TC alone and in combination with UDCA or 
NorUDCA was investigated in the fetal heart model using optical recording of calcium transients. 
Excitation of the cell leads to internal calcium mobilisation which results in a calcium transient and 
which subsequently activates the contraction machinery which leads to cardiomyocyte contraction. 
A comparison between UDCA and NorUDCA was made to see whether either or both were able to 
prevent TC induced abnormalities in calcium signalling [Figure 3.19 and 3.20 respectively]. 
 
Addition of 0.1 mM TC (608.8 ms ± 23.3; n = 8, i = 4, p ≤ 0.001) significantly prolonged the calcium 
duration in comparison to control (382.0 ms ± 72.2; n = 18, i = 4), whilst 0.1 mM TC in combination 
with 1 µM UDCA (326.3 ms ± 95.3; n = 8, i = 2)  and 1 µM NorUDCA (357.0 ± 52.82; n = 10, i = 2) 
showed a similar calcium duration as was seen in control [Figure 3.19a and 3.20a]. A significant 
reduction in duration was seen when comparing 0.1 mM TC (608.8 ms ± 23.3) and 0.1 mM TC + 1 µM 
UDCA (326.3 ms ± 95.3; p ≤ 0.05) [Figure 3.19a]. When TC was incubated with 1 µM NorUDCA, 
NorUDCA (357.0 ms ± 16.70; p ≤ 0.05) was also capable of attenuating the TC induced increase in 
calcium duration [Figure 3.20a]. 
 
The time it takes until the peak of the calcium transient, which is the time it takes for all the 
calcium to be released from the sarcoplasmic reticulum after Ryanodine Receptor activation can be 
measured by calculating the time it takes from the start of the transient until peak amplitude. There 
is a significant increase in time needed for the full release of calcium after TC (69.73 ms ± 4.1; p ≤ 
0.001) treatment compared to control (50.08 ms ± 1.6). This was attenuated by UDCA treatment 
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together with TC (54.38 ms ± 4.0; p ≤ 0.05) [Figure 3.19b] and by NorUDCA treatment together with 
TC (45.25 ms ± 1.47; p < 0.001) [Figure 3.20b]. 
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FIGURE 3.19. UDCA ATTENUATES CALCIUM TRANSIENT DURATION PROLONGATION INDUCED BY   TC 
 
a) Incubation with 1 µM Ursodeoxycholic acid (UDCA) with 0.1 mM Taurocholic acid (TC) attenuates the increase 
in calcium duration seen after incubation with 0.1 mM TC alone. TC treatment increased calcium duration 
significantly (608.8 ± 23.29) in comparison to control (382.0 ± 17.01). The reduction TC with UDCA (326.3 ±  
42.61) was significant in comparison to TC, leading to a return to baseline values. b) The time to full calcium 
release (peak of the calcium trace) was calculated for each treatment. There is a significant increase in time 
needed for the full release of calcium after TC (69.73 ± 4.12) treatment compared to control (50.08 ± 1.62). This 
was attenuated by UDCA treatment together with TC (54.38 ± 3.98). N = number of dishes (preparations) from 
multiple isolations and multiple traces (5 – 10 / treatment) were taken per dish and averaged. Values represent 
MEAN ± SEM. *** p ≤ 0.001, * p ≤ 0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.20. NorUDCA ATTENUATES CALCIUM TRANSIENT DURATION PROLONGATION INDUCED BY   TC 
 
a) Incubation with 1 µM NorUrsodeoxycholic acid (NorUDCA) with 0.1 mM Taurocholic acid (TC) attenuates the 
increase in calcium duration seen after incubation with 0.1 mM TC alone. TC treatment increased calcium 
duration significantly (608.8 ± 23.29) in comparison to control (382.0 ± 17.01). The reduction TC with NorUDCA 
(357.0 ± 16.70) was significant in comparison to TC, leading to a return to baseline values. b) The time to full 
calcium release (peak of the calcium trace) was calculated for each treatment. There is a significant increase in 
time needed for the full release of calcium after TC (69.73 ± 4.12) treatment compared to control (50.08 ± 1.62). 
This was similarly to UDCA attenuated by NorUDCA treatment together with TC (45.25 ± 1.47). N = number of 
dishes (preparations), multiple isolations were used and multiple traces (5 – 10 / treatment) were taken per dish 
and averaged. Values represent MEAN ± SEM. *** p ≤ 0.001, ** p ≤ 0.01 (One-Way ANOVA + post-tests). 
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3.8.2 TC  INDUCED  PROLONGATION  OF  ACTION  POTENTIALS IS  ATTENUATED BY UDCA 
 
AND NORUDCA IN THE NEONATAL RAT MODEL OF THE FETAL    HEART 
 
 
Changes in calcium duration may be due to changes in action potential duration and 
repolarisation time. These changes may lead to early afterdepolarisations and to changes in 
propagation, which may lead to brady- or tachycardia or to re-entry, which can have fatal 
consequences for the fetus if this occurred in the fetal heart. Previously the effect of TC alone and in 
conjunction on conduction velocity was analysed (Miragoli, Kadir, Sheppard, et al., 2011). For this 
work a rather high concentration of TC was used (0.5 mM) and therefore further analysis of action 
potentials was carried out using a lower concentration of TC (0.1 mM) and with the focus on action 
potential duration of the cardiomyocytes rather than conduction velocity across the preparation 
(Miragoli, Kadir, Sheppard, et al., 2011). 
 
The effect of TC on action potential duration (APD) in the cardiomyocytes of the fetal heart model 
was analysed when plated with myofibroblasts [Figure 3.21]. Addition of 0.1 mM TC (271.0 ms ± 
41.0; n = 20, i = 3, p ≤ 0.001) leads to a significant increase in action potential duration, as measured 
by the APD90% in comparison to control (242.1 ms ± 26.5; n = 21, i = 3). When 1 µM UDCA (226.5 ms 
± 29.0; n = 12, i = 3, p ≤ 0.001) is subsequently added to the 0.1 mM TC, a significant reduction in 
APD90% can be seen. A significant reduction in APD90% can also be seen after the addition of 1 µM 
NorUDCA together with the 0.1 mM TC (260.2 ms ± 11.8; n = 19, i = 3, p ≤ 0.05). 
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FIGURE 3.21. TC INDUCED PROLONGATION OF ACTION POTENTIALS IS ATTENUATED BY UDCA 
AND NORUDCA IN THE NEONATAL RAT MODEL OF THE FETAL   HEART 
 
Neonatal rat cardiomyocytes (CMs) were seeded together with myofibroblasts (MFBs) in a 10:1 ratio and 
optical recording after di-8-Anepps incubation was carried out. Treatment with 0.1 mM Taurocholic acid 
(TC) leads to a significant increase in the APD90 (285.5 ms ± 7.52; n = 21) in comparison to control (242.1 
ms ± 5.79; n = 21). Coincubation of 0.1 mM TC with a) 1 µM Ursodeoxycholic acid (UDCA) (253.9 ms ± 4.72; 
n = 26) or b) 1 µM NorUrsodeoxycholic acid (NorUDCA) (262.1 ms ± 3.23; n = 20) attenuates the increase in 
action potential duration seen after incubation with 0.1 mM TC alone. TC treatment increased action 
potential duration significantly in comparison to control, whilst the reduction after UDCA or NorUDCA was 
also significantly decreased in comparison to TC, leading to a return to baseline values. N represents the 
number of traces analysed, multiple dishes and isolations were used per treatment group. 
Values represent MEAN ± SEM, * p ≤ 0.05, *** p ≤ 0.001 (One-way ANOVA + post-tests). 
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3.8.3 TC  INDUCED BRADYCARDIA IS  PARTIALLY RESTORED BY  UDCA AND NORUDCA   IN 
 
THE NEONATAL RAT MODEL OF THE FETAL   HEART 
 
 
Changes in the duration of calcium transients and action potentials led to changes in contraction 
and rhythmicity of the beating cells. Both dramatic increases (tachycardia) and decreases in heart 
rate (bradycardia) can have fatal consequences for the fetus. A few studies have reported abnormal 
fetal heart rates (≤ 100 or ≥ 180 beats per minute (bpm)) as well as reduced heart rate variability 
(Reid, Ivey, Rencoret, et al., 1976; Laatikainen, 1975; Inizi, Gupta, Gale, et al., 2006; Shand, Dickinson 
& D’Orsogna, 2008; Gorelik, Shevchuk, Diakonov, et al., 2003). 
 
The spontaneous beating rate of neonatal rat cardiomyocytes cultured with myofibroblasts was 
scored for 30 seconds and the number of beats per minute (bpm) was calculated. The baseline 
control was set as 100% (n = 86, i = 4) and deviation from the baseline was calculated for 0.1 mM TC 
and subsequently the incubation of 0.1 mM TC together with either 1 µM UDCA or 1 µM NorUDCA 
[Figure 3.22]. 
 
Incubation with 0.1 mM TC led to a significant reduction in beating rate (bradycardia) compared 
to the baseline (71.29% ± 2.96, n = 80, i = 4, p ≤ 0.001). Coincubation of 0.1 mM TC and 1 µM UDCA 
led to a partial, but significant improvement in beating rate when compared to TC (87.62% ± 2.64,  n 
= 27, i = 4, p ≤ 0.001). Incubation of TC with 1 µM NorUDCA led to a smaller, but still significant 
improvement in beating rate compared to TC (82.44% ± 7.14; n =42, i = 4, p ≤ 0.05). 
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FIGURE 3.22. SPONTANEOUS BEATING IS REDUCED BY  TC, BUT  
PARTIALLY RESTORED BY ADDITION OF UDCA OR  NORUDCA 
 
Neonatal cardiomyocytes (CMs) were seeded together with myofibroblasts 
(MFBs) in a 10:1 ratio and spontaneous beating was scored for 30 seconds. 
Baseline with control solution was set to 100% (n=80). Treatment with 0.1 mM 
Taurocholic acid (TC) (71.29% ± 2.96; n=80) leads to a significant reduction in 
beating rate of about 30%. Addition of 1 µM Ursodeoxycholic acid (UDCA) or 
NorUrsodeoxycholic acid (NorUDCA) to TC leads to a significant, but partial 
recovery to between 80-90% of baseline; 1 µM UDCA (87.62% ± 2.64; n = 42)   or 
1 µM NorUDCA (82.44% ± 7.14; n = 26). 
N represents the number of beating clusters of CMs scored, multiple dishes and 
isolations were used per treatment group. Values represent MEAN ± SEM, *** p 
≤ 0.001, * p ≤ 0.05 (One-way ANOVA + post-tests). 
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3.9.1 TC INDUCED PROLONGATION OF CALCIUM TRANSIENTS IS ATTENUATED BY    UDCA 
 
AND NORUDCA IN THE CDI MODEL OF THE FETAL    HEART 
 
 
The iPS-derived cardiomyocytes from CDI were used as a human model of the fetal heart. Optical 
recording of calcium transients was carried out and the duration (90%), time to peak (full release) 
and time to decay, the time it takes before the calcium is reabsorbed into the sarcoplasmic reticulum 
stores (peak to t90%), was calculated [Figure 3.23]. 
 
There was a significant prolongation of calcium transients after incubation with 0.1 mM TC (116.7 
 
± 2.45; n = 52, p ≤ 0.001) compared to control (102.4 ± 3.03) [Figure 3.23a]. Incubation of 1 µM  
UDCA in addition to 0.1 mM TC (90.73 ± 3.33; n = 37, p ≤ 0.001) led to a significant decrease in 
duration compared to TC alone [Figure 3.23a]. Addition of 1 µM NorUDCA together with 0.1 mM TC 
(127.5 ± 1.49; n = 13) did not attenuate the prolongation induced by 0.1 mM TC [Figure 3.23a]. This  
is potentially due to the difference in the mechanism of action of UDCA and NorUDCA. NorUDCA was 
shown to be more effective in reducing fibrosis and differentiation into myofibroblasts in the liver in 
a mouse model (Halilbasic, Fiorotto, Fickert, et al., 2009). But in this model no fibroblasts were 
plated. It may indicate that UDCA and NorUDCA act on different receptors, or that the loss of part of 
the side chain prevents the protective action of NorUDCA in cardiomyocytes, but not in fibroblasts. 
 
The time until full release was analysed from the time of the peak to the transient start, there 
was a significant prolongation after 0.1 mM TC (43.57 ± 1.47; n = 52, p ≤ 0.001) compared to control 
(33.89 ± 1.25; n = 83) [Figure 3.23b]. Addition of 1 µM UDCA to 0.1 mM TC (32.41 ± 3.11; n = 37; p ≤ 
0.001) attenuated the increase induced by TC, whilst addition of 1 µM NorUDCA did not (45.80 ± 
0.26; n = 13) [Figure 3.23b]. 
 
The time until levels of calcium were restored to the sarcoplasmic reticulum was calculated from 
the peak to the t90%. No significant differences between any of the treatments (0.1 mM TC: 81.07 ± 
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FIGURE 3.23. UDCA PROTECTS AGAINST TC INDUCED PROLONGED CALCIUM TRANSIENTS IN   CDI 
 
CDI were plated in confluent monolayers and optical recording of calcium transients was carried out. a) 
Calcium transient duration was significantly increased after incubation with 0.1 mM Taurocholic acid (TC) 
(116.7 ms ± 2.45) compared to control (102.4 ms ± 3.03). This was attenuated by 1 µM UDCA (90.73 ms ± 
3.33) but not by 1 µM NorUDCA (127.5 ms ± 1.49). 
b) The time until full release was significant prolonged by 0.1 mM TC (43.57 ms ± 1.47) compared to 
control (33.89 ms ± 1.25). Addition of 1 µM UDCA to 0.1 mM TC (32.41 ms ± 3.11) attenuated the increase 
induced by TC, whilst addition of 1 µM NorUDCA did not (45.80 ms ± 0.26). 
c) No significant differences in time to restoration of calcium to the sarcoplasmic reticulum between any of 
the treatments (0.1 mM TC: 81.07 ms ± 2.45, 0.1 mM TC + 1 µM UDCA: 76.83 ms ± 3.65 and 0.1 mM TC + 1 
µM NorUDCA: 83.19 ms ± 1.31) were found in comparison to control (82.12 ms ± 2.58). 
N represents the number of traces analysed, multiple dishes and different batches of CDI were used per 
treatment group. Values represent MEAN ± SEM, ** p ≤ 0.01, *** p ≤ 0.001 (One-way ANOVA + post- 
tests). 
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2.45, 0.1 mM TC + 1 µM UDCA: 76.83 ± 3.65 and 0.1 mM TC + 1 µM NorUDCA: 83.19 ± 1.31) were 
 
found in comparison to control (82.12 ± 2.58; n = 83, p > 0.05) [Figure 3.23c]. 
 
 
 
 
 
 
3.9.2 TC INDUCED PROLONGATION OF CALCIUM TRANSIENTS IS ATTENUATED BY    UDCA 
 
IN THE HUMAN FETAL  HEART 
 
 
Human fetal samples were obtained from terminations of pregnancies, the cardiomyocytes and 
fibroblasts isolated as described in Chapter 2, similarly to the neonatal rat cardiomyocytes and 
myofibroblasts. When beating cardiomyocytes were seen optical recording was carried out on 
monolayers of cardiomyocytes [Figure 3.24]. Due to the increased culture time, an increased 
presence of myofibroblasts was seen in these cultures. Therefore no additional fibroblasts needed to 
be seeded in as in the neonatal rat model [Figure 3C, D left]. To reduce the amount of fibroblast 
infiltration additional experiments were carried out after 3 hours of preplating for 1 isolation [Figure 
3C, D right]. 
 
There was a significant increase in calcium transient duration after incubation with 0.1 mM TC 
(180.7 ms ± 26.0; n = 15, i = 2, p ≤ 0.05) compared to control (144.4 ms ± 15.2; n = 51, i = 3) [Figure 
3C]. Addition of 1 μM UDCA and 0.1 mM TC showed that UDCA attenuated the increase in calcium 
transient duration induced by TC (119.4 ms ± 11.1; n = 55, i = 2, p ≤ 0.001) [Figure 3C]. Additionally, 
after 3 hours of preplating preliminary data indicates that no changes calcium transient duration 
occurred after incubation with 0.1 mM TC (149.4 ms ± 6.3; n = 4, i = 2 dishes, 1 isolation) compared 
to control (193.6 ms ± 9.8; n = 5, i = 2 dishes, 1 isolation). 
 
Incubation with TC also led to a significant increase in time to transient peak (65.2 ms ± 3.4; p ≤ 
0.001) compared to control (37.7 ms ± 4.3) [Figure 3D]. This increase was prevented when UDCA was 
applied together with TC (38.0 ms ± 4.5). Additionally, after 3 hours of preplating preliminary data 
indicates that no changes in time to peak occurred after incubation with TC (53.3 ms ± 2.1)  
compared to control (58.6 ms ± 4.0). 
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FIGURE 3.24. UDCA PROTECTS AGAINST TC INDUCED PROLONGED CALCIUM TRANSIENTS IN 
HUMAN FETAL CMS 
 
Monolayers of human fetal CMs were plated and allowed to mature until beating CMs could be seen. 
Optical recording of calcium transients was subsequently carried out. Similarly to the neonatal rat 
cocultures, in a culture of human fetal cardiomyocytes, which showed a higher level fibroblast infiltration, 
TC induces increases in a) calcium transient duration and b) time to peak (n = 15, i = 2, p ≤ 0.05 and p ≤ 
0.001 respectively) compared to control (n = 51, i = 3), this effect of 0.1 mM TC is reversed by 1 µM UDCA  
(n = 55, i = 2, p ≤ 0.001) (a, b, left). In human fetal cultures with little fibroblast infiltration, 0.1 mM TC (n = 
4, i = 2 dishes, 1 isolation) did not induce a significant increase in either calcium transient duration or in 
time to peak (n = 5, i = 2 dishes, 1 isolation) (a,b, right). C) Time to decay after TC was also prolonged 
compared to control were also found in the cultures with high fibroblast infiltration. Values represent 
MEAN ± SEM. 
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3.10.1 SUMMARY 
 
 
The work in this chapter focussed on the development of novel models of the human fetal heart. 
For the first time, the isolation of beating human fetal cardiomyocytes was successful in our lab. 
These human fetal cardiomyocytes were then characterised using immunofluorescence microscopy 
to visualise the expression and localisation of various proteins known to be involved in the 
development and maturation of cardiomyocytes. The human fetal cardiomyocytes were compared  
to neonatal rat cardiomyocytes, CDI and human adult cardiomyocytes. The CDI were found to be 
structurally immature and similar to the human fetal cardiomyocytes. Both had similar calcium 
transient durations, providing further evidence that the CDI can be used as a model of the human 
fetal heart, especially when in future combined with human fetal fibroblasts. 
 
The human fetal cardiomyocytes and CDI were used to provide further insight into the arrhythmic 
effect of TC and the potential protective effect of UDCA. In both the human fetal cardiomyocytes  
and CDI, TC induced calcium transient abnormalities which were attenuated by UDCA. Work using 
neonatal rat cardiomyocytes and myofibroblasts indicated that neither UDCA nor NorUDCA would  
be toxic to the fetal heart at the concentrations used. Additionally, further work into changes in 
action potential duration and beating rate were investigated in neonatal cardiomyocytes and 
myofibroblasts after treatment with TC alone and together with UDCA or NorUDCA. 
 
Lastly, preliminary evidence of the expression of TGR5 in the fetal and neonatal heart, as well as 
CDI, but not in Adult cardiomyocytes was shown here, providing a basis for further work into the 
involvement of TGR5 in bile acid induced arrhythmias in the heart. 
3.10 DISCUSSION 
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3.10.2 LOCALISATION OF CARDIAC MARKERS IN THE FETAL   HEART 
 
 
The suitability of rat neonatal cardiomyocytes and human iPS-derived stem cells differentiated 
into cardiomyocytes (CDI) as a model was investigated by comparison of various cardiac markers 
with the primary human fetal cardiomyocytes isolated from terminations of pregnancy. The 
morphology and cell shape of these cells are more similar to the human fetal cardiomyocytes than to 
adult cardiomyocytes. The CDI and other stem cell-derived cardiomyocytes are often used as a 
model for drug discovery, but most are morphologically immature and are more similar to the 
neonatal rat and human fetal cardiomyocytes (Harding, Ali, Brito-Martins, et al., 2007). In addition, if 
differentiating stem cells in house, the purity of the population differs between differentiations. The 
CDI are commercially available and are guaranteed 95-99% pure cardiomyocytes. Gorelik et al.  
(2006) previously used SICM as a functional method to identify individual cardiomyocytes in a mixed 
population (Gorelik, Ali, Shevchuk, et al., 2006). In this chapter, the localisation and SICM studies 
show that CDI, neonatal rat and human fetal cardiomyocytes are often round or star shaped and 
have a more dome shaped volume in contrast to the rod-shape of adult cardiomyocytes. 
 
The heart continues to develop after birth including the change in morphology and maturation of 
internal structures to those seen in adult cardiomyocytes (Chen, Guo, Zhang, et al., 2013; Ziman, 
Gómez-Viquez, Bloch, et al., 2010). In a comparative study in our lab, using cardiomyocytes isolated 
from hearts of neonate rat pups aged 2 – 18 days it became apparent that the morphology of 
isolated neonatal rat cardiomyocytes changes with the age of the pups, which is in accordance with 
previously published work [unpublished data, reproduced with permission in Appendix B1] (Ziman, 
Gómez-Viquez, Bloch, et al., 2010; Chen, Guo, Zhang, et al., 2013; Reynolds, Chiang, Wang, et al., 
2013). The cardiomyocytes from the earliest ages were similar in morphology to the human fetal 
cardiomyocytes and CDI, round to oval or triangular to star shaped. With increasing age, the cells 
became more and more oval to rectangular and by 18 days (dN18) cardiomyocytes were rod-shaped 
similar to adult rat cardiomyocytes [unpublished data, reproduced with permission in Appendix  B1]. 
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The development of the heart of a human neonate presumably occurs along similar lines but would 
take an increased amount of time due to developmental differences in human and rodent. 
 
CDI are structurally immature and have no T-tubules, Z-grooves or crest structures like the adult 
cardiomyocyte. Human fetal cardiomyocytes and neonatal rat cardiomyocytes also do not have 
crests, Z-grooves or T-tubules. These appear later on as the heart continues its structural 
development after birth. 
 
α-Actinin, Junctophillin 2, Caveolin 3 (Cav3), cardiac Troponin T, Connexin43 and Calsequestrin 2 
are proteins essential for the correct functioning of the excitation-coupling machinery of the adult 
cardiomyocyte. Most of these show maturation and development after birth, making them useful 
markers for the maturity of the CDI and for a comparison between fetal and neonatal state. In 
addition, Cx43 is important for the CM-CM or CM-FB coupling, which will be discussed in more detail 
in subsequent chapters (Jalife, Morley & Vaidya, 1999; Miragoli, Gaudesius & Rohr, 2006; Camelliti, 
Devlin, Matthews, et al., 2004). 
 
All cardiac markers chosen for evaluation were expressed in the rat neonatal and human fetal 
cardiomyocytes and in the CDI. The expression patterns between rat neonatal cardiomyocytes and 
human fetal cardiomyocytes was very similar, they showed an immature phenotype for many of the 
markers listed above when compared to the adult ‘organised’ phenotype. In many cases the CDI 
more closely resembled the more immature phenotype than the adult phenotype. In summary the 
neonatal rat, human fetal cardiomyocytes and CDI have a more similar morphology to each other 
than to adult rat cardiomyocytes. They are more often ‘fried egg’ shaped and have a larger depth 
compared to fibroblasts which are relatively flat and spread out. None of these cell types show the 
well-structured crests and T-tubules within Z-grooves which the adult cardiomyocytes  possess. 
These structures develop later on in gestation and after birth the cardiomyocytes continue  to 
mature before reaching full maturity. The development and maturation of T-tubules has been 
described in animal models (Al-Qusairi & Laporte, 2011; Seki, 2003; Chen, Guo, Zhang, et al.,   2013). 
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In rodents, T-tubules develop during the first two weeks after birth, with rudimentary structures 
appearing by 8 days after birth. These structures show increased maturity, complexity and 
magnitude by 14 days after birth (Seki, 2003; Ziman, Gómez-Viquez, Bloch, et al., 2010). Work in our 
group showed significant differences between T-tubule density and regularity between post-natal 
day 8, day 12 and day 18 neonatal rat cardiomyocytes, with regularity and density increasing as the 
animals became older [unpublished data, reproduced with permission in Appendix B1]. By day 18  
the cell morphology also changed from the round/triangular/star shape of day 2 neonatal rat 
cardiomyocytes to the rod-shaped appearance of adult cardiomyocytes [unpublished data, 
reproduced with permission in Appendix B1]. Hence these cells were not considered mature yet, as 
the density and regularity of T-tubules were still significantly lower than that of adult rat 
cardiomyocytes [unpublished data, reproduced with permission in Appendix B1]. Cardiomyocyte 
differentiation continued until post-natal day 20, by this time the T-tubular morphology was found  
to be indiscernible from adult rat ventricular cardiomyocytes (Ziman, Gómez-Viquez, Bloch, et al., 
2010). 
 
α-Actinin is essential for the organisation of Z-lines and is therefore a marker of development of 
the T-tubular system and Z-lines. There were ‘tire’ tracks of α-Actinin visible in the human fetal, 
neonatal rat cardiomyocytes and CDIs, but possibly due to their shape these did not seem to be 
organised in the same manner as adult cardiomyocytes, where they are perpendicular to the 
longitudinal axis of the cardiomyocyte. Instead the α-Actinin staining appear disordered following no 
discernible alignment. As these “immature” cells are not rod-shaped, unlike the adult 
cardiomyocytes, the perpendicular line may not follow the shape of the cell and subsequent lines of 
α-Actinin may not be arranged next the lines closest to the membrane. A clear organisation develops 
in the weeks (or months) after birth when the cardiomyocytes of a neonatal rat or newborn baby 
mature into their adult counterpart. Phalloidin staining was used in our group to visualise the actin 
cytoskeleton and therefore the development of Z-lines [unpublished data, reproduced with 
permission  in  Appendix  B2].  The  maturation  of  Z-lines  progressively  occurs  during        neonatal 
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development and clear striations can be seen at postnatal day 18 (dN18) [unpublished data, 
reproduced with permission in Appendix B2]. 
 
Cav3 knockdown was shown to disrupt T-tubule regularity and structure, indicating that Cav3 is 
necessary in T-tubule biogenesis (Galbiati, Engelman, Volonte, et al., 2001). In comparison to adult 
cardiomyocytes the localisation of Cav3 was mostly cytosolic in the neonatal rat, human fetal 
cardiomyocytes and CDI, indicating that these cells are still immature and membrane localisation of 
Cav3 occurs later in development of the neonatal and fetal cardiomyocytes. In a study of neonatal 
development (postnatal day 2 – 18 pups), Cav3 was shown to be initially perinuclear with 
subsequent redistribution to the cytosol [unpublished data, reproduced with permission in Appendix 
B2]. Cav3 localisation became more peripheral by dN18, although the presence of striations 
remained inconclusive at that time [unpublished data, reproduced with permission in Appendix B2]. 
In the human fetal cardiomyocytes, neonatal rat cardiomyocytes and CDI presented in this chapter 
the distribution of Cav3 was mostly cytosolic with increased density in the area around the nucleus, 
although some CDI also showed peripheral localisation of Cav3. 
 
Junctophillin 2 plays a critical role in maintaining the space between the plasma membrane 
and the sarcoplasmic reticulum allowing for efficient excitation contraction coupling of adult 
cardiomyocytes. Human adult cardiomyocytes have high expression levels of Junctophillin 2, which 
are localised along the T-tubules. By keeping the T-tubule membranes and the sarcoplasmic 
reticulum in close proximity of each other Junctophillin 2 supports the rapid transmission of the 
excitatory signals that leads to the contraction of the cardiomyocyte. Therefore the localisation of 
Junctophillin 2 was investigated in neonatal rat and human fetal cardiomyocytes as well as  CDI, 
which all express Junctophillin 2, but do not yet show the striated pattern found in adult 
cardiomyocytes. The organisation and localisation of Junctophillin 2 continues to mature after birth 
with the development of the T-tubular system, therefore, Junctophillin 2 can be used as a marker for 
the maturity of cardiomyocytes (Chen, Guo, Zhang, et al., 2013; Reynolds, Chiang, Wang, et al., 
2013). In our group the localisation of Junctophillin 2 was found to be primarily cytosolic during 
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neonatal development, although striations were clearly visible by dN18 [unpublished data, 
reproduced with permission in Appendix B2]. 
 
Connexin43 is important for cell-cell signalling and localisation of Cx43 along the intercalated 
discs (along the short ends of the cardiomyocyte) in adult cardiomyocytes facilitates the inter- 
cellular exchange of molecules. In neonatal rat, human fetal cardiomyocytes and CDI the  
morphology of the cells is not yet rod-shaped and therefore no clear intercalated discs can be 
identified. It is clear though, that Cx43 is expressed in the junctional areas between cells. Cultures of 
neonatal rat cardiomyocytes combined with neonatal rat fibroblasts, or CDI or human fetal 
cardiomyocytes cultured with human fetal fibroblasts showed that Cx43 connections formed 
between the different cell types. This observation is important, as interaction between 
cardiomyocytes and myofibroblasts may lead to cardiomyocyte depolarisation and thereby an 
increased  propensity  of  cardiomyocyte  arrhythmic  contractions,  as  will  be  discussed  in  section 
3.10.4. Fibroblast depolarisation and the effects of bile acids on this will be discussed in Chapter 4, 
whilst the functionality of the interaction between cardiomyocytes and fibroblasts will be explored 
further in Chapter 5. 
 
Calsequestrin 2 was used as a marker for maturity of the sarcoplasmic reticulum, as it has been 
shown that there is a switch from Calreticulin, a functional homologue of Calsequestrin, to 
Calsequestrin during the fetal development in the rat (Imanaka-Yoshida, Amitani, Ioshii, et al., 1996). 
This switch is due to the change of cellular reliance on an endoplasmic reticulum storage of Ca2+ 
facilitated  by  Calreticulin  to  cellular  development  of   a   sarcoplasmic   reticulum   storage   of 
Ca2+ facilitated by Calsequestrin (Imanaka-Yoshida, Amitani, Ioshii, et al., 1996). For further insights 
into the gradual overturn of Calreticulin to Calsequestrin it would be of interest to obtain staining of 
the human fetal cardiomyocytes with Calsequestrin 2, but this has not yet been done due to the 
limited number of samples available. 
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LIMITATIONS AND FUTURE DIRECTIONS FOR LOCALISATION AND EXPRESSION   STUDIES 
 
 
Due to the limited number of human fetal samples the primary focus in this thesis was placed on 
the optical recording and subsequent localisation studies using confocal microscopy of the markers 
described above. The localisation of Calsequestrin 2 has not yet been carried out in the fetal samples 
and remains to be done in future. Other markers known to change during fetal and neonatal 
development of the heart may also be further explored in the future. There is a functional transition 
from T-type calcium channels to L-type calcium channels during the development of the heart and 
the expression and localisation of these channels could be the focus of future work (Ono & Iijima, 
2010). Functional studies of T-type and L-type calcium channel activity and of how they are affected 
by bile acids is the subject of the publication by O. Adeyemi et al. (including myself) which is in 
preparation to be submitted. 
 
On their future arrival new samples will also be used for the analysis of mRNA content and 
protein expression of markers described above. The resulting data can then be compared to human 
adult cardiomyocyte expression levels. Similarly, it will be of interest to compare expression levels of 
maturation markers within the CDI with human fetal and adult cardiomyocyte expression to obtain 
more information on the similarity of the CDI to either of these physiological cell types. 
 
 
 
 
 
3.10.3 TGR5 AND THE  HEART 
 
 
The staining with the TGR5 antibody from Nigel Bunnett provides new insights into expression of 
bile acid (BA) sensitive receptors in cardiomyocytes and fibroblasts and to possibility that TGR5 is 
involved in bile acid induced arrhythmias. 
 
The differential expression of TGR5 in the human fetal cardiomyocytes and neonatal rat 
cardiomyocytes but not in adult cardiomyocytes may indicate a role for TGR5 in bile acid induced 
arrhythmias in the fetal heart of fetuses from ICP pregnancies, as the mother does not have any 
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arrhythmias. The involvement of TGR5 is still under investigation [unpublished work carried out in 
our group]. Current work in our lab is now focussing on further investigation of TGR5 expression in 
human fetal and neonatal rat tissue and cells using PCR and Western Blotting [unpublished data]. 
Functional studies into the involvement of TGR5 bile acid signalling is also being carried out 
[unpublished data]. This further work will provide further insight into the mechanisms of bile acid 
induced arrhythmias. TGR5 is also expressed in both neonatal rat and human fetal fibroblasts, from 
where it may also indirectly influence cardiomyocyte function in the fetal heart. 
 
Finally, for the first time it was shown that TGR5 is also found in human adult fibroblasts from a 
dilated cardiomyopathy patient (DCM). If healthy adult fibroblasts do not express TGR5 this 
differential expression may implicate another G-protein coupled receptor that may be involved in 
disease-associated arrhythmias in the adult heart. Rainer et al. (2013) showed increased  levels of 
bile acids other than UDCA in patients with atrial fibrillation (AF) and that TC can induce arrhythmias 
in isolated atrial trabeculae (Rainer, Primessnig, Harenkamp, et al., 2013). As there is a phenotypical 
switch of fibroblasts to myofibroblasts in disease and there are increased levels of both fibroblasts 
and myofibroblasts in diseased hearts it would be of interest to investigate the involvement of TGR5 
in arrhythmic signalling in diseased hearts. The involvement of TGR5 in adult cardiac disease has 
been investigated in mouse models by Desai et al., who showed that in a model of biliary fibrosis 
functional, electrophysiological and metabolic changes occur in the mouse heart reminiscent of 
human cirrhotic cardiomyopathy (Desai, Shabier, Taylor, et al., 2010). They also showed expression 
of TGR5 in the adult mouse heart, although this was carried out using whole heart preparations 
(Desai, Shabier, Taylor, et al., 2010). The effect of TGR5 agonist treatment (TCDCA and LCA)  
activated AKT and inhibited GSK3β in a manner similar to the biliary fibrosis model of 3,5- 
diethoxycar- bonyl-1,4-dihydroxychollidine (DDC) fed mice (Desai, Shabier, Taylor, et al., 2010). 
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LIMITATIONS AND FUTURE DIRECTIONS 
 
 
The original staining carried out for the human fetal and neonatal rat cardiomyocytes and 
fibroblasts was carried out as singular staining for TGR5. It is difficult to discern between the two cell 
types in these cultures, so staining of TGR5 in conjunction with either α-Actinin for cardiomyocytes  
or αSMA/Vimentin for fibroblasts will be necessary. Further work into the expression of TGR5 and 
the involvement of TGR5 in bile acid induced arrhythmias is necessary. This work can be pursued  
into multiple directions. Functional assessment of TGR5 involvement in bile acid induced cAMP 
production needs to be assessed using natural TGR5 ligands and the potent TGR5 specific ligand 
INT777 (Rizzo, Passeri, Franco, et al., 2010). Förster Resonance Energy Transfer (FRET) analysis using 
transgenic neonatal mouse cardiomyocytes and fibroblasts expressing a fluorescent  sensor 
containing the EPAC1 domain to detect changes in cAMP can be used to this end (Nikolaev, 
Bünemann, Schmitteckert, et al., 2006). At the same time knockdown of TGR5 using siRNA or using 
cardiomyocytes and fibroblasts from TGR5 null mouse pups transfected with this sensor will provide 
further information on the involvement of TGR5 in bile acid induced arrhythmias. Furthermore, the 
expression of TGR5 should be analysed in the neonatal rat and mouse hearts, single cardiomyocytes 
and fibroblasts as well as in human fetal cardiomyocytes and fibroblasts to obtain further 
information on TGR5 RNA and protein expression. Continuation of beating experiments and the 
optical recording of calcium transients and action potentials in the fetal heart models with natural 
ligands or INT777 would help elucidate the involvement of TGR5 in the bile acid induced  
arrhythmias. 
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3.10.4 BILE ACIDS AND THE FETAL  HEART 
 
 
The deleterious effect of TC on beating rate, amplitude, calcium transients and action potential 
conduction velocity has previously been shown in neonatal rat cardiomyocytes and in a further 
expansion of the fetal heart model of neonatal rat CMs + FBs (Gorelik, Harding, Shevchuk, et al., 
2002; Gorelik, Shevchuk, de Swiet, et al., 2004; Williamson, Gorelik, Eaton, et al., 2001; Kadir, 
Miragoli, Abu-Hayyeh, et al., 2010; Miragoli, Kadir, Sheppard, et al., 2011). 
 
Miragoli et al. (2011) subsequently showed that UDCA can protect against the arrhythmic 
properties of TC, if incubated simultaneously with TC in the neonatal rat model of the fetal heart 
(Miragoli, Kadir, Sheppard, et al., 2011). Incubation with 0.5 mM TC led to conduction velocity 
slowing and formation of re-entry circuits in the fetal heart model, which did not occur after 
incubation of 0.5 mM TC together with 100 nM UDCA. The same study found that co-incubation of 
UDCA with TC abolishes the arrhythmic effect of TC in the fetal heart model (Miragoli et al., 2011). 
Conduction velocity slowing was seen after 0.5 mM TC incubation, but was shown to be increased 
upon treatment with 100 nM UDCA together with 0.5 mM in the fetal heart model (CMs + MFBs), 
but did not change in the maternal heart (CMs only) (Miragoli, Kadir, Sheppard, et al., 2011). This 
chapter describes the work that has been carried out to expand on this research. Firstly, to ensure 
that UDCA and NorUDCA did not have toxic effects on the cardiomyocytes alone or on the co- 
cultures, optical recording of calcium transients was carried out with control (HBSS) solutions 
followed by one of three doses of UDCA or NorUDCA (10 nM, 100 nM or 1 µM), followed by a 
washout period of HBSS- solution to show that neither UDCA nor NorUDCA has any lasting (negative) 
effects on the cells. These concentrations were chosen for both UDCA and NorUDCA was based on 
the efficiency of displacement by UDCA in the radioligand binding assay and the fact that they used 
100 nM in their subsequent experiments Miragoli (Miragoli, Kadir, Sheppard, et al., 2011). No toxic 
effects or long lasting negative effects were found after incubation with UDCA or NorUDCA at any of 
the concentrations used in either the maternal or fetal model of neonatal rat CMs ± MFBs. This 
would indicate that UDCA and NorUDCA are safe to use at the doses examined in neonatal rat 
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cardiomyocytes and myofibroblasts. This is beneficial not only to our work developing protection 
against arrhythmias using various fetal heart models, but also for clinical practice as these are within 
the range of UDCA found to cross the placenta in ICP pregnancies treated with UDCA, which was 
found to range from 0.6 – 2.6 µmol/L (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). The total 
bile acid levels found to cross the placenta ranged from 2 – 10 µmol/L in ICP pregnancies, with UDCA 
treatment reducing this total level significantly. In addition, UDCA was well tolerated in patients with 
chronic heart failure (Von Haehling, Schefold, Jankowska, et al., 2012; Tousoulis, Papageorgiou & 
Stefanadis, 2012; Sinisalo, Vanhanen, Pajunen, et al., 1999). 
 
Subsequently, the effect of TC on calcium transients was investigated and whether UDCA or 
NorUDCA was more effective at attenuation of the negative effect found after TC treatment. 
Increases in calcium transient duration, the time it takes before the all the Ca2+ is released from 
sarcoplasmic reticulum stores and the time taken until full relaxation (reabsorption back into the 
sarcoplasmic reticulum) of the cardiomyocyte occurs can have arrhythmogenic effects, as increased 
levels of Ca2+ in the cytoplasm can lead to a pro-arrhythmogenic state of the cell (Scoote & Williams, 
2004). After excitation of the cardiomyocyte, Ca2+ is used to achieve synchronised depolarisation of 
the cardiomyocyte and subsequent activation of the contraction machinery in a process called 
excitation-contraction coupling (Scoote & Williams, 2004). Activation of the L-Type (and in the fetus 
also T-Type) calcium channels leads to an influx of Ca2+ ions, which in turn elicit the release of Ca2+ 
from the sarcoplasmic reticulum. This process is called calcium-induced calcium release (Scoote & 
Williams, 2004). Prolongation of the time needed to release the Ca2 from internal stores may lead to 
disruption or prolongation of the activation of contractile proteins, which may lead to 
desynchronised contraction and therefore an increased chance in arrhythmic propagation of 
contraction within the heart (Scoote & Williams, 2004). In healthy hearts the intracellular Ca2+ 
homeostasis is carefully regulated to ensure synchronised depolarisation and contraction within the 
heart (Scoote & Williams, 2004). Prolongation in the time for the Ca2+ reuptake into internal stores, 
including the sarcoplasmic reticulum, may also lead to a pro-arrhythmic state, as increased   internal 
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Ca2+ levels may activate additional ectopic beats (Scoote & Williams, 2004). TC was shown to induce 
increased calcium transient duration and increased time to full release, which was attenuated by 
both UDCA and NorUDCA, indicating that UDCA and NorUDCA may both prevent TC induced 
arrhythmias. 
 
Action potential duration was also analysed, as increased action potential durations may lead to 
early afterdepolarisations and re-entry formation. Previously, action potential conduction velocity 
was analysed to see whether changes in propagation occurred after treatment with TC or TC and 
UDCA (Miragoli, Kadir, Sheppard, et al., 2011). Conduction velocity slowing and re-entries induced by 
TC were attenuated by UDCA in the neonatal rat model of the fetal heart (Miragoli, Kadir, Sheppard, 
et al., 2011). In this chapter, action potential duration of the cardiomyocytes was also analysed.  
Here, action potential duration increases were shown after treatment with TC. This was attenuated 
by both UDCA and NorUDCA, although UDCA seems slightly more efficient (not significant). 
Spontaneous beating was also assessed. There was a significant reduction in bpm by almost 30% 
after TC treatment. Addition of UDCA or NorUDCA led to a partial recovery to 80-90% of control, 
whereby UDCA was again more effective than NorUDCA. There was a significant improvement, 
although complete recovery was not obtained. This may be due to a slight natural slowing in beating 
rate over time. 
 
The use of human models of the fetal heart provided further improvement of the rat model of 
the fetal heart. Firstly, CDI were used as human fetal-like cardiomyocytes. As with the neonatal 
model, CDI show bile acid sensitivity as shown by optical recording. TC induced similar calcium 
duration abnormalities which could be prevented by incubation with UDCA. NorUDCA does not  
seem to be as effective in the CDI as it was in the neonatal CMs + MFBs, although an increase in N 
may provide a more accurate picture. 
 
Finally, it was possible to obtain a few hearts for isolation of human fetal cardiomyocytes and 
fibroblasts.  Optical  recording  was  obtained  with  monolayers  of  cardiomyocytes  from  2  hearts. 
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Recordings were done for control solutions, 0.1 mM TC and 0.1 mM TC together with 1 µM UDCA, as 
UDCA was more effective in the CDI and in studies presented in the next chapter. These monolayers 
were grown in culture for a number of days, which allowed for the proliferation of residual 
fibroblasts. As will be presented in the next chapter, a large percentage of these were actually 
myofibroblasts. Therefore, no additional myofibroblasts were seeded in these cultures and a 
comparison with the neonatal work can still be achieved. Additional myofibroblasts seeded in 
prevented the optical recording, as there was not enough conduction between the cardiomyocytes 
which prevented synchronous calcium transients from being recorded. Although the n is too low to 
apply statistical analysis, TC seems to induce prolongation of various properties of calcium transients 
similar to the other models presented here, while UDCA may be able to prevent this. 
 
 
 
 
 
LIMITATIONS AND FUTURE DIRECTIONS 
 
 
One of the limitations of the present studies is the relatively high concentration of TC used 
compared to what was recently shown to cross the placenta or accumulate in the fetus close to the 
time of delivery (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). The total CA levels ranged   from 
0.5 – 5 µmol/L, of which TC ranged from 0.5 – 1.5 µmol/L (Geenes, Lövgren-Sandblom, Benthin, et 
al., 2014). As there may be a cumulative effect of the bile acid exposure over a long period of time 
found in the fetus, which has not been replicated in the neonatal rat models, this higher dose was 
chosen as it is similar to levels that can be found in the mother. Hence it may still provide valuable 
information with regards to the effects of TC on cardiomyocytes and fibroblasts. 
 
The iPS-derived cardiomyocytes from CDI were used as a human model of the fetal heart. CDI can 
be obtained commercially; can be cultured in monolayers similar to the neonatal rat cardiomyocytes 
and after a short maturation time in culture various experiments can be carried out. There is little 
variation within batches, although batch-to-batch variation is larger. In addition, there are  
similarities between human fetal cardiomyocytes and CDI in cell morphology and the manner of 
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localisation of various markers is similar between the two, which makes the CDI a useful human 
model for the fetal heart.  In this chapter only the single cultures of CDI were presented, but with   
the availability of fresh human fetal fibroblasts this work can be expanded on using the fetal model 
presented by Miragoli et al. (2011) for the neonatal rat models (Miragoli, Kadir, Sheppard, et al., 
2011). This would allow for the further exploration of the effect of bile acids and the interaction of 
cardiomyocytes (CDI) and myofibroblasts on cardiomyocyte electrophysiology and contraction. 
Optical recording of calcium transients and action potentials for conduction velocity and action 
potential duration would also provide information with regards to the effect of TC and UDCA on the 
excitation-contraction coupling and propagation of action potentials. 
 
More experiments were carried out with TC only in CDI and human fetal cardiomyocytes, but 
some recordings were not analysed as there seems to be an increased sensitivity in human fetal 
cardiomyocytes especially to TC compared to neonatal rat cardiomyocytes. This led to a reduction in 
the detectable fluorescence signal of Fluo4 and often led to unresponsiveness to the electrical 
stimulation and therefore to the ability to obtain calcium transient recordings. Therefore, a lower 
dose of TC (for example 50 µM instead of 100 µM used currently) should be used in future and the 
TC only and in combination with UDCA or NorUDCA experiments should be expanded upon using  
this lower dose of TC. This would be more in line with the levels of TC occurring in ICP pregnancies 
and those that may cross the placenta and accumulate over time in the fetus. Preliminary work not 
presented here with CDI and human fetal fibroblasts was carried out, but due to the higher 
sensitivity of CDI to TC the data was not analysed as either the signal to noise ratio was too low, or  
no recordings were obtained due to the lack of calcium transients in the cardiomyocytes. 
 
During the course of this PhD it was only possible to obtain 5 fetal heart tissues. From these it 
was possible to isolate good cardiomyocytes from only 4 hearts. Of these isolations, monolayers 
were prepared from 3 isolations and optical recording data of calcium transients was obtained from 
only 2. It is therefore necessary to further optimise the method of the isolation and plating and the 
recording methods. Due to the low number of traces and isolations, no statistical analysis was 
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carried out as these recordings were obtained from only 1 – 2 hearts (control: 2 hearts, 5 dishes, TC: 
1 heart, 1 dish, TC + UDCA: 2 hearts, 4 dishes). Additional work with TC was carried out, but 
potentially due to the toxicity of TC, the human fetal cardiomyocytes stopped beating almost 
instantly after TC perfusion, which led to the inability to obtain calcium transients from these dishes 
or if obtained the traces were not analysed due to the low signal to noise ratio. It is therefore 
necessary to do additional experiments with a lower dose of TC in future. If additional samples can 
be obtained, it would be of interest to carry out optical recording of action potentials to obtain 
action potential duration and conduction velocity data. Beating rate experiments using spontaneous 
beating cardiomyocytes would also provide valuable information into the effect of bile acids on the 
human fetal heart. In addition, the characterisation of the human fetal cardiomyocytes of the 
expression levels of various cardiac markers and bile acid receptors using mRNA and protein analysis 
would be of interest in the future and the subsequent comparison to the expression levels of these 
in CDI and neonatal rat cardiomyocytes. 
 
But the ability to obtain human fetal tissues did provide valuable information with regards to the 
suitability of CDI as a model for the fetal heart. Firstly, the similarity between the CDI and the human 
fetal cardiomyocytes obtained indicated that the future use of CDI together with the newly obtained 
fetal human fibroblasts from these tissues would be able to provide further exploration into the 
effects of bile acids on the fetal heart and further elucidation of bile acid signalling pathways. 
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This chapter focusses on further investigation of the influence of bile acids on fibroblasts isolated 
from neonatal rat, human fetal [Figure 4.1], adult rat control and MI and adult human hearts and on 
further elucidation of the mechanism of action of UDCA. Further analysis of the expression of KATP 
channel subunits and localisation of these in the myofibroblasts is needed, which will be discussed 
later in this chapter. 
 
 
 
 
FIGURE 4.1. VIMENTIN LOCALISATION IN HUMAN FETAL  FIBROBLASTS 
 
To confirm the cells isolated from the human fetal tissues were fibroblasts, staining was 
carried out, 4 human fetal fibroblasts are shown, as can be seen by the Vimentin 
(chicken-568). Scale bar: 100 µm. 
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The previous chapter investigated the effect of bile acids on the cardiomyocytes (CMs) alone and 
in combination with myofibroblasts (MFBs). The arrhythmogenic effect of TC is thought to be in part 
due to the presence of myofibroblasts in the neonatal rat model. It was previously postulated that 
the protective effect of UDCA was also induced via the myofibroblasts. The protective effect of  
UDCA is thought to occur through hyperpolarisation of the membrane potential in myofibroblasts, 
which allows for better signal conduction between cardiomyocytes, as it was shown that 
myofibroblasts infiltration interferes with conduction velocity in a monolayer of cardiomyocytes with 
myofibroblasts seeded on top (Souders, Bowers & Baudino, 2009; Rosker, Salvarani, Schmutz, et al., 
2011; McAnulty, 2007; Gaudesius, Miragoli, Thomas, et al., 2003; Miragoli, Gaudesius & Rohr, 2006; 
Miragoli, Kadir, Sheppard, et al., 2011). Miragoli et al. (2011) previously showed that acute UDCA 
treatment induced hyperpolarisation in monolayers of neonatal rat myofibroblasts, but not in the 
co-cultures or single cardiomyocyte cultures [Figure 4.2a] (Miragoli, Kadir, Sheppard, et al., 2011). 
Chronic treatment (12 – 16h) of UDCA also led to hyperpolarisation in myofibroblast cultures, but 
additionally led to hyperpolarisation in the co-cultures [Figure 4.2b] (Miragoli, Kadir, Sheppard, et  
al., 2011). These changes in resting membrane potential indicated that myofibroblasts may be 
involved in fetal ICP-induced arrhythmia and sudden fetal death and that the protection by UDCA is 
through myofibroblast membrane potential modulation. Subsequently, the mechanism of UDCA was 
investigated. When myofibroblasts were incubated with Glibenclamide, an ATP-sensitive potassium 
channel blocker (KATP) in addition to UDCA, no hyperpolarisation occurred and the myofibroblasts 
resting membrane potential remained unchanged from control [Figure 4.3a]. This indicated that 
UDCA may act through KATP channels and that the hyperpolarising effect is due to an increase in 
potassium conductance, via direct binding of UDCA to sulfonylurea receptor expressed on 
myofibroblasts (Miragoli et al., 2011, Benamer et al., 2009). Recent evidence shows that potassium 
channels are involved in maintaining the membrane potential of ventricular fibroblasts and that KATP 
channel subunits are expressed in cultured fibroblasts.   KATP       channels are a valuable target as they 
4.1 INTRODUCTION 
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are thought to have a cardioprotective role during ischaemic and hypoxic conditions. KATP channels 
are well established pharmacological targets that control cellular energy production through 
alteration of electrical properties of the membrane of the cell. A recent study has demonstrated that 
the membrane potential of isolated fibroblasts can be regulated by K+ current (Chilton, Ohya, Freed, 
et al., 2005; Shibukawa, Chilton, Maccannell, et al., 2005). Although several different types of K+ 
channels were shown to be expressed in cardiac fibroblasts, KATP  channel function was the    focus of 
this chapter and previous work (Walsh & Zhang, 2008; Chilton, Ohya, Freed, et al., 2005; Shibukawa, 
Chilton, Maccannell, et al., 2005; Miragoli, Kadir, Sheppard, et al., 2011). The interaction of UDCA 
with KATP channels was further confirmed using a Radioligand binding assay carried out on  
membrane fractions of myofibroblasts using radioactive ([3H]-Glibenclamide) and incrementing 
doses of UDCA [Figure 4.3b]. UDCA competitively displaced the [3H]-Glibenclamide from the 
membranes, again, indicating that UDCA may affect the KATP channels. 
 
But UDCA is not only used for treatment of maternal bile acids and itch in ICP, it is also in clinical 
trials for adult cardiac disease and it was shown that patients with Atrial Fibrillation have lower  
levels of circulating UDCA (Von Haehling, Schefold, Jankowska, et al., 2012; Tousoulis, Papageorgiou 
& Stefanadis, 2012; Rainer, Primessnig, Harenkamp, et al., 2013; Sinisalo, Vanhanen, Pajunen, et al., 
1999). In cardiac disorders, including ischemic and dilated cardiomyopathies (ICM and DCM 
respectively), there is an increase in differentiation of fibroblasts into myofibroblasts (Souders, 
Bowers & Baudino, 2009; Rosker, Salvarani, Schmutz, et al., 2011). These myofibroblasts are 
important for the healing process after an infarct, they were shown to play role in the fibrosis 
formation essential for the reparation of the healing scar region of the infarcted heart (Souders, 
Bowers & Baudino, 2009; Calderone, Bel-Hadj, Drapeau, et al., 2006). Although neither fibroblasts 
nor myofibroblasts have their own action potential, myofibroblasts are electrically excitable. 
Myofibroblast – cardiomyocyte coupling leads to altered electrophysiological and mechanical 
properties of the cardiomyocytes, which can lead to the formation of arrhythmias (Nguyen, Xie, 
Garfinkel,  et  al.,  2012;  Vasquez  &  Morley,  2012).  Unlike  fibroblasts,  which  form  few  GJs   with 
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cardiomyocytes and therefore do not interfere with cardiomyocyte action potentials, 
myofibroblasts, which are relatively depolarised form GJs away from the intercalated discs of 
cardiomyocytes, leading to an overall depolarisation of the cardiomyocytes and interference with 
propagation of the electrical signals through the heart (Camelliti, Devlin, Matthews, et al., 2004; 
Baum & Duffy, 2011). UDCA was previously shown to induce hyperpolarisation in neonatal rat 
myofibroblasts, which may have implications for the use of UDCA in adult disease to promote 
hyperpolarisation of myofibroblasts and thereby reduce depolarisation of the neighbouring 
cardiomyocytes and promoting electrical propagation. 
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FIGURE 4.2. UDCA INDUCES HYPERPOLARISATION IN MYOFIBROBLAST MONOLAYERS  AFTER  
ACUTE AND CHRONIC EXPOSURE 
 
Both (a) acute and (b) chronic (12 – 16h) exposure to UDCA (Ursodeoxycholic acid) led to a significantly 
more negative (hyperpolarised) resting membrane potential (Vm) in monolayers of myofibroblasts (green 
dots) when compared to control. Acute treatment (a) did not have a significant effect on either the fetal 
heart model of cardiomyocytes and fibroblasts (yellow) or maternal heart model of cardiomyocyte only 
(red), whilst chronic exposure had a significant hyperpolarising effect on the fetal heart model (yellow), but 
not on the maternal heart model (red) (Miragoli, Kadir, Sheppard, et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 4.3. UDCA ACTS THROUGH SULFONYLUREA RECEPTORS IN   MYOFIBROBLASTS 
 
 
Hyperpolarisation of myofibroblasts by UDCA occurs to increased potassium conductance via the ATP- 
sensitive potassium channels. a) Incubation with Glibenclamide counteracted the hyperpolarising effect 
of UDCA (Ursodeoxycholic acid) indicating that UDCA is involved in the modulation of potassium 
conductance by interaction with the Sulfonylurea Receptors. b) This was further corroborated by the 
fact that [3H]-Glibenclamide was competitively displaced from the Sulfonylurea receptor by increasing 
concentrations of UDCA (Miragoli, Kadir, Sheppard, et al., 2011). 
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4.2.1 HUMAN AND RAT  FIBROBLASTS 
 
 
Fibroblasts were obtained from various human and rat sources. For further elucidation of the 
effect of bile acids in the fibroblasts of fetal heart model, a comparison of neonatal rat and human 
fetal fibroblasts was made. In addition, a further investigation of the mechanism of action of UDCA 
and its potential application as protection against arrhythmias in ICP fetuses or in adult cardiac 
disease was made in the neonatal rat and human fetal fibroblasts, human adult fibroblasts obtained 
from patients with ischemic or dilated cardiomyopathies (ICM or DCM respectively) and adult rat 
fibroblasts obtained from the Myocardial Infarction (MI) rat model and their time matched controls. 
Isolation methods of different fibroblasts were described more extensively in Chapter 2. Treatment 
with hypoxia was carried out at 37°C, 8% O2 and 1% CO2; normoxia was carried out at 37°C and 1% 
CO2 and normal oxygen tension. 1 µM UDCA treatment was carried out either acutely (15 – 20 
minutes incubation) or for 24h at 37°C. The concentration of UDCA was chosen based on the amount 
of UDCA that would cross the placenta in ICP pregnancies treated with UDCA (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014). Treatment of adult cardiac disease with UDCA (500 mg, daily) leads 
to a higher concentration of unconjugated UDCA (7.16 ± 5.18 µmol/L) in the blood. Although the 
values of total and unconjugated UDCA levels were relatively high compared to the treatment 
concentration chosen used here; there was a lot of variability in the levels (Von Haehling, Schefold, 
Jankowska, et al., 2012). 
 
 
 
 
 
4.2.2 MEASUREMENT OF MEMBRANE POTENTIAL OF FIBROBLASTS 
MEASUREMENT OF MEMBRANE POTENTIAL USING  IMPALEMENT 
 
Impalement was carried out on a Nikon Eclipse TE300 using Axopatch 2b with Clampex 8.0 to 
record resting membrane potential. Neonatal rat fibroblasts, human fetal fibroblasts, adult rat 
control and MI fibroblasts and human adult fibroblasts from DCM/ICM patients were maintained  on 
4.2 METHODOLOGY 
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the system with HBSS- containing 1% NCS. Cells were impaled by sharp nanopipettes containing 3M 
KCl and 10s recordings were taken. Resting membrane potential was averaged each trace. After 
control traces were taken, the solution was changed to 0.2 mM TC, 1µM UDCA or 1µM NorUDCA  
and cells were allowed to adjust before subsequent traces were taken. After experiments with TC, 
0.2 mM TC together with 1µM UDCA or 1 µM NorUDCA was added to record UDCA or NorUDCA 
induced changes in membrane potential. 
 
 
 
 
 
MEASUREMENT OF MEMBRANE POTENTIAL USING A VOLTAGE SENSITIVE   DYE 
 
 
Changes in the resting membrane potential of neonatal rat myofibroblasts was analysed using 
changes in fluorescence of DiBAC4(3) [Bis-(1,3-dibuylbarbitic acid) trimethine oxonol]. This dye 
allowed for the analysis of multiple drugs in a 96 well format over 1h. The drugs P1075 and KCl were 
chosen as a method to calibrate the fluorescence, as P1075, a KATP channel opener, is known to 
hyperpolarise cells and KCl is known to depolarise cells (Lange, Löffler-Walz, Englert, et al., 2002). In 
addition, 2 different concentrations of TC (0.2 and 0.5 mM) and 3 different concentrations of UDCA, 
NorUDCA and TauroUDCA (10 nM, 100 nM and 1 µM) were chosen for this experiment. 
 
8 day old MFB were seeded at 10,000 cells per well in a 96 well plate format. In addition, 
Background measurements were taken, which contained no cells with dye and Blank measurements 
were taken, with cells but no dye. A row of wells was also designated ‘control’, where dye was added 
to the cells, but no additional drug. These measurements were taken as a baseline to which the 
treatments were subsequently compared to. Two drugs were taken as control treatments, as 
Potassium Chloride (KCl) is known to depolarize cells, while P1075 (N-cyano-N'-(1,1-dimethylpropyl)- 
N''-3-pyridylguanidine) is known to hyperpolarize cells, as this is a potent KATP channel  opener, 
binding with high affinity to SUR2A/2B (Lange, Löffler-Walz, Englert, et al., 2002). The DiBAC4(3) dye 
was prepared at a 5 µM concentration in clear HBSS. Drugs were either added at the same time as 
the DiBAC4(3) dye (chronic) or directly before measurement (acute). Drugs were diluted to the  final 
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concentration in DiBAC4(3) for chronic treatment (UDCA, NorUDCA and TauroUDCA at  10nM, 
100nM and 1 µM) or in a small volume for later addition for acute treatment (10µM P1075, 60 mM 
KCl and 0.2 or 0.5 mM TC). Medium was taken off the cells and the cells were stained for 30 minutes 
before measurement. To the ‘control’ and ‘background’ wells 100 µL DiBAC4(3) was added, to wells 
for chronic treatment 100 µL DiBAC4(3) containing the drugs was added. 100 µL of clear HBSS was 
added to 4 wells for ‘blank’ readings. Wells for acute treatment were loaded with 80 µL of dye and a 
subsequent 20 µL containing the concentrated drug was added to the appropriate final 
concentration before the plate was mounted on the reader. 
 
 
 
 
 
4.2.3 RADIOLIGAND BINDING 
 
 
Neonatal rat and human adult fibroblasts from DCM/ICM patients were cultured until sufficient 
cell numbers were reached. Cells were washed in PBS, detached, pelleted and frozen at -80˚C until 
use. Cells were homogenized and cell debris was collected by centrifugation. The supernatant was 
then ultracentrifuged for 30 minutes at 50 000g. The pellet containing the cell membranes was 
carefully resuspended in the assay buffer. 10 – 20 µg protein was incubated for 2h at 37˚C in 200 µl 
assay buffer containing 20 mmol/L TRIS, 100 mmol/L NaCl, 1 mmol/L EDTA (pH 7.6), together with 
0.1-1 nmol/L [3H]-Glibenclamide (PerkinElmer) and increasing concentrations of unlabeled UDCA or 
NorUDCA ranging from 1-5 to 1000 µmol/L. Reactions were terminated by vacuum filtration through 
GF/F glass fibre filters (Millipore, Germany) before bound radioactivity was measured. 
 
 
 
 
 
4.2.4 MOLECULAR BIOLOGY 
 
 
Immunofluorescence microscopy and western blotting was carried out as described in Chapter 2 
[Table 2.2]. Western blotting was carried out for αSMA and GAPDH. Immunofluorescence  was 
carried out for the fibroblast marker Vimentin (diluted 1 : 5000), the myofibroblast specific marker 
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αSMA (1 : 100 rabbit; 1 : 1000 mouse) and the ATP-sensitive potassium channel subunits (Kir6.1, 
Kir6.2, SUR1 and SUR2A/B; 1 : 100 for all). Colocalisation of αSMA and Kir6.1 / Kir6.2 was assessed 
using FIJI (colocalisation_analysis plugin). This is based on Pearson’s coefficient. A small rectangular 
area of the same size in each image near the nucleus was selected. FIJI then calculates the number  
of pixels that overlap and gives a value between -1 (no correlation) and 1 (full overlap). Correlations 
close to 0 or negative correlations are difficult to interpret accurately, but a good  correlation 
(around 1) indicates that the fluorescence markers are localised together. The values were averaged 
for a number of images per treatments. Significance between treatments of the  colocalisation 
studies was analysed using a One-way ANOVA. 
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Changes in the resting membrane potential of neonatal rat myofibroblasts was analysed over 1h 
using changes in fluorescence of DiBAC4(3) [Bis-(1,3-dibuylbarbitic acid) trimethine oxonol] [Figure 
4.4]. The drugs P1075 and KCl were chosen as method of calibration for the fluorescence, as P1075, 
a KATP channel opener, is known to hyperpolarise cells and KCl is known to depolarise cells (Lange, 
Löffler-Walz, Englert, et al., 2002). In addition, 2 different concentrations of TC (0.2 and 0.5 mM) and 
3 different concentrations of UDCA, NorUDCA and TauroUDCA (10 nM, 100 nM and 1 µM) were 
chosen for this experiment. Significant changes from baseline control (set to 0 fluorescence) were 
seen for all treatments, changes are represented as positive (hyperpolarisation, more negative 
resting membrane potential) or negative (depolarisation, less negative resting membrane potential) 
as analysed by a two-way ANOVA (p ≤ 0.001). P1075 (n = 70) hyperpolarised the myofibroblasts as 
expected, whilst KCl (n = 52) depolarised the MFBs compared to control (n = 67). 
 
The drugs UDCA (n = 56, 68 and 56) and NorUDCA (n = 56, 68 and 56) induced a significant 
increase in fluorescence, which corresponds to hyperpolarisation of myofibroblasts. 
 
TC (n = 16 for each concentration) on the other hand induced a depolarisation of myofibroblasts, 
as can be seen by a significant decrease in fluorescence. TauroUDCA was also tested, interestingly it 
seemed to have a dose dependent effect in either direction (n = 24, 24 and 56). 
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FIGURE 4.4. MEMBRANE POTENTIAL CHANGES IN NEONATAL RAT MYOFIBROBLASTS UPON 
TREATMENT WITH BILE ACIDS 
 
Changes in membrane potential of myofibroblasts (MFBs) after treatment with bile acids or the 
drugs P1075 and KCl were analysed using DiBAC4(3) [Bis-(1,3-dibuylbarbitic acid) trimethine oxonol]. 
Significant changes from baseline control (set to 0 fluorescence) were seen for all treatments (***  p 
≤ 0.001). The data is represented as the changes from the baseline (MEAN ± SD). P1075, a KATP 
channel opener, known to hyperpolarise cells and KCl, known to depolarise cells, were used as a 
control for the fluorescence. P1075 (n = 70) hyperpolarised the MFBs as expected, whilst KCl (n = 52) 
depolarised the MFBs compared to control (n = 67). The drugs Ursodeoxycholic acid (n = 56, 68   and 
56) and NorUrsodeoxycholic acid (n = 56, 68 and 56) induced a significant increase in fluorescence, 
which corresponds to hyperpolarisation of MFBs. Taurocholic acid (n = 16 for each concentration) on 
the other hand induced a depolarisation of MFBs, as can be seen by a significant decrease in 
fluorescence. TauroUrsodeoxycholic acid was also tested, interestingly it seemed to have a dose 
dependent effect in either direction (n = 24, 24 and 56). Data was analysed using a 2-way ANOVA for 
treatment and time. N is represented by separate wells tested for each treatment. 
8 wells were used per 96 well dish for bile acid treatments, 4 – 6 wells were used for the controls and 
P1075/KCl per plate. 2 – 7 isolations were used for these results (2 isolations for TC, 3 or more for 
UDCA and derivatives). 
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The effect of bile acids on fibroblast resting membrane potential was investigated to evaluate 
whether changes in calcium transients of cardiomyocytes were due to changes in resting membrane 
potential of fibroblasts [Figure 4.5a (rat) and 4.5c (human)] and/or cardiomyocytes [Figure 4.5b]. 0.2 
mM TC and 0.2 mM TC combined with 100 nM UDCA did not affect the resting membrane potential 
of neonatal rat cardiomyocytes (0.2 mM TC; -66.0 mV ± 6.6; n = 3; i = 2, 0.2 mM TC and 100 nM 
UDCA; -82.2 mV ± 1.0; n = 4, i = 2, 100 nM UDCA; -78.2 mV ± 2.1; n = 12, i = 2) compared to control (- 
 
66.2 mV ± 3.9; n = 20, i = 2) [Figure 4.5b]. However, the resting membrane potential of both  
neonatal rat fibroblasts (control; -18.1 mV ± 2.5; n = 30, i = 3) [Figure 4.5a] and human fetal 
fibroblasts (-21.7 mV ± 1.0; n = 78, i = 4) [Figure 4.5c] became more negative following the 
application of 1 µM UDCA (-34.8 mV ± 3.9; n = 28, i = 3, p ≤ 0.01; -41.0 mV ± 2.1; n = 85, i = 4, p ≤ 
0.001, respectively), after 0.2 mM TC treatment the resting membrane potential became more 
positive in both neonatal rat and human fetal fibroblasts (-6.6 mV ± 0.7; n = 35, i = 3, p ≤ 0.001; -17.9 
mV ± 0.5; n = 47, i = 3, p ≤ 0.05, respectively). The resting membrane potential of both neonatal rat 
and human fetal fibroblasts were significantly more negative after TC and UDCA treatment 
compared to TC alone (-25.0 mV ± 2.9; n = 7, i = 2, p ≤ 0.001; -26.3 mV ± 0.9; n = 31, i = 3, p ≤ 0.01 
respectively). In addition, the resting membrane potential of human fetal fibroblasts was further 
hyperpolarized by UDCA in the combined treatment in comparison to control (p ≤ 0.01). Both 100 
µM pinacidil (-43.0 mV ± 4.4; n = 8, i = 2, p ≤ 0.001) and P1075 (-49.2 mV ± 1.6; n = 7, i = 2 p ≤ 0.001) 
induced a significant hyperpolarisation of the neonatal rat fibroblasts. In human fetal fibroblasts 
pinacidil was more potent (-51.5 mV ± 3.3; n = 37, i = 3) when compared to P1075 (-32.1 mV ± 2.0;  n 
= 36, i  =  3, p  ≤  0.05),  both of which induced  significant  hyperpolarisation compared  to untreated 
 
fibroblasts (P1075: p ≤ 0.01; pinacidil: p ≤ 0.001). 
 
 
Blockade of KATP channels by 20 µM glibenclamide did not induce significant changes in resting 
membrane potential of human fetal fibroblasts (-36.3 mV ± 3.1; n = 14, i = 1) compared to matched 
controls (-43.9 mV ± 3.2; n = 14, i = 1) [Figure 4.5d]. Furthermore, addition of 20 µM glibenclamide 
prevented UDCA-induced hyperpolarisation in human fetal fibroblasts (-48.2 mV ± 4.7; n = 21, i =  1). 
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The resting membrane potential of human fetal fibroblasts from this isolation was on average more 
negative than from previous isolations, potentially due to differences in genetic background or 
gestation. Additional recordings with 1 µM UDCA showed that UCDCA induced further 
hyperpolarisation also in these fibroblasts (-66.8 mV ± 4.7; n = 23 cells, i = 1, p ≤ 0.01). These results 
suggest that both neonatal rat and human fetal fibroblasts express functional KATP channels. 
Expression of the KATP channel subunits Kir6.1, Kir6.2, SUR1 and SUR2 was investigated in neonatal  
rat cardiomyocytes and fibroblasts (n = 5) and was normalised to the housekeeping gene GAPDH 
[Figure 4.6]. Kir6.1 was found in both neonatal rat cardiomyocytes and fibroblasts. Kir6.2 mRNA 
expression levels were very low in both neonatal rat cardiomyocytes and fibroblasts. SUR1 and SUR2 
were both expressed in neonatal rat cardiomyocytes and fibroblasts. 
  
FIGURE 4.5. RESTING MEMBRANE POTENTIAL OF NEONATAL RAT MFBS AND HUMAN FETAL FIBROBLASTS 
AFTER BILE ACID TREATMENT 
 
a) Acutely applied 1 µM UDCA (n = 28 cells, i = 3 isolations, p ≤ 0.01) resulted in a significant hyperpolarising shift in resting 
membrane potential of neonatal rat fibroblasts whilst acutely applied 0.2 mM TC (n = 35, i = 2, p ≤ 0.001) resulted in a significant 
depolarising shift in neonatal rat fibroblasts compared to control (n = 30, i = 3). b) Mean resting membrane potentials in neonatal 
rat cardiomyocytes, on the other hand remained unchanged following treatment with 0.2 mM TC (n = 3; i = 2), 100 nM UDCA (n = 
12, i = 2) or 0.2 mM TC and 100 nM UDCA (n = 4, i = 2) compared to control (n = 20, i = 2). c) In human fetal fibroblasts 1 µM  
UDCA treatment (n = 85, i = 4, p ≤ 0.001) also led to a significantly hyperpolarising shift compared to control (n = 78, i = 4), 
similarly to the neonatal rat fibroblasts. In addition, 0.2 mM TC (n = 47, i = 3, p ≤ 0.05) had a significant depolarising effect on the 
human fetal fibroblasts. a, c) Depolarising effects of 0.2 mM TC were reversed by the presence of 1 µM UDCA in fibroblasts from 
both species (n = 7, i = 2, p ≤ 0.001; n = 31, i = 3, p ≤ 0.01 respectively). In addition, the RMP of human fetal fibroblasts was further 
hyperpolarized by UDCA in the combined treatment in comparison to control (p ≤ 0.01). Acute incubation with KATP channel 
openers 30 µM P1075 and 100 µM pinacidil resulted in significant hyperpolarising shift of the resting membrane potential in both 
neonatal rat (n = 7, i = 2, p ≤ 0.001; n = 8, i = 2, p ≤ 0.001 respectively) and human fetal fibroblasts (n = 36, i = 3, p ≤ 0.01; n = 37, i 
= 3, p ≤ 0.001), although in the human fetal fibroblasts pinacidil was more potent compared to P1075 (p ≤ 0.05). d) Acute 
application of 20 µM glibenclamide (n = 14, i = 1) did not induce significant changes in resting membrane potential of human  
fetal fibroblasts compared to matched controls (n = 14, i = 1). Subsequent incubation of 20 µM glibenclamide with 1 µM UDCA  (n 
= 21, i = 1) prevents UDCA induced hyperpolarisation of human fetal fibroblasts, similar to neonatal rat fibroblasts (Miragoli, 
Kadir, Sheppard, et al., 2011). The RMP of human fetal fibroblasts from this isolation was on average more negative than from 
previous isolations, potentially due to differences in genetic background or gestation. Additional recordings with 1 µM UDCA 
showed that UCDCA induced further hyperpolarisation also in these fibroblasts (n = 23 cells, i = 1, p ≤ 0.01). Data is represented 
as MEAN ± SEM, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, analysed using a One-Way ANOVA. Page | 180 
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FIGURE 4.6.   MRNA EXPRESSION OF THE KATP CHANNEL SUBUNITS IN NEONATAL    RAT 
CARDIOMYOCYTES AND FIBROBLASTS 
 
 
Expression of the KATP channel subunits Kir6.1, Kir6.2, SUR1 and SUR2 was investigated in neonatal rat 
cardiomyocytes and fibroblasts and was normalised over the housekeeping gene GAPDH. a) K ir6.1 is 
expressed in both neonatal rat cardiomyocytes and fibroblasts (n = 5). b) Kir6.2 mRNA expression levels 
were very low in both neonatal rat cardiomyocytes and fibroblasts (n = 5). c) SUR1 is expressed in both 
neonatal rat cardiomyocytes and fibroblasts (n = 5). d) SUR2 is expressed in both cardiomyocytes and 
fibroblasts (n = 5).  Data is represented as MEAN ± SEM. 
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The fetus is normally in a state of partial hypoxia for the duration of the pregnancy. Therefore, 
further investigation into the effect of hypoxia on the neonatal rat and human fetal fibroblasts was 
carried out and whether UDCA had any effect on this. 
 
The number of myofibroblasts in the fibroblast population was first characterised by comparing 
the number of αSMA-positive myofibroblasts in the total population of cells (based on nuclei count). 
Vimentin staining was used to confirm that the remaining cells were fibroblasts. In neonatal rat 
fibroblasts, hypoxia treatment (24h) led to a significantly increased number of αSMA positive cells 
(82.80% ± 4.34, n = 10) compared to normoxia (24.00% ± 1.67, n = 11, p ≤ 0.001) [Figure 4.7]. This is 
significantly reduced by UDCA treatment during hypoxia compared to hypoxia alone (43.00% ± 8.23, 
n = 14, p ≤ 0.001). Lastly, the preliminary results of the protein analysis of αSMA expression after 
various treatments are shown in Figure 4.7c for n = 1. 
 
In human fetal fibroblasts, a large percentage of cells is αSMA positive even in normoxia  (78.84% 
 
± 4.22, n = 34) [Figure 4.8]. After hypoxia treatment (24h) there is an increased number of αSMA 
positive cells (95.88% ± 3.1, n = 17), but as there are already almost 100% αSMA positive cells in 
normoxia this is not significant. 24h treatment with 1 µM UDCA led to a significant reduction in 
αSMA positive cells in both normoxia (59.67% ± 4.62, n = 39, p ≤ 0.05) and hypoxia (73.39% ± 4.77, n 
= 45, p ≤ 0.05). The preliminary results of the protein analysis of αSMA expression after various 
 
treatments are shown in Figure 4.8. 
4.4 HYPOXIA  INDUCES  αSMOOTH  MUSCLE  ACTIN  EXPRESSION  IN  NEONATAL    RAT 
AND HUMAN FETAL FIBROBLASTS SIMILAR TO HEART FAILURE IN    ADULT 
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FIGURE 4.7. HYPOXIA INDUCES MYOFIBROBLAST DIFFERENTIATION IN NEONATAL RAT FIBROBLASTS AND THIS IS ATTENUATED BY UDCA 
 
 
The number of myofibroblasts (MFBs) after treatment with hypoxia and/or 1 µM Ursodeoxycholic acid (UDCA) was calculated using neonatal rat fibroblasts 
(a) stained for the myofibroblast marker αSmooth Muscle Actin (αSMA) (red, rabbit-546) and DAPI (blue) (b). A number of fields (n) were taken from at least 
3 different isolations. a) Quantification of the % αSMA positive cells. After hypoxia treatment (24h) there is a significantly increased number of αSMA  
positive cells (82.80% ± 4.34) compared to normoxia (24.00% ± 1.67, p ≤ 0.001). This is significantly reduced by UDCA treatment during hypoxia compared to 
hypoxia (43.00% ± 8.23, p ≤ 0.001). Data is represented by MEAN ± SEM, *** p ≤ 0.001, analysed using a One-Way ANOVA. N represents the number of 
random fields of view counted. At least 3 isolations were used for the neonatal MFBs. b) Representative images of the treatment groups. Scale bar: 25 µM. 
c) Western blot analysis of αSMA expression normalised to GAPDH after hypoxia and/or 1 µM UDCA treatment over 24h (n = 1). 
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FIGURE 4.8. MOST HUMAN FETAL FIBROBLASTS ARE MYOFIBROBLASTS, THIS IS REDUCED WITH    UDCA TREATMENT 
 
 
The number of myofibroblasts (MFBs) after treatment with hypoxia and/or 1 µM Ursodeoxycholic acid (UDCA) was calculated using human fetal 
fibroblasts (a) stained for the myofibroblast marker αSmooth Muscle Actin (αSMA) (red, mouse-546) and DAPI (blue) (b). A number of fields (n) were 
taken. a) Quantification of the % αSMA positive cells. A large percentage of cells is αSMA positive even in normoxia (78.84% ± 4.22). After hypoxia 
treatment (24h) there is an increased number of αSMA positive cells (95.88% ± 3.1), but as there are already almost 100% αSMA positive cells in 
normoxia this is not significant. 24h treatment with 1 µM UDCA led to a significant reduction in αSMA positive cells in both normoxia (59.67% ± 4.62, p 
≤ 0.05) and hypoxia (73.39% ± 4.77, p ≤ 0.05). Data is represented by MEAN ± SEM, * p ≤ 0.05, analysed using a One-Way ANOVA. N represents the 
number of random fields of view counted. The human fetal FBs come from 2 hearts, but multiple passages were used for each. b) Representative 
images of the treatment groups. Scale bar: 25 µM. c) Western blot quantification of αSMA expression normalised to GAPDH (n = 2). 
 There is increased myofibroblast differentiation during myocardial infarction (MI) (Souders, 
Bowers & Baudino, 2009; Rosker, Salvarani, Schmutz, et al., 2011; McAnulty, 2007). After MI a larger 
percentage of cells is αSMA positive (83.13% ± 5.09, n = 8, p ≤ 0.001) compared to control (15.60% ± 
1.36, n = 10) [Figure 4.9a, b]. 24h treatment with 1 µM UDCA of the MI myofibroblasts led to a 
significant reduction in the number of αSMA positive cells (32.00% ± 9.29, n = 12, p ≤ 0.001) 
compared to MI. Western blot quantification of αSMA expression normalised to GAPDH showed a 
significant increase in αSMA protein expression in MI fibroblasts (1.075 ± 0.12, n = 5, p ≤ 0.01) 
compared to control (0.030 ± 0.00775, n = 4), this was reduced after 24h UDCA treatment, albeit not 
significantly (0.63 ± 0.23, n = 4, p > 0.05) [Figure 4.9c]. 
 
The number of myofibroblasts in fibroblasts populations isolated from transplanted hearts with 
dilated or ischemic cardiomyopathy (DCM or ICM respectively) was characterised [Figure 4.10]. 54% 
of fibroblasts from patients with cardiomyopathies are αSMA (54.62% ± 3.99, n = 67). When treated 
with 1 µM UDCA this is significantly decreased (29.17% ± 3.90, n = 33, p ≤ 0.001). 
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FIGURE 4.9. MYOCARDIAL INFARCTION INDUCES MYOFIBROBLAST 
DIFFERENTIATION 
The number of myofibroblasts (MFBs) in time matched control adult rats 
and rats with a myocardial infarction (MI) was calculated (a) stained for 
the myofibroblast marker  αSmooth  Muscle Actin  (αSMA) (red,    rabbit- 
546) and DAPI (blue) (b). A number of fields (n) were taken from n = 2 
time matched or MI rats. 
a) Quantification of the % αSMA positive cells. After MI a larger percentage of cells is αSMA positive (83.13% ± 5.09, p ≤ 0.001) compared to control (15.60% ± 
1.36). 24h treatment with 1 µM UDCA of the MI MFBs led to a significant reduction in the number of αSMA positive cells (32.00% ± 9.29, p ≤ 0.001) compared to 
MI. Data is represented by MEAN ± SEM, *** p ≤ 0.001, analysed using a One-Way ANOVA. N represents the number of random fields of view counted, FBs were 
isolated from 2 MI or control hearts. b) Representative images of the treatment groups. Scale bar: 25 µM. c) Western blot quantification of αSMA expression 
normalised to GAPDH (n = 4, 5, 4 respectively). MFBs isolated from MI rats show significantly increased αSMA protein expression (** p ≤ 0.01). Page | 186 
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FIGURE 4.10. UDCA TREATMENT REDUCES THE NUMBER OF 
MYOFIBROBLASTS IN CULTURES OF HUMAN ADULT DCM/ICM 
PATIENTS 
 
The number of myofibroblasts (MFBs) in fibroblasts populations  isolated 
from transplanted hearts with dilated or ischemic cardiomyopathy (DCM or 
ICM respectively) was calculated (a) stained for the myofibroblast marker 
αSmooth Muscle Actin (αSMA) (red, mouse-546) and DAPI (blue) (b). A 
number of fields (n) were taken from multiple patients. a) Quantification of 
the % αSMA positive cells. 54% of fibroblasts from patients with 
cardiomyopathies are αSMA (54.62% ± 3.99). When treated with 1 µM 
Ursodeoxycholic acid (UDCA) this is significantly decreased (29.17% ± 3.90, p 
≤ 0.001). Data is represented as MEAN ± SEM, *** p ≤ 0.001 and was 
analysed using a Student’s T-test. N represents the number of random fields 
of view counted, cells were isolated from transplanted hearts of 3   patients. 
b) Representative images of the treatment groups. Scale bar: 25 µM. 
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Myofibroblasts are relatively depolarised compared to the surrounding cardiomyocyte 
population, whilst UDCA induced hyperpolarisation of myofibroblasts after acute treatment and 
hyperpolarisation in both cardiomyocytes and myofibroblasts co-cultures and myofibroblasts after 
chronic (16h) treatment (Baum & Duffy, 2011; Miragoli, Kadir, Sheppard, et al., 2011). The effect of 
UDCA on myofibroblasts of fetal/neonatal and adult origin from both human and rat hearts was 
investigated. 
 
24h treatment with hypoxia did not lead to significant changes in resting membrane potential of 
the neonatal rat myofibroblasts (-16.3 mV ± 2.3; n = 6, i = 2) compared to normoxia (-18.1 mV ± 1.7; 
n = 30, i = 3) [Figure 4.11a]. Acute 1 µM UDCA treatment induced significant hyperpolarisation in 
normoxia (-34.8 mV ± 3.9; n = 28, i = 3, p ≤ 0.01) and in hypoxia (-28.1 mV ± 4.6; n = 6, i = 2, p ≤ 0.05). 
 
In human fetal fibroblasts, 24h treatment with hypoxia led to a significant depolarisation of 
resting membrane potential (-8.3 mV ± 1.2; n = 12, i = 3, p ≤ 0.05) compared to normoxia (-22.5 mV ± 
2.9; n = 25, i = 3) [Figure 4.11b]. Acute treatment with 1 µM UDCA also induced hyperpolarisation in 
both normoxia (-41.0 mV ± 2.1; n = 60, i = 3, p ≤ 0.001) and hypoxia (-22.7 mV ± 2.3; n = 17, i = 3, p  ≤ 
0.05). 
4.5 THE HYPERPOLARISING EFFECT OF UDCA ON   FIBROBLASTS 
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FIGURE 4.11. HYPOXIA INDUCES DEPOLARISATION IN NEONATAL RAT AND HUMAN FETAL FBS, 
WHILST UDCA INDUCES HYPERPOLARISATION 
 
Resting membrane potential was measured using sharp electrode impalement of the neonatal rat 
myofibroblasts (MFBs) (a) and human fetal fibroblasts (FBs) (b) after treatment with 24h of hypoxia and 
subsequently acute treatment of 1 µM Ursodeoxycholic acid (UDCA). a) 24h treatment with hypoxia led to 
depolarisation of the neonatal rat MFBs (-16.28 mV ± 2.29) compared to control (normoxia) (-18.13 mV ± 
1.74). Acute 1 µM UDCA treatment induced significant hyperpolarisation in both normoxia (-34.80 mV ± 
3.87, p ≤ 0.01) and hypoxia (-28.05 mV ± 4.58, p ≤ 0.05) compared to untreated normoxia or hypoxia 
respectively. b) In human fetal fibroblasts, 24h treatment with hypoxia led to a significant depolarisation of 
resting membrane potential (-8.29 mV ± 1.24, p ≤ 0.05) compared to control (-22.50 mV ± 2.88,). Acute 
treatment with 1 µM UDCA induced hyperpolarisation in both normoxia (-41.03 mV ± 2.05, p ≤ 0.001) and 
hypoxia (-22.71 mV ± 2.28, p ≤ 0.05). Data is represented in a) and b) as MEAN ± SEM, * p ≤ 0.05, ** p ≤ 
0.01, *** p ≤ 0.001, analysed using a One-Way ANOVA. N represents the number of cells recorded. At least 
3 isolations were used for the neonatal MFBs, the human fetal FBs come from 2 hearts, but multiple 
passages were used for each. 
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Resting membrane potential was measured in the adult rat fibroblasts isolated from control and 
MI rat hearts [Figure 4.12a] and human adult fibroblasts isolated from transplanted hearts of DCM / 
ICM patients [Figure 4.12b] after acute treatment of 1 µM UDCA. 
 
MI fibroblasts (-13.32 mV ± 1.88, n = 6, p ≤ 0.05) were significantly depolarised compared to time 
matched control fibroblasts (-27.06 mV ± 2.29, n = 16) [Figure 4.12a]. The addition of 1 µM UDCA 
leads to a significant hyperpolarisation of both control (-40.65 mV ± 2.07, n = 20, p ≤ 0.001) and MI 
fibroblasts (-29.76 mV ± 3.47, n = 6, p ≤ 0.05). 
 
Human adult fibroblasts were isolated from transplanted hearts with DCM or ICM and resting 
membrane potential was recorded. Acute treatment with 1 µM UDCA induced significant 
hyperpolarisation of these fibroblasts (-46.30 mV ± 2.42, n = 51, p ≤ 0.001) compared to untreated (-
30.42 mV ± 2.99, n = 43) [Figure 4.12b]. 
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FIGURE 4.12. UDCA INDUCES HYPERPOLARISATION IN ADULT RAT FIBROBLASTS AND HUMAN 
ADULT FIBROBLASTS FROM CARDIOMYOPATHIES 
 
Resting membrane potential was measured using sharp electrode impalement of the adult rat fibroblasts 
(FBs) from control and Myocardial Infarction (MI) rats (a) and human adult FBs from Dilated / ischemic 
cardiomyopathy (DCM / ICM) patients (b) after acute treatment of 1 µM Ursodeoxycholic acid (UDCA). a) 
MI FBs (-13.32 mV ± 1.88, p ≤ 0.05) were significantly depolarised compared to time matched control FBs (- 
27.06 mV ± 2.29). The addition of 1 µM UDCA leads to a significant hyperpolarisation of both control (- 
40.65 mV ± 2.07, p ≤ 0.001) and MI fibroblasts (-29.76 mV ± 3.47, p ≤ 0.05). b) Human adult FBs were 
isolated from transplanted hearts with DCM or ICM and resting membrane potential was recorded. Acute 
treatment with 1 µM UDCA induced significant hyperpolarisation of these FBs (-46.30 mV ± 2.42, p ≤ 0.001) 
compared to untreated (-30.42 mV ± 2.99). Data is represented in a) and b) as MEAN ± SEM, * p ≤ 0.05, 
*** p ≤ 0.001, analysed using a One-Way ANOVA (a) or Students T-Test (b). N represents the number of 
cells recorded. 2 isolations of control / MI FBs were used, 3 isolations of human adult FBS were used. 
Page | 192  
 
4.6.1 UDCA AND NorUDCA BIND TO THE SULFONYLUREA   RECEPTOR 
 
 
Further elucidation of the mechanism of action of UDCA and NorUDCA is necessary to understand 
how these drugs acts on the myofibroblasts. It was previously shown that UDCA interacts with the 
sulfonylurea receptors (SURs) of the ATP-sensitive potassium channels (KATP) (Miragoli, Kadir, 
Sheppard, et al., 2011). This led to the further question whether NorUDCA also acted through the 
SURs, or had a differential mechanism of action. It was therefore decided to perform additional 
radioligand binding experiments using increments of UDCA or NorUDCA on myofibroblast 
membranes prepared from neonatal rat or human adult (DCM / ICM) fibroblasts [Figure 4.13 and 
4.14 respectively]. 
 
Neonatal rat myofibroblast membranes were incubated with [3H]-Glibenclamide and increasing 
concentrations of UDCA [Figure 4.13a] or NorUDCA [Figure 4.13b], similarly to previously published 
work, UDCA showed competitive binding to the sulfonylurea receptors (SUR), as shown by 
displacement of the [3H]-Glibenclamide from the neonatal rat fibroblast membranes (n = 1) 
(Miragoli, Kadir, Sheppard, et al., 2011). NorUDCA also shows competitive displacement of [3H]- 
Glibenclamide from the SUR, although there seems to be more variability than UDCA (n = 4). 
 
Human adult fibroblast membranes from DCM or ICM patients were also incubated with [3H]-
Glibenclamide and increasing concentrations of UDCA or NorUDCA [Figure 4.14a and 4.14b 
respectively]. Similarly to the neonatal rat work, UDCA showed competitive binding to the 
sulfonylurea receptors (SUR), as shown by displacement of the [3H]-Glibenclamide from the 
fibroblast membranes (Miragoli, Kadir, Sheppard, et al., 2011). b) NorUDCA also shows competitive 
displacement of [3H]-Glibenclamide from the SUR. 
4.6 UDCA  AND  NorUDCA  ACT  ON  ATP-SENSITIVE  POTASSIUM  CHANNELS THROUGH 
THE SULFONYLUREA RECEPTOR 
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FIGURE 4.13. UDCA AND NorUDCA SHOW SPECIFIC DISPLACEMENT OF [3H]-GLIBENCLAMIDE 
FROM NEONATAL RAT MYOFIBROBLAST  MEMBRANES 
Neonatal rat myofibroblast membranes were incubated with [3H]-Glibenclamide and increasing 
concentrations of Ursodeoxycholic acid (UDCA) or NorUrsodeoxycholic acid (NorUDCA). a) Similarly to 
previously published work, UDCA showed competitive binding to the sulfonylurea receptors (SUR), as 
shown by displacement of the [3H]-Glibenclamide from the neonatal rat fibroblast membranes (n = 1) 
(Miragoli, Kadir, Sheppard, et al., 2011). b) NorUDCA also shows competitive displacement of [3H]- 
Glibenclamide from the SUR. Data represented by MEAN ± SEM, n = 4. Figures reproduced with permission 
from Prof. Viacheslav Nikolaev and Mr. Christian Dees. I am grateful for their expertise and for carrying out 
the radioligand binding assays. 
 
 
 
FIGURE 4.14. UDCA AND NorUDCA SHOW SPECIFIC DISPLACEMENT OF [3H]-GLIBENCLAMIDE 
FROM HUMAN ADULT FIBROBLAST  MEMBRANES 
 
Human adult fibroblast membranes from Dilated or Ischemic cardiomyopathy (DCM/ICM) patients were 
incubated with [3H]-Glibenclamide and increasing concentrations of Ursodeoxycholic acid (UDCA) or 
NorUrsodeoxycholic acid (NorUDCA). a) Similarly to the neonatal rat work, UDCA showed competitive 
binding to the sulfonylurea receptors (SUR), as shown by displacement of the [3H]-Glibenclamide from the 
fibroblast membranes (Miragoli, Kadir, Sheppard, et al., 2011). b) NorUDCA also shows competitive 
displacement of [3H]-Glibenclamide from the SUR. Data represented in a) and b) by MEAN ± SEM, n = 4. 
Figures reproduced with permission from Prof. Viacheslav Nikolaev and Mr. Christian Dees. I am grateful 
for their expertise and for carrying out the radioligand binding assays. 
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4.6.2 LOCALISATION OF ATP-SENSITIVE POTASSIUM CHANNEL SUBUNITS IN   NEONATAL 
 
RAT FIBROBLASTS 
 
 
The expression of the subunits of KATP channels has previously been described in adult rat and 
human fibroblasts and these are involved in the maintenance of resting membrane potential 
(Chilton, Ohya, Freed, et al., 2005; Benamer, Vasquez, Mahoney, et al., 2013; Shibukawa, Chilton, 
Maccannell, et al., 2005). Adult rat ventricular fibroblasts express the KATP  channel subunits Kir6.1, 
KIR 6.2 and SUR2, of which KIR 6.2 and SUR2 were shown to be upregulated in the scar area of 
infarcted rat hearts (Benamer, Maati, Demolombe, et al., 2009; Chilton, Ohya, Freed, et al., 2005; 
Shibukawa, Chilton, Maccannell, et al., 2005; Benamer, Vasquez, Mahoney, et al., 2013). The scar 
area is associated with increased infiltration of myofibroblasts. Neonatal rat myofibroblasts have a  
K+ current, but not much is known about which subunits are involved in these cells (Walsh & Zhang, 
2008). Using a set of antibodies described previously, localisation of each of the 4 KATP channel 
subunits, KIR 6.1, KIR 6.2, SUR1, SUR2(A/B), was analysed in neonatal rat myofibroblasts in 
combination with the myofibroblast marker αSMA (Morrissey, Rosner, Lanning, et al., 2005). The 
localisation of these markers was evaluated after treatment with 24h hypoxia and/or 1 µM UDCA  
and images for KIR 6.1, KIR 6.2, SUR1, SUR2(A/B) can be found in Figures 4.15, 4.16, 4.17 and 4.18 
respectively. The negative control for the goat-488 (all subunits) and rabbit-546 is shown in Figure 
6.14c. 
 
The antibodies show localisation of all 4 subunits in the neonatal rat fibroblasts, although the 
expression level changes cannot be assessed in this manner. Interestingly, after hypoxia treatment 
seemed to have induced colocalisation of KIR 6.1 or KIR 6.2 with αSMA. This colocalisation is 
significantly higher in hypoxia treatment compared to control and is reduced with 1 µM UDCA 
treatment, albeit not significantly [Figure 4.15a and 4.15b respectively]. 
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FIGURE 4.15. HYPOXIA INDUCES INCREASED COLOCALISATION OF KIR6.1/6.2 WITH α SMOOTH 
MUSCLE ACTIN IN NEONATAL RAT  MYOFIBROBLASTS 
 
Neonatal rat myofibroblasts (MFBs) were stained with αSmooth Muscle Actin (αSMA, rabbit-546) and 
KIR6.1 or KIR6.2 (goat-488) and localisation of the antibodies was assessed after treatment with hypoxia 
and/or 1 µM Ursodeoxycholic acid (UDCA). Interestingly, hypoxia seemed to induce colocalisation of KIR6.1 
or KIR6.2 with αSMA, this was reduced by UDCA treatment. The colocalisation was calculated using FIJI. a) 
KIR6.1 or b) KIR6.2 do not localise significantly with αSMA in control (Rr close to 0/- values indicate no 
correlation. Hypoxia treatment induced colocalisation of KIR6.1 (p ≤ 0.01) or KIR6.2 (p ≤ 0.05) with αSMA. c) 
Negative controls for Kir6.1, Kir6.2, SUR1 and SUR2 (goat-488) and αSMA (rabbit-546). Scale bar: 50 µm. 
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KIR 6.1 seems to be localised in the cytoplasm and on the membrane during normoxia, which did 
not chance after treatment with 1 µM UDCA [Figure 4.16]. Treatment with hypoxia led to 
reorganisation of KIR 6.1 along the αSMA, possibly due to increased trafficking to/from the 
membrane. Treatment of 1 µM UDCA during hypoxia reduced this colocalisation again to the dense 
clusters seen in normoxia. 
 
KIR 6.2 seems to have a more nuclear distribution, although it is localised throughout the cell 
[Figure 4.17]. Treatment with 1 µM UDCA seems to increase membrane bound intensity. KATP 
channels have an inward and outward rectifying component depending on the membrane potential. 
As UDCA hyperpolarises the cell membrane, it leads to an efflux of the K+. Increased intensity at the 
membrane may indicate that it is sequestered by UDCA, which leads to channel activation and K+ 
efflux. Again, there is an increased colocalisation of KIR 6.2 along the αSMA after hypoxia, which is 
abolished by 1 µM UDCA. 
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FIGURE 4.16. HYPOXIA INDUCES INCREASED COLOCALISATION OF KIR6.1 WITH αSMOOTH 
MUSCLE ACTIN IN NEONATAL RAT  MYOFIBROBLASTS 
 
Neonatal rat myofibroblasts (MFBs) were stained with αSmooth Muscle Actin (αSMA, rabbit-546) 
and KIR6.1 (goat-488) and localisation of the antibodies was assessed after treatment with hypoxia 
and/or 1 µM Ursodeoxycholic acid (UDCA). Interestingly, hypoxia seemed to induce colocalisation of 
KIR6.1 with αSMA, this was reduced by UDCA treatment. The colocalisation was calculated using FIJI 
and is shown in Figure 4.14a. 
Page | 198  
 
FIGURE 4.17. HYPOXIA INDUCES INCREASED COLOCALISATION OF KIR6.2 WITH αSMOOTH 
MUSCLE ACTIN IN NEONATAL RAT  MYOFIBROBLASTS 
 
 
Neonatal rat myofibroblasts (MFBs) were stained with αSmooth Muscle Actin (αSMA, rabbit-546) 
and KIR6.2 (goat-488) and localisation of the antibodies was assessed after treatment with hypoxia 
and/or 1 µM Ursodeoxycholic acid (UDCA). Interestingly, hypoxia seemed to induce colocalisation of 
KIR6.2 with αSMA, this was reduced by UDCA treatment. The colocalisation was calculated using FIJI 
and is shown in Figure 4.14b. 
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SUR1 seems to have an even distribution throughout the cell, but 1 µM UDCA seems to induce 
changes in cluster size in both hypoxia and normoxia [Figure 4.18]. 
 
SUR2 seems to have a more nuclear localisation than SUR1, although there is an even distribution 
throughout the cytoplasm also [Figure 4.19]. Hypoxia seems to induce increased cluster size of SUR2, 
which is reduced after 1 µM UDCA. 
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FIGURE 4.18. SUR1 LOCALISATION IN NEONATAL RAT  MYOFIBROBLASTS 
 
 
Neonatal rat myofibroblasts (MFBs) were stained with αSmooth Muscle Actin (αSMA, rabbit-546) and 
SUR1 after which localisation of the antibodies was assessed after treatment with hypoxia and/or 1 
µM Ursodeoxycholic acid (UDCA). SUR1 seems to have an even distribution throughout the cell, but   1 
µM UDCA seems to induce changes in cluster size in both hypoxia and normoxia. 
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FIGURE 4.19. SUR2 LOCALISATION IN NEONATAL RAT  MYOFIBROBLASTS 
 
 
Neonatal rat myofibroblasts (MFBs) were stained with αSmooth Muscle Actin (αSMA, rabbit-546) and 
SUR2 after which localisation of the antibodies was assessed after treatment with hypoxia and/or 1 
µM Ursodeoxycholic acid (UDCA). SUR2 seems to have a more nuclear localisation than SUR1, 
although there is an even distribution throughout the cytoplasm also. Hypoxia seems to induce 
increased cluster size of SUR2, which is reduced after 1 µM UDCA. 
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4.7.1 SUMMARY 
 
 
This chapter describes a more in-depth analysis of the major population of the heart, the 
fibroblasts (FBs). Firstly, an analysis of the percentage of fibroblasts to myofibroblasts (MFBs) was 
carried out in human and rat fibroblasts using immunofluorescence microscopy and western 
blotting. Subsequently the effect of bile acids on the resting membrane potential of neonatal rat and 
fetal human fibroblasts was investigated. The effect of hypoxia with and without UDCA was also 
investigated in these cells. Additionally, effect of UDCA on human and rat adult fibroblasts from 
infarcted hearts was analysed and in the rat compared to control. Subsequently, the mechanism of 
action of UDCA and NorUDCA was further investigated. 
 
 
 
 
 
4.7.2 THE EFFECT OF BILE ACIDS ON NEONATAL RAT AND HUMAN FETAL FIBROBLASTS 
 
 
Firstly, the number of myofibroblasts in neonatal rat and human fetal fibroblast populations were 
compared. An increased number of αSMA positive human fetal fibroblasts were found even under 
control circumstances. Upon treatment with hypoxia, this number went up even higher and hypoxia 
induced significant depolarisation in these human fetal fibroblasts. Taken together with the work 
described in the previous chapter, it further shows that the natural ‘contamination’ seen in the 
human fetal cardiomyocyte culture is similar to the gestational appearance of myofibroblasts during 
the development of the fetal heart, similarly to the neonatal rat co-cultures described here and 
previously (Miragoli, Kadir, Sheppard, et al., 2011). Interestingly, UDCA treatment led to a reduction 
in the number of myofibroblasts. This is similar to the effect of UDCA and NorUDCA on liver fibrosis 
(Halilbasic, Fiorotto, Fickert, et al., 2009; Fickert, Wagner, Marschall, et al., 2006). The study of 
NorUDCA on the number of myofibroblasts and αSMA is ongoing, as NorUDCA was found to be more 
effective in the prevention of fibrosis (Fickert, Wagner, Marschall, et al., 2006; Halilbasic, Fiorotto, 
Fickert, et al., 2009). 
4.7 DISCUSSION 
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Subsequently, the effect of bile acids on the membrane potential of human fetal and neonatal rat 
fibroblasts was analysed. 0.2 mM TC induced depolarisation in both neonatal rat and human fetal 
fibroblasts. Additionally, both 1 µM UDCA and NorUDCA induced hyperpolarisation in both these cell 
types. When combined with 0.2 mM TC, only UDCA induced hyperpolarisation of the human fetal 
fibroblasts, although the resting membrane potential was more negative for both cases, NorUDCA 
only induced hyperpolarisation of the human fetal fibroblasts back to control levels. In neonatal rat 
fibroblasts, both UDCA and NorUDCA, when combined with TC, induced significant hyperpolarisation 
compared to the resting membrane potential of TC, but again only UDCA with TC induced further 
hyperpolarisation when compared to control. 
 
Since the fetus develops in partial hypoxia, the effect of hypoxia and 1 µM UDCA on resting 
membrane potential was investigated. Hypoxia induced a relative depolarisation in both neonatal rat 
and human fetal fibroblasts, although this was only found to be significant in the human fetal 
fibroblasts. Acute treatment with 1 µM UDCA led to significant hyperpolarisation of the hypoxic 
neonatal rat and human fetal fibroblasts, similarly to normoxic conditions when treated with 1 µM 
UDCA. 
 
Previously, it was demonstrated that UDCA acted as a modulator of potassium conductance and 
that UDCA could displace radiolabelled Glibenclamide from neonatal rat myofibroblasts (Miragoli, 
Kadir, Sheppard, et al., 2011). It was therefore decided to investigate whether NorUDCA acted 
through similar pathways, or, due to its shorter side chain, whether NorUDCA would act through 
other mechanisms. When radioligand binding experiments with neonatal rat and human adult 
fibroblasts  incubated  with  [3H]-Glibenclamide  and  increasing  doses  of  UDCA  or  NorUDCA  were 
carried out, both UDCA and NorUDCA showed displacement of the [3H]-Glibenclamide, although in 
 
the neonatal rat myofibroblasts NorUDCA seemed to show more variability than was previously 
shown for UDCA (Miragoli, Kadir, Sheppard, et al., 2011). 
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Finally, a more in-depth analysis of the ATP-sensitive potassium channel subunits was carried out. 
For this reason, localisation studies of KIR 6.1, KIR 6.2, SUR1 and SUR2(A/B) were carried out in the 
neonatal rat myofibroblasts. All 4 subunits were found in neonatal rat myofibroblasts treated 
with/without hypoxia and/or UDCA. 
 
 
 
 
 
4.7.3 THE  EFFECT  OF  UDCA  ON  FIBROBLASTS  FROM  THE  HUMAN  AND  RAT    ADULT 
 
HEART 
 
 
There is not only a transient induction of myofibroblasts in the human fetus, which is possibly due 
to the hypoxia the fetus experiences, the induction of the differentiation of fibroblasts into 
myofibroblasts can also be seen in rat models of infarction, like our MI model, or in human hearts 
with cardiomyopathies. Therefore, the potential treatment of cardiac disease with UDCA has been 
suggested. It was previously shown that UDCA was well-tolerated in patients with chronic heart 
failure and it induced improved peripheral blood flow in these patients, as well as improved nitric 
oxide-independent endothelial vasodilation in coronary heart disease patients with depressed 
endothelial function (Von Haehling, Schefold, Jankowska, et al., 2012; Sinisalo, Vanhanen, Pajunen, 
et al., 1999). 
 
But UDCA may be effective in treating not only fetal arrhythmias in ICP but also in adult cardiac 
disease by acting on myofibroblasts from infarcted hearts. In adult rats after MI, an increased 
number of myofibroblasts was found and an increase in protein level of αSMA when compared to 
control fibroblasts. This is in accordance with the idea that after cardiac insult fibroblasts 
differentiate into myofibroblasts, although Vasquez et al. (2010) showed a decrease in relative αSMA 
levels (Vasquez, Mohandas, Louie, et al., 2010). This difference is potentially due to the duration of 
MI that was chosen. In their model the animals were sacrificed during the early stage of MI, after 7 
days of infarction, whilst our model is a 16 week MI which induces heart failure, not only scar 
formation and initial remodelling (Vasquez, Mohandas, Louie, et al., 2010). It could be expected that, 
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as the time passes by and the heart remodels to a heart failure phenotype, the scar becomes 
increasingly infiltrated by αSMA positive myofibroblasts, thus leading to an increased number of 
myofibroblasts after isolation. 
 
In adult rat control very few cells were αSMA positive, whilst in adult rat MI fibroblasts a large 
percentage of cells was αSMA positive. UDCA induced a significant reduction in the percentage  
αSMA positive MI fibroblasts and a reduction in αSMA protein levels, although this was not 
significant. UDCA also led to a decreased number of myofibroblasts in the fibroblast population of 
isolated from human adult DCM/ICM hearts. Potentially, reduced myofibroblast differentiation 
induced by UDCA treatment could prevent excessive ECM deposition, which could lead to reduced 
scar formation or growth of the scar after it has been formed. However, too little fibrosis and 
scarring would mean that the cardiac wall would become too thin thereby leading to increase risk of 
rupture. The timing of UDCA treatment may therefore be critical, so as to ensure a sufficiently thick 
scar is formed but not excessively. Additionally, if further expansion of the scar border zone can be 
reduced or prevented, taken together with the hyperpolarising effect of UDCA on (myo)fibroblasts, 
this could reduce arrhythmias in the border zone. 
 
Subsequently, the resting membrane potential of adult rat and human adult fibroblasts was 
analysed and the effect of 1 µM UDCA assessed. Adult rat MI myofibroblasts are significantly 
depolarised compared to adult rat control fibroblasts. 1 µM UDCA induced significant 
hyperpolarisation in both MI myofibroblasts and control fibroblasts. Similarly, 1 µM UDCA induced 
significant hyperpolarisation of the human adult fibroblasts from DCM/ICM hearts. 
 
The concentration of UDCA presented in this thesis was chosen based on the amount of UDCA 
that would cross the placenta in ICP pregnancies treated with UDCA (Geenes, Lövgren-Sandblom, 
Benthin, et al., 2014). Treatment of adult cardiac disease with UDCA leads to a higher concentration 
of UDCA in the blood. Von Haehling (2012) reported total UDCA levels of 13.72 ± 10.21 µmol/L after 
daily ingestion of 500 mg UDCA, of which 7.16 ± 5.18 µmol/L was shown to be unconjugated UDCA 
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(Von Haehling, Schefold, Jankowska, et al., 2012). Placebo treated patients were shown to have total 
UDCA levels of 0.11 ± 0.13 µmol/L; of which 0.02 ± 0.04 µmol/L was shown to be unconjugated  
UDCA (Von Haehling, Schefold, Jankowska, et al., 2012). Although the values of total and 
unconjugated UDCA levels were relatively high compared to the treatment concentration chosen 
used here, there was a lot of variability in the levels (Von Haehling, Schefold, Jankowska, et al., 
2012). 
 
 
 
 
 
LIMITATIONS AND FUTURE DIRECTIONS 
 
 
Even though the number of myofibroblasts in neonatal rat single cultures is low after short  
culture periods, the majority of fibroblasts differentiate into myofibroblasts when cultured with 
cardiomyocytes due to various factors secreted by the cardiomyocytes and the fact that fibroblasts 
differentiate into myofibroblasts when cultured on a ‘hard’ substrate (Rohr, 2011). The human fetal 
fibroblasts were cultured for a longer period of time, as there is a limited number of heart tissues 
available, whilst there was an abundancy of neonatal rat fibroblasts. In addition, neonatal rats, 
although young, have been out of hypoxia for at least 1 -2 days before sacrifice. Miragoli et al. (2011) 
showed a rapid disappearance of the myofibroblasts in postnatal hearts, suggesting that 1-2 days 
may be sufficient for the neonatal rat myofibroblasts to regress or dedifferentiate back into 
fibroblasts (Miragoli, Kadir, Sheppard, et al., 2011). It would be of interest to further investigate how 
long this hypoxia induced phenotypic switch to myofibroblasts from neonatal rat fibroblasts lasts, as 
it may be of interest to pre-incubate the myofibroblasts used in the fetal heart model with hypoxia 
for 24h before seeding in with the cardiomyocytes. 
 
Hypoxia was included, as the fetus develops in chronic hypoxia (Webster & Abela, 2007). Partial 
pressure of oxygen (PO2) of 12 – 13 kPA (90 – 100 mmHg) and saturation levels (SO2 ) of 95-100% are 
considered normal in arterial blood gas readings (adult), maternal recordings in normoxia during 
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pregnancy were recorded to be PO2: 102 mmHg and So2: 96% (Meschia, 2011). Hypoxia is regarded 
to be: PO2 < 12 – 13 kPA (90 – 100 mmHg) and SO2 <95% (adult). 
 
In the fetus, partial pressure of oxygen (PO2 ) in the umbilical vein is around 4.7 kPa, 28 mmHg  
and the fetal blood is 60–90% saturated (umbilical vein) (Murphy, 2005; Richardson, Nodwell, 
Webster, et al., 1998; Meschia, 2011). In the left atrium, the oxygen saturation of fetal blood is 65%, 
whilst in the lower portions of the body the SO2 is around 25-40% (Murphy, 2005). The majority of 
the left ventricular blood is delivered to the brain and heart thus ensuring that blood with the 
highest possible oxygen concentration is delivered to these vital structures during development 
(Murphy, 2005). 
 
Hypoxia, potentially via increased HIF-1α expression induces activation of fibroblasts and 
differentiation into myofibroblasts acutely or chronically (Webster & Abela, 2007). Therefore, the 
chronic hypoxia in which the fetus develops could potentially lead to a chronic increase in 
myofibroblasts, which was seen by Miragoli (Miragoli, Kadir, Sheppard, et al., 2011). Truly chronic 
incubations with hypoxia or UDCA are difficult, due to the transient nature of the cultures. A 
significant increase in the number of myofibroblasts over the number of fibroblasts was seen after 
even after 24h. 
 
Adult rat MI and control fibroblasts were isolated and used within 2 passages after isolation (1 – 2 
weeks), to have a population representative of the MI or control heart. Due to the slow proliferation 
of the human adult fibroblasts, this was not possible for these cells. The culture period for these cells 
was longer and until recently it was difficult to obtain fibroblasts from human adult control samples. 
Current work is ongoing repeating these experiments with human adult control fibroblasts  from 
atrial and ventricular tissue. Therefore, no comparison in human adult fibroblasts can be made 
currently, although the current results are similar to those found in the adult rat MI myofibroblasts. 
 
Functional studies into the effect of UDCA and NorUDCA on the KATP channels are also in  
progress.  For  these  studies  human  fetal  and  human  adult  fibroblasts  were  treated  acutely (20 
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minutes) after control recordings or chronically (24h) with 1 µM UDCA or NorUDCA and the KATP 
currents were recorded. Before acute UDCA/NorUDCA treatment, control or pinacidil treatment and 
recordings were carried out in the same cell. Using this method, inward and outward currents can be 
assessed. This could provide further information into the mechanism of action of UDCA and 
NorUDCA. 
 
One of the limitations of the current western blotting results of the human fetal fibroblasts is the 
fact that it was carried out together with the neonatal rat western blotting. For this, the rabbit αSMA 
(Abcam) antibody was used. The results indicated that there was very little αSMA in the human fetal 
fibroblasts, less than the neonatal rat. This is in contrast to the localisation studies, where most of 
the human fetal fibroblasts were αSMA positive. It is therefore important to separate the western 
blotting for human and rat fibroblasts, as the mouse monoclonal αSMA antibody (DAKO) is specific  
to the human αSMA and may provide a more accurate representation of the αSMA protein levels in 
human fetal fibroblasts in normoxia and hypoxia. Analysis of the expression levels of αSMA using 
western blots in fibroblasts obtained from the human and rat hearts is of importance. This is 
necessary to confirm that the increase in αSMA positive cells after hypoxia and the decrease in 
myofibroblasts after UDCA are associated with an increase in protein levels. It will also be of interest 
to investigate whether NorUDCA can potentially prevent differentiation into αSMA positive 
myofibroblasts in both human fetal fibroblasts and neonatal rat myofibroblasts. 
 
Further investigation of the expression levels of αSMA using western blots in fibroblasts obtained 
from the human and rat hearts is currently ongoing, to confirm the increase in αSMA positive cells in 
MI / adult failure is associated with an increase in protein levels. The effect of NorUDCA is also 
ongoing with respect to the reduction in myofibroblast transformation, to investigate whether UDCA 
and NorUDCA have differential effects on αSMA expression. 
 
In addition, it will be of interest to further investigate the expression levels of mRNA and protein 
and localisation of the KATP  channel subunits (KIR 6.1, KIR 6.2, SUR1 and SUR2(A/B)) in the   fibroblasts 
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obtained from human and rat adult hearts. Previously, KIR 6.1, KIR 6.2 and SUR2(A/B) were described 
to be expressed in adult rat fibroblasts and of which KIR 6.2 and SUR2 were shown to be upregulated 
in the scar area of infarcted rat hearts (Benamer, Maati, Demolombe, et al., 2009; Chilton, Ohya, 
Freed, et al., 2005; Shibukawa, Chilton, Maccannell, et al., 2005; Benamer, Vasquez, Mahoney, et al., 
2013). It would be interesting to analyse whether in our heart failure model of 16 weeks MI this 
upregulation remains the same as previously published in earlier MI models or whether this changes 
with progression to heart failure. In addition, not much is known about the expression and 
localisation of these subunits in human ventricular fibroblasts in health and disease. 
 
The expression level of mRNA and protein as well as the localisation of KIR 6.1, KIR 6.2, SUR1 and 
SUR2(A/B) in human fetal and neonatal rat fibroblasts has not been described previously and should 
be investigated further. 
 
The antibodies used for the staining of KIR 6.1, KIR 6.2, SUR1 and SUR2(A/B) in the fibroblasts were 
all goat antibodies, leaving us unable to colocalisation studies of KIR 6.1 and KIR 6.2 with SUR1 and 
SUR2(A/B)). In addition, the specificity of these antibodies has been questioned by us and others 
[personal communication]. It will, therefore, be of interest to further investigate the expression 
levels of mRNA and protein and localisation of the KATP channel subunits (KIR 6.1, KIR 6.2, SUR1 and 
SUR2(A/B)) in the fibroblasts obtained from human and rat hearts. 
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CHAPTER 5: ELUCIDATION OF THE INTERACTION BETWEEN 
CARDIOMYOCYTES AND MYOFIBROBLASTS WITH THE FOCUS ON 
FUNCTIONAL CONTACTS AND GAP  JUNCTIONS 
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In this chapter the interaction between cardiomyocytes (CMs) and myofibroblasts (MFBs) will be 
further investigated with a focus on the role of Cx43 in the interaction between these cell types 
[Figure 5.1], as this plays an important role in both adult myocardial injuries and in the fetal heart 
where MFB induced depolarisation of neighbouring cardiomyocytes may sensitise cardiomyocytes to 
bile acid induced arrhythmias (Miragoli, Kadir, Sheppard, et al., 2011). This interaction was assessed 
by investigating whether functional contacts and gap junctions are formed between both cell types 
and what the effect of Connexin43 modulation and hypoxia is on this contact. 
 
 
FIGURE 5.1. CARDIOMYOCYTE – MYOFIBROBLAST COUPLING 
BY CONNEXIN43 
 
The interaction between neonatal rat cardiomyocytes (CMs) and 
myofibroblasts (MFBs) by gap junctional formation between the 
cell types is shown here. CMs and MFBs were cultured together. 
MFB (Vimentin, red, left) and CM (Connexin43, green) were shown 
to be coupled by Connexin43 (green, circled area). Scale bar: 15 
µm. 
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The modelling of the fetal and maternal heart using neonatal rat cardiomyocytes (CMs) and 
myofibroblasts (MFBs) described in the previous chapters and elsewhere showed that there was 
conduction velocity slowing, prolongation of calcium transients and re-entry formation when 
myofibroblasts were introduced, especially after treatment with TC (Miragoli, Kadir, Sheppard, et al., 
2011; Miragoli, Gaudesius & Rohr, 2006; Miragoli, Salvarani & Rohr, 2007; Gaudesius, Miragoli, 
Thomas, et al., 2003). This assumes that there is an interaction between these two cell types and 
that there is functional gap junction formation. 
 
Healthy adult cardiomyocytes are coupled end to end at the intercalated discs by gap junctions 
(Rhett & Gourdie, 2012). This direct electrical coupling allows for the conduction of action potentials 
between cells, propagating through the tissue and therefore ensures rhythmic contraction of the 
heart. In diseased hearts adverse remodelling of gap junctions occur. Especially in the border zone 
surrounding the scar where there is a loss of gap junctions at the intercalated discs and increased 
expression of the gap junctional protein connexin43 (Cx43) at the lateral domains of sarcolemma 
(O’Quinn, Palatinus, Harris, et al., 2011). In vitro studies are often carried out using rat neonatal 
cardiomyocytes and myofibroblasts (Miragoli, Gaudesius & Rohr, 2006; Miragoli, Salvarani & Rohr, 
2007; Gaudesius, Miragoli, Thomas, et al., 2003). These studies have shown that fibroblasts 
sporadically interspersed between cardiomyocytes synchronized spontaneous contractions of 
cardiomyocytes, but that high infiltration of fibroblasts can lead to conduction slowing due  to 
relative cardiomyocyte membrane potential depolarisation (Hyde, Blondel, Matter, et al., 1969; 
Miragoli, Gaudesius & Rohr, 2006; Rohr, 2009). This is due to heterocellular gap junctions formed 
between cardiomyocytes and myofibroblasts (Rohr, 2009; Miragoli, Gaudesius & Rohr, 2006). 
 
After an infarct or ischemic event, especially in the scar region where the injury occurred and in 
the surrounding area known as the border zone, fibroblasts are replaced by or switch to 
myofibroblasts, characterized by expression of αSMA. These myofibroblasts are implicated in the 
5.1 INTRODUCTION 
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initial formation of the scar and subsequent border zone / scar expansion (Miragoli et al. 2006; 
Gaudesius et al. 2003; Biernacka & Frangogiannis 2011; Rohr 2009; McAnulty 2007; O’Quinn et al. 
2011). The border zone is the area surrounding the scar where there is infiltration of myofibroblasts 
but there are still cardiomyocytes surviving, in contrast to the scar area where very few 
cardiomyocytes survive due to necrosis (O’Quinn, Palatinus, Harris, et al., 2011). This transformation 
or infiltration of myofibroblasts is thought to be triggered by a multitude of signals, including local 
inflammatory reactions, mechanical stress and various cytokines and biochemical factors (Rohr, 
2009). Numerous factors have been implicated in myofibroblast activation, phenotype and function, 
including transforming growth factor β1 (TGF-β1), basic fibroblast growth factor (bFGF), insulin-like 
growth factors (IGF) angiotensin II as well as catecholamines and insulin-like growth factor (Rohr, 
2009; Manabe, Shindo & Nagai, 2002). Myofibroblasts have a low resting membrane potential,  
which can be modulated by axial stretch, hypoxia and humoral activity (Chilton, Giles & Smith, 2007, 
Kamkin et al., 2005, Kamkin et al., 2003). Myofibroblasts contribute to the arrhythmogenesis that 
occurs in diseased hearts, by structural remodelling of the heart. There are two components to 
structural remodelling, the fibrotic and electrical component which both contribute to arrhythmias. 
Fibrosis, or the excess deposition of ECM leads to disruption of the three-dimensional network of 
electrically coupled cardiomyocytes (Miragoli, Gaudesius & Rohr, 2006; Gaudesius, Miragoli, 
Thomas, et al., 2003; Biernacka & Frangogiannis, 2011; Rohr, 2009; McAnulty, 2007; Camelliti, Borg 
& Kohl, 2005; O’Quinn, Palatinus, Harris, et al., 2011). These collagenous depositions separate 
bundles of cardiomyocytes, which reduces their electrical coupling and leads to disruption of 
synchronous electrical activation and leads to uneven conduction and even conduction block of 
electrical impulses. The other component to structural remodelling is related to the cardiomyocytes 
electrophysiology and is due to changes in expression and function of ion channels, receptors and 
calcium handling proteins associated with excitation-contraction coupling, as well as modification in 
gap junction (GJ) function and location (Rohr, 2009). In addition, myofibroblasts are also capable of 
establishing heterocellular gap junctions with cardiomyocytes, which results in the modulation of 
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cardiomyocyte electrophysiology and can lead to development of arrhythmia in vitro (Miragoli, 
Salvarani & Rohr, 2007, Miragoli, Gaudesius & Rohr, 2006, Gaudesius et al., 2003). 
 
Myofibroblasts were found to express two type of connexions, Cx43 and Cx45 with which they 
can establish contacts between myofibroblasts and with cardiomyocytes (Miragoli, Gaudesius & 
Rohr, 2006; Rohr, 2009; Li, Sun, Chen, et al., 2009). These homo- or heterocellular contacts between 
cardiomyocytes and myofibroblasts consist of gap junctions which are aggregates of two connected 
hexamers of connexins (Cx43, Cx45 or Cx40) called hemichannels which together form an intercellar 
connexon channel through which signals are propagated between the two connected cells (Rhett & 
Gourdie, 2012). The most common connexin expressed in the heart is Cx43, although Cx40 and Cx45 
are also expressed during development and in specific tissues (the atria, AV node). There are a 
number of other proteins also associated with Cx43, which help regulate gap junction size and Cx43 
channel formation. Cx43 hemichannels are recruited from the edge of the GJ which is called the 
perinexus to form new channels (Gaietta, Deerinck, Adams, et al., 2002; Rhett & Gourdie, 2012). One 
of the associated regulatory proteins is the membrane associated guanylate kinase (MAGUK) 
scaffolding protein Zonula occludens-1 (ZO-1). ZO-1 colocalises with Cx43 preferentially in the 
perinexus and regulates GJ size by interacting with Cx43 (Rhett, Jourdan & Gourdie, 2011; Rhett & 
Gourdie, 2012). ZO-1 is part of the MAGUK family of adaptor proteins which are regulators of 
channel properties, including clustering and trafficking of channels and signalling properties. ZO-1 
and other MAGUKs have an amino-terminal protein-protein binding domain which is called Post- 
synaptic-density/Disks-large/ZO-1 or PDZ domain, for the MAGUKs that have one or more of these 
motifs in their sequence. A complementary 4 amino acid (AA) PDZ-binding domain sequence was 
found at the carboxyl terminus (CT) of Cx43, although for stable binding the last 19 AAs of Cx43 are 
needed (Sorgen, Duffy, Sahoo, et al., 2004; Rhett & Gourdie, 2012). It was previously shown that ZO- 
1 preferentially localizes to the periphery of the Cx43 GJ plaques in neonatal rat cardiomyocytes 
(Hunter, Barker, Zhu, et al., 2005; Zhu, Barker, Hunter, et al., 2005). Modulation of Cx43 by ZO-1 
leads to changes in GJs and therefore can lead to changes in interaction between cardiomyocytes 
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and fibroblasts. This may lead to modification of electrical conduction and cardiomyocyte 
electrophysiology. 
 
To further investigate the mechanisms that organise the GJs a mimetic peptide consisting of the 
Cx43 PDZ-binding domain (αCT1 peptide) and an inactive peptide consisting of the reverse sequence 
(Reverse peptide) was generated (Hunter, Barker, Zhu, et al., 2005). Incubation with this peptide in 
HeLa cells expressing Cx43 and neonatal rat cardiomyocytes led to a reduction of peripheral 
association of ZO-1 with Cx43 and a significant increase in plaque size (Hunter, Barker, Zhu, et al., 
2005). This increase in size resulted from increased, unregulated accumulation of GJ channels from 
non-junctional pools resulting, rather than an increase in protein expression or a decrease in 
turnover (Hunter, Barker, Zhu, et al., 2005). This indicated that ZO-1 regulates the rate of Cx43 
channel formation at the GJ peripheries and therefore regulates the GJ size and distribution (Hunter, 
Barker, Zhu, et al., 2005). 
 
This changed distribution of Cx43 induced by the αCT1 peptide led to the question whether the 
αCT1 peptide had similar effects on GJ remodelling in the myocardium in vivo and whether the αCT1 
peptide could prevent GJ remodelling in the border zone of myocardial injury (O’Quinn, Palatinus, 
Harris, et al., 2011). A cryoinjury model in adult mice was used to generate an injury border zone in 
the left ventricle and methylcellulose patches containing the αCT1 peptide were applied for slow 
release of the peptide into the injury (O’Quinn, Palatinus, Harris, et al., 2011). Cx43-ZO-1 
colocalisation in the border zone was reduced in αCT1 treated hearts compared to controls by 24h of 
treatment (O’Quinn, Palatinus, Harris, et al., 2011). αCT1 peptide treated heart also showed reduced 
inducible arrhythmias after injury as indicated by optical recording of voltage transients and 
programmed electric stimulation (O’Quinn, Palatinus, Harris, et al., 2011). The αCT1 peptide reduced 
injury related Cx43 remodelling away from the intercalated discs in the border zone area 1 week 
after injury, whilst in control Cx43 showed intercalated disc remodelling leading to increased 
lateralized Cx43 distribution (O’Quinn, Palatinus, Harris, et al., 2011). 
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The work presented in this chapter will shortly be submitted as an article and was carried out 
mostly by myself, but with help of others as indicated in the figure legend of relevant figures. 
 
 
 
 
 
 
5.2.1 CELL MODELS USED FOR CONTACT MOTILITY  STUDIES 
 
 
Neonatal rat ventricular cardiomyocytes (CM) and myofibroblasts (MFB) were used for the  
border zone experiments. CM and MFB were isolated as previously described. Single cultures of CM 
or MFB were seeded into Mattek (13 cm2) or plastic bottom dishes (35 mm). For the co-culture 
experiments, CM were plated in Mattek (13 cm2) or plastic bottom dishes (35 mm) and the 
subsequent day MFB were detached as previously described, spun and resuspended in 1 mL HBSS- / 
1 million cells. The MFB were then dyed by incubating for 20 minutes at 37°C / 1% CO2 with either 
Vybrant  DiI  (Invitrogen,  excitation  /  emission:  549  nm  /  565  nm)  or  WGA-488  (Wheat     Germ 
Agglutinin-488, Invitrogen, excitation / emission: 495 nm / 519 nm) for recognition afterwards. The 
MFB were then seeded in with the CM and were left to make GJs for 24h before imaging. 
 
These neonatal models were compared to a single culture of MFBs from an adult rat model of 
myocardial infarction (MI). The rat model of MI was generated by ligation of the left anterior 
descending coronary artery, MFB were isolated after 16 weeks MI or age-matched controls. This 
allows for the comparison of neonatal MFB with MI MFBs. 
To signify the different cultures used a cartoon version of the cells is used as follows: 
 
 
 
 
5.2 METHODOLOGY 
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5.2.2 MODULATION OF GAP JUNCTIONS AND  CONNEXIN43 
 
 
Various methods to modulate gap junctions were used. Heptanol was used to completely 
uncouple gap junctions (Takens-Kwak, Jongsma, Rook, et al., 1992). 
 
Hypoxia leads to internalisation of Cx43 (Danon, Zeevi-Levin, Pinkovich, et al., 2010). Hypoxia was 
induced by incubation in an incubator at 37°C / 1% CO2 / 8% O2 and was carried out overnight  
(~15h), the single cultures were seeded at least 24h before placed in the hypoxic incubator. In the 
co-cultures, the MFBs were seeded approximately 4h before placement in the hypoxic incubator at 
the end of the day. 
 
Cx43 was both overexpressed using a Cx43-GFP virus (courtesy of Prof. Robert Gourdie) and 
knocked-down using siRNA and a GFP-Cx43-Kd-virus (Courtesy of Prof. Daniel Pijnappels). Knock- 
down using this virus was achieved as previously published (Askar, Bingen, Swildens, et al., 2012). 
 
Cx43 modulation by ZO-1 was inhibited by a membrane-permeable peptide inhibitor that 
contains the Cx43 PDZ-binding domain (αCT1 peptide). A peptide with the reverse sequence was 
used as control (Reverse peptide) (Hunter, Barker, Zhu, et al., 2005) [Figure 5.2]. CM and/or MFBs 
were incubated for ~4h with the αCT1 or Reverse peptide (100 µmol/L). 
 
 
 
 
 
5.2.3 SCANNING ION CONDUCTANCE MICROSCOPY 
 
 
Scanning Ion Conductance Microscopy (SICM) was used to image the contact area between cells. 
Briefly SICM provides continuous topographical images in hopping mode via a feedback-controlled 
nanopipette scan with a minimal spatial drift (few nanometers, (Novak, Li, Shevchuk, et al., 2009)). 
SICM is a non-contact method of imaging the topography of intact cells (Miragoli, Moshkov, Novak, 
et al., 2011; Nikolaev, Moshkov, Lyon, et al., 2010; Novak, Li, Shevchuk, et al., 2009). Surface 
topographical images of cardiomyocytes and fibroblasts were acquired by SICM at 25C in a low 
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calcium physiological solution, FRET buffer or HBSS- (pH = 7.4) in order to avoid contraction. A large 
scan (60 - 100 x 60 - 100 µm) was carried out to identify contact areas between cells. After that a 
smaller, higher resolution scan of ~15 x 15 µm of the contact area was carried out and repeated for 
1h (‘loop’) to visualise changes in contact area between two cells [Figure 5.3a]. Afterwards, the 
images (15 x 15 m) were processed in chronological order by the CellTrack® software program 
(http://bio.cse.ohio-state.edu/CellTrack/, (Sacan, Ferhatosmanoglu & Coskun, 2008)) [Figure 5.3a]. 
The program returns the average of the speed (pixel/frame) from the randomly selected points 
within the selected contact area [Figure 5.3b]. By knowing the time of each acquired images 
(hh:mm:ss) and the number of pixels for each images (512 x 512 pixels) it was possible to evaluate 
the average border-zone movement velocity in (m/min). 
 
 
 
 
 
5.2.4 SCANNING ION CONDUCTANCE MICROSCOPY IN  COMBINATION WITH   CONFOCAL 
 
MICROSCOPY 
 
 
Surface topographical images of cardiomyocytes and fibroblasts were acquired by SICM at 25C in 
low calcium physiological solution (FRET buffer), pH = 7.4 in order to avoid contraction. For the 
visualization of the Cx43 in the junctions, cells were transfected for 24h with the Cx43-GFP virus  
after which an additional 48h was allowed for expression (MOI: 9, the titer was 4.5x108 pfu/mL and 
the virus was an Adenovirus Type V E1, E3 deleted, pLP-Adeno-X-CMV Connexin43-EGFPN1). Cx43- 
GFP was excited at a wavelength of 473 nm with a StradusTM 473 laser (Vortran) and confocal images 
were taken at 100x magnification using a Photomultiplier Detection System (PTI). Using the SICM 
setup, the tip of the pipette was aligned with the laser beam. The surface of the cell was then 
scanned as a conventional SCIM image. The same area was subsequently scanned with the confocal 
microscopy to visualize the Cx43. The resulting images could be overlapped with the corresponding 
topography image of the surface [Figure 5.4]. 
  
FIGURE 5.2. DOMAIN ORGANIZATION OF FULL-LENGTH CONNEXIN43 AND 
ANTENNAPEDIA PEPTIDES 
 
The interaction of Zonula occludens-1 (ZO-1) and Connexin43 (Cx43) was inhibited by a peptide 
inhibitor that binds specifically to the second PDZ domain of ZO-1. Domain organization of full- 
length Cx43 and the antennapedia peptides, the inhibitor peptide (αCT1 peptide) and the 
inactive peptide (Reverse peptide), from: (Hunter, Barker, Zhu, et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 5.3. SCHEMATIC REPRESENTATION OF CONTACT ANALYSIS AND  CELLTRACK 
 
 
a) Schematic representation of the contact area of a cardiomyocyte (CM, red) and myofibroblast (MFB, 
green). The contact area was scanned using Scanning Ion Conductance Microscopy and then the 
contact zone (circle) selected for analysis with CellTrack®. Contact points are represented by yellow 
blocks. 
b) Representative set of scans for the analysis of cell-cell dynamisms in a control culture of MFB using 
CellTrack®. The area of interest was selected (in red), CellTrack® then generates 100 random points 
which it follows throughout the scans. The contact movement is calculated by the distance moved by 
these points. Figure reproduced with permission from Dr. Michele Miragoli. Page | 219 
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5.2.5 MOLECULAR BIOLOGY 
 
 
Immunofluorescence microscopy of Vimentin, αSMA, α-Actinin and Cx43 was used to assess the 
internalisation of Cx43 after hypoxia and the effects of the peptides. αSMA and N-Cadherin were 
used to image the gap junctions between CMs and MFBs, Cx43 and αSMA were used to image the 
GJs between MFBs. Phalloidin (F-Actin) was used to assess lamellipodia formation after treatment 
with the αCT1 or Reverse peptide. Streptavidin-488, which binds to the biotin tag of the αCT1 or 
Reverse peptide was used to image the localisation of the αCT1 or Reverse peptide and  
colocalisation with Cx43 in CMs (as indicated by α-Actinin) and MFBs (αSMA) . 
 
Western blots for the gap junctional proteins N-Cadherin, Cx43 and Desmoglein-2 was carried out 
as described previously, α-Tubulin was used as a loading control. 
 
 
 
 
 
5.2.6 PARACHUTE ASSAY 
 
 
Neonatal rat ventricular myocyte acceptor cells were seeded and grown to confluence on 2-well 
glass chamber slides coated with gelatin. Donor neonatal rat ventricular fibroblasts were grown in 6- 
well plates. Donor and acceptor cells were treated with 100 µM αCT1 or reverse control peptide or 
vehicle control for 48 hours with daily media changes. At the time of parachute, donor cells were 
loaded with 5 µM calcein AM (Invitrogen) and 2.5 µM CellTracker Orange (CMRA) (Invitrogen) in 
OptiMEM (Gibco) for 45 minutes at 37°C. Donor fibroblasts were washed in PBS, trypsinized, and 
parachuted in complete medium with 100 µM treatments. Transfer was allowed to progress for 4 
hours at 37°C and cells were mounted in OptiMEM and imaged on an Olympus BX61VS slide scanner. 
Only communication competent cells (transferring cells) were counted. Acceptor cell number 
between groups was significant by ANOVA with post-hoc analysis by Least Significant Difference 
(LSD) at p < 0.05. 
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5.2.7 STATISTICAL ANALYSIS 
 
 
Statistical analysis was carried in Graphpad out for all the scanning data. All data was tested for 
normality before a One-way ANOVA with post-tests for data with all samples (n ≥ 4) or a Kruskal- 
Wallis test with post-test for data with samples of (n ≥ 3) was carried out. All data is shown as  Mean 
+ SEM and in all scanning data ‘n’ represents the number of 1 hour scan sets that were used. More 
sets were carried out, but may not have been used for various reasons, including noise in the scan 
due to debris on the cell which interferes with the scan of the membrane. All data was carried out 
with at least 1 dish of cells, dishes were changed after 1 - 2 scan sets, especially for the hypoxia (+ 
peptide) work, as the scans were carried out at normal oxygen tension which meant that changes 
induced by hypoxia may have reverted back after 1 - 2h. Most work was carried out with cells from  
at least 2 separate isolations, except for the MI MFBs which were from the same adult rat. 
 
 
 
 
 
5.3.1 DYNAMIC MEASUREMENT OF CELL-CELL  CONTACT 
 
 
High spatial resolution images of cell-cell contact were achieved by acquiring topographical 
images in loop configuration for one hour using a combination of SICM and confocal microscopy. 
Cell-cell gap junctional coupling was confirmed using cells which were transfected with Cx43-GFP, a 
topographical image was obtained and subsequently using confocal microscopy the same area was 
imaged and the Cx43-GFP was visualized. Each scan took approximately 5 minutes, representative 
images and confocal images of Cx43-GFP at the junctions are represented in Figure 5.4. A junction 
between two CM is visualized in Figure 5.4a, whilst a heterocellular junction between a CM-MFB is 
visualized in Figure 5.4b. 
5.3 RESULTS 
  
 
 
FIGURE 5.4. REPRESENTATIVE SCANS AND CONFOCAL IMAGES OF CONNEXIN43-GFP OF CONTACTS BETWEEN CARDIOMYOCYTES AND 
MYOFIBROBLASTS 
 
Single cardiomyocyte (CM) cultures (a) or co-cultures of CMs with myofibroblasts (MFBs) (b) were infected with the Connexin43-GFP virus (Cx43-GFP) for 48h 
before scanning on the Scanning Ion Conductance Microscopy/Confocal system. A scan of the junctional area was carried out first, and using the laser, 
aligned to the pipette tip, the same area was scanned using the 488 nm laser. Representative images of the junctional area between 2 CMs is shown in a), 
consisting of the SICM scan (left), the Cx43-GFP scan (middle) and the overlay of both (right). The junctional area of a CM and MFB is smaller, and is shown in 
b) consisting of the SICM scan (left), the Cx43-GFP scan (middle) and the overlay of both (right). Figure reproduced with permission from Dr. Jose Sachez- 
Alonso and Dr. Anita Alvarez-Laviada. 
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5.3.2 CONNEXIN43-MEDIATED  COUPLING  HAS  IMPLICATIONS  FOR  CELL-CELL BORDER 
 
ZONE DYNAMISMS 
 
 
The first aim was to evaluate the dynamisms of neonatal rat ventricular CM-CM, CM-MFB and 
MFB-MFB contacts [Figure 5.5a, 5.5b]. The CM-CM pairs, known to be coupled by the electrical gap 
junctional protein Cx43, show minimal movement (0.04 ± 0.005 µm/min, n = 14) while the border 
zone as modelled by a CM coupled with a MFB showed a significant increment of dynamism (0.12   ± 
0.03 µm/min, n = 11). Interestingly MFB-MFB contacts have a high-level of dynamism in culture (0.22 
 
± 0.03 µm/min, n = 8) suggesting that Cx43-mediated MFBs coupling is involved in this process. 
Finally, the dynamisms from MI-MI MFB was analyzed to compare the neonatal rat MFBs to the MI 
fibroblasts (0.32 ± 0.18 µm/min, n = 3). Both MI and neonatal rat MFBs show a high level of 
dynamism. 
 
 
 
 
5.3.3    MEMBRANE CONNEXIN43-DEFICIENT CELLS SHOW LIMITED  DYNAMISMS 
 
 
The involvement of Cx43 in the CM-MFB and MFB-MFB dynamism was then elucidated by either 
infecting MFBs with a GFP-Cx43-Kd-virus [Figure 5.5c]. MFBs were labeled with either Vybrant DiI or 
WGA-488 in order to differentiate between myofibroblasts and cardiomyocytes and identify a 
myofibroblast in close contact with a cardiomyocyte. Knock-down intervention methods inducing  
the absence of Cx43 on the membrane significantly limits the cell-cell dynamism: (CM-MFB: 0.02 ± 
0.001 µm/min, n = 6; MFB-MFB: 0.02 ± 0.006 µm/min, n = 7) [Figure 5.5c and 5.5d]. On the other 
hand using 5 µM Heptanol as gap junctional uncoupler in basal CM-MFB configuration CM-MFB 
(0.047 ± 0.01, n = 7) and MFB-MFB (0.06 ± 0.016, n = 6) does not limit the dynamism suggesting that 
it is the presence and not the function of Cx43-mediated electrical coupling on the MFBs membrane 
that is a requirement to activate the dynamic coupling [Figure 5.5d]. 
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FIGURE 5.5. CONNEXIN43-MEDIATED COUPLING HAS IMPLICATIONS FOR CELL-CELL BORDER ZONE   DYNAMISMS 
 
 
Representative scan sets of a) control and b) Connexin43-Knock down (Cx43-KD) of cardiomyocytes (CMs, top), co-cultures (middle) and Myofibroblasts (MFBs, 
bottom). b) The base movement of CMs is low, whilst MFBs and Myocardial Infarction (MI) MFBs show a large amount of dynamism. In the co-cultures the 
dynamism between both cell types is increased. (a p ≤ 0.01, b p ≤ 0.05). d) Cx43-KD using the Cx43-Kd virus led to a significant decrease in dynamism in MFBs (a p 
≤ 0.01, b p ≤0.001). Cx43 Kd figure reproduced with permission from Dr. Michele Miragoli. Page | 224 
 The presence of Cx43 on the membrane of wild-type CM and MFBs was removed by culturing 
them in hypoxic condition (8% O2) for 12-16 hours prior to acquiring the cell-cell dynamism. Hypoxia 
is known internalize the connexons in the plasmalemma [Figure 5.6a] (Danon, Zeevi-Levin, Pinkovich, 
et al., 2010). A representative image of gap junctional formation under normal oxygen conditions 
between CM-MFBs is shown in Figure 5.6b]. As expected for both CM-MFB (0.067 ± 0.02, n = 7,          
p = 0.055) and MFB-MFB configurations (0.10 ± 0.02492, n = 13, p ≤ 0.05) limited dynamism was 
found when cells were cultured in hypoxic condition compared to normoxic conditions, although this 
did not quite reach significance in the co-cultures, indicating once more that the presence of Cx43 
(and thus the possibility to establish cell-cell electrical coupling) is a sine qua non conditio for cell-cell 
border zone movement [Figure 5.7]. 
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FIGURE 5.6. HYPOXIA LEADS TO INTERNALISATION OF   CONNEXIN43 
 
 
Danon et al. (2010) previously showed that hypoxia led to internalisation of Connexin43 (Cx43) from the 
membrane in cardiomyocytes (CMs), this is also the case in myofibroblasts (MFBs).  a)  Representative 
images of MFBs after hypoxia (8% O2, 16h) of Vimentin (green) and Cx43 (red). Cx43 is no longer localised at 
the membrane, but is found mostly near the nucleus (DAPI, blue). Scale bar: 50 µm. b) Under normal culture 
conditions CMs and MFBs form junctions in co-cultures. Cx43 is represented in green, some Cx43 is found at 
the membrane in the MFB (Vimentin, red) near the top (arrow), but most is found near the contact area 
with the CMs (arrows). Scale bar: 20 µm. Page | 226 
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FIGURE 5.7. INTERNALIZATION OF CONNEXIN43 DUE TO HYPOXIA LEADS TO REDUCED   DYNAMISMS 
 
 
Representative scan sets of a) hypoxia of co-cultures consisting of cardiomyocytes and myofibroblasts (MFBs) 
(top) and MFBs (bottom 3). b) After internalisation of Connexin43 due to hypoxia the base movement is 
reduced in all cultures (a p ≤ 0.01, b p ≤ 0.05). The reduction in MFBs is significant, whilst there is a strong 
trend in the reduction in the co-cultures which did not quite achieve significance (p = 0.055). 
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5.3.4 ADHERENT JUNCTIONS ARE NOT INVOLVED IN THE CELL-CELL   DYNAMISMS 
 
 
Subsequently the effect of the absence of Cx43 on the membrane on mechanical junctions at the 
cell-cell level was evaluated. Using confocal microscopy, it was shown that there was a robust 
presence of N-cadherin proteins, which mechanically coupled CM-MFB and MFB-MFB [Figure 5.8a]. 
N-Cadherin co-localized together with Cx43 at the border zone [Figure 5.8b]; however western blot 
analysis [Figure 5.8c and 5.8d] demonstrates that reducing expression of Cx43 by GFP-Cx43_Kd virus 
does not alter the protein expression of N-cadherin and desmoglein-2 in both CMs and MFBs 
resulting in an independent role of Cx43 in modulation of the cell dynamisms. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 5.8. ADHERENT JUNCTIONS ARE NOT INVOLVED IN THE CELL-CELL   DYNAMISMS 
 
 
How the absence of Connexin43 (Cx43) on the membrane may affect the mechanical junction at the cell-cell 
level was evaluated. a) There was a robust presence of N-cadherin proteins which mechanical coupled CM- 
MFB and MFB-MFB. b) N-Cadherin co-localized together with Cx43 at the border zone. c), d) However western 
blot analysis demonstrates that reducing expression of Cx43 by GFP-Cx43-KD virus does not alter the protein 
expression of N-cadherin and desmoglein-2 in both CMs and MFBs resulting in an independent role of Cx43   in 
modulation of the cell dynamisms. Scale bar: 10 µm. Figure reproduced with permission from Dr. Michele 
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5.3.5 FORCING THE PRESENCE OF CONNEXIN43 ON THE MEMBRANE USING    A  MIMETIC 
 
CONNEXIN43 PEPTIDE INCREASES CELL-CELL  DYNAMISM 
 
 
The Cx43-mediated dynamisms was further investigated by forcing the expression and presence 
of connexons of Cx43 on MFBs by using the mimetic Cx43 αCT1 peptide (Hunter, Barker, Zhu, et al., 
2005). The αCT1 peptide has previously been shown to reduce inducible-arrhythmias at the injury 
border zone following ventricular cryoinjury (O’Quinn, Palatinus, Harris, et al., 2011). This has never 
been investigated in the cellular model of infarct border zone. In both single CMs and MFBs as well  
as in the co-cultures, the αCT1 peptide enforced the occurrence of Cx43 at the contact between  
cells, as visualized using Streptavidin-488 to visualize the peptide in conjunction with Cx43 and either 
αSMA or αActinin to visualize MFBs or CMs respectively [Figure 5.9 and 5.10 respectively]. 
 
The  enforced-presence  of  CX43s  invariably  increases  the  CM-MFBs  dynamism  (0.41  ±    0.08 
 
µm/min, n = 5) while hypoxic conditions, in the presence of the αCT1 peptide or hypoxia after pre- 
incubation of the αCT1 peptide and although Cx43 is still localized at the heterocellular junction, 
significantly reduces the dynamism also (0.05 ± 0.01 µm/min, n = 6) indicating once again a novel 
‘mechanical’ role for an ‘electrical’ intercellular connection [Figure 5.11]. 
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FIGURE 5.9. THE αCT1 PEPTIDE INDUCES INCREASED CONNEXIN43 PRESENCE AT THE 
MEMBRANE OF MYOFIBROBLASTS 
 
a) Myofibroblasts (MFBs) show a low basal level of Connexin43 (Cx43) at the membrane. b), c) The 
amount of Cx43 at the membrane of MFBs was increased after incubation with the inhibitory αCT1 
peptide (labelled with Streptavidin). Scale bar: 50 µm. 
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FIGURE 5.10. THE αCT1 PEPTIDE INDUCES INCREASED CONNEXIN43 PRESENCE AT 
THE MEMBRANE OF CARDIOMYOCYTES 
 
a) Cardiomyocytes (CMs) show a higher basal level of Connexin43 (Cx43) at the membrane 
than myofibroblasts (MFBs). Scale bar: 20 µm. b) The amount of Cx43 at the membrane was 
also increased after incubation with the inhibitory αCT1 peptide (labelled with Streptavidin). 
Scale bar: 10 µm. 
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FIGURE 5.11. THE PRESENCE OF CONNEXIN43 ON THE MEMBRANE USING THE αCT1 
PEPTIDE INCREASES CELL-CELL DYNAMISM 
 
Although more Connexin43 (Cx43) remains on the membrane after incubation with the inhibitory 
αCT1 peptide and subsequent hypoxia (8% O2, 16h), this could not prevent the reduction in 
dynamism (a). Scale bar: 50 µm (top), 30 µm (bottom). b) The αCT1 peptide increased the 
movement in the co-cultures the most, due to the increased presence of Cx43 at the membrane of 
both cell types (a p ≤ 0.01, b p ≤ 0.001, c p ≤ 0.001, d p ≤ 0.001, e p ≤ 0.001, f p ≤ 0.001). 
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Finally, the question whether the forced Cx43-mediated coupling was functional in terms of 
intercellular communication between CM and MFBs was addressed [Figure 5.12]. MFBs were 
labelled with the cell permeable dye Calcein (green) and cell impermeable dye Celltracker (orange) 
and either the αCT1 or Reverse peptide and were ‘parachuted’ onto CMs, which were also treated 
with either peptide. The diffusion via gap junctions was measured using a time-course of the 
fluorophore flowing into adjacent MFBs [Figure 5.12]. 
 
There is a reduction in gap junction intercellular communication after treatment with αCT1 
peptide in comparison to the control. A smaller, but still significant reduction was also found with  
the Reverse peptide compared to control. This indicates that the increase in dynamism is associated 
with a decrease in heterocellular junctional coupling. 
 
Interestingly, a change in MFB morphology was observed after incubation with the αCT1 peptide 
was observed by myself and others, which was not observed after the Reverse peptide [internal 
communication]. Interference with Cx43 modulation by the αCT1 Peptide induces lamellipodia 
formation in MFB but this does not occur with the Reverse peptide [Figure 5.13 and 5.14]. The 
lamellipodia were visualised using the SICM as small tentacle like protrusions, or as extensions of the 
MFB [Figure 5.13a]. The Reverse peptide did not induce changes in cell morphology as visualised 
using SICM [Figure 5.13b]. Lamellipodia formation after Reverse or αCT1 peptide incubation in MFBs 
was also assessed using the F-Actin label Phalloidin. MFBs incubated with the αCT1 peptide showed 
a more elongated overall shape and show lamellipodia like protrusions, whilst incubation with the 
Reverse peptide does not [Figure 5.14]. 
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FIGURE 5.12. INCREASED DYNAMISM IS ASSOCIATED WITH A DECREASE IN HETEROCELLULAR JUNCTIONAL    COUPLING 
 
 
Gap junction intercellular communication is reduced between myocytes and fibroblasts treated with αCT1. a) Dye transfer between parachuted donor cells 
(arrowhead) loaded with Calcein AM and acceptor cell layer (arrow) in a parachute assay of communication. b) Graph of number of acceptor cells per 
parachuted donor cell, with non-communicating cells excluded. Probability values were generated by ANOVA with post-hoc comparison by Least Signficant 
Difference. Scale bar = 250 μm. 
Figure reproduced with permission from Dr. Emily Ongstad and Prof. Robert Gourdie. 
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FIGURE 5.13. THE αCT1 PEPTIDE INDUCES LAMELLIPODIA FORMATION IN MYOFIBROBLASTS, BUT THE REVERSE PEPTIDE DOES NOT 
 
 
Interference with Connexin43 (Cx43) modulation by the inhibitory αCT1 peptide induces lamellipodia formation in Myofibroblasts (MFB) (a) but this does 
not occur with the Reverse peptide (b). a) The lamellipodia are visualised using the Scanning Ion Conductance Microscopy as small tentacle like protrusions, 
or as extensions of the MFB. b) The Reverse peptide did not induce changes in cell morphology. 
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FIGURE 5.14. THE αCT1 PEPTIDE INDUCES LAMELLIPODIA FORMATION IN 
MYOFIBROBLASTS, BUT THE REVERSE PEPTIDE DOES  NOT 
 
Lamellipodia formation after Reverse (a) or αCT1 peptide (b) incubation in myofibroblasts 
(MFBs) was assessed using the F-Actin label Phalloidin. b) MFBs incubated with the inhibitory 
αCT1 peptide showed a more elongated overall shape and show lamellipodia like protrusions, 
whilst incubation with the Reverse peptide does not (a). Scale bar: 25 µm. 
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5.4.1 SUMMARY 
 
 
In this chapter the interaction between neonatal rat CMs and MFBs was investigated further. The 
dynamics of the contact between monolayers of single and co-cultures were analysed using SICM. 
Gap junction (GJ) formation in these contacts between CMs and MFBs was shown after transfection 
of GFP-Cx43, indicating that there are functional GJs between these cells. CM single cultures form 
stable contacts as indicated by very low contact movement. Neonatal rat myofibroblasts and MI 
myofibroblasts on the other hand show highly motile contacts, with formation of new contact areas 
and loss of contact in other areas. When CMs and MFBs were cultured together, there was a 
significant increase in motility compared to CM single cultures. 
 
Cx43 knockdown or Cx43 internalisation after hypoxia leads to a significant decrease in 
movement in MFBs, indicating that GJs may be involved. Subsequently, it was demonstrated that 
adherent junctions were not involved, providing further indication it is Cx43 related changes that are 
important. 
 
MFBs have a lower basal expression of Cx43 compared to CMs (Askar, Bingen, Swildens, et al., 
2012), this could be increased using overexpression of GFP-Cx43. The fluorescence of GFP-Cx43 in 
junctions of co-cultures was smaller than in CM cultures, indicating fewer GJs were created between 
CMs and MFBs. The αCT1 peptide induces Cx43 hemichannel aggregation into the gap junctional 
plaque, increasing the number of functional Cx43 channels. This leads to a significant increase in 
motility in especially the co-cultures, providing further evidence of mechanical coupling between 
these two cell types. Finally, using a functional assay of dye diffusion the number of cells coupled to 
a single MFB was assessed in CM cultures with MFBs parachuted on. These cultures were incubated 
with either the αCT1 peptide or the Reverse peptide. The increased dye diffusion to neighboring  
CMs after incubation with the αCT1 peptide indicated that the increase in dynamism is associated 
with an increase in heterocellular junctional coupling. 
5.4 DISCUSSION 
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5.4.2 CARDIOMYOCYTE –  MYOFIBROBLAST INTERACTIONS AND  ARRHYTHMIAS 
 
 
Studies have previously been carried out showing that when myofibroblasts are added to 
cardiomyocyte cultures changes in cardiomyocyte electrophysiological and mechanical properties 
occur (Gaudesius, Miragoli, Thomas, et al., 2003; Miragoli, Gaudesius & Rohr, 2006; Miragoli, 
Salvarani & Rohr, 2007; Yue, Xie & Nattel, 2011; Camelliti, Borg & Kohl, 2005). 
 
Whether arrhythmogenesis occurs in vivo, depends on the degree of coupling, whether 
heterocellular coupling occurs, and the density and the size of fibrotic areas, which are all 
prerequisites for eliciting ectopic activity in vitro and in vivo (Miragoli & Glukhov, 2015), regardless  
of the source-sink relationship on intracellular space (safety factor > 1). This work provides further 
investigation into the coupling between CMs and MFBs in vitro. CMs need stable Cx43 based gap 
junctional coupling for the rapid exchange of information and propagation of electrical impulses in 
order to contract synchronously (Rhett & Gourdie, 2012). MFBs on the other hand are cells that help 
provide structural support, in addition to other roles. In order to efficiently perform these roles, 
movement of the MFBs is important and therefore a lower number of GJs can be advantageous, so  
as not to ‘stick’ too much to other cells, but it is important to have a sufficient number of GJs to be 
able to interact with the neighbours. After an infarct, there is a change in expression profile of 
connexins in MFBs, leading to increased expression of Cx43 and potentially functional GJ formation 
(Camelliti, Devlin, Matthews, et al., 2004). In addition, when forcing Cx43 onto the membrane, αCT1 
peptide infected MFBs showed increased lamellipodia formation, which may indicate the ‘search’ for 
stable connections with neighbouring cells. Hypoxia on the other hand led to partial internalisation  
of Cx43 and was associated with a reduction in movement. This is important for the fetal heart work, 
as these hearts are in partial hypoxia during fetal development (Webster & Abela, 2007; Patterson & 
Zhang, 2010). The transient appearance in MFBs in fetal heart tissue, which increased  over  
gestation, leads to an increased number of MFBs per CMs in the fetal heart (Miragoli, Kadir, 
Sheppard, et al., 2011). In the fetal heart model of the neonatal rat described in the previous 
chapters, MFB : CM were seeded at 1 : 10, approximately. The ratio in the dishes used for optical 
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recording of human fetal CMs was higher than that, although this was not quantified. In research of 
cardiac disease, the ratio of MFB : CM can be as high as 2 : 1, which is based on the fact that there 
are more fibroblasts than cardiomyocytes in the heart (Cartledge, Kane, Dias, et al., 2015; Camelliti, 
Borg & Kohl, 2005). This increased number of myofibroblasts may lead to an overall depolarisation  
of the cardiomyocyte layer and therefore sensitize the heart to arrhythmias induced by TC or other 
arrhythmogenic agents (Miragoli, Kadir, Sheppard, et al., 2011). And although there is internalisation 
of Cx43, sufficient Cx43 may remain on the membrane of CMs and MFBs to form more stable GJs, as 
these cells show a reduction in dynamism, which may lead to further depolarisation of the CMs and 
therefore may lead to an increased sensitivity to arrhythmia, especially in ICP pregnancies (Miragoli, 
Kadir, Sheppard, et al., 2011). In the neonatal rat co-cultures, most fibroblasts were αSMA positive 
myofibroblasts, as previous research showed that extensive culture on a hard substrate induces 
αSMA expression (Miragoli, Kadir, Sheppard, et al., 2011; Miragoli, Gaudesius & Rohr, 2006). These 
MFBs are relatively depolarised and as was shown in this chapter, form functional GJs with CMs. This 
can lead to the decreased conduction velocity and increased propensity to form re-entries shown 
previously (Miragoli, Kadir, Sheppard, et al., 2011; Miragoli, Gaudesius & Rohr, 2006; Gaudesius, 
Miragoli, Thomas, et al., 2003). 
 
In addition, MI adult rat fibroblasts, like hypoxic fetal or neonatal fibroblasts, are relatively 
depolarised and show a high level of dynamism. In the cardiac border zone, there is an increased 
expression level of Cx43 in these MI myofibroblasts, which may induce more stable contact with 
surviving CMs, thereby depolarising these CMs and providing additional substrates for conduction 
velocity slowing and arrhythmias in the border zone area. 
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LIMITATIONS AND FUTURE DIRECTIONS 
 
 
In the co-culture models, both CMs and MFBs underwent the various treatments. It would be of 
interest to investigate whether the peptide has a differential effect when only the MFBs have been 
treated, but it is difficult to monitor the internalisation of the peptide and therefore select only  
MFBs which have internalised the peptide. It would be possible to obtain this information, but only 
after the experiment, as one can then stain for the peptide (using streptavidin) or use single cell PCR, 
to ensure the peptide was present. 
 
Further functional studies of the gap junction would be of interest, especially the possibility to 
patch the contact area for channel activity. It would be necessary to transfect CMs and/or MFBs with 
the Cx43-GFP construct, scan this area to measure the contact dynamism, scan the Cx43-GFP and 
then patch the area on either the CM or MFB membrane. This has been attempted before, but is not 
as easy as it sounds. Optimisation of the protocol will be necessary to obtain more information on 
this. 
 
Optogenetic studies, using MFBs transfected with halorhodopsin, which is a light-sensitive 
chloride pump that can hyperpolarize a cell when stimulated with light at 580 nm may also be of 
interest (Schobert & Lanyi, 1982; Butler, 2012). Using this, it would be possible to investigate the 
degree of coupling, membrane potential changes and changes in movement. 
 
Further studies into the effect of the peptide would be interesting. Optical recording of action 
potentials and propagation of the action potential across a monolayer of CMs with/without MFBs 
incubated with reverse and αCT1 peptides and control (no peptide) would be of importance to 
understand the mechanisms of action of this αCT1 peptide on the CMs and MFBs. The effect of the 
αCT1 peptide on resting membrane potential CMs or MFBs in monolayers of CMs, MFBs or both is 
also of interest and whether UDCA has any further effect on this. It may be that UDCA induces 
further hyperpolarisation of the MFBs after infection with the αCT1 peptide. 
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Finally, the hypoxia work (8% O2 ) is very important, especially in light of the previous chapters. 
The difficulty remains that the effect of the hypoxia can only be assumed to remain for a short time, 
as the SICM system operates under normal oxygen tensions. If it is possible to isolate the chamber 
and oxygenate this chamber separately with low oxygen, studies of longer duration may be feasible. 
In addition, the fact that hypoxia induces further depolarisation of the MFBs and increased numbers 
of αSMA positive cells, optical recording after the neonatal rat CMs and MFBs have been incubated 
with hypoxia would be an even closer approximation of the effects of TC and UDCA on the fetal 
heart. For longer experiments it may be possible to bubble low oxygen in the perfusion solutions, 
thereby maintaining a low oxygen environment similar to the hypoxia in the incubator. 
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CHAPTER 6: THE EFFECT OF BILE ACIDS ON THE   MYOMETRIUM 
& 
THE GENERATION OF A STEM CELL DERIVED MODEL FOR THE 
DIFFERENTIATION OF MYOMETRIAL SMOOTH MUSCLE  CELLS 
  
 
 
 
A major risk for mother and fetus in ICP is spontaneous preterm labour. The first half of this 
chapter describes work carried out in myometrial smooth muscle strips and cells. This part describes 
the effect of bile acids on myometrial contractility and the work on bile acid receptors and whether 
these are expressed in myometrium and in myometrial cultures and whether bile acid effects on 
myometrial function are mediated through other labour associated proteins. 
 
Secondly, as part of this project I aimed to develop an human pluripotent stem cell derived model 
of myometrial smooth muscle cells (myometrial SMCs) using CombiCult® (Plasticell Ltd.) in 
conjunction with Plasticell. The work pertaining to this will be described in the second half of this 
chapter. For this work 3 markers for myometrial smooth muscle cells were chosen, namely Estrogen 
Receptor-α, αSmooth muscle actin and Oxytocin Receptor [Figure 6.1]. These 3 markers are each 
expressed in other tissues, but are expressed in combination with each other only in the 
myometrium. 
 
FIGURE 6.1. MYOMETRIAL SMOOTH MUSCLE CELLS MARKERS: ESTROGEN RECEPTOR-α, 
αSMOOTH MUSCLE ACTIN AND OXYTOCIN RECEPTOR IN PRIMARY MYOMETRIAL SMOOTH 
MUSCLE CELLS 
 
Myometrial smooth muscle cells stained with a combination of markers, Estrogen Receptor-α (green, 
left), αSmooth Muscle Actin (red, both) and Oxytocin Receptor (green, right); these were chosen for 
confirmation of differentiation of the human pluripotent stem cells. Scale bars: 40 µm. Page | 244 
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There is an increased risk of spontaneous preterm labour associated with severe cases of ICP and 
this risk increases with increased bile acid levels (Glantz, Marschall & Mattsson, 2004). Bile acid 
signalling in the myometrium, the contracting muscle of the uterus, was further investigated in 
tissues, strips and cells, which will be described in the first half of this chapter. The second part of 
this chapter focusses on the novel work carried out to generate protocols for the differentiation of 
human pluripotent stem cells into myometrial smooth muscle cells. For this work three markers 
were chosen, Estrogen Receptor-α, αSmooth Muscle Actin (red) and Oxytocin Receptor [Figure 6.1]. 
Although they are separately expressed in other tissues also, this combination of markers is unique 
to the myometrium. 
 
Recently a large case-control study was published which compared severe cases of ICP with 
controls (Geenes, Chappell, Seed, et al., 2013). In this study, as well as previous studies, there was an 
increase in preterm deliveries (164/664; 25% vs. 144/2200; 6.5%; adjusted Odds Ratio [OR] 5.39,  
95%  Confidence Interval [CI] 4.17 to 6.98, p < 0.001); this included both spontaneous (50/664;  7.5% 
vs. 84/2200; 3.8%; adjusted OR 2.25, 95% Cl 1.54 to 3.27, p < 0.001) and iatrogenic preterm  delivery 
 
(114/664; 17% vs. 60/2200; 2.7%; adjusted OR 8.75, 95% CI 6.19 to 12.37, p < 0.001) (Lammert, 
 
Marschall, Glantz, et al., 2000; Geenes, Chappell, Seed, et al., 2013; Glantz, Marschall & Mattsson, 
2004). In addition, a significant relationship between maternal serum bile acids and spontaneous 
preterm labour was found in this study, indicating that there may be a role of bile acids in the 
induction of labour. Previously Germain et al. (2003) showed that women with ICP were more 
sensitive to Oxytocin, needing a lower dose to induce contractions compared to controls (Germain, 
Kato, Carvajal, et al., 2003). In addition, tissues from both ICP women or controls incubated with 
cholic acid, showed increased sensitivity to Oxytocin, potentially due to increased expression of the 
Oxytocin receptor (OTR) (Germain, Kato, Carvajal, et al., 2003). It is currently not established 
whether bile acids solely signal through the OTR or whether they also signal through known bile acid 
receptors. 
6.1 INTRODUCTION 
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Patients with ICP are not the only ones at risk of preterm labour. In the normal population 
preterm labour and delivery occurs in about 10% of all deliveries and is associated with an increased 
risk of morbidity and mortality (Terzidou, 2007; Goldenberg, Culhane, Iams, et al., 2008b, 2008a). 
Research into the causes and prevention of preterm labour is often carried out using myometrial 
tissue from human term pregnancies obtained from elective caesarean sections. These samples are 
mostly non-labouring samples, meaning that they are responsive to Oxytocin and other labour 
inducing drugs, but they are term tissues. It is very difficult to obtain non-labouring preterm samples 
with no pathological background. In addition, comparison to term or preterm labouring samples is 
complicated. Furthermore, to obtain a large enough cell number to carry out experiments, tissue 
samples are cultured for multiple passages and are then treated with bile acids or labour inducing 
drugs depending on the study. Passages may induce changes in baseline expression levels of the 
proteins of interest, leading to changes in responses compared to unpassaged cells. 
 
As part of this project I developed an human pluripotent stem cell derived model of myometrial 
smooth muscle cells (myometrial SMCs) using CombiCult® (Plasticell Ltd.) in conjunction with 
Plasticell (Tarunina, Hernandez, Johnson, et al., 2014). This method allowed us to test 10,000 
combinations of media compositions to define the most efficient protocols for the differentiation of 
human pluripotent stem cells into myometrial smooth muscle cells. This method combines 
miniaturisation of cell culture on microcarrier beads, a pooling/splitting protocol and a unique 
tagging system which allows the testing of multiple combinations of media, using different parental 
cell lines and ending in multiple stages of differentiation. 
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6.2.1 PATIENT SELECTION 
 
 
Approval from the ethics committee was granted for the studies performed (local ethics 
committee, REC 3357 for myometrium) and patients gave informed consent before the collection of 
tissue samples. Myometrial biopsies were taken from the upper part of the incision in the lower 
segment of the uterus of women undergoing an elective caesarean section for breech presentation 
or previous caesarean section (labour -) or during an emergency section after labour started  (labour 
+) for both uncomplicated and ICP pregnancies. Biopsies from uncomplicated pregnancies were used 
for primary cell culture or snap-frozen. Biopsies from ICP pregnancies were snap-frozen. All snap- 
frozen material was stored at -80°C before use for either RNA or protein extraction. 
 
 
 
 
 
6.2.2 PREPARATION OF PRIMARY MYOMETRIAL  CULTURES 
 
 
Myometrial cultures were prepared from most of the biopsy and a small piece was snap-frozen. 
Cells were grown in full DMEM medium containing 10% FCS and 1% AB/AM in an incubator at 37°C 
and 5% CO2. Cells were grown for two types of experiments. Cells were grown either in 2 T25 flasks 
(Corning) for passage experiments until passage 4 or for treatment at passage 4. Cells were passaged 
upon confluency. For passage experiments, 1 T25 was washed in PBS and frozen in 350 µL RLT- 
buffer. The other flask was washed and trypsinized in 0.25% Trypsin-EDTA for 5 minutes, before 
inhibition by full medium. Cells were pelleted, resuspended and split into 2 new T25. At passage 4, 1 
flask was kept in full medium and 1 flask was serum-starved in 1% DCC-FCS overnight. Both flasks 
were washed and frozen in RLT-buffer. 
 
For treatments, cells were harvested as above and subsequently cultured in larger flasks to 
increase cell number. Passage 4 cells were plated into 6 well dishes in DMEM containing 10% 
Dextran coated Charcoal stripped serum [DCC-FCS] and 1% AB/AM. Upon confluency, the medium 
6.2 METHODOLOGY 
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was removed and the cells serum-starved by addition of DMEM without Phenol Red containing 1% 
DCC-FCS overnight before treatment the following day. 100 µM TC or TCDCA was added for 
overnight treatment or for 10h, 6h, 1h, 15 min, 5 min or no BA (control). 
 
 
 
 
 
6.2.3 MYOMETRIAL CONTRACTION USING A  CONTRACTILITY  MACHINE 
 
 
Myometrial strips were prepared from a small part of the biopsy, avoiding blood vessels. The 
tissue was divided into 8 – 10 strips of about 3 mm by 6 mm, which were then mounted in the 
chambers of a contractility machine (DMT). Chambers contained preheated KREBS solution which 
was prepared according to Sigma manual K3753 for a KREBS solution containing 2000 mg/L D- 
Glucose dissolved in dH2O. The strips were incubated at 37°C with 5% CO2  and stretched to a  
tension of 3.5g after which they were allowed to adapt to the KREBS solution for 1 hour to allow for 
the initiation of contractions. Contractions were recorded via the PowerLab Chart 5 software (AD 
Instruments Ltd., Oxfordshire, UK). Drugs were added upon change of KREBS solution. Treatments 
included a dose response curve of doses between 20 µM and 100 µM TCwhereby the dose was 
increased every 30 minutes. To the final treatment 10 nM Oxytocin (OT) was added to each of the 
treated and untreated strips, to confirm that the strip was still alive and capable to contract in 
addition to assessing whether TC influences OT induced contractions. A number of parameters were 
analysed using Chartlab (v5.5.6), in order to assess whether TC has an influence on contractions. The 
area under the curve (AUC) and total AUC were analysed, to assess the total work done by the strip, 
as well as the amplitude or strength of contractions, duration of each contraction and the rate of 
contraction [Figure 6.2]. The contractions were normalized to initial spontaneous contractions to 
account for natural degeneration over time of the tissue. Treated samples were then compared to 
the control measurements to determine whether there are any effects of different bile acid 
treatment on the contractions. 
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FIGURE 6.2. MYOMETRIAL STRIP CONTRACTION PROTOCOL AND  EXAMPLES 
 
Myometrial strips were placed on the contractility machine and allowed to settle for 1 – 1.5h. 
After that treatment with one of 2 protocols was carried out (a.). Treatment was with either 
control (KREBS) or increments of TC. A dose response curve was carried out using doses between 
20 µM and 100 µM Taurocholic acid (TC) whereby the dose was increased every 30 minutes. To  
the final treatment 10 nM Oxytocin (OT) was added to each of the treated and untreated strips, to 
confirm that the strip was still alive and capable of contraction in addition to assessing whether  
TC influences OT induced contractions. All treatments and controls were normalised to the 
spontaneous contractions, after which treatment was compared to control strips. 
For each strip the contraction amplitude, duration, rate and the Area under the Curve were 
analysed per 30 minute time period. All treatments and controls were normalised to the 
spontaneous contractions, after which treatment was compared to control strips. 
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6.3.1 EFFECT OF TAUROCHOLATE ON MYOMETRIAL  CONTRACTILITY 
 
 
The effect of TC on contractility of myometrial strips was assessed using a dose response curve 
ranging from 20 to 100 µM TC. Parameters analysed were the average rate of contraction, the 
average duration, the average amplitude, or strength of contractions, average area under the curve 
(AUC), which represents the average strength and duration of contractions, the total area under the 
curve, which represents the total work done per time period. The means with standard deviation are 
shown in tabular form in Table 6.1 and means with SEM in Figures 6.3a-e. No significant difference 
between the treatments and control was found for any concentration of TC or after Oxytocin (OT) 
treatment for any of the parameters analysed (n = 7, analysed by a Student’s t-test). This was mostly 
due to the variability between strips. There was an overall decrease in contraction rate in both 
control and TC treated strips [Figure 6.3a]. 
 
As there seemed to be changes over time, these changes were analysed using a two-way ANOVA. 
The rate of contractions changed over time, there is a decline in contraction rate seen in both the 
treated and untreated groups (p ≤ 0.0001) [Figure 6.3a]. There was a significant change in area  
under the curve over time (p = 0.0002), with significant differences between the treated and 
untreated groups at the final OT treatment (p = 0.483) [Figure 6.3b]. There were no significant 
changes over time in the peak amplitude of the contractions [Figure 6.3c]. The duration of the 
contractions changed significantly over time (p = 0.0347), with a significant difference in durations 
between treated and untreated after OT treatment, the control group has significantly increased 
contraction duration compared to TC treated when stimulated with OT (p ≤ 0.01) [Figure 6.3d].  
There were significant changes over time in the total work done by the strips, as calculated by the 
total area under the curve, a reduction over time in work can be seen over time (p ≤ 0.01) [Figure 
6.3e]. 
6.3 THE EFFECTS OF BILE ACIDS ON MYOMETRIAL   CONTRACTIONS 
 TABLE 6.1. THE EFFECT OF BILE ACIDS ON CONTRACTILITY OF MYOMETRIAL   STRIPS 
 
For each experiment, the average rate of contraction, area under the curve (AUC), amplitude of contractions, 
contraction duration and total AUC was calculated. For each time point a matched untreated control was run. 
During the final treatment both TC and Control groups were treated with Oxytocin. 
 
 
 
 Treatment Rate  AUC (g.s) Amplitude  (g) Duration (s) Total AUC 
 Mean SD Mean SD Mean SD Mean SD Mean SD 
1 Spontaneous 100.00 0.00 100.00 0.00 100.00 0.00 100.00 0.00 100.00 0.00 
2 20 µM TC 99.49 30.44 120.85 22.34 117.02 13.15 110.31 19.78 116.11 40.37 
3 40 µM TC 94.05 31.93 113.51 34.49 119.83 36.34 105.14 16.33 102.51 42.69 
4 60 µM TC 93.42 35.61 93.90 13.16 102.79 4.46 106.36 19.72 81.80 14.01 
5 80 µM TC 80.86 38.72 93.70 18.91 104.02 15.02 110.58 18.75 68.66 17.54 
6 100 µM TC 60.72 25.47 101.06 33.61 106.37 17.18 120.23 36.79 54.35 5.24 
7 100 µM TC + 
10 nM OT 
70.22 30.08 164.58 109.54 107.03 25.71 113.39 36.56 90.39 37.52 
 
 Control Rate  AUC (g.s) Amplitude (g) Duration (s) Total AUC 
 Mean SD Mean SD Mean SD Mean SD Mean SD 
1 Spontaneous 100.00 0.00 100.00 0.00 100.00 0.00 100.00 0.00 100.00 0.00 
2 Spontaneous 109.69 34.06 125.01 51.64 119.25 36.55 106.45 18.51 138.14 100.45 
3 Spontaneous 82.25 18.45 151.74 88.03 143.29 78.78 117.78 15.67 131.10 104.34 
4 Spontaneous 80.00 12.41 111.97 65.02 116.93 50.80 113.73 31.59 84.65 34.57 
5 Spontaneous 63.16 22.75 106.30 77.43 104.29 54.47 113.11 33.62 62.87 39.55 
6 Spontaneous 52.73 18.42 113.17 62.96 112.14 52.07 117.51 22.63 58.70 30.94 
7 10 nM OT 54.38 12.60 325.79 248.26 131.70 52.23 178.20 98.24 153.16 95.16 
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FIGURE 6.3. THE EFFECT OF BILE ACIDS ON  
CONTRACTILITY OF MYOMETRIAL  STRIPS 
Strips were treated with an increasing dose of TC, until the final 
treatment where after 30 minutes of 100 µM TC 10 nM 
Oxytocin (OT) was added to each of the control and TC treated 
strips. The data was analysed by a Mann-Whitney U Test or 
Student’s t-test. No significant change was found between 
treated and control strips (n = 7) in any of the parameters, 
although the control strips seem more responsive to the final 
OT treatment. a) The number of contractions within each time 
period was calculated, there seems to be a non-significant 
increase in contraction rate for treated strips. There is an 
overall reduction in rate for both the TC and control treated 
strips. The rate of contractions changed over time, there is a 
decline in contraction rate seen in both the treated and 
untreated groups (p ≤ 0.0001). 
b) The area under the curve, or work per contraction, was calculated per contraction and averaged per time period. 
The AUC is an integral of the area under each contraction curve. There was a significant change in area under the curve 
over time (p = 0.0002), with significant differences between the treated and untreated groups at the final OT treatment 
(p = 0.483). c) The strength of contractions was assessed by the peak amplitude (force, g) and compared between TC 
treated and control strips. d) The length of each contraction (s) was calculated and averaged per time period. The 
duration of the contractions changed significantly over time (p = 0.0347), with a significant difference in durations 
between treated and untreated after OT treatment, the control group has significantly increased contraction duration 
compared to TC treated when stimulated with OT (p ≤ 0.01). e) The Average Total work per time period was calculated 
based on the AUC. There were significant changes over time in the total work done by the strips, as calculated by the 
total area under the curve, a reduction over time in work can be seen over time (p ≤ 0.01). 
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A number of nuclear and membrane bound receptors that are activated by bile acids have been 
described over the last decade. In addition, the Oxytocin receptor has been previously described as 
playing a role in Oxytocin-induced contractility in the myometrium (Germain et al., 2003).  
Expression levels of both bile acid receptors and contraction associated proteins were investigated 
firstly in labouring and non-labouring flash frozen tissue samples of term pregnancies, tables with 
ΔΔCT values can be found in Appendix C. Receptors expressed in the tissue were subsequently 
confirmed in plated cells. Changes in expression level over the passages were investigated in order  
to confirm expression at the passage cells were treated. 
 
 
 
 
6.4.1 EXPRESSION OF NUCLEAR  RECEPTORS 
 
A number of nuclear receptors were studied. One of the most important regulatory receptors in 
the liver, the Farnesoid X Receptor (FXR) was shown not to be expressed in myometrial biopsy 
samples [Appendix C1]. Previous studies have shown that Liver X Receptor-β (LXRβ) is expressed in 
mouse myometrium and may affect contractility (Mouzat, Prod’homme, Volle, et al., 2007). Both 
LXRα and LXRβ are expressed in flash frozen myometrial tissue [Appendix C1] and show no  
significant changes throughout the passages (n = 5) [Figure 6.4a and 6.4b]. The Peroxisome 
proliferator-activated receptors PPARα and PPARγ are also expressed in flash frozen myometrial 
tissue [Appendix C1] and show no significant differences over the passages, although there seems to 
be a high variability between cultures [Figure 6.4c and 6.4d]. The Vitamin D Receptor (VDR), which 
binds Vitamin D, but also has a low affinity for LCA does not seem to be expressed in myometrial 
tissue [Appendix C1] (van Mil, Houwen & Klomp, 2005). The xenobiotic/endobiotic receptors 
Pregnane X receptor (PXR) and Constitutive Androstane receptor (CAR) are both expressed in 
myometrial tissue, albeit at a low level. CAR expression seems to be increased in labour [Appendix 
C1]. The LXRβ binding partner Retinoid X receptor (RXR) is also expressed in the myometrial tissue 
and remains expressed throughout the passages [Figure 6.4e]. 
6.4 BILE ACID SIGNALLING PATHWAYS IN THE  MYOMETRIUM 
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FIGURE 6.4. NUCLEAR BILE ACID RECEPTOR EXPRESSION THROUGHOUT PASSAGE 0 TO PASSAGE   4 
 
Gene expression of nuclear bile acid receptors, LXRα, LXRβ, PPARα PPARγ and RXR was followed over the 
Passage 0 - 3 (P0-3) in medium. For the final Passage cells were either incubated in medium (P4 M) or 
serum starved (P4S) as most experiments are carried out in low serum medium. Values represent fold 
change from control and are presented as mean + SEM for n = 5. The data was analysed by a One-Way 
ANOVA or Kruskal-Wallis ANOVA. 
a) No significant changes in gene expression of LXRα were seen over Passage 0 - 4. 
b) No significant changes in gene expression of LXRβ were seen over Passage 0 - 4. 
c) No significant changes in gene expression of PPARα were seen over Passage 0 - 4. 
d) No significant changes in gene expression of PPARγ were seen over Passage 0 - 4. 
e) No significant changes in gene expression of RXR were seen over Passage 0 – 4. 
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6.4.2 EXPRESSION OF G-PROTEIN COUPLED  RECEPTORS 
 
 
G-protein coupled receptors (GPCRs) play an important role in the signalling pathways that lead  
to contraction. Both relaxation and excitation in myometrial smooth muscle cells are regulated by 
GPCRs. Research in animal models has shown that muscarinic receptor subtypes are expressed in 
smooth muscle and in the uterus of both rodents and in the pig (Schölch, Schölch, Strahl, et al., 
2012). In the porcine uterus addition of the cholinergic agonist Carbachol leads to strong 
contractions and the M3 muscarinic receptor is shown to be present by both functional and 
radioligand binding studies (Schölch, Schölch, Strahl, et al., 2012). Gene expression of the Muscarinic 
receptor subtypes CHRM1-5 was therefore investigated. 
 
Muscarinic receptors CHRM1, CHRM3 and CHRM4 are not expressed in flash frozen samples of 
labouring and non-labouring myometrium, whilst CHRM5 may be expressed, but at very low levels 
[Appendix C2]. 
 
TGR5 is a G-protein coupled receptor that has been shown to have a role in second messenger 
signalling (cAMP) in a variety of tissues and was therefore also investigated in the myometrium. 
GPCRs play an important role in downstream contraction signalling. TGR5 expression was 
investigated in myometrial tissue as well as in the passages. The expression level of TGR5 is low in 
myometrial tissue, although it seems there is an increased expression in labour samples [Appendix 
C2]. TGR5 expression is stable throughout passaging [Figure 6.5]. 
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FIGURE 6.5. TGR5 IS EXPRESSED THROUGHOUT  
PASSAGE 0 TO PASSAGE  4 
 
Gene expression of TGR5 was followed over the Passage 0 - 3 
(P0-3) in medium. For the final Passage cells were either 
incubated in medium (P4 M) or serum starved (P4S) as most 
experiments are carried out in low serum medium. The data 
was analysed by a One-Way ANOVA. 
No significant changes in gene expression of TGR5 were seen 
over Passage 0 - 4. Values represent fold change from control 
and are presented as mean + SEM for n = 3-4. 
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6.4.3 BILE ACID ACTIVATION OF CONTRACTION-ASSOCIATED  PROTEINS 
 
 
If bile acids signals play a role in the initiation of preterm labour, they could bind directly to bile 
acid receptors, but may also bind to labour associated receptors, whereby the downstream effectors 
would be activated and the balance between quiescence and labour tipped in favour of a labouring 
state. Therefore changes in genes of contraction-associated proteins (CAPs) were investigated. 
Firstly, expression levels of COX2 and OTR were investigated, as these proteins form an integral part 
of the labouring signalling cascade. COX2 expression is induced at the start of labour and is 
important for the increase in prostaglandins, which feedback to an increase in prolabour gene 
expression. OTR is a GPCR that affects the contractile state of myometrial cells and administration of 
Oxytocin (OT) leads to an increase in contraction in the uterus. 
 
COX2 expression was found to decrease after Passage 0, whereby the expression level steadily 
decreased with increasing Passage number [Figure 6.6a.], whilst OTR expression remained stable 
during passages [Figure 6.6b.]. 
 
Changes in gene expression after treatment of 100 µM TC or TCDCA was investigated for the 
Oxytocin receptor (OTR), as previous research by Germain et al. (2003) indicates that the OTR may 
have an important role in the sensitivity of the myometrium to labour inducing factors (Germain, 
Kato, Carvajal, et al., 2003). OTR expression was significantly increased by both 100 µM TC and 
TCDCA treatment after 4h and 5h respectively and expression remained increased for up to 10h 
[Figure 6.7a and 6.7b respectively]. Overnight treatment showed that expression levels had returned 
to baseline, indicating that long term exposure may lead to desensitisation of the Receptor to TC or 
TCDCA [Figure 6.7c]. 
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FIGURE 6.6. COX2 AND OTR ARE EXPRESSED THROUGHOUT PASSAGE 0 TO PASSAGE   4 
Gene expression of COX2 and OTR was followed over the Passage 0 - 3 (P0-3) in medium. For the final 
Passage cells were either incubated in medium (P4 M) or serum starved (P4S) as most experiments are  
carried out in low serum medium. The data was analysed by a One-Way ANOVA. a) A significant reduction in 
COX2 expression was found after passaging to P1. This reduction is maintained over the passages. Values 
represent fold change from control and are presented as mean + SEM for n = 5, *** p ≤ 0.001, ** p ≤ 0.01, * p 
≤ 0.05. b) No significant changes in gene expression of OTR were seen over Passage 0 - 4. Values represent 
fold change from control and are presented as mean + SEM for n = 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6.7. TREATMENT WITH BILE ACIDS  LEADS  TO  AN  INCREASE 
IN RNA EXPRESSION OF THE OXYTOCIN  RECEPTOR 
Expression levels of OTR after treatment with 100 µM TC or 100 µM TCDCA 
were investigated over a period of time between 15 minutes, 1 hour and 10 
hours, and overnight. a) Treatment with 100 µM TC leads to a significant 
increase in OTR production after 4h, which is maintained up to 10 hours. 
Values represent fold change from control and are presented as mean + 
standard error of the mean (SEM) for n = 4-6, lines: ** p ≤ 0.01, * p ≤ 0.05. 
The data was analysed by a Kruskal-Wallis ANOVA. b) Treatment with   100 
µM TCDCA led to a significant increase in OTR production after 5h, which is 
maintained up to 10 hours. Values represent fold change from control and 
are presented as mean + standard error of the mean (SEM) for n = 4-6,  
lines: * p ≤ 0.05. The data was analysed by a One-Way ANOVA. 
c) Overnight treatment does not led to a significant change in OTR 
expression. Expression levels have gone back to baseline. Values represent 
fold change from control and are presented as mean + standard error of the 
mean (SEM) for n = 4. The data was analysed by a One-Way ANOVA. 
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In this subchapter the development of the CombiCult screen (Plasticell) will be described. 
Currently most research is carried out on human samples from myometrial biopsies, taken from  
term elective non-labouring caesarean sections. These samples are then digested as described above 
and cultured for weeks to achieve the number of cells needed for the research to be carried out. In 
this time, the expression level of potentially important receptors and associated proteins may 
change. Therefore, iPS-derived (EhiPS) or Embryonic Stem Cells (SHEF3) derived models of 
myometrial cells would prove very useful. This would potentially allow for cells to be of more or less 
mature state and the addition of labour-inducing drugs such as Oxytocin would allow for a more 
labouring phenotype. This would reduce the need for biopsies and would enable cells to always be  
at the same stage after differentiation allowing for more uniform experiments. 
 
The CombiCult screen workflow consists of 6 main stages; 
 
1. Assay development: selection of appropriate markers for positive hit isolation 
 
2. Matrix construction: definition of media components and composition 
 
3. Cell seeding and split-pooling: the screen 
 
4. Isolation of positive hits: beads are stained for markers of differentiation and positive hits are 
isolated using a large particle sorter (COPAS) 
5. Deconvolution of beads: the tag content of each bead is analysed by flow cytometry 
 
6. Software analysis: results of the previous stage are fed onto the Ariadne™ software for analysis 
and prediction of best protocols. 
 
For this CombiCult a multi exit, multiplex screen consisting of 4 stages with exit points after Stage 
III and IV and 2 different cell lines, an iPS and a hES cell line was chosen. The total duration of the 
differentiation was 16 days. 
6.5 DIFFERENTIATION OF HUMAN MYOMETRIAL SMOOTH MUSCLE   CELLS 
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6.5.1 ASSAY DEVELOPMENT 
 
 
CombiCult screening is based on the use of a large number of beads seeded with iPS or ES cells 
which are differentiated during 4 stages. Selection of differentiated cells is based on fluorescence of 
the markers selected for this assay. These markers are selected based on high levels of expression in 
the myometrial tissue and the combination of all markers should be unique to the tissue of interest. 
 
Myometrial SMCs show high expression levels of αSmooth Muscle Actin (αSMA), as well as early 
expression of the Estrogen Receptor-α (ERα) in both non-pregnant and pregnant myometrium 
(Mosher, Rainey, Bolstad, et al., 2013). Oxytocin Receptor (OTR) occurs later on in the differentiation 
of precursors to myometrial SMCs and highest expression levels of OTR are during pregnancy, 
especially when nearing term (Mosher, Rainey, Bolstad, et al., 2013; Terzidou, 2009). 
 
These markers alone show expression in other tissue types, but the combination of all 3 markers 
is unique to the myometrium. Even if two markers are also expressed elsewhere, and this could lead 
to the selection of beads of a different cell type, these would usually be eliminated in the final 
selection process. Only pathways which have multiple beads passing through were selected for 
validation. 
 
The markers for the Early Exit, after Stage III were αSMA and ERα, whilst the Final Exit were  
αSMA and OTR. Untreated primary myometrial SMCs from term pregnancies were used as positive 
control to optimise antibodies and dilutions. Primary myometrial SMCs were seeded on coverslips 
and fixed with Methanol or Paraformaldehyde (PFA) and on beads fixed with PFA and were 
subsequently stained with αSMA (1:1000) and ERα (1:100) [Figure 6.8 and Figure 6.10] or αSMA and 
OTR (1:50-100) [Figure 6.9 and Figure 6.11]. Primary myometrial SMCs with stained with secondary 
antibodies only were used as a negative control to obtain background fluorescence of the cells and 
beads (rabbit-488, goat-488 and mouse-546 for ERα, OTR and αSMA respectively) [Appendix D1]. 
Undifferentiated EhiPS and SHEF3 on beads were used to confirm these markers were not natively 
expressed by either cell line. EhiPS do not express ERα, OTR and αSMA [Appendix D1]. The SHEF3 
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cells were also negative for the markers ERα, OTR and αSMA, although a small amount of 
contamination with the feeder population of Mouse Embryonic Fibroblasts (MEFs) occurs leading to 
a small number of αSMA positive cells on the beads [Appendix D1]. EhiPS and SHEF3 cells on beads 
stained with secondary antibody only were used as negative control to obtain background 
fluorescence of the cells and beads [Appendix D1]. 
 
 
 
 
 
MATRIX CONSTRUCTION 
 
 
In this screen 10,000 possible pathways were evaluated. This consisted of testing 10 different 
media compositions at each of the 4 different stages making the total number of possible 
combinations 10X10X10X10= 10,000. In order to have “biological repeats” for each possible  
pathway, a redundancy is in-built by using 30 beads for each pathway evaluated, making the total 
number of beads included in the screen 300,000. Next the composition of each  media  to  be 
sampled is decided based on a variety of sources including previously published protocols, known 
developmental pathways and Plasticells in house knowledge of differentiation induction. Several 
basal media with supplements are used and a variety of growth factors and small molecule known to 
induce developmental pathways are screened for their effects on the cells. 
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FIGURE 6.8. OPTIMISATION OF ESTROGEN RECEPTOR-α AND αSMOOTH MUSCLE ACTIN 
ANTIBODIES IN HUMAN MYOMETRIAL SMOOTH MUSCLE CELLS ON COVERSLIPS AND   BEADS 
 
Primary human myometrial smooth muscle cells were used to optimise the antibodies to be used in 
the CombiCult. Myometrial smooth muscle cells stained with Estrogen Receptor-α (rabbit-488) and 
αSmooth Muscle Actin (mouse-546) and DAPI were imaged on the confocal. Myometrial smooth 
muscle cells were seeded on: 
a) Coverslips fixed with Methanol (top panels) or 4% PFA (bottom panels). 63x magnification, scale 
bar: 50 µM. 
b) Beads fixed with 4% PFA. 40x magnification, scale bar: 50 µM. 
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FIGURE 6.9. OPTIMISATION OF OXYTOCIN RECEPTOR AND αSMOOTH MUSCLE ACTIN 
ANTIBODIES IN HUMAN MYOMETRIAL SMOOTH MUSCLE CELLS ON COVERSLIPS AND   BEADS 
 
Primary human myometrial smooth muscle cells were used to optimise the antibodies to be used in 
the CombiCult. Myometrial smooth muscle cells stained with Oxytocin Receptor (goat-488) and 
αSmooth Muscle Actin (mouse-546) and DAPI were imaged on the confocal. Myometrial smooth 
muscle cells were seeded on: 
a) Coverslips fixed with Methanol (top panels) or 4% PFA (bottom panels). 63x magnification, scale 
bar: 50 µM. 
b) Beads fixed with 4% PFA. 40x magnification, scale bar: 50 µM. 
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FIGURE 6.10. OPTIMISATION OF ESTROGEN RECEPTOR-α AND αSMOOTH MUSCLE ACTIN 
ANTIBODIES USING HUMAN MYOMETRIAL SMOOTH MUSCLE CELLS SEEDED ON   BEADS 
 
Primary human myometrial smooth muscle cells were used to optimise the antibodies to be used in the 
CombiCult. Myometrial smooth muscle cells were seeded on beads and were stained with Estrogen 
Receptor-α (rabbit-488) and αSmooth Muscle Actin (mouse-546) and Hoechst before imaging on the 
epifluorescence microscope. Representative images at 4x (top; scale bar: 170 µM), 10x (middle; scale bar: 
70 µM) and 20x (bottom; scale bar: 350 µM) magnification. 
 
 
FIGURE 6.11. OPTIMISATION OF OXYTOCIN RECEPTOR AND αSMOOTH MUSCLE ACTIN 
ANTIBODIES IN HUMAN MYOMETRIAL SMOOTH MUSCLE CELLS SEEDED ON   BEADS 
 
Primary human myometrial smooth muscle cells were used to optimise the antibodies to be used in the 
CombiCult. Myometrial smooth muscle cells were seeded on beads and were stained with Oxytocin 
Receptor (goat-488) and αSmooth Muscle Actin (mouse-546) and Hoechst before imaging on the 
epifluorescence microscope. Representative images at 10x (scale bar: 70 µM), Oxytocin Receptor antibody 
was diluted at 1 : 100 (top) and 1 : 50 (bottom). 
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6.5.2 MEDIA COMPOSITION 
 
 
The full list of small molecules and other reagents used in the CombiCult are described in Table 
 
6.2. The exact formulation of the matrix will not be described here and can be provided if   required. 
 
This is to protect any patentable IP. The media for each stage will be referred to as media 1.1 – 1.10 
for Stage I, 2.1 - 2.10 for Stage II, 3.1 – 3.10 for Stage III and 4.1 – 4.10 for Stage IV. The two cell lines 
are the EhiPS (1) or SHEF3 (2). 
 
The basal media used in the CombiCult are one of the following for each medium: 50% KO-DMEM 
(Invitrogen) + 50% HAM-F12 (Ham's F12 Nutrient Mixture, Invitrogen), DMEM-HAM-F12 (Invitrogen), 
50% IMDM (Iscove's Modified Dulbecco's Medium, Invitrogen) + 50% HAM-F12, Stemline (Sigma) or 
DMEM (Invitrogen). Supplements included ROCK inhibitor, to increase attachment of the cells to the 
beads and cell survival, insulin, transferrin, KSR, ITS (ITS Liquid Media Supplement, a mixture of 
human insulin, human transferrin and sodium selenite), BSA or lipid concentrate. 
 
Different molecules were chosen because they are known to induce pathways of interest, are 
growth factors or reproductive hormones. Different molecules with similar effect were chosen to 
determine whether there was a potent activator or inhibitor that led the differentiation of the 
myometrial smooth muscle cells (SMCs). For the induction of mesoderm known reagents such as 
Bone morphogenetic protein 4 (BMP4) and Activin A) were used. 
 
Transforming growth factor-β (TGFβ) is involved in the differentiation of myometrial SMCs, thus 
inhibitors or activators of the TGFβ pathways were used, such as SB-431542, TGFβ, IDE1 and 
Asiaticoside (Yan, Zhang, Xu, et al., 2014). Olfactomedin-2 was included as it was shown to be 
important in smooth muscle differentiation of human embryonic stem cell-derived mesenchymal 
cells (Shi, Guo & Chen, 2014). Olfactomedin-2 was shown to be a nuclear factor involved in the 
regulation of smooth muscle contractile genes. It is regulated by SMAD proteins, which are known to 
translocate to the nucleus to regulate smooth muscle gene expression induced by TGFβ (Shi, Guo & 
Chen, 2014). 
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Molecules that are important in the Wnt/β-Catenin pathways by inhibition of GSK3 or activation 
of Wnt were used (Nelson & Nusse, 2004; Arango, Szotek, Manganaro, et al., 2005; Xavier & Allard, 
2003). The following GSK inhibitors CHIR99021, BIO (GSK3 Inhibitor IX), Kenpaullone, TWS119, 
Lithium Chloride (LiCl) and for the induction of Wnt/β-Catenin, R-Spondin (RSPO1), Wnt7a, WNT 
agonist, GPR40 agonist were used. 
 
Other factors such as Vascular endothelial growth factor (VEGF), Insulin-like growth factor (IGF1), 
Epidermal growth factor (EGF), Basic fibroblast growth factor (bFGF) and Hepatocyte growth factor 
(HGF) were included too. Platelet-derived growth factor-bb (PDGF-bb) was used to induce cell 
expansion. Finally, reproductive hormones such as Prostaglandin E2 (PGE2), Estrogen (Estrodiol) and 
Progesterone were used. 
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TABLE 6.2. SMALL MOLECULES USED IN THE COMBICULT FOR MYOMETRIAL SMOOTH   MUSCLE 
 
All small molecules and other reagents used for the myometrial smooth muscle CombiCult for all 4 
stages. The list is in random order. KSR: Knock-out serum replacement, BSA: Bovine serum albumin, ITS: 
ITS Liquid Media Supplement, a mixture of human insulin, human transferrin, and sodium selenite, 
bFGF: Basic fibroblast growth factor, BMP2/4: Bone morphogenetic protein-2/4, VEGF: Vascular 
endothelial growth factor, atRA: all-trans Retinoic Acid, PDGF-bb: Platelet-derived growth factor-bb, 
TGFβ: Transforming growth factor-β, PGE2: Prostaglandin E2, IGF1: Insulin-like growth factor-1, HGF: 
Hepatocyte growth factor, EGF: Epidermal growth factor. 
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6.5.3 DIFFERENTIATION METHODOLOGY 
ES AND iPS CELL LINE  GENERATION 
 
The use of iPS and ES stem cells to differentiate into difficult to obtain cell types, or by using iPS 
cells derived from patients themselves, has long been used for a variety of studies including drug 
testing. The first human ES cell lines were generated by Thomson et al. in 1998 (Aflatoonian, Ruban, 
Shamsuddin, et al., 2010). The ES cell line used in this project is one of several human embryonic cell 
lines called ‘Sheffield’ or SHEF generated by Aflatoonian et al. (Aflatoonian, Ruban, Shamsuddin, et 
al., 2010). ES cells are cultured on a feeder layer of either inactivated mouse or human embryonic 
fibroblasts (Aflatoonian, Ruban, Shamsuddin, et al., 2010). The SHEF cell lines were cultured on  
MEFs. Aflatoonian et al. developed a microdrop system where ES cells are allowed to grown in 
‘microdrops’ or colonies to preserve essential growth factors in the direct environment of the 
growing colonies (Aflatoonian, Ruban, Shamsuddin, et al., 2010). In order to obtain the SHEF cell 
lines embryos were cultured until the blastocyst stage and the zona pellucida was removed with 
pronase. The blastocyst was then placed in a small drop on a culture dish containing a confluent  
layer of MEFs (Aflatoonian, Ruban, Shamsuddin, et al., 2010). The ES cells were then passaged by 
manual dissection until a stable cell line was established (Aflatoonian, Ruban, Shamsuddin, et al., 
2010). One of these lines, the SHEF3 line was used for this project (obtained from the UK Stem Cell 
Bank). 
 
Induced pluripotent stem cells (iPS) were first generated from mouse somatic cells by Takahashi 
and Yamanaka in 2006 (Takahashi & Yamanaka, 2006). Takahashi et al. showed that by introduction 
of only 4 essential transcription factors (OCT3/4, Sox2, c-Myc and Klf4) into mouse or human somatic 
cells pluripotent cells could be generated (Takahashi & Yamanaka, 2006; Takahashi, Tanabe, Ohnuki, 
et al., 2007). These induced pluripotent stem cells resembled ES cells in many aspects including 
morphology, gene expression and in vitro differentiation ability (Takahashi, Tanabe, Ohnuki, et al., 
2007).       As somatic skin cells are readily available, it allows for the generation of iPS cells from any 
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genetic background, including patients. This enables further exploration of disease mechanisms and 
drug discovery using cells from any patient which can be derived into the cell type needed. The 
availability of iPS cell lines of healthy subjects allows for the generation of healthy derived cells of 
interest, which in this case would be myometrial smooth muscle cells. The iPS cell line used in this 
project was obtained from Invitrogen and is an episomal cell line which transiently express 7 
transcription factors (including the 4 essential transcription factors) in a total of 3 plasmids (Gibco® 
Human Episomal iPSC Line, shortened to EhiPS) (Burridge, Thompson, Millrod, et al., 2011). 
 
 
 
 
 
EihPS AND SHEF3 CELL  CULTURE 
 
 
In order to obtain a large enough number of undifferentiated SCs, both cell lines were passaged 
until sufficient cell numbers were achieved. The SHEF3 line was grown on mouse embryonic 
fibroblasts (MEFs), whilst the EhiPS line was grown feeder free on Vitronectin coated plates. MEFs 
were generated from E13-14 mouse embryos, grown for 3-4 passaged before Mitomycin-C 
inactivation. 
 
The day before passaging fresh MEFS were grown in MEF medium, consisting of high glucose 
DMEM (Invitrogen, 1x non-essential amino acids (Invitrogen), L-Glutamine (Glutamax, Invitrogen) 
and 10% heat-inactivated FBS (Invitrogen). This medium was replaced with hES medium shortly 
before plating the SHEF3 colonies. The subsequent day the SHEF3 dishes were incubated with 
Collagenase for 5 minutes at 37°C. Collagenase was removed and replaced with hES medium, which 
consisted of KO-DMEM (Knock-out Dulbecco’s Modified Eagles Medium, Invitrogen), 15% Knock-out 
serum replacement (KSR, Invitrogen), 1% L-Glutamine, 1% non-essential amino acids, 0.1 mM β- 
Mercaptoethanol (Sigma) and 8 ng/mL bFGF (R&D). Good colonies with undifferentiated cells and no 
dead areas were then scraped off using a needle. Colonies were collected and divided onto new 
dishes with MEFs and allowed to grow for a few days, medium was replaced daily. On the starting 
day of the differentiation screen, the bad colonies were removed and the rest of the cells were 
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harvested as single cells using Accutase (Sigma), cells were then collected and centrifuged before 
being resuspended in fresh hES medium and counted. 
 
The EhiPS line was grown in E8 medium consisting of E8 medium (Invitrogen), 1x E8 supplement 
(Invitrogen) and 1% Pen/Strep. The EhiPS line was also passaged mechanically, any bad colonies 
were removed before scraping the whole plate in fresh E8 medium which was then divided into new 
Vitronectin-coated dishes (Invitrogen). On the starting day of the differentiation screen, the bad 
colonies were removed and the rest of the cells were harvested using EDTA before use in the 
CombiCult®. 
 
 
 
 
 
6.5.4 COMBICULT DIFFERENTIATION PROTOCOL 
 
 
On the day of a split-pool experiment (d0), 3.3X105 PTC5000 microcarrier beads, previously 
reconstituted and sterilised by autoclaving and a further 3.3X105 also reconstituted and  sterilised 
and further coated in human recombinant Vitronectin, were equilibrated in standard DMEM/F12 
medium and transferred, in equal amounts, into 10 falcon tubes (50 mL). The beads were allowed to 
settle, the supernatant was removed and the beads in each of the tubes were resuspended in each  
of the 10 media cocktails for stage I of the screen. The beads were subsequently plated into 12 well 
suspension culture plates (Greiner Bio) at a concentration of 4000 beads/well in 3 mL of media 
[Figure 6.12]. Cells were seeded onto beads by adding 0.1ml of cell suspension to each well. SHEF3 
cells were seeded at a concentration of ~160 cells/bead while the EhiPS cells were seeded at ~110 
cells/bead onto the Vitronectin coated beads. The next day beads were tagged by addition of a 
unique mixture of fluorescent tags (previously sterilised by ethanol treatment) which identified the 
cell type and the media type contained in each group. Tags are used at a ratio of 500 tags/bead. Tags 
used in the experiment comprised forty unique populations of inert fluorescent microspheres 
(Plasticell) that adhere strongly to PTC5000 beads under cell culture conditions. Discrete populations 
in the size range of 1-10 microns were assigned according to diameter (three size groups: S, M, L) 
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and fluorescence intensity (ten gradations for each size group 1-10). The binding efficiency of all tag 
species to the beads was very similar, thus there was no significant bias towards a specific 
interaction. So for example SHEF3 cells in media 1 had tags BLM09 and RM01 while EhiPs in media 1 
had tags BLM05 and RM01. 
 
A small proportion of cells and beads were kept in hES medium for use as negative control 
(medium 1.0). The subsequent day, 200 µL of each condition, each cell line and from both negative 
controls was taken for cell survival analysis and plated in a 24 well flat bottom dish. Calcein-AM (ex / 
em: 495 / 515 nM) (Invitrogen) was added at a final dilution of 1:1000 and incubated at 37°C for 30- 
45 minutes. The beads were then checked under an immunofluorescence microscope (using 488 
filters) and imaged to confirm cell attachment to the beads. 
 
On d2, 6 and 9, beads from different media groups were transferred into separate 70µM cell 
strainers (Falcon), washed with DMEM to remove residual medium and unbound tags; then beads 
were pooled, mixed thoroughly and split equally into 10 sets which were incubated in media and 
tags as required for the next stage of the experiment. In the last split no tags were added. The tags 
species used were MR1-MR10 for medium conditions 1.1 - 1.10, SR1 – SR10 and LR1 – LR10 were 
used for medium conditions 2.1 – 2.10 and 3.1 – 3.10 respectively. 
 
At the end of stage III, 10% of the pooled beads were removed from the pool, washed and fixed 
with 4% PFA. At the end of the differentiation process each Stage IV condition was collected into a 
separate 50 mL falcon, washed with PBS and fixed in 4% PFA for 30 min, washed and kept in PBS at 
4°C until stained. 
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FIGURE 6.12. COMBICULT PROTOCOL 
 
a) Description of the different stages of the Combicult screen carried out for the differentiation of 
myometrial smooth muscle cells. PFA – paraformaldehyde, d: day. 
b) Schematic representation of the Combicult screen. Media are labelled by numbers 1-4 for the 
different stages, 1-10 for the media type of each stage. Medium 1.0 is the undifferentiated negative 
control consisting of the maintenance media of each cell line, hES medium for SHEF3, E8 medium for 
EhiPS cells. 
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6.5.5 STAINING AND IDENTIFICATION OF POSITIVE  BEADS 
 
 
The beads were stained using a protocol for immunofluorescence similar to the general one 
described in Chapter 2. The main difference is the beads were stained in 15mL falcons and allowed  
to sediment before new solutions were added. Stock solutions were prepared and diluted 1:2 to 
allow for the volume of beads. 3-4mL total volume was used, of which 1.5-2mL was the volume of 
the beads. The beads were allowed to sediment  before  the  PBS  was  removed  until  
approximately 5mL was left. This was then transferred to a clean 15mL falcon, the remaining PBS 
was removed, until 1.5-2mL was left which was mostly the pellet of the beads. Subsequently 0.1% 
Triton X100 (Sigma) was added for 10-15 minutes to the falcons, which were placed on a rocker 
rocking gently. To remove the Triton, the beads were allowed to sediment before  removal. The 
beads were then washed with PBS before Blocking Buffer (0.1% Tween-20 [Sigma], 5% horse serum 
[Invitrogen], 1% BSA [Invitrogen]) was added and the tubes were placed on the rocker for 1h. 
Primary antibodies were allowed to incubate overnight at 4°C. The antibodies were diluted in 
Blocking Buffer at 1:100 for Estrogen Receptor-α (ERα, SantaCruz), 1:50-1:100 for Oxytocin Receptor 
(OTR, SantaCruz) and 1:1000 for αSmooth Muscle Actin (αSMA, DAKO). The aliquot from the first  
exit was stained with ERα and αSMA, all the pools from the final exit were stained per pool for OTR 
and αSMA. The following day, the beads were allowed to sediment, the antibodies removed and 
washed in PBS. The secondary antibodies were added in Blocking Buffer at 1:400 for all antibodies 
and the beads were allowed to rock for 1h. ERα and OTR were detected with a 488 donkey-anti- 
rabbit and donkey-anti-goat antibody respectively, whilst αSMA was detected with a 546 donkey- 
anti-mouse antibody. After the secondary antibody, the beads were washed again 3x20 minutes in 
PBS. Hoechst33342 (Invitrogen) was added at 1:10 000 during the second wash. After the final wash 
the PBS was removed until approximately 5mL was left and the falcons were wrapped in foil and 
kept at 4°C until needed. 
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6.5.6 BEAD SELECTION AND TAG  DECONVOLUTION 
 
 
Beads which were positive for ERα/OTR & αSMA staining were sorted using a COPAS PLUS (Union 
Biometrica) large particle flow sorter equipped with 488 nm and 561 nm solid state lasers and Green 
PMT 514/23 nm, Yellow PMT 585/20 nm, Red PMT 615/45 nm optical emission filters. The 
instrument was calibrated using a reference sample of beads. Sorting gates for size (TOF), optical 
density (EXT) and fluorescence parameters for each experiment were set using representative 
samples of beads that contained both cells and tags and were labelled with secondary antibody only 
as negative control. Beads seeded with primary human myometrial cells and stained for the 3 
markers above were used as positive controls. Samples for each of the pools were sorted separately. 
Beads were sorted at a speed of 50/sec and those decorated with red and green fluorescent cell 
clusters were dispensed automatically into separate wells of a 96-well plate. Wells were 
subsequently checked using a Nikon Eclipse 2000-S inverted epifluorescence microscope equipped 
with filter sets for visualization of TRITC, DAPI, GFP-B (all from Nikon) and Cy5.5 (Chroma 
Technology). 
 
For tag analysis, beads were digested and the tags transferred into separate FACS tubes in a total 
volume of 300 µL. A mixture of all the tags was used as a ‘control’ for the gates. 
 
Tags were analysed using FACSCanto II equipped with 488, 635 and 405 nm lasers (Red PMT 
710/50 nm) [Becton Dickinson] flow cytometer. Prior to tag analysis, a reference tag set was used to 
establish side and forward scattering gates and to calibrate fluorescence intensity of each tag set. 
 
The forward and side scatter gates of the tags were first set up using a ‘control’ set which was a 
mixture of all the tags used. The control set was also used to calibrate the fluorescence intensity (the 
populations) of each tag set [Figure 6.13].  This control was run before the samples of each Plate.  
The correct tags were selected based on the 3 populations of tag sizes and then subselected on the 
basis of the Red or Blue colour tag. Only 2 Blue tags were used and so gates were set up for only 
these tags. There were 30 Red tags used of 3 sizes (Small [S] / Medium [M] / Large [L]) and of 10 
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different intensities which correspond to the 10 media types per Stage. Gates were also set up for 
each of the 10 intensities with a window for each of the 3 sizes, Figure 6.13 shows the gates for the 
Control set. The media types for each Stage were analysed with Plasticell Red, Stage I is represented 
in Red (M tags), Stage II in Green (S tags) and Stage III in Blue (L tags). The cell lines were analysed 
with Plasticell Blue and are represented in Pink. 
 
The FACS files were then imported into ARIADNE™ (Plasticell), a customised bioinformatics 
program. This program was used to collate the data. It predicts the most effective protocols by 
making a hierarchy of most likely media combinations that lead to a positive bead. It shows how 
many beads came through each medium and which subsequent media it passed through.  This  
allows for the ranking of the most likely protocols to produce early or late stage myometrial SMCs. 
Once protocol(s) are discovered, they need to be validated. This is generally achieved by plating iPS 
or ES cells of the same type as previously used onto fresh beads and in a 384 or 96 well plate format 
and differentiating them as the discovered protocol describes. After differentiation the cells are  
fixed and stained for the markers mentioned previously. After confirmation of the protocol, it can be 
tweaked by extending or reducing time period for each stage or by modifying the reagent 
concentrations etc. The obtained SMCs can then be characterized by gene and protein expression 
and used for many purposes. 
  
FIGURE 6.13. FACS ANALYSIS OF CONTROL  TAGS 
 
The cell culture history of each of the beads using the tags was deconvoluted based on the Plasticell protocol of 3 lasers (488, 635 and 405 nm lasers (Red PMT 710/50 
nm)) and 8 colours (4-2-2). a) The forward and side scatter gates of the tags of the Control set containing a mixture of all the tags used. b) The control set was also used 
to calibrate the fluorescence intensity (the populations) of each tag set. A set of 30 unique Red distinguishable by size (Small, Medium or large) and fluorescence 
intensity (ten levels for each size set) was used to spike cell culture media in the first three stages of differentiation. Each size set was used for a different Stage. The 
count represents the number of tags for each intensity, with the gates encompassing a scatter of a bell shaped peak of intensities for each tag. c) A set of two Blue tags 
of the same size but with different intensity was used to distinguish between cell lines. d-f) The media types for each Stage were analysed with Plasticell Red, d) Stage  I 
is represented in Red (M tags), e) Stage II in Green (S tags) and f) Stage III in Blue (L tags). g) The cell lines were analysed with Plasticell Blue and are represented in Pink. 
The two peaks represent the two cell lines with 1 corresponding to EhiPS cells and 2 to SHEF3 cells. Page | 276 
Page | 277  
 
 
6.6.1 VIABILITY TESTING 
 
 
The viability of the EhiPS and SHEF3 cells seeded on the beads was assessed after 24h using 
Calcein-AM (excitation / emission: 495/515 nM), a cell-permeable viability dye (Invitrogen). An 
aliquot was taken of each of the cell types and each medium type (1.1 – 1.10) as well as the 1.0 
undifferentiated media, consisting of the maintenance media (E8 or hES) media for EhiPS and SHEF3 
respectively. Bright field images of the beads and images of the Calcein stained cells were taken at 
10x magnification. Representative images of the EhiPS and SHEF3 seeded beads in each of the media 
1.0, 1.1 – 1.10 can be found in Appendix D2. Seeding of both cell lines in all 10 media conditions was 
successful as indicated by the bright staining of Calcein in all the bead samples. 
 
 
 
 
 
6.6.2 EARLY EXIT 
 
 
3000 beads were collected from the Early Exit and fixed in 4% PFA. These beads were stained for 
the ‘early’ markers, ERα and αSMA. ERα is expressed in the myometrium in both its pregnant and 
non-pregnant state. The early exit was meant as an indicator whether any differentiation into 
myometrial SMCs was achieved and potentially as a differential stage for non-pregnant or early 
pregnant (preterm) like myometrial SMCs. 
 
A small aliquot of beads was imaged under the microscope, before returning them to the Early 
Exit pool [Figures 6.14 and 6.15]. Prior to running the beads through the COPAS, the  positive 
(primary myometrial SMCs) and negative controls, an aliquot of differentiated beads with secondary 
antibody only were run through the COPAS to obtain the gating settings [Appendix D3]. These were 
then adjusted as the beads were run, due to differences in fluorescence between the strongly 
positive myometrial cells and the differentiated beads. The beads of interest or ‘hits’ that passed the 
fluorescence gating were sorted into single wells of a 96 well plate. The COPAS sorted 826 wells with 
6.6 RESULTS OF THE  COMBICULT 
Page | 278  
‘positive’ beads some of these were false positives and some wells contained multiple beads, these 
were not used for further analysis. Of these half were digested and deconvoluted to obtain the tag 
IDs and therefore the media the beads had passed through. Representative images were taken of 
single beads after sorting [Figure 6.16]. Representative FACS images of a set of tags which has a 
single tag for each Stage / Cell line and a ‘bad’ set with a double peak are shown in Figures 6.17  and 
6.18 respectively. The double peak (red) is probably due to the fact that there were originally two 
separate beads which after Stage I (red) became attached to each other and stayed together in 
subsequent Stages (II & III). 
  
 
 
FIGURE 6.14. REPRESENTATIVE BEADS OF THE EARLY EXIT POOL STAINED WITH ESTROGEN RECEPTOR-α AND αSMOOTH MUSCLE ACTIN 
 
An aliquot of the beads stained with ERα (rabbit-488) and αSMA (mouse-546) and Hoechst were imaged on an epifluorescence microscope. Staining 
indicated that cells on a number of beads have differentiated, although the number of cells / bead differs and the different intensity of the markers 
indicates that there are differences in effectiveness of the differentiation between beads. It is not possible to differentiate between the two cell lines 
without tag analysis. 
Representative images at 10x (top; scale bar: 70 µM) and 4x (bottom; scale bar: 330 µM) magnification. Circles encompass beads with differentiated 
cells; 
Hoechst: Blue / ERα: Green / αSMA: Red / Merge: Purple. Orange circles: examples of beads with no differentiated cells. 
A number of differentiated beads can be seen in these images, indicating that there were be successful protocols which could be determined by further 
analysis. 
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FIGURE 6.15. REPRESENTATIVE BEADS OF THE EARLY EXIT POOL STAINED WITH ESTROGEN RECEPTOR-α AND αSMOOTH MUSCLE ACTIN 
 
An aliquot of the beads stained with ERα (rabbit-488) and αSMA (mouse-546) and Hoechst were imaged on an epifluorescence microscope. Staining 
indicated that cells on a number of beads have differentiated, although the number of cells / bead differs and the different intensity of the markers 
indicates that there are differences in effectiveness of the differentiation between beads. Even within a bead not all cells may have differentiated 
equally (middle set). It is not possible to differentiate between the two cell lines without tag analysis. Representative images at 20x magnification, (top; 
scale bar: 35 µM, middle, bottom; scale bar: 70 µM). Page | 280 
  
FIGURE 6.16. REPRESENTATIVE SORTED BEADS FROM THE EARLY EXIT STAINED WITH ERα 
AND αSMA 
 
After the beads from the early exit were sorted by the COPAS, the plates were checked under the 
epifluorescence microscope. These are representative images of beads with more or less cells and 
different intensities for the different markers, ERα (rabbit-488) and αSMA (mouse-546) and 
Hoechst. It is not possible to differentiate between the two cell lines without tag analysis. Scale: 35 
µm. 
Differentiated single beads can be seen in these images, indicating that there were be successful 
protocols which could be determined by further analysis. 
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FIGURE 6.17. REPRESENTATIVE FACS PROFILES FOR A ‘GOOD’ SET OF   TAGS 
 
The cell culture history of each of the beads using the tags was deconvoluted based on the Plasticell protocol. a) The forward and side scatter gates of the 
tags. b) The tags were selected based on the calibrated fluorescence intensity (the populations) of each tag set. Each size set was used for a different Stage. 
The count represents the number of tags for each intensity, with the gates encompassing a scatter of a bell shaped peak of intensities for each tag. c) A set of 
two Blue tags of the same size but with different intensity was used to distinguish between cell lines. d-f) The media types for each Stage were analysed with 
Plasticell Red. d) Stage I is represented in Red (M tags), this bead passed through medium 1.3 based on the tag count. e) Stage II in Green (S tags), with the 
bead passing through medium 2.1 and f) Stage III in Blue (L tags), the bead passed through medium 3.4. g) The cell lines were analysed with Plasticell Blue and 
are represented in Pink. This bead was seeded with SHEF3 cells. Page | 282 
  
FIGURE 6.18. REPRESENTATIVE FACS PROFILES FOR A  SET OF TAGS CONTAINING A  DOUBLET OF    BEADS 
The cell culture history of each of the beads using the tags was deconvoluted based on the Plasticell protocol. a) The forward and side scatter gates of the tags. b) The tags were 
selected based on the calibrated fluorescence intensity (the populations) of each tag set. Each size set was used for a different Stage. The count represents the number of tags for 
each intensity, with the gates encompassing a scatter of a bell shaped peak of intensities for each tag. c) A set of two Blue tags of the same size but with different intensity was 
used to distinguish between cell lines. d-f) The media types for each Stage were analysed with Plasticell Red. d) Stage I is represented in Red (M tags), this is a set of two beads 
that passed through medium 1.1 and 1.7 based on the tag count. The beads then clumped together and passed through the subsequent media together e) Stage II in Green (S 
tags), with the beads passing through medium 2.7 or 2.8 and f) Stage III in Blue (L tags), the bead passed through medium 3.8. g) The cell lines were analysed with Plasticell Blue 
and are represented in Pink. This bead was seeded with SHEF3 cells. 
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6.6.3 FINAL EXIT 
 
 
At the end of the final differentiation stage, individual pools of beads corresponding to each 
condition, were collected separately and fixed in 4% PFA after the final stage. The beads were then 
stained with the late markers OTR and αSMA. OTR was chosen, as it becomes expressed later on 
during pregnancy (Mosher, Rainey, Bolstad, et al., 2013; Terzidou, 2009). αSMA was continued as it  
is one of the most highly expressed markers for myometrial SMCs and there might be changes in 
expression level of αSMA after an extra stage of differentiation. 
 
All the beads were then passed through the COPAS, Table 6.3 and Figure 6.19 summarize the hits 
for both the Early and Final exit beads. The Exit and Final exit pools combined had 3150 hits, of  
which 1129 were analysed. There were 826 hits out of ~3000 beads in the early exit, of which 
approximately half were analysed. The Final exit had a total of 2324 hits, which were confirmed by 
microscopy. A total of 711 beads were deconvoluted for the Final exit, the remaining 1613 were 
multiples or otherwise discarded as not suitable (negative for either markers, not real fluorescence), 
see Table 6.3 for the number of hits / group. Pool 1, 2, 7, 9 and 10 had the most hits, with 250 – 400 
hits per pool. The other pools had 100 – 200 hits each. It was quite striking how diverse the COPAS 
profiles were, some pools had more expression for either of the markers [Appendix D3]. Pool 1 
seems to have 2 populations, with some beads having a higher intensity for green than red and 
others a higher intensity for red than green. Pools 3, 4 and 5 contained beads that were more or less 
equal in fluorescence for both markers, although there were fewer hits than other pools and the 
fluorescence profiles were relatively low fluorescence.  Pools 2, 7, 9 and 10 had profiles with a  
higher intensity for red and these pools (together with pool 1) had the most hits. Pools 6 and 8 had a 
higher intensity for green. 
 
When placed on the microscope, it became apparent that the intensity of αSMA was increased 
compared to the Early Exit, indicating that the cells may have needed a little longer to become more 
mature. OTR was generally relatively faint, although some beads showed quite high fluorescence. 
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A few positive beads from each pool were imaged and images are presented in Figures 6.20 – 
 
6.21. Not all beads were positive, a set of beads sorted into a single well negative for both markers is 
presented in Figure 6.22. Additional images of the Final exit beads can be found in Appendix D2. 
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TABLE 6.3. SUMMARY OF HITS FROM COPAS AND SUBSEQUENTLY ANALYSED   BEADS 
 
The number of ‘hits’ from the COPAS, these beads were subsequently digested and the tags 
deconvoluted using the FACS CANTO. The Exit and Final exit pools combined had 3150 hits, of 
which 1129 were analysed. There were 826 hits out of ~3000 beads in the early exit, of which 
approximately half was analysed. The Final exit had a total of 2324 hits, which were confirmed by 
microscope. A total of 711 beads were deconvoluted of the Final exit, the remaining 1613 were 
multiples   or  otherwise   discarded   as   not   suitable   (negative   for  either   markers,   not  real 
 
FIGURE 6.19. GRAPHICAL REPRESENTATION OF ANALYSED  HITS 
 
The number of ‘hits’ from the COPAS, which were subsequently digested and the tags 
deconvoluted using the FACS CANTO. The Exit and Final exit pools combined had 3150 hits, of 
which 1129 were analysed. There were 826 hits out of ~3000 beads in the early exit, of which 
approximately half was analysed. The Final exit had a total of 2324 hits, which were confirmed 
by microscope. A total of 711 beads were deconvoluted of the Final exit, the remaining 1613 
were multiples or otherwise discarded as not suitable (negative for either markers, not real 
fluorescence), see Table 6.3 for the number of hits / group. Columns show the hits stacked for 
deconvoluted hits (Purple) and not analysed hits (Black). 
fluorescence). 
  
 
FIGURE 6.20. REPRESENTATIVE BEADS OF THE FINAL EXIT POOLS STAINED WITH OXYTOCIN RECEPTOR AND αSMOOTH 
MUSCLE ACTIN 
 
All beads from separate pools were stained with OTR (goat-488) and αSMA (mouse-546) and Hoechst and were imaged on an 
epifluorescence microscope. Staining indicated that cells on a number of beads have differentiated, although the number of cells / 
bead differs and the different intensity of the markers indicates that there are differences in effectiveness of the differentiation 
between beads. Even within a bead not all cells may have differentiated equally. It is not possible to differentiate between the two  
cell lines without tag analysis. Representative images from pool 4 (top), 6 (middle) and 10 (bottom) at 10x magnification (scale bar: 
70 µM). 
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FIGURE 6.21. REPRESENTATIVE BEADS OF THE FINAL EXIT POOLS STAINED WITH OTR AND    αSMA 
 
All beads from separate pools were stained with OTR (goat-488) and αSMA (mouse-546) and Hoechst and  
were imaged on an epifluorescence microscope. Staining indicated that cells on a number of beads have 
differentiated, although the number of cells / bead differs and the different intensity of the markers indicates 
that there are differences in effectiveness of the differentiation between beads. Even within a bead not all cells 
may have differentiated equally. It is not possible to differentiate between the two cell lines without tag 
analysis. Representative images from various pools at 20x magnification (scale bar: 35 µM). Page | 288 
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FIGURE 6.22. REPRESENTATIVE NEGATIVE BEADS OF THE FINAL EXIT   POOLS 
 
All beads from separate pools were stained with OTR (goat-488) and αSMA (mouse-546) and 
Hoechst and were imaged on an epifluorescence microscope. Staining indicated that cells on a 
number of beads have differentiated, although the number of cells / bead differs and the different 
intensity of the markers indicates that there are differences in effectiveness of the differentiation 
between beads. Not all beads sorted by the COPAS were positive. Representative images from a set 
of two beads sorted together in a single well negative for both markers at 20x magnification (scale 
bar: 35 µM). 
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6.6.4 PROTOCOL ANALYSIS 
 
 
After all the beads were digested and the tags analysed by FACS, deconvolution of the tags was 
carried out separately as well as combined for the Early and Final Exit beads using Ariadne™ 
software. Deconvolution in this context means the use of the tagging data obtained with the FACS to 
map the cell culture history of each bead. 
 
Ariadne was used to analyse the media each analysed bead passed through, it provides an output 
in various different formats which allows for visualisation of the connections between different 
Stages in different manners, most of which can be found in Appendix D4. It highlights the most 
commonly used media. The different analysis outputs are shown in the subsequent figures showing 
first the Early Exit and then the combined exits; pathway analysis [Figure 6.23 and 6.24], fingerprint 
analysis [Appendix Figures D4.1 and D4.2, the full fingerprint analysis can be found in Appendix E on 
the DVD], dendograms [Appendix Figures D4.3 and D4.4] and similarity matrices [Appendix Figures 
D4.5 and D4.6]. 
 
Each beads was analysed separately and could pass or fail depending on whether the peaks of 
each tag analysed passed the threshold. To pass there has to be at least 3-5x more tags in one peak 
than the other peaks. Multiple high peaks in one intensity were designated to have ‘failed’. The 
history of each bead was a combination of the tags of the cell line and the different stages. It was 
possible to have a partial pathway, if one of the media contained not enough tags or a lot of noise. A 
total of 119 beads were used in the Early Exit analysis and 420 beads were used in the Final exit 
analysis. 
 
The pathway analysis of the Early Exit only is described in Figure 6.23, the first ‘split’ (Split 1) is 
based on the two cell lines, the EhiPS were designated ‘1’ and the SHEF3 ‘2’. The subsequent splits 
represent Stage I – III. The image clearly shows that the majority of positive beads with 
differentiated cells were seeded with SHEF3 cells (103 vs 16). The number of beads passing through 
each of the media in Stage I (Split 2) differs with more beads passing through media 1.1 (15   beads), 
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1.2 (14), 1.4 (22), 1.8 (17) or 1.9 (14) and relatively few beads passing through 1.3 (5), 1.7 (8) or  1.10 
 
(3). In Stage II (Split 3) approximately half of the beads passed through either 2.1 (26) or 2.2 (27), 
with the remaining beads passing more or less equally through the remainder of the media. In Stage 
III (Split 4) there are again multiple media that have multiple beads passing through, with the  media 
3.5 the highest at 18 beads. 
 
 
Interestingly, the beads from Stage 1 (Pools 1.1, 1.2 1.4, 1.8, 1.9) go to either 2.1 or 2.2. Of those, 
beads from 1.4 are most likely to go to 2.2 and beads from 1.8 to 2.1. From there the beads from 2.1 
are more likely to go to 3.5, whilst those from 2.2 go to 3.9. There is therefore a set of pathways that 
are most likely to pass from the SHEF3 (2) to 1.4 – 2.2 – 3.9, from SHEF3 to 1.8 - 2.1 - 3.5. Other likely 
sets are from SHEF3 to 1.1 – 2.1, SHEF3 to 1.1 – 2.2 or SHEF3 to 1.4 – 2.2, with the Stage III varying. 
Page | 292  
 
FIGURE 6.23. EARLY EXIT PATHWAY  ANALYSIS 
 
Schematic of the pathway analysis carried out by Ariadne showing all protocols from the Early Exit hits.  
Each medium type is represented by a box, with the numbers 1 – 10 representing the media subtypes per 
Stage. Except for Split 1 which represents the two cell lines, 1: EhiPS and 2: SHEF3. Split 2 – 4 represent the 
Stages I – III. The height of each box is proportional to the number of hits in that medium, the number of  
hits are described as small numbers in each box. The lines link the media between stages where a bead 
passes from one media into a certain other. The opacity of the lines is proportional to the number of hits 
generated by specific combinations of media. The darkest line corresponds to 21 beads passing along that 
line. 
The majority of positive beads with differentiated cells were seeded with SHEF3 cells (103 vs 16). 
The highest number of beads in Stage 1 passed through media 1.1 (15 beads), 1.2 (14), 1.4 (22), 1.8 (17)  or 
1.9 (14). 
In Stage II (Split 3) approximately half of all the beads passed through either 2.1 (26) or 2.2 (27). 
In Stage III (Split 4) there are again multiple media that have multiple beads passing through, with the 
media 3.5 the highest at 18 beads. 
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The pathway analysis of the Final Exit only is described in Figure 6.24, the first ‘split’ (Split 1) is 
based on the two cell lines, the EhiPS were designated ‘1’ and the SHEF3 ‘2’. The subsequent splits 
represent Stage I – IV. Again, the majority of positive beads with differentiated cells were seeded 
with SHEF3 cells (348 vs 72). In Stage I (Split 2), the majority of beads passed through media 1.1 (73 
beads), 1.5 (78) or 1.9 (79), while the remaining beads passed more or less equally through the other 
media. Media 1.1 or 1.9 also came up in the Early Exit media, although other media had more hits 
(media 1.4 or 1.8), which in the Final Exit had less hits than 1.1 and 1.9 and were 3rd and 4th. In 
Stage II (Split 3) most beads passed through media 2.1 (69), 2.2 (51), 2.6 (53) or 2.7 (49), although 
the beads showed more dispersal across the media than in the Early Exit, with media 2.1 and 2.2 
coming up the same as in the Early Exit. In Stage III (Split 4) the majority of beads passed through 
media 3.1 (55), 3.8 (59), 3.9 (43) or 3.10 (52). In the Final Stage (Split 5), the majority of beads 
finished in media 4.1 (58), 4.3 (58), 4.7 (67) or 4.10 (56). 
 
 
A strong correlation was seen for the first 2 Stages (I, II) and the final Stage (IV) whilst it seems 
that Stage III has no preferential media. Partial pathways found started with SHEF3 go to 1.9 – 2.1, 
1.1 – 2.1, 1.5 – 2.1 or 1.5 – 2.2, after which they pass through any of the Stage 3 media, before 
ending often in 4.7, although 4.1 and 4.3 also come up. 
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FIGURE 6.24. FINAL EXIT PATHWAY  ANALYSIS 
 
Schematic of the pathway analysis carried out by Ariadne showing all protocols from the 
Final Exit hits. Each medium type is represented by a box, with the numbers 1 – 10 
representing the media subtypes per Stage. Except for Split 1 which represents the two cell 
lines, 1: EhiPS and 2: SHEF3. Split 2 – 5 represent the Stages I – IV. The height of each box is 
proportional to the number of hits in that medium, the number of hits are described as 
small numbers in each box. The lines link the media between stages where a bead passes 
from one media into a certain other. The opacity of the lines is proportional to the number 
of hits generated by specific combinations of media. The darkest line corresponds to 64 
beads passing along that line. The majority of positive beads with differentiated cells were 
seeded with SHEF3 cells (348 vs 72). In Stage I the majority of beads passed through media 
1.1 (73 beads), 1.5 (78) or 1.9 (79). In Stage II most beads passed through media 2.1 (69), 
2.2 (51), 2.6 (53) or 2.7 (49). 
In Stage III the majority of beads passed through media 3.1 (55), 3.8 (59), 3.9 (43) or 3.10 
(52). In the Final Stage (Split 5), the majority of beads finished in media 4.1 (58), 4.3 (58), 
4.7 (67) or 4.10 (56). 
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Ariadne also analyses all the tags and provides fingerprint analysis. Fingerprint analysis was then 
carried out to see whether any beads share pathways or partial pathways. Part of the fingerprint 
analysis carried out for the Early Exit and Early + Final exit combined respectively is shown in 
Appendix Figures D4.1 and D4.2 respectively, a full list of the fingerprint analysis can be found in 
Appendix E on the DVD. The fingerprint analysis shows any pathways that are shared by 2 or more 
beads and can be ordered in various ways, by descending number of matches (matching media), 
number of beads, or increasing probability, these are all supplied for the Early and Combined Exits in 
Appendix E on the DVD. Figures in Appendix D4 show the beads ordered by increasing probability. 
The lower the probability, the less likely the bead passed through a certain combination of media by 
chance. The Figures in Appendix D4 provide information on the number of matching Stages, the 
number of beads in that pathway and the probability followed by the media of each Stage of these 
pathways and finally all the bead IDs that follow this pathway. The numbers in the splits represent 
the media numbers, with – representing multiple possible conditions or both cell lines. 
 
The probability was calculated by Ariadne by using a probability simulation, as was previously 
published (Tarunina, Hernandez, Johnson, et al., 2014). Probability values for the occurrence of given 
events by chance were obtained from computer simulation experiments. A Mersenne Twister 
random number generator was used to output uniformly distributed 32-bit integers which were 
scaled to cover 10,000, 1,000 or 100 possible pathways, when simulating common cell culture media 
on four out of four splits, three out of four splits or two out of four splits (Tarunina, Hernandez, 
Johnson, et al., 2014). Simulation begins by setting tally counters associated with each pathway to 
zero. To simulate probabilities for the screen, 96 paths were chosen at random and their counters 
incremented. Should any such counter exceed the specified threshold (2, 3, 4, 5, …, n beads per 
pathway), a positive result was recorded. Event probabilities were computed by repeating the 
process 100 million times and dividing the number of positive results by the total number of 
simulations, resulting in probability values accurate to eight decimal places. 
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The dendograms shown in Appendix Figure D4.3 and D4.4 for the Early and Final Exit respectively 
show the hierarchical clustering of families with similar media. These families of highly related 
protocols are often very efficient at directing differentiation. As can be seen in the Figures there is a 
split in the first instance of the SHEF3 (orange) and EhiPS cell line (red). There seem to be 6 major 
families in the SHEF3 line with protocols within each family more similar to each other than to other 
families. 1 or 2 protocols from each family were chosen for validation. 
 
Ariadne also provides a pair-wise comparison of all the protocols as represented in  the 
hierarchical clustering, this comparison is presented as a similarity matrix [Appendix Figures D4.5  
and D4.6 for Early and Final Exit respectively]. In this matrix the protocols are organised so that each 
row and each column represent a protocol. The brightness of each cell in the matrix is proportional 
to the number of cell culture media shared by the protocols. The brightest red corresponds to two 
identical protocols, whilst black corresponds to protocols with no common media. The diagonal line 
comprises of the protocols compared to themselves. Families of protocols with high similarity and 
internal homology look like as bright red squares. In both Figures there is a split in clusters 
depending on the cell line, with a large square representing the SHEF3 line and the small square the 
EhiPS line. Along the diagonal line there are a number of families which contain clusters of similar 
media. There seem to be 6 clusters of media for the SHEF3 line in the Early Exit, which are 
represented by the bright red squares along the diagonal line. This can also be seen along the top 
axis, where the family origins are presented as a family trees. Broadly there seem to be 6 similar 
trees for the SHEF3 [Appendix Figure D4.5]. 
 
These clusters are a little smaller in the Final Exit, with a larger number of smaller families of 
media [Figure D4.6]. This may be due to the fact that although there seemed to be crucial media 
compositions in Stage I & II, there was a more diffuse distribution in Stage III. 
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Finally, the separate components as mentioned in Table 6.2 were analysed using a component 
analysis to obtain information about the efficiency of the different components at driving the 
differentiation of the cells. This was normalised over the total media each component was present 
in, as not all components were repeated across Stages or present in all media. Some components 
were only present in one or two media while others were present in many of the media in one or 
more Stages. Figure 6.25 shows the list of components analysed, in order of normalised frequency 
used. 
 
Some components, such as BSA, ITS and lipid concentrate were used in most of the protocols to 
provide basic nutrients for the cells, therefore these were discounted in the final analysis of 
efficiency, as they or similar components are necessary for the cells. Not all of these were equally 
efficient at driving the differentiation, which in future may be reflected in the use of some, but not 
other components whilst optimising the media composition. 
 
The addition of TGFβ and Wnt or its agonists have a substantial effect on the differentiation of 
the cells. PDGF-bb seems to have a substantial effect on the efficiency of cell expansion. 
Interestingly, factors with similar effects but different targets upstream or downstream in the target 
pathway were not always equally effective at induction of differentiation. Equally, the hormones 
chosen were not all equally effective in driving differentiation. 
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FIGURE 6.25. COMPONENT ANALYSIS OF THE COMBINED  EXITS 
 
Component analysis was used to obtain information about the efficiency of the different 
components at driving the differentiation of the cells. This was normalised over the total 
media each component was present in, as not all components were repeated across Stages  
or present in all media. Some components were only present in one or two media while  
others were present in many of the media in one or more Stages. 
Some components, such as BSA, ITS and lipid concentrate were used in most of the protocols 
to provide basic nutrients for the cells, therefore these were discounted in the final analysis  
of efficiency, as they or similar components are necessary for the cells. 
The addition of TGFβ and Wnt or its agonists have a substantial effect on the differentiation 
of the cells. PDGF-bb seems to have a substantial effect on the efficiency of cell expansion. 
Interestingly, factors with similar effects but different targets upstream or downstream in the 
target pathway were not always equally effective at induction of differentiation. 
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Due to time restraints, during this project only data for the CombiCult, tag analysis and first 
validation were obtained. 
 
The validation was carried out using the SHEF3 cell line in the first instance. 10 protocols from the 
early exit and 16 protocols from the final exit were selected. SHEF3 cells were dissociated with 
Accutase as before, counted and seeded at 300 000 cells per well of a 6 well plate per protocol (day 
0). The protocols chosen for validation are described in Table 6.4. The differentiation media were 
changed as follows: Seeding + Stage I: d0, Stage II: d3, Stage III: d7, Stage IV: d10. All the Early Exit 
and 1 96 well plate of the Final Exit were fixed or the cells collected for PCR on day 10 and the 
remaining plates of the Final Exit were fixed or collected on d16. 
 
By day 3 the cells had become almost confluent, it was therefore decided to split the cells into 
the 96 wells at Stage II instead of Stage III. Even at this early stage there were clear differences in 
morphology, representative photographs were taken of the cells using a phase contrast microscope 
(Nikon). Images of the 7 conditions from Stage I that were chosen for the validation are shown in 
Figure 6.26, with the numbers indicating the Stage I medium the cells were plated in. Not all media 
were found to be effective and are therefore missing. There were multiple wells of each condition 
(26 in total), but only 1 was imaged per medium. Subsequently, cells from each protocol were 
harvested with Accutase (2 minutes at 37°C), spun and seeded in 32 wells of a 96 well plate and 1 
well in a 12 well. 
 
Cells in the different protocols were photographed again on d7. The cells seemed to have 
differentiated into a variety of different types, with cells often forming large sheets of spherical 
shapes like embryo bodies or elongated clusters of cells. Under some conditions cell survival after 
enzymatic passaging is poor. The size and shape of the single cells also differs between long thin cells 
when attached to the bottom of the dish or in elongated clusters and more rounded cells in the 
6.7 VALIDATION OF SELECTED  PROTOCOLS 
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clusters. Representative images of each of the protocols 1 – 26 are shown in Figure 6.27 [pages x and 
y]. 
 
On day 10 the dishes from protocols 1 – 10 were collected for PCR or fixed in Methanol or 4% 
PFA. One 96 well plate (8 wells per protocol) of protocols 11 – 26 was also fixed in Methanol for  
Early Exit analysis. The remaining 24 wells and the wells in the 12 well plate were changed to the 
media of Stage IV. Before collection and media change cells from all the protocols were 
photographed. Representative images for protocols 1 – 26 are shown in Figure 6.28 [pages x and y]. 
 
On day 16 all the remaining dishes for protocols 11 – 26 were imaged and collected for PCR or 
fixed in Methanol or 4% PFA.     Representative images for protocols 1 – 26 are shown in Figure 6.29. 
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TABLE 6.4. VALIDATION PROTOCOLS 
 
Protocols chosen for the validation. These protocols had a high ranking (ARIADNE) and multiple 
beads going through the protocol. Early exit and final exits were analysed separately as well as 
together. The Early exit beads went through Stages I – III (therefore – for the final stage). All 
protocols chosen were for the SHEF3 line (cell line 2). Protocols were numbered arbitrarily (1 – 26). 
Numbers in Stage I - IV correspond to media from the Matrix. 
 
 
  
FIGURE 6.26. REPRESENTATIVE IMAGES OF DIFFERENTIATING SHEF3 AFTER INCUBATION WITH STAGE  I  
MEDIA 
 
The different conditions showed that the SHEF3 cells had clear morphological differences after incubation with 
each of the Stage I media. This indicated that each medium had driven the cells to differentiate differently. 
Representative images of the 7 conditions from Stage I that were chosen for the validation at 4x (scale bar: 170 
µM), 10x (scale bar: 70 µM) and 20x magnification (scale bar: 35 µM). The numbers represent the Stage I  media 
the cells were plated in. There were multiple wells of each condition (26 in total), but only 1 was imaged per 
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medium. 
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FIGURE 6.27. REPRESENTATIVE IMAGES OF DIFFERENTIATING SHEF3 AFTER STAGE I AND  II 
MEDIA 
 
The different conditions showed that the SHEF3 cells had clear morphological differences after  
incubation with each of the Stage I and II media. This indicated that each medium had driven the cells to 
differentiate differently.  Representative images of the 26 protocols that were chosen for the validation  
at 10x (scale bar: 70 µM) and 20x magnification (scale bar: 35 µM). The numbers represent the protocol 
the cells experienced. 
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FIGURE 6.27. REPRESENTATIVE IMAGES OF DIFFERENTIATING SHEF3  AFTER  STAGE I  AND  
II MEDIA (CONTINUED) 
 
The different conditions showed that the SHEF3 cells had clear morphological differences after 
incubation with each of the Stage I and II media. This indicated that each medium had driven the 
cells to differentiate differently. Representative images of the 26 protocols that were chosen for  
the validation at 10x (scale bar: 70 µM) and 20x magnification (scale bar: 35 µM). The numbers 
represent the protocol the cells experienced. 
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FIGURE  6.28.  REPRESENTATIVE  IMAGES  OF  DIFFERENTIATING  SHEF3  AFTER  STAGE  I,  II 
AND III MEDIA 
 
The different conditions showed that the SHEF3 cells had clear morphological differences after 
incubation with each of the Stage I, II and III media. This indicated that each medium had driven the 
cells to differentiate differently. Representative images of the 26 protocols that were chosen for the 
validation at 10x (scale bar: 100 µM) and 20x magnification (scale bar: 100 µM). The numbers 
represent the protocol the cells experienced. 
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FIGURE 6.28. REPRESENTATIVE IMAGES OF DIFFERENTIATING SHEF3  AFTER  STAGE  I,  II 
AND III MEDIA (CONTINUED) 
 
The different conditions showed that the SHEF3 cells had clear morphological differences after 
incubation with each of the Stage I, II and III media. This indicated that each medium had driven the 
cells to differentiate differently. Representative images of the 26 protocols that were chosen for the 
validation at 10x (scale bar: 100 µM) and 20x magnification (scale bar: 100 µM). The numbers 
represent the protocol the cells experienced. 
  
FIGURE 6.29. REPRESENTATIVE IMAGES OF DIFFERENTIATED SHEF3 AT THE FINAL   STAGE 
 
The different conditions showed that the SHEF3 cells had clear morphological differences after incubation 
with each of the Stage I, II, III and IV media. This indicated that each medium had driven the cells to 
differentiate differently. Representative images of the 16 remaining Final Exit protocols that were chosen 
for the validation at 4x (scale bar: 100 µm), 10x (scale bar: 100 µm) and 20x magnification (scale bar: 100 
µm). The numbers represent the protocol the cells experienced. Page | 307 
  
6.7.1 IMMUNOFLUORESCENCE ANALYSIS OF PROTOCOL  EFFICIENCY 
 
 
When all the plates of all protocols had been collected or fixed the final analysis of the protocol 
efficiency was carried out. The cells for all the protocols were stained for Hoechst and the Early (ERα 
[rabbit-488] and αSMA [mouse-647]) and Final Exit markers (OTR [goat-488] and αSMA [mouse- 
647]) in duplicate and one well was devoted to their respective negative controls. The plate was  
then imaged using the epifluorescence microscope [Figure 6.30 and 6.31 for Early and Final Exit 
respectively] before subsequent analysis using a high content screening platform called Cellinsight 
NXT [ThermoFisher]. High Content Screening or automated cell analysis is an automated method  
that combines fluorescence microscopy, automated cell calculations and phenotyping using image 
processing algorithms and informatics. It allows for the analysis of the validation protocols for the 
cells of interest using the markers chosen. This allows for the acquisition of quantitative data to see 
the proportion of differentiated cells of the chosen phenotype in each protocol. 
 
It allows for the analysis of the level of differentiation induced by each protocol, as it compares 
the efficiency of each wells (protocol) by obtaining images and subsequent analysis of 10 fields of 
view per well. It first calculates the number of cells in each well (the object count) by analysis of the 
Hoechst staining. It is possible to set thresholds for nucleus size, so very small or very large nuclei are 
discarded, as well as those with a weird shape or when many nuclei are clustered together. Then it 
overlays the target fluorescence signals (ERα, OTR, αSMA) and calculates the fluorescence in an area 
around the cell. The size of this area is set by the user based on the positive controls of each marker. 
It obtains the mean intensity of each of these markers in each ‘cell’ area. It then calculates the 
percentage of responders by taking how many objects (cells) counted had fluorescence over the 
threshold set using the negative controls over the total number of objects (cells). This gives an 
indication of the efficiency of each protocol. 
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FIGURE 6.30. REPRESENTATIVE IMMUNOFLUORESCENCE IMAGES OF THE EARLY EXIT VALIDATION STAINED WITH ESTROGEN RECEPTOR-α AND 
αSMOOTH MUSCLE ACTIN OR OXYTOCIN  RECEPTOR 
 
After fixation of all the protocols in the Early Exit, the wells were stained in duplicate for a) ERα (rabbit-488 and αSMA (mouse-647) or b) in singular for OTR 
(goat-488) and αSMA, as well as negative controls. Hoechst was used for cell visualisation purposes. Positive cells were imaged from pools with cells surviving 
in the wells. Representative images from various pools were taken at 20x magnification (scale bar: 100 µm). a) Robust staining for ERα was found throughout 
the protocols. αSMA staining was more disperse, but when cells were αSMA positive, they showed robust expression. b) OTR expression was more variable, 
but it is still early, so expression may still be low. Page | 309 
  
FIGURE 6.31. REPRESENTATIVE IMMUNOFLUORESCENCE IMAGES OF THE FINAL EXIT VALIDATION STAINED WITH ESTROGEN RECEPTOR-α AND 
αSMOOTH MUSCLE ACTIN OR OXYTOCIN  RECEPTOR 
 
After fixation of all the protocols in the Final Exit, the wells were stained in duplicate for a) ERα (rabbit-488 and αSMA (mouse-647) or b) OTR (goat-488) and 
αSMA, as well as negative controls. Hoechst was used for cell visualisation purposes. Positive cells were imaged from pools with cells surviving in the wells. 
Representative images from various pools were taken at 20x magnification (scale bar: 100 µm). a) Robust staining for ERα was found throughout the protocols. 
αSMA staining was more disperse, but was increased compared to the Early Exit. When cells were αSMA positive, they showed robust expression. b) OTR 
expression was more variable, but was also more increased compared to the Early Exit. Page | 310 
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As not all wells had equal numbers of cells, a threshold was selected in order to only include 
those protocols where enough cells survived to accurately analyse. Figures 6.32a and 6.32b show the 
cell counts based on the nuclei of all the protocols of the Early Exit validation and those of the Final 
Exit validation respectively. All protocols were represented in the Early Exit, whilst only protocols 11 
-26 were continued into the Final Exit. The threshold chosen was for both roughly 500 cells [dashed 
blue line]. Fewer cells survived at the end of the Validation, possibly due to overgrowth of the 96 
well plate resulting in cell death. Some protocols had high density sheets or clumps of cells, which 
may not be analysed accurately due to the density of nuclei. 
 
Any protocols with approximately those numbers of cells or more were then further analysed and 
the graphs included in this section. The most successful protocols of the Early Exit are shown in 
Figure 6.44, with separate graphs for ERα [Figure 6.33a, green bars], OTR [Figure 6.33b, orange bars] 
and αSMA [Figure 6.33c, red bars] as well as a combined graph shown in Figure 6.33d. The most 
successful protocols of the Final Exit are shown in Figure 6.34, with separate graphs for ERα [Figure 
6.34a, green bars], OTR [Figure 6.34b, orange bars] and αSMA [Figure 6.34c, red bars] as well as a 
combined graph shown in Figure 6.34d. The %responders indicate the number of positive cells over 
the total number of nuclei (cells) counted; this is measure of differentiation efficiency. The full 
Cellinsight analysis, including the analysis of all protocols not shown here can be found in Appendix 
B4. 
 
There were 9 protocols in the Early Exit which showed high numbers of surviving cells and had a 
high number of responders for the markers [Figure 6.33]. These protocols were protocol number: 2, 
3, 4, 5, 6, 7, 8, 11 and 17. The variability in the % responding between markers was quite large. The 
overall expression of αSMA (red bars) was low for all protocols. ERα (green bars) showed robust 
expression over all the chosen protocols. OTR expression (orange bars) was variable between 
protocols. Of these 9 protocols, the best protocols with robust expression of the markers were 
protocols 6, 11 and 17. All have strong expression of ERα, with 6 and 11 showing robust expression  
of  αSMA  and  OTR.  Protocol  17  had  a  very  high  number  of  cells,  so  may  not  be   represented 
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accurately, as Cellinsight analysis assumes similar numbers of cells in each well. Therefore, even 
though the marker expression of αSMA and OTR was low, it still seems an efficient protocol. 
Protocols 3 and 4 also had high cell numbers, with robust ERα expression, albeit low αSMA and OTR 
expression. 
 
For the Final Exit 5 protocols were chosen, protocols 11, 17, 19, 23 and 25, mainly due to the fact 
that they had surviving cells [Figure 6.34]. Excitingly, protocols 11 and 17 come up in both the Early 
and Final Exits. Protocol 11 showed the highest expression of all three of the markers; whilst the 
other protocols showed lower, but still reasonable expression of the markers. Again, the expression 
level of the markers was variable, but all three markers were expressed. 
Page | 313  
 
 
FIGURE 6.32. CELL COUNT OF THE VALIDATION  PROTOCOLS 
 
The number of cells in each of the wells was analysed by determination of the number of nuclei 
of appropriate size and shape. Very large and very small nuclei, as well as misshaped or clumps 
of nuclei were disregarded. Some protocols showed very high cell density, which complicated 
accurate analysis of cell number. a) The cell count of all the protocols in the Early Exit. A 
threshold was set to eliminate those protocols with very few cells from further analysis. 
Protocols 2, 3, 4, 5, 6, 7, 8, 11 and 17 had sufficient numbers of cells to allow further analysis. 
b) The cell count of the Final exit protocols. A lower number of cells survived after the final 
stage. This may be due to overgrowth and subsequent loss due to cell death or lifting off of the 
cell sheets or clumps. Protocols 11, 17, 19, 23 and 25 were analysed further. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 6.33. EXPRESSION OF ESTROGEN RECEPTOR-α, OXYTOCIN RECEPTOR, αSMOOTH MUSCLE ACTIN IN THE EARLY EXIT PROTOCOLS 
 
 
The expression levels of the markers ERα (a), OTR (b), αSMA (c) separately and combined (d) normalised over the number of nuclei in each well. The 
protocols shown are those with sufficient cells for accurate analysis. a) ERα shows robust expression in all protocols with 20 – 60% of cells showing ERα 
expression. b) OTR expression is more variable, and the number of OTR positive cells is low in some protocols, but this may be due to the early stage of 
differentiation. OTR was chosen as a marker of more mature cells, and the low expression may reflect this. c) Similar to the results found in the COPAS sort 
the number of αSMA expressing cells was still relatively low at this stage. d) The combination of all the markers shows that protocol 11 has the most robust 
overall expression of the markers, with a large percentage of cells positive for the markers. Protocol 6 also shows a large number of cells positive for ERα 
and OTR, although less positive for αSMA and although protocol 17 has low numbers of positive cells for each of the markers, the high total number of cells 
may represent this less accurately. Page | 314 
  
FIGURE 6.34. EXPRESSION OF ESTROGEN RECEPTOR-α, OXYTOCIN RECEPTOR, αSMOOTH MUSCLE ACTIN IN THE FINAL EXIT PROTOCOLS 
 
The expression levels of the markers ERα (a), OTR (b), αSMA (c) separately and combined (d) normalised over the number of nuclei in each well. The protocols 
shown are those with sufficient cells for accurate analysis. a) ERα shows robust expression in all protocols with 20 – 60% of cells showing ERα expression. b)  
OTR expression is more variable, and the number of OTR positive cells is low in some protocols, indicating that further maturation may be necessary. c) αSMA 
expression had generally increased, with noticeable increases in αSMA positive cells in protocol 11 compared to the early stage. d) The combination of all the 
markers shows that protocol 11 has the most robust overall expression of the markers, with a large percentage of cells positive for the markers. Protocol 19  
also shows a large number of cells positive for ERα although less positive for αSMA and OTR and although protocol 17 has low numbers of positive cells for 
each of the markers, its continuation from the Early Exit makes it interesting to further investigate. 
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6.8.1 SUMMARY OF THE  COMBICULT 
 
 
For the first time the differentiation of human myometrial smooth muscle cells from human 
pluripotent stem cells (ES and iPS) was shown using a novel bead-based combinatorial technique for 
the rapid screening of a large number of protocols, namely CombiCult. The outcome of the 
CombiCult was successful and many beads had cells that were positive for the markers chosen for 
the Early Exit (Estrogen Receptor-α, ERα and αSmooth Muscle Actin, αSMA) and Final Exit (Oxytocin 
Receptor, OTR and αSMA). After initial analysis of the CombiCult 26 protocols were chosen for 
further validation in a 96 well plate set-up seeded with SHEF3 cells. 10 protocols were Early Exit only, 
whilst 16 were continued for the Final Exit. All protocols had at least 1 96 well plate fixed for Early 
Exit analysis. After staining with all three markers (ERα, OTR and αSMA) the wells were imaged and 
the number of cells and positive cells were quantified. There was an unequal number of cells 
surviving in different wells, therefore a threshold of a minimum of 500 nuclei was set. Protocols 
above this threshold were considered for further analysis. For the Early Exit 9 protocols were 
considered (protocols 2, 3, 4, 5, 6, 7, 8, 11 and 17). Of these the protocols with the most robust 
expression were protocols 6, 11 and 17, although 3 and 4 also showed high cell numbers. For the 
Final Exit, 5 protocols were considered (protocols 11, 17, 19, 23 and 25). Of these protocols 11 and 
17 were repeated from the Early Exit, indicating that these may be robust protocols. They showed 
robust expression of all markers, with increased numbers of positive cells for especially αSMA in the 
Final Exit. 
 
Further analysis of the media compositions of these 12 protocols shows that there are similarities 
between the successful protocols [Table 6.5]. For the modelling of more immature myometrial 
smooth muscle cells (the Early Exit), successful protocols started in either media 1.4 or 1.5, whilst for 
the late myometrial smooth muscle cells (Final Exit) media 1.5 was the most successful. During Stage 
2 for both Early and Final Exits media 2.2 was used the most. During Stage III and IV a number of 
media  came  up  (3.1,  3.3,  3.5,  3.6,  3.8  and  4.8  and  4.10  respectively),  indicating  that       some 
6.8 DISCUSSION 
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optimisation of these stages may be necessary. In addition, the expression level of OTR and αSMA is 
still relatively low in a number of protocols, indicating that these may still be relatively immature. It 
may be necessary to optimise the time of the later stages to increase the expression of OTR to more 
closely resemble the term pregnant myometrial smooth muscle cell expression. This may also lead to 
increased expression of αSMA, which showed relatively low expression throughout, although if a cell 
was positive for αSMA it showed robust staining for this marker. 
 
These protocols provide the opportunity for further investigation into the state of differentiation 
of these cells and whether these are more immature or mature. These cells can now be analysed for 
expression of other myometrial markers. Once this has been achieved, these cells can be used for 
future drug studies. 
 
TABLE 6.5. SUCCESSFUL VALIDATION  PROTOCOLS 
 
The most successful protocols from the validation, in bold the protocols with the most robust 
expression of the markers ERα, OTR and αSMA. Protocols 11 and 17 are repeated in both the Early  
and Final Exit. Further analysis of the media compositions of these 12 protocols shows that there are 
similarities between the successful protocols. Most protocols that were successful in the Early Exit 
started either in media 1.4 or 1.5. For the Final Exit, media 1.5 seems to be the most robust. During 
Stage II, media 2.2 seems to be the best, whilst during Stage III and IV a variety of media comes up, 
indicating that some optimisation of these stages may be necessary. 
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LIMITATIONS AND FUTURE DIRECTIONS FOR THE COMBICULT  WORK 
 
 
Due to time constraints it was decided to only include the validation of the SHEF3 line in this 
chapter. Validation of the EhiPS cells is currently in progress. The main limitation of the current 
validation is the change in culture system. The beads provide a 3D structure for the cells to grow on 
and attach to, it is difficult to accurately estimate the amount of cells needed in a monolayer culture. 
Due to the high proliferation of the cells in Stage I it was decided to split the cells at this stage. But 
this may not have been the right time for some of the differentiating cells, which led to the cell  
death and loss of these protocols from the validation, as very few cells survived in some of the wells. 
In addition, some protocols induced sheet formation of the cells or large, dense clusters of cells. This 
may lead to detachment of the cells if they become too dense and the loss of these protocols. For 
future application, a sheet or monolayer of cells or cluster of cells may be more appropriate, so cell 
clustering should also be analysed. The validation of the 26 protocols will be repeated in the SHEF3 
line, with a variety of seeding densities as well as on beads. Based on the validation so far, 12 
protocols seem to show robust cell proliferation and differentiation into myometrial smooth muscle- 
like cells. These protocols can then be optimised to obtain the highest possible yield of differentiated 
cells. It is also important to analyse the cells obtained from these protocols further for other 
myometrial markers and compare the gene expression profiles of these cells to myometrial smooth 
muscle cells from pregnant or non-pregnant individuals. Once the most robust protocols for both 
differentiation exits have been obtained, these can then be used to differentiate cells for drug 
studies. Examples of possible drug studies is the investigation into the effect of labour inducing 
agents, such as pregnancy hormones (Progesterone, Estrogen, Oxytocin), inflammatory cytokines or 
ICP associated bile acids. 
 
There are many advantages to the use of CombiCult for discovery of new protocols for 
differentiation of stem cells into a tissue or cell type of interest, in this case the cells of interest were 
myometrial smooth muscle cells of the myometrium. There are, however, a number of challenges. 
Firstly, the selection of markers is firstly based on those proteins that show high expression in the 
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tissue and are conjunctively solely expressed in the tissue of interest. The difficulty lies in the fact 
that these markers need to be unique to the tissue as a single marker or as a combination and that 
there need to be robust antibodies available. The αSMA antibody and ERα antibody used were 
robust and showed strong expression in the myometrial cells. The OTR antibody was a weaker 
antibody and did not show such robust staining in the myometrial cells and needed to be used at a 
very high concentration (1:50 – 1:100) on the beads to be detected. This could potentially lead to 
difficulties selecting beads for further analysis. Validation was carried out in the first place based on 
the combination of markers separately, but in the second validation, all three markers were used in 
conjunction to select for those cells showing expression of αSMA (first selection) together with ERα 
and OTR. 
 
During the validation it was noted that a large number of protocols showed high expression of 
ERα and low expression of αSMA and OTR. OTR expression remained in the late stage, indicating  
that these cells were not as mature as we hoped they would be. This indicates, that although 
CombiCult can provide information on robust protocols that lead to differentiation of the cells into 
the desired cell type, optimisation of these protocols (timing of the stages, duration of the protocol, 
concentrations of the small molecules) need to be carried out after a number of protocols have been 
selected. 
 
Protein expression can be induced by small molecules or transfection of genetic constructs or 
viruses with the sequence for the protein of interest. Differentiation of the cells using CombiCult is 
based on the use of a combination of small molecules. The more information available on the tissue 
of interest, such as pathways necessary for the development or differentiation of these cells (such as 
the Wnt/TGFβ pathways described in this thesis), the easier it is to generate a robust matrix of small 
molecules which may induce differentiation to the cell type of interest. 
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The number of positive beads differs between types of assays and more or less positive beads 
depend on the success of the differentiation, the antibodies used to select the protocols and the 
number of cells per bead. 
 
The CombiCult described in this thesis used both ES and iPS derived stem cells. At the start of the 
CombiCult, less iPS cells were seeded per bead than originally planned, potentially leading to less 
efficient differentiation and less positive beads. In the subsequent validation only the SHEF3 cells  
(ES) were used. In the second validation, both cell types were used, but again the iPS were less 
robust in differentiation, indicating that the specific cell line (EhiPS) may not be the best line to use, 
and that the original seeding density of the cells needed to be optimised. 
 
Validation is normally carried out on both beads and dishes, as the change in substrate from a 3D 
construct to a 2D dish can induce changes in differentiation efficiency. In addition, estimation of 
seeding density is difficult when changing substrate. 
 
Finally, before the use of these cells for drug treatments, the expression patterns of various 
proteins of interest need to be validated. In addition, to use the cells for various experiments it 
should be possible to split and possibly freeze differentiating cells. The optimal splitting (and 
freeze/thawing) time needs to be optimised after the CombiCult screen and validation. 
 
 
 
 
 
6.8.2 CANCER, PREGNANCY AND THE  MYOMETRIUM 
 
 
The importance of the above development of novel protocols for the differentiation of human 
myometrial smooth muscle cells becomes more obvious in the larger context of not only ICP and 
preterm labour, but also for leiomyoma, also known as uterine fibroids or leiomyosarcoma of the 
myometrium (Di Luigi, D’Alfonso, Patacchiola, et al., 2015; Hayashi, Horiuchi, Sano, et al.; Ciarmela, 
Islam, Reis, et al., 2011). These are benign or malignant growths of the myometrium respectively. 
Leiomyosarcoma are rare, but if a leiomyosarcoma does occur, they can be extremely malignant 
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with a high chance of metastasis, resistance to chemotherapy and recurrence (Di Luigi, D’Alfonso, 
Patacchiola, et al., 2015; Hayashi, Horiuchi, Sano, et al.; Ciarmela, Islam, Reis, et al., 2011). The 
underlying mechanisms that lead to the development of uterine leiomyosarcomas remain to be 
elucidated (Di Luigi, D’Alfonso, Patacchiola, et al., 2015). Uterine fibroids, on the other hand, are 
relatively common benign growths which arise from a single uterine smooth muscle cell (Wallach & 
Vlahos, 2004; Ciarmela, Islam, Reis, et al., 2011). Even though they are benign of themselves, they 
are associated with infertility and recurrent abortion and can lead to complications during pregnancy 
(Walker & Stewart, 2005; Ciarmela, Islam, Reis, et al., 2011). Uterine fibroids have a tendency to 
grow rapidly during pregnancy and can therefore result in obstructed labour, fetal malpresentation 
and fetal anomalies and affected women are at an increased risk of post-partum haemorrhage 
(Walker & Stewart, 2005; Ciarmela, Islam, Reis, et al., 2011). 
 
There are a number of similarities between fibroids and myometrial smooth muscle cells during 
parturition (Walker & Stewart, 2005; Ciarmela, Islam, Reis, et al., 2011). In both fibroids and 
pregnant myometrium cells undergo changes in expression profile leading to altered physiology and 
the ability to contract. In addition, both cell types show high expansion rates and increased 
deposition of extracellular matrix proteins (Walker & Stewart, 2005; Ciarmela, Islam, Reis, et al., 
2011). Fibroids show expression of contraction-associated proteins (CAPs), similar to pregnant 
myometrium. But unlike healthy myometrium, which regresses after the baby has been born, via 
apoptosis and cell dedifferentiation, fibroids do not regress (Andersen, Grine, Eng, et al., 1993; 
Walker & Stewart, 2005; Ciarmela, Islam, Reis, et al., 2011). 
 
Our understanding of preterm labour is still limited and is further complicated by the difficulty of 
obtaining samples of preterm labouring or non-labouring patients. At the other end of the spectrum, 
10% of pregnancies are prolonged and delivery occurs post-dates and this also carries risks for both 
mother and fetus (Arrowsmith, Quenby, Weeks, et al., 2012). Little is known about the aetiology of 
prolonged pregnancy (Arrowsmith, Quenby, Weeks, et al., 2012). Furthermore, labouring samples 
are relatively unresponsive to further stimulation with labour-inducing drugs, such as Oxytocin or 
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cytokines, further complicating drug discovery studies. It would therefore be beneficial to be able to 
study how to induce or prevent labour when it is not clinically appropriate using cellular models of 
human myometrial cells which can be differentiated to different stages using the same protocol. 
 
Finally, our understanding of how the changes in bile acids levels and other hormones in ICP lead 
to preterm labour is still limited. 
 
 
 
 
 
FUTURE  DIRECTIONS  FOR  THE  USE  OF  PLURIPOTENT  STEM  CELL  DERIVED   MYOMETRIAL 
 
SMOOTH MUSCLE CELLS FOR DRUG DISCOVERY OR DISEASE  MODELLING 
 
 
The fact that multiple protocols seem effective at the differentiation into myometrial smooth 
muscle cells may be beneficial, as different studies may require different types of  myometrial 
smooth muscle cells. For example, low expression of αSMA and OTR (like in protocols 3, 4, 17) may 
simulate more early or non-pregnant myometrium and could be used for early pregnancy / preterm 
labour or fibroid studies. A high proliferation efficiency may also be beneficial for  studies  into 
tumour growth (fibroids or leiomyosarcomas) and therefore these protocols may be more 
appropriate for these kinds of studies. Expression profiles of various profiles should first be 
compared to fibroid or leiomyosarcoma profiles. The manner of growth of these cells, in clusters or 
sheets may also be of importance in different studies. Dense cell clusters seen in some protocols  
may better mimic large fibroids or leiomyosarcomas and may be quite useful for the analysis of 
apoptosis in the centre or the efficiency of drugs or nutrients in reaching the inner cells in the 
cluster. Finally, once a comparison has been made with the expression profiles of preterm / term 
labouring samples, protocols with similar profiles can be used for further investigation of preterm 
labour and ICP. The great advantage of the use of pluripotent stem cells, is the reproducibility of the 
cells once an optimised protocol (or protocols) has been obtained and the availability of the cells, 
especially iPS cells which can be obtained commercially and are not under ethical restraints (unlike 
ES cells). As mentioned before, different protocols may be optimal for different applications. It 
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enables the use of human cells for the investigation of human disease, having different protocols will 
provide the opportunity of having different cell types for different drug studies and comparison of 
for example preterm and term-like cells or labouring or non-labouring cells. It circumvents the 
difficulty of obtaining tissue from human sources, reduces variability due to reduced genetic 
variability and it avoids the necessity of extensive culture time which may lead to changed 
expression profiles between tissue and the cells used. It also allows for the genetic modification of 
the expression of abnormal proteins using transfection methods, enabling a more accurate  
modelling of myometrial disease. The use of iPS derived stem cells also allows for the possibility of 
using stem cells differentiated from skin fibroblasts of a patient with pregnancy related problems or 
who has uterine fibroids or cancer. 
 
There are a number of advantages to the use of patient specific iPS derived stem cells. Cell lines 
cannot always be generated from each patient. This would also necessitate the removal of tissue 
from the fibroid or cancer and the collection of this tissue for research purposes (as well as medical 
analysis), which normally would often be done but not always; it would also mean that there has to 
be consents in place for the acquisition of the removed tissue. On the other hand, iPS cell lines can 
be generated from skin fibroblasts of any patient and there are robust reprogramming protocols. 
Potentially, this could mean that a cell line for each patient could be generated and analysis could be 
carried out on cells derived from the patient. For patients with other pregnancy related problems 
this would mean removal of tissue which would not necessarily be done otherwise. 
 
 
 
 
 
6.8.3 BILE ACIDS AND THE  MYOMETRIUM 
 
 
To expand our knowledge into the effects of bile acids on and signalling pathways in the 
myometrium, investigation of the effect of TC on myometrial strip contraction and the expression 
levels of known bile acid responsive receptors was carried out. 
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No significant differences were found in any of the analysed parameters between acute, 
incrementing doses of TC and control. Significant differences over time were found, although this 
may often be due to the reduction in contractions of the myometrium after longer incubation. Some 
parameters showed a significant difference in the effect of Oxytocin (OT); control strips showed a 
significantly larger contraction duration upon OT treatment. The lack of significance found in the 
present study of myometrial strip contraction may be due to the short incubation time compared to 
the study performed by Germain et al. (Germain, Kato, Carvajal, et al., 2003). Further investigation  
of different bile acids (including TCDCA, GCDCA and GC) and longer term incubations (overnight) are 
necessary to obtain a more complete picture with regards to the effect of bile acids on myometrial 
contraction. 
 
The expression levels of bile acid responsive receptors was investigated in myometrial tissue from 
labouring and non-labouring term pregnancies. For those expressed in tissue, the cellular levels 
during culture over multiple passages were investigated, as extensive culture may lead to changes in 
expression profiles of myometrial smooth muscle cells. 
 
Interestingly, the nuclear bile acid receptor FXR was not found in this present study. Similar to 
mouse studies, LXRβ and its binding partner RXR were found to be expressed and showed similar 
expression levels over the culture time investigated (Mouzat, Prod’homme, Volle, et al., 2007). LXRα, 
PPARα and PPARγ were also found to be expressed. 
 
As GPCRs regulate contraction in myometrial smooth muscle cells, various GPCRs were 
investigated. TGR5 is expressed in both tissue and in culture. It will therefore be of interest to 
investigate whether there are any changes in TGR5 expression after treatment with bile acids. 
 
The other GPCRs investigated in this study were the muscarinic receptor subtypes M1 – M5. 
Interestingly no expression was found for M1, M3 and M4, whilst very low levels of M5 were 
detected. This is in contrast to research in animal models which showed that muscarinic receptor 
subtypes are expressed in smooth muscle and in the uterus of both rodents and in the pig   (Schölch, 
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Schölch, Strahl, et al., 2012). In the porcine uterus addition of the cholinergic agonist Carbachol leads 
to strong contractions and the M3 muscarinic receptor is shown to be present by both functional  
and radioligand binding studies (Schölch, Schölch, Strahl, et al., 2012). 
 
 
 
 
 
LIMITATIONS AND FUTURE DIRECTIONS 
 
 
There was a large variability between myometrial strips of different patients, possibly due to the 
difference in muscle of different patients. Some patients had more vessels or fat deposits lining the 
muscle and although care was taken to avoid these when preparing the strips, this was not always 
possible. Additionally, there is always a little variability in the size of the strips, some may be a little 
longer or thicker than others as these strips are generated by hand. In addition, some data had to be 
discarded because the strip had come loose or stopped contracting. It is therefore important to 
obtain data from more patients before any further conclusions can be drawn for this work. In 
addition the effect of other bile acids on myometrial strip contraction may be of interest. It is also 
relevant to investigate the long term (overnight) effect of various bile acids (TC, GC, TCDCA, GCDCA) 
on myometrial strip contraction, as this would more accurately represent the environment of ICP. It 
may also be of interest to investigate whether UDCA has a differential effect on contraction. 
 
Current work in our lab has also focussed on the impact of sulfated Progesterone metabolites in 
ICP (Abu-Hayyeh, Martinez-Becerra, Sheikh Abdul Kadir, et al., 2010; Abu-Hayyeh, Papacleovoulou, 
Lövgren-Sandblom, et al., 2013; Abu-Hayyeh & Williamson, 2015). Sulfated Progesterone  
metabolites are raised in normal pregnancy, but are increased substantially in ICP (Reyes, Sjovall & 
Sjövall, 2000; Abu-Hayyeh, Martinez-Becerra, Sheikh Abdul Kadir, et al., 2010; Abu-Hayyeh, 
Papacleovoulou, Lövgren-Sandblom, et al., 2013). Whether there is a link between preterm labour 
and increased levels of sulfated Progesterone metabolites in combination with bile acids is worth 
investigating. 
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CHAPTER 7: GENERAL DISCUSSION 
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The work presented in this thesis aimed to develop novel cellular models for the investigation of 
fetal arrhythmia and preterm labour with the focus on the effect of bile acids on both mother and 
fetus in ICP. This work can be divided into two parts, the development of novel models for the 
investigation of the effect of bile acids on the fetal heart and for the investigation of the effect of  
bile acids and the expression of bile acid receptors in the myometrium of the mother, with the focus 
on bile acids and preterm labour. 
 
Both parts focus on the development of novel cellular models which can be used for a variety of 
different research projects. In addition, in both fetal heart and myometrium, previous work has 
shown that cholic acid (CA) and conjugates, especially TC can lead to changes in these tissues. In the 
fetal heart this can cause arrhythmias and changes in contraction parameters. In the mother it may 
result in induction of preterm labour due to increased sensitivity to Oxytocin (Gorelik, Harding, 
Shevchuk, et al., 2002; Gorelik, Shevchuk, de Swiet, et al., 2004; Miragoli, Kadir, Sheppard, et al., 
2011; Germain, Kato, Carvajal, et al., 2003). In this thesis the protective effect of UDCA and its 
derivative NorUDCA was shown in the fetal heart. As both the heart and the myometrium are 
contracting muscles, in future studies, the effect of UDCA on the myometrium should be explored,  
as it may be possible to prevent or counteract early contractions in preterm labour with UDCA, not 
only in ICP. However, much needs to be done before it can be proposed for clinical use. UDCA is 
currently in use in ICP for the mother. UDCA treatment leads to a normalisation of bile acids and a 
reduction in itching (Geenes, Lövgren-Sandblom, Benthin, et al., 2014; Chappell, Gurung, Seed, et al., 
2012; Geenes, Chappell, Seed, et al., 2013). No evidence of UDCA toxicity was found in neonatal rat 
cardiomyocytes and myofibroblasts at concentrations reflecting the concentrations crossing over the 
placenta in ICP pregnancies treated with UDCA (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). 
Further work needs to be performed to establish whether the serum levels of UDCA resulting from 
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maternal treatment may in fact not only treat the mother but also protect her child and whether 
these levels of UDCA are sufficient to prevent arrhythmias in the fetus. 
 
 
 
 
 
7.1.1. BILE ACIDS IN THE  FETUS 
 
 
Chapters 3, 4 and 5 describe the work carried out to develop novel models of the human fetal 
heart and the effect of bile acids on these. Chapter 3 describes the development and 
characterisation of two human models of the fetal heart, which included the use of human fetal 
cardiomyocytes from fetal tissues. It was possible, for the first time, to obtain beating 
cardiomyocytes which were subsequently used for optical recording studies. Subsequently,  the 
effect of bile acids on the cardiomyocytes of the fetal heart models were investigated and the 
influence of myofibroblasts on this. The effect of arrhythmogenic and protective bile acids can be 
divided into the effect on the cardiomyocytes and on the myofibroblasts. Changes in myofibroblasts 
may lead to sensitisation of cardiomyocytes to arrhythmias; therefore, the elucidation of the effect 
of bile acids on myofibroblasts was focussed on in Chapter 4. When the dishes used for optical 
recording of the human fetal cardiomyocytes were stained with α-Actinin (for CMs) and αSMA (for 
MFBs), it became clear that there was a large natural contamination of myofibroblasts in these 
dishes due to the longer culture period compared to the rat work. In addition, as described in 
Chapter 4, most of the human fetal fibroblasts were myofibroblasts; in normoxia almost 80% were 
αSMA positive. This reflects the circumstances found in the human fetal heart, where a transient 
increase in myofibroblasts was found; further validating the use of both neonatal rat cardiomyocytes 
and myofibroblasts in the rat model of the fetal heart (Miragoli, Kadir, Sheppard, et al., 2011). 
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The interaction between cardiomyocytes and myofibroblasts was further investigated in  Chapter 
 
5. Previous work indicated that myofibroblasts can form gap junctions with adjacent cardiomyocytes 
in both the adult heart and in neonatal co-culture models. This contributes to cardiomyocyte 
depolarization, impulse propagation slowing and ectopic activity (Camelliti, Devlin, Matthews, et al., 
2004; Miragoli, Gaudesius & Rohr, 2006; Miragoli, Salvarani & Rohr, 2007). Cx43 plays an important 
role in establishing electrical coupling, but its involvement in the dynamics of heterocellular coupling 
has never been investigated in live cells, due to the limit of the nanoscale resolution. Scanning Ion 
Conductance Microscopy (SICM) can be used to overcome this limit. SICM is a non-invasive method 
capable of resolving the dynamics of live cell-to-cell contact between neonatal rat cardiomyocytes 
and myofibroblasts. 
 
 
 
 
 
7.1.2. BILE ACIDS IN THE  MOTHER 
 
 
Maternal complications of ICP are generally less severe than those of the fetus. Although mothers 
with ICP may call the pruritus a major complication, as the severity of the itch can be very distracting 
and frustrating, especially at night and it is very difficult to alleviate the itch even with creams or 
drugs. On the other hand, the itch is not life-threatening in itself and often disappears quickly after 
delivery of the baby, although some women experience menstrual cycle induced itch (Geenes & 
Williamson, 2009). But high serum bile acid levels can lead to spontaneous preterm labour, which 
can have devastating effects on the health of the baby (Glantz, Marschall & Mattsson, 2004; 
Lammert, Marschall, Glantz, et al., 2000; Geenes, Chappell, Seed, et al., 2013). In addition, in the 
normal population preterm labour and delivery occurs in about 10% of all deliveries and is  
associated with an increased risk of morbidity and mortality (Terzidou, 2007; Goldenberg, Culhane, 
Iams, et al., 2008b, 2008a). 
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The contracting muscle of uterus, the myometrium, may be influenced by bile acids and  
therefore the expression levels of bile acid receptors was investigated in myometrial tissues and cells 
in Chapter 6. A number of bile acid receptors were found to be expressed, whilst the bile acid  
nuclear receptor FXR was not. Further study into expression levels after bile acid treatments should 
be pursued. The effect of incremental doses of TC on the contraction of myometrial strips was also 
studied and although no clear differences between TC and control were found, further investigation 
of long term TC treatment may provide information with regards to the effect of TC on myometrial 
strips. 
 
The development of novel protocols for the differentiation of myometrial smooth muscle cells 
have also been described in Chapter 6. A number of protocols have been highlighted for further 
investigation, whereby the differentiation will be repeated and the cells collected for mRNA and 
protein analysis of various myometrial markers. These protocols can then be used to obtain cells for 
functional studies, including various drug treatments. It is of importance to note that the focus of  
the study, whether it is preterm labour, delayed labour or cancer, may determine which protocol is 
the most suitable for the work. It is therefore possible that multiple protocols will be investigated 
further. 
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7.2.1. THE USE OF CELLULAR MODELS FOR THE STUDY OF THE WHOLE FETAL HEART 
 
 
In this thesis, the fetal heart work was carried out using cellular models of the fetal heart. These 
models provide valuable information with regards to the effect of bile acids on cardiomyocytes and 
fibroblasts from human fetal and neonatal rat hearts, as well as CDI. However, it is important to 
consider to what extent that this 2-dimensional model reflects the reality of a whole heart in situ. 
Whilst studies using optical recording of whole fetal or neonatal rat hearts are challenging, they have 
been carried out in our lab and will shortly be published (O. Adeyemi et al.). The work currently 
presented for the CDI cells consists of the CDI model only, Optimisation of the CDI model in 
combination with human fetal fibroblasts is currently in progress due to the availability of ‘fresh’ 
human fetal tissue and the fact that these human fetal fibroblasts can be cultured. Both the CDI and 
human fetal cardiomyocytes showed increased sensitivity of to TC. A reduction in the concentration 
of TC will be necessary to provide an accurate picture of the effect of this bile acid on human 
cardiomyocytes, as an overly high dose will lead to the cessation of beating and therefore of 
recordable calcium transients or action potentials. 
 
A number of models of the fetal and adult heart were used. Human models of the fetal heart 
were developed in order to reduce the number of animals used and to reduce the use of neonatal 
rat cardiomyocytes and fibroblasts derived from newborn rats. Two novel models of the human  
fetal heart were developed and these were compared to the previously described neonatal rat 
models of the fetal/maternal heart, consisting of cardiomyocytes and fibroblasts or cardiomyocytes 
only respectively. For the first time we obtained beating cardiomyocytes from human fetal tissues 
from terminations of pregnancy due to scan or genetic abnormalities [detailed in table 2.4]. 
 
There are however, some limitations associated with the tissue obtained from these fetuses, as 
there could potentially be structural abnormalities of the heart due to the genetic anomalies; in 
addition trisomy 13, 18 and 21 are known to cause an increased risk of heart defects and  congenital 
7.2.  STUDY LIMITATIONS 
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heart disease (Yates, Hoffman, Shepherd, et al., 2011; Costello, Weiderhold, Louis, et al., 2015; 
Meyer, Liu, Gilboa, et al., 2015; Stoll, Dott, Alembik, et al., 2015). However, the work obtained with 
these cells would still bring valuable knowledge with regards to the effect of bile acids on human 
fetal cells. For the work carried out in this thesis, it has been assumed that cells from these trisomic 
hearts react in the same manner as euploid cells would. The fact that these cells show similar 
expression of markers such as αActinin to the neonatal rat cardiomyocytes and CDI, and show similar 
responses to bile acids indicates that this may well be the case. It is, however, important to in future 
obtain tissue from hearts with no known pathology to confirm this. Therefore, human 
cardiomyocytes derived from induced pluripotent stem cells were used (CDI) to model human fetal- 
like heart cells (Chapter 3), although these cells are reprogrammed from stem cells and are not 
necessarily the same as fetal cells, they are structurally and functionally immature and more similar 
to the human fetal and neonatal cells described here than to adult cardiomyocytes. 
 
Finally, the neonatal heart models were used to expand upon the research first published in 2011 
by Miragoli et al. (Miragoli, Kadir, Sheppard, et al., 2011) and these models were used to compare 
the human models to. Neonatal rat cells were derived from a different species with different 
gestations and different heart development and which at least for a postnatal day experienced a 
different environment than the fetus. These cells may also have different sensitivity to bile acids 
compared to human fetuses. In addition, these cells were used for the contact modelling described 
in Chapter 5. This was done due to the fact that there is a limited amount of human fetal tissue and 
therefore human fetal cells available. In addition, the isolation of neonatal rat cells is robust and 
neonatal cardiomyocytes and fibroblasts have been used to model the borderzone and interactions 
between the cell types previously (Miragoli, Gaudesius & Rohr, 2006; Miragoli, Salvarani & Rohr, 
2007; Gaudesius, Miragoli, Thomas, et al., 2003; Kohl & Gourdie, 2014). Neonatal cells were used, as 
these can be plated in monolayers and these can still form functional contacts. The adult 
cardiomyocytes on the other hand can usually only be found as single cells after isolation and would 
not normally form functional gap junctions with other cardiomyocytes or fibroblasts. 
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7.2.2. THE LONG TERM CULTURE OF  FIBROBLASTS 
 
 
The human fetal and human adult fibroblasts are kept in culture for a long period of time, due to 
the sparseness of the tissue and the slow proliferation of the human adult fibroblasts. It is difficult to 
obtain sufficient quantities of cells for mRNA or protein analysis. Therefore, in the first instance the 
focus was on the functional studies of the various fibroblasts, which requires fewer cells. It is 
important to understand whether the long culture period introduced any phenotypic changes in 
these fibroblasts. The first study of the αSMA positive cell number was carried out with passage 1 
human fetal and passage 2 – 3 human adult fibroblasts, which should still reflect the populations 
found in the heart. 
 
The adult rat control and neonatal rat fibroblasts were obtained regularly, as there is a sufficient 
number of animals being prepared for other cardiac work every week. It is therefore not necessary  
to cultivate these fibroblasts for longer than 1 -2 weeks at a time. Only a few MI rats have been  
used, but these were also kept in culture for a relatively short time to ensure there were few to no 
phenotypic changes from the phenotype found in the MI heart. 
 
 
 
 
 
7.2.3. THE   USE   OF   TERM  NON-LABOURING   TISSUE   FOR   THE   INVESTIGATION   OF 
 
PRETERM LABOUR 
 
 
Most work carried out on the myometrium is carried out with non-labouring tissue from term 
control patients, who undergo a caesarean section for breech presentation or for previous sections. 
How much does this reflect the myometrium from preterm tissues or from pregnancies complicated 
with ICP or other problems? The advantage of these tissues aside from availability, is that unlike 
labouring tissues, they are still responsive to stimulation by labour inducing drugs and cytokines. This 
allows for the mimicking of the induction of labour using various drugs and to see the interaction of 
bile acids with labour inducing cytokines or drugs like Oxytocin. 
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7.2.4. THE   DEVELOPMENT   OF   PROTOCOLS   TO   GENERATE   MYOMETRIAL   SMOOTH 
 
MUSCLE CELLS GENERATED FROM STEM  CELLS 
 
 
The first validation of a selection of protocols obtained from the CombiCult has currently been 
carried out only in the SHEF3 cell line. This cell line was chosen for the first validation, as sufficient 
cells were available and the majority of protocols were derived from SHEF3 cells. The difficulty of 
changing from a 3-dimensional (beads) to a 2-dimensional culture substrate (dishes), is that it makes 
the estimation of the correct number of starting cells more difficult. In this validation, the cells 
proliferated rapidly during the first Stage, leading to the decision to split all protocols after Stage I, 
instead of after Stage II. This may not have been optimal for all differentiating cells, leading to the 
loss of a number of protocols due to the loss of sufficient cell numbers to compare these protocols 
accurately to those that had sufficient cells. It will be necessary to repeat the validation in a 2D and 
3D setup with varying cell densities to optimise the number of cells for the SHEF3, before any 
functional or expression studies are carried out. 
 
It is also necessary to perform these validations in the EhiPS cell line, as it would be more 
convenient to use iPS derived stem cells rather than embryonic stem cells. This is for ethical reasons, 
as these human embryonic stem cells would not be available to labs around the world. Human iPS 
derived stem cells, on the other hand, are commercially available. Furthermore, the use of iPS 
derived stem cells would allow for the possibility to differentiate stem cells obtained from the skin of 
a patient, who either has previously had preterm, or post-date pregnancies or has uterine fibroids or 
leiomyosarcomas. This would allow for a closer genetic background for the differentiated cells than 
commercially obtained iPS cells. 
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7.3.1. BILE ACID SIGNALLING IN THE FETAL   HEART 
 
 
In this thesis it was shown that CDI alone are already sensitive to TC induced arrhythmias. When 
coupled with fibroblasts this sensitivity may lead to complete cessation of beating and therefore no 
optical recordings of action potentials or calcium transients can be obtained. It is therefore prudent 
to reduce the concentration of TC to levels more closely reflected by the levels found in the fetus 
(Geenes, Lövgren-Sandblom, Benthin, et al., 2014). At the start of this work, the levels found in the 
fetus were not published yet and 0.1 mM TC was chosen as it would be sufficiently high to show  
clear differences and was still within the range of bile acids found in ICP. The fact that human 
cardiomyocytes from human fetal tissue and CDI are more sensitive to TC than rat cardiomyocytes 
may be due to differences between species and the fact that the neonatal rats were born whilst the 
fetal cardiomyocytes were still developing in utero. The CDI are more similar to fetal cardiomyocytes 
than adult cardiomyocytes, which may be why they reflect the fetal sensitivity to TC. 
 
In ICP pregnancies treated with UDCA, there is a significant increase in circulating UDCA and 
derivatives (Geenes, Lövgren-Sandblom, Benthin, et al., 2014). In this work the focus was on the 
effect of UDCA and NorUDCA. It would be of interest in future to investigate the effect of glycine- 
and taurine-conjugated UDCA. Preliminary work using the voltage sensitive dye DIBAC4(3) indicated 
that TauroUDCA may have a concentration dependent effect on neonatal rat myofibroblasts. This 
differential effect needs to be investigated further, but may be due to the taurine conjugation. 
 
The elucidation of the mechanisms of action of UDCA and NorUDCA in cardiomyocytes and 
myofibroblasts has been expanded upon in this thesis. Additional evidence that UDCA and NorUDCA 
act upon the KATP channels of myofibroblasts has been provided here. Further work is still necessary 
in order to elucidate the effect of UDCA and NorUDCA on each of the subunits of these channels and 
the influence of hypoxia on these channels. The electrophysiology of these channels and the effect  
of UDCA and NorUDCA should be further investigated. 
7.3.  FUTURE DIRECTIONS 
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The characterisation of human fetal cardiomyocytes should be expanded upon, to investigate the 
expression levels of bile acid receptors like TGR5 in these cardiomyocytes. Previous work showed the 
expression of a number of bile acid transporters in fetal cardiomyocytes and the expression of FXR 
and the Muscarinic M2 receptor was described in neonatal rat cardiomyocytes, but not much is 
known about the expression of these receptors in the human fetal cardiomyocytes and should be 
investigated (Gorelik, Patel, Ng’andwe, et al., 2006; Kadir, Miragoli, Abu-Hayyeh, et al., 2010). The 
work presented here focussed on the effect of TC on cardiomyocytes and myofibroblasts, but this is 
not the only bile acid found to be elevated in maternal serum and fetal cord blood (Geenes, Lövgren- 
Sandblom, Benthin, et al., 2014). Although both glycine- and taurine-conjugated CA and CDCA were 
found to be raised in both maternal and fetal serum samples, the ratio between these two 
conjugates is altered more towards the taurine-conjugates. It would therefore be of interest to 
investigate the effect of TCDCA, but also GC and GCDCA on the neonatal rat, human fetal 
cardiomyocytes or CDI. 
 
In this thesis optical recording of calcium transients of CDI and human fetal cardiomyocytes alone 
have been carried out. The analysis of action potentials and conduction velocity in these 
cardiomyocytes should provide further insight into the arrhythmic effect of TC and protection 
provided by UDCA for these cells, as this has previously only been shown in neonatal rat 
cardiomyocytes (Miragoli, Kadir, Sheppard, et al., 2011). This work should also be expanded upon to 
include optical recording of calcium transients and action potentials after treatment with TCDCA, as 
this conjugate is a principal bile acid that is raised in maternal serum in ICP (Geenes & Williamson, 
2009; Geenes, Lövgren-Sandblom, Benthin, et al., 2014). Preliminary work in our group indicated  
that TCDCA induces calcium transient prolongation and changes in beating rate similar to TC. These 
were reduced by partial knockdown of TGR5 using siRNA. TGR5 expression was found to be low in 
the neonatal rat cardiomyocytes and myofibroblasts, but knockdown studies using siRNA indicate it 
may be involved in TCDCA induced changes in calcium transients and beating rate. This work is 
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currently ongoing and the abolishment of TGR5 using a TGR5 knock-out mouse will allow us to 
further investigate the involvement of TGR5. 
 
The fact that both the human fetal cardiomyocytes and CDI, but not the adult cardiomyocytes 
express TGR5 may be worth investigating further. It may be that TGR5 is also involved in fetal 
arrhythmias, via other mechanisms or due to other bile acids than those described in this thesis. 
TGR5 is a GPCR, whose activation will lead to changes in cAMP in the cell. Förster Resonance Energy 
Transfer (FRET) analysis using transgenic neonatal mouse cardiomyocytes and fibroblasts expressing 
a fluorescent sensor containing the EPAC1 domain or human fetal cardiomyocytes transfected with a 
virus containing the EPAC2 domain to detect changes in cAMP can be used to this end (Nikolaev, 
Bünemann, Schmitteckert, et al., 2006; Miragoli, Moshkov, Novak, et al., 2011; Nikolaev, Moshkov, 
Lyon, et al., 2010). This sensor consists of two fluorophores, cyan and yellow fluorescent proteins 
(CFP and YFP respectively) connected by a hinge containing the cAMP binding domain (EPAC1 or 
EPAC2) [Figure 7.1]. When there are low levels of cAMP the fluorophores are in close proximity to 
each other and CFP can donate energy to YFP upon excitation, this is regarded as ‘high FRET’. Upon 
stimulation of a GPCR cAMP is produced, this leads to an increase in cellular cAMP levels and 
therefore to the binding of cAMP in the binding pocket on the FRET sensor, inducing a 
conformational change leading to distancing of the two fluorophores. This leads to a reduction in the 
energy transfer and therefore leads to low FRET. This can be measured using a camera and beam 
splitter, with separate filters for CFP and YFP by analysing the ratio between the two fluorophores. 
 
 
 
 
 
7.3.2. DIFFERENTIATION OF STEM CELLS INTO MYOMETRIAL SMOOTH MUSCLE   CELLS 
 
 
After the initial CombiCult, a number of protocols were selected for further validation. The work 
in this thesis only describes the initial validation of the SHEF3 cells. Additional validations using the 
EhiPS cell line are currently under way. Once the validation and optimisation of a select number of 
protocols  is  complete,  these  cells  can  be  characterised  using  immunofluorescence  microscopy, 
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mRNA and protein analysis using markers of myometrial smooth muscle cells described in literature. 
It is important to consider differential gene expression of myometrial smooth muscle cells derived 
from the upper or lower segment of the uterine incision, or from term and preterm samples 
(Charpigny, Leroy, Breuiller-Fouché, et al., 2003; Mosher, Rainey, Bolstad, et al., 2013; Havelock, 
Keller, Muleba, et al., 2005). This would allow for the selection of appropriate protocols for term or 
preterm myometrial smooth muscle cells. 
 
Once these protocols have been evaluated, additional drug discovery studies can be carried out. 
Firstly, the analysis of the expression of previously mentioned bile acid receptors, in this case 
including FXR, LXR, PPAR, TGR5 and Muscarinic receptors would provide information on whether 
these cells express the receptors similarly to the primary smooth muscle cells, or show differential 
expression. Subsequently, it would be possible to investigate the effect of bile acids on these cells by 
analysis of changes of these receptors in comparison to the results obtained from primary 
myometrial smooth muscle cells. In addition, these cells can also be used for the investigation of 
various other hormones, including Progesterone or Estrogen metabolites which have recently been 
shown to be elevated in ICP pregnancies and can interact, at least in the liver, with FXR (Abu-Hayyeh 
& Williamson, 2015; Abu-Hayyeh, Papacleovoulou, Lövgren-Sandblom, et al., 2013; Abu-Hayyeh & 
Williamson, 2014). 
 
Myometrial smooth muscle cells are contractile cells, which show calcium transients and action 
potentials of a much larger scale than previously mentioned for cardiac cells (Shmygol, Blanks, Bru- 
Mercier, et al., 2007). It is possible to map these transients but due to the longer duration of each 
contraction, it is necessary to expose these primary smooth muscle cells to light for longer, which 
increases the risk of bleaching of the cells. It would be of interest to obtain information on the ability 
of the stem cell derived myometrial smooth muscle cells to contract and whether these cells have 
action potentials or calcium transients, on a similar scale to those in myometrial smooth muscle cells 
or of a shorter duration, which would be more easily analysed. 
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7.3.3. BILE ACID SIGNALLING IN THE  MYOMETRIUM 
 
 
The work presented in this thesis was carried out with cells isolated from control term tissues and 
mRNA isolated from term labouring and non-labouring tissue. A small number of stored frozen 
tissues from ICP patients are available and it will therefore be of interest to validate the expression 
levels of TGR5 and other bile acid receptors described in this thesis in these tissues. This would be 
best carried out after validation of expression level changes of these receptors after treatment of 
control myometrial smooth muscle cells with TC or TCDCA. 
 
The continuation of the myometrial contraction studies is also of interest, including the longer- 
term effect of TC, or TCDCA, or other bile acids, or even sulfated Progesterone metabolites, which 
were found to be raised in ICP (Abu-Hayyeh, Papacleovoulou, Lövgren-Sandblom, et al., 2013; Abu- 
Hayyeh & Williamson, 2015). In addition, the myometrium is also a contracting muscle; as with the 
heart, it may be of interest to study the effect of UDCA and NorUDCA on the contraction of these 
cells. 
 
If there is a differential expression of TGR5 after treatment with bile acids, the function of TGR5 
could be further investigated using the FRET based system described in the previous section by 
analysis of cAMP production induced by stimulation of the TGR5 receptor [Figure 7.1]. Human 
primary myometrial smooth muscle cells isolated from control and potentially ICP pregnancies could 
be transfected with the EPAC2-camps virus and FRET based studies using bile acids could be carried 
out. Once validated and optimised protocols have been obtained from the CombiCult, the cells 
differentiated from these protocols could also be analysed for TGR5 expression and if there is 
expression of TGR5, cAMP production could be analysed. 
 
OTR is also a GPCR, which can induce changes in cAMP levels. Induction of changes after bile acid 
treatment can also be analysed using this FRET based system in primary myometrial smooth muscle 
cells as well as stem cell derived myometrial smooth muscle cells. 
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FIGURE 7.1. SCHEMATIC OF THE FLUORESCENT SENSOR USED FOR FÖRSTER RESONANCE 
ENERGY TRANSFER (FRET) 
 
Receptor activity can be measured by analysis of the production of cAMP by EPAC1 / EPAC2- 
camps, a set of Förster Resonance Energy Transfer-based cAMP sensors which are either 
expressed in a transgenic mouse or can be transfected by virus or plasmid introduction. A 
conformational change of the sensor occurs when cAMP binds, which leads to the prevention of 
energy transfer of CFP to YFP. Based on (Nikolaev, Moshkov, Lyon, et al., 2010; Nikolaev, 
Bünemann, Schmitteckert, et al., 2006). 
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7.4.1. TREATMENT OF THE FETUS IN ICP AND ADULT CARDIAC    DISEASE 
 
 
This thesis presents further evidence that bile acids can induce changes in cardiomyocytes and 
fibroblasts in vitro that could potentially lead to fetal death and arrhythmia. For the first time a novel 
model of human fetal cardiomyocytes and fibroblasts isolated from fetal tissue from surgical 
terminations of pregnancy due to genetic or scan abnormalities was used. It was shown that TC 
induced calcium transient abnormalities and that at the high concentration used here the human 
cardiomyocytes stopped beating. Further work needs to be carried out using lower concentrations of 
TC, to investigate the action potential properties and beating rate of these cells. 
 
It was also shown here that UDCA, at concentrations found in the fetus after UDCA treatment, 
can protect against the arrhythmic effect of TC . This indicates that the fetus in ICP, whose mother 
receives UDCA treatment, may already experience partial (or full) protection against arrhythmia. 
Further work needs to be done before treatment of the fetus with UDCA is realistic. 
 
Similarly, this thesis shows that UDCA may be effective at prevention of myofibroblast 
differentiation of human fetal and human adult fibroblasts, as well as neonatal rat and adult rat 
fibroblasts. 
 
The use of UDCA to treat adult cardiac disease may also be of interest to investigate, as reduced 
myofibroblast differentiation could prevent excessive ECM deposition, which could lead to reduced 
scar formation or growth of the scar after it has been formed. However, too little fibrosis and 
scarring would mean that the cardiac wall would become too thin thereby leading to increase risk of 
rupture. The timing of UDCA treatment may therefore be critical, so as to ensure a sufficiently thick 
scar is formed but not excessively. Additionally, if further expansion of the scar border zone can be 
reduced or prevented, taken together with the hyperpolarising effect of UDCA on (myo)fibroblasts, 
this could reduce arrhythmias in the border zone. 
7.4. CLINICAL IMPLICATIONS 
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7.4.2. PRETERM LABOUR AND ICP 
 
 
The work in this thesis describes the expression of bile acid receptors and the effect of bile acids 
on myometrial strips. More work needs to be carried out to acertain whether TC and other bile acid 
induce changes in contraction properties of the myometrium and whether UDCA or NorUDCA could 
potentially prevent these changes. Further investigation into the changes in expression of bile acid 
receptors and labour associated proteins after bile acid treatment is also necessary before 
correlations to preterm labour in ICP can be made. If further evidence can be provided that UDCA 
may provide an effective treatment, this may be of clinical relevance. 
 
The use of stem cell derived myometrial cells, especially if these can be generated from iPS 
derived stem cells, potentially from patients, could provide further information on patient specific 
causes of preterm labour or other pregnancy related disease. But much work is necessary before this 
is the case. 
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The work presented in this thesis provides new insight into the effect of bile acids on the fetal 
heart, with the focus on the development of novel cellular models of the human heart. For the first 
time beating human fetal cardiomyocytes were isolated in our lab. The characterisation of human 
fetal cardiomyocytes and CDI was carried out using immunofluorescence staining of cardiac markers, 
which show changes upon maturation of the heart. Both the CDI and human fetal cardiomyocytes 
show an immature phenotype of these markers, similar to the neonatal rat cardiomyocytes. Optical 
recording of human fetal cardiomyocytes containing naturally occurring myofibroblasts showed that, 
similar to the neonatal rat model of the fetal heart, TC leads to calcium transient duration 
prolongation which can be prevented by UDCA. This provides the first insight into the effect of bile 
acids on cardiomyocytes and myofibroblasts, although further work needs to be carried out. 
Subsequently, further work into the elucidation of the mechanism of action of UDCA was carried out 
in myofibroblasts from human and rat hearts. Further insight into the interaction of cardiomyocytes 
and myofibroblasts was also provided using SICM as a non-contact, high-resolution method for the 
visualisation of live contact dynamics between the cell types. It was shown that Cx43 is involved in 
this interaction and that the cardiomyocytes and myofibroblasts are functionally coupled by GJs. 
 
Furthermore, work presented in this thesis provides further insight into the expression bile acid 
receptors in the myometrium, by providing evidence of the expression of various bile acid sensitive 
receptors, including the GPCR TGR5. However, more work needs to be performed to investigate 
which bile acid receptors are involved in bile acid signalling in these cells. Finally, for the first time, 
novel protocols were developed for the differentiation of myometrial smooth muscle cells. These 
protocols need to be further validated, but when finalised will be able to provide the ability to 
differentiate human pluripotent stem cells into myometrial smooth muscle cells at different stages  
of maturity. This can provide the basis for cellular models for the research of not only preterm and 
term labour, or post-date pregnancy, but also for research into the aetiology and treatment of 
uterine cancers, both benign fibroids and malignant leiomyosarcomas of the myometrium. 
7.5.  FINAL CONCLUSIONS 
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Prof. Nigel Bunnett’s rabbit antibody was used for all TGR5 staining shown, it will be in future 
referred to as NB antibody, whilst the Secondary only (Alexa-Fluor488 donkey-anti-rabbit) was used 
as a negative control. Figures are representative images of TGR5 and DAPI. In contrast to the 
antibody used previously by Sheik Abdul Kadir et al. (2010), this antibody did detect TGR5 in the 
neonatal rat cardiomyocytes and fibroblasts, as this was only single staining, it is not possible to 
discern with certainty which cell type these are. [Figure A1.1] (Kadir, Miragoli, Abu-Hayyeh, et al., 
2010). In addition, in our lab expression of TGR5 RNA was shown in both neonatal rat 
cardiomyocytes and fibroblasts, although the expression level was very low [unpublished data].  
TGR5 was also detected in human fetal cardiomyocytes and fibroblasts, again due to natural 
contamination of fibroblasts, it is not certain which cells these are [Figure A1.2]. 
APPENDIX A: TGR5 AND THE  HEART 
APPENDIX A1: TGR5 IN CARDIOMYOCYTES &   FIBROBLASTS 
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FIGURE A1.1. TGR5 WAS DETECTED IN 
NEONATAL RAT CARDIOMYOCYTES 
 
Localisation of TGR5 in cultured neonatal rat 
cardiomyocytes. Neonatal rat CMs were cultured 
as described previously and fixed in Methanol 
before staining with the NB antibody provided by 
Prof. Nigel Bunnett (rabbit; secondary: donkey- 
anti-rabbit-488).  Scale bar:  20  µm  (top) and 15 
µm (bottom 3 sets). Contrary to previously 
published work, TGR5 localisation was shown in 
neonatal rat CMs. 
FIGURE A1.2. FOR THE FIRST TIME, TGR5 WAS 
DETECTED IN HUMAN FETAL  CARDIOMYOCYTES 
 
Localisation of TGR5 in cultured human fetal 
cardiomyocytes. Human fetal CMs were cultured as 
described previously and fixed in Methanol before staining 
with: a) the NB antibody provided by Prof. Nigel Bunnett 
(rabbit; secondary: donkey-anti-rabbit-488) or b) the 
secondary antibody only. Scale bar: 20 µm. 
For the first time localisation of TGR5 was shown in 
human fetal CMs. 
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Work carried out as part of an MRes project by Susana Teixeira e Rodrigues Ramos. Methods and 
results are reproduced with permission for additional information to results presented in Chapter 3. 
 
 
 
 
 
B1.1 METHODS: IMAGING OF T-TUBULE STRUCTURES BY CONFOCAL   MICROSCOPY 
 
 
Neonatal cardiomyocytes from pups post-natal day 2, day 8, day 12 and day 18 were isolated as 
described in the Method section. T-tubule structures were visualised by staining the cardiomyocytes 
from day 2, 8, 12 and 18 pups with the membrane dye Di-8-ANEPPS (4-(2-[6-(Dioctylamin)-2- 
naphthalenyl] ethenyl)-1-(3-sulfopropyl) pyridinium inner salt; Biotium Bioscience, Germany). Di-8- 
ANNEPS (10μM) was diluted in 1 ml of Ca2+-free FRET buffer, pre-heated to 55°C to increase  
solubility and sonicated for 1 minute. Cardiomyocytes were washed with FRET buffer before adding 
1ml of Di-8-ANNEPS solution for 1 minute. The dye was removed and the cardiomyocytes were 
washed before adding 500 μl of FRET buffer and adding NucBlue® Live ReadyProbes® Reagent (2 
drops/ml; Life Technologies, USA) to counterstain the nucleus. Cardiomyocytes were imaged using a 
Zeiss LSM780 Laser Scanning Confocal Microscope (Carl Zeiss, Germany) equipped with a Zeiss DIC 
Plan-Apochromat x63 oil-immersion lens (numerical aperture 1.4; Carl Zeiss, Germany) using an 
Argon laser (exitation / emission: 488nm / 619nm). Images were processed using the ZEN 2011 
software package (Carl Zeiss, Germany). T-tubule density and regularity were calculated using  
ImageJ 1.46 (ImageJ, USA) and MATLAB software (The Mathworks Inc., USA), respectively. Analytical 
procedures were adapted from previous publications (Wei et al., 2010; Ibrahim et al., 2013). 
APPENDIX B1: ANALYSIS OF T-TUBULE STRUCTURES IN NEONATAL RAT 
CARDIOMYOCYTES 
APPENDIX B: THE TRANSVERSE (T)-TUBULE: A STUDY OF VENTRICULAR 
CARDIOMYOCYTE TUBULATION 
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B1.2 T-TUBULE STRUCTURE IN NEONATAL RAT  CARDIOMYOCYTES 
 
 
T-tubule density and regularity was quantified during postnatal development of cardiomyocyte 
differentiation by obtaining high-resolution confocal images of neonatal rat CMs and subsequent 
visualisation of the developing t-tubule structural systems in 3-dimensional images (dN2 to 18). For 
every cell (n=8 for each age), binary images were produced from five arbitrarily selected XY slices in 
each z-stack. Rectangular areas of 21.5.85.5 pixels were excised for densitometric analysis. 
Waveforms (or intensity profiles) were generated and converted into power of regularity peaks  
using a custom-written MATLAB script (Dr. Cesare M. Terracciano and Dr. Michael Ibrahim), which 
enabled the Fast Fourier transformation of di-8-ANEPPS signals. The mean threshold of pixel  
intensity (percentage, %) was used to measure t-tubule density and mean t-tubule power (TT power) 
for regularity, as a quantitative index of system organisation (arbitrary units, AU). 
 
At dN2, CMs were devoid of sarcolemmal invaginations [Figure B1.1a], hence no intensity profiles 
or regularity peaks are shown in Figure B1.1b. At dN8 and dN12 rudimentary t-tubule structures 
became apparent, this can be seen as by punctuate and fragmented di-8-ANEPPS staining [Figure 
B1.1a]. These structures showed maturation with increasing age and by dN18 striated t-tubule 
systems were observed [Figure B1.1a]. No statistically significant differences were observed (P>0.05) 
between the densities of dN8 (6.47±1.51%; n = 8) and dN12 (8.77±2.36%; n = 8). Significant increases 
were, however, observed at dN18 whereby t-tubules showed a density of 24.25 ±6.63% (n = 8) (dN8 
vs. dN18, P≤0.01; dN12 vs. dN18, P≤0.05) [Figure B1.1b]. Quantification of t-tubule regularity  
showed concurrent increases between dN8, dN12 and dN18. Increases in wavelength amplitude and 
the establishment of the oscillating pattern of intensity at dN18 are indicative of t-tubule  
maturation. The singular and elevated peak of regularity observed at dN18 corresponds to a 
relatively organised and regular t-tubular system, contrasting with the diminished peaks observed at 
dN8 and dN12. dN18 peaks of regularity are similar to those found in adult rat CMs and exhibits the 
strongest TT power (4.63±0.7 AUx106; n = 8), although these are still not fully mature as both the 
density and regularity of t-tubules remained significantly lower than in adult rat CMs (P≤0.05 and 
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P≤0.01, respectively; unpaired t-test) [Figure B1.1c]. Regularity peaks of intermediate ages were 
significantly weaker with 0.84±0.17 AUx106 at dN8 (P≤0.0001; n = 8) and 1.65±0.85 AUx106 at dN12 
(P≤0.01; n = 8). At dN18, the transition from triangular to rectangular (or rod-shaped) morphology 
characteristic of cardiomyocytes is apparent [Figure B1.1a]. 
 
 
 
 
 
 
B2.1 CAV3 AND JUNCTOPHILLIN 2 LOCALISATION IN NEONATAL RAT 
 
CARDIOMYOCYTES 
 
 
Cav3 and Junctophillin 2 localisation was analysed in the neonatal rat CMs from postnatal pups 
aged 2 – 18. Phalloidin was used to visualise the actin cytoskeleton and emerging z-lines. During 
postnatal development Phalloidin becomes more striated and similar to adult CMs as the cells 
become more rod-shaped with increasing age. Cav3 localisation was initially perinuclear and re- 
distribution of Cav3 to the cytosol was evident between dN8 and dN12 [Figure B2.1]. Localisation of 
Cav3 became primarily peripheral by dN18, showing diminished cytosolic distribution. The presence 
of striations at this time point is inconclusive. 
 
Junctophillin 2 expression, on the other hand, was primarily cytosolic during cardiomyocyte 
differentiation [Figure B2.2]. Additionally, there is a clear presence of striated Junctophillin 2 by 
dN18. 
APPENDIX B2: CAV3 AND JUNCTOPHILLIN 2 EXPRESSION IN NEONATAL RAT 
CARDIOMYOCYTES 
  
FIGURE B1.1. VISUALISATION AND QUANTITATIVE ANALYSIS OF T-TUBULES IN   CMS 
 
a) Representative confocal images (63x), revealing the appearance of t-tubules from dN8. 
Although rudimentary, these systems became progressively more intricate by dN18. Note the 
transition from triangular to rectangular morphology between dN12 and dN18. Scale bar: 15 
µm. 
b) T-tubule density (left) and regularity (right) calculations, showed concurrent increases  in 
these parameters, as cardiomyocytes differentiated. Statistically significant increases were 
observed between dN18 and dN2 (density and regularity, P≤0.001), dN8 (density, P≤0.01; 
regularity, P≤0.001) and dN12 (density, P≤0.05; regularity, P≤0.01). No significant differences 
were observed between the density or regularity of dN8 and dN12 (density and regularity, 
P>0.05). Data represents mean ± SEM of 5 stacks per cell (n=8) for each day. Differences were 
tested  by  One-Way  ANOVA  with  post-hoc  Bonferroni  corrections;  ***P≤0.0001;   **P≤0.01; 
*P≤0.05; NS, no significance. 
c) Comparisons of t-tubule density and regularity between 18 day old neonatal rat CMs (dN18) 
and Adult Rat CMs (dA0) revealed statistically significant differences (P≤0.01 and P≤0.05, 
respectively). CMs exhibited a density of 24.25 ±6.63% (n=8), which was incomparable to that of 
ARVCMs (50.73±4.02%, n=10). TT power was one order of magnitude higher in adults  
(1.72±0.34 AUx107, n=10) in comparison to neonates (4.63±0.7 AUx106, n=8). Data   represents 
mean ± SEM of 5 (dN18) or 8 stacks per cell (adult, dA0). Differences were tested by Unpaired t- 
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tests; **P≤0.01; *P≤0.05). 
Page | 364  
 
FIGURE    B2.1.    IMMUNOCYTOCHEMICAL    ANALYSIS    OF    CAV-3    LOCALISATION   IN 
NEONATAL RAT CARDIOMYOCYTES 
 
Neonatal rat cardiomyocytes of the various postnatal ages were stained for Cav3 (green), 
phalloidin (red) and DAPI (blue). Cav3 localisation was initially perinuclear, but became 
progressively more peripheral. The presence of striations at dN18 is inconclusive. Scale bar: 
15μm. 
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FIGURE B2.2. IMMUNOCYTOCHEMICAL ANALYSIS OF  JUNCTOPHILLIN 2  LOCALISATION 
IN NEONATAL RAT CARDIOMYOCYTES 
 
Neonatal rat cardiomyocytes of the various postnatal ages were stained for Junctophillin 2 
(green), phalloidin (red) and DAPI (blue). Junctophillin 2 was homogenously distributed within 
the cytosol during cardiomyocyte differentiation. The reorganisation of Junctophillin 2 into 
striations became apparent at dN18. Scale bar: 15μm. 
Page | 366  
 
 
A number of nuclear and membrane bound receptors that are activated by bile acids have been 
described over the last decade. In addition, the Oxytocin receptor has been previously described as 
playing a role in Oxytocin induced contractility in the myometrium (Germain et al.,  2003).  
Expression levels of both bile acid receptors and contraction associated proteins were investigated 
firstly in labouring and non-labouring flash frozen tissue samples of term pregnancies. Receptors 
expressed in the tissue were subsequently confirmed in plated cells. Changes in expression level 
over the passages were investigated in order to confirm expression at the passage cells  were 
treated. 
 
 
 
 
 
 
A number of nuclear receptors were studied. One of the most important regulatory receptors in 
the liver, the Farnesoid X Receptor (FXR) was shown not to be expressed in myometrial biopsy 
samples [Table C1.1]. Previous studies have shown that Liver X Receptor-β (LXRβ) is expressed in 
mouse myometrium and may affect contractility (Mouzat, Prod’homme, Volle, et al., 2007). Both 
LXRα and LXRβ are expressed in flash frozen myometrial tissue [Table C1.1] and show no significant 
changes throughout the passages (n = 5) [Figure 6.7]. The Peroxisome proliferator-activated 
receptors PPARα and PPARγ are also expressed in flash frozen myometrial tissue [Table C1.2] and 
show no significant differences over the passages, although there seems to be a high variability 
between cultures [Figure 6.8]. The Vitamin D Receptor (VDR), which binds Vitamin D, but also has a 
low affinity for LCA does not seem to be expressed in myometrial tissue [Table C1.3] (van Mil, 
Houwen & Klomp, 2005). The xenobiotic/endobiotic receptors Pregnane X receptor (PXR) and 
Constitutive Androstane receptor (CAR) are both expressed in myometrial tissue, albeit at a low 
level.  CAR  expression  seems  to  be  increased  in  labour  [Table  C1.3].  The  LXRβ  binding  partner 
APPENDIX C1: EXPRESSION OF NUCLEAR  RECEPTORS 
APPENDIX C: BILE ACID SIGNALLING PATHWAYS IN THE   MYOMETRIUM 
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Retinoid X receptor (RXR) is also expressed in the myometrial tissue and remains expressed 
throughout the passages [Figure 6.9]. 
 
 
 
G-protein coupled receptors (GPCRs) play an important role in the signalling pathways that lead  
to contraction. Both relaxation and excitation in myometrial smooth muscle cells are regulated by 
GPCRs. Research in animal models has shown that muscarinic receptor subtypes are expressed in 
smooth muscle and in the uterus of both rodents and in the pig (Schölch, Schölch, Strahl, et al., 
2012). In the porcine uterus addition of the cholinergic agonist Carbachol leads to strong 
contractions and the M3 muscarinic receptor is shown to be present by both functional and 
radioligand binding studies (Schölch, Schölch, Strahl, et al., 2012). Gene expression of the Muscarinic 
receptor subtypes CHRM1-5 were therefore investigated. 
 
Muscarinic receptors CHRM1, CHRM3 and CHRM4 are not expressed in flash frozen samples of 
labouring and non-labouring myometrium, whilst CHRM5 may be expressed, but at very low levels 
[Table C2.1]. 
 
TGR5 is a G-protein coupled receptor that has been shown to have a role in signalling in a variety 
of tissues and was therefore also investigated in the myometrium. GPCRs play an important role in 
downstream contraction signalling. TGR5 expression was investigated in myometrial tissue as well as 
in the passages. The expression level of TGR5 is low in myometrial tissue, although it seems there is 
an increased expression in labour samples [Table C2.2]. TGR5 expression is stable throughout 
passaging [Figure 6.10]. 
APPENDIX C2: EXPRESSION OF G-PROTEIN COUPLED  RECEPTORS 
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TABLE C1.1. EXPRESSION OF NUCLEAR RECEPTORS LXRα, LXRβ AND FXR IN FLASH FROZEN 
HUMAN MYOMETRIUM 
 
Ct values of L19, FXR, LXRα and LXRβ mRNA expression isolated from myometrial tissue and positive 
controls. The HUH7 hepatoma cell line was used as positive control. Undetermined indicates no  
gene expression was detected. -1, -3, JB, JC, JD, +4, +5 and +6 are patient identification codes. 
 
 
TABLE C1.2. EXPRESSION OF NUCLEAR RECEPTORS PPARα AND PPARγ IN FLASH FROZEN 
HUMAN MYOMETRIUM 
 
Ct values of L19, PPARα and PPARγ mRNA expression isolated from myometrial tissue and positive 
controls. The HUH7 hepatoma cell line was used as positive control for both PPARα and PPARγ, 
whilst RNA from white (WAT) and brown adipose tissue (BAT) was used as a control for PPARγ. -3, - 
4, -7, -8, -9, JB, JD, +2, +4, +5, +6 and +9 are patient identification codes. 
 TABLE C1.3. EXPRESSION OF NUCLEAR RECEPTORS PXR, VDR, CAR AND RXR IN FLASH FROZEN 
HUMAN MYOMETRIUM 
Ct values of L19, PXR, VDR, CAR and RXR mRNA expression isolated from myometrial tissue and positive 
controls. The HUH7 hepatoma cell line was used as positive control. The intestinal cell line CACO, which 
are epithelial colorectal adenocarcinoma cells was used as a control for VDR. Undetermined indicates 
no gene expression was detected. 
-1, -3, JB, JC, JD, -4, -7, -8, +2, +4, +5, +6 and +9 are patient identification codes. 
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TABLE C2.1. EXPRESSION OF THE CHOLINERGIC MUSCARINIC RECEPTORS IN FLASH FROZEN 
HUMAN MYOMETRIUM 
 
Ct values of L19, CHRM 1 – 5 mRNA expression isolated from myometrial tissue and positive controls. 
Undetermined indicates no gene expression was detected. CHRM1 -5 – Muscarinic receptor subtype 1 – 5. 
PFC - Prefrontal Cortex, AMY – Amygdala, CER – Cerebral cortex, which were obtained from the human 
tissue bank. SM – Smooth muscle (Ambion). 3, -4, -7, -8, -9, JB, JC, JD, +2, +4, +5, +6 and +9 are patient 
identification codes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE C2.2. EXPRESSION OF TGR5 IN FLASH FROZEN HUMAN 
MYOMETRIUM 
Ct values of L19 and TGR5 mRNA expression isolated from myometrial 
tissue and positive controls. Undetermined indicates no gene 
expression was detected. White blood cells mRNA (WBC) and a  
plasmid containing GFP-TGR5 were used as a control. No RT controls 
(RT -) were used as negative controls.  -9, JN-7, JN-8,  JN-11, +2, +4, +5, 
+6, JN+1, JN+2, JN+3 are patient identification codes. 
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Additional figures from the CombiCult. These are included here as they only provide background 
information and additional images. 
 
In Appendix D1 the background fluorescence and native expression of the EhiPS and SHEF3 cells 
of the markers was analysed. No expression of Estrogen Receptor-α (ERα), Oxytocin Receptor (OTR) 
nor αSmooth Muscle Actin (αSMA) was found in either cell line. 
 
Appendix D2 presents the images from the viability testing carried out to ensure that beads in all 
media types had surviving cells and additional images of the beads after fluorescence staining 
 
Appendix D3 provides information on the COPAS gating settings. 
Appendix D4 describes the additional analysis provided by Ariadne. 
Appendix D5 shows the full immunofluorescence analysis of protocol efficiency obtained from the 
Cellinsight. 
APPENDIX D: ADDITIONAL WORK FROM THE  COMBICULT 
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Myometrial SMCs show high expression levels of αSmooth Muscle Actin (αSMA), as well as early 
expression of the Estrogen Receptor α (ERα) in both non-pregnant and pregnant myometrium 
(Mosher, Rainey, Bolstad, et al., 2013). Oxytocin receptor (OTR) occurs later on in the differentiation 
of precursors to myometrial SMCs and highest expression levels of OTR are during pregnancy, 
especially when nearing term (Mosher, Rainey, Bolstad, et al., 2013; Terzidou, 2009). The markers 
for the Early Exit, after Stage III were αSMA and ERα, whilst the Final Exit were αSMA and OTR. 
Untreated primary myometrial SMCs from term pregnancies were stained with secondary antibodies 
only as negative control negative control to obtain background fluorescence of the cells and beads 
(rabbit-488, goat-488 and mouse-546 for ERα, OTR and αSMA respectively) [Appendix Figure D1.1]. 
Undifferentiated EhiPS and SHEF3 on beads were used to confirm these markers were not natively 
expressed by either cell line. EhiPS do not express ERα, OTR and αSMA [Appendix Figures D1.2 and 
D1.3]. The SHEF3 cells were also negative for the markers ERα, OTR and αSMA, although a small of 
contamination with the feeder population of Mouse Embryonic Fibroblasts (MEFs) occurs leading to 
a small number of αSMA positive cells on the beads [Appendix Figures D1.5 and D1.6]. EhiPS and 
SHEF3 cells on beads stained with secondary antibody only were used as negative control to obtain 
background fluorescence of the cells and beads [Appendix Figures D1.4 and D1.7]. 
APPENDIX D1: ANTIBODY CONTROLS FOR THE  HUMAN  MYOMETRIAL  CELLS  AND  
HUMAN ES AND IPS  CELLS 
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FIGURE D1.1. BACKGROUND FLUORESCENCE FOR MYOMETRIAL SMOOTH MUSCLE 
CELLS 
 
Primary human myometrial smooth muscle cells were seeded on beads and stained with only 
the secondary antibodies (rabbit-488 and mouse-546) and Hoechst (blue) to provide 
background fluorescence measurements of the beads and these were imaged on the 
epifluorescence microscope. Representative images at 4x (top; scale bar: 170 µM), 10x 
(middle; scale bar: 70 µM) and 20x (bottom; scale bar: 350 µM) magnification. 
There were clearly human myometrial cells seeded on the beads, as can be seen by Hoechst 
staining, but there was only low background staining of the rabbit-488 and mouse-546 
antibodies. 
Page | 374  
 
FIGURE D1.2. ESTROGEN RECEPTOR-α AND αSMOOTH MUSCLE ACTIN ARE NOT 
NATIVELY EXPRESSED BY THE EhIPS  CELLS 
 
EhiPS cells were seeded on beads and stained with the antibodies to be used in the CombiCult 
and Hoechst and were subsequently imaged on the epifluorescence microscope. EhiPS cells do 
not express Estrogen Receptor-α (rabbit-488) and αSmooth Muscle Actin (mouse-546). 
Representative images at 4x (top; scale bar: 170 µM), 10x (middle; scale bar: 70 µM) and 20x 
(bottom; scale bar: 350 µM) magnification. 
EhiPS cells were seeded on the beads, as can clearly be seen by Hoechst staining, but there 
was only low background staining of the Estrogen Receptor-α (rabbit-488) or αSmooth Muscle 
Actin (mouse-546) antibodies, indicating that there was no native expression of either of these 
markers in the EhiPS cells. Therefore any positive cells found after differentiation would be  
due to the differentiation process, not background expression. 
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FIGURE D1.3. OXYTOCIN RECEPTOR AND αSMOOTH MUSCLE ACTIN ARE  NOT 
NATIVELY EXPRESSED BY THE EhIPS  CELLS 
 
EhiPS cells were seeded on beads and stained with the antibodies to be used in the CombiCult 
and Hoechst and were subsequently imaged on the epifluorescence microscope. EhiPS cells do 
not express Oxytocin Receptor (goat-488) and αSmooth Muscle Actin (mouse-546). 
Representative images at 4x (top; scale bar: 170 µM), 10x (middle; scale bar: 70 µM) and 20x 
(bottom; scale bar: 350 µM) magnification. 
EhiPS cells were seeded on the beads, as can clearly be seen by Hoechst staining, but there 
was only low background staining of the Oxytocin Receptor (goat-488) or αSmooth Muscle 
Actin (mouse-546) antibodies, indicating that there was no native expression of either of these 
markers in the EhiPS cells. Therefore any positive cells found after differentiation would be  
due to the differentiation process, not background expression. 
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FIGURE D1.4. BACKGROUND FLUORESCENCE FOR EhiPS  CELLS 
 
EhiPS cells were seeded on beads and stained with only the secondary antibodies (goat-88  
and 
mouse-546) and Hoechst to provide background fluorescence measurements of the beads and 
these were imaged on the epifluorescence microscope. Representative images at 4x (top; 
scale bar: 170 µM), 10x (middle; scale bar: 70 µM) and 20x (bottom; scale bar: 350 µM) 
magnification. 
EhiPS cells were seeded on the beads, as can clearly be seen by Hoechst staining, but there 
was only low background staining of -488 and -546 antibodies. 
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FIGURE D1.5. ESTROGEN RECEPTORα AND αSMOOTH MUSCLE ACTIN ARE NOT 
NATIVELY EXPRESSED BY THE SHEF3  CELLS 
 
SHEF3 cells were seeded on beads and stained with the antibodies to be used in the CombiCult 
and Hoechst and were subsequently imaged on the epifluorescence microscope. SHEF3 cells  
do not express Oxytocin Receptor (goat-488) and αSmooth Muscle Actin (mouse-546). There is 
a small amount of contamination with αSMA positive MEFs. Representative images at 4x (top; 
scale bar: 170 µM), 10x (middle; scale bar: 70 µM) and 20x (bottom; scale bar: 350 µM) 
magnification. 
SHEF3 cells were seeded on the beads, as can clearly be seen by Hoechst staining, but there 
was only low background staining of the Estrogen Receptor-α (rabbit-488) or αSmooth Muscle 
Actin (mouse-546) antibodies, indicating that there was no native expression of either of these 
markers in the SHEF3 cells. There were a few positive cells found sporadically, but these are 
most likely the feeder cells, the Mouse Embryonic Fibroblasts which were transferred during 
the splitting process. 
Therefore any positive cells found after differentiation would be due to the differentiation 
process, not background expression. 
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FIGURE D1.6. OXYTOCIN RECEPTOR AND αSMOOTH MUSCLE ACTIN ARE  NOT 
NATIVELY EXPRESSED BY THE SHEF3  CELLS 
 
SHEF3 cells were seeded on beads and stained with the antibodies to be used in CombiCult  
and Hoechst and were subsequently imaged on the epifluorescence microscope. SHEF3 cells  
do not express Oxytocin Receptor (goat-488) and αSmooth Muscle Actin (mouse-546). There is 
a small amount of contamination with αSMA positive MEFs. Representative images at 4x (top; 
scale bar: 170 µM), 10x (middle; scale bar: 70 µM) and 20x (bottom; scale bar: 350 µM) 
magnification. 
SHEF3 cells were seeded on the beads, as can clearly be seen by Hoechst staining, but there 
was only low background staining of the Oxytocin Receptor (goat-488) or αSmooth Muscle 
Actin (mouse-546) antibodies, indicating that there was no native expression of either  of 
these markers in the SHEF3 cells. There were a few positive cells found sporadically, but these 
are most likely the feeder cells, the Mouse Embryonic Fibroblasts which were transferred 
during the splitting process. 
Therefore any positive cells found after differentiation would be due to the differentiation 
process, not background expression. 
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FIGURE D1.7. BACKGROUND FLUORESCENCE FOR SHEF3  CELLS 
 
SHEF3 cells were seeded on beads and stained with only the secondary antibodies (rabbit-488 
and mouse-546) and Hoechst to provide background fluorescence measurements of the beads 
and these were imaged on the epifluorescence microscope. Representative images at 4x (top; 
scale bar: 170 µM), 10x (middle; scale bar: 70 µM) and 20x (bottom; scale bar: 350 µM) 
magnification. 
SHEF3 cells were seeded on the beads, as can clearly be seen by Hoechst staining, but there 
was only low background staining of -488 and -546 antibodies. 
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D2.1 VIABILITY TESTING OF THE SHEF3 AND EHIPS CELLS AFTER   SEEDING 
 
 
The viability of the EhiPS and SHEF3 cells seeded on the beads was assessed after 24h using 
Calcein-AM (excitation / emission: 495/515 nM), a cell-permeable viability dye (Invitrogen). An 
aliquot was taken of each of the cell types and each medium type (1.1 – 1.10) as well as the 1.0 
undifferentiated media, consisting of the maintenance media (E8 or hES) media for EhiPS and SHEF3 
respectively. Bright field images of the beads and images of the Calcein stained cells were taken at 
10x magnification. Representative images of the EhiPS and SHEF3 seeded beads in each of the media 
1.0, 1.1 – 1.10 can be found in Appendix Figures D2.1 and D2.2 respectively. Appendix Figure D2.1 
shows the Calcein staining for the EhiPS cells as well as bright field images [pages D11 and D12]. 
Appendix Figure D2.2 shows the Calcein staining of the SHEF3 cells [pages D13 and D14]. Seeding of 
both cell lines in all 10 media conditions was successful as indicated by the bright staining of Calcein 
in all the bead samples. 
 
 
 
 
 
D2.2 ADDITIONAL IMAGES OF THE  BEADS 
 
 
When placed on the microscope, it became apparent that the intensity of αSMA was increased 
compared to the Early Exit, indicating that the cells may have needed a little longer to become more 
mature. OTR was generally relatively faint, although some beads showed quite high fluorescence. 
This indicated that it might be beneficial for the final stage to be extended in order for the cells to 
mature further. Although, these low OTR expressing cells may represent a more ‘preterm’ 
phenotype, so it might be depending on the research question whether the cells need to be  
matured. This shows the importance of the optimisation of the protocols after validation and further 
investigation of expression levels of the proteins of interest. A few positive beads from each pool 
were imaged and images are presented in Appendix Figure D2.3 [pages D15 – D18]. 
APPENDIX D2: VIABILITY TESTING OF THE SHEF3 AND EHIPS CELLS AFTER SEEDING ON 
BEADS FOR THE COMBICULT AND ADDITIONAL IMAGES OF   BEADS 
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FIGURE D2.1. VIABILITY OF THE EHIPS SEEDED ON THE BEADS AT D1 
The viability of the EhiPS cells on the beads was checked using Calcein-AM after 24h of culture. Images of the 
Calcein, bright field images of the beads and overlay images of the Calcein and bright field of the beads were 
taken. - Control: The undifferentiated EhiPS cells in their maintenance (E8) medium. 4x magnification, scale 
bar: 170 µm. Cells survived the seeding on beads in all media. 
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FIGURE D2.1. VIABILITY OF THE EHIPS SEEDED ON THE BEADS AT D1    (CONTINUED) 
 
The viability of the EhiPS cells on the beads was checked using Calcein-AM after 24h of culture. 
Images of the Calcein, bright field images of the beads and overlay images of the Calcein and bright 
field of the beads were taken. 4x magnification, scale bar: 170 µm. Cells survived the seeding on 
beads in all media. 
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FIGURE D2.2. VIABILITY OF THE SHEF3 SEEDED ON THE BEADS AT D1 
 
The viability of the SHEF3 cells on the beads was checked using Calcein-AM after 24h of culture. Images of the 
Calcein, bright field images of the beads and overlay images of the Calcein and bright field of the beads were 
taken. - Control: The undifferentiated SHEF3 cells in their maintenance (hES) medium. 4x magnification, scale 
bar: 170 µm. Cells survived the seeding on beads in all media. 
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FIGURE D2.2. VIABILITY OF  THE SHEF3 SEEDED ON  THE    BEADS 
AT D1 (CONTINUED) 
 
The viability of the SHEF3 cells on the beads was checked using 
Calcein-AM after 24h of culture. Images of the Calcein, bright field 
images of the beads and overlay images of the Calcein and bright  
field of the beads were taken. - Control: The undifferentiated SHEF3 
cells in their maintenance (hES) medium. 4x magnification, scale bar: 
170 µm. Cells survived the seeding on beads in all media. 
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FIGURE D2.3. REPRESENTATIVE BEADS OF THE FINAL EXIT  POOLS 
 
All beads from separate pools were stained with OTR (goat-488) and αSMA (mouse-546) and Hoechst 
and were imaged on an epifluorescence microscope. Staining indicated that cells on a number of 
beads have differentiated, although the number of cells / bead differs and the different intensity of 
the markers indicates that there are differences in effectiveness of the differentiation between beads. 
Even within a bead not all cells may have differentiated equally. It is not possible to differentiate 
between the two cell lines without tag analysis. Representative images from various pools at 20x 
magnification (scale bar: 35 µM). 
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FIGURE D2.3. REPRESENTATIVE BEADS OF THE FINAL EXIT POOLS  (CONTINUED) 
 
All beads from separate pools were stained with OTR (goat-488) and αSMA (mouse-546) and  
Hoechst and were imaged on an epifluorescence microscope. Staining indicated that cells on a 
number of beads have differentiated, although the number of cells / bead differs and the different 
intensity of the markers indicates that there are differences in effectiveness of the differentiation 
between beads. Even within a bead not all cells may have differentiated equally. It is not possible to 
differentiate between the two cell lines without tag analysis. Representative images from various 
pools at 20x magnification (scale bar: 35 µM). 
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FIGURE D2.3. REPRESENTATIVE BEADS OF THE FINAL EXIT POOLS  (CONTINUED) 
 
All beads from separate pools were stained with OTR (goat-488) and αSMA (mouse-546) and 
Hoechst and were imaged on an epifluorescence microscope. Staining indicated that cells on a 
number of beads have differentiated, although the number of cells / bead differs and the different 
intensity of the markers indicates that there are differences in effectiveness of the differentiation 
between beads. Even within a bead not all cells may have differentiated equally. It is not possible to 
differentiate between the two cell lines without tag analysis. Representative images from various 
pools at 20x magnification (scale bar: 35 µM). 
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FIGURE D2.3. REPRESENTATIVE BEADS OF THE FINAL EXIT POOLS  (CONTINUED) 
 
All beads from separate pools were stained with OTR (goat-488) and αSMA (mouse-546) and 
Hoechst and were imaged on an epifluorescence microscope. Staining indicated that cells on a 
number of beads have differentiated, although the number of cells / bead differs and the different 
intensity of the markers indicates that there are differences in effectiveness of the differentiation 
between beads. Even within a bead not all cells may have differentiated equally. It is not possible to 
differentiate between the two cell lines without tag analysis. Representative images from various 
pools at 20x magnification (scale bar: 35 µM). 
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All the beads were passed through the COPAS. Prior to running the beads through the COPAS, the 
positive (primary myometrial SMCs) and negative controls, an aliquot of differentiated beads with 
secondary antibody only were run through the COPAS to obtain the gating settings [Appendix Figure 
D3.1]. These were then adjusted as the beads were run, due to differences in fluorescence between 
the strongly positive myometrial cells and the differentiated beads. The beads of interest or ‘hits’ 
that passed the fluorescence gating were sorted into single wells of a 96 well plate. Appendix Figure 
D3.1 shows the sorting profiles and gates for the Early Exit, whilst Figure D3.2 shows the sorting 
profiles for each of the Final Exit pools. 
 
The Exit and Final exit pools combined had 3150 hits, of which 1129 were analysed. There were 
826 hits out of ~3000 beads in the early exit, of which approximately half were analysed. The Final 
exit had a total of 2324 hits, which were confirmed by microscopy. A total of 711 beads were 
deconvoluted of the Final exit, the remaining 1613 were multiples or otherwise discarded as not 
suitable (negative for either markers, not real fluorescence), see Table 6.8 for the number of hits / 
group. Pool 1, 2, 7, 9 and 10 had the most hits, with 250 – 400 hits per pool. The other pools had 100 
– 200 hits each. It was quite striking how diverse the COPAS profiles were, some pools had more 
expression of one or the other marker [Figure D3.2]. Pool 1 seems to have 2 populations, with some 
beads having a higher intensity for green than red and others a higher intensity for red than green. 
Pools 3, 4 and 5 contained beads that were more or less equal in fluorescence for both markers, 
although there were fewer hits than other pools and the fluorescence profiles were relatively low 
fluorescence. Pools 2, 7, 9 and 10 had profiles with a higher intensity for red and these pools 
(together with pool 1) had the most hits. Pools 6 and 8 had a higher intensity for green. 
APPENDIX D3: COPAS GATING  SETTINGS 
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FIGURE D3.1. COPAS SETTINGS FOR THE EARLY  EXIT 
 
The beads were sorted based on fluorescence for ERα (rabbit-488; ‘Green’) and αSMA (mouse-546; ‘Red’) 
using the COPAS. The beads were analysed for size and fluorescence. A gate was set for single beads, with 
larger particles indicating multiples of beads clumped together, and smaller particles than the gate most 
likely partial beads and other debris (top panels). Beads with fluorescence above the ‘Red’ and ‘Green’ 
gates were then sorted into single wells of a 96-well plate for further analysis (bottom panels). To obtain 
the correct gates a positive (primary myometrial smooth muscle cells) and negative control (secondary 
only stained Early Exit beads) was used, these beads were sorted but not collected. The Early Exit beads 
were then sorted and collected using these gates. 
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FIGURE D3.2 COPAS SETTINGS FOR THE FINAL  EXIT 
 
The beads were sorted based on fluorescence for OTR (goat-488; ‘Green’) and αSMA (mouse-546; ‘Red’) using the COPAS. The beads were analysed for size 
and fluorescence. A gate was set for single beads, with larger particles indicating multiples of beads clumped together, and smaller particles than the gate 
most likely partial beads and other debris (top panels). Beads with fluorescence above the ‘Red’ and ‘Green’ gates were then sorted into single wells of a 96- 
well plate for further analysis (bottom panels). To obtain the correct gates a positive (a mixed aliquot of all the pools of Final Exit beads) and negative control 
(secondary only stained Final Exit beads) was used, these beads were sorted but not collected. The Final Exit beads were then sorted per pool and collected 
using these gates. 
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FIGURE D3.2 COPAS SETTINGS FOR THE FINAL EXIT  (CONTINUED) 
 
The beads were sorted based on fluorescence for OTR (goat-488; ‘Green’) and αSMA (mouse-546; ‘Red’) using the COPAS. The beads were analysed for size 
and fluorescence. A gate was set for single beads, with larger particles indicating multiples of beads clumped together, and smaller particles than the gate 
most likely partial beads and other debris (top panels). Beads with fluorescence above the ‘Red’ and ‘Green’ gates were then sorted into single wells of a 96- 
well plate for further analysis (bottom panels). To obtain the correct gates a positive (a mixed aliquot of all the pools of Final Exit beads) and negative control 
(secondary only stained Final Exit beads) was used, these beads were sorted but not collected. The Final Exit beads were then sorted per pool and collected 
using these gates. 
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Ariadne provides various output methods for analysis. This section describes various these 
methods. Firstly, Ariadne analyses all the tags and provides fingerprint analysis. Fingerprint analysis 
was then carried out to see whether any beads share pathways or partial pathways. Figure D4.1 and 
D4.2 show part of the fingerprint analysis carried out for the Early Exit and Early + Final exit 
combined respectively, a full list of the fingerprint analysis can be found in Appendix E on the DVD. 
The fingerprint analysis shows any pathways that are shared by 2 or more beads and can be ordered 
in various ways, by descending number of matches (matching media), number of beads, or  
increasing probability, these are all supplied for the Early and Combined Exits in Appendix E on the 
DVD. Figures D4.1 and D4.2 show the beads ordered by increasing probability. The lower the 
probability, the less likely the bead passed through a certain combination of media by chance. 
Figures D4.1 and D4.2 provide information on the number of matching Stages, the number of beads 
in that pathway and the probability followed by the media of each Stage of these pathways and 
finally all the bead IDs that follow this pathway. The numbers in the splits represent the media 
numbers, with – representing multiple possible conditions or both cell lines. 
The probability was calculated by Ariadne by using a probability simulation, as was previously 
published (Tarunina, Hernandez, Johnson, et al., 2014). Probability values for the occurrence of given 
events by chance were obtained from computer simulation experiments. A Mersenne Twister 
random number generator was used to output uniformly distributed 32-bit integers which were 
scaled to cover 10,000, 1,000 or 100 possible pathways, when simulating common cell culture media 
on four out of four splits, three out of four splits or two out of four splits (Tarunina, Hernandez, 
Johnson, et al., 2014). 
APPENDIX D4: ANALYSIS OF THE  COMBICULT 
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FIGURE D4.1. FINGERPRINT ANALYSIS OF THE EARLY  EXIT 
 
Part of the fingerprint analysis carried out for the Early Exit. The list shows any pathways that are shared 
by 2 or more beads and is ordered increased probability, whereby the top hits have a very small chance of 
occurring by chance. The list provides information on the number of matching Stages, the number of beads 
in that pathway and the probability followed by the media of each Stage of these pathways and finally all 
the beads that follow this pathway. The numbers in the splits represent the media numbers, with – 
representing multiple possible conditions, except for Split 5 which was not carried out in the Early Exit. 
 
 
 
 
 
 
FIGURE D4.2. FINGERPRINT ANALYSIS OF THE EARLY + FINAL EXIT   COMBINED 
 
Part of the fingerprint analysis carried out for the Early + Final Exit. The list shows any pathways that are 
shared by 2 or more beads and is ordered by increased probability, whereby the top hits have a very small 
chance of occurring by chance. The list provides information on the number of matching Stages, the 
number of beads in that pathway and the probability followed by the media of each Stage of these 
pathways and finally all the beads that follow this pathway. The numbers in the splits represent the media 
numbers, with – representing multiple possible conditions. 
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The dendograms shown in Figure D4.3 and D4.4 show the hierarchical clustering of families with 
similar media. These families of highly related protocols are often very efficient at directing 
differentiation. As can be seen in the figure there is a split in the first instance of the SHEF3 (orange) 
and EhiPS cell line (red). There seem to be 6 major families in the SHEF3 line with protocols within 
each family more similar to each other than to other families. 1 or 2 protocols from each family were 
chosen for validation. 
 
Ariadne also provides a pair-wise comparison of all the protocols as represented in the 
hierarchical clustering, this comparison is presented as a similarity matrix [Figures D4.5 and D4.6 for 
the Early and Final Exit respectively]. In this matrix the protocols are organised so that each row and 
each column represent a protocol. The brightness of each cell in the matrix is proportional to the 
number of cell culture media shared by the protocols. The brightest red corresponds to two identical 
protocols, whilst black corresponds to protocols with no common media. The diagonal line  
comprises of the protocols compared to themselves. Families of protocols with high similarity and 
internal homology look like as bright red squares. In both Figures there is a split in clusters 
depending on the cell line, with a large square representing the SHEF3 line and the small square the 
EhiPS line. Along the diagonal line there are a number of families which contain clusters of similar 
media. There seem to be 6 clusters of media for the SHEF3 line in the Early Exit, which are 
represented by the bright red squares along the diagonal line. This can also be seen along the top 
axis, where the family origins are presented as a family trees. Broadly there seem to be 6 similar 
trees for the SHEF3 [Figure D4.5]. 
 
These clusters are a little smaller in the Final Exit, with a larger number of smaller families of 
media [Figure D4.6]. This may be due to the fact that although there seemed to be crucial media 
compositions    in    Stage    I    &    II,    there    was    a    more    diffuse    distribution    in    Stage    III. 
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FIGURE D4.3. HIERARCHICAL CLUSTERING OF THE BEADS FOR THE EARLY   EXIT 
 
The dendogram shows hierarchical clustering of families with similar media. These families of highly 
related protocols are often very efficient at directing differentiation. As can be seen in the figure there is a 
split in the first instance of the SHEF3 (orange) and EhiPS cell line (red). There seem to be 6 major families 
in the SHEF3 line with protocols within each family more similar to each other than to other families. 1 or 2 
protocols from each family were chosen for validation. 
 
 
 
 
FIGURE D4.4. HIERARCHICAL CLUSTERING OF THE BEADS FOR THE FINAL   EXIT 
 
The dendogram shows hierarchical clustering of families with similar media. These families of highly 
related protocols are often very efficient at directing differentiation. As can be seen in the figure there is a 
split in the first instance of the SHEF3 (orange) and EhiPS cell line (red). There seem to be 6 major families 
in the SHEF3 line with protocols within each family more similar to each other than to other families. 1 or 2 
protocols from each family were chosen for validation. 
Page | 397  
 
 
FIGURE         D4.5.         SIMILARITY         MATRIX         OF          THE         EARLY        EXIT 
A similarity matrix was generated by Ariadne with the protocols organised so that each row 
and each column represent a protocol. The brightness of each cell in the matrix is 
proportional to the number of cell culture media shared by the protocols. The brightest red 
corresponds to two identical protocols, whilst black corresponds to protocols with no 
common media. The diagonal line comprises of the protocols compared to themselves. 
Families of protocols with high similarity and internal homology look like as bright red 
squares. The large square indicates the SHEF3 cell line, the smaller square the EhiPS line. A 
number of clusters or families with similar media can be seen in the SHEF3 cell line, as can be 
seen by the 6 or so largest red blocks along the diagonal line, similarly to the hierarchical 
clustering. 
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FIGURE D4.6. SIMILARITY MATRIX OF THE FINAL  EXIT 
 
A similarity matrix was generated by Ariadne with the protocols organised so that each row and each 
column represent a protocol. The brightness of each cell in the matrix is proportional to the number of 
cell culture media shared by the protocols. The brightest red corresponds to two identical protocols, 
whilst black corresponds to protocols with no common media. The diagonal line comprises of the 
protocols compared to themselves. Families of protocols with high similarity and internal homology 
look like as bright red squares. The large square indicates the SHEF3 cell line, the smaller square the 
EhiPS line. The clusters are smaller than in the Early Exit, but a number of clusters can still be found. 
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When all the plates of all protocols had been collected or fixed the final analysis of the protocol 
efficiency was carried out. The cells for all the protocols were stained for Hoechst and the Early (ERα 
[rabbit-488] and αSMA [mouse-647]) and Final Exit markers (OTR [goat-488] and αSMA [mouse- 
647]) in duplicate and one well was devoted to their respective negative controls. The plate was  
then imaged using the epifluorescence microscope. Before subsequent analysis using a high content 
screening platform called Cellinsight NXT [ThermoFisher]. High Content Screening or automated cell 
analysis is an automated method that combines fluorescence microscopy, automated cell 
calculations and phenotyping using image processing algorithms and informatics. It allows for the 
analysis of the validation protocols for the cells of interest using the markers chosen. This allows for 
the acquisition of quantitative data to see whether there was any differentiation in any of the 
validation protocols. 
 
It allows for the analysis of the level of differentiation induced by each protocol, as it compares 
the efficiency of each wells (protocol) by obtaining images and subsequent analysis of 10 fields of 
view per well. It first calculates the number of cells in each well (the object count) by analysis of the 
Hoechst staining. It is possible to set thresholds for nucleus size, so very small or very large nuclei are 
discarded, as well as those with a weird shape or when many nuclei are clustered together. Then it 
overlays the target fluorescence signals (ERα, OTR, αSMA) and calculates the fluorescence in an area 
around the cell. The size of this area is set by the user based on the positive controls of each marker. 
It then obtains the mean intensity of each of these markers in each ‘cell’ area. It then calculates the 
percentage of responders by taking how many objects (cells) counted had fluorescence over the 
threshold set using the negative controls over the total number of objects (cells). This gives an 
indication of the efficiency of each protocol. 
 
The full Cellinsight analysis is shown in Appendix Figures D5.1 – D5.4. A combined figure of the 
 
Early Exit is shown in Appendix Figure D5.1, separate figures for ERα, OTR and αSMA are shown in 
APPENDIX D5: IMMUNOFLUORESCENCE ANALYSIS OF PROTOCOL  EFFICIENCY 
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Appendix Figure D5.2a – c respectively. A combined figure of the Final Exit is shown in Appendix 
Figure D5.3, separate figures for ERα, OTR and αSMA are shown in Appendix Figure D5.4a – c 
respectively. 
 
There were 9 protocols in the Early Exit which showed high numbers of surviving cells and had a 
high number of responders for the markers [Figure 6.4]. These protocols were protocol number: 2,  
3, 4, 5, 6, 7, 8, 11 and 17. The variability of the responders was quite large. The overall expression of 
αSMA was low for all protocols. ERα showed robust expression over all the chosen protocols. OTR 
expression was variable between protocols. Of these 9 protocols, the best protocols with robust 
expression of the markers were protocols 6, 11 and 17. All have strong expression of ERα, with 6 and 
11 showing robust expression of αSMA and OTR. Protocol 17 had a very high number of cells, so may 
not be represented accurately, as Cellinsight analysis assumes similar amounts of cells in each wells. 
Therefore, even though the marker expression of αSMA and OTR was low, it still seems a robust 
protocol. 
 
For the Final Exit 5 protocols were chosen, protocols 11, 17, 19, 23 and 25, mainly due to the fact 
that they had surviving cells. Excitingly, protocols 11 and 17 come up in both the Early and Final  
Exits. Protocol 11 showed the most robust expression of all three of the markers, whilst the other 
protocols showed lower, but still reasonably nice expression of the markers. Again, the expression 
level of the markers was variable, but all three markers were expressed. 
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FIGURE D5.1. EXPRESSION OF ESTROGEN RECEPTOR-α, OXYTOCIN RECEPTOR, αSMOOTH MUSCLE ACTIN IN THE EARLY EXIT PROTOCOLS 
 
The expression levels of the markers ERα (green), OTR (orange), αSMA (red) normalised over the  number  of  nuclei  in  each  well  in all protocols were  
analysed. Due to the differences in the number of cells in each protocol, only protocols 2, 3, 4, 5, 6, 7, 8, 11 and 17 were selected for further analysis, as these 
protocols reached the threshold value of 500 nuclei / well. The other protocols may show a large percentage of positive cells, but this may not be representative 
of the protocol as only few cells survived. ERα shows robust expression in all protocols with 20 – 60% of cells showing ERα expression. OTR expression is more 
variable, and the number of OTR positive cells is low in some protocols, but this may be due to the early stage of differentiation. OTR was chosen as a marker of 
more mature cells, and the low expression may reflect this. Similar to the results found in the COPAS sort the number of αSMA expressing cells was still  
relatively low at this stage. The combination of all the markers shows that protocol 11 has the most robust overall expression of the markers, with a large 
percentage of cells positive for the markers. Protocol 6 also shows a large number of cells positive for ERα and OTR, although less positive for αSMA and 
although protocol 17 has low numbers of positive cells for each of the markers the high total number of cells may represent this less   accurately. 
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FIGURE  D5.2.   EXPRESSION  OF   ESTROGEN  RECEPTOR-α,  OXYTOCIN   RECEPTOR, 
αSMOOTH MUSCLE ACTIN IN THE EARLY EXIT   PROTOCOLS 
The expression levels of the markers a) ERα (green), b) OTR (orange), c) αSMA (red) 
normalised over the number of nuclei in each well was analysed for all protocols. Due to 
the differences in the number of cells in each protocol, only protocols 2, 3, 4, 5, 6, 7, 8, 11 
and 17 were selected for further analysis, as these protocols reached the threshold value  
of 500 nuclei / well. The other protocols may show a large percentage of positive cells, but 
this may not be representative of the protocol as only few cells survived. ERα shows robust 
expression in all protocols with 20 – 60% of cells showing ERα expression. OTR expression  
is more variable, and the number of OTR positive cells is low in some protocols, but this 
may be due to the early stage of differentiation. OTR was chosen as a marker of more 
mature cells, and the low expression may reflect this. Similar to the results found in the 
COPAS sort the number of αSMA expressing cells was still relatively low at this stage. The 
combination of all the markers shows that protocol 11 has the most robust overall 
expression of the markers, with a large percentage of cells positive for the markers. 
Protocol 6 also shows a large number of cells positive for ERα and OTR, although less 
positive for αSMA and although protocol 17 has low numbers of positive cells for each of 
the markers, the high total number of cells may represent this less accurately. 
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FIGURE D5.3. EXPRESSION OF ESTROGEN RECEPTOR-α, OXYTOCIN RECEPTOR, αSMOOTH MUSCLE ACTIN IN THE FINAL EXIT PROTOCOLS 
 
The expression levels of the markers ERα (green), OTR (orange), αSMA (red) normalised over the number of nuclei in each well was analysed for all protocols. Due to  
the differences in the number of cells in each protocol, only protocols 11, 17, 19, 23 and 25 were selected for further analysis, as these protocols reached the threshold 
value of 500 nuclei / well. The other protocols may show a large percentage of positive cells, but this may not be representative of the protocol as only few cells 
survived. ERα shows robust expression in all protocols with 20 – 60% of cells showing ERα expression. OTR expression is more variable, and the number of OTR positive 
cells is low in some protocols, indicating that further maturation may be necessary. αSMA expression had generally increased,  with noticeable increases in αSMA 
positive cells in protocol 11 compared to the early stage. The combination of all the markers shows that protocol 11 has the most robust overall expression of the 
markers, with a large percentage of cells positive for the markers. Protocol 19 also shows a large number of cells positive for ERα although less positive for αSMA and 
OTR and although protocol 17 has low numbers of positive cells for each of the markers, its continuation from the Early Exit makes it interesting to further investigate. 
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FIGURE   D5.4.   EXPRESSION   OF   ESTROGEN   RECEPTOR-α,   OXYTOCIN RECEPTOR, 
αSMOOTH MUSCLE ACTIN IN THE FINAL EXIT   PROTOCOLS 
The expression levels of the markers a) ERα (green), b) OTR (orange), c) αSMA (red) 
normalised over the number of nuclei in each well was analysed for all protocols. Due to the 
differences in the number of cells in each protocol, only protocols 11, 17, 19, 23 and 25 were 
selected for further analysis, as these protocols reached the threshold value of 500 nuclei / 
well. The other protocols may show a large percentage of positive cells, but this may not be 
representative of the protocol as only few cells survived. ERα shows robust expression in all 
protocols with 20 – 60% of cells showing ERα expression. OTR expression is more variable, 
and the number of OTR positive cells is low in some protocols, indicating that further 
maturation may be necessary. αSMA expression had generally increased, with noticeable 
increases in αSMA positive cells in protocol 11 compared to the early stage. The  
combination of all the markers shows that protocol 11 has the most robust overall 
expression of the markers, with a large percentage of cells positive for the markers. Protocol 
19 also shows a large number of cells positive for ERα although less positive for αSMA and 
OTR and although protocol 17 has low numbers of positive cells for each of the markers, its 
continuation from the Early Exit makes it interesting to further investigate. 
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 APPENDIX E: COMPLETE FINGERPRINT ANALYSIS  
The fingerprint analysis shows any pathways that are shared by 2 or more beads and can be 
ordered in various ways, by descending number of matches (matching media), number of 
beads, or increasing probability, these are all supplied for the Early and Combined Exits in 
Appendix E. Appendix E1 shows the fingerprint analysis for the Early Exit sorted by the number 
of matches, Appendix E2 is ordered by the number of beads and Appendix E3 ordered by the 
probabilityfrom the lowest probability (very significant) to the highest (most likely by chance). 
Appendix E4 shows the fingerprint analysis for the combined exits ordered by the number of 
matches, Appendix E5 is ordered based on the number of beads and Appendix E6 is ordered   
by probability, from the lowest probability (very significant) to the highest (most likely by 
chance). The lower the probability, the less likely the bead passed through a certain 
combination of media by chance. The analysis provides information on the number of 
matching Stages, the number of beads in that pathway and the probability followed by the 
media of each Stage of these pathways and finally all the bead IDs that follow this pathway. 
The numbers in the splits represent the media numbers, with 0 representing multiple possible 
conditions or both cell lines. 
The probability was calculated by Ariadne by using a probability simulation, as was previously 
published (Tarunina et al., 2014). Probability values for the occurrence of given events by 
chance were obtained from computer simulation experiments. A Mersenne Twister random 
number generator was used to output uniformly distributed 32-bit integers which were scaled 
to cover 10,000, 1,000 or 100 possible pathways, when simulating common cell culture media 
on four out of four splits, three out of four splits or two out of four splits (Tarunina et al.,  
2014). Simulation begins by setting tally counters associated with each pathway to zero. To 
simulate probabilities for the screen, 96 paths were chosen at random and their counters 
incremented. Should any such counter exceed the specified threshold (2, 3, 4, 5, …, n beads  
per pathway), a positive result was recorded. Event probabilities were computed by repeating 
the process 100 million times and dividing the number of positive results by the total number 
of simulations, resulting in probability values accurate to eight decimal places. 
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Appendix E1: COMPLETE FINGERPRINT ANALYSIS OF THE EARLY EXIT ORDERED BY NUMBER OF MATCHES 
 
Matches 
 
Samples 
 
Probability  
Split   Bead IDs 1 2 3 4 
4 2 0.93230078 2 1 1 1 81 87       4 2 0.93230078 2 2 2 7 86 253       
4 2 0.93230078 2 2 2 8 58 123       
4 2 0.93230078 2 4 2 5 41 137       
4 2 0.93230078 2 4 4 3 158 205       
4 2 0.93230078 2 4 5 5 52 254       
4 2 0.93230078 2 8 1 7 70 242       
4 2 0.93230078 2 8 4 4 79 94       
3 8 0.00001404 2 1 1 0 18 28 36 81 87 114 124 157 
3 7 0.00022536 2 0 2 8 21 58 80 123 159 171 246  
3 6 0.00315986 2 4 2 0 41 71 98 137 144 171   
3 5 0.03787424 2 2 2 0 1 58 86 123 253    
3 5 0.03787424 2 0 2 5 1 39 41 95 137    
3 4 0.32785137 2 4 0 5 41 52 137 254     
3 4 0.32785137 2 5 2 0 29 111 159 201     
3 4 0.32785137 2 6 2 0 38 95 139 235     
3 4 0.32785137 2 8 1 0 70 168 182 242     
3 4 0.32785137 2 0 1 1 81 87 218 230     
3 4 0.32785137 2 0 2 2 38 50 98 203     
3 3 0.97083234 2 4 5 0 52 126 254      
3 3 0.97083234 2 4 0 3 74 158 205      
3 3 0.97083234 2 4 0 6 2 75 144      
3 3 0.97083234 2 8 4 0 79 94 167      
3 3 0.97083234 2 8 0 4 76 79 94      
3 3 0.97083234 2 9 0 5 39 54 170      
3 3 0.97083234 2 0 1 5 28 156 252      
3 3 0.97083234 2 0 1 7 18 70 242      
3 3 0.97083234 2 0 1 9 91 114 168      
3 3 0.97083234 2 0 2 1 29 71 139      
3 3 0.97083234 2 0 2 6 43 111 144      
3 3 0.97083234 2 0 2 7 86 201 253      
3 3 0.97083234 2 0 4 3 158 167 205      
3 3 0.97083234 2 0 4 4 79 94 229      
3 2 1 1 5 0 1 83 145       
3 2 1 1 0 4 7 4 186       
3 2 1 2 1 2 0 193 246       
3 2 1 2 1 4 0 210 229       
3 2 1 2 1 0 1 81 87       
3 2 1 2 1 0 2 35 124       
3 2 1 2 1 0 3 148 157       
3 2 1 2 1 0 4 193 229       
3 2 1 2 1 0 5 28 210       
3 2 1 2 2 5 0 130 187       
3 2 1 2 2 6 0 128 135       
3 2 1 2 2 0 1 12 130       
3 2 1 2 2 0 6 118 173       
3 2 1 2 2 0 7 86 253       
3 2 1 2 2 0 8 58 123       
3 2 1 2 2 0 9 135 187       
3 2 1 2 4 1 0 75 230       
3 2 1 2 4 4 0 158 205       
3 2 1 2 4 7 0 60 74       
3 2 1 2 4 0 1 71 230       
3 2 1 2 4 0 2 60 98       
3 2 1 2 4 0 4 126 204       
3 2 1 2 5 10 0 32 175       
3 2 1 2 5 0 3 32 129       
3 2 1 2 5 0 5 175 252       
3 2 1 2 6 1 0 62 166       
3 2 1 2 6 0 1 139 238       
3 2 1 2 6 0 7 61 66       
3 2 1 2 7 6 0 55 90       
3 2 1 2 7 0 5 90 156       
3 2 1 2 7 0 9 55 250       
3 2 1 2 8 0 2 67 182       
3 2 1 2 8 0 3 167 206       
3 2 1 2 8 0 7 70 242       
3 2 1 2 9 1 0 10 218       
3 2 1 2 9 2 0 39 50       
3 2 1 2 9 10 0 59 170       
3 2 1 2 9 0 3 10 59       
3 2 1 2 0 1 2 124 182       
3 2 1 2 0 1 3 10 157       
3 2 1 2 0 1 6 36 75       
3 2 1 2 0 3 3 92 206       
3 2 1 2 0 5 5 52 254       
3 2 1 2 0 6 3 128 129       
3 2 1 2 0 6 5 54 90       
3 2 1 2 0 6 9 55 135       
3 2 1 2 0 7 3 74 148       
3 2 1 2 0 10 3 32 59       
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3 2 1 2 0 10 5 170 175                     3 2 0.99611998 0 1 1 1 81 87                     
3 2 0.99611998 0 2 2 7 86 253                     
3 2 0.99611998 0 2 2 8 58 123                     
3 2 0.99611998 0 4 2 5 41 137                     
3 2 0.99611998 0 4 4 3 158 205                     
3 2 0.99611998 0 4 5 5 52 254                     
3 2 0.99611998 0 8 1 7 70 242                     
3 2 0.99611998 0 8 3 3 206 215                     
3 2 0.99611998 0 8 4 4 79 94                     
2 27 0 2 0 2 0 1 21 29 38 39 41 43 50 58 71 80 86 95 98 111 123 137 139 144 159 171 193 
                        201 203 235 246 253 
2 21 0.00001294 2 0 1 0 10 18 28 36 62 70 75 81 87 91 114 124 156 157 166 168 182 218 230 242 252  
2 18 0.00062503 2 4 0 0 2 41 52 60 71 74 75 98 126 137 144 158 171 204 205 230 245 254     
2 16 0.00595027 2 0 0 5 1 28 34 39 41 52 54 90 95 137 156 170 175 210 252 254       
2 14 0.04313851 2 1 0 0 18 28 35 36 81 87 114 124 148 157 193 210 229 246         
2 14 0.04313851 2 0 0 3 10 32 59 74 92 128 129 148 157 158 167 205 206 235         
2 13 0.10223377 2 2 0 0 1 12 58 86 118 123 128 130 135 173 187 222 253          
2 12 0.21515463 2 8 0 0 34 67 70 76 79 80 94 167 168 182 206 242           
2 11 0.38503423 2 0 0 2 35 38 50 60 65 67 98 124 182 203 222            
2 10 0.56884275 2 0 0 1 12 29 71 81 87 130 139 218 230 238             
2 9 0.74064264 2 6 0 0 38 61 62 66 95 139 166 235 238              
2 9 0.74064264 2 0 4 0 61 65 79 94 158 167 205 210 229              
2 9 0.74064264 2 0 0 8 21 58 62 80 102 123 159 171 246              
2 8 0.91535035 2 5 0 0 29 32 111 129 159 175 201 252               
2 8 0.91535035 2 9 0 0 10 39 50 54 59 102 170 218               
2 8 0.91535035 2 0 6 0 2 54 55 67 90 128 129 135               
2 8 0.91535035 2 0 0 4 76 79 94 126 166 193 204 229               
2 8 0.91535035 2 0 0 6 2 36 43 75 111 118 144 173               
2 8 0.91535035 2 0 0 7 18 61 66 70 86 201 242 253               
2 8 0.91535035 2 0 0 9 55 91 114 135 168 187 245 250               
2 8 0.0010976 0 1 1 0 18 28 36 81 87 114 124 157               
2 7 0.99526331 2 0 10 0 32 59 170 173 175 238 245                
2 7 0.00909277 0 4 2 0 41 71 98 119 137 144 171                
2 7 0.00909277 0 0 2 8 21 58 80 123 159 171 246                
2 6 0.99999842 2 7 0 0 21 55 65 90 156 250                 
2 6 0.06414353 0 0 2 5 1 39 41 95 137 185                 
2 5 1 2 0 3 0 12 35 66 92 206                  
2 5 1 2 0 5 0 52 126 130 187 254                  
2 5 0.34340116 0 2 2 0 1 58 86 123 253                  
2 4 1 1 0 0 7 4 42 163 186                   
2 4 1 2 0 7 0 60 74 76 148                   
2 4 1 2 0 8 0 102 118 204 250                   
2 4 0.90746194 0 4 0 3 74 119 158 205                   
2 4 0.90746194 0 4 0 5 41 52 137 254                   
2 4 0.90746194 0 5 2 0 29 111 159 201                   
2 4 0.90746194 0 6 2 0 38 95 139 235                   
2 4 0.90746194 0 8 1 0 70 168 182 242                   
2 4 0.90746194 0 0 1 1 81 87 218 230                   
2 4 0.90746194 0 0 2 2 38 50 98 203                   
2 4 0.90746194 0 0 2 7 42 86 201 253                   
2 3 1 1 10 0 0 6 163 208                    
2 3 1 1 0 2 0 42 119 185                    
2 3 1 1 0 0 1 83 145 198                    
2 3 1 2 3 0 0 43 91 92                    
2 3 0.99999791 0 1 4 0 4 210 229                    
2 3 0.99999791 0 4 5 0 52 126 254                    
2 3 0.99999791 0 4 0 6 2 75 144                    
2 3 0.99999791 0 5 0 1 29 83 145                    
2 3 0.99999791 0 8 4 0 79 94 167                    
2 3 0.99999791 0 8 0 3 167 206 215                    
2 3 0.99999791 0 8 0 4 76 79 94                    
2 3 0.99999791 0 9 2 0 39 42 50                    
2 3 0.99999791 0 9 0 5 39 54 170                    
2 3 0.99999791 0 0 1 5 28 156 252                    
2 3 0.99999791 0 0 1 7 18 70 242                    
2 3 0.99999791 0 0 1 9 91 114 168                    
2 3 0.99999791 0 0 2 1 29 71 139                    
2 3 0.99999791 0 0 2 6 43 111 144                    
2 3 0.99999791 0 0 3 3 92 206 215                    
2 3 0.99999791 0 0 4 3 158 167 205                    
2 3 0.99999791 0 0 4 4 79 94 229                    
2 3 0.99999791 0 0 4 7 4 61 186                    
2 2 1 1 3 0 0 185 198                     
2 2 1 1 5 0 0 83 145                     
2 2 1 1 0 3 0 208 215                     
2 2 1 1 0 4 0 4 186                     
2 2 1 1 0 0 3 119 215                     
2 2 1 2 0 9 0 34 222                     
2 2 1 0 1 2 0 193 246                     
2 2 1 0 1 0 1 81 87                     
2 2 1 0 1 0 2 35 124                     
2 2 1 0 1 0 3 148 157                     
2 2 1 0 1 0 4 193 229                     
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2 2 1 0 1 0 5 28 210 
2 2 1 0 1 0 7 4 18 
2 2 1 0 2 5 0 130 187 
2 2 1 0 2 6 0 128 135 
2 2 1 0 2 0 1 12 130 
2 2 1 0 2 0 6 118 173 
2 2 1 0 2 0 7 86 253 
2 2 1 0 2 0 8 58 123 
2 2 1 0 2 0 9 135 187 
2 2 1 0 3 2 0 43 185 
2 2 1 0 4 1 0 75 230 
2 2 1 0 4 4 0 158 205 
2 2 1 0 4 7 0 60 74 
2 2 1 0 4 0 1 71 230 
2 2 1 0 4 0 2 60 98 
2 2 1 0 4 0 4 126 204 
2 2 1 0 5 10 0 32 175 
2 2 1 0 5 0 3 32 129 
2 2 1 0 5 0 5 175 252 
2 2 1 0 6 1 0 62 166 
2 2 1 0 6 0 1 139 238 
2 2 1 0 6 0 7 61 66 
2 2 1 0 7 4 0 65 186 
2 2 1 0 7 6 0 55 90 
2 2 1 0 7 0 5 90 156 
2 2 1 0 7 0 9 55 250 
2 2 1 0 8 3 0 206 215 
2 2 1 0 8 0 2 67 182 
2 2 1 0 8 0 7 70 242 
2 2 1 0 9 1 0 10 218 
2 2 1 0 9 10 0 59 170 
2 2 1 0 9 0 3 10 59 
2 2 1 0 0 1 2 124 182 
2 2 1 0 0 1 3 10 157 
2 2 1 0 0 1 6 36 75 
2 2 1 0 0 2 3 119 235 
2 2 1 0 0 5 1 130 198 
2 2 1 0 0 5 5 52 254 
2 2 1 0 0 6 3 128 129 
2 2 1 0 0 6 5 54 90 
2 2 1 0 0 6 9 55 135 
2 2 1 0 0 7 3 74 148 
2 2 1 0 0 10 3 32 59 
2 2 1 0 0 10 5 170 175 
2 2 1 0 0 10 9 6 245 
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Appendix E2: COMPLETE FINGERPRINT ANALYSIS OF THE EARLY EXIT ORDERED BY NUMBER OF BEADS 
 
Matches 
 
Samples 
 
Probability  
Split   Bead IDs 1 2 3 4 
2 27 0 2 0 2 0 1 21 29 38 39 41 43 50 58 71 80 86 95 98 111 123 137 139 144 159 171 193 
                        201 203 235 246 253 
2 21 0.00001294 2 0 1 0 10 18 28 36 62 70 75 81 87 91 114 124 156 157 166 168 182 218 230 242 252  
2 18 0.00062503 2 4 0 0 2 41 52 60 71 74 75 98 126 137 144 158 171 204 205 230 245 254     
2 16 0.00595027 2 0 0 5 1 28 34 39 41 52 54 90 95 137 156 170 175 210 252 254       
2 14 0.04313851 2 1 0 0 18 28 35 36 81 87 114 124 148 157 193 210 229 246         
2 14 0.04313851 2 0 0 3 10 32 59 74 92 128 129 148 157 158 167 205 206 235         
2 13 0.10223377 2 2 0 0 1 12 58 86 118 123 128 130 135 173 187 222 253          
2 12 0.21515463 2 8 0 0 34 67 70 76 79 80 94 167 168 182 206 242           
2 11 0.38503423 2 0 0 2 35 38 50 60 65 67 98 124 182 203 222            
2 10 0.56884275 2 0 0 1 12 29 71 81 87 130 139 218 230 238             
2 9 0.74064264 2 6 0 0 38 61 62 66 95 139 166 235 238              
2 9 0.74064264 2 0 4 0 61 65 79 94 158 167 205 210 229              
2 9 0.74064264 2 0 0 8 21 58 62 80 102 123 159 171 246              
3 8 0.00001404 2 1 1 0 18 28 36 81 87 114 124 157               
2 8 0.91535035 2 5 0 0 29 32 111 129 159 175 201 252               
2 8 0.91535035 2 9 0 0 10 39 50 54 59 102 170 218               
2 8 0.91535035 2 0 6 0 2 54 55 67 90 128 129 135               
2 8 0.91535035 2 0 0 4 76 79 94 126 166 193 204 229               
2 8 0.91535035 2 0 0 6 2 36 43 75 111 118 144 173               
2 8 0.91535035 2 0 0 7 18 61 66 70 86 201 242 253               
2 8 0.91535035 2 0 0 9 55 91 114 135 168 187 245 250               
2 8 0.0010976 0 1 1 0 18 28 36 81 87 114 124 157               
3 7 0.00022536 2 0 2 8 21 58 80 123 159 171 246                
2 7 0.99526331 2 0 10 0 32 59 170 173 175 238 245                
2 7 0.00909277 0 4 2 0 41 71 98 119 137 144 171                
2 7 0.00909277 0 0 2 8 21 58 80 123 159 171 246                
3 6 0.00315986 2 4 2 0 41 71 98 137 144 171                 
2 6 0.99999842 2 7 0 0 21 55 65 90 156 250                 
2 6 0.06414353 0 0 2 5 1 39 41 95 137 185                 
3 5 0.03787424 2 2 2 0 1 58 86 123 253                  
3 5 0.03787424 2 0 2 5 1 39 41 95 137                  
2 5 1 2 0 3 0 12 35 66 92 206                  
2 5 1 2 0 5 0 52 126 130 187 254                  
2 5 0.34340116 0 2 2 0 1 58 86 123 253                  
3 4 0.32785137 2 4 0 5 41 52 137 254                   
3 4 0.32785137 2 5 2 0 29 111 159 201                   
3 4 0.32785137 2 6 2 0 38 95 139 235                   
3 4 0.32785137 2 8 1 0 70 168 182 242                   
3 4 0.32785137 2 0 1 1 81 87 218 230                   
3 4 0.32785137 2 0 2 2 38 50 98 203                   
2 4 1 1 0 0 7 4 42 163 186                   
2 4 1 2 0 7 0 60 74 76 148                   
2 4 1 2 0 8 0 102 118 204 250                   
2 4 0.90746194 0 4 0 3 74 119 158 205                   
2 4 0.90746194 0 4 0 5 41 52 137 254                   
2 4 0.90746194 0 5 2 0 29 111 159 201                   
2 4 0.90746194 0 6 2 0 38 95 139 235                   
2 4 0.90746194 0 8 1 0 70 168 182 242                   
2 4 0.90746194 0 0 1 1 81 87 218 230                   
2 4 0.90746194 0 0 2 2 38 50 98 203                   
2 4 0.90746194 0 0 2 7 42 86 201 253                   
3 3 0.97083234 2 4 5 0 52 126 254                    
3 3 0.97083234 2 4 0 3 74 158 205                    
3 3 0.97083234 2 4 0 6 2 75 144                    
3 3 0.97083234 2 8 4 0 79 94 167                    
3 3 0.97083234 2 8 0 4 76 79 94                    
3 3 0.97083234 2 9 0 5 39 54 170                    
3 3 0.97083234 2 0 1 5 28 156 252                    
3 3 0.97083234 2 0 1 7 18 70 242                    
3 3 0.97083234 2 0 1 9 91 114 168                    
3 3 0.97083234 2 0 2 1 29 71 139                    
3 3 0.97083234 2 0 2 6 43 111 144                    
3 3 0.97083234 2 0 2 7 86 201 253                    
3 3 0.97083234 2 0 4 3 158 167 205                    
3 3 0.97083234 2 0 4 4 79 94 229                    
2 3 1 1 10 0 0 6 163 208                    
2 3 1 1 0 2 0 42 119 185                    
2 3 1 1 0 0 1 83 145 198                    
2 3 1 2 3 0 0 43 91 92                    
2 3 0.99999791 0 1 4 0 4 210 229                    
2 3 0.99999791 0 4 5 0 52 126 254                    
2 3 0.99999791 0 4 0 6 2 75 144                    
2 3 0.99999791 0 5 0 1 29 83 145                    
2 3 0.99999791 0 8 4 0 79 94 167                    
2 3 0.99999791 0 8 0 3 167 206 215                    
2 3 0.99999791 0 8 0 4 76 79 94                    
2 3 0.99999791 0 9 2 0 39 42 50                    
2 3 0.99999791 0 9 0 5 39 54 170                    
2 3 0.99999791 0 0 1 5 28 156 252                    
2 3 0.99999791 0 0 1 7 18 70 242                    
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2 3 0.99999791 0 0 1 9 91 114 168 
2 3 0.99999791 0 0 2 1 29 71 139 
2 3 0.99999791 0 0 2 6 43 111 144 
2 3 0.99999791 0 0 3 3 92 206 215 
2 3 0.99999791 0 0 4 3 158 167 205 
2 3 0.99999791 0 0 4 4 79 94 229 
2 3 0.99999791 0 0 4 7 4 61 186 
4 2 0.93230078 2 1 1 1 81 87  
4 2 0.93230078 2 2 2 7 86 253  
4 2 0.93230078 2 2 2 8 58 123  
4 2 0.93230078 2 4 2 5 41 137  
4 2 0.93230078 2 4 4 3 158 205  
4 2 0.93230078 2 4 5 5 52 254  
4 2 0.93230078 2 8 1 7 70 242  
4 2 0.93230078 2 8 4 4 79 94  
3 2 1 1 5 0 1 83 145  
3 2 1 1 0 4 7 4 186  
3 2 1 2 1 2 0 193 246  
3 2 1 2 1 4 0 210 229  
3 2 1 2 1 0 1 81 87  
3 2 1 2 1 0 2 35 124  
3 2 1 2 1 0 3 148 157  
3 2 1 2 1 0 4 193 229  
3 2 1 2 1 0 5 28 210  
3 2 1 2 2 5 0 130 187  
3 2 1 2 2 6 0 128 135  
3 2 1 2 2 0 1 12 130  
3 2 1 2 2 0 6 118 173  
3 2 1 2 2 0 7 86 253  
3 2 1 2 2 0 8 58 123  
3 2 1 2 2 0 9 135 187  
3 2 1 2 4 1 0 75 230  
3 2 1 2 4 4 0 158 205  
3 2 1 2 4 7 0 60 74  
3 2 1 2 4 0 1 71 230  
3 2 1 2 4 0 2 60 98  
3 2 1 2 4 0 4 126 204  
3 2 1 2 5 10 0 32 175  
3 2 1 2 5 0 3 32 129  
3 2 1 2 5 0 5 175 252  
3 2 1 2 6 1 0 62 166  
3 2 1 2 6 0 1 139 238  
3 2 1 2 6 0 7 61 66  
3 2 1 2 7 6 0 55 90  
3 2 1 2 7 0 5 90 156  
3 2 1 2 7 0 9 55 250  
3 2 1 2 8 0 2 67 182  
3 2 1 2 8 0 3 167 206  
3 2 1 2 8 0 7 70 242  
3 2 1 2 9 1 0 10 218  
3 2 1 2 9 2 0 39 50  
3 2 1 2 9 10 0 59 170  
3 2 1 2 9 0 3 10 59  
3 2 1 2 0 1 2 124 182  
3 2 1 2 0 1 3 10 157  
3 2 1 2 0 1 6 36 75  
3 2 1 2 0 3 3 92 206  
3 2 1 2 0 5 5 52 254  
3 2 1 2 0 6 3 128 129  
3 2 1 2 0 6 5 54 90  
3 2 1 2 0 6 9 55 135  
3 2 1 2 0 7 3 74 148  
3 2 1 2 0 10 3 32 59  
3 2 1 2 0 10 5 170 175  
3 2 0.99611998 0 1 1 1 81 87  
3 2 0.99611998 0 2 2 7 86 253  
3 2 0.99611998 0 2 2 8 58 123  
3 2 0.99611998 0 4 2 5 41 137  
3 2 0.99611998 0 4 4 3 158 205  
3 2 0.99611998 0 4 5 5 52 254  
3 2 0.99611998 0 8 1 7 70 242  
3 2 0.99611998 0 8 3 3 206 215  
3 2 0.99611998 0 8 4 4 79 94  
2 2 1 1 3 0 0 185 198  
2 2 1 1 5 0 0 83 145  
2 2 1 1 0 3 0 208 215  
2 2 1 1 0 4 0 4 186  
2 2 1 1 0 0 3 119 215  
2 2 1 2 0 9 0 34 222  
2 2 1 0 1 2 0 193 246  
2 2 1 0 1 0 1 81 87  
2 2 1 0 1 0 2 35 124  
2 2 1 0 1 0 3 148 157  
2 2 1 0 1 0 4 193 229  
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2 2 1 0 1 0 5 28 210 
2 2 1 0 1 0 7 4 18 
2 2 1 0 2 5 0 130 187 
2 2 1 0 2 6 0 128 135 
2 2 1 0 2 0 1 12 130 
2 2 1 0 2 0 6 118 173 
2 2 1 0 2 0 7 86 253 
2 2 1 0 2 0 8 58 123 
2 2 1 0 2 0 9 135 187 
2 2 1 0 3 2 0 43 185 
2 2 1 0 4 1 0 75 230 
2 2 1 0 4 4 0 158 205 
2 2 1 0 4 7 0 60 74 
2 2 1 0 4 0 1 71 230 
2 2 1 0 4 0 2 60 98 
2 2 1 0 4 0 4 126 204 
2 2 1 0 5 10 0 32 175 
2 2 1 0 5 0 3 32 129 
2 2 1 0 5 0 5 175 252 
2 2 1 0 6 1 0 62 166 
2 2 1 0 6 0 1 139 238 
2 2 1 0 6 0 7 61 66 
2 2 1 0 7 4 0 65 186 
2 2 1 0 7 6 0 55 90 
2 2 1 0 7 0 5 90 156 
2 2 1 0 7 0 9 55 250 
2 2 1 0 8 3 0 206 215 
2 2 1 0 8 0 2 67 182 
2 2 1 0 8 0 7 70 242 
2 2 1 0 9 1 0 10 218 
2 2 1 0 9 10 0 59 170 
2 2 1 0 9 0 3 10 59 
2 2 1 0 0 1 2 124 182 
2 2 1 0 0 1 3 10 157 
2 2 1 0 0 1 6 36 75 
2 2 1 0 0 2 3 119 235 
2 2 1 0 0 5 1 130 198 
2 2 1 0 0 5 5 52 254 
2 2 1 0 0 6 3 128 129 
2 2 1 0 0 6 5 54 90 
2 2 1 0 0 6 9 55 135 
2 2 1 0 0 7 3 74 148 
2 2 1 0 0 10 3 32 59 
2 2 1 0 0 10 5 170 175 
2 2 1 0 0 10 9 6 245 
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Appendix E3: COMPLETE FINGERPRINT ANALYSIS OF THE EARLY EXIT ORDERED BY PROBABILITY 
 
Matches 
 
Samples 
 
Probability  
Split   Bead IDs 1 2 3 4 
2 27 0 2 0 2 0 1 21 29 38 39 41 43 50 58 71 80 86 95 98 111 123 137 139 144 159 171 193 
                        201 203 235 246 253 
2 21 0.00001294 2 0 1 0 10 18 28 36 62 70 75 81 87 91 114 124 156 157 166 168 182 218 230 242 252  
3 8 0.00001404 2 1 1 0 18 28 36 81 87 114 124 157               
3 7 0.00022536 2 0 2 8 21 58 80 123 159 171 246                
2 18 0.00062503 2 4 0 0 2 41 52 60 71 74 75 98 126 137 144 158 171 204 205 230 245 254     
2 8 0.0010976 0 1 1 0 18 28 36 81 87 114 124 157               
3 6 0.00315986 2 4 2 0 41 71 98 137 144 171                 
2 16 0.00595027 2 0 0 5 1 28 34 39 41 52 54 90 95 137 156 170 175 210 252 254       
2 7 0.00909277 0 4 2 0 41 71 98 119 137 144 171                
2 7 0.00909277 0 0 2 8 21 58 80 123 159 171 246                
3 5 0.03787424 2 2 2 0 1 58 86 123 253                  
3 5 0.03787424 2 0 2 5 1 39 41 95 137                  
2 14 0.04313851 2 1 0 0 18 28 35 36 81 87 114 124 148 157 193 210 229 246         
2 14 0.04313851 2 0 0 3 10 32 59 74 92 128 129 148 157 158 167 205 206 235         
2 6 0.06414353 0 0 2 5 1 39 41 95 137 185                 
2 13 0.10223377 2 2 0 0 1 12 58 86 118 123 128 130 135 173 187 222 253          
2 12 0.21515463 2 8 0 0 34 67 70 76 79 80 94 167 168 182 206 242           
3 4 0.32785137 2 4 0 5 41 52 137 254                   
3 4 0.32785137 2 5 2 0 29 111 159 201                   
3 4 0.32785137 2 6 2 0 38 95 139 235                   
3 4 0.32785137 2 8 1 0 70 168 182 242                   
3 4 0.32785137 2 0 1 1 81 87 218 230                   
3 4 0.32785137 2 0 2 2 38 50 98 203                   
2 5 0.34340116 0 2 2 0 1 58 86 123 253                  
2 11 0.38503423 2 0 0 2 35 38 50 60 65 67 98 124 182 203 222            
2 10 0.56884275 2 0 0 1 12 29 71 81 87 130 139 218 230 238             
2 9 0.74064264 2 6 0 0 38 61 62 66 95 139 166 235 238              
2 9 0.74064264 2 0 4 0 61 65 79 94 158 167 205 210 229              
2 9 0.74064264 2 0 0 8 21 58 62 80 102 123 159 171 246              
2 4 0.90746194 0 4 0 3 74 119 158 205                   
2 4 0.90746194 0 4 0 5 41 52 137 254                   
2 4 0.90746194 0 5 2 0 29 111 159 201                   
2 4 0.90746194 0 6 2 0 38 95 139 235                   
2 4 0.90746194 0 8 1 0 70 168 182 242                   
2 4 0.90746194 0 0 1 1 81 87 218 230                   
2 4 0.90746194 0 0 2 2 38 50 98 203                   
2 4 0.90746194 0 0 2 7 42 86 201 253                   
2 8 0.91535035 2 5 0 0 29 32 111 129 159 175 201 252               
2 8 0.91535035 2 9 0 0 10 39 50 54 59 102 170 218               
2 8 0.91535035 2 0 6 0 2 54 55 67 90 128 129 135               
2 8 0.91535035 2 0 0 4 76 79 94 126 166 193 204 229               
2 8 0.91535035 2 0 0 6 2 36 43 75 111 118 144 173               
2 8 0.91535035 2 0 0 7 18 61 66 70 86 201 242 253               
2 8 0.91535035 2 0 0 9 55 91 114 135 168 187 245 250               
4 2 0.93230078 2 1 1 1 81 87                     
4 2 0.93230078 2 2 2 7 86 253                     
4 2 0.93230078 2 2 2 8 58 123                     
4 2 0.93230078 2 4 2 5 41 137                     
4 2 0.93230078 2 4 4 3 158 205                     
4 2 0.93230078 2 4 5 5 52 254                     
4 2 0.93230078 2 8 1 7 70 242                     
4 2 0.93230078 2 8 4 4 79 94                     
3 3 0.97083234 2 4 5 0 52 126 254                    
3 3 0.97083234 2 4 0 3 74 158 205                    
3 3 0.97083234 2 4 0 6 2 75 144                    
3 3 0.97083234 2 8 4 0 79 94 167                    
3 3 0.97083234 2 8 0 4 76 79 94                    
3 3 0.97083234 2 9 0 5 39 54 170                    
3 3 0.97083234 2 0 1 5 28 156 252                    
3 3 0.97083234 2 0 1 7 18 70 242                    
3 3 0.97083234 2 0 1 9 91 114 168                    
3 3 0.97083234 2 0 2 1 29 71 139                    
3 3 0.97083234 2 0 2 6 43 111 144                    
3 3 0.97083234 2 0 2 7 86 201 253                    
3 3 0.97083234 2 0 4 3 158 167 205                    
3 3 0.97083234 2 0 4 4 79 94 229                    
2 7 0.99526331 2 0 10 0 32 59 170 173 175 238 245                
3 2 0.99611998 0 1 1 1 81 87                     
3 2 0.99611998 0 2 2 7 86 253                     
3 2 0.99611998 0 2 2 8 58 123                     
3 2 0.99611998 0 4 2 5 41 137                     
3 2 0.99611998 0 4 4 3 158 205                     
3 2 0.99611998 0 4 5 5 52 254                     
3 2 0.99611998 0 8 1 7 70 242                     
3 2 0.99611998 0 8 3 3 206 215                     
3 2 0.99611998 0 8 4 4 79 94                     
2 3 0.99999791 0 1 4 0 4 210 229                    
2 3 0.99999791 0 4 5 0 52 126 254                    
2 3 0.99999791 0 4 0 6 2 75 144                    
2 3 0.99999791 0 5 0 1 29 83 145                    
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2 3 0.99999791 0 8 4 0 79 94 167    2 3 0.99999791 0 8 0 3 167 206 215    
2 3 0.99999791 0 8 0 4 76 79 94    
2 3 0.99999791 0 9 2 0 39 42 50    
2 3 0.99999791 0 9 0 5 39 54 170    
2 3 0.99999791 0 0 1 5 28 156 252    
2 3 0.99999791 0 0 1 7 18 70 242    
2 3 0.99999791 0 0 1 9 91 114 168    
2 3 0.99999791 0 0 2 1 29 71 139    
2 3 0.99999791 0 0 2 6 43 111 144    
2 3 0.99999791 0 0 3 3 92 206 215    
2 3 0.99999791 0 0 4 3 158 167 205    
2 3 0.99999791 0 0 4 4 79 94 229    
2 3 0.99999791 0 0 4 7 4 61 186    
2 6 0.99999842 2 7 0 0 21 55 65 90 156 250 
2 2 1 1 3 0 0 185 198     
3 2 1 1 5 0 1 83 145     
2 2 1 1 5 0 0 83 145     
2 3 1 1 10 0 0 6 163 208    
2 3 1 1 0 2 0 42 119 185    
2 2 1 1 0 3 0 208 215     
3 2 1 1 0 4 7 4 186     
2 2 1 1 0 4 0 4 186     
2 3 1 1 0 0 1 83 145 198    
2 2 1 1 0 0 3 119 215     
2 4 1 1 0 0 7 4 42 163 186   
3 2 1 2 1 2 0 193 246     
3 2 1 2 1 4 0 210 229     
3 2 1 2 1 0 1 81 87     
3 2 1 2 1 0 2 35 124     
3 2 1 2 1 0 3 148 157     
3 2 1 2 1 0 4 193 229     
3 2 1 2 1 0 5 28 210     
3 2 1 2 2 5 0 130 187     
3 2 1 2 2 6 0 128 135     
3 2 1 2 2 0 1 12 130     
3 2 1 2 2 0 6 118 173     
3 2 1 2 2 0 7 86 253     
3 2 1 2 2 0 8 58 123     
3 2 1 2 2 0 9 135 187     
2 3 1 2 3 0 0 43 91 92    
3 2 1 2 4 1 0 75 230     
3 2 1 2 4 4 0 158 205     
3 2 1 2 4 7 0 60 74     
3 2 1 2 4 0 1 71 230     
3 2 1 2 4 0 2 60 98     
3 2 1 2 4 0 4 126 204     
3 2 1 2 5 10 0 32 175     
3 2 1 2 5 0 3 32 129     
3 2 1 2 5 0 5 175 252     
3 2 1 2 6 1 0 62 166     
3 2 1 2 6 0 1 139 238     
3 2 1 2 6 0 7 61 66     
3 2 1 2 7 6 0 55 90     
3 2 1 2 7 0 5 90 156     
3 2 1 2 7 0 9 55 250     
3 2 1 2 8 0 2 67 182     
3 2 1 2 8 0 3 167 206     
3 2 1 2 8 0 7 70 242     
3 2 1 2 9 1 0 10 218     
3 2 1 2 9 2 0 39 50     
3 2 1 2 9 10 0 59 170     
3 2 1 2 9 0 3 10 59     
3 2 1 2 0 1 2 124 182     
3 2 1 2 0 1 3 10 157     
3 2 1 2 0 1 6 36 75     
3 2 1 2 0 3 3 92 206     
2 5 1 2 0 3 0 12 35 66 92 206  
3 2 1 2 0 5 5 52 254     
2 5 1 2 0 5 0 52 126 130 187 254  
3 2 1 2 0 6 3 128 129     
3 2 1 2 0 6 5 54 90     
3 2 1 2 0 6 9 55 135     
3 2 1 2 0 7 3 74 148     
2 4 1 2 0 7 0 60 74 76 148   
2 4 1 2 0 8 0 102 118 204 250   
2 2 1 2 0 9 0 34 222     
3 2 1 2 0 10 3 32 59     
3 2 1 2 0 10 5 170 175     
2 2 1 0 1 2 0 193 246     
2 2 1 0 1 0 1 81 87     
2 2 1 0 1 0 2 35 124     
2 2 1 0 1 0 3 148 157     
2 2 1 0 1 0 4 193 229     
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2 2 1 0 1 0 5 28 210 
2 2 1 0 1 0 7 4 18 
2 2 1 0 2 5 0 130 187 
2 2 1 0 2 6 0 128 135 
2 2 1 0 2 0 1 12 130 
2 2 1 0 2 0 6 118 173 
2 2 1 0 2 0 7 86 253 
2 2 1 0 2 0 8 58 123 
2 2 1 0 2 0 9 135 187 
2 2 1 0 3 2 0 43 185 
2 2 1 0 4 1 0 75 230 
2 2 1 0 4 4 0 158 205 
2 2 1 0 4 7 0 60 74 
2 2 1 0 4 0 1 71 230 
2 2 1 0 4 0 2 60 98 
2 2 1 0 4 0 4 126 204 
2 2 1 0 5 10 0 32 175 
2 2 1 0 5 0 3 32 129 
2 2 1 0 5 0 5 175 252 
2 2 1 0 6 1 0 62 166 
2 2 1 0 6 0 1 139 238 
2 2 1 0 6 0 7 61 66 
2 2 1 0 7 4 0 65 186 
2 2 1 0 7 6 0 55 90 
2 2 1 0 7 0 5 90 156 
2 2 1 0 7 0 9 55 250 
2 2 1 0 8 3 0 206 215 
2 2 1 0 8 0 2 67 182 
2 2 1 0 8 0 7 70 242 
2 2 1 0 9 1 0 10 218 
2 2 1 0 9 10 0 59 170 
2 2 1 0 9 0 3 10 59 
2 2 1 0 0 1 2 124 182 
2 2 1 0 0 1 3 10 157 
2 2 1 0 0 1 6 36 75 
2 2 1 0 0 2 3 119 235 
2 2 1 0 0 5 1 130 198 
2 2 1 0 0 5 5 52 254 
2 2 1 0 0 6 3 128 129 
2 2 1 0 0 6 5 54 90 
2 2 1 0 0 6 9 55 135 
2 2 1 0 0 7 3 74 148 
2 2 1 0 0 10 3 32 59 
2 2 1 0 0 10 5 170 175 
2 2 1 0 0 10 9 6 245 
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Appendix E4: COMPLETE FINGERPRINT ANALYSIS OF THE FINAL EXIT ORDERED BY NUMBER OF MATCHES 
 
Matches 
 
Samples 
 
Probability   
Split   Bead IDs 1 2 3 4 5 
5 2 0.99930654 2 1 4 10 8 403 425    5 2 0.99930654 2 5 1 1 1 302 331    
5 2 0.99930654 2 5 2 1 8 413 420    
5 2 0.99930654 2 5 2 10 1 301 307    
5 2 0.99930654 2 5 5 4 8 416 443    
5 2 0.99930654 2 6 2 10 1 263 314    
5 2 0.99930654 2 9 1 1 3 592 598    
5 2 0.99930654 2 9 1 9 7 692 768    
5 2 0.99930654 2 9 6 2 7 688 710    
5 2 0.99930654 2 9 8 8 3 615 620    
5 2 0.99930654 2 10 2 1 5 500 523    
4 5 0.02015554 2 9 0 9 7 650 676 692 768 780 
4 5 0.02015554 2 0 1 1 1 296 302 319 328 331 
4 5 0.02015554 2 0 2 10 1 263 301 307 314 327 
4 4 0.30386886 2 5 1 1 0 302 331 528 649  
4 4 0.30386886 2 5 2 1 0 413 420 491 821  
4 4 0.30386886 2 9 1 1 0 150 296 592 598  
4 4 0.30386886 2 9 1 0 3 539 592 598 614  
4 4 0.30386886 2 9 2 0 6 351 358 368 401  
4 4 0.30386886 2 9 7 0 7 666 683 700 780  
4 4 0.30386886 2 9 0 8 6 351 354 359 389  
4 4 0.30386886 2 0 1 8 3 537 563 614 632  
4 4 0.30386886 2 0 3 10 3 540 579 593 600  
4 3 0.99371495 2 1 1 6 0 195 685 743   
4 3 0.99371495 2 1 4 10 0 403 425 586   
4 3 0.99371495 2 1 5 0 7 636 757 776   
4 3 0.99371495 2 1 6 2 0 525 728 795   
4 3 0.99371495 2 1 6 9 0 453 568 958   
4 3 0.99371495 2 1 6 0 3 554 559 568   
4 3 0.99371495 2 1 7 7 0 483 588 656   
4 3 0.99371495 2 1 10 0 7 653 687 695   
4 3 0.99371495 2 1 0 8 7 679 687 711   
4 3 0.99371495 2 1 0 10 3 554 586 593   
4 3 0.99371495 2 5 1 8 0 563 633 857   
4 3 0.99371495 2 5 1 0 5 510 528 530   
4 3 0.99371495 2 5 1 0 7 633 649 672   
4 3 0.99371495 2 5 2 0 1 301 307 326   
4 3 0.99371495 2 5 3 9 0 366 534 640   
4 3 0.99371495 2 5 6 2 0 590 670 858   
4 3 0.99371495 2 5 6 9 0 297 518 796   
4 3 0.99371495 2 5 6 0 10 796 858 867   
4 3 0.99371495 2 5 0 2 6 364 386 391   
4 3 0.99371495 2 6 2 0 1 263 281 314   
4 3 0.99371495 2 6 0 1 7 657 693 705   
4 3 0.99371495 2 8 1 7 0 2 242 722   
4 3 0.99371495 2 8 2 0 1 257 276 315   
4 3 0.99371495 2 9 1 3 0 169 539 884   
4 3 0.99371495 2 9 1 8 0 354 515 614   
4 3 0.99371495 2 9 1 0 7 692 768 778   
4 3 0.99371495 2 9 2 2 0 209 368 921   
4 3 0.99371495 2 9 5 8 0 83 417 777   
4 3 0.99371495 2 9 6 0 7 650 688 710   
4 3 0.99371495 2 9 8 8 0 34 615 620   
4 3 0.99371495 2 9 0 2 7 688 700 710   
4 3 0.99371495 2 9 0 8 3 614 615 620   
4 3 0.99371495 2 0 1 2 7 654 672 681   
4 3 0.99371495 2 0 1 3 7 634 772 785   
4 3 0.99371495 2 0 4 8 2 724 739 747   
4 3 0.99371495 2 0 5 1 3 569 578 595   
4 3 0.99371495 2 0 6 2 7 670 688 710   
4 3 0.99371495 2 0 8 8 3 550 615 620   
4 3 0.220039 0 5 2 10 1 288 301 307   
4 3 0.220039 0 5 5 4 8 416 439 443   
4 2 1 1 2 0 2 9 911 961    
4 2 1 1 5 2 10 0 288 617    
4 2 1 1 5 9 1 0 15 350    
4 2 1 1 6 0 1 10 841 885    
4 2 1 1 8 0 8 10 805 837    
4 2 1 1 9 6 2 0 398 742    
4 2 1 1 9 8 0 1 293 324    
4 2 1 1 9 0 10 10 820 893    
4 2 1 1 10 7 1 0 428 631    
4 2 1 1 0 2 10 1 280 288    
4 2 1 1 0 5 3 8 419 429    
4 2 1 2 1 1 3 0 89 356    
4 2 1 2 1 1 7 0 177 410    
4 2 1 2 1 1 9 0 46 553    
4 2 1 2 1 2 7 0 573 822    
4 2 1 2 1 2 0 10 818 822    
4 2 1 2 1 3 8 0 291 679    
4 2 1 2 1 4 4 0 229 370    
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4 2 1 2 1 4 0 7 704 711 
4 2 1 2 1 4 0 8 403 425 
4 2 1 2 1 5 3 0 460 636 
4 2 1 2 1 5 0 10 824 880 
4 2 1 2 1 6 5 0 347 759 
4 2 1 2 1 6 8 0 506 559 
4 2 1 2 1 6 0 4 453 459 
4 2 1 2 1 6 0 5 506 525 
4 2 1 2 1 7 4 0 344 628 
4 2 1 2 1 7 9 0 464 673 
4 2 1 2 1 7 0 1 339 344 
4 2 1 2 1 7 0 3 588 628 
4 2 1 2 1 7 0 4 464 483 
4 2 1 2 1 7 0 7 656 673 
4 2 1 2 1 8 0 1 311 340 
4 2 1 2 1 10 0 4 447 458 
4 2 1 2 1 0 1 7 695 756 
4 2 1 2 1 0 3 6 356 365 
4 2 1 2 1 0 3 7 636 704 
4 2 1 2 1 0 4 6 353 370 
4 2 1 2 1 0 7 3 573 588 
4 2 1 2 1 0 7 4 447 483 
4 2 1 2 1 0 7 7 656 757 
4 2 1 2 1 0 8 1 266 291 
4 2 1 2 1 0 9 3 553 568 
4 2 1 2 1 0 9 4 453 464 
4 2 1 2 1 0 9 10 818 869 
4 2 1 2 1 0 10 8 403 425 
4 2 1 2 2 6 6 0 143 629 
4 2 1 2 2 6 0 3 610 629 
4 2 1 2 2 8 0 7 646 647 
4 2 1 2 2 10 6 0 105 639 
4 2 1 2 2 0 4 3 536 626 
4 2 1 2 2 0 9 10 809 813 
4 2 1 2 3 1 0 7 634 708 
4 2 1 2 4 1 2 0 334 681 
4 2 1 2 4 1 10 0 5 179 
4 2 1 2 4 1 0 7 681 772 
4 2 1 2 4 2 5 0 69 200 
4 2 1 2 4 2 6 0 38 76 
4 2 1 2 4 3 0 1 278 336 
4 2 1 2 4 3 0 3 571 624 
4 2 1 2 4 4 3 0 90 137 
4 2 1 2 4 5 5 0 211 254 
4 2 1 2 4 5 10 0 223 859 
4 2 1 2 4 5 0 3 541 595 
4 2 1 2 4 7 6 0 308 548 
4 2 1 2 4 7 0 1 275 308 
4 2 1 2 4 10 4 0 433 882 
4 2 1 2 4 0 4 1 275 337 
4 2 1 2 4 0 5 3 583 624 
4 2 1 2 4 0 7 1 265 336 
4 2 1 2 4 0 10 10 800 859 
4 2 1 2 5 1 2 0 391 672 
4 2 1 2 5 1 5 0 252 530 
4 2 1 2 5 1 0 1 302 331 
4 2 1 2 5 1 0 3 563 619 
4 2 1 2 5 2 8 0 91 326 
4 2 1 2 5 2 10 0 301 307 
4 2 1 2 5 2 0 4 478 491 
4 2 1 2 5 2 0 8 413 420 
4 2 1 2 5 3 10 0 412 540 
4 2 1 2 5 3 0 5 526 534 
4 2 1 2 5 5 4 0 416 443 
4 2 1 2 5 5 8 0 713 761 
4 2 1 2 5 5 0 8 416 443 
4 2 1 2 5 6 5 0 555 867 
4 2 1 2 5 6 0 3 555 590 
4 2 1 2 5 7 0 6 364 388 
4 2 1 2 5 7 0 7 709 771 
4 2 1 2 5 8 0 5 498 503 
4 2 1 2 5 9 0 6 386 400 
4 2 1 2 5 0 1 1 302 331 
4 2 1 2 5 0 1 7 649 771 
4 2 1 2 5 0 1 8 413 420 
4 2 1 2 5 0 2 3 552 590 
4 2 1 2 5 0 2 7 670 672 
4 2 1 2 5 0 4 4 465 475 
4 2 1 2 5 0 4 8 416 443 
4 2 1 2 5 0 6 3 544 619 
4 2 1 2 5 0 7 7 668 709 
4 2 1 2 5 0 8 5 498 520 
4 2 1 2 5 0 8 7 633 761 
4 2 1 2 5 0 8 10 793 857 
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4 2 1 2 5 0 9 5 518 534 
4 2 1 2 5 0 10 1 301 307 
4 2 1 2 5 0 10 3 540 577 
4 2 1 2 6 1 6 0 737 948 
4 2 1 2 6 1 8 0 221 537 
4 2 1 2 6 2 10 0 263 314 
4 2 1 2 6 4 0 7 677 693 
4 2 1 2 6 6 1 0 333 705 
4 2 1 2 6 6 0 7 637 705 
4 2 1 2 6 0 2 5 521 522 
4 2 1 2 6 0 4 9 901 954 
4 2 1 2 6 0 6 1 271 281 
4 2 1 2 6 0 9 10 794 881 
4 2 1 2 6 0 10 1 263 314 
4 2 1 2 7 1 5 0 88 575 
4 2 1 2 7 2 9 0 752 890 
4 2 1 2 7 5 0 3 569 603 
4 2 1 2 7 6 1 0 662 879 
4 2 1 2 7 10 10 0 316 423 
4 2 1 2 7 10 0 10 791 808 
4 2 1 2 7 0 10 1 259 316 
4 2 1 2 8 2 0 10 799 891 
4 2 1 2 8 4 4 0 11 26 
4 2 1 2 8 6 2 0 226 451 
4 2 1 2 8 6 7 0 454 616 
4 2 1 2 8 6 0 4 451 454 
4 2 1 2 8 6 0 7 645 760 
4 2 1 2 8 7 4 0 8 504 
4 2 1 2 8 0 4 7 690 760 
4 2 1 2 9 1 4 0 382 435 
4 2 1 2 9 1 9 0 692 768 
4 2 1 2 9 1 10 0 172 514 
4 2 1 2 9 1 0 5 514 515 
4 2 1 2 9 1 0 6 354 382 
4 2 1 2 9 2 3 0 358 576 
4 2 1 2 9 2 4 0 274 401 
4 2 1 2 9 2 8 0 351 731 
4 2 1 2 9 2 0 7 665 766 
4 2 1 2 9 3 0 6 378 392 
4 2 1 2 9 5 1 0 714 823 
4 2 1 2 9 5 10 0 203 664 
4 2 1 2 9 5 0 3 558 612 
4 2 1 2 9 5 0 5 507 531 
4 2 1 2 9 5 0 7 664 777 
4 2 1 2 9 5 0 10 823 860 
4 2 1 2 9 6 2 0 688 710 
4 2 1 2 9 6 10 0 148 482 
4 2 1 2 9 7 1 0 683 732 
4 2 1 2 9 8 7 0 492 862 
4 2 1 2 9 8 0 3 615 620 
4 2 1 2 9 9 1 0 485 699 
4 2 1 2 9 9 0 7 676 699 
4 2 1 2 9 10 3 0 218 493 
4 2 1 2 9 0 1 2 714 732 
4 2 1 2 9 0 1 3 592 598 
4 2 1 2 9 0 1 7 683 699 
4 2 1 2 9 0 2 9 921 936 
4 2 1 2 9 0 3 3 539 576 
4 2 1 2 9 0 4 6 382 401 
4 2 1 2 9 0 6 6 378 387 
4 2 1 2 9 0 7 7 665 778 
4 2 1 2 9 0 8 7 666 777 
4 2 1 2 10 2 1 0 500 523 
4 2 1 2 10 2 0 5 500 523 
4 2 1 2 10 8 4 0 481 863 
4 2 1 2 10 0 1 5 500 523 
4 2 1 2 10 0 3 7 669 785 
4 2 1 2 10 0 4 9 898 907 
4 2 1 2 10 0 8 3 599 632 
4 2 1 2 0 1 1 3 592 598 
4 2 1 2 0 1 5 5 524 530 
4 2 1 2 0 1 6 2 737 743 
4 2 1 2 0 1 8 5 515 517 
4 2 1 2 0 1 8 6 354 395 
4 2 1 2 0 1 9 7 692 768 
4 2 1 2 0 2 1 5 500 523 
4 2 1 2 0 2 1 8 413 420 
4 2 1 2 0 2 1 10 799 821 
4 2 1 2 0 2 4 1 274 315 
4 2 1 2 0 2 6 1 257 281 
4 2 1 2 0 2 8 2 729 731 
4 2 1 2 0 2 8 3 535 599 
4 2 1 2 0 2 9 2 725 752 
4 2 1 2 0 2 9 10 818 890 
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4 2 1 2 0 3 4 5 512 526                 4 2 1 2 0 3 6 1 271 287                 
4 2 1 2 0 4 10 8 403 425                 
4 2 1 2 0 5 1 10 811 823                 
4 2 1 2 0 5 4 8 416 443                 
4 2 1 2 0 5 6 10 824 860                 
4 2 1 2 0 5 7 3 541 603                 
4 2 1 2 0 5 8 7 761 777                 
4 2 1 2 0 5 9 5 509 531                 
4 2 1 2 0 5 10 10 803 859                 
4 2 1 2 0 6 1 3 570 610                 
4 2 1 2 0 6 1 7 662 705                 
4 2 1 2 0 6 2 10 795 858                 
4 2 1 2 0 6 9 9 925 958                 
4 2 1 2 0 6 9 10 794 796                 
4 2 1 2 0 7 1 7 683 771                 
4 2 1 2 0 7 2 6 364 369                 
4 2 1 2 0 7 4 1 275 344                 
4 2 1 2 0 7 6 10 792 819                 
4 2 1 2 0 7 7 3 588 608                 
4 2 1 2 0 7 7 7 656 709                 
4 2 1 2 0 7 8 10 793 839                 
4 2 1 2 0 7 9 7 673 780                 
4 2 1 2 0 8 7 4 455 492                 
4 2 1 2 0 8 7 10 844 862                 
4 2 1 2 0 9 1 7 657 699                 
4 2 1 2 0 10 4 8 426 433                 
4 2 1 2 0 10 10 4 471 477                 
4 2 0.99999958 0 1 4 10 8 403 425                 
4 2 0.99999958 0 3 2 10 10 806 830                 
4 2 0.99999958 0 5 1 1 1 302 331                 
4 2 0.99999958 0 5 2 1 8 413 420                 
4 2 0.99999958 0 5 6 9 1 297 303                 
4 2 0.99999958 0 6 2 10 1 263 314                 
4 2 0.99999958 0 9 1 1 3 592 598                 
4 2 0.99999958 0 9 1 9 7 692 768                 
4 2 0.99999958 0 9 6 2 7 688 710                 
4 2 0.99999958 0 9 8 8 3 615 620                 
4 2 0.99999958 0 9 9 10 10 820 828                 
4 2 0.99999958 0 10 2 1 5 500 523                 
3 18 0.00000015 2 9 1 0 0 150 169 172 296 354 382 435 514 515 539 592 598 614 692 768 778 884 936 
3 16 0.0000051 2 9 0 0 7 650 664 665 666 676 683 688 692 699 700 710 766 768 777 778 780   
3 15 0.0000326 2 5 1 0 0 252 302 331 391 404 475 510 528 530 563 619 633 649 672 857    
3 14 0.00018655 2 1 0 0 7 636 653 656 673 679 685 687 695 704 711 756 757 759 776     
3 14 0.00018655 2 9 0 8 0 34 83 351 354 359 389 417 515 614 615 620 666 731 777     
3 14 0.00018655 2 0 1 0 7 633 634 649 654 672 681 685 690 692 708 768 772 778 785     
3 13 0.00099931 2 1 1 0 0 13 32 46 56 89 177 187 195 356 410 553 685 743      
3 12 0.00495671 2 1 6 0 0 347 453 459 506 525 554 559 568 728 759 795 958       
3 12 0.00495671 2 1 7 0 0 80 339 344 369 446 464 483 588 628 656 673 814       
3 12 0.00495671 2 5 2 0 0 43 91 133 301 307 326 413 420 478 491 821 847       
3 12 0.00495671 2 9 2 0 0 198 209 274 351 358 368 401 576 665 731 766 921       
3 12 0.00495671 2 9 5 0 0 83 203 417 507 531 558 612 664 714 777 823 860       
3 12 0.00495671 2 0 1 1 0 13 150 296 302 319 328 331 528 592 598 649 894       
3 12 0.00495671 2 0 1 8 0 221 354 395 469 515 517 537 563 614 632 633 857       
3 11 0.02253171 2 1 0 9 0 46 453 464 509 553 568 673 735 818 869 958        
3 11 0.02253171 2 5 0 1 0 302 331 413 420 491 528 578 649 717 771 821        
3 11 0.02253171 2 9 0 1 0 150 296 485 592 598 683 699 714 732 823 946        
3 11 0.02253171 2 9 0 0 6 351 354 358 359 368 378 382 387 389 392 401        
3 11 0.02253171 2 0 2 1 0 3 71 157 413 420 491 500 523 756 799 821        
3 11 0.02253171 2 0 2 0 1 257 263 274 276 281 301 307 314 315 326 327        
3 11 0.02253171 2 0 6 9 0 67 214 297 453 518 568 650 794 796 925 958        
3 11 0.02253171 2 0 0 8 3 535 537 550 559 563 571 599 614 615 620 632        
3 10 0.09175675 2 1 0 7 0 177 311 410 447 483 573 588 656 757 822         
3 10 0.09175675 2 1 0 8 0 266 291 446 506 559 679 687 711 729 880         
3 10 0.09175675 2 1 0 10 0 32 327 372 403 425 554 586 593 653 814         
3 10 0.09175675 2 5 6 0 0 61 297 465 518 555 590 670 796 858 867         
3 10 0.09175675 2 5 0 8 0 91 326 498 520 563 633 713 761 793 857         
3 10 0.09175675 2 0 1 2 0 56 114 334 391 522 654 672 681 715 936         
3 10 0.09175675 2 0 1 0 3 537 539 553 563 575 592 598 614 619 632         
3 10 0.09175675 2 0 2 8 0 12 91 103 180 326 351 535 599 729 731         
3 10 0.09175675 2 0 6 2 0 226 451 525 590 670 688 710 728 795 858         
3 10 0.09175675 2 0 6 0 7 637 645 650 662 670 688 705 710 759 760         
3 10 0.09175675 2 0 0 1 7 649 657 662 683 693 695 699 705 756 771         
3 10 0.09175675 2 0 0 10 1 259 263 278 292 301 307 314 316 317 327         
3 9 0.31096464 2 1 0 0 3 553 554 559 568 573 586 588 593 628          
3 9 0.31096464 2 5 0 2 0 364 386 391 478 552 590 670 672 858          
3 9 0.31096464 2 5 0 0 3 540 544 552 555 563 577 578 590 619          
3 9 0.31096464 2 5 0 0 5 498 503 510 518 520 526 528 530 534          
3 9 0.31096464 2 5 0 0 7 633 640 649 668 670 672 709 761 771          
3 9 0.31096464 2 9 0 0 3 539 558 576 592 598 612 614 615 620          
3 9 0.31096464 2 0 1 3 0 89 169 356 404 539 634 772 785 884          
3 9 0.31096464 2 0 1 7 0 2 131 177 242 410 510 722 778 900          
3 9 0.31096464 2 0 6 0 3 554 555 559 568 570 590 610 616 629          
3 9 0.31096464 2 0 7 0 7 656 663 666 673 683 700 709 771 780          
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3 9 0.31096464 2 0 0 9 10 794 796 798 809 813 818 869 881 890 
3 8 0.73183986 2 1 4 0 0 142 229 370 403 425 586 704 711  
3 8 0.73183986 2 1 5 0 0 372 460 509 636 757 776 824 880  
3 8 0.73183986 2 1 0 0 4 447 453 458 459 460 464 473 483  
3 8 0.73183986 2 4 5 0 0 58 211 223 254 541 595 859 915  
3 8 0.73183986 2 5 7 0 0 364 388 422 577 709 771 793 848  
3 8 0.73183986 2 5 0 9 0 297 366 486 518 534 640 796 848  
3 8 0.73183986 2 9 0 2 0 209 368 688 700 710 727 921 936  
3 8 0.73183986 2 9 0 3 0 169 218 358 493 507 539 576 884  
3 8 0.73183986 2 0 1 0 5 510 514 515 517 522 524 528 530  
3 8 0.73183986 2 0 5 0 10 803 807 811 823 824 859 860 880  
3 8 0.73183986 2 0 6 1 0 333 459 570 610 662 705 879 946  
3 8 0.73183986 2 0 7 0 1 264 268 275 292 308 313 339 344  
3 8 0.73183986 2 0 0 2 7 646 654 670 672 681 688 700 710  
3 8 0.73183986 2 0 0 8 7 633 666 679 687 711 712 761 777  
3 8 0.73183986 2 0 0 10 3 540 554 577 579 584 586 593 600  
3 7 0.98518164 2 1 2 0 0 125 327 573 729 756 818 822   
3 7 0.98518164 2 1 0 2 0 56 194 340 369 525 728 795   
3 7 0.98518164 2 1 0 3 0 80 89 356 365 460 636 704   
3 7 0.98518164 2 1 0 4 0 125 229 344 353 370 628 776   
3 7 0.98518164 2 1 0 0 1 266 291 311 327 339 340 344   
3 7 0.98518164 2 1 0 0 6 347 353 356 365 369 370 372   
3 7 0.98518164 2 1 0 0 10 795 814 818 822 824 869 880   
3 7 0.98518164 2 2 10 0 0 105 332 426 471 639 813 962   
3 7 0.98518164 2 4 1 0 0 5 7 179 334 681 772 894   
3 7 0.98518164 2 4 0 4 0 58 136 275 337 381 433 882   
3 7 0.98518164 2 4 0 5 0 69 200 211 254 375 583 624   
3 7 0.98518164 2 4 0 10 0 5 179 223 278 477 800 859   
3 7 0.98518164 2 4 0 0 1 265 275 278 308 334 336 337   
3 7 0.98518164 2 4 0 0 10 798 800 844 859 882 892 894   
3 7 0.98518164 2 5 3 0 0 366 412 526 534 540 640 717   
3 7 0.98518164 2 5 5 0 0 285 416 443 486 578 713 761   
3 7 0.98518164 2 5 0 0 1 285 297 301 302 307 326 331   
3 7 0.98518164 2 5 0 0 8 404 412 413 416 420 422 443   
3 7 0.98518164 2 6 1 0 0 98 131 221 522 537 737 948   
3 7 0.98518164 2 6 2 0 0 27 71 197 235 263 281 314   
3 7 0.98518164 2 6 0 1 0 71 238 333 657 693 705 811   
3 7 0.98518164 2 8 1 0 0 2 100 114 242 517 690 722   
3 7 0.98518164 2 8 2 0 0 12 257 276 315 725 799 891   
3 7 0.98518164 2 8 4 0 0 11 26 70 99 273 436 747   
3 7 0.98518164 2 8 0 4 0 8 11 26 315 504 690 760   
3 7 0.98518164 2 9 6 0 0 148 213 482 650 688 710 946   
3 7 0.98518164 2 9 7 0 0 264 468 666 683 700 732 780   
3 7 0.98518164 2 9 0 9 0 256 531 650 676 692 768 780   
3 7 0.98518164 2 9 0 10 0 148 172 203 482 514 664 828   
3 7 0.98518164 2 0 1 6 0 7 195 619 685 737 743 948   
3 7 0.98518164 2 0 2 2 0 135 197 209 276 368 478 921   
3 7 0.98518164 2 0 2 6 0 38 43 76 202 257 281 766   
3 7 0.98518164 2 0 2 10 0 104 263 301 307 314 327 830   
3 7 0.98518164 2 0 2 0 10 799 818 821 822 830 890 891   
3 7 0.98518164 2 0 3 0 3 536 540 571 579 593 600 624   
3 7 0.98518164 2 0 5 1 0 62 569 578 595 714 811 823   
3 7 0.98518164 2 0 5 8 0 83 417 713 761 777 880 915   
3 7 0.98518164 2 0 5 0 3 541 558 569 578 595 603 612   
3 7 0.98518164 2 0 6 0 4 451 453 454 459 465 472 482   
3 7 0.98518164 2 0 0 1 1 296 302 319 328 331 333 339   
3 7 0.98518164 2 0 0 1 3 569 570 578 592 595 598 610   
3 7 0.98518164 2 0 0 3 7 634 636 637 669 704 772 785   
3 7 0.98518164 2 0 0 9 7 640 650 673 676 692 768 780   
3 7 0.0015603 0 0 2 10 1 263 280 288 301 307 314 327   
3 6 0.99999524 2 1 3 0 0 194 291 473 593 679 869    
3 6 0.99999524 2 1 10 0 0 365 447 458 653 687 695    
3 6 0.99999524 2 2 0 6 0 50 105 143 456 629 639    
3 6 0.99999524 2 4 2 0 0 3 38 69 76 103 200    
3 6 0.99999524 2 4 4 0 0 78 90 137 337 375 800    
3 6 0.99999524 2 4 7 0 0 6 219 275 308 548 798    
3 6 0.99999524 2 4 10 0 0 245 265 346 433 477 882    
3 6 0.99999524 2 4 0 6 0 7 38 76 161 308 548    
3 6 0.99999524 2 4 0 0 3 541 548 571 583 595 624    
3 6 0.99999524 2 5 0 4 0 388 416 443 465 475 526    
3 6 0.99999524 2 5 0 0 6 364 366 386 388 391 400    
3 6 0.99999524 2 5 0 0 10 793 796 821 857 858 867    
3 6 0.99999524 2 6 6 0 0 333 472 637 705 794 954    
3 6 0.99999524 2 6 0 0 1 263 268 271 281 314 333    
3 6 0.99999524 2 7 1 0 0 88 319 395 575 654 900    
3 6 0.99999524 2 7 6 0 0 22 214 259 662 736 879    
3 6 0.99999524 2 7 0 10 0 259 316 423 457 584 803    
3 6 0.99999524 2 7 0 0 10 791 803 808 852 879 890    
3 6 0.99999524 2 8 6 0 0 226 451 454 616 645 760    
3 6 0.99999524 2 9 8 0 0 34 492 615 620 746 862    
3 6 0.99999524 2 9 0 5 0 102 198 213 468 612 746    
3 6 0.99999524 2 9 0 7 0 264 392 492 665 778 862    
3 6 0.99999524 2 0 1 4 0 98 382 435 475 690 898    
3 6 0.99999524 2 0 1 5 0 88 187 252 524 530 575    
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3 6 0.99999524 2 0 1 9 0 23 46 100 553 692 768 
3 6 0.99999524 2 0 1 10 0 5 32 172 179 514 708 
3 6 0.99999524 2 0 1 0 1 296 302 319 328 331 334 
3 6 0.99999524 2 0 2 4 0 125 274 315 401 489 626 
3 6 0.99999524 2 0 2 5 0 27 69 160 198 200 762 
3 6 0.99999524 2 0 3 10 0 278 412 540 579 593 600 
3 6 0.99999524 2 0 4 8 0 359 520 711 724 739 747 
3 6 0.99999524 2 0 5 10 0 203 223 372 664 803 859 
3 6 0.99999524 2 0 5 0 7 636 664 757 761 776 777 
3 6 0.99999524 2 0 6 5 0 22 213 347 555 759 867 
3 6 0.99999524 2 0 6 0 10 794 795 796 858 867 879 
3 6 0.99999524 2 0 7 2 0 96 219 313 364 369 700 
3 6 0.99999524 2 0 7 4 0 8 275 344 388 504 628 
3 6 0.99999524 2 0 7 6 0 308 422 456 548 792 819 
3 6 0.99999524 2 0 7 7 0 264 483 588 608 656 709 
3 6 0.99999524 2 0 7 9 0 52 464 673 780 798 848 
3 6 0.99999524 2 0 7 0 10 792 793 798 814 819 839 
3 6 0.99999524 2 0 8 8 0 34 498 550 615 620 712 
3 6 0.99999524 2 0 0 1 10 799 811 821 823 879 894 
3 6 0.99999524 2 0 0 4 6 353 370 381 382 388 401 
3 6 0.99999524 2 0 0 7 3 541 573 588 603 608 616 
3 6 0.99999524 2 0 0 7 7 656 665 668 709 757 778 
3 6 0.99999524 2 0 0 8 2 713 724 729 731 739 747 
3 6 0.99999524 2 0 0 8 10 793 808 839 857 880 892 
3 6 0.99999524 2 0 0 10 10 800 803 814 828 830 859 
3 5 1 1 0 0 10 1 269 280 283 286 288  
3 5 1 2 1 0 1 0 13 339 459 695 756  
3 5 1 2 1 0 5 0 142 187 347 458 759  
3 5 1 2 1 0 6 0 195 473 685 743 824  
3 5 1 2 2 2 0 0 104 157 160 253 626  
3 5 1 2 2 6 0 0 60 67 143 610 629  
3 5 1 2 2 8 0 0 10 50 455 646 647  
3 5 1 2 2 0 1 0 62 157 171 328 610  
3 5 1 2 2 0 9 0 10 67 119 809 813  
3 5 1 2 2 0 0 3 536 608 610 626 629  
3 5 1 2 4 0 3 0 6 90 137 407 772  
3 5 1 2 4 0 9 0 78 245 502 723 798  
3 5 1 2 5 0 3 0 61 191 285 404 847  
3 5 1 2 5 0 5 0 107 252 530 555 867  
3 5 1 2 5 0 6 0 43 422 503 544 619  
3 5 1 2 5 0 7 0 133 400 510 668 709  
3 5 1 2 5 0 10 0 301 307 412 540 577  
3 5 1 2 5 0 0 4 465 475 478 486 491  
3 5 1 2 6 0 0 7 637 657 677 693 705  
3 5 1 2 6 0 0 9 901 935 948 954 957  
3 5 1 2 8 7 0 0 8 52 504 726 819  
3 5 1 2 8 0 6 0 70 132 257 645 819  
3 5 1 2 8 0 7 0 2 242 454 616 722  
3 5 1 2 9 9 0 0 389 485 676 699 828  
3 5 1 2 9 10 0 0 102 218 256 387 493  
3 5 1 2 9 0 4 0 274 382 401 435 558  
3 5 1 2 9 0 0 2 714 727 731 732 746  
3 5 1 2 9 0 0 4 468 482 485 492 493  
3 5 1 2 9 0 0 10 823 828 860 862 884  
3 5 1 2 10 0 4 0 481 512 863 898 907  
3 5 1 2 0 1 0 6 354 356 382 391 395  
3 5 1 2 0 2 3 0 235 358 576 847 891  
3 5 1 2 0 2 7 0 133 253 573 665 822  
3 5 1 2 0 2 0 3 535 573 576 599 626  
3 5 1 2 0 3 0 1 271 278 287 291 336  
3 5 1 2 0 4 3 0 90 99 137 309 704  
3 5 1 2 0 4 4 0 11 26 229 337 370  
3 5 1 2 0 5 4 0 58 416 443 558 776  
3 5 1 2 0 7 8 0 268 446 666 793 839  
3 5 1 2 0 7 10 0 292 457 577 726 814  
3 5 1 2 0 7 0 3 548 577 588 608 628  
3 5 1 2 0 7 0 4 456 457 464 468 483  
3 5 1 2 0 8 7 0 311 455 492 844 862  
3 5 1 2 0 8 9 0 10 250 502 735 881  
3 5 1 2 0 8 0 3 550 583 584 615 620  
3 5 1 2 0 10 3 0 191 218 365 493 962  
3 5 1 2 0 10 10 0 316 423 471 477 653  
3 5 1 2 0 10 0 4 447 458 471 477 493  
3 5 1 2 0 10 0 7 639 653 668 687 695  
3 5 1 2 0 0 2 6 364 368 369 386 391  
3 5 1 2 0 0 4 1 274 275 315 337 344  
3 5 1 2 0 0 4 8 416 426 433 435 443  
3 5 1 2 0 0 5 3 555 575 583 612 624  
3 5 1 2 0 0 6 1 257 271 281 287 308  
3 5 1 2 0 0 7 4 447 454 455 483 492  
3 5 1 2 0 0 8 5 498 506 515 517 520  
3 5 1 2 0 0 8 6 351 354 359 389 395  
3 5 1 2 0 0 9 5 502 509 518 531 534  
3 5 0.21190326 0 9 0 9 7 650 676 692 768 780  
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3 5 0.21190326 0 0 1 1 1 296 302 319 328 331 
3 4 1 1 5 4 0 0 325 409 551 787  
3 4 1 1 5 0 0 1 288 303 306 325  
3 4 1 1 5 0 0 6 349 350 383 385  
3 4 1 1 8 0 0 10 805 837 883 887  
3 4 1 1 9 1 0 0 397 427 877 923  
3 4 1 1 9 0 10 0 204 427 820 893  
3 4 1 1 9 0 0 6 376 397 398 402  
3 4 1 1 0 2 10 0 280 288 617 806  
3 4 1 1 0 7 1 0 77 428 631 841  
3 4 1 2 1 8 0 0 311 340 353 735  
3 4 1 2 1 0 0 2 728 729 735 743  
3 4 1 2 1 0 0 8 403 410 425 446  
3 4 1 2 2 7 0 0 292 456 608 839  
3 4 1 2 2 0 10 0 104 292 471 647  
3 4 1 2 2 0 0 1 292 309 328 332  
3 4 1 2 2 0 0 4 455 456 469 471  
3 4 1 2 3 1 0 0 23 524 634 708  
3 4 1 2 3 2 0 0 202 489 535 830  
3 4 1 2 4 3 0 0 278 336 571 624  
3 4 1 2 4 8 0 0 136 502 583 844  
3 4 1 2 4 0 1 0 3 346 595 894  
3 4 1 2 4 0 7 0 265 336 541 844  
3 4 1 2 4 0 8 0 103 571 892 915  
3 4 1 2 5 10 0 0 107 191 544 668  
3 4 1 2 6 0 2 0 197 521 522 957  
3 4 1 2 6 0 6 0 271 281 737 948  
3 4 1 2 6 0 8 0 221 268 472 537  
3 4 1 2 7 2 0 0 180 752 762 890  
3 4 1 2 7 10 0 0 316 423 791 808  
3 4 1 2 7 0 1 0 319 569 662 879  
3 4 1 2 7 0 2 0 96 224 654 791  
3 4 1 2 7 0 5 0 22 88 575 762  
3 4 1 2 7 0 8 0 180 395 808 908  
3 4 1 2 7 0 9 0 214 250 752 890  
3 4 1 2 7 0 0 3 569 575 584 603  
3 4 1 2 8 0 2 0 114 226 276 451  
3 4 1 2 8 0 3 0 99 138 494 891  
3 4 1 2 8 0 8 0 12 517 550 747  
3 4 1 2 8 0 0 1 257 273 276 315  
3 4 1 2 8 0 0 2 722 725 726 747  
3 4 1 2 9 0 6 0 378 387 766 860  
3 4 1 2 9 0 0 1 256 264 274 296  
3 4 1 2 9 0 0 5 507 514 515 531  
3 4 1 2 10 2 0 0 135 500 523 599  
3 4 1 2 10 0 0 3 570 579 599 632  
3 4 1 2 0 1 0 2 715 722 737 743  
3 4 1 2 0 1 0 9 898 900 936 948  
3 4 1 2 0 2 9 0 725 752 818 890  
3 4 1 2 0 2 0 2 725 729 731 752  
3 4 1 2 0 2 0 6 351 358 368 401  
3 4 1 2 0 2 0 7 665 756 762 766  
3 4 1 2 0 3 6 0 271 287 378 473  
3 4 1 2 0 3 8 0 291 571 679 908  
3 4 1 2 0 3 9 0 366 534 640 869  
3 4 1 2 0 4 5 0 142 273 375 677  
3 4 1 2 0 4 10 0 403 425 586 800  
3 4 1 2 0 4 0 7 677 693 704 711  
3 4 1 2 0 5 3 0 285 460 507 636  
3 4 1 2 0 5 5 0 211 254 612 807  
3 4 1 2 0 5 9 0 119 486 509 531  
3 4 1 2 0 6 3 0 60 61 407 637  
3 4 1 2 0 6 4 0 465 736 760 954  
3 4 1 2 0 6 6 0 143 161 629 645  
3 4 1 2 0 6 10 0 148 259 482 554  
3 4 1 2 0 6 0 9 925 946 954 958  
3 4 1 2 0 7 1 0 339 683 732 771  
3 4 1 2 0 8 4 0 136 353 481 863  
3 4 1 2 0 8 0 10 844 862 863 881  
3 4 1 2 0 9 1 0 485 657 699 939  
3 4 1 2 0 9 0 6 381 386 389 400  
3 4 1 2 0 9 0 7 657 669 676 699  
3 4 1 2 0 10 1 0 238 346 495 695  
3 4 1 2 0 10 4 0 426 433 882 907  
3 4 1 2 0 10 5 0 102 107 332 458  
3 4 1 2 0 10 6 0 105 387 544 639  
3 4 1 2 0 10 0 1 256 265 316 332  
3 4 1 2 0 10 0 8 423 424 426 433  
3 4 1 2 0 10 0 10 791 808 813 882  
3 4 1 2 0 0 1 5 495 500 523 528  
3 4 1 2 0 0 2 1 276 313 334 340  
3 4 1 2 0 0 4 3 536 558 626 628  
3 4 1 2 0 0 4 4 465 475 481 489  
3 4 1 2 0 0 4 9 898 901 907 954  
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3 4 1 2 0 0 5 7 663 677 759 762 
3 4 1 2 0 0 6 3 544 548 619 629 
3 4 1 2 0 0 6 7 639 645 685 766 
3 4 1 2 0 0 6 10 792 819 824 860 
3 4 1 2 0 0 7 1 264 265 311 336 
3 4 1 2 0 0 8 1 266 268 291 326 
3 4 1 2 0 0 9 2 723 725 735 752 
3 4 1 2 0 0 9 9 848 925 935 958 
3 4 1 2 0 0 10 4 457 471 477 482 
3 4 1 2 0 0 10 7 647 653 664 708 
3 4 1 2 0 0 10 8 403 412 423 425 
3 4 0.90236622 0 1 0 8 7 679 687 691 711 
3 4 0.90236622 0 5 1 1 0 302 331 528 649 
3 4 0.90236622 0 5 2 1 0 413 420 491 821 
3 4 0.90236622 0 5 2 10 0 288 301 307 617 
3 4 0.90236622 0 5 2 0 1 288 301 307 326 
3 4 0.90236622 0 5 6 9 0 297 303 518 796 
3 4 0.90236622 0 9 1 1 0 150 296 592 598 
3 4 0.90236622 0 9 1 0 3 539 592 598 614 
3 4 0.90236622 0 9 2 0 6 351 358 368 401 
3 4 0.90236622 0 9 6 2 0 398 688 710 742 
3 4 0.90236622 0 9 6 0 7 650 688 710 786 
3 4 0.90236622 0 9 7 0 7 666 683 700 780 
3 4 0.90236622 0 9 0 8 6 351 354 359 389 
3 4 0.90236622 0 0 1 8 3 537 563 614 632 
3 4 0.90236622 0 0 3 10 3 540 579 593 600 
3 3 1 1 1 1 0 0 501 691 950  
3 3 1 1 1 4 0 0 163 393 930  
3 3 1 1 5 10 0 0 349 585 738  
3 3 1 1 5 0 1 0 15 77 350  
3 3 1 1 5 0 3 0 325 383 585  
3 3 1 1 5 0 6 0 385 551 769  
3 3 1 1 5 0 10 0 288 409 617  
3 3 1 1 5 0 0 3 551 585 617  
3 3 1 1 6 0 0 10 841 875 885  
3 3 1 1 9 6 0 0 398 742 786  
3 3 1 1 9 8 0 0 293 324 893  
3 3 1 1 9 0 2 0 293 398 742  
3 3 1 1 9 0 0 1 293 324 330  
3 3 1 1 9 0 0 10 820 877 893  
3 3 1 1 10 0 1 0 428 631 947  
3 3 1 1 10 0 0 8 411 428 431  
3 3 1 1 0 1 0 9 911 923 950  
3 3 1 1 0 4 1 0 393 750 906  
3 3 1 1 0 5 3 0 376 419 429  
3 3 1 1 0 5 0 1 269 306 330  
3 3 1 1 0 5 0 8 419 429 439  
3 3 1 1 0 8 0 10 837 865 893  
3 3 1 1 0 9 10 0 286 781 820  
3 3 1 1 0 10 9 0 165 261 738  
3 3 1 1 0 10 0 3 556 585 606  
3 3 1 1 0 0 3 6 376 383 396  
3 3 1 1 0 0 3 8 411 419 429  
3 3 1 1 0 0 5 1 306 324 342  
3 3 1 1 0 0 10 10 806 820 893  
3 3 1 2 1 0 0 5 506 509 525  
3 3 1 2 2 1 0 0 328 469 715  
3 3 1 2 2 3 0 0 171 421 536  
3 3 1 2 2 4 0 0 309 724 809  
3 3 1 2 2 0 2 0 154 646 715  
3 3 1 2 2 0 3 0 60 309 962  
3 3 1 2 2 0 4 0 426 536 626  
3 3 1 2 2 0 5 0 160 332 421  
3 3 1 2 2 0 7 0 253 455 608  
3 3 1 2 2 0 8 0 469 724 839  
3 3 1 2 2 0 0 7 639 646 647  
3 3 1 2 2 0 0 10 809 813 839  
3 3 1 2 3 0 8 0 535 712 739  
3 3 1 2 3 0 10 0 317 708 830  
3 3 1 2 3 0 0 7 634 708 712  
3 3 1 2 4 9 0 0 381 723 892  
3 3 1 2 4 0 2 0 219 334 681  
3 3 1 2 4 0 0 6 346 375 381  
3 3 1 2 6 4 0 0 677 693 935  
3 3 1 2 6 0 4 0 98 901 954  
3 3 1 2 6 0 9 0 794 881 935  
3 3 1 2 6 0 0 10 794 811 881  
3 3 1 2 7 5 0 0 569 603 803  
3 3 1 2 7 8 0 0 250 584 846  
3 3 1 2 7 0 0 1 259 316 319  
3 3 1 2 7 0 0 7 654 662 762  
3 3 1 2 7 0 0 9 846 900 908  
3 3 1 2 8 9 0 0 193 494 939  
3 3 1 2 8 0 1 0 436 799 939  
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3 3 1 2 8 0 9 0 52 100 725 
3 3 1 2 8 0 0 3 550 600 616 
3 3 1 2 8 0 0 5 494 504 517 
3 3 1 2 8 0 0 7 645 690 760 
3 3 1 2 8 0 0 10 799 819 891 
3 3 1 2 9 3 0 0 378 392 727 
3 3 1 2 9 0 0 9 921 936 946 
3 3 1 2 10 1 0 0 632 785 898 
3 3 1 2 10 3 0 0 287 512 579 
3 3 1 2 10 0 1 0 500 523 570 
3 3 1 2 10 0 5 0 466 663 807 
3 3 1 2 10 0 8 0 424 599 632 
3 3 1 2 10 0 0 5 500 512 523 
3 3 1 2 10 0 0 7 663 669 785 
3 3 1 2 10 0 0 10 792 807 863 
3 3 1 2 0 1 0 8 404 410 435 
3 3 1 2 0 1 0 10 857 884 894 
3 3 1 2 0 2 0 4 478 489 491 
3 3 1 2 0 3 3 0 24 138 852 
3 3 1 2 0 3 4 0 512 526 536 
3 3 1 2 0 3 7 0 225 336 392 
3 3 1 2 0 3 0 5 512 526 534 
3 3 1 2 0 3 0 6 366 378 392 
3 3 1 2 0 4 9 0 78 809 935 
3 3 1 2 0 4 0 1 273 309 337 
3 3 1 2 0 4 0 2 724 739 747 
3 3 1 2 0 4 0 6 359 370 375 
3 3 1 2 0 4 0 8 403 425 436 
3 3 1 2 0 5 6 0 132 824 860 
3 3 1 2 0 5 7 0 541 603 757 
3 3 1 2 0 5 0 5 507 509 531 
3 3 1 2 0 5 0 8 416 417 443 
3 3 1 2 0 6 8 0 472 506 559 
3 3 1 2 0 6 0 1 259 297 333 
3 3 1 2 0 6 0 5 506 518 525 
3 3 1 2 0 7 0 6 364 369 388 
3 3 1 2 0 8 6 0 50 503 846 
3 3 1 2 0 8 0 4 455 481 492 
3 3 1 2 0 8 0 5 498 502 503 
3 3 1 2 0 8 0 7 646 647 712 
3 3 1 2 0 9 8 0 266 389 892 
3 3 1 2 0 10 7 0 265 447 668 
3 3 1 2 0 10 8 0 424 687 808 
3 3 1 2 0 10 9 0 245 256 813 
3 3 1 2 0 10 0 6 346 365 387 
3 3 1 2 0 0 1 2 714 717 732 
3 3 1 2 0 0 1 4 459 485 491 
3 3 1 2 0 0 1 8 413 420 436 
3 3 1 2 0 0 2 2 715 727 728 
3 3 1 2 0 0 2 5 521 522 525 
3 3 1 2 0 0 2 9 921 936 957 
3 3 1 2 0 0 2 10 791 795 858 
3 3 1 2 0 0 3 6 356 358 365 
3 3 1 2 0 0 3 10 852 884 891 
3 3 1 2 0 0 4 5 504 512 526 
3 3 1 2 0 0 4 7 690 760 776 
3 3 1 2 0 0 5 4 458 466 468 
3 3 1 2 0 0 7 10 822 844 862 
3 3 1 2 0 0 8 8 417 424 446 
3 3 1 2 0 0 9 4 453 464 486 
3 3 1 0 1 1 3 0 89 356 501 
3 3 1 0 1 1 6 0 195 685 743 
3 3 1 0 1 4 10 0 403 425 586 
3 3 1 0 1 5 0 7 636 757 776 
3 3 1 0 1 6 2 0 525 728 795 
3 3 1 0 1 6 9 0 453 568 958 
3 3 1 0 1 6 0 3 554 559 568 
3 3 1 0 1 7 7 0 483 588 656 
3 3 1 0 1 10 0 7 653 687 695 
3 3 1 0 1 0 7 3 573 588 606 
3 3 1 0 1 0 10 3 554 586 593 
3 3 1 0 4 7 0 1 275 308 342 
3 3 1 0 5 1 8 0 563 633 857 
3 3 1 0 5 1 0 5 510 528 530 
3 3 1 0 5 1 0 7 633 649 672 
3 3 1 0 5 3 9 0 366 534 640 
3 3 1 0 5 5 4 0 416 439 443 
3 3 1 0 5 5 0 8 416 439 443 
3 3 1 0 5 6 2 0 590 670 858 
3 3 1 0 5 6 0 10 796 858 867 
3 3 1 0 5 9 0 6 350 386 400 
3 3 1 0 5 0 2 6 364 386 391 
3 3 1 0 5 0 2 7 670 672 787 
3 3 1 0 5 0 4 8 416 439 443 
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3 3 1 0 5 0 6 3 544 551 619 
3 3 1 0 5 0 10 1 288 301 307 
3 3 1 0 5 0 10 3 540 577 617 
3 3 1 0 6 2 0 1 263 281 314 
3 3 1 0 6 0 1 7 657 693 705 
3 3 1 0 6 0 1 10 811 841 885 
3 3 1 0 8 1 7 0 2 242 722 
3 3 1 0 8 2 0 1 257 276 315 
3 3 1 0 8 2 0 10 799 805 891 
3 3 1 0 9 1 3 0 169 539 884 
3 3 1 0 9 1 8 0 354 515 614 
3 3 1 0 9 1 10 0 172 427 514 
3 3 1 0 9 1 0 6 354 382 397 
3 3 1 0 9 1 0 7 692 768 778 
3 3 1 0 9 2 2 0 209 368 921 
3 3 1 0 9 5 8 0 83 417 777 
3 3 1 0 9 8 8 0 34 615 620 
3 3 1 0 9 0 2 7 688 700 710 
3 3 1 0 9 0 8 3 614 615 620 
3 3 1 0 9 0 8 7 666 777 786 
3 3 1 0 9 0 10 10 820 828 893 
3 3 1 0 0 1 2 7 654 672 681 
3 3 1 0 0 1 3 7 634 772 785 
3 3 1 0 0 4 8 2 724 739 747 
3 3 1 0 0 4 10 8 403 409 425 
3 3 1 0 0 5 1 3 569 578 595 
3 3 1 0 0 5 4 8 416 439 443 
3 3 1 0 0 6 2 7 670 688 710 
3 3 1 0 0 8 8 3 550 615 620 
3 2 1 1 1 0 7 0 163 606  
3 2 1 1 1 0 8 0 691 930  
3 2 1 1 1 0 10 0 283 781  
3 2 1 1 1 0 0 7 691 781  
3 2 1 1 1 0 0 9 930 950  
3 2 1 1 2 2 0 0 280 961  
3 2 1 1 2 0 2 0 911 961  
3 2 1 1 2 0 0 9 911 961  
3 2 1 1 3 2 0 0 117 806  
3 2 1 1 3 5 0 0 130 419  
3 2 1 1 3 0 10 0 556 806  
3 2 1 1 3 0 0 8 406 419  
3 2 1 1 4 2 0 0 51 587  
3 2 1 1 4 0 3 0 51 429  
3 2 1 1 4 0 0 1 286 342  
3 2 1 1 5 2 0 0 288 617  
3 2 1 1 5 3 0 0 237 385  
3 2 1 1 5 5 0 0 306 439  
3 2 1 1 5 6 0 0 303 383  
3 2 1 1 5 9 0 0 15 350  
3 2 1 1 5 0 9 0 303 738  
3 2 1 1 5 0 0 7 769 787  
3 2 1 1 5 0 0 8 409 439  
3 2 1 1 6 7 0 0 231 841  
3 2 1 1 6 10 0 0 261 885  
3 2 1 1 6 0 1 0 841 885  
3 2 1 1 7 4 0 0 118 906  
3 2 1 1 8 1 0 0 35 883  
3 2 1 1 8 0 5 0 35 887  
3 2 1 1 8 0 8 0 805 837  
3 2 1 1 8 0 0 2 749 750  
3 2 1 1 9 5 0 0 330 376  
3 2 1 1 9 7 0 0 204 922  
3 2 1 1 9 0 5 0 324 877  
3 2 1 1 9 0 7 0 201 397  
3 2 1 1 9 0 9 0 402 922  
3 2 1 1 9 0 0 9 922 923  
3 2 1 1 10 3 0 0 140 396  
3 2 1 1 10 7 0 0 428 631  
3 2 1 1 10 0 3 0 396 411  
3 2 1 1 0 1 2 0 883 911  
3 2 1 1 0 1 5 0 35 877  
3 2 1 1 0 1 6 0 406 923  
3 2 1 1 0 1 0 8 406 427  
3 2 1 1 0 1 0 10 877 883  
3 2 1 1 0 2 0 1 280 288  
3 2 1 1 0 2 0 3 587 617  
3 2 1 1 0 2 0 10 805 806  
3 2 1 1 0 3 3 0 147 396  
3 2 1 1 0 3 0 6 385 396  
3 2 1 1 0 4 6 0 551 784  
3 2 1 1 0 4 7 0 118 163  
3 2 1 1 0 4 0 6 393 402  
3 2 1 1 0 4 0 7 784 787  
3 2 1 1 0 4 0 9 906 930  
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3 2 1 1 0 5 4 0 330 439 
3 2 1 1 0 5 5 0 306 753 
3 2 1 1 0 6 2 0 398 742 
3 2 1 1 0 6 3 0 383 875 
3 2 1 1 0 6 0 6 383 398 
3 2 1 1 0 7 10 0 204 231 
3 2 1 1 0 8 3 0 411 865 
3 2 1 1 0 8 0 1 293 324 
3 2 1 1 0 9 1 0 15 350 
3 2 1 1 0 10 0 10 885 887 
3 2 1 1 0 0 1 6 350 393 
3 2 1 1 0 0 1 9 906 947 
3 2 1 1 0 0 1 10 841 885 
3 2 1 1 0 0 2 9 911 961 
3 2 1 1 0 0 3 10 865 875 
3 2 1 1 0 0 5 10 877 887 
3 2 1 1 0 0 6 7 769 784 
3 2 1 1 0 0 8 6 349 371 
3 2 1 1 0 0 8 7 691 786 
3 2 1 1 0 0 8 10 805 837 
3 2 1 1 0 0 9 1 261 303 
3 2 1 1 0 0 10 3 556 617 
3 2 1 1 0 0 10 8 409 427 
3 2 1 2 2 5 0 0 62 119 
3 2 1 2 2 0 0 2 715 724 
3 2 1 2 2 0 0 8 421 426 
3 2 1 2 3 0 3 0 24 634 
3 2 1 2 3 0 9 0 23 925 
3 2 1 2 3 0 0 1 313 317 
3 2 1 2 3 0 0 5 495 524 
3 2 1 2 4 6 0 0 161 407 
3 2 1 2 4 0 0 7 681 772 
3 2 1 2 4 0 0 8 407 433 
3 2 1 2 5 4 0 0 520 552 
3 2 1 2 5 8 0 0 498 503 
3 2 1 2 5 9 0 0 386 400 
3 2 1 2 5 0 0 2 713 717 
3 2 1 2 5 0 0 9 847 848 
3 2 1 2 6 3 0 0 225 271 
3 2 1 2 6 5 0 0 811 957 
3 2 1 2 6 9 0 0 657 901 
3 2 1 2 6 10 0 0 238 521 
3 2 1 2 6 0 3 0 235 637 
3 2 1 2 6 0 5 0 27 677 
3 2 1 2 6 0 7 0 131 225 
3 2 1 2 6 0 10 0 263 314 
3 2 1 2 6 0 0 5 521 522 
3 2 1 2 7 3 0 0 852 908 
3 2 1 2 7 7 0 0 96 457 
3 2 1 2 7 0 7 0 603 900 
3 2 1 2 7 0 0 2 736 752 
3 2 1 2 8 3 0 0 138 600 
3 2 1 2 8 0 5 0 193 273 
3 2 1 2 8 0 10 0 600 726 
3 2 1 2 8 0 0 4 451 454 
3 2 1 2 9 0 0 8 417 435 
3 2 1 2 10 7 0 0 663 792 
3 2 1 2 10 8 0 0 481 863 
3 2 1 2 10 9 0 0 466 669 
3 2 1 2 10 10 0 0 424 907 
3 2 1 2 10 0 3 0 669 785 
3 2 1 2 10 0 6 0 287 792 
3 2 1 2 10 0 0 4 466 481 
3 2 1 2 10 0 0 9 898 907 
3 2 1 2 0 1 0 4 469 475 
3 2 1 2 0 2 0 5 500 523 
3 2 1 2 0 2 0 8 413 420 
3 2 1 2 0 2 0 9 847 921 
3 2 1 2 0 3 1 0 171 717 
3 2 1 2 0 3 2 0 194 727 
3 2 1 2 0 3 5 0 421 624 
3 2 1 2 0 3 0 2 717 727 
3 2 1 2 0 3 0 7 640 679 
3 2 1 2 0 3 0 8 412 421 
3 2 1 2 0 3 0 10 852 869 
3 2 1 2 0 4 1 0 436 693 
3 2 1 2 0 4 2 0 224 552 
3 2 1 2 0 4 0 3 552 586 
3 2 1 2 0 4 0 10 800 809 
3 2 1 2 0 5 0 2 713 714 
3 2 1 2 0 5 0 4 460 486 
3 2 1 2 0 5 0 9 915 957 
3 2 1 2 0 6 7 0 454 616 
3 2 1 2 0 6 0 2 728 736 
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3 2 1 2 0 7 3 0 6 80 
3 2 1 2 0 7 5 0 468 663 
3 2 1 2 0 7 0 2 726 732 
3 2 1 2 0 7 0 8 422 446 
3 2 1 2 0 8 2 0 340 646 
3 2 1 2 0 8 5 0 583 746 
3 2 1 2 0 8 10 0 584 647 
3 2 1 2 0 8 0 1 311 340 
3 2 1 2 0 8 0 2 735 746 
3 2 1 2 0 9 2 0 154 386 
3 2 1 2 0 9 3 0 494 669 
3 2 1 2 0 9 4 0 381 901 
3 2 1 2 0 9 5 0 193 466 
3 2 1 2 0 9 9 0 676 723 
3 2 1 2 0 9 10 0 317 828 
3 2 1 2 0 9 0 1 266 317 
3 2 1 2 0 9 0 4 466 485 
3 2 1 2 0 9 0 9 901 939 
3 2 1 2 0 9 0 10 828 892 
3 2 1 2 0 10 2 0 521 791 
3 2 1 2 0 10 0 5 495 521 
3 2 1 2 0 10 0 9 907 962 
3 2 1 2 0 0 1 9 939 946 
3 2 1 2 0 0 2 3 552 590 
3 2 1 2 0 0 2 4 451 478 
3 2 1 2 0 0 3 1 285 309 
3 2 1 2 0 0 3 3 539 576 
3 2 1 2 0 0 3 4 460 493 
3 2 1 2 0 0 3 5 494 507 
3 2 1 2 0 0 3 8 404 407 
3 2 1 2 0 0 3 9 847 962 
3 2 1 2 0 0 4 10 863 882 
3 2 1 2 0 0 5 1 273 332 
3 2 1 2 0 0 5 5 524 530 
3 2 1 2 0 0 5 6 347 375 
3 2 1 2 0 0 5 10 807 867 
3 2 1 2 0 0 6 2 737 743 
3 2 1 2 0 0 6 4 456 473 
3 2 1 2 0 0 6 6 378 387 
3 2 1 2 0 0 6 9 846 948 
3 2 1 2 0 0 7 6 392 400 
3 2 1 2 0 0 8 4 469 472 
3 2 1 2 0 0 8 9 908 915 
3 2 1 2 0 0 9 1 256 297 
3 2 1 2 0 0 9 3 553 568 
3 2 1 0 1 1 7 0 177 410 
3 2 1 0 1 1 9 0 46 553 
3 2 1 0 1 1 0 7 685 691 
3 2 1 0 1 2 7 0 573 822 
3 2 1 0 1 2 0 10 818 822 
3 2 1 0 1 3 8 0 291 679 
3 2 1 0 1 3 10 0 283 593 
3 2 1 0 1 3 0 1 283 291 
3 2 1 0 1 4 4 0 229 370 
3 2 1 0 1 4 8 0 711 930 
3 2 1 0 1 4 0 6 370 393 
3 2 1 0 1 4 0 7 704 711 
3 2 1 0 1 4 0 8 403 425 
3 2 1 0 1 5 3 0 460 636 
3 2 1 0 1 5 0 10 824 880 
3 2 1 0 1 6 5 0 347 759 
3 2 1 0 1 6 8 0 506 559 
3 2 1 0 1 6 0 4 453 459 
3 2 1 0 1 6 0 5 506 525 
3 2 1 0 1 7 4 0 344 628 
3 2 1 0 1 7 9 0 464 673 
3 2 1 0 1 7 0 1 339 344 
3 2 1 0 1 7 0 3 588 628 
3 2 1 0 1 7 0 4 464 483 
3 2 1 0 1 7 0 7 656 673 
3 2 1 0 1 8 0 1 311 340 
3 2 1 0 1 10 7 0 447 606 
3 2 1 0 1 10 0 4 447 458 
3 2 1 0 1 0 1 7 695 756 
3 2 1 0 1 0 3 6 356 365 
3 2 1 0 1 0 3 7 636 704 
3 2 1 0 1 0 4 6 353 370 
3 2 1 0 1 0 7 4 447 483 
3 2 1 0 1 0 7 7 656 757 
3 2 1 0 1 0 8 1 266 291 
3 2 1 0 1 0 9 3 553 568 
3 2 1 0 1 0 9 4 453 464 
3 2 1 0 1 0 9 10 818 869 
3 2 1 0 1 0 10 1 283 327 
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3 2 1 0 1 0 10 7 653 781 
3 2 1 0 1 0 10 8 403 425 
3 2 1 0 2 1 2 0 715 911 
3 2 1 0 2 2 10 0 104 280 
3 2 1 0 2 6 6 0 143 629 
3 2 1 0 2 6 0 3 610 629 
3 2 1 0 2 7 8 0 371 839 
3 2 1 0 2 8 0 7 646 647 
3 2 1 0 2 10 6 0 105 639 
3 2 1 0 2 0 2 9 911 961 
3 2 1 0 2 0 4 3 536 626 
3 2 1 0 2 0 9 10 809 813 
3 2 1 0 2 0 10 1 280 292 
3 2 1 0 3 1 0 7 634 708 
3 2 1 0 3 2 10 0 806 830 
3 2 1 0 3 2 0 10 806 830 
3 2 1 0 3 0 10 10 806 830 
3 2 1 0 4 1 2 0 334 681 
3 2 1 0 4 1 10 0 5 179 
3 2 1 0 4 1 0 7 681 772 
3 2 1 0 4 2 5 0 69 200 
3 2 1 0 4 2 6 0 38 76 
3 2 1 0 4 3 0 1 278 336 
3 2 1 0 4 3 0 3 571 624 
3 2 1 0 4 4 3 0 90 137 
3 2 1 0 4 5 5 0 211 254 
3 2 1 0 4 5 10 0 223 859 
3 2 1 0 4 5 0 3 541 595 
3 2 1 0 4 7 6 0 308 548 
3 2 1 0 4 10 4 0 433 882 
3 2 1 0 4 0 3 8 407 429 
3 2 1 0 4 0 4 1 275 337 
3 2 1 0 4 0 5 3 583 624 
3 2 1 0 4 0 7 1 265 336 
3 2 1 0 4 0 10 1 278 286 
3 2 1 0 4 0 10 10 800 859 
3 2 1 0 5 1 2 0 391 672 
3 2 1 0 5 1 5 0 252 530 
3 2 1 0 5 1 0 1 302 331 
3 2 1 0 5 1 0 3 563 619 
3 2 1 0 5 2 8 0 91 326 
3 2 1 0 5 2 0 4 478 491 
3 2 1 0 5 2 0 8 413 420 
3 2 1 0 5 3 10 0 412 540 
3 2 1 0 5 3 0 5 526 534 
3 2 1 0 5 3 0 6 366 385 
3 2 1 0 5 4 2 0 552 787 
3 2 1 0 5 4 0 3 551 552 
3 2 1 0 5 5 8 0 713 761 
3 2 1 0 5 5 0 1 285 306 
3 2 1 0 5 6 3 0 61 383 
3 2 1 0 5 6 5 0 555 867 
3 2 1 0 5 6 0 1 297 303 
3 2 1 0 5 6 0 3 555 590 
3 2 1 0 5 7 1 0 77 771 
3 2 1 0 5 7 0 6 364 388 
3 2 1 0 5 7 0 7 709 771 
3 2 1 0 5 8 6 0 503 769 
3 2 1 0 5 8 0 5 498 503 
3 2 1 0 5 9 1 0 15 350 
3 2 1 0 5 10 3 0 191 585 
3 2 1 0 5 10 0 3 544 585 
3 2 1 0 5 0 1 1 302 331 
3 2 1 0 5 0 1 7 649 771 
3 2 1 0 5 0 1 8 413 420 
3 2 1 0 5 0 2 3 552 590 
3 2 1 0 5 0 3 1 285 325 
3 2 1 0 5 0 4 4 465 475 
3 2 1 0 5 0 7 7 668 709 
3 2 1 0 5 0 8 5 498 520 
3 2 1 0 5 0 8 7 633 761 
3 2 1 0 5 0 8 10 793 857 
3 2 1 0 5 0 9 1 297 303 
3 2 1 0 5 0 9 5 518 534 
3 2 1 0 5 0 10 8 409 412 
3 2 1 0 6 1 6 0 737 948 
3 2 1 0 6 1 8 0 221 537 
3 2 1 0 6 2 10 0 263 314 
3 2 1 0 6 4 0 7 677 693 
3 2 1 0 6 6 1 0 333 705 
3 2 1 0 6 6 3 0 637 875 
3 2 1 0 6 6 0 7 637 705 
3 2 1 0 6 6 0 10 794 875 
3 2 1 0 6 10 1 0 238 885 
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3 2 1 0 6 0 2 5 521 522 
3 2 1 0 6 0 4 9 901 954 
3 2 1 0 6 0 6 1 271 281 
3 2 1 0 6 0 9 10 794 881 
3 2 1 0 6 0 10 1 263 314 
3 2 1 0 7 1 5 0 88 575 
3 2 1 0 7 2 9 0 752 890 
3 2 1 0 7 5 0 3 569 603 
3 2 1 0 7 6 1 0 662 879 
3 2 1 0 7 10 10 0 316 423 
3 2 1 0 7 10 0 10 791 808 
3 2 1 0 7 0 10 1 259 316 
3 2 1 0 8 1 2 0 114 883 
3 2 1 0 8 2 8 0 12 805 
3 2 1 0 8 3 3 0 138 147 
3 2 1 0 8 4 1 0 436 750 
3 2 1 0 8 4 4 0 11 26 
3 2 1 0 8 4 0 2 747 750 
3 2 1 0 8 6 2 0 226 451 
3 2 1 0 8 6 7 0 454 616 
3 2 1 0 8 6 0 4 451 454 
3 2 1 0 8 6 0 7 645 760 
3 2 1 0 8 7 4 0 8 504 
3 2 1 0 8 7 6 0 749 819 
3 2 1 0 8 7 0 2 726 749 
3 2 1 0 8 8 8 0 550 837 
3 2 1 0 8 0 4 7 690 760 
3 2 1 0 8 0 8 10 805 837 
3 2 1 0 9 1 4 0 382 435 
3 2 1 0 9 1 7 0 397 778 
3 2 1 0 9 1 9 0 692 768 
3 2 1 0 9 1 0 5 514 515 
3 2 1 0 9 1 0 8 427 435 
3 2 1 0 9 1 0 9 923 936 
3 2 1 0 9 1 0 10 877 884 
3 2 1 0 9 2 3 0 358 576 
3 2 1 0 9 2 4 0 274 401 
3 2 1 0 9 2 7 0 201 665 
3 2 1 0 9 2 8 0 351 731 
3 2 1 0 9 2 0 7 665 766 
3 2 1 0 9 3 0 6 378 392 
3 2 1 0 9 4 0 6 359 402 
3 2 1 0 9 5 1 0 714 823 
3 2 1 0 9 5 3 0 376 507 
3 2 1 0 9 5 4 0 330 558 
3 2 1 0 9 5 10 0 203 664 
3 2 1 0 9 5 0 3 558 612 
3 2 1 0 9 5 0 5 507 531 
3 2 1 0 9 5 0 7 664 777 
3 2 1 0 9 5 0 10 823 860 
3 2 1 0 9 6 10 0 148 482 
3 2 1 0 9 7 1 0 683 732 
3 2 1 0 9 7 9 0 780 922 
3 2 1 0 9 8 5 0 324 746 
3 2 1 0 9 8 7 0 492 862 
3 2 1 0 9 8 0 1 293 324 
3 2 1 0 9 8 0 3 615 620 
3 2 1 0 9 8 0 10 862 893 
3 2 1 0 9 9 1 0 485 699 
3 2 1 0 9 9 10 0 820 828 
3 2 1 0 9 9 0 7 676 699 
3 2 1 0 9 9 0 10 820 828 
3 2 1 0 9 10 3 0 218 493 
3 2 1 0 9 0 1 2 714 732 
3 2 1 0 9 0 1 3 592 598 
3 2 1 0 9 0 1 7 683 699 
3 2 1 0 9 0 2 2 727 742 
3 2 1 0 9 0 2 6 368 398 
3 2 1 0 9 0 2 9 921 936 
3 2 1 0 9 0 3 3 539 576 
3 2 1 0 9 0 3 6 358 376 
3 2 1 0 9 0 4 1 274 330 
3 2 1 0 9 0 4 6 382 401 
3 2 1 0 9 0 6 6 378 387 
3 2 1 0 9 0 7 6 392 397 
3 2 1 0 9 0 7 7 665 778 
3 2 1 0 10 2 1 0 500 523 
3 2 1 0 10 2 0 5 500 523 
3 2 1 0 10 3 4 0 140 512 
3 2 1 0 10 6 1 0 570 947 
3 2 1 0 10 7 1 0 428 631 
3 2 1 0 10 8 4 0 481 863 
3 2 1 0 10 9 5 0 431 466 
3 2 1 0 10 0 1 3 570 631 
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3 2 1 0 10 0 1 5 500 523                    3 2 1 0 10 0 3 7 669 785                    
3 2 1 0 10 0 4 9 898 907                    
3 2 1 0 10 0 8 3 599 632                    
3 2 1 0 0 1 1 3 592 598                    
3 2 1 0 0 1 2 9 911 936                    
3 2 1 0 0 1 4 9 898 950                    
3 2 1 0 0 1 5 5 524 530                    
3 2 1 0 0 1 6 2 737 743                    
3 2 1 0 0 1 6 9 923 948                    
3 2 1 0 0 1 8 5 515 517                    
3 2 1 0 0 1 8 6 354 395                    
3 2 1 0 0 1 8 7 633 691                    
3 2 1 0 0 1 9 7 692 768                    
3 2 1 0 0 2 1 5 500 523                    
3 2 1 0 0 2 1 8 413 420                    
3 2 1 0 0 2 1 10 799 821                    
3 2 1 0 0 2 2 9 921 961                    
3 2 1 0 0 2 4 1 274 315                    
3 2 1 0 0 2 6 1 257 281                    
3 2 1 0 0 2 8 2 729 731                    
3 2 1 0 0 2 8 3 535 599                    
3 2 1 0 0 2 9 2 725 752                    
3 2 1 0 0 2 9 10 818 890                    
3 2 1 0 0 2 10 10 806 830                    
3 2 1 0 0 3 4 5 512 526                    
3 2 1 0 0 3 6 1 271 287                    
3 2 1 0 0 3 6 6 378 385                    
3 2 1 0 0 3 10 1 278 283                    
3 2 1 0 0 4 3 1 309 325                    
3 2 1 0 0 5 1 10 811 823                    
3 2 1 0 0 5 3 8 419 429                    
3 2 1 0 0 5 6 10 824 860                    
3 2 1 0 0 5 7 3 541 603                    
3 2 1 0 0 5 8 7 761 777                    
3 2 1 0 0 5 9 5 509 531                    
3 2 1 0 0 5 10 10 803 859                    
3 2 1 0 0 6 1 3 570 610                    
3 2 1 0 0 6 1 7 662 705                    
3 2 1 0 0 6 1 9 946 947                    
3 2 1 0 0 6 2 2 728 742                    
3 2 1 0 0 6 2 10 795 858                    
3 2 1 0 0 6 9 1 297 303                    
3 2 1 0 0 6 9 9 925 958                    
3 2 1 0 0 6 9 10 794 796                    
3 2 1 0 0 7 1 7 683 771                    
3 2 1 0 0 7 2 6 364 369                    
3 2 1 0 0 7 4 1 275 344                    
3 2 1 0 0 7 6 10 792 819                    
3 2 1 0 0 7 7 3 588 608                    
3 2 1 0 0 7 7 7 656 709                    
3 2 1 0 0 7 8 10 793 839                    
3 2 1 0 0 7 9 7 673 780                    
3 2 1 0 0 7 9 9 848 922                    
3 2 1 0 0 8 2 1 293 340                    
3 2 1 0 0 8 7 4 455 492                    
3 2 1 0 0 8 7 10 844 862                    
3 2 1 0 0 9 1 7 657 699                    
3 2 1 0 0 9 10 1 286 317                    
3 2 1 0 0 9 10 10 820 828                    
3 2 1 0 0 10 4 8 426 433                    
3 2 1 0 0 10 9 1 256 261                    
3 2 1 0 0 10 10 4 471 477                    
2 83 0 2 0 1 0 0 2 5 7 13 23 32 46 56 88 89 98 100 114 131 150 169 172 177 179 187 195 
2 77 0 2 1 0 0 0 13 32 46 56 80 89 125 142 177 187 194 195 229 266 291 311 327 339 340 344 347 
2 76 0 2 9 0 0 0 34 83 102 148 150 169 172 198 203 209 213 218 256 264 274 296 351 354 358 359 368 
2 69 0.0000001 2 5 0 0 0 43 61 91 107 133 191 252 285 297 301 302 307 326 331 364 366 386 388 391 400 404 
2 68 0.0000003 2 0 2 0 0 3 12 27 38 43 69 71 76 91 103 104 125 133 135 157 160 180 197 198 200 202 
2 61 0.00005223 2 0 0 0 7 633 634 636 637 639 640 645 646 647 649 650 653 654 656 657 662 663 664 665 666 668 
2 59 0.00019647 2 0 0 8 0 12 34 83 91 103 180 221 266 268 291 326 351 354 359 389 395 417 424 446 469 472 
2 56 0.00124251 2 0 6 0 0 22 60 61 67 143 148 161 213 214 226 259 297 333 347 407 451 453 454 459 465 472 
2 54 0.00386314 2 0 0 1 0 3 13 62 71 150 157 171 238 296 302 319 328 331 333 339 346 413 420 436 459 485 
2 52 0.01109328 2 4 0 0 0 3 5 6 7 38 58 69 76 78 90 103 136 137 161 179 200 211 219 223 245 254 
2 51 0.01823055 2 0 0 0 3 535 536 537 539 540 541 544 548 550 552 553 554 555 558 559 563 568 569 570 571 573 
2 48 0.07042222 2 0 7 0 0 6 8 52 80 96 219 264 268 275 292 308 313 339 344 364 369 388 422 446 456 457 
2 48 0.07042222 2 0 0 9 0 10 23 46 52 67 78 100 119 214 245 250 256 297 366 453 464 486 502 509 518 531 
2 47 0.10466423 2 0 0 10 0 5 32 104 148 172 179 203 223 259 263 278 292 301 307 314 316 317 327 372 403 412 
2 45 0.2081044 2 0 0 4 0 8 11 26 58 98 125 136 229 274 275 315 337 344 353 370 381 382 388 401 416 426 
2 45 0.2081044 2 0 0 0 1 256 257 259 263 264 265 266 268 271 273 274 275 276 278 281 285 287 291 292 296 297 
2 44 0.27516937 2 0 5 0 0 58 62 83 119 132 203 211 223 254 285 372 416 417 443 460 486 507 509 531 541 558 
2 44 0.27516937 2 0 0 2 0 56 96 114 135 154 194 197 209 219 224 226 276 313 334 340 364 368 369 386 391 451 
2 44 0.27516937 2 0 0 0 10 791 792 793 794 795 796 798 799 800 803 807 808 809 811 813 814 818 819 821 822 823 
2 39 0.50109449 2 8 0 0 0 2 8 11 12 26 52 70 99 100 114 132 138 193 226 242 257 273 276 315 436 451 
2 39 0.50109449 2 0 0 3 0 6 24 60 61 80 89 90 99 137 138 169 191 218 235 285 309 356 358 365 404 407 
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3 2 1 0 10 0 3 7                      3 2 1 0 10 0 4 9                      
3 2 1 0 10 0 8 3                      
3 2 1 0 0 1 1 3                      
3 2 1 0 0 1 2 9                      
3 2 1 0 0 1 4 9                      
3 2 1 0 0 1 5 5                      
3 2 1 0 0 1 6 2                      
3 2 1 0 0 1 6 9                      
3 2 1 0 0 1 8 5                      
3 2 1 0 0 1 8 6                      
3 2 1 0 0 1 8 7                      
3 2 1 0 0 1 9 7                      
3 2 1 0 0 2 1 5                      
3 2 1 0 0 2 1 8                      
3 2 1 0 0 2 1 10                      
3 2 1 0 0 2 2 9                      
3 2 1 0 0 2 4 1                      
3 2 1 0 0 2 6 1                      
3 2 1 0 0 2 8 2                      
3 2 1 0 0 2 8 3                      
3 2 1 0 0 2 9 2                      
3 2 1 0 0 2 9 10                      
3 2 1 0 0 2 10 10                      
3 2 1 0 0 3 4 5                      
3 2 1 0 0 3 6 1                      
3 2 1 0 0 3 6 6                      
3 2 1 0 0 3 10 1                      
3 2 1 0 0 4 3 1                      
3 2 1 0 0 5 1 10                      
3 2 1 0 0 5 3 8                      
3 2 1 0 0 5 6 10                      
3 2 1 0 0 5 7 3                      
3 2 1 0 0 5 8 7                      
3 2 1 0 0 5 9 5                      
3 2 1 0 0 5 10 10                      
3 2 1 0 0 6 1 3                      
3 2 1 0 0 6 1 7                      
3 2 1 0 0 6 1 9                      
3 2 1 0 0 6 2 2                      
3 2 1 0 0 6 2 10                      
3 2 1 0 0 6 9 1                      
3 2 1 0 0 6 9 9                      
3 2 1 0 0 6 9 10                      
3 2 1 0 0 7 1 7                      
3 2 1 0 0 7 2 6                      
3 2 1 0 0 7 4 1                      
3 2 1 0 0 7 6 10                      
3 2 1 0 0 7 7 3                      
3 2 1 0 0 7 7 7                      
3 2 1 0 0 7 8 10                      
3 2 1 0 0 7 9 7                      
3 2 1 0 0 7 9 9                      
3 2 1 0 0 8 2 1                      
3 2 1 0 0 8 7 4                      
3 2 1 0 0 8 7 10                      
3 2 1 0 0 9 1 7                      
3 2 1 0 0 9 10 1                      
3 2 1 0 0 9 10 10                      
3 2 1 0 0 10 4 8                      
3 2 1 0 0 10 9 1                      
3 2 1 0 0 10 10 4                      
2 83 0 2 0 1 0 0 221 242 252 296 302 319 328 331 334 354 356 382 391 395 404 410 435 469 475 510 514 
2 77 0 2 1 0 0 0 353 356 365 369 370 372 403 410 425 446 447 453 458 459 460 464 473 483 506 509 525 
2 76 0 2 9 0 0 0 378 382 387 389 392 401 417 435 468 482 485 492 493 507 514 515 531 539 558 576 592 
2 69 0.0000001 2 5 0 0 0 412 413 416 420 422 443 465 475 478 486 491 498 503 510 518 520 526 528 530 534 540 
2 68 0.0000003 2 0 2 0 0 209 235 253 257 263 274 276 281 301 307 314 315 326 327 351 358 368 401 413 420 478 
2 61 0.00005223 2 0 0 0 7 669 670 672 673 676 677 679 681 683 685 687 688 690 692 693 695 699 700 704 705 708 
2 59 0.00019647 2 0 0 8 0 498 506 515 517 520 535 537 550 559 563 571 599 614 615 620 632 633 666 679 687 711 
2 56 0.00124251 2 0 6 0 0 482 506 518 525 554 555 559 568 570 590 610 616 629 637 645 650 662 670 688 705 710 
2 54 0.00386314 2 0 0 1 0 491 495 500 523 528 569 570 578 592 595 598 610 649 657 662 683 693 695 699 705 714 
2 52 0.01109328 2 4 0 0 0 265 275 278 308 334 336 337 346 375 381 407 433 477 502 541 548 571 583 595 624 681 
2 51 0.01823055 2 0 0 0 3 575 576 577 578 579 583 584 586 588 590 592 593 595 598 599 600 603 608 610 612 614 
2 48 0.07042222 2 0 7 0 0 464 468 483 504 548 577 588 608 628 656 663 666 673 683 700 709 726 732 771 780 792 
2 48 0.07042222 2 0 0 9 0 534 553 568 640 650 673 676 692 723 725 735 752 768 780 794 796 798 809 813 818 848 
2 47 0.10466423 2 0 0 10 0 423 425 457 471 477 482 514 540 554 577 579 584 586 593 600 647 653 664 708 726 800 
2 45 0.2081044 2 0 0 4 0 433 435 443 465 475 481 489 504 512 526 536 558 626 628 690 736 760 776 863 882 898 
2 45 0.2081044 2 0 0 0 1 301 302 307 308 309 311 313 314 315 316 317 319 326 327 328 331 332 333 334 336 337 
2 44 0.27516937 2 0 5 0 0 569 578 595 603 612 636 664 713 714 757 761 776 777 803 807 811 823 824 859 860 880 
2 44 0.27516937 2 0 0 2 0 478 521 522 525 552 590 646 654 670 672 681 688 700 710 715 727 728 791 795 858 921 
2 44 0.27516937 2 0 0 0 10 824 828 830 839 844 852 857 858 859 860 862 863 867 869 879 880 881 882 884 890 891 
2 39 0.50109449 2 8 0 0 0 454 494 504 517 550 600 616 645 690 722 725 726 747 760 799 819 891 939    
2 39 0.50109449 2 0 0 3 0 460 493 494 507 539 576 634 636 637 669 704 772 785 847 852 884 891 962    
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3 2 1 0 10 0 3 7                      3 2 1 0 10 0 4 9                      
3 2 1 0 10 0 8 3                      
3 2 1 0 0 1 1 3                      
3 2 1 0 0 1 2 9                      
3 2 1 0 0 1 4 9                      
3 2 1 0 0 1 5 5                      
3 2 1 0 0 1 6 2                      
3 2 1 0 0 1 6 9                      
3 2 1 0 0 1 8 5                      
3 2 1 0 0 1 8 6                      
3 2 1 0 0 1 8 7                      
3 2 1 0 0 1 9 7                      
3 2 1 0 0 2 1 5                      
3 2 1 0 0 2 1 8                      
3 2 1 0 0 2 1 10                      
3 2 1 0 0 2 2 9                      
3 2 1 0 0 2 4 1                      
3 2 1 0 0 2 6 1                      
3 2 1 0 0 2 8 2                      
3 2 1 0 0 2 8 3                      
3 2 1 0 0 2 9 2                      
3 2 1 0 0 2 9 10                      
3 2 1 0 0 2 10 10                      
3 2 1 0 0 3 4 5                      
3 2 1 0 0 3 6 1                      
3 2 1 0 0 3 6 6                      
3 2 1 0 0 3 10 1                      
3 2 1 0 0 4 3 1                      
3 2 1 0 0 5 1 10                      
3 2 1 0 0 5 3 8                      
3 2 1 0 0 5 6 10                      
3 2 1 0 0 5 7 3                      
3 2 1 0 0 5 8 7                      
3 2 1 0 0 5 9 5                      
3 2 1 0 0 5 10 10                      
3 2 1 0 0 6 1 3                      
3 2 1 0 0 6 1 7                      
3 2 1 0 0 6 1 9                      
3 2 1 0 0 6 2 2                      
3 2 1 0 0 6 2 10                      
3 2 1 0 0 6 9 1                      
3 2 1 0 0 6 9 9                      
3 2 1 0 0 6 9 10                      
3 2 1 0 0 7 1 7                      
3 2 1 0 0 7 2 6                      
3 2 1 0 0 7 4 1                      
3 2 1 0 0 7 6 10                      
3 2 1 0 0 7 7 3                      
3 2 1 0 0 7 7 7                      
3 2 1 0 0 7 8 10                      
3 2 1 0 0 7 9 7                      
3 2 1 0 0 7 9 9                      
3 2 1 0 0 8 2 1                      
3 2 1 0 0 8 7 4                      
3 2 1 0 0 8 7 10                      
3 2 1 0 0 9 1 7                      
3 2 1 0 0 9 10 1                      
3 2 1 0 0 9 10 10                      
3 2 1 0 0 10 4 8                      
3 2 1 0 0 10 9 1                      
3 2 1 0 0 10 10 4                      
2 83 0 2 0 1 0 0 515 517 522 524 528 530 537 539 553 563 575 592 598 614 619 632 633 634 649 654 672 
2 77 0 2 1 0 0 0 553 554 559 568 573 586 588 593 628 636 653 656 673 679 685 687 695 704 711 728 729 
2 76 0 2 9 0 0 0 598 612 614 615 620 650 664 665 666 676 683 688 692 699 700 710 714 727 731 732 746 
2 69 0.0000001 2 5 0 0 0 544 552 555 563 577 578 590 619 633 640 649 668 670 672 709 713 717 761 771 793 796 
2 68 0.0000003 2 0 2 0 0 489 491 500 523 535 573 576 599 626 665 725 729 731 752 756 762 766 799 818 821 822 
2 61 0.00005223 2 0 0 0 7 709 710 711 712 756 757 759 760 761 762 766 768 771 772 776 777 778 780 785   
2 59 0.00019647 2 0 0 8 0 712 713 724 729 731 739 747 761 777 793 808 839 857 880 892 908 915     
2 56 0.00124251 2 0 6 0 0 728 736 759 760 794 795 796 858 867 879 925 946 954 958        
2 54 0.00386314 2 0 0 1 0 717 732 756 771 799 811 821 823 879 894 939 946          
2 52 0.01109328 2 4 0 0 0 723 772 798 800 844 859 882 892 894 915            
2 51 0.01823055 2 0 0 0 3 615 616 619 620 624 626 628 629 632             
2 48 0.07042222 2 0 7 0 0 793 798 814 819 839 848                
2 48 0.07042222 2 0 0 9 0 869 881 890 925 935 958                
2 47 0.10466423 2 0 0 10 0 803 814 828 830 859                 
2 45 0.2081044 2 0 0 4 0 901 907 954                   
2 45 0.2081044 2 0 0 0 1 339 340 344                   
2 44 0.27516937 2 0 5 0 0 915 957                    
2 44 0.27516937 2 0 0 2 0 936 957                    
2 44 0.27516937 2 0 0 0 10 892 894                    
2 39 0.50109449 2 8 0 0 0                      
2 39 0.50109449 2 0 0 3 0                      
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3 2 1 0 10 0 3 7                     3 2 1 0 10 0 4 9                     
3 2 1 0 10 0 8 3                     
3 2 1 0 0 1 1 3                     
3 2 1 0 0 1 2 9                     
3 2 1 0 0 1 4 9                     
3 2 1 0 0 1 5 5                     
3 2 1 0 0 1 6 2                     
3 2 1 0 0 1 6 9                     
3 2 1 0 0 1 8 5                     
3 2 1 0 0 1 8 6                     
3 2 1 0 0 1 8 7                     
3 2 1 0 0 1 9 7                     
3 2 1 0 0 2 1 5                     
3 2 1 0 0 2 1 8                     
3 2 1 0 0 2 1 10                     
3 2 1 0 0 2 2 9                     
3 2 1 0 0 2 4 1                     
3 2 1 0 0 2 6 1                     
3 2 1 0 0 2 8 2                     
3 2 1 0 0 2 8 3                     
3 2 1 0 0 2 9 2                     
3 2 1 0 0 2 9 10                     
3 2 1 0 0 2 10 10                     
3 2 1 0 0 3 4 5                     
3 2 1 0 0 3 6 1                     
3 2 1 0 0 3 6 6                     
3 2 1 0 0 3 10 1                     
3 2 1 0 0 4 3 1                     
3 2 1 0 0 5 1 10                     
3 2 1 0 0 5 3 8                     
3 2 1 0 0 5 6 10                     
3 2 1 0 0 5 7 3                     
3 2 1 0 0 5 8 7                     
3 2 1 0 0 5 9 5                     
3 2 1 0 0 5 10 10                     
3 2 1 0 0 6 1 3                     
3 2 1 0 0 6 1 7                     
3 2 1 0 0 6 1 9                     
3 2 1 0 0 6 2 2                     
3 2 1 0 0 6 2 10                     
3 2 1 0 0 6 9 1                     
3 2 1 0 0 6 9 9                     
3 2 1 0 0 6 9 10                     
3 2 1 0 0 7 1 7                     
3 2 1 0 0 7 2 6                     
3 2 1 0 0 7 4 1                     
3 2 1 0 0 7 6 10                     
3 2 1 0 0 7 7 3                     
3 2 1 0 0 7 7 7                     
3 2 1 0 0 7 8 10                     
3 2 1 0 0 7 9 7                     
3 2 1 0 0 7 9 9                     
3 2 1 0 0 8 2 1                     
3 2 1 0 0 8 7 4                     
3 2 1 0 0 8 7 10                     
3 2 1 0 0 9 1 7                     
3 2 1 0 0 9 10 1                     
3 2 1 0 0 9 10 10                     
3 2 1 0 0 10 4 8                     
3 2 1 0 0 10 9 1                     
3 2 1 0 0 10 10 4                     
2 83 0 2 0 1 0 0 681 685 690 692 708 715 722 737 743 768 772 778 785 857 884 894 898 900 936 948 
2 77 0 2 1 0 0 0 735 743 756 757 759 776 795 814 818 822 824 869 880 958       
2 76 0 2 9 0 0 0 766 768 777 778 780 823 828 860 862 884 921 936 946        
2 69 0.0000001 2 5 0 0 0 821 847 848 857 858 867               
2 68 0.0000003 2 0 2 0 0 830 847 890 891 921                
2 61 0.00005223 2 0 0 0 7                     
2 59 0.00019647 2 0 0 8 0                     
2 56 0.00124251 2 0 6 0 0                     
2 54 0.00386314 2 0 0 1 0                     
2 52 0.01109328 2 4 0 0 0                     
2 51 0.01823055 2 0 0 0 3                     
2 48 0.07042222 2 0 7 0 0                     
2 48 0.07042222 2 0 0 9 0                     
2 47 0.10466423 2 0 0 10 0                     
2 45 0.2081044 2 0 0 4 0                     
2 45 0.2081044 2 0 0 0 1                     
2 44 0.27516937 2 0 5 0 0                     
2 44 0.27516937 2 0 0 2 0                     
2 44 0.27516937 2 0 0 0 10                     
2 39 0.50109449 2 8 0 0 0                     
2 39 0.50109449 2 0 0 3 0                     
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2 39 0.50109449 2 0 0 6 0 7 38 43 50 70 76 105 132 143 161 195 202 257 271 281 287 308 378 387 422 456 
2 38 0.50760048 2 2 0 0 0 10 50 60 62 67 104 105 119 143 154 157 160 171 253 292 309 328 332 421 426 455 
2 38 0.50760048 2 0 0 5 0 22 27 69 88 102 107 142 160 187 193 198 200 211 213 252 254 273 332 347 375 421 
2 37 0.51474779 2 0 10 0 0 102 105 107 191 218 238 245 256 265 316 332 346 365 387 423 424 426 433 447 458 471 
2 37 0.51474779 2 0 0 7 0 2 131 133 177 225 242 253 264 265 311 336 392 400 410 447 454 455 483 492 510 541 
2 33 0.62731421 2 6 0 0 0 27 71 98 131 197 221 225 235 238 263 268 271 281 314 333 472 521 522 537 637 657 
2 33 0.62731421 2 0 3 0 0 24 138 171 194 225 271 278 287 291 336 366 378 392 412 421 473 512 526 534 536 540 
2 32 0.69435517 2 0 4 0 0 11 26 70 78 90 99 137 142 224 229 273 309 337 359 370 375 403 425 436 520 552 
2 31 0.77722135 2 7 0 0 0 22 88 96 180 214 224 250 259 316 319 395 423 457 569 575 584 603 654 662 736 752 
2 30 0.86445525 2 0 0 0 4 447 451 453 454 455 456 457 458 459 460 464 465 466 468 469 471 472 473 475 477 478 
2 29 0.9373832 2 0 8 0 0 10 34 50 136 250 311 340 353 455 481 492 498 502 503 550 583 584 615 620 646 647 
2 28 0.98103458 2 0 0 0 6 346 347 351 353 354 356 358 359 364 365 366 368 369 370 372 375 378 381 382 386 387 
2 27 0.99700221 2 0 0 0 5 494 495 498 500 502 503 504 506 507 509 510 512 514 515 517 518 520 521 522 523 524 
2 22 1 2 0 0 0 2 713 714 715 717 722 723 724 725 726 727 728 729 731 732 735 736 737 739 743 746 747 
2 22 0.00000485 0 9 1 0 0 150 169 172 296 354 382 397 427 435 514 515 539 592 598 614 692 768 778 877 884 923 
2 20 1 2 10 0 0 0 135 287 424 466 481 500 512 523 570 579 599 632 663 669 785 792 807 863 898 907  
2 20 1 2 0 9 0 0 154 193 266 317 381 386 389 400 466 485 494 657 669 676 699 723 828 892 901 939  
2 20 1 2 0 0 0 8 403 404 407 410 412 413 416 417 420 421 422 423 424 425 426 433 435 436 443 446  
2 20 1 2 0 0 0 9 846 847 848 898 900 901 907 908 915 921 925 935 936 939 946 948 954 957 958 962  
2 19 1 1 5 0 0 0 15 77 237 288 303 306 325 349 350 383 385 409 439 551 585 617 738 769 787   
2 17 1 1 9 0 0 0 201 204 293 324 330 376 397 398 402 427 742 786 820 877 893 922 923     
2 17 0.00430046 0 9 0 0 7 650 664 665 666 676 683 688 692 699 700 710 766 768 777 778 780 786     
2 16 0.01413298 0 1 1 0 0 13 32 46 56 89 177 187 195 356 410 501 553 685 691 743 950      
2 16 0.01413298 0 1 0 0 7 636 653 656 673 679 685 687 691 695 704 711 756 757 759 776 781      
2 15 1 1 0 0 10 0 204 231 269 280 283 286 288 409 427 556 617 781 806 820 893       
2 15 1 2 3 0 0 0 23 24 202 313 317 489 495 524 535 634 708 712 739 830 925       
2 15 0.04343585 0 5 1 0 0 252 302 331 391 404 475 510 528 530 563 619 633 649 672 857       
2 15 0.04343585 0 9 0 8 0 34 83 351 354 359 389 417 515 614 615 620 666 731 777 786       
2 15 0.04343585 0 9 0 0 6 351 354 358 359 368 376 378 382 387 389 392 397 398 401 402       
2 15 0.04343585 0 0 1 0 7 633 634 649 654 672 681 685 690 691 692 708 768 772 778 785       
2 15 0.04343585 0 0 0 10 1 259 263 269 278 280 283 286 288 292 301 307 314 316 317 327       
2 14 0.12235477 0 5 2 0 0 43 91 133 288 301 307 326 413 420 478 491 617 821 847        
2 14 0.12235477 0 5 0 1 0 15 77 302 331 350 413 420 491 528 578 649 717 771 821        
2 14 0.12235477 0 9 5 0 0 83 203 330 376 417 507 531 558 612 664 714 777 823 860        
2 13 1 1 0 0 3 0 51 147 325 376 383 396 411 419 429 501 585 865 875         
2 13 1 1 0 0 0 1 261 269 280 283 286 288 293 303 306 324 325 330 342         
2 13 0.30368808 0 9 2 0 0 198 201 209 274 351 358 368 401 576 665 731 766 921         
2 13 0.30368808 0 0 1 8 0 221 354 395 469 515 517 537 563 614 632 633 691 857         
2 13 0.30368808 0 0 2 0 1 257 263 274 276 280 281 288 301 307 314 315 326 327         
2 12 1 1 0 4 0 0 118 163 325 393 402 409 551 750 784 787 906 930          
2 12 1 1 0 0 1 0 15 77 130 350 393 428 631 750 841 885 906 947          
2 12 1 1 0 0 0 10 805 806 820 837 841 865 875 877 883 885 887 893          
2 12 0.61303025 0 1 6 0 0 347 453 459 506 525 554 559 568 728 759 795 958          
2 12 0.61303025 0 1 7 0 0 80 339 344 369 446 464 483 588 628 656 673 814          
2 12 0.61303025 0 1 0 7 0 163 177 311 410 447 483 573 588 606 656 757 822          
2 12 0.61303025 0 1 0 8 0 266 291 446 506 559 679 687 691 711 729 880 930          
2 12 0.61303025 0 1 0 10 0 32 283 327 372 403 425 554 586 593 653 781 814          
2 12 0.61303025 0 5 6 0 0 61 297 303 383 465 518 555 590 670 796 858 867          
2 12 0.61303025 0 5 0 0 3 540 544 551 552 555 563 577 578 585 590 617 619          
2 12 0.61303025 0 0 1 1 0 13 150 296 302 319 328 331 528 592 598 649 894          
2 12 0.61303025 0 0 1 2 0 56 114 334 391 522 654 672 681 715 883 911 936          
2 12 0.61303025 0 0 6 2 0 226 398 451 525 590 670 688 710 728 742 795 858          
2 12 0.61303025 0 0 6 9 0 67 214 297 303 453 518 568 650 794 796 925 958          
2 11 1 1 0 1 0 0 35 397 406 427 501 691 877 883 911 923 950           
2 11 1 1 0 0 0 6 349 350 371 376 383 385 393 396 397 398 402           
2 11 0.9061659 0 1 4 0 0 142 163 229 370 393 403 425 586 704 711 930           
2 11 0.9061659 0 1 0 9 0 46 453 464 509 553 568 673 735 818 869 958           
2 11 0.9061659 0 5 0 8 0 91 326 349 498 520 563 633 713 761 793 857           
2 11 0.9061659 0 5 0 0 1 285 288 297 301 302 303 306 307 325 326 331           
2 11 0.9061659 0 5 0 0 7 633 640 649 668 670 672 709 761 769 771 787           
2 11 0.9061659 0 9 0 1 0 150 296 485 592 598 683 699 714 732 823 946           
2 11 0.9061659 0 9 0 2 0 209 293 368 398 688 700 710 727 742 921 936           
2 11 0.9061659 0 9 0 10 0 148 172 203 204 427 482 514 664 820 828 893           
2 11 0.9061659 0 0 2 1 0 3 71 157 413 420 491 500 523 756 799 821           
2 11 0.9061659 0 0 2 8 0 12 91 103 180 326 351 535 599 729 731 805           
2 11 0.9061659 0 0 2 10 0 104 263 280 288 301 307 314 327 617 806 830           
2 11 0.9061659 0 0 6 0 7 637 645 650 662 670 688 705 710 759 760 786           
2 11 0.9061659 0 0 0 8 3 535 537 550 559 563 571 599 614 615 620 632           
2 10 1 1 1 0 0 0 163 283 393 501 606 691 753 781 930 950            
2 10 1 1 0 2 0 0 51 117 201 280 288 587 617 805 806 961            
2 10 1 1 0 5 0 0 130 248 269 306 330 376 419 429 439 753            
2 10 1 1 0 7 0 0 77 204 231 342 371 428 631 749 841 922            
2 10 0.99651754 0 1 0 0 3 553 554 559 568 573 586 588 593 606 628            
2 10 0.99651754 0 5 0 2 0 364 386 391 478 552 590 670 672 787 858            
2 10 0.99651754 0 5 0 9 0 297 303 366 486 518 534 640 738 796 848            
2 10 0.99651754 0 5 0 0 6 349 350 364 366 383 385 386 388 391 400            
2 10 0.99651754 0 9 6 0 0 148 213 398 482 650 688 710 742 786 946            
2 10 0.99651754 0 0 1 3 0 89 169 356 404 501 539 634 772 785 884            
2 10 0.99651754 0 0 1 7 0 2 131 177 242 397 410 510 722 778 900            
2 10 0.99651754 0 0 1 0 3 537 539 553 563 575 592 598 614 619 632            
2 10 0.99651754 0 0 0 1 7 649 657 662 683 693 695 699 705 756 771            
2 10 0.99651754 0 0 0 8 7 633 666 679 687 691 711 712 761 777 786            
2 10 0.99651754 0 0 0 10 3 540 554 556 577 579 584 586 593 600 617            
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2 39 0.50109449 2 0 0 6 0 473 503 544 548 619 629 639 645 685 737 743 766 792 819 824 846 860 948 
2 38 0.50760048 2 2 0 0 0 456 469 471 536 608 610 626 629 639 646 647 715 724 809 813 839 962  
2 38 0.50760048 2 0 0 5 0 458 466 468 524 530 555 575 583 612 624 663 677 746 759 762 807 867  
2 37 0.51474779 2 0 10 0 0 477 493 495 521 544 639 653 668 687 695 791 808 813 882 907 962   
2 37 0.51474779 2 0 0 7 0 573 588 603 608 616 656 665 668 709 722 757 778 822 844 862 900   
2 33 0.62731421 2 6 0 0 0 677 693 705 737 794 811 881 901 935 948 954 957       
2 33 0.62731421 2 0 3 0 0 571 579 593 600 624 640 679 717 727 852 869 908       
2 32 0.69435517 2 0 4 0 0 586 677 693 704 711 724 739 747 800 809 935        
2 31 0.77722135 2 7 0 0 0 762 791 803 808 846 852 879 890 900 908         
2 30 0.86445525 2 0 0 0 4 481 482 483 485 486 489 491 492 493          
2 29 0.9373832 2 0 8 0 0 712 735 746 844 846 862 863 881           
2 28 0.98103458 2 0 0 0 6 388 389 391 392 395 400 401            
2 27 0.99700221 2 0 0 0 5 525 526 528 530 531 534             
2 22 1 2 0 0 0 2 752                  
2 22 0.00000485 0 9 1 0 0 936                  
2 20 1 2 10 0 0 0                   
2 20 1 2 0 9 0 0                   
2 20 1 2 0 0 0 8                   
2 20 1 2 0 0 0 9                   
2 19 1 1 5 0 0 0                   
2 17 1 1 9 0 0 0                   
2 17 0.00430046 0 9 0 0 7                   
2 16 0.01413298 0 1 1 0 0                   
2 16 0.01413298 0 1 0 0 7                   
2 15 1 1 0 0 10 0                   
2 15 1 2 3 0 0 0                   
2 15 0.04343585 0 5 1 0 0                   
2 15 0.04343585 0 9 0 8 0                   
2 15 0.04343585 0 9 0 0 6                   
2 15 0.04343585 0 0 1 0 7                   
2 15 0.04343585 0 0 0 10 1                   
2 14 0.12235477 0 5 2 0 0                   
2 14 0.12235477 0 5 0 1 0                   
2 14 0.12235477 0 9 5 0 0                   
2 13 1 1 0 0 3 0                   
2 13 1 1 0 0 0 1                   
2 13 0.30368808 0 9 2 0 0                   
2 13 0.30368808 0 0 1 8 0                   
2 13 0.30368808 0 0 2 0 1                   
2 12 1 1 0 4 0 0                   
2 12 1 1 0 0 1 0                   
2 12 1 1 0 0 0 10                   
2 12 0.61303025 0 1 6 0 0                   
2 12 0.61303025 0 1 7 0 0                   
2 12 0.61303025 0 1 0 7 0                   
2 12 0.61303025 0 1 0 8 0                   
2 12 0.61303025 0 1 0 10 0                   
2 12 0.61303025 0 5 6 0 0                   
2 12 0.61303025 0 5 0 0 3                   
2 12 0.61303025 0 0 1 1 0                   
2 12 0.61303025 0 0 1 2 0                   
2 12 0.61303025 0 0 6 2 0                   
2 12 0.61303025 0 0 6 9 0                   
2 11 1 1 0 1 0 0                   
2 11 1 1 0 0 0 6                   
2 11 0.9061659 0 1 4 0 0                   
2 11 0.9061659 0 1 0 9 0                   
2 11 0.9061659 0 5 0 8 0                   
2 11 0.9061659 0 5 0 0 1                   
2 11 0.9061659 0 5 0 0 7                   
2 11 0.9061659 0 9 0 1 0                   
2 11 0.9061659 0 9 0 2 0                   
2 11 0.9061659 0 9 0 10 0                   
2 11 0.9061659 0 0 2 1 0                   
2 11 0.9061659 0 0 2 8 0                   
2 11 0.9061659 0 0 2 10 0                   
2 11 0.9061659 0 0 6 0 7                   
2 11 0.9061659 0 0 0 8 3                   
2 10 1 1 1 0 0 0                   
2 10 1 1 0 2 0 0                   
2 10 1 1 0 5 0 0                   
2 10 1 1 0 7 0 0                   
2 10 0.99651754 0 1 0 0 3                   
2 10 0.99651754 0 5 0 2 0                   
2 10 0.99651754 0 5 0 9 0                   
2 10 0.99651754 0 5 0 0 6                   
2 10 0.99651754 0 9 6 0 0                   
2 10 0.99651754 0 0 1 3 0                   
2 10 0.99651754 0 0 1 7 0                   
2 10 0.99651754 0 0 1 0 3                   
2 10 0.99651754 0 0 0 1 7                   
2 10 0.99651754 0 0 0 8 7                   
2 10 0.99651754 0 0 0 10 3                   
Page | E31  
2 9 1 1 8 0 0 0 35 147 269 749 750 805 837 883 887 
2 9 1 1 0 10 0 0 165 261 349 556 585 606 738 885 887 
2 9 1 1 0 0 5 0 35 117 306 324 342 431 753 877 887 
2 9 1 1 0 0 0 8 406 409 411 419 427 428 429 431 439 
2 9 0.99999821 0 1 5 0 0 372 460 509 636 753 757 776 824 880 
2 9 0.99999821 0 4 5 0 0 58 211 223 254 429 541 595 859 915 
2 9 0.99999821 0 4 0 0 1 265 275 278 286 308 334 336 337 342 
2 9 0.99999821 0 5 3 0 0 237 366 385 412 526 534 540 640 717 
2 9 0.99999821 0 5 5 0 0 285 306 416 439 443 486 578 713 761 
2 9 0.99999821 0 5 7 0 0 77 364 388 422 577 709 771 793 848 
2 9 0.99999821 0 5 0 0 5 498 503 510 518 520 526 528 530 534 
2 9 0.99999821 0 5 0 0 8 404 409 412 413 416 420 422 439 443 
2 9 0.99999821 0 6 0 1 0 71 238 333 657 693 705 811 841 885 
2 9 0.99999821 0 8 1 0 0 2 35 100 114 242 517 690 722 883 
2 9 0.99999821 0 9 7 0 0 204 264 468 666 683 700 732 780 922 
2 9 0.99999821 0 9 8 0 0 34 293 324 492 615 620 746 862 893 
2 9 0.99999821 0 9 0 3 0 169 218 358 376 493 507 539 576 884 
2 9 0.99999821 0 9 0 9 0 256 402 531 650 676 692 768 780 922 
2 9 0.99999821 0 9 0 0 3 539 558 576 592 598 612 614 615 620 
2 9 0.99999821 0 0 1 6 0 7 195 406 619 685 737 743 923 948 
2 9 0.99999821 0 0 1 0 5 501 510 514 515 517 522 524 528 530 
2 9 0.99999821 0 0 2 0 10 799 805 806 818 821 822 830 890 891 
2 9 0.99999821 0 0 6 1 0 333 459 570 610 662 705 879 946 947 
2 9 0.99999821 0 0 6 0 3 554 555 559 568 570 590 610 616 629 
2 9 0.99999821 0 0 7 0 1 264 268 275 292 308 313 339 342 344 
2 9 0.99999821 0 0 7 0 7 656 663 666 673 683 700 709 771 780 
2 9 0.99999821 0 0 0 2 7 646 654 670 672 681 688 700 710 787 
2 9 0.99999821 0 0 0 9 10 794 796 798 809 813 818 869 881 890 
2 9 0.99999821 0 0 0 10 10 800 803 806 814 820 828 830 859 893 
2 8 1 1 10 0 0 0 140 165 396 411 428 431 631 947  
2 8 1 1 0 0 8 0 248 349 371 691 786 805 837 930  
2 8 1 1 0 0 0 9 906 911 922 923 930 947 950 961  
2 8 1 0 1 0 3 0 80 89 356 365 460 501 636 704  
2 8 1 0 1 0 4 0 125 229 344 353 370 628 776 950  
2 8 1 0 1 0 0 1 266 283 291 311 327 339 340 344  
2 8 1 0 1 0 0 4 447 453 458 459 460 464 473 483  
2 8 1 0 1 0 0 6 347 353 356 365 369 370 372 393  
2 8 1 0 4 2 0 0 3 38 51 69 76 103 200 587  
2 8 1 0 4 0 5 0 69 200 211 254 342 375 583 624  
2 8 1 0 4 0 10 0 5 179 223 278 286 477 800 859  
2 8 1 0 5 0 3 0 61 191 285 325 383 404 585 847  
2 8 1 0 5 0 6 0 43 385 422 503 544 551 619 769  
2 8 1 0 5 0 10 0 288 301 307 409 412 540 577 617  
2 8 1 0 8 2 0 0 12 257 276 315 725 799 805 891  
2 8 1 0 8 4 0 0 11 26 70 99 273 436 747 750  
2 8 1 0 9 0 5 0 102 198 213 324 468 612 746 877  
2 8 1 0 9 0 7 0 201 264 392 397 492 665 778 862  
2 8 1 0 9 0 0 10 820 823 828 860 862 877 884 893  
2 8 1 0 0 1 5 0 35 88 187 252 524 530 575 877  
2 8 1 0 0 2 2 0 135 197 209 276 368 478 921 961  
2 8 1 0 0 5 1 0 62 130 569 578 595 714 811 823  
2 8 1 0 0 5 8 0 83 248 417 713 761 777 880 915  
2 8 1 0 0 5 0 10 803 807 811 823 824 859 860 880  
2 8 1 0 0 7 1 0 77 339 428 631 683 732 771 841  
2 8 1 0 0 0 1 3 569 570 578 592 595 598 610 631  
2 8 1 0 0 0 1 10 799 811 821 823 841 879 885 894  
2 8 1 0 0 0 8 10 793 805 808 837 839 857 880 892  
2 7 1 1 0 6 0 0 303 383 398 742 786 875 947   
2 7 1 1 0 8 0 0 293 324 411 769 837 865 893   
2 7 1 1 0 0 2 0 293 398 742 787 883 911 961   
2 7 1 1 0 0 6 0 385 406 551 749 769 784 923   
2 7 1 1 0 0 9 0 165 261 303 402 587 738 922   
2 7 1 1 0 0 0 3 551 556 585 587 606 617 631   
2 7 1 0 1 2 0 0 125 327 573 729 756 818 822   
2 7 1 0 1 3 0 0 194 283 291 473 593 679 869   
2 7 1 0 1 10 0 0 365 447 458 606 653 687 695   
2 7 1 0 1 0 2 0 56 194 340 369 525 728 795   
2 7 1 0 1 0 0 10 795 814 818 822 824 869 880   
2 7 1 0 2 2 0 0 104 157 160 253 280 626 961   
2 7 1 0 2 10 0 0 105 332 426 471 639 813 962   
2 7 1 0 4 1 0 0 5 7 179 334 681 772 894   
2 7 1 0 4 4 0 0 78 90 137 337 375 784 800   
2 7 1 0 4 7 0 0 6 219 275 308 342 548 798   
2 7 1 0 4 0 3 0 6 51 90 137 407 429 772   
2 7 1 0 4 0 4 0 58 136 275 337 381 433 882   
2 7 1 0 4 0 6 0 7 38 76 161 308 548 784   
2 7 1 0 4 0 0 3 541 548 571 583 587 595 624   
2 7 1 0 4 0 0 10 798 800 844 859 882 892 894   
2 7 1 0 5 10 0 0 107 191 349 544 585 668 738   
2 7 1 0 5 0 4 0 388 416 439 443 465 475 526   
2 7 1 0 6 1 0 0 98 131 221 522 537 737 948   
2 7 1 0 6 2 0 0 27 71 197 235 263 281 314   
2 7 1 0 6 6 0 0 333 472 637 705 794 875 954   
2 7 1 0 6 0 0 1 261 263 268 271 281 314 333   
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2 7 1 0 8 0 4 0 8 11 26 315 504 690 760 
2 7 1 0 8 0 0 10 799 805 819 837 883 887 891 
2 7 1 0 9 0 0 1 256 264 274 293 296 324 330 
2 7 1 0 0 1 4 0 98 382 435 475 690 898 950 
2 7 1 0 0 1 10 0 5 32 172 179 427 514 708 
2 7 1 0 0 1 0 9 898 900 911 923 936 948 950 
2 7 1 0 0 2 5 0 27 69 117 160 198 200 762 
2 7 1 0 0 2 6 0 38 43 76 202 257 281 766 
2 7 1 0 0 2 0 3 535 573 576 587 599 617 626 
2 7 1 0 0 3 10 0 278 283 412 540 579 593 600 
2 7 1 0 0 3 0 3 536 540 571 579 593 600 624 
2 7 1 0 0 4 8 0 359 520 711 724 739 747 930 
2 7 1 0 0 5 3 0 285 376 419 429 460 507 636 
2 7 1 0 0 5 4 0 58 330 416 439 443 558 776 
2 7 1 0 0 5 10 0 203 223 269 372 664 803 859 
2 7 1 0 0 5 0 3 541 558 569 578 595 603 612 
2 7 1 0 0 6 0 4 451 453 454 459 465 472 482 
2 7 1 0 0 6 0 10 794 795 796 858 867 875 879 
2 7 1 0 0 7 6 0 308 422 456 548 749 792 819 
2 7 1 0 0 7 9 0 52 464 673 780 798 848 922 
2 7 1 0 0 7 10 0 204 231 292 457 577 726 814 
2 7 1 0 0 7 0 10 792 793 798 814 819 839 841 
2 7 1 0 0 8 8 0 34 498 550 615 620 712 837 
2 7 1 0 0 8 0 10 837 844 862 863 865 881 893 
2 7 1 0 0 0 1 1 296 302 319 328 331 333 339 
2 7 1 0 0 0 3 7 634 636 637 669 704 772 785 
2 7 1 0 0 0 7 3 541 573 588 603 606 608 616 
2 7 1 0 0 0 8 6 349 351 354 359 371 389 395 
2 7 1 0 0 0 9 7 640 650 673 676 692 768 780 
2 6 1 1 3 0 0 0 117 130 406 419 556 806  
2 6 1 1 4 0 0 0 51 286 342 429 587 784  
2 6 1 1 6 0 0 0 231 248 261 841 875 885  
2 6 1 1 0 3 0 0 140 147 237 283 385 396  
2 6 1 1 0 9 0 0 15 286 350 431 781 820  
2 6 1 1 0 0 7 0 118 163 201 237 397 606  
2 6 1 1 0 0 0 7 691 769 781 784 786 787  
2 6 1 0 1 0 1 0 13 339 393 459 695 756  
2 6 1 0 1 0 5 0 142 187 347 458 753 759  
2 6 1 0 2 8 0 0 10 50 455 646 647 865  
2 6 1 0 2 0 6 0 50 105 143 456 629 639  
2 6 1 0 3 2 0 0 117 202 489 535 806 830  
2 6 1 0 4 10 0 0 245 265 346 433 477 882  
2 6 1 0 4 0 9 0 78 245 502 587 723 798  
2 6 1 0 5 4 0 0 325 409 520 551 552 787  
2 6 1 0 5 0 5 0 107 252 306 530 555 867  
2 6 1 0 5 0 7 0 133 237 400 510 668 709  
2 6 1 0 5 0 0 10 793 796 821 857 858 867  
2 6 1 0 6 0 0 10 794 811 841 875 881 885  
2 6 1 0 7 1 0 0 88 319 395 575 654 900  
2 6 1 0 7 6 0 0 22 214 259 662 736 879  
2 6 1 0 7 0 10 0 259 316 423 457 584 803  
2 6 1 0 7 0 0 10 791 803 808 852 879 890  
2 6 1 0 8 6 0 0 226 451 454 616 645 760  
2 6 1 0 8 7 0 0 8 52 504 726 749 819  
2 6 1 0 8 0 6 0 70 132 257 645 749 819  
2 6 1 0 8 0 8 0 12 517 550 747 805 837  
2 6 1 0 8 0 0 2 722 725 726 747 749 750  
2 6 1 0 9 9 0 0 389 485 676 699 820 828  
2 6 1 0 9 0 4 0 274 330 382 401 435 558  
2 6 1 0 9 0 0 2 714 727 731 732 742 746  
2 6 1 0 10 0 1 0 428 500 523 570 631 947  
2 6 1 0 10 0 4 0 140 481 512 863 898 907  
2 6 1 0 0 1 9 0 23 46 100 553 692 768  
2 6 1 0 0 1 0 1 296 302 319 328 331 334  
2 6 1 0 0 1 0 6 354 356 382 391 395 397  
2 6 1 0 0 2 3 0 51 235 358 576 847 891  
2 6 1 0 0 2 4 0 125 274 315 401 489 626  
2 6 1 0 0 2 7 0 133 201 253 573 665 822  
2 6 1 0 0 3 0 1 271 278 283 287 291 336  
2 6 1 0 0 4 3 0 90 99 137 309 325 704  
2 6 1 0 0 4 0 7 677 693 704 711 784 787  
2 6 1 0 0 5 5 0 211 254 306 612 753 807  
2 6 1 0 0 5 0 7 636 664 757 761 776 777  
2 6 1 0 0 5 0 8 416 417 419 429 439 443  
2 6 1 0 0 6 3 0 60 61 383 407 637 875  
2 6 1 0 0 6 5 0 22 213 347 555 759 867  
2 6 1 0 0 7 2 0 96 219 313 364 369 700  
2 6 1 0 0 7 4 0 8 275 344 388 504 628  
2 6 1 0 0 7 7 0 264 483 588 608 656 709  
2 6 1 0 0 7 8 0 268 371 446 666 793 839  
2 6 1 0 0 7 0 3 548 577 588 608 628 631  
2 6 1 0 0 9 1 0 15 350 485 657 699 939  
2 6 1 0 0 10 3 0 191 218 365 493 585 962  
2 6 1 0 0 10 9 0 165 245 256 261 738 813  
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2 6 1 0 0 10 10 0 316 423 471 477 556 653 
2 6 1 0 0 10 0 10 791 808 813 882 885 887 
2 6 1 0 0 0 2 6 364 368 369 386 391 398 
2 6 1 0 0 0 3 6 356 358 365 376 383 396 
2 6 1 0 0 0 4 1 274 275 315 330 337 344 
2 6 1 0 0 0 4 6 353 370 381 382 388 401 
2 6 1 0 0 0 4 8 416 426 433 435 439 443 
2 6 1 0 0 0 6 7 639 645 685 766 769 784 
2 6 1 0 0 0 7 7 656 665 668 709 757 778 
2 6 1 0 0 0 8 2 713 724 729 731 739 747 
2 6 1 0 0 0 10 8 403 409 412 423 425 427 
2 5 1 1 2 0 0 0 280 371 865 911 961  
2 5 1 1 0 0 0 2 738 742 749 750 753  
2 5 1 0 1 0 6 0 195 473 685 743 824  
2 5 1 0 1 0 0 2 728 729 735 743 753  
2 5 1 0 2 6 0 0 60 67 143 610 629  
2 5 1 0 2 7 0 0 292 371 456 608 839  
2 5 1 0 2 0 1 0 62 157 171 328 610  
2 5 1 0 2 0 2 0 154 646 715 911 961  
2 5 1 0 2 0 9 0 10 67 119 809 813  
2 5 1 0 2 0 10 0 104 280 292 471 647  
2 5 1 0 2 0 0 1 280 292 309 328 332  
2 5 1 0 2 0 0 3 536 608 610 626 629  
2 5 1 0 3 1 0 0 23 406 524 634 708  
2 5 1 0 3 0 10 0 317 556 708 806 830  
2 5 1 0 5 0 0 4 465 475 478 486 491  
2 5 1 0 6 0 8 0 221 248 268 472 537  
2 5 1 0 6 0 0 7 637 657 677 693 705  
2 5 1 0 6 0 0 9 901 935 948 954 957  
2 5 1 0 7 0 1 0 319 569 662 879 906  
2 5 1 0 8 0 2 0 114 226 276 451 883  
2 5 1 0 8 0 3 0 99 138 147 494 891  
2 5 1 0 8 0 7 0 2 242 454 616 722  
2 5 1 0 8 0 0 1 257 269 273 276 315  
2 5 1 0 9 10 0 0 102 218 256 387 493  
2 5 1 0 9 0 6 0 378 387 766 860 923  
2 5 1 0 9 0 0 4 468 482 485 492 493  
2 5 1 0 9 0 0 9 921 922 923 936 946  
2 5 1 0 10 3 0 0 140 287 396 512 579  
2 5 1 0 10 0 0 3 570 579 599 631 632  
2 5 1 0 0 1 0 8 404 406 410 427 435  
2 5 1 0 0 1 0 10 857 877 883 884 894  
2 5 1 0 0 2 9 0 587 725 752 818 890  
2 5 1 0 0 3 3 0 24 138 147 396 852  
2 5 1 0 0 3 6 0 271 287 378 385 473  
2 5 1 0 0 3 0 6 366 378 385 392 396  
2 5 1 0 0 4 1 0 393 436 693 750 906  
2 5 1 0 0 4 4 0 11 26 229 337 370  
2 5 1 0 0 4 10 0 403 409 425 586 800  
2 5 1 0 0 4 0 6 359 370 375 393 402  
2 5 1 0 0 6 0 9 925 946 947 954 958  
2 5 1 0 0 7 0 4 456 457 464 468 483  
2 5 1 0 0 8 7 0 311 455 492 844 862  
2 5 1 0 0 8 9 0 10 250 502 735 881  
2 5 1 0 0 8 0 3 550 583 584 615 620  
2 5 1 0 0 9 10 0 286 317 781 820 828  
2 5 1 0 0 9 0 6 350 381 386 389 400  
2 5 1 0 0 9 0 7 657 669 676 699 781  
2 5 1 0 0 10 1 0 238 346 495 695 885  
2 5 1 0 0 10 5 0 102 107 332 458 887  
2 5 1 0 0 10 0 1 256 261 265 316 332  
2 5 1 0 0 10 0 4 447 458 471 477 493  
2 5 1 0 0 10 0 7 639 653 668 687 695  
2 5 1 0 0 0 2 1 276 293 313 334 340  
2 5 1 0 0 0 2 9 911 921 936 957 961  
2 5 1 0 0 0 3 8 404 407 411 419 429  
2 5 1 0 0 0 3 10 852 865 875 884 891  
2 5 1 0 0 0 4 9 898 901 907 950 954  
2 5 1 0 0 0 5 1 273 306 324 332 342  
2 5 1 0 0 0 5 3 555 575 583 612 624  
2 5 1 0 0 0 6 1 257 271 281 287 308  
2 5 1 0 0 0 6 3 544 548 551 619 629  
2 5 1 0 0 0 7 4 447 454 455 483 492  
2 5 1 0 0 0 8 5 498 506 515 517 520  
2 5 1 0 0 0 9 2 723 725 735 738 752  
2 5 1 0 0 0 9 5 502 509 518 531 534  
2 5 1 0 0 0 9 9 848 922 925 935 958  
2 5 1 0 0 0 10 7 647 653 664 708 781  
2 4 1 1 0 0 4 0 140 330 439 950   
2 4 1 0 1 8 0 0 311 340 353 735   
2 4 1 0 1 0 0 5 501 506 509 525   
2 4 1 0 1 0 0 8 403 410 425 446   
2 4 1 0 2 1 0 0 328 469 715 911   
2 4 1 0 2 0 3 0 60 309 865 962   
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2 4 1 0 2 0 8 0 371 469 724 839 
2 4 1 0 2 0 0 4 455 456 469 471 
2 4 1 0 2 0 0 10 809 813 839 865 
2 4 1 0 4 3 0 0 278 336 571 624 
2 4 1 0 4 8 0 0 136 502 583 844 
2 4 1 0 4 9 0 0 286 381 723 892 
2 4 1 0 4 0 1 0 3 346 595 894 
2 4 1 0 4 0 7 0 265 336 541 844 
2 4 1 0 4 0 8 0 103 571 892 915 
2 4 1 0 5 9 0 0 15 350 386 400 
2 4 1 0 6 10 0 0 238 261 521 885 
2 4 1 0 6 0 2 0 197 521 522 957 
2 4 1 0 6 0 6 0 271 281 737 948 
2 4 1 0 6 0 9 0 261 794 881 935 
2 4 1 0 7 2 0 0 180 752 762 890 
2 4 1 0 7 10 0 0 316 423 791 808 
2 4 1 0 7 0 2 0 96 224 654 791 
2 4 1 0 7 0 5 0 22 88 575 762 
2 4 1 0 7 0 8 0 180 395 808 908 
2 4 1 0 7 0 9 0 214 250 752 890 
2 4 1 0 7 0 0 3 569 575 584 603 
2 4 1 0 7 0 0 9 846 900 906 908 
2 4 1 0 8 0 1 0 436 750 799 939 
2 4 1 0 8 0 5 0 35 193 273 887 
2 4 1 0 9 0 0 5 507 514 515 531 
2 4 1 0 10 2 0 0 135 500 523 599 
2 4 1 0 10 7 0 0 428 631 663 792 
2 4 1 0 10 0 3 0 396 411 669 785 
2 4 1 0 10 0 5 0 431 466 663 807 
2 4 1 0 10 0 0 8 411 424 428 431 
2 4 1 0 0 1 0 2 715 722 737 743 
2 4 1 0 0 2 0 2 725 729 731 752 
2 4 1 0 0 2 0 6 351 358 368 401 
2 4 1 0 0 2 0 7 665 756 762 766 
2 4 1 0 0 3 4 0 140 512 526 536 
2 4 1 0 0 3 7 0 225 237 336 392 
2 4 1 0 0 3 8 0 291 571 679 908 
2 4 1 0 0 3 9 0 366 534 640 869 
2 4 1 0 0 4 5 0 142 273 375 677 
2 4 1 0 0 4 9 0 78 402 809 935 
2 4 1 0 0 4 0 1 273 309 325 337 
2 4 1 0 0 4 0 2 724 739 747 750 
2 4 1 0 0 4 0 8 403 409 425 436 
2 4 1 0 0 5 9 0 119 486 509 531 
2 4 1 0 0 5 0 1 269 285 306 330 
2 4 1 0 0 6 4 0 465 736 760 954 
2 4 1 0 0 6 6 0 143 161 629 645 
2 4 1 0 0 6 8 0 472 506 559 786 
2 4 1 0 0 6 10 0 148 259 482 554 
2 4 1 0 0 6 0 1 259 297 303 333 
2 4 1 0 0 7 0 6 364 369 371 388 
2 4 1 0 0 8 4 0 136 353 481 863 
2 4 1 0 0 8 6 0 50 503 769 846 
2 4 1 0 0 8 0 1 293 311 324 340 
2 4 1 0 0 8 0 7 646 647 712 769 
2 4 1 0 0 10 4 0 426 433 882 907 
2 4 1 0 0 10 6 0 105 387 544 639 
2 4 1 0 0 10 7 0 265 447 606 668 
2 4 1 0 0 10 8 0 349 424 687 808 
2 4 1 0 0 10 0 3 544 556 585 606 
2 4 1 0 0 10 0 6 346 349 365 387 
2 4 1 0 0 10 0 8 423 424 426 433 
2 4 1 0 0 0 1 2 714 717 732 750 
2 4 1 0 0 0 1 5 495 500 523 528 
2 4 1 0 0 0 1 8 413 420 428 436 
2 4 1 0 0 0 1 9 906 939 946 947 
2 4 1 0 0 0 2 2 715 727 728 742 
2 4 1 0 0 0 2 10 791 795 858 883 
2 4 1 0 0 0 4 3 536 558 626 628 
2 4 1 0 0 0 4 4 465 475 481 489 
2 4 1 0 0 0 5 7 663 677 759 762 
2 4 1 0 0 0 5 10 807 867 877 887 
2 4 1 0 0 0 6 10 792 819 824 860 
2 4 1 0 0 0 7 1 264 265 311 336 
2 4 1 0 0 0 8 1 266 268 291 326 
2 4 1 0 0 0 9 1 256 261 297 303 
2 4 1 0 0 0 10 4 457 471 477 482 
2 3 1 0 1 0 0 9 930 950 958  
2 3 1 0 2 3 0 0 171 421 536  
2 3 1 0 2 4 0 0 309 724 809  
2 3 1 0 2 0 4 0 426 536 626  
2 3 1 0 2 0 5 0 160 332 421  
2 3 1 0 2 0 7 0 253 455 608  
2 3 1 0 2 0 0 7 639 646 647  
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2 3 1 0 2 0 0 9 911 961 962 
2 3 1 0 3 0 3 0 24 419 634 
2 3 1 0 3 0 8 0 535 712 739 
2 3 1 0 3 0 0 7 634 708 712 
2 3 1 0 4 0 2 0 219 334 681 
2 3 1 0 4 0 0 6 346 375 381 
2 3 1 0 4 0 0 7 681 772 784 
2 3 1 0 4 0 0 8 407 429 433 
2 3 1 0 5 8 0 0 498 503 769 
2 3 1 0 5 0 0 2 713 717 738 
2 3 1 0 6 4 0 0 677 693 935 
2 3 1 0 6 5 0 0 248 811 957 
2 3 1 0 6 7 0 0 231 268 841 
2 3 1 0 6 0 3 0 235 637 875 
2 3 1 0 6 0 4 0 98 901 954 
2 3 1 0 6 0 10 0 231 263 314 
2 3 1 0 7 4 0 0 118 224 906 
2 3 1 0 7 5 0 0 569 603 803 
2 3 1 0 7 8 0 0 250 584 846 
2 3 1 0 7 0 7 0 118 603 900 
2 3 1 0 7 0 0 1 259 316 319 
2 3 1 0 7 0 0 7 654 662 762 
2 3 1 0 8 3 0 0 138 147 600 
2 3 1 0 8 9 0 0 193 494 939 
2 3 1 0 8 0 9 0 52 100 725 
2 3 1 0 8 0 10 0 269 600 726 
2 3 1 0 8 0 0 3 550 600 616 
2 3 1 0 8 0 0 5 494 504 517 
2 3 1 0 8 0 0 7 645 690 760 
2 3 1 0 9 3 0 0 378 392 727 
2 3 1 0 9 0 0 8 417 427 435 
2 3 1 0 10 1 0 0 632 785 898 
2 3 1 0 10 8 0 0 411 481 863 
2 3 1 0 10 9 0 0 431 466 669 
2 3 1 0 10 10 0 0 165 424 907 
2 3 1 0 10 0 8 0 424 599 632 
2 3 1 0 10 0 0 5 500 512 523 
2 3 1 0 10 0 0 7 663 669 785 
2 3 1 0 10 0 0 9 898 907 947 
2 3 1 0 10 0 0 10 792 807 863 
2 3 1 0 0 2 0 4 478 489 491 
2 3 1 0 0 2 0 9 847 921 961 
2 3 1 0 0 3 0 5 512 526 534 
2 3 1 0 0 4 2 0 224 552 787 
2 3 1 0 0 4 6 0 70 551 784 
2 3 1 0 0 4 0 3 551 552 586 
2 3 1 0 0 4 0 9 906 930 935 
2 3 1 0 0 5 6 0 132 824 860 
2 3 1 0 0 5 7 0 541 603 757 
2 3 1 0 0 5 0 2 713 714 753 
2 3 1 0 0 5 0 5 507 509 531 
2 3 1 0 0 6 0 2 728 736 742 
2 3 1 0 0 6 0 5 506 518 525 
2 3 1 0 0 6 0 6 347 383 398 
2 3 1 0 0 7 5 0 342 468 663 
2 3 1 0 0 7 0 2 726 732 749 
2 3 1 0 0 7 0 8 422 428 446 
2 3 1 0 0 8 2 0 293 340 646 
2 3 1 0 0 8 5 0 324 583 746 
2 3 1 0 0 8 10 0 584 647 893 
2 3 1 0 0 8 0 4 455 481 492 
2 3 1 0 0 8 0 5 498 502 503 
2 3 1 0 0 9 5 0 193 431 466 
2 3 1 0 0 9 8 0 266 389 892 
2 3 1 0 0 9 0 1 266 286 317 
2 3 1 0 0 9 0 10 820 828 892 
2 3 1 0 0 0 1 4 459 485 491 
2 3 1 0 0 0 1 6 346 350 393 
2 3 1 0 0 0 2 5 521 522 525 
2 3 1 0 0 0 3 1 285 309 325 
2 3 1 0 0 0 3 3 539 576 585 
2 3 1 0 0 0 3 5 494 501 507 
2 3 1 0 0 0 4 5 504 512 526 
2 3 1 0 0 0 4 7 690 760 776 
2 3 1 0 0 0 5 4 458 466 468 
2 3 1 0 0 0 6 2 737 743 749 
2 3 1 0 0 0 6 6 378 385 387 
2 3 1 0 0 0 6 9 846 923 948 
2 3 1 0 0 0 7 6 392 397 400 
2 3 1 0 0 0 7 10 822 844 862 
2 3 1 0 0 0 8 8 417 424 446 
2 3 1 0 0 0 8 9 908 915 930 
2 3 1 0 0 0 9 3 553 568 587 
2 3 1 0 0 0 9 4 453 464 486 
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2 2 1 1 7 0 0 0 118 906 
2 2 1 0 1 9 0 0 266 781 
2 2 1 0 2 5 0 0 62 119 
2 2 1 0 2 0 0 2 715 724 
2 2 1 0 2 0 0 8 421 426 
2 2 1 0 3 5 0 0 130 419 
2 2 1 0 3 10 0 0 495 556 
2 2 1 0 3 0 1 0 130 495 
2 2 1 0 3 0 5 0 117 524 
2 2 1 0 3 0 6 0 202 406 
2 2 1 0 3 0 9 0 23 925 
2 2 1 0 3 0 0 1 313 317 
2 2 1 0 3 0 0 3 535 556 
2 2 1 0 3 0 0 5 495 524 
2 2 1 0 3 0 0 8 406 419 
2 2 1 0 3 0 0 10 806 830 
2 2 1 0 4 6 0 0 161 407 
2 2 1 0 5 0 0 9 847 848 
2 2 1 0 6 3 0 0 225 271 
2 2 1 0 6 9 0 0 657 901 
2 2 1 0 6 0 5 0 27 677 
2 2 1 0 6 0 7 0 131 225 
2 2 1 0 6 0 0 5 521 522 
2 2 1 0 7 3 0 0 852 908 
2 2 1 0 7 7 0 0 96 457 
2 2 1 0 7 0 0 2 736 752 
2 2 1 0 8 5 0 0 132 269 
2 2 1 0 8 8 0 0 550 837 
2 2 1 0 8 0 0 4 451 454 
2 2 1 0 9 4 0 0 359 402 
2 2 1 0 10 6 0 0 570 947 
2 2 1 0 10 0 6 0 287 792 
2 2 1 0 10 0 0 4 466 481 
2 2 1 0 0 1 0 4 469 475 
2 2 1 0 0 2 0 5 500 523 
2 2 1 0 0 2 0 8 413 420 
2 2 1 0 0 3 1 0 171 717 
2 2 1 0 0 3 2 0 194 727 
2 2 1 0 0 3 5 0 421 624 
2 2 1 0 0 3 0 2 717 727 
2 2 1 0 0 3 0 7 640 679 
2 2 1 0 0 3 0 8 412 421 
2 2 1 0 0 3 0 10 852 869 
2 2 1 0 0 4 7 0 118 163 
2 2 1 0 0 4 0 10 800 809 
2 2 1 0 0 5 0 4 460 486 
2 2 1 0 0 5 0 6 372 376 
2 2 1 0 0 5 0 9 915 957 
2 2 1 0 0 6 7 0 454 616 
2 2 1 0 0 7 3 0 6 80 
2 2 1 0 0 7 0 9 848 922 
2 2 1 0 0 8 3 0 411 865 
2 2 1 0 0 8 0 2 735 746 
2 2 1 0 0 9 2 0 154 386 
2 2 1 0 0 9 3 0 494 669 
2 2 1 0 0 9 4 0 381 901 
2 2 1 0 0 9 9 0 676 723 
2 2 1 0 0 9 0 4 466 485 
2 2 1 0 0 9 0 9 901 939 
2 2 1 0 0 10 2 0 521 791 
2 2 1 0 0 10 0 5 495 521 
2 2 1 0 0 10 0 9 907 962 
2 2 1 0 0 0 2 3 552 590 
2 2 1 0 0 0 2 4 451 478 
2 2 1 0 0 0 3 4 460 493 
2 2 1 0 0 0 3 9 847 962 
2 2 1 0 0 0 4 10 863 882 
2 2 1 0 0 0 5 2 746 753 
2 2 1 0 0 0 5 5 524 530 
2 2 1 0 0 0 5 6 347 375 
2 2 1 0 0 0 5 8 421 431 
2 2 1 0 0 0 6 4 456 473 
2 2 1 0 0 0 6 8 406 422 
2 2 1 0 0 0 8 4 469 472 
2 2 1 0 0 0 9 6 366 402 
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Appendix E5: COMPLETE FINGERPRINT ANALYSIS OF THE FINAL EXIT ORDERED BY NUMBER OF BEADS 
 
Matches 
 
Samples 
 
Probability 
  Split   Bead IDs 1 2 3 4 5 
2 83 0 2 0 1 0 0 2 5 7 13 23 32 46 56 88 89 98 100 114 131 150 169 172 177 179 187 195 
2 77 0 2 1 0 0 0 13 32 46 56 80 89 125 142 177 187 194 195 229 266 291 311 327 339 340 344 347 
2 76 0 2 9 0 0 0 34 83 102 148 150 169 172 198 203 209 213 218 256 264 274 296 351 354 358 359 368 
2 69 0.0000001 2 5 0 0 0 43 61 91 107 133 191 252 285 297 301 302 307 326 331 364 366 386 388 391 400 404 
2 68 0.0000003 2 0 2 0 0 3 12 27 38 43 69 71 76 91 103 104 125 133 135 157 160 180 197 198 200 202 
2 61 0.00005223 2 0 0 0 7 633 634 636 637 639 640 645 646 647 649 650 653 654 656 657 662 663 664 665 666 668 
2 59 0.00019647 2 0 0 8 0 12 34 83 91 103 180 221 266 268 291 326 351 354 359 389 395 417 424 446 469 472 
2 56 0.00124251 2 0 6 0 0 22 60 61 67 143 148 161 213 214 226 259 297 333 347 407 451 453 454 459 465 472 
2 54 0.00386314 2 0 0 1 0 3 13 62 71 150 157 171 238 296 302 319 328 331 333 339 346 413 420 436 459 485 
2 52 0.01109328 2 4 0 0 0 3 5 6 7 38 58 69 76 78 90 103 136 137 161 179 200 211 219 223 245 254 
2 51 0.01823055 2 0 0 0 3 535 536 537 539 540 541 544 548 550 552 553 554 555 558 559 563 568 569 570 571 573 
2 48 0.07042222 2 0 7 0 0 6 8 52 80 96 219 264 268 275 292 308 313 339 344 364 369 388 422 446 456 457 
2 48 0.07042222 2 0 0 9 0 10 23 46 52 67 78 100 119 214 245 250 256 297 366 453 464 486 502 509 518 531 
2 47 0.10466423 2 0 0 10 0 5 32 104 148 172 179 203 223 259 263 278 292 301 307 314 316 317 327 372 403 412 
2 45 0.2081044 2 0 0 4 0 8 11 26 58 98 125 136 229 274 275 315 337 344 353 370 381 382 388 401 416 426 
2 45 0.2081044 2 0 0 0 1 256 257 259 263 264 265 266 268 271 273 274 275 276 278 281 285 287 291 292 296 297 
2 44 0.27516937 2 0 5 0 0 58 62 83 119 132 203 211 223 254 285 372 416 417 443 460 486 507 509 531 541 558 
2 44 0.27516937 2 0 0 2 0 56 96 114 135 154 194 197 209 219 224 226 276 313 334 340 364 368 369 386 391 451 
2 44 0.27516937 2 0 0 0 10 791 792 793 794 795 796 798 799 800 803 807 808 809 811 813 814 818 819 821 822 823 
2 39 0.50109449 2 8 0 0 0 2 8 11 12 26 52 70 99 100 114 132 138 193 226 242 257 273 276 315 436 451 
2 39 0.50109449 2 0 0 3 0 6 24 60 61 80 89 90 99 137 138 169 191 218 235 285 309 356 358 365 404 407 
2 39 0.50109449 2 0 0 6 0 7 38 43 50 70 76 105 132 143 161 195 202 257 271 281 287 308 378 387 422 456 
2 38 0.50760048 2 2 0 0 0 10 50 60 62 67 104 105 119 143 154 157 160 171 253 292 309 328 332 421 426 455 
2 38 0.50760048 2 0 0 5 0 22 27 69 88 102 107 142 160 187 193 198 200 211 213 252 254 273 332 347 375 421 
2 37 0.51474779 2 0 10 0 0 102 105 107 191 218 238 245 256 265 316 332 346 365 387 423 424 426 433 447 458 471 
2 37 0.51474779 2 0 0 7 0 2 131 133 177 225 242 253 264 265 311 336 392 400 410 447 454 455 483 492 510 541 
2 33 0.62731421 2 6 0 0 0 27 71 98 131 197 221 225 235 238 263 268 271 281 314 333 472 521 522 537 637 657 
2 33 0.62731421 2 0 3 0 0 24 138 171 194 225 271 278 287 291 336 366 378 392 412 421 473 512 526 534 536 540 
2 32 0.69435517 2 0 4 0 0 11 26 70 78 90 99 137 142 224 229 273 309 337 359 370 375 403 425 436 520 552 
2 31 0.77722135 2 7 0 0 0 22 88 96 180 214 224 250 259 316 319 395 423 457 569 575 584 603 654 662 736 752 
2 30 0.86445525 2 0 0 0 4 447 451 453 454 455 456 457 458 459 460 464 465 466 468 469 471 472 473 475 477 478 
2 29 0.9373832 2 0 8 0 0 10 34 50 136 250 311 340 353 455 481 492 498 502 503 550 583 584 615 620 646 647 
2 28 0.98103458 2 0 0 0 6 346 347 351 353 354 356 358 359 364 365 366 368 369 370 372 375 378 381 382 386 387 
2 27 0.99700221 2 0 0 0 5 494 495 498 500 502 503 504 506 507 509 510 512 514 515 517 518 520 521 522 523 524 
2 22 1 2 0 0 0 2 713 714 715 717 722 723 724 725 726 727 728 729 731 732 735 736 737 739 743 746 747 
2 22 0.00000485 0 9 1 0 0 150 169 172 296 354 382 397 427 435 514 515 539 592 598 614 692 768 778 877 884 923 
2 20 1 2 10 0 0 0 135 287 424 466 481 500 512 523 570 579 599 632 663 669 785 792 807 863 898 907  
2 20 1 2 0 9 0 0 154 193 266 317 381 386 389 400 466 485 494 657 669 676 699 723 828 892 901 939  
2 20 1 2 0 0 0 8 403 404 407 410 412 413 416 417 420 421 422 423 424 425 426 433 435 436 443 446  
2 20 1 2 0 0 0 9 846 847 848 898 900 901 907 908 915 921 925 935 936 939 946 948 954 957 958 962  
2 19 1 1 5 0 0 0 15 77 237 288 303 306 325 349 350 383 385 409 439 551 585 617 738 769 787   
3 18 0.00000015 2 9 1 0 0 150 169 172 296 354 382 435 514 515 539 592 598 614 692 768 778 884 936    
2 17 1 1 9 0 0 0 201 204 293 324 330 376 397 398 402 427 742 786 820 877 893 922 923     
2 17 0.00430046 0 9 0 0 7 650 664 665 666 676 683 688 692 699 700 710 766 768 777 778 780 786     
3 16 0.0000051 2 9 0 0 7 650 664 665 666 676 683 688 692 699 700 710 766 768 777 778 780      
2 16 0.01413298 0 1 1 0 0 13 32 46 56 89 177 187 195 356 410 501 553 685 691 743 950      
2 16 0.01413298 0 1 0 0 7 636 653 656 673 679 685 687 691 695 704 711 756 757 759 776 781      
3 15 0.0000326 2 5 1 0 0 252 302 331 391 404 475 510 528 530 563 619 633 649 672 857       
2 15 1 1 0 0 10 0 204 231 269 280 283 286 288 409 427 556 617 781 806 820 893       
2 15 1 2 3 0 0 0 23 24 202 313 317 489 495 524 535 634 708 712 739 830 925       
2 15 0.04343585 0 5 1 0 0 252 302 331 391 404 475 510 528 530 563 619 633 649 672 857       
2 15 0.04343585 0 9 0 8 0 34 83 351 354 359 389 417 515 614 615 620 666 731 777 786       
2 15 0.04343585 0 9 0 0 6 351 354 358 359 368 376 378 382 387 389 392 397 398 401 402       
2 15 0.04343585 0 0 1 0 7 633 634 649 654 672 681 685 690 691 692 708 768 772 778 785       
2 15 0.04343585 0 0 0 10 1 259 263 269 278 280 283 286 288 292 301 307 314 316 317 327       
3 14 0.00018655 2 1 0 0 7 636 653 656 673 679 685 687 695 704 711 756 757 759 776        
3 14 0.00018655 2 9 0 8 0 34 83 351 354 359 389 417 515 614 615 620 666 731 777        
3 14 0.00018655 2 0 1 0 7 633 634 649 654 672 681 685 690 692 708 768 772 778 785        
2 14 0.12235477 0 5 2 0 0 43 91 133 288 301 307 326 413 420 478 491 617 821 847        
2 14 0.12235477 0 5 0 1 0 15 77 302 331 350 413 420 491 528 578 649 717 771 821        
2 14 0.12235477 0 9 5 0 0 83 203 330 376 417 507 531 558 612 664 714 777 823 860        
3 13 0.00099931 2 1 1 0 0 13 32 46 56 89 177 187 195 356 410 553 685 743         
2 13 1 1 0 0 3 0 51 147 325 376 383 396 411 419 429 501 585 865 875         
2 13 1 1 0 0 0 1 261 269 280 283 286 288 293 303 306 324 325 330 342         
2 13 0.30368808 0 9 2 0 0 198 201 209 274 351 358 368 401 576 665 731 766 921         
2 13 0.30368808 0 0 1 8 0 221 354 395 469 515 517 537 563 614 632 633 691 857         
2 13 0.30368808 0 0 2 0 1 257 263 274 276 280 281 288 301 307 314 315 326 327         
3 12 0.00495671 2 1 6 0 0 347 453 459 506 525 554 559 568 728 759 795 958          
3 12 0.00495671 2 1 7 0 0 80 339 344 369 446 464 483 588 628 656 673 814          
3 12 0.00495671 2 5 2 0 0 43 91 133 301 307 326 413 420 478 491 821 847          
3 12 0.00495671 2 9 2 0 0 198 209 274 351 358 368 401 576 665 731 766 921          
3 12 0.00495671 2 9 5 0 0 83 203 417 507 531 558 612 664 714 777 823 860          
3 12 0.00495671 2 0 1 1 0 13 150 296 302 319 328 331 528 592 598 649 894          
3 12 0.00495671 2 0 1 8 0 221 354 395 469 515 517 537 563 614 632 633 857          
2 12 1 1 0 4 0 0 118 163 325 393 402 409 551 750 784 787 906 930          
2 12 1 1 0 0 1 0 15 77 130 350 393 428 631 750 841 885 906 947          
2 12 1 1 0 0 0 10 805 806 820 837 841 865 875 877 883 885 887 893          
2 12 0.61303025 0 1 6 0 0 347 453 459 506 525 554 559 568 728 759 795 958          
2 12 0.61303025 0 1 7 0 0 80 339 344 369 446 464 483 588 628 656 673 814          
2 12 0.61303025 0 1 0 7 0 163 177 311 410 447 483 573 588 606 656 757 822          
2 12 0.61303025 0 1 0 8 0 266 291 446 506 559 679 687 691 711 729 880 930          
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2 83 0 2 0 1 0 0 221 242 252 296 302 319 328 331 334 354 356 382 391 395 404 410 435 469 475 510 514 
2 77 0 2 1 0 0 0 353 356 365 369 370 372 403 410 425 446 447 453 458 459 460 464 473 483 506 509 525 
2 76 0 2 9 0 0 0 378 382 387 389 392 401 417 435 468 482 485 492 493 507 514 515 531 539 558 576 592 
2 69 0.0000001 2 5 0 0 0 412 413 416 420 422 443 465 475 478 486 491 498 503 510 518 520 526 528 530 534 540 
2 68 0.0000003 2 0 2 0 0 209 235 253 257 263 274 276 281 301 307 314 315 326 327 351 358 368 401 413 420 478 
2 61 0.00005223 2 0 0 0 7 669 670 672 673 676 677 679 681 683 685 687 688 690 692 693 695 699 700 704 705 708 
2 59 0.00019647 2 0 0 8 0 498 506 515 517 520 535 537 550 559 563 571 599 614 615 620 632 633 666 679 687 711 
2 56 0.00124251 2 0 6 0 0 482 506 518 525 554 555 559 568 570 590 610 616 629 637 645 650 662 670 688 705 710 
2 54 0.00386314 2 0 0 1 0 491 495 500 523 528 569 570 578 592 595 598 610 649 657 662 683 693 695 699 705 714 
2 52 0.01109328 2 4 0 0 0 265 275 278 308 334 336 337 346 375 381 407 433 477 502 541 548 571 583 595 624 681 
2 51 0.01823055 2 0 0 0 3 575 576 577 578 579 583 584 586 588 590 592 593 595 598 599 600 603 608 610 612 614 
2 48 0.07042222 2 0 7 0 0 464 468 483 504 548 577 588 608 628 656 663 666 673 683 700 709 726 732 771 780 792 
2 48 0.07042222 2 0 0 9 0 534 553 568 640 650 673 676 692 723 725 735 752 768 780 794 796 798 809 813 818 848 
2 47 0.10466423 2 0 0 10 0 423 425 457 471 477 482 514 540 554 577 579 584 586 593 600 647 653 664 708 726 800 
2 45 0.2081044 2 0 0 4 0 433 435 443 465 475 481 489 504 512 526 536 558 626 628 690 736 760 776 863 882 898 
2 45 0.2081044 2 0 0 0 1 301 302 307 308 309 311 313 314 315 316 317 319 326 327 328 331 332 333 334 336 337 
2 44 0.27516937 2 0 5 0 0 569 578 595 603 612 636 664 713 714 757 761 776 777 803 807 811 823 824 859 860 880 
2 44 0.27516937 2 0 0 2 0 478 521 522 525 552 590 646 654 670 672 681 688 700 710 715 727 728 791 795 858 921 
2 44 0.27516937 2 0 0 0 10 824 828 830 839 844 852 857 858 859 860 862 863 867 869 879 880 881 882 884 890 891 
2 39 0.50109449 2 8 0 0 0 454 494 504 517 550 600 616 645 690 722 725 726 747 760 799 819 891 939    
2 39 0.50109449 2 0 0 3 0 460 493 494 507 539 576 634 636 637 669 704 772 785 847 852 884 891 962    
2 39 0.50109449 2 0 0 6 0 473 503 544 548 619 629 639 645 685 737 743 766 792 819 824 846 860 948    
2 38 0.50760048 2 2 0 0 0 456 469 471 536 608 610 626 629 639 646 647 715 724 809 813 839 962     
2 38 0.50760048 2 0 0 5 0 458 466 468 524 530 555 575 583 612 624 663 677 746 759 762 807 867     
2 37 0.51474779 2 0 10 0 0 477 493 495 521 544 639 653 668 687 695 791 808 813 882 907 962      
2 37 0.51474779 2 0 0 7 0 573 588 603 608 616 656 665 668 709 722 757 778 822 844 862 900      
2 33 0.62731421 2 6 0 0 0 677 693 705 737 794 811 881 901 935 948 954 957          
2 33 0.62731421 2 0 3 0 0 571 579 593 600 624 640 679 717 727 852 869 908          
2 32 0.69435517 2 0 4 0 0 586 677 693 704 711 724 739 747 800 809 935           
2 31 0.77722135 2 7 0 0 0 762 791 803 808 846 852 879 890 900 908            
2 30 0.86445525 2 0 0 0 4 481 482 483 485 486 489 491 492 493             
2 29 0.9373832 2 0 8 0 0 712 735 746 844 846 862 863 881              
2 28 0.98103458 2 0 0 0 6 388 389 391 392 395 400 401               
2 27 0.99700221 2 0 0 0 5 525 526 528 530 531 534                
2 22 1 2 0 0 0 2 752                     
2 22 0.00000485 0 9 1 0 0 936                     
2 20 1 2 10 0 0 0                      
2 20 1 2 0 9 0 0                      
2 20 1 2 0 0 0 8                      
2 20 1 2 0 0 0 9                      
2 19 1 1 5 0 0 0                      
3 18 0.00000015 2 9 1 0 0                      
2 17 1 1 9 0 0 0                      
2 17 0.00430046 0 9 0 0 7                      
3 16 0.0000051 2 9 0 0 7                      
2 16 0.01413298 0 1 1 0 0                      
2 16 0.01413298 0 1 0 0 7                      
3 15 0.0000326 2 5 1 0 0                      
2 15 1 1 0 0 10 0                      
2 15 1 2 3 0 0 0                      
2 15 0.04343585 0 5 1 0 0                      
2 15 0.04343585 0 9 0 8 0                      
2 15 0.04343585 0 9 0 0 6                      
2 15 0.04343585 0 0 1 0 7                      
2 15 0.04343585 0 0 0 10 1                      
3 14 0.00018655 2 1 0 0 7                      
3 14 0.00018655 2 9 0 8 0                      
3 14 0.00018655 2 0 1 0 7                      
2 14 0.12235477 0 5 2 0 0                      
2 14 0.12235477 0 5 0 1 0                      
2 14 0.12235477 0 9 5 0 0                      
3 13 0.00099931 2 1 1 0 0                      
2 13 1 1 0 0 3 0                      
2 13 1 1 0 0 0 1                      
2 13 0.30368808 0 9 2 0 0                      
2 13 0.30368808 0 0 1 8 0                      
2 13 0.30368808 0 0 2 0 1                      
3 12 0.00495671 2 1 6 0 0                      
3 12 0.00495671 2 1 7 0 0                      
3 12 0.00495671 2 5 2 0 0                      
3 12 0.00495671 2 9 2 0 0                      
3 12 0.00495671 2 9 5 0 0                      
3 12 0.00495671 2 0 1 1 0                      
3 12 0.00495671 2 0 1 8 0                      
2 12 1 1 0 4 0 0                      
2 12 1 1 0 0 1 0                      
2 12 1 1 0 0 0 10                      
2 12 0.61303025 0 1 6 0 0                      
2 12 0.61303025 0 1 7 0 0                      
2 12 0.61303025 0 1 0 7 0                      
2 12 0.61303025 0 1 0 8 0                      
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2 83 0 2 0 1 0 0 515 517 522 524 528 530 537 539 553 563 575 592 598 614 619 632 633 634 649 654 672 
2 77 0 2 1 0 0 0 553 554 559 568 573 586 588 593 628 636 653 656 673 679 685 687 695 704 711 728 729 
2 76 0 2 9 0 0 0 598 612 614 615 620 650 664 665 666 676 683 688 692 699 700 710 714 727 731 732 746 
2 69 0.0000001 2 5 0 0 0 544 552 555 563 577 578 590 619 633 640 649 668 670 672 709 713 717 761 771 793 796 
2 68 0.0000003 2 0 2 0 0 489 491 500 523 535 573 576 599 626 665 725 729 731 752 756 762 766 799 818 821 822 
2 61 0.00005223 2 0 0 0 7 709 710 711 712 756 757 759 760 761 762 766 768 771 772 776 777 778 780 785   
2 59 0.00019647 2 0 0 8 0 712 713 724 729 731 739 747 761 777 793 808 839 857 880 892 908 915     
2 56 0.00124251 2 0 6 0 0 728 736 759 760 794 795 796 858 867 879 925 946 954 958        
2 54 0.00386314 2 0 0 1 0 717 732 756 771 799 811 821 823 879 894 939 946          
2 52 0.01109328 2 4 0 0 0 723 772 798 800 844 859 882 892 894 915            
2 51 0.01823055 2 0 0 0 3 615 616 619 620 624 626 628 629 632             
2 48 0.07042222 2 0 7 0 0 793 798 814 819 839 848                
2 48 0.07042222 2 0 0 9 0 869 881 890 925 935 958                
2 47 0.10466423 2 0 0 10 0 803 814 828 830 859                 
2 45 0.2081044 2 0 0 4 0 901 907 954                   
2 45 0.2081044 2 0 0 0 1 339 340 344                   
2 44 0.27516937 2 0 5 0 0 915 957                    
2 44 0.27516937 2 0 0 2 0 936 957                    
2 44 0.27516937 2 0 0 0 10 892 894                    
2 39 0.50109449 2 8 0 0 0                      
2 39 0.50109449 2 0 0 3 0                      
2 39 0.50109449 2 0 0 6 0                      
2 38 0.50760048 2 2 0 0 0                      
2 38 0.50760048 2 0 0 5 0                      
2 37 0.51474779 2 0 10 0 0                      
2 37 0.51474779 2 0 0 7 0                      
2 33 0.62731421 2 6 0 0 0                      
2 33 0.62731421 2 0 3 0 0                      
2 32 0.69435517 2 0 4 0 0                      
2 31 0.77722135 2 7 0 0 0                      
2 30 0.86445525 2 0 0 0 4                      
2 29 0.9373832 2 0 8 0 0                      
2 28 0.98103458 2 0 0 0 6                      
2 27 0.99700221 2 0 0 0 5                      
2 22 1 2 0 0 0 2                      
2 22 0.00000485 0 9 1 0 0                      
2 20 1 2 10 0 0 0                      
2 20 1 2 0 9 0 0                      
2 20 1 2 0 0 0 8                      
2 20 1 2 0 0 0 9                      
2 19 1 1 5 0 0 0                      
3 18 0.00000015 2 9 1 0 0                      
2 17 1 1 9 0 0 0                      
2 17 0.00430046 0 9 0 0 7                      
3 16 0.0000051 2 9 0 0 7                      
2 16 0.01413298 0 1 1 0 0                      
2 16 0.01413298 0 1 0 0 7                      
3 15 0.0000326 2 5 1 0 0                      
2 15 1 1 0 0 10 0                      
2 15 1 2 3 0 0 0                      
2 15 0.04343585 0 5 1 0 0                      
2 15 0.04343585 0 9 0 8 0                      
2 15 0.04343585 0 9 0 0 6                      
2 15 0.04343585 0 0 1 0 7                      
2 15 0.04343585 0 0 0 10 1                      
3 14 0.00018655 2 1 0 0 7                      
3 14 0.00018655 2 9 0 8 0                      
3 14 0.00018655 2 0 1 0 7                      
2 14 0.12235477 0 5 2 0 0                      
2 14 0.12235477 0 5 0 1 0                      
2 14 0.12235477 0 9 5 0 0                      
3 13 0.00099931 2 1 1 0 0                      
2 13 1 1 0 0 3 0                      
2 13 1 1 0 0 0 1                      
2 13 0.30368808 0 9 2 0 0                      
2 13 0.30368808 0 0 1 8 0                      
2 13 0.30368808 0 0 2 0 1                      
3 12 0.00495671 2 1 6 0 0                      
3 12 0.00495671 2 1 7 0 0                      
3 12 0.00495671 2 5 2 0 0                      
3 12 0.00495671 2 9 2 0 0                      
3 12 0.00495671 2 9 5 0 0                      
3 12 0.00495671 2 0 1 1 0                      
3 12 0.00495671 2 0 1 8 0                      
2 12 1 1 0 4 0 0                      
2 12 1 1 0 0 1 0                      
2 12 1 1 0 0 0 10                      
2 12 0.61303025 0 1 6 0 0                      
2 12 0.61303025 0 1 7 0 0                      
2 12 0.61303025 0 1 0 7 0                      
2 12 0.61303025 0 1 0 8 0                      
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2 83 0 2 0 1 0 0 681 685 690 692 708 715 722 737 743 768 772 778 785 857 884 894 898 900 936 948 
2 77 0 2 1 0 0 0 735 743 756 757 759 776 795 814 818 822 824 869 880 958       
2 76 0 2 9 0 0 0 766 768 777 778 780 823 828 860 862 884 921 936 946        
2 69 0.0000001 2 5 0 0 0 821 847 848 857 858 867               
2 68 0.0000003 2 0 2 0 0 830 847 890 891 921                
2 61 0.00005223 2 0 0 0 7                     
2 59 0.00019647 2 0 0 8 0                     
2 56 0.00124251 2 0 6 0 0                     
2 54 0.00386314 2 0 0 1 0                     
2 52 0.01109328 2 4 0 0 0                     
2 51 0.01823055 2 0 0 0 3                     
2 48 0.07042222 2 0 7 0 0                     
2 48 0.07042222 2 0 0 9 0                     
2 47 0.10466423 2 0 0 10 0                     
2 45 0.2081044 2 0 0 4 0                     
2 45 0.2081044 2 0 0 0 1                     
2 44 0.27516937 2 0 5 0 0                     
2 44 0.27516937 2 0 0 2 0                     
2 44 0.27516937 2 0 0 0 10                     
2 39 0.50109449 2 8 0 0 0                     
2 39 0.50109449 2 0 0 3 0                     
2 39 0.50109449 2 0 0 6 0                     
2 38 0.50760048 2 2 0 0 0                     
2 38 0.50760048 2 0 0 5 0                     
2 37 0.51474779 2 0 10 0 0                     
2 37 0.51474779 2 0 0 7 0                     
2 33 0.62731421 2 6 0 0 0                     
2 33 0.62731421 2 0 3 0 0                     
2 32 0.69435517 2 0 4 0 0                     
2 31 0.77722135 2 7 0 0 0                     
2 30 0.86445525 2 0 0 0 4                     
2 29 0.9373832 2 0 8 0 0                     
2 28 0.98103458 2 0 0 0 6                     
2 27 0.99700221 2 0 0 0 5                     
2 22 1 2 0 0 0 2                     
2 22 0.00000485 0 9 1 0 0                     
2 20 1 2 10 0 0 0                     
2 20 1 2 0 9 0 0                     
2 20 1 2 0 0 0 8                     
2 20 1 2 0 0 0 9                     
2 19 1 1 5 0 0 0                     
3 18 0.00000015 2 9 1 0 0                     
2 17 1 1 9 0 0 0                     
2 17 0.00430046 0 9 0 0 7                     
3 16 0.0000051 2 9 0 0 7                     
2 16 0.01413298 0 1 1 0 0                     
2 16 0.01413298 0 1 0 0 7                     
3 15 0.0000326 2 5 1 0 0                     
2 15 1 1 0 0 10 0                     
2 15 1 2 3 0 0 0                     
2 15 0.04343585 0 5 1 0 0                     
2 15 0.04343585 0 9 0 8 0                     
2 15 0.04343585 0 9 0 0 6                     
2 15 0.04343585 0 0 1 0 7                     
2 15 0.04343585 0 0 0 10 1                     
3 14 0.00018655 2 1 0 0 7                     
3 14 0.00018655 2 9 0 8 0                     
3 14 0.00018655 2 0 1 0 7                     
2 14 0.12235477 0 5 2 0 0                     
2 14 0.12235477 0 5 0 1 0                     
2 14 0.12235477 0 9 5 0 0                     
3 13 0.00099931 2 1 1 0 0                     
2 13 1 1 0 0 3 0                     
2 13 1 1 0 0 0 1                     
2 13 0.30368808 0 9 2 0 0                     
2 13 0.30368808 0 0 1 8 0                     
2 13 0.30368808 0 0 2 0 1                     
3 12 0.00495671 2 1 6 0 0                     
3 12 0.00495671 2 1 7 0 0                     
3 12 0.00495671 2 5 2 0 0                     
3 12 0.00495671 2 9 2 0 0                     
3 12 0.00495671 2 9 5 0 0                     
3 12 0.00495671 2 0 1 1 0                     
3 12 0.00495671 2 0 1 8 0                     
2 12 1 1 0 4 0 0                     
2 12 1 1 0 0 1 0                     
2 12 1 1 0 0 0 10                     
2 12 0.61303025 0 1 6 0 0                     
2 12 0.61303025 0 1 7 0 0                     
2 12 0.61303025 0 1 0 7 0                     
2 12 0.61303025 0 1 0 8 0                     
Page | E41  
2 12 0.61303025 0 1 0 10 0 32 283 327 372 403 425 554 586 593 653 781 814 
2 12 0.61303025 0 5 6 0 0 61 297 303 383 465 518 555 590 670 796 858 867 
2 12 0.61303025 0 5 0 0 3 540 544 551 552 555 563 577 578 585 590 617 619 
2 12 0.61303025 0 0 1 1 0 13 150 296 302 319 328 331 528 592 598 649 894 
2 12 0.61303025 0 0 1 2 0 56 114 334 391 522 654 672 681 715 883 911 936 
2 12 0.61303025 0 0 6 2 0 226 398 451 525 590 670 688 710 728 742 795 858 
2 12 0.61303025 0 0 6 9 0 67 214 297 303 453 518 568 650 794 796 925 958 
3 11 0.02253171 2 1 0 9 0 46 453 464 509 553 568 673 735 818 869 958  
3 11 0.02253171 2 5 0 1 0 302 331 413 420 491 528 578 649 717 771 821  
3 11 0.02253171 2 9 0 1 0 150 296 485 592 598 683 699 714 732 823 946  
3 11 0.02253171 2 9 0 0 6 351 354 358 359 368 378 382 387 389 392 401  
3 11 0.02253171 2 0 2 1 0 3 71 157 413 420 491 500 523 756 799 821  
3 11 0.02253171 2 0 2 0 1 257 263 274 276 281 301 307 314 315 326 327  
3 11 0.02253171 2 0 6 9 0 67 214 297 453 518 568 650 794 796 925 958  
3 11 0.02253171 2 0 0 8 3 535 537 550 559 563 571 599 614 615 620 632  
2 11 1 1 0 1 0 0 35 397 406 427 501 691 877 883 911 923 950  
2 11 1 1 0 0 0 6 349 350 371 376 383 385 393 396 397 398 402  
2 11 0.9061659 0 1 4 0 0 142 163 229 370 393 403 425 586 704 711 930  
2 11 0.9061659 0 1 0 9 0 46 453 464 509 553 568 673 735 818 869 958  
2 11 0.9061659 0 5 0 8 0 91 326 349 498 520 563 633 713 761 793 857  
2 11 0.9061659 0 5 0 0 1 285 288 297 301 302 303 306 307 325 326 331  
2 11 0.9061659 0 5 0 0 7 633 640 649 668 670 672 709 761 769 771 787  
2 11 0.9061659 0 9 0 1 0 150 296 485 592 598 683 699 714 732 823 946  
2 11 0.9061659 0 9 0 2 0 209 293 368 398 688 700 710 727 742 921 936  
2 11 0.9061659 0 9 0 10 0 148 172 203 204 427 482 514 664 820 828 893  
2 11 0.9061659 0 0 2 1 0 3 71 157 413 420 491 500 523 756 799 821  
2 11 0.9061659 0 0 2 8 0 12 91 103 180 326 351 535 599 729 731 805  
2 11 0.9061659 0 0 2 10 0 104 263 280 288 301 307 314 327 617 806 830  
2 11 0.9061659 0 0 6 0 7 637 645 650 662 670 688 705 710 759 760 786  
2 11 0.9061659 0 0 0 8 3 535 537 550 559 563 571 599 614 615 620 632  
3 10 0.09175675 2 1 0 7 0 177 311 410 447 483 573 588 656 757 822   
3 10 0.09175675 2 1 0 8 0 266 291 446 506 559 679 687 711 729 880   
3 10 0.09175675 2 1 0 10 0 32 327 372 403 425 554 586 593 653 814   
3 10 0.09175675 2 5 6 0 0 61 297 465 518 555 590 670 796 858 867   
3 10 0.09175675 2 5 0 8 0 91 326 498 520 563 633 713 761 793 857   
3 10 0.09175675 2 0 1 2 0 56 114 334 391 522 654 672 681 715 936   
3 10 0.09175675 2 0 1 0 3 537 539 553 563 575 592 598 614 619 632   
3 10 0.09175675 2 0 2 8 0 12 91 103 180 326 351 535 599 729 731   
3 10 0.09175675 2 0 6 2 0 226 451 525 590 670 688 710 728 795 858   
3 10 0.09175675 2 0 6 0 7 637 645 650 662 670 688 705 710 759 760   
3 10 0.09175675 2 0 0 1 7 649 657 662 683 693 695 699 705 756 771   
3 10 0.09175675 2 0 0 10 1 259 263 278 292 301 307 314 316 317 327   
2 10 1 1 1 0 0 0 163 283 393 501 606 691 753 781 930 950   
2 10 1 1 0 2 0 0 51 117 201 280 288 587 617 805 806 961   
2 10 1 1 0 5 0 0 130 248 269 306 330 376 419 429 439 753   
2 10 1 1 0 7 0 0 77 204 231 342 371 428 631 749 841 922   
2 10 0.99651754 0 1 0 0 3 553 554 559 568 573 586 588 593 606 628   
2 10 0.99651754 0 5 0 2 0 364 386 391 478 552 590 670 672 787 858   
2 10 0.99651754 0 5 0 9 0 297 303 366 486 518 534 640 738 796 848   
2 10 0.99651754 0 5 0 0 6 349 350 364 366 383 385 386 388 391 400   
2 10 0.99651754 0 9 6 0 0 148 213 398 482 650 688 710 742 786 946   
2 10 0.99651754 0 0 1 3 0 89 169 356 404 501 539 634 772 785 884   
2 10 0.99651754 0 0 1 7 0 2 131 177 242 397 410 510 722 778 900   
2 10 0.99651754 0 0 1 0 3 537 539 553 563 575 592 598 614 619 632   
2 10 0.99651754 0 0 0 1 7 649 657 662 683 693 695 699 705 756 771   
2 10 0.99651754 0 0 0 8 7 633 666 679 687 691 711 712 761 777 786   
2 10 0.99651754 0 0 0 10 3 540 554 556 577 579 584 586 593 600 617   
3 9 0.31096464 2 1 0 0 3 553 554 559 568 573 586 588 593 628    
3 9 0.31096464 2 5 0 2 0 364 386 391 478 552 590 670 672 858    
3 9 0.31096464 2 5 0 0 3 540 544 552 555 563 577 578 590 619    
3 9 0.31096464 2 5 0 0 5 498 503 510 518 520 526 528 530 534    
3 9 0.31096464 2 5 0 0 7 633 640 649 668 670 672 709 761 771    
3 9 0.31096464 2 9 0 0 3 539 558 576 592 598 612 614 615 620    
3 9 0.31096464 2 0 1 3 0 89 169 356 404 539 634 772 785 884    
3 9 0.31096464 2 0 1 7 0 2 131 177 242 410 510 722 778 900    
3 9 0.31096464 2 0 6 0 3 554 555 559 568 570 590 610 616 629    
3 9 0.31096464 2 0 7 0 7 656 663 666 673 683 700 709 771 780    
3 9 0.31096464 2 0 0 9 10 794 796 798 809 813 818 869 881 890    
2 9 1 1 8 0 0 0 35 147 269 749 750 805 837 883 887    
2 9 1 1 0 10 0 0 165 261 349 556 585 606 738 885 887    
2 9 1 1 0 0 5 0 35 117 306 324 342 431 753 877 887    
2 9 1 1 0 0 0 8 406 409 411 419 427 428 429 431 439    
2 9 0.99999821 0 1 5 0 0 372 460 509 636 753 757 776 824 880    
2 9 0.99999821 0 4 5 0 0 58 211 223 254 429 541 595 859 915    
2 9 0.99999821 0 4 0 0 1 265 275 278 286 308 334 336 337 342    
2 9 0.99999821 0 5 3 0 0 237 366 385 412 526 534 540 640 717    
2 9 0.99999821 0 5 5 0 0 285 306 416 439 443 486 578 713 761    
2 9 0.99999821 0 5 7 0 0 77 364 388 422 577 709 771 793 848    
2 9 0.99999821 0 5 0 0 5 498 503 510 518 520 526 528 530 534    
2 9 0.99999821 0 5 0 0 8 404 409 412 413 416 420 422 439 443    
2 9 0.99999821 0 6 0 1 0 71 238 333 657 693 705 811 841 885    
2 9 0.99999821 0 8 1 0 0 2 35 100 114 242 517 690 722 883    
2 9 0.99999821 0 9 7 0 0 204 264 468 666 683 700 732 780 922    
2 9 0.99999821 0 9 8 0 0 34 293 324 492 615 620 746 862 893    
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2 9 0.99999821 0 9 0 3 0 169 218 358 376 493 507 539 576 884 
2 9 0.99999821 0 9 0 9 0 256 402 531 650 676 692 768 780 922 
2 9 0.99999821 0 9 0 0 3 539 558 576 592 598 612 614 615 620 
2 9 0.99999821 0 0 1 6 0 7 195 406 619 685 737 743 923 948 
2 9 0.99999821 0 0 1 0 5 501 510 514 515 517 522 524 528 530 
2 9 0.99999821 0 0 2 0 10 799 805 806 818 821 822 830 890 891 
2 9 0.99999821 0 0 6 1 0 333 459 570 610 662 705 879 946 947 
2 9 0.99999821 0 0 6 0 3 554 555 559 568 570 590 610 616 629 
2 9 0.99999821 0 0 7 0 1 264 268 275 292 308 313 339 342 344 
2 9 0.99999821 0 0 7 0 7 656 663 666 673 683 700 709 771 780 
2 9 0.99999821 0 0 0 2 7 646 654 670 672 681 688 700 710 787 
2 9 0.99999821 0 0 0 9 10 794 796 798 809 813 818 869 881 890 
2 9 0.99999821 0 0 0 10 10 800 803 806 814 820 828 830 859 893 
3 8 0.73183986 2 1 4 0 0 142 229 370 403 425 586 704 711  
3 8 0.73183986 2 1 5 0 0 372 460 509 636 757 776 824 880  
3 8 0.73183986 2 1 0 0 4 447 453 458 459 460 464 473 483  
3 8 0.73183986 2 4 5 0 0 58 211 223 254 541 595 859 915  
3 8 0.73183986 2 5 7 0 0 364 388 422 577 709 771 793 848  
3 8 0.73183986 2 5 0 9 0 297 366 486 518 534 640 796 848  
3 8 0.73183986 2 9 0 2 0 209 368 688 700 710 727 921 936  
3 8 0.73183986 2 9 0 3 0 169 218 358 493 507 539 576 884  
3 8 0.73183986 2 0 1 0 5 510 514 515 517 522 524 528 530  
3 8 0.73183986 2 0 5 0 10 803 807 811 823 824 859 860 880  
3 8 0.73183986 2 0 6 1 0 333 459 570 610 662 705 879 946  
3 8 0.73183986 2 0 7 0 1 264 268 275 292 308 313 339 344  
3 8 0.73183986 2 0 0 2 7 646 654 670 672 681 688 700 710  
3 8 0.73183986 2 0 0 8 7 633 666 679 687 711 712 761 777  
3 8 0.73183986 2 0 0 10 3 540 554 577 579 584 586 593 600  
2 8 1 1 10 0 0 0 140 165 396 411 428 431 631 947  
2 8 1 1 0 0 8 0 248 349 371 691 786 805 837 930  
2 8 1 1 0 0 0 9 906 911 922 923 930 947 950 961  
2 8 1 0 1 0 3 0 80 89 356 365 460 501 636 704  
2 8 1 0 1 0 4 0 125 229 344 353 370 628 776 950  
2 8 1 0 1 0 0 1 266 283 291 311 327 339 340 344  
2 8 1 0 1 0 0 4 447 453 458 459 460 464 473 483  
2 8 1 0 1 0 0 6 347 353 356 365 369 370 372 393  
2 8 1 0 4 2 0 0 3 38 51 69 76 103 200 587  
2 8 1 0 4 0 5 0 69 200 211 254 342 375 583 624  
2 8 1 0 4 0 10 0 5 179 223 278 286 477 800 859  
2 8 1 0 5 0 3 0 61 191 285 325 383 404 585 847  
2 8 1 0 5 0 6 0 43 385 422 503 544 551 619 769  
2 8 1 0 5 0 10 0 288 301 307 409 412 540 577 617  
2 8 1 0 8 2 0 0 12 257 276 315 725 799 805 891  
2 8 1 0 8 4 0 0 11 26 70 99 273 436 747 750  
2 8 1 0 9 0 5 0 102 198 213 324 468 612 746 877  
2 8 1 0 9 0 7 0 201 264 392 397 492 665 778 862  
2 8 1 0 9 0 0 10 820 823 828 860 862 877 884 893  
2 8 1 0 0 1 5 0 35 88 187 252 524 530 575 877  
2 8 1 0 0 2 2 0 135 197 209 276 368 478 921 961  
2 8 1 0 0 5 1 0 62 130 569 578 595 714 811 823  
2 8 1 0 0 5 8 0 83 248 417 713 761 777 880 915  
2 8 1 0 0 5 0 10 803 807 811 823 824 859 860 880  
2 8 1 0 0 7 1 0 77 339 428 631 683 732 771 841  
2 8 1 0 0 0 1 3 569 570 578 592 595 598 610 631  
2 8 1 0 0 0 1 10 799 811 821 823 841 879 885 894  
2 8 1 0 0 0 8 10 793 805 808 837 839 857 880 892  
3 7 0.98518164 2 1 2 0 0 125 327 573 729 756 818 822   
3 7 0.98518164 2 1 0 2 0 56 194 340 369 525 728 795   
3 7 0.98518164 2 1 0 3 0 80 89 356 365 460 636 704   
3 7 0.98518164 2 1 0 4 0 125 229 344 353 370 628 776   
3 7 0.98518164 2 1 0 0 1 266 291 311 327 339 340 344   
3 7 0.98518164 2 1 0 0 6 347 353 356 365 369 370 372   
3 7 0.98518164 2 1 0 0 10 795 814 818 822 824 869 880   
3 7 0.98518164 2 2 10 0 0 105 332 426 471 639 813 962   
3 7 0.98518164 2 4 1 0 0 5 7 179 334 681 772 894   
3 7 0.98518164 2 4 0 4 0 58 136 275 337 381 433 882   
3 7 0.98518164 2 4 0 5 0 69 200 211 254 375 583 624   
3 7 0.98518164 2 4 0 10 0 5 179 223 278 477 800 859   
3 7 0.98518164 2 4 0 0 1 265 275 278 308 334 336 337   
3 7 0.98518164 2 4 0 0 10 798 800 844 859 882 892 894   
3 7 0.98518164 2 5 3 0 0 366 412 526 534 540 640 717   
3 7 0.98518164 2 5 5 0 0 285 416 443 486 578 713 761   
3 7 0.98518164 2 5 0 0 1 285 297 301 302 307 326 331   
3 7 0.98518164 2 5 0 0 8 404 412 413 416 420 422 443   
3 7 0.98518164 2 6 1 0 0 98 131 221 522 537 737 948   
3 7 0.98518164 2 6 2 0 0 27 71 197 235 263 281 314   
3 7 0.98518164 2 6 0 1 0 71 238 333 657 693 705 811   
3 7 0.98518164 2 8 1 0 0 2 100 114 242 517 690 722   
3 7 0.98518164 2 8 2 0 0 12 257 276 315 725 799 891   
3 7 0.98518164 2 8 4 0 0 11 26 70 99 273 436 747   
3 7 0.98518164 2 8 0 4 0 8 11 26 315 504 690 760   
3 7 0.98518164 2 9 6 0 0 148 213 482 650 688 710 946   
3 7 0.98518164 2 9 7 0 0 264 468 666 683 700 732 780   
3 7 0.98518164 2 9 0 9 0 256 531 650 676 692 768 780   
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3 7 0.98518164 2 9 0 10 0 148 172 203 482 514 664 828 
3 7 0.98518164 2 0 1 6 0 7 195 619 685 737 743 948 
3 7 0.98518164 2 0 2 2 0 135 197 209 276 368 478 921 
3 7 0.98518164 2 0 2 6 0 38 43 76 202 257 281 766 
3 7 0.98518164 2 0 2 10 0 104 263 301 307 314 327 830 
3 7 0.98518164 2 0 2 0 10 799 818 821 822 830 890 891 
3 7 0.98518164 2 0 3 0 3 536 540 571 579 593 600 624 
3 7 0.98518164 2 0 5 1 0 62 569 578 595 714 811 823 
3 7 0.98518164 2 0 5 8 0 83 417 713 761 777 880 915 
3 7 0.98518164 2 0 5 0 3 541 558 569 578 595 603 612 
3 7 0.98518164 2 0 6 0 4 451 453 454 459 465 472 482 
3 7 0.98518164 2 0 0 1 1 296 302 319 328 331 333 339 
3 7 0.98518164 2 0 0 1 3 569 570 578 592 595 598 610 
3 7 0.98518164 2 0 0 3 7 634 636 637 669 704 772 785 
3 7 0.98518164 2 0 0 9 7 640 650 673 676 692 768 780 
3 7 0.0015603 0 0 2 10 1 263 280 288 301 307 314 327 
2 7 1 1 0 6 0 0 303 383 398 742 786 875 947 
2 7 1 1 0 8 0 0 293 324 411 769 837 865 893 
2 7 1 1 0 0 2 0 293 398 742 787 883 911 961 
2 7 1 1 0 0 6 0 385 406 551 749 769 784 923 
2 7 1 1 0 0 9 0 165 261 303 402 587 738 922 
2 7 1 1 0 0 0 3 551 556 585 587 606 617 631 
2 7 1 0 1 2 0 0 125 327 573 729 756 818 822 
2 7 1 0 1 3 0 0 194 283 291 473 593 679 869 
2 7 1 0 1 10 0 0 365 447 458 606 653 687 695 
2 7 1 0 1 0 2 0 56 194 340 369 525 728 795 
2 7 1 0 1 0 0 10 795 814 818 822 824 869 880 
2 7 1 0 2 2 0 0 104 157 160 253 280 626 961 
2 7 1 0 2 10 0 0 105 332 426 471 639 813 962 
2 7 1 0 4 1 0 0 5 7 179 334 681 772 894 
2 7 1 0 4 4 0 0 78 90 137 337 375 784 800 
2 7 1 0 4 7 0 0 6 219 275 308 342 548 798 
2 7 1 0 4 0 3 0 6 51 90 137 407 429 772 
2 7 1 0 4 0 4 0 58 136 275 337 381 433 882 
2 7 1 0 4 0 6 0 7 38 76 161 308 548 784 
2 7 1 0 4 0 0 3 541 548 571 583 587 595 624 
2 7 1 0 4 0 0 10 798 800 844 859 882 892 894 
2 7 1 0 5 10 0 0 107 191 349 544 585 668 738 
2 7 1 0 5 0 4 0 388 416 439 443 465 475 526 
2 7 1 0 6 1 0 0 98 131 221 522 537 737 948 
2 7 1 0 6 2 0 0 27 71 197 235 263 281 314 
2 7 1 0 6 6 0 0 333 472 637 705 794 875 954 
2 7 1 0 6 0 0 1 261 263 268 271 281 314 333 
2 7 1 0 8 0 4 0 8 11 26 315 504 690 760 
2 7 1 0 8 0 0 10 799 805 819 837 883 887 891 
2 7 1 0 9 0 0 1 256 264 274 293 296 324 330 
2 7 1 0 0 1 4 0 98 382 435 475 690 898 950 
2 7 1 0 0 1 10 0 5 32 172 179 427 514 708 
2 7 1 0 0 1 0 9 898 900 911 923 936 948 950 
2 7 1 0 0 2 5 0 27 69 117 160 198 200 762 
2 7 1 0 0 2 6 0 38 43 76 202 257 281 766 
2 7 1 0 0 2 0 3 535 573 576 587 599 617 626 
2 7 1 0 0 3 10 0 278 283 412 540 579 593 600 
2 7 1 0 0 3 0 3 536 540 571 579 593 600 624 
2 7 1 0 0 4 8 0 359 520 711 724 739 747 930 
2 7 1 0 0 5 3 0 285 376 419 429 460 507 636 
2 7 1 0 0 5 4 0 58 330 416 439 443 558 776 
2 7 1 0 0 5 10 0 203 223 269 372 664 803 859 
2 7 1 0 0 5 0 3 541 558 569 578 595 603 612 
2 7 1 0 0 6 0 4 451 453 454 459 465 472 482 
2 7 1 0 0 6 0 10 794 795 796 858 867 875 879 
2 7 1 0 0 7 6 0 308 422 456 548 749 792 819 
2 7 1 0 0 7 9 0 52 464 673 780 798 848 922 
2 7 1 0 0 7 10 0 204 231 292 457 577 726 814 
2 7 1 0 0 7 0 10 792 793 798 814 819 839 841 
2 7 1 0 0 8 8 0 34 498 550 615 620 712 837 
2 7 1 0 0 8 0 10 837 844 862 863 865 881 893 
2 7 1 0 0 0 1 1 296 302 319 328 331 333 339 
2 7 1 0 0 0 3 7 634 636 637 669 704 772 785 
2 7 1 0 0 0 7 3 541 573 588 603 606 608 616 
2 7 1 0 0 0 8 6 349 351 354 359 371 389 395 
2 7 1 0 0 0 9 7 640 650 673 676 692 768 780 
3 6 0.99999524 2 1 3 0 0 194 291 473 593 679 869  
3 6 0.99999524 2 1 10 0 0 365 447 458 653 687 695  
3 6 0.99999524 2 2 0 6 0 50 105 143 456 629 639  
3 6 0.99999524 2 4 2 0 0 3 38 69 76 103 200  
3 6 0.99999524 2 4 4 0 0 78 90 137 337 375 800  
3 6 0.99999524 2 4 7 0 0 6 219 275 308 548 798  
3 6 0.99999524 2 4 10 0 0 245 265 346 433 477 882  
3 6 0.99999524 2 4 0 6 0 7 38 76 161 308 548  
3 6 0.99999524 2 4 0 0 3 541 548 571 583 595 624  
3 6 0.99999524 2 5 0 4 0 388 416 443 465 475 526  
3 6 0.99999524 2 5 0 0 6 364 366 386 388 391 400  
3 6 0.99999524 2 5 0 0 10 793 796 821 857 858 867  
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3 6 0.99999524 2 6 6 0 0 333 472 637 705 794 954 
3 6 0.99999524 2 6 0 0 1 263 268 271 281 314 333 
3 6 0.99999524 2 7 1 0 0 88 319 395 575 654 900 
3 6 0.99999524 2 7 6 0 0 22 214 259 662 736 879 
3 6 0.99999524 2 7 0 10 0 259 316 423 457 584 803 
3 6 0.99999524 2 7 0 0 10 791 803 808 852 879 890 
3 6 0.99999524 2 8 6 0 0 226 451 454 616 645 760 
3 6 0.99999524 2 9 8 0 0 34 492 615 620 746 862 
3 6 0.99999524 2 9 0 5 0 102 198 213 468 612 746 
3 6 0.99999524 2 9 0 7 0 264 392 492 665 778 862 
3 6 0.99999524 2 0 1 4 0 98 382 435 475 690 898 
3 6 0.99999524 2 0 1 5 0 88 187 252 524 530 575 
3 6 0.99999524 2 0 1 9 0 23 46 100 553 692 768 
3 6 0.99999524 2 0 1 10 0 5 32 172 179 514 708 
3 6 0.99999524 2 0 1 0 1 296 302 319 328 331 334 
3 6 0.99999524 2 0 2 4 0 125 274 315 401 489 626 
3 6 0.99999524 2 0 2 5 0 27 69 160 198 200 762 
3 6 0.99999524 2 0 3 10 0 278 412 540 579 593 600 
3 6 0.99999524 2 0 4 8 0 359 520 711 724 739 747 
3 6 0.99999524 2 0 5 10 0 203 223 372 664 803 859 
3 6 0.99999524 2 0 5 0 7 636 664 757 761 776 777 
3 6 0.99999524 2 0 6 5 0 22 213 347 555 759 867 
3 6 0.99999524 2 0 6 0 10 794 795 796 858 867 879 
3 6 0.99999524 2 0 7 2 0 96 219 313 364 369 700 
3 6 0.99999524 2 0 7 4 0 8 275 344 388 504 628 
3 6 0.99999524 2 0 7 6 0 308 422 456 548 792 819 
3 6 0.99999524 2 0 7 7 0 264 483 588 608 656 709 
3 6 0.99999524 2 0 7 9 0 52 464 673 780 798 848 
3 6 0.99999524 2 0 7 0 10 792 793 798 814 819 839 
3 6 0.99999524 2 0 8 8 0 34 498 550 615 620 712 
3 6 0.99999524 2 0 0 1 10 799 811 821 823 879 894 
3 6 0.99999524 2 0 0 4 6 353 370 381 382 388 401 
3 6 0.99999524 2 0 0 7 3 541 573 588 603 608 616 
3 6 0.99999524 2 0 0 7 7 656 665 668 709 757 778 
3 6 0.99999524 2 0 0 8 2 713 724 729 731 739 747 
3 6 0.99999524 2 0 0 8 10 793 808 839 857 880 892 
3 6 0.99999524 2 0 0 10 10 800 803 814 828 830 859 
2 6 1 1 3 0 0 0 117 130 406 419 556 806 
2 6 1 1 4 0 0 0 51 286 342 429 587 784 
2 6 1 1 6 0 0 0 231 248 261 841 875 885 
2 6 1 1 0 3 0 0 140 147 237 283 385 396 
2 6 1 1 0 9 0 0 15 286 350 431 781 820 
2 6 1 1 0 0 7 0 118 163 201 237 397 606 
2 6 1 1 0 0 0 7 691 769 781 784 786 787 
2 6 1 0 1 0 1 0 13 339 393 459 695 756 
2 6 1 0 1 0 5 0 142 187 347 458 753 759 
2 6 1 0 2 8 0 0 10 50 455 646 647 865 
2 6 1 0 2 0 6 0 50 105 143 456 629 639 
2 6 1 0 3 2 0 0 117 202 489 535 806 830 
2 6 1 0 4 10 0 0 245 265 346 433 477 882 
2 6 1 0 4 0 9 0 78 245 502 587 723 798 
2 6 1 0 5 4 0 0 325 409 520 551 552 787 
2 6 1 0 5 0 5 0 107 252 306 530 555 867 
2 6 1 0 5 0 7 0 133 237 400 510 668 709 
2 6 1 0 5 0 0 10 793 796 821 857 858 867 
2 6 1 0 6 0 0 10 794 811 841 875 881 885 
2 6 1 0 7 1 0 0 88 319 395 575 654 900 
2 6 1 0 7 6 0 0 22 214 259 662 736 879 
2 6 1 0 7 0 10 0 259 316 423 457 584 803 
2 6 1 0 7 0 0 10 791 803 808 852 879 890 
2 6 1 0 8 6 0 0 226 451 454 616 645 760 
2 6 1 0 8 7 0 0 8 52 504 726 749 819 
2 6 1 0 8 0 6 0 70 132 257 645 749 819 
2 6 1 0 8 0 8 0 12 517 550 747 805 837 
2 6 1 0 8 0 0 2 722 725 726 747 749 750 
2 6 1 0 9 9 0 0 389 485 676 699 820 828 
2 6 1 0 9 0 4 0 274 330 382 401 435 558 
2 6 1 0 9 0 0 2 714 727 731 732 742 746 
2 6 1 0 10 0 1 0 428 500 523 570 631 947 
2 6 1 0 10 0 4 0 140 481 512 863 898 907 
2 6 1 0 0 1 9 0 23 46 100 553 692 768 
2 6 1 0 0 1 0 1 296 302 319 328 331 334 
2 6 1 0 0 1 0 6 354 356 382 391 395 397 
2 6 1 0 0 2 3 0 51 235 358 576 847 891 
2 6 1 0 0 2 4 0 125 274 315 401 489 626 
2 6 1 0 0 2 7 0 133 201 253 573 665 822 
2 6 1 0 0 3 0 1 271 278 283 287 291 336 
2 6 1 0 0 4 3 0 90 99 137 309 325 704 
2 6 1 0 0 4 0 7 677 693 704 711 784 787 
2 6 1 0 0 5 5 0 211 254 306 612 753 807 
2 6 1 0 0 5 0 7 636 664 757 761 776 777 
2 6 1 0 0 5 0 8 416 417 419 429 439 443 
2 6 1 0 0 6 3 0 60 61 383 407 637 875 
2 6 1 0 0 6 5 0 22 213 347 555 759 867 
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2 6 1 0 0 7 2 0 96 219 313 364 369 700 
2 6 1 0 0 7 4 0 8 275 344 388 504 628 
2 6 1 0 0 7 7 0 264 483 588 608 656 709 
2 6 1 0 0 7 8 0 268 371 446 666 793 839 
2 6 1 0 0 7 0 3 548 577 588 608 628 631 
2 6 1 0 0 9 1 0 15 350 485 657 699 939 
2 6 1 0 0 10 3 0 191 218 365 493 585 962 
2 6 1 0 0 10 9 0 165 245 256 261 738 813 
2 6 1 0 0 10 10 0 316 423 471 477 556 653 
2 6 1 0 0 10 0 10 791 808 813 882 885 887 
2 6 1 0 0 0 2 6 364 368 369 386 391 398 
2 6 1 0 0 0 3 6 356 358 365 376 383 396 
2 6 1 0 0 0 4 1 274 275 315 330 337 344 
2 6 1 0 0 0 4 6 353 370 381 382 388 401 
2 6 1 0 0 0 4 8 416 426 433 435 439 443 
2 6 1 0 0 0 6 7 639 645 685 766 769 784 
2 6 1 0 0 0 7 7 656 665 668 709 757 778 
2 6 1 0 0 0 8 2 713 724 729 731 739 747 
2 6 1 0 0 0 10 8 403 409 412 423 425 427 
4 5 0.02015554 2 9 0 9 7 650 676 692 768 780  
4 5 0.02015554 2 0 1 1 1 296 302 319 328 331  
4 5 0.02015554 2 0 2 10 1 263 301 307 314 327  
3 5 1 1 0 0 10 1 269 280 283 286 288  
3 5 1 2 1 0 1 0 13 339 459 695 756  
3 5 1 2 1 0 5 0 142 187 347 458 759  
3 5 1 2 1 0 6 0 195 473 685 743 824  
3 5 1 2 2 2 0 0 104 157 160 253 626  
3 5 1 2 2 6 0 0 60 67 143 610 629  
3 5 1 2 2 8 0 0 10 50 455 646 647  
3 5 1 2 2 0 1 0 62 157 171 328 610  
3 5 1 2 2 0 9 0 10 67 119 809 813  
3 5 1 2 2 0 0 3 536 608 610 626 629  
3 5 1 2 4 0 3 0 6 90 137 407 772  
3 5 1 2 4 0 9 0 78 245 502 723 798  
3 5 1 2 5 0 3 0 61 191 285 404 847  
3 5 1 2 5 0 5 0 107 252 530 555 867  
3 5 1 2 5 0 6 0 43 422 503 544 619  
3 5 1 2 5 0 7 0 133 400 510 668 709  
3 5 1 2 5 0 10 0 301 307 412 540 577  
3 5 1 2 5 0 0 4 465 475 478 486 491  
3 5 1 2 6 0 0 7 637 657 677 693 705  
3 5 1 2 6 0 0 9 901 935 948 954 957  
3 5 1 2 8 7 0 0 8 52 504 726 819  
3 5 1 2 8 0 6 0 70 132 257 645 819  
3 5 1 2 8 0 7 0 2 242 454 616 722  
3 5 1 2 9 9 0 0 389 485 676 699 828  
3 5 1 2 9 10 0 0 102 218 256 387 493  
3 5 1 2 9 0 4 0 274 382 401 435 558  
3 5 1 2 9 0 0 2 714 727 731 732 746  
3 5 1 2 9 0 0 4 468 482 485 492 493  
3 5 1 2 9 0 0 10 823 828 860 862 884  
3 5 1 2 10 0 4 0 481 512 863 898 907  
3 5 1 2 0 1 0 6 354 356 382 391 395  
3 5 1 2 0 2 3 0 235 358 576 847 891  
3 5 1 2 0 2 7 0 133 253 573 665 822  
3 5 1 2 0 2 0 3 535 573 576 599 626  
3 5 1 2 0 3 0 1 271 278 287 291 336  
3 5 1 2 0 4 3 0 90 99 137 309 704  
3 5 1 2 0 4 4 0 11 26 229 337 370  
3 5 1 2 0 5 4 0 58 416 443 558 776  
3 5 1 2 0 7 8 0 268 446 666 793 839  
3 5 1 2 0 7 10 0 292 457 577 726 814  
3 5 1 2 0 7 0 3 548 577 588 608 628  
3 5 1 2 0 7 0 4 456 457 464 468 483  
3 5 1 2 0 8 7 0 311 455 492 844 862  
3 5 1 2 0 8 9 0 10 250 502 735 881  
3 5 1 2 0 8 0 3 550 583 584 615 620  
3 5 1 2 0 10 3 0 191 218 365 493 962  
3 5 1 2 0 10 10 0 316 423 471 477 653  
3 5 1 2 0 10 0 4 447 458 471 477 493  
3 5 1 2 0 10 0 7 639 653 668 687 695  
3 5 1 2 0 0 2 6 364 368 369 386 391  
3 5 1 2 0 0 4 1 274 275 315 337 344  
3 5 1 2 0 0 4 8 416 426 433 435 443  
3 5 1 2 0 0 5 3 555 575 583 612 624  
3 5 1 2 0 0 6 1 257 271 281 287 308  
3 5 1 2 0 0 7 4 447 454 455 483 492  
3 5 1 2 0 0 8 5 498 506 515 517 520  
3 5 1 2 0 0 8 6 351 354 359 389 395  
3 5 1 2 0 0 9 5 502 509 518 531 534  
3 5 0.21190326 0 9 0 9 7 650 676 692 768 780  
3 5 0.21190326 0 0 1 1 1 296 302 319 328 331  
2 5 1 1 2 0 0 0 280 371 865 911 961  
2 5 1 1 0 0 0 2 738 742 749 750 753  
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2 5 1 0 1 0 6 0 195 473 685 743 824 
2 5 1 0 1 0 0 2 728 729 735 743 753 
2 5 1 0 2 6 0 0 60 67 143 610 629 
2 5 1 0 2 7 0 0 292 371 456 608 839 
2 5 1 0 2 0 1 0 62 157 171 328 610 
2 5 1 0 2 0 2 0 154 646 715 911 961 
2 5 1 0 2 0 9 0 10 67 119 809 813 
2 5 1 0 2 0 10 0 104 280 292 471 647 
2 5 1 0 2 0 0 1 280 292 309 328 332 
2 5 1 0 2 0 0 3 536 608 610 626 629 
2 5 1 0 3 1 0 0 23 406 524 634 708 
2 5 1 0 3 0 10 0 317 556 708 806 830 
2 5 1 0 5 0 0 4 465 475 478 486 491 
2 5 1 0 6 0 8 0 221 248 268 472 537 
2 5 1 0 6 0 0 7 637 657 677 693 705 
2 5 1 0 6 0 0 9 901 935 948 954 957 
2 5 1 0 7 0 1 0 319 569 662 879 906 
2 5 1 0 8 0 2 0 114 226 276 451 883 
2 5 1 0 8 0 3 0 99 138 147 494 891 
2 5 1 0 8 0 7 0 2 242 454 616 722 
2 5 1 0 8 0 0 1 257 269 273 276 315 
2 5 1 0 9 10 0 0 102 218 256 387 493 
2 5 1 0 9 0 6 0 378 387 766 860 923 
2 5 1 0 9 0 0 4 468 482 485 492 493 
2 5 1 0 9 0 0 9 921 922 923 936 946 
2 5 1 0 10 3 0 0 140 287 396 512 579 
2 5 1 0 10 0 0 3 570 579 599 631 632 
2 5 1 0 0 1 0 8 404 406 410 427 435 
2 5 1 0 0 1 0 10 857 877 883 884 894 
2 5 1 0 0 2 9 0 587 725 752 818 890 
2 5 1 0 0 3 3 0 24 138 147 396 852 
2 5 1 0 0 3 6 0 271 287 378 385 473 
2 5 1 0 0 3 0 6 366 378 385 392 396 
2 5 1 0 0 4 1 0 393 436 693 750 906 
2 5 1 0 0 4 4 0 11 26 229 337 370 
2 5 1 0 0 4 10 0 403 409 425 586 800 
2 5 1 0 0 4 0 6 359 370 375 393 402 
2 5 1 0 0 6 0 9 925 946 947 954 958 
2 5 1 0 0 7 0 4 456 457 464 468 483 
2 5 1 0 0 8 7 0 311 455 492 844 862 
2 5 1 0 0 8 9 0 10 250 502 735 881 
2 5 1 0 0 8 0 3 550 583 584 615 620 
2 5 1 0 0 9 10 0 286 317 781 820 828 
2 5 1 0 0 9 0 6 350 381 386 389 400 
2 5 1 0 0 9 0 7 657 669 676 699 781 
2 5 1 0 0 10 1 0 238 346 495 695 885 
2 5 1 0 0 10 5 0 102 107 332 458 887 
2 5 1 0 0 10 0 1 256 261 265 316 332 
2 5 1 0 0 10 0 4 447 458 471 477 493 
2 5 1 0 0 10 0 7 639 653 668 687 695 
2 5 1 0 0 0 2 1 276 293 313 334 340 
2 5 1 0 0 0 2 9 911 921 936 957 961 
2 5 1 0 0 0 3 8 404 407 411 419 429 
2 5 1 0 0 0 3 10 852 865 875 884 891 
2 5 1 0 0 0 4 9 898 901 907 950 954 
2 5 1 0 0 0 5 1 273 306 324 332 342 
2 5 1 0 0 0 5 3 555 575 583 612 624 
2 5 1 0 0 0 6 1 257 271 281 287 308 
2 5 1 0 0 0 6 3 544 548 551 619 629 
2 5 1 0 0 0 7 4 447 454 455 483 492 
2 5 1 0 0 0 8 5 498 506 515 517 520 
2 5 1 0 0 0 9 2 723 725 735 738 752 
2 5 1 0 0 0 9 5 502 509 518 531 534 
2 5 1 0 0 0 9 9 848 922 925 935 958 
2 5 1 0 0 0 10 7 647 653 664 708 781 
4 4 0.30386886 2 5 1 1 0 302 331 528 649  
4 4 0.30386886 2 5 2 1 0 413 420 491 821  
4 4 0.30386886 2 9 1 1 0 150 296 592 598  
4 4 0.30386886 2 9 1 0 3 539 592 598 614  
4 4 0.30386886 2 9 2 0 6 351 358 368 401  
4 4 0.30386886 2 9 7 0 7 666 683 700 780  
4 4 0.30386886 2 9 0 8 6 351 354 359 389  
4 4 0.30386886 2 0 1 8 3 537 563 614 632  
4 4 0.30386886 2 0 3 10 3 540 579 593 600  
3 4 1 1 5 4 0 0 325 409 551 787  
3 4 1 1 5 0 0 1 288 303 306 325  
3 4 1 1 5 0 0 6 349 350 383 385  
3 4 1 1 8 0 0 10 805 837 883 887  
3 4 1 1 9 1 0 0 397 427 877 923  
3 4 1 1 9 0 10 0 204 427 820 893  
3 4 1 1 9 0 0 6 376 397 398 402  
3 4 1 1 0 2 10 0 280 288 617 806  
3 4 1 1 0 7 1 0 77 428 631 841  
3 4 1 2 1 8 0 0 311 340 353 735  
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3 4 1 2 1 0 0 2 728 729 735 743 
3 4 1 2 1 0 0 8 403 410 425 446 
3 4 1 2 2 7 0 0 292 456 608 839 
3 4 1 2 2 0 10 0 104 292 471 647 
3 4 1 2 2 0 0 1 292 309 328 332 
3 4 1 2 2 0 0 4 455 456 469 471 
3 4 1 2 3 1 0 0 23 524 634 708 
3 4 1 2 3 2 0 0 202 489 535 830 
3 4 1 2 4 3 0 0 278 336 571 624 
3 4 1 2 4 8 0 0 136 502 583 844 
3 4 1 2 4 0 1 0 3 346 595 894 
3 4 1 2 4 0 7 0 265 336 541 844 
3 4 1 2 4 0 8 0 103 571 892 915 
3 4 1 2 5 10 0 0 107 191 544 668 
3 4 1 2 6 0 2 0 197 521 522 957 
3 4 1 2 6 0 6 0 271 281 737 948 
3 4 1 2 6 0 8 0 221 268 472 537 
3 4 1 2 7 2 0 0 180 752 762 890 
3 4 1 2 7 10 0 0 316 423 791 808 
3 4 1 2 7 0 1 0 319 569 662 879 
3 4 1 2 7 0 2 0 96 224 654 791 
3 4 1 2 7 0 5 0 22 88 575 762 
3 4 1 2 7 0 8 0 180 395 808 908 
3 4 1 2 7 0 9 0 214 250 752 890 
3 4 1 2 7 0 0 3 569 575 584 603 
3 4 1 2 8 0 2 0 114 226 276 451 
3 4 1 2 8 0 3 0 99 138 494 891 
3 4 1 2 8 0 8 0 12 517 550 747 
3 4 1 2 8 0 0 1 257 273 276 315 
3 4 1 2 8 0 0 2 722 725 726 747 
3 4 1 2 9 0 6 0 378 387 766 860 
3 4 1 2 9 0 0 1 256 264 274 296 
3 4 1 2 9 0 0 5 507 514 515 531 
3 4 1 2 10 2 0 0 135 500 523 599 
3 4 1 2 10 0 0 3 570 579 599 632 
3 4 1 2 0 1 0 2 715 722 737 743 
3 4 1 2 0 1 0 9 898 900 936 948 
3 4 1 2 0 2 9 0 725 752 818 890 
3 4 1 2 0 2 0 2 725 729 731 752 
3 4 1 2 0 2 0 6 351 358 368 401 
3 4 1 2 0 2 0 7 665 756 762 766 
3 4 1 2 0 3 6 0 271 287 378 473 
3 4 1 2 0 3 8 0 291 571 679 908 
3 4 1 2 0 3 9 0 366 534 640 869 
3 4 1 2 0 4 5 0 142 273 375 677 
3 4 1 2 0 4 10 0 403 425 586 800 
3 4 1 2 0 4 0 7 677 693 704 711 
3 4 1 2 0 5 3 0 285 460 507 636 
3 4 1 2 0 5 5 0 211 254 612 807 
3 4 1 2 0 5 9 0 119 486 509 531 
3 4 1 2 0 6 3 0 60 61 407 637 
3 4 1 2 0 6 4 0 465 736 760 954 
3 4 1 2 0 6 6 0 143 161 629 645 
3 4 1 2 0 6 10 0 148 259 482 554 
3 4 1 2 0 6 0 9 925 946 954 958 
3 4 1 2 0 7 1 0 339 683 732 771 
3 4 1 2 0 8 4 0 136 353 481 863 
3 4 1 2 0 8 0 10 844 862 863 881 
3 4 1 2 0 9 1 0 485 657 699 939 
3 4 1 2 0 9 0 6 381 386 389 400 
3 4 1 2 0 9 0 7 657 669 676 699 
3 4 1 2 0 10 1 0 238 346 495 695 
3 4 1 2 0 10 4 0 426 433 882 907 
3 4 1 2 0 10 5 0 102 107 332 458 
3 4 1 2 0 10 6 0 105 387 544 639 
3 4 1 2 0 10 0 1 256 265 316 332 
3 4 1 2 0 10 0 8 423 424 426 433 
3 4 1 2 0 10 0 10 791 808 813 882 
3 4 1 2 0 0 1 5 495 500 523 528 
3 4 1 2 0 0 2 1 276 313 334 340 
3 4 1 2 0 0 4 3 536 558 626 628 
3 4 1 2 0 0 4 4 465 475 481 489 
3 4 1 2 0 0 4 9 898 901 907 954 
3 4 1 2 0 0 5 7 663 677 759 762 
3 4 1 2 0 0 6 3 544 548 619 629 
3 4 1 2 0 0 6 7 639 645 685 766 
3 4 1 2 0 0 6 10 792 819 824 860 
3 4 1 2 0 0 7 1 264 265 311 336 
3 4 1 2 0 0 8 1 266 268 291 326 
3 4 1 2 0 0 9 2 723 725 735 752 
3 4 1 2 0 0 9 9 848 925 935 958 
3 4 1 2 0 0 10 4 457 471 477 482 
3 4 1 2 0 0 10 7 647 653 664 708 
3 4 1 2 0 0 10 8 403 412 423 425 
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3 4 0.90236622 0 1 0 8 7 679 687 691 711 
3 4 0.90236622 0 5 1 1 0 302 331 528 649 
3 4 0.90236622 0 5 2 1 0 413 420 491 821 
3 4 0.90236622 0 5 2 10 0 288 301 307 617 
3 4 0.90236622 0 5 2 0 1 288 301 307 326 
3 4 0.90236622 0 5 6 9 0 297 303 518 796 
3 4 0.90236622 0 9 1 1 0 150 296 592 598 
3 4 0.90236622 0 9 1 0 3 539 592 598 614 
3 4 0.90236622 0 9 2 0 6 351 358 368 401 
3 4 0.90236622 0 9 6 2 0 398 688 710 742 
3 4 0.90236622 0 9 6 0 7 650 688 710 786 
3 4 0.90236622 0 9 7 0 7 666 683 700 780 
3 4 0.90236622 0 9 0 8 6 351 354 359 389 
3 4 0.90236622 0 0 1 8 3 537 563 614 632 
3 4 0.90236622 0 0 3 10 3 540 579 593 600 
2 4 1 1 0 0 4 0 140 330 439 950 
2 4 1 0 1 8 0 0 311 340 353 735 
2 4 1 0 1 0 0 5 501 506 509 525 
2 4 1 0 1 0 0 8 403 410 425 446 
2 4 1 0 2 1 0 0 328 469 715 911 
2 4 1 0 2 0 3 0 60 309 865 962 
2 4 1 0 2 0 8 0 371 469 724 839 
2 4 1 0 2 0 0 4 455 456 469 471 
2 4 1 0 2 0 0 10 809 813 839 865 
2 4 1 0 4 3 0 0 278 336 571 624 
2 4 1 0 4 8 0 0 136 502 583 844 
2 4 1 0 4 9 0 0 286 381 723 892 
2 4 1 0 4 0 1 0 3 346 595 894 
2 4 1 0 4 0 7 0 265 336 541 844 
2 4 1 0 4 0 8 0 103 571 892 915 
2 4 1 0 5 9 0 0 15 350 386 400 
2 4 1 0 6 10 0 0 238 261 521 885 
2 4 1 0 6 0 2 0 197 521 522 957 
2 4 1 0 6 0 6 0 271 281 737 948 
2 4 1 0 6 0 9 0 261 794 881 935 
2 4 1 0 7 2 0 0 180 752 762 890 
2 4 1 0 7 10 0 0 316 423 791 808 
2 4 1 0 7 0 2 0 96 224 654 791 
2 4 1 0 7 0 5 0 22 88 575 762 
2 4 1 0 7 0 8 0 180 395 808 908 
2 4 1 0 7 0 9 0 214 250 752 890 
2 4 1 0 7 0 0 3 569 575 584 603 
2 4 1 0 7 0 0 9 846 900 906 908 
2 4 1 0 8 0 1 0 436 750 799 939 
2 4 1 0 8 0 5 0 35 193 273 887 
2 4 1 0 9 0 0 5 507 514 515 531 
2 4 1 0 10 2 0 0 135 500 523 599 
2 4 1 0 10 7 0 0 428 631 663 792 
2 4 1 0 10 0 3 0 396 411 669 785 
2 4 1 0 10 0 5 0 431 466 663 807 
2 4 1 0 10 0 0 8 411 424 428 431 
2 4 1 0 0 1 0 2 715 722 737 743 
2 4 1 0 0 2 0 2 725 729 731 752 
2 4 1 0 0 2 0 6 351 358 368 401 
2 4 1 0 0 2 0 7 665 756 762 766 
2 4 1 0 0 3 4 0 140 512 526 536 
2 4 1 0 0 3 7 0 225 237 336 392 
2 4 1 0 0 3 8 0 291 571 679 908 
2 4 1 0 0 3 9 0 366 534 640 869 
2 4 1 0 0 4 5 0 142 273 375 677 
2 4 1 0 0 4 9 0 78 402 809 935 
2 4 1 0 0 4 0 1 273 309 325 337 
2 4 1 0 0 4 0 2 724 739 747 750 
2 4 1 0 0 4 0 8 403 409 425 436 
2 4 1 0 0 5 9 0 119 486 509 531 
2 4 1 0 0 5 0 1 269 285 306 330 
2 4 1 0 0 6 4 0 465 736 760 954 
2 4 1 0 0 6 6 0 143 161 629 645 
2 4 1 0 0 6 8 0 472 506 559 786 
2 4 1 0 0 6 10 0 148 259 482 554 
2 4 1 0 0 6 0 1 259 297 303 333 
2 4 1 0 0 7 0 6 364 369 371 388 
2 4 1 0 0 8 4 0 136 353 481 863 
2 4 1 0 0 8 6 0 50 503 769 846 
2 4 1 0 0 8 0 1 293 311 324 340 
2 4 1 0 0 8 0 7 646 647 712 769 
2 4 1 0 0 10 4 0 426 433 882 907 
2 4 1 0 0 10 6 0 105 387 544 639 
2 4 1 0 0 10 7 0 265 447 606 668 
2 4 1 0 0 10 8 0 349 424 687 808 
2 4 1 0 0 10 0 3 544 556 585 606 
2 4 1 0 0 10 0 6 346 349 365 387 
2 4 1 0 0 10 0 8 423 424 426 433 
2 4 1 0 0 0 1 2 714 717 732 750 
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2 4 1 0 0 0 1 5 495 500 523 528 
2 4 1 0 0 0 1 8 413 420 428 436 
2 4 1 0 0 0 1 9 906 939 946 947 
2 4 1 0 0 0 2 2 715 727 728 742 
2 4 1 0 0 0 2 10 791 795 858 883 
2 4 1 0 0 0 4 3 536 558 626 628 
2 4 1 0 0 0 4 4 465 475 481 489 
2 4 1 0 0 0 5 7 663 677 759 762 
2 4 1 0 0 0 5 10 807 867 877 887 
2 4 1 0 0 0 6 10 792 819 824 860 
2 4 1 0 0 0 7 1 264 265 311 336 
2 4 1 0 0 0 8 1 266 268 291 326 
2 4 1 0 0 0 9 1 256 261 297 303 
2 4 1 0 0 0 10 4 457 471 477 482 
4 3 0.99371495 2 1 1 6 0 195 685 743  
4 3 0.99371495 2 1 4 10 0 403 425 586  
4 3 0.99371495 2 1 5 0 7 636 757 776  
4 3 0.99371495 2 1 6 2 0 525 728 795  
4 3 0.99371495 2 1 6 9 0 453 568 958  
4 3 0.99371495 2 1 6 0 3 554 559 568  
4 3 0.99371495 2 1 7 7 0 483 588 656  
4 3 0.99371495 2 1 10 0 7 653 687 695  
4 3 0.99371495 2 1 0 8 7 679 687 711  
4 3 0.99371495 2 1 0 10 3 554 586 593  
4 3 0.99371495 2 5 1 8 0 563 633 857  
4 3 0.99371495 2 5 1 0 5 510 528 530  
4 3 0.99371495 2 5 1 0 7 633 649 672  
4 3 0.99371495 2 5 2 0 1 301 307 326  
4 3 0.99371495 2 5 3 9 0 366 534 640  
4 3 0.99371495 2 5 6 2 0 590 670 858  
4 3 0.99371495 2 5 6 9 0 297 518 796  
4 3 0.99371495 2 5 6 0 10 796 858 867  
4 3 0.99371495 2 5 0 2 6 364 386 391  
4 3 0.99371495 2 6 2 0 1 263 281 314  
4 3 0.99371495 2 6 0 1 7 657 693 705  
4 3 0.99371495 2 8 1 7 0 2 242 722  
4 3 0.99371495 2 8 2 0 1 257 276 315  
4 3 0.99371495 2 9 1 3 0 169 539 884  
4 3 0.99371495 2 9 1 8 0 354 515 614  
4 3 0.99371495 2 9 1 0 7 692 768 778  
4 3 0.99371495 2 9 2 2 0 209 368 921  
4 3 0.99371495 2 9 5 8 0 83 417 777  
4 3 0.99371495 2 9 6 0 7 650 688 710  
4 3 0.99371495 2 9 8 8 0 34 615 620  
4 3 0.99371495 2 9 0 2 7 688 700 710  
4 3 0.99371495 2 9 0 8 3 614 615 620  
4 3 0.99371495 2 0 1 2 7 654 672 681  
4 3 0.99371495 2 0 1 3 7 634 772 785  
4 3 0.99371495 2 0 4 8 2 724 739 747  
4 3 0.99371495 2 0 5 1 3 569 578 595  
4 3 0.99371495 2 0 6 2 7 670 688 710  
4 3 0.99371495 2 0 8 8 3 550 615 620  
4 3 0.220039 0 5 2 10 1 288 301 307  
4 3 0.220039 0 5 5 4 8 416 439 443  
3 3 1 1 1 1 0 0 501 691 950  
3 3 1 1 1 4 0 0 163 393 930  
3 3 1 1 5 10 0 0 349 585 738  
3 3 1 1 5 0 1 0 15 77 350  
3 3 1 1 5 0 3 0 325 383 585  
3 3 1 1 5 0 6 0 385 551 769  
3 3 1 1 5 0 10 0 288 409 617  
3 3 1 1 5 0 0 3 551 585 617  
3 3 1 1 6 0 0 10 841 875 885  
3 3 1 1 9 6 0 0 398 742 786  
3 3 1 1 9 8 0 0 293 324 893  
3 3 1 1 9 0 2 0 293 398 742  
3 3 1 1 9 0 0 1 293 324 330  
3 3 1 1 9 0 0 10 820 877 893  
3 3 1 1 10 0 1 0 428 631 947  
3 3 1 1 10 0 0 8 411 428 431  
3 3 1 1 0 1 0 9 911 923 950  
3 3 1 1 0 4 1 0 393 750 906  
3 3 1 1 0 5 3 0 376 419 429  
3 3 1 1 0 5 0 1 269 306 330  
3 3 1 1 0 5 0 8 419 429 439  
3 3 1 1 0 8 0 10 837 865 893  
3 3 1 1 0 9 10 0 286 781 820  
3 3 1 1 0 10 9 0 165 261 738  
3 3 1 1 0 10 0 3 556 585 606  
3 3 1 1 0 0 3 6 376 383 396  
3 3 1 1 0 0 3 8 411 419 429  
3 3 1 1 0 0 5 1 306 324 342  
3 3 1 1 0 0 10 10 806 820 893  
3 3 1 2 1 0 0 5 506 509 525  
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3 3 1 2 2 1 0 0 328 469 715 
3 3 1 2 2 3 0 0 171 421 536 
3 3 1 2 2 4 0 0 309 724 809 
3 3 1 2 2 0 2 0 154 646 715 
3 3 1 2 2 0 3 0 60 309 962 
3 3 1 2 2 0 4 0 426 536 626 
3 3 1 2 2 0 5 0 160 332 421 
3 3 1 2 2 0 7 0 253 455 608 
3 3 1 2 2 0 8 0 469 724 839 
3 3 1 2 2 0 0 7 639 646 647 
3 3 1 2 2 0 0 10 809 813 839 
3 3 1 2 3 0 8 0 535 712 739 
3 3 1 2 3 0 10 0 317 708 830 
3 3 1 2 3 0 0 7 634 708 712 
3 3 1 2 4 9 0 0 381 723 892 
3 3 1 2 4 0 2 0 219 334 681 
3 3 1 2 4 0 0 6 346 375 381 
3 3 1 2 6 4 0 0 677 693 935 
3 3 1 2 6 0 4 0 98 901 954 
3 3 1 2 6 0 9 0 794 881 935 
3 3 1 2 6 0 0 10 794 811 881 
3 3 1 2 7 5 0 0 569 603 803 
3 3 1 2 7 8 0 0 250 584 846 
3 3 1 2 7 0 0 1 259 316 319 
3 3 1 2 7 0 0 7 654 662 762 
3 3 1 2 7 0 0 9 846 900 908 
3 3 1 2 8 9 0 0 193 494 939 
3 3 1 2 8 0 1 0 436 799 939 
3 3 1 2 8 0 9 0 52 100 725 
3 3 1 2 8 0 0 3 550 600 616 
3 3 1 2 8 0 0 5 494 504 517 
3 3 1 2 8 0 0 7 645 690 760 
3 3 1 2 8 0 0 10 799 819 891 
3 3 1 2 9 3 0 0 378 392 727 
3 3 1 2 9 0 0 9 921 936 946 
3 3 1 2 10 1 0 0 632 785 898 
3 3 1 2 10 3 0 0 287 512 579 
3 3 1 2 10 0 1 0 500 523 570 
3 3 1 2 10 0 5 0 466 663 807 
3 3 1 2 10 0 8 0 424 599 632 
3 3 1 2 10 0 0 5 500 512 523 
3 3 1 2 10 0 0 7 663 669 785 
3 3 1 2 10 0 0 10 792 807 863 
3 3 1 2 0 1 0 8 404 410 435 
3 3 1 2 0 1 0 10 857 884 894 
3 3 1 2 0 2 0 4 478 489 491 
3 3 1 2 0 3 3 0 24 138 852 
3 3 1 2 0 3 4 0 512 526 536 
3 3 1 2 0 3 7 0 225 336 392 
3 3 1 2 0 3 0 5 512 526 534 
3 3 1 2 0 3 0 6 366 378 392 
3 3 1 2 0 4 9 0 78 809 935 
3 3 1 2 0 4 0 1 273 309 337 
3 3 1 2 0 4 0 2 724 739 747 
3 3 1 2 0 4 0 6 359 370 375 
3 3 1 2 0 4 0 8 403 425 436 
3 3 1 2 0 5 6 0 132 824 860 
3 3 1 2 0 5 7 0 541 603 757 
3 3 1 2 0 5 0 5 507 509 531 
3 3 1 2 0 5 0 8 416 417 443 
3 3 1 2 0 6 8 0 472 506 559 
3 3 1 2 0 6 0 1 259 297 333 
3 3 1 2 0 6 0 5 506 518 525 
3 3 1 2 0 7 0 6 364 369 388 
3 3 1 2 0 8 6 0 50 503 846 
3 3 1 2 0 8 0 4 455 481 492 
3 3 1 2 0 8 0 5 498 502 503 
3 3 1 2 0 8 0 7 646 647 712 
3 3 1 2 0 9 8 0 266 389 892 
3 3 1 2 0 10 7 0 265 447 668 
3 3 1 2 0 10 8 0 424 687 808 
3 3 1 2 0 10 9 0 245 256 813 
3 3 1 2 0 10 0 6 346 365 387 
3 3 1 2 0 0 1 2 714 717 732 
3 3 1 2 0 0 1 4 459 485 491 
3 3 1 2 0 0 1 8 413 420 436 
3 3 1 2 0 0 2 2 715 727 728 
3 3 1 2 0 0 2 5 521 522 525 
3 3 1 2 0 0 2 9 921 936 957 
3 3 1 2 0 0 2 10 791 795 858 
3 3 1 2 0 0 3 6 356 358 365 
3 3 1 2 0 0 3 10 852 884 891 
3 3 1 2 0 0 4 5 504 512 526 
3 3 1 2 0 0 4 7 690 760 776 
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3 3 1 2 0 0 5 4 458 466 468 
3 3 1 2 0 0 7 10 822 844 862 
3 3 1 2 0 0 8 8 417 424 446 
3 3 1 2 0 0 9 4 453 464 486 
3 3 1 0 1 1 3 0 89 356 501 
3 3 1 0 1 1 6 0 195 685 743 
3 3 1 0 1 4 10 0 403 425 586 
3 3 1 0 1 5 0 7 636 757 776 
3 3 1 0 1 6 2 0 525 728 795 
3 3 1 0 1 6 9 0 453 568 958 
3 3 1 0 1 6 0 3 554 559 568 
3 3 1 0 1 7 7 0 483 588 656 
3 3 1 0 1 10 0 7 653 687 695 
3 3 1 0 1 0 7 3 573 588 606 
3 3 1 0 1 0 10 3 554 586 593 
3 3 1 0 4 7 0 1 275 308 342 
3 3 1 0 5 1 8 0 563 633 857 
3 3 1 0 5 1 0 5 510 528 530 
3 3 1 0 5 1 0 7 633 649 672 
3 3 1 0 5 3 9 0 366 534 640 
3 3 1 0 5 5 4 0 416 439 443 
3 3 1 0 5 5 0 8 416 439 443 
3 3 1 0 5 6 2 0 590 670 858 
3 3 1 0 5 6 0 10 796 858 867 
3 3 1 0 5 9 0 6 350 386 400 
3 3 1 0 5 0 2 6 364 386 391 
3 3 1 0 5 0 2 7 670 672 787 
3 3 1 0 5 0 4 8 416 439 443 
3 3 1 0 5 0 6 3 544 551 619 
3 3 1 0 5 0 10 1 288 301 307 
3 3 1 0 5 0 10 3 540 577 617 
3 3 1 0 6 2 0 1 263 281 314 
3 3 1 0 6 0 1 7 657 693 705 
3 3 1 0 6 0 1 10 811 841 885 
3 3 1 0 8 1 7 0 2 242 722 
3 3 1 0 8 2 0 1 257 276 315 
3 3 1 0 8 2 0 10 799 805 891 
3 3 1 0 9 1 3 0 169 539 884 
3 3 1 0 9 1 8 0 354 515 614 
3 3 1 0 9 1 10 0 172 427 514 
3 3 1 0 9 1 0 6 354 382 397 
3 3 1 0 9 1 0 7 692 768 778 
3 3 1 0 9 2 2 0 209 368 921 
3 3 1 0 9 5 8 0 83 417 777 
3 3 1 0 9 8 8 0 34 615 620 
3 3 1 0 9 0 2 7 688 700 710 
3 3 1 0 9 0 8 3 614 615 620 
3 3 1 0 9 0 8 7 666 777 786 
3 3 1 0 9 0 10 10 820 828 893 
3 3 1 0 0 1 2 7 654 672 681 
3 3 1 0 0 1 3 7 634 772 785 
3 3 1 0 0 4 8 2 724 739 747 
3 3 1 0 0 4 10 8 403 409 425 
3 3 1 0 0 5 1 3 569 578 595 
3 3 1 0 0 5 4 8 416 439 443 
3 3 1 0 0 6 2 7 670 688 710 
3 3 1 0 0 8 8 3 550 615 620 
2 3 1 0 1 0 0 9 930 950 958 
2 3 1 0 2 3 0 0 171 421 536 
2 3 1 0 2 4 0 0 309 724 809 
2 3 1 0 2 0 4 0 426 536 626 
2 3 1 0 2 0 5 0 160 332 421 
2 3 1 0 2 0 7 0 253 455 608 
2 3 1 0 2 0 0 7 639 646 647 
2 3 1 0 2 0 0 9 911 961 962 
2 3 1 0 3 0 3 0 24 419 634 
2 3 1 0 3 0 8 0 535 712 739 
2 3 1 0 3 0 0 7 634 708 712 
2 3 1 0 4 0 2 0 219 334 681 
2 3 1 0 4 0 0 6 346 375 381 
2 3 1 0 4 0 0 7 681 772 784 
2 3 1 0 4 0 0 8 407 429 433 
2 3 1 0 5 8 0 0 498 503 769 
2 3 1 0 5 0 0 2 713 717 738 
2 3 1 0 6 4 0 0 677 693 935 
2 3 1 0 6 5 0 0 248 811 957 
2 3 1 0 6 7 0 0 231 268 841 
2 3 1 0 6 0 3 0 235 637 875 
2 3 1 0 6 0 4 0 98 901 954 
2 3 1 0 6 0 10 0 231 263 314 
2 3 1 0 7 4 0 0 118 224 906 
2 3 1 0 7 5 0 0 569 603 803 
2 3 1 0 7 8 0 0 250 584 846 
2 3 1 0 7 0 7 0 118 603 900 
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2 3 1 0 7 0 0 1 259 316 319 
2 3 1 0 7 0 0 7 654 662 762 
2 3 1 0 8 3 0 0 138 147 600 
2 3 1 0 8 9 0 0 193 494 939 
2 3 1 0 8 0 9 0 52 100 725 
2 3 1 0 8 0 10 0 269 600 726 
2 3 1 0 8 0 0 3 550 600 616 
2 3 1 0 8 0 0 5 494 504 517 
2 3 1 0 8 0 0 7 645 690 760 
2 3 1 0 9 3 0 0 378 392 727 
2 3 1 0 9 0 0 8 417 427 435 
2 3 1 0 10 1 0 0 632 785 898 
2 3 1 0 10 8 0 0 411 481 863 
2 3 1 0 10 9 0 0 431 466 669 
2 3 1 0 10 10 0 0 165 424 907 
2 3 1 0 10 0 8 0 424 599 632 
2 3 1 0 10 0 0 5 500 512 523 
2 3 1 0 10 0 0 7 663 669 785 
2 3 1 0 10 0 0 9 898 907 947 
2 3 1 0 10 0 0 10 792 807 863 
2 3 1 0 0 2 0 4 478 489 491 
2 3 1 0 0 2 0 9 847 921 961 
2 3 1 0 0 3 0 5 512 526 534 
2 3 1 0 0 4 2 0 224 552 787 
2 3 1 0 0 4 6 0 70 551 784 
2 3 1 0 0 4 0 3 551 552 586 
2 3 1 0 0 4 0 9 906 930 935 
2 3 1 0 0 5 6 0 132 824 860 
2 3 1 0 0 5 7 0 541 603 757 
2 3 1 0 0 5 0 2 713 714 753 
2 3 1 0 0 5 0 5 507 509 531 
2 3 1 0 0 6 0 2 728 736 742 
2 3 1 0 0 6 0 5 506 518 525 
2 3 1 0 0 6 0 6 347 383 398 
2 3 1 0 0 7 5 0 342 468 663 
2 3 1 0 0 7 0 2 726 732 749 
2 3 1 0 0 7 0 8 422 428 446 
2 3 1 0 0 8 2 0 293 340 646 
2 3 1 0 0 8 5 0 324 583 746 
2 3 1 0 0 8 10 0 584 647 893 
2 3 1 0 0 8 0 4 455 481 492 
2 3 1 0 0 8 0 5 498 502 503 
2 3 1 0 0 9 5 0 193 431 466 
2 3 1 0 0 9 8 0 266 389 892 
2 3 1 0 0 9 0 1 266 286 317 
2 3 1 0 0 9 0 10 820 828 892 
2 3 1 0 0 0 1 4 459 485 491 
2 3 1 0 0 0 1 6 346 350 393 
2 3 1 0 0 0 2 5 521 522 525 
2 3 1 0 0 0 3 1 285 309 325 
2 3 1 0 0 0 3 3 539 576 585 
2 3 1 0 0 0 3 5 494 501 507 
2 3 1 0 0 0 4 5 504 512 526 
2 3 1 0 0 0 4 7 690 760 776 
2 3 1 0 0 0 5 4 458 466 468 
2 3 1 0 0 0 6 2 737 743 749 
2 3 1 0 0 0 6 6 378 385 387 
2 3 1 0 0 0 6 9 846 923 948 
2 3 1 0 0 0 7 6 392 397 400 
2 3 1 0 0 0 7 10 822 844 862 
2 3 1 0 0 0 8 8 417 424 446 
2 3 1 0 0 0 8 9 908 915 930 
2 3 1 0 0 0 9 3 553 568 587 
2 3 1 0 0 0 9 4 453 464 486 
5 2 0.99930654 2 1 4 10 8 403 425  
5 2 0.99930654 2 5 1 1 1 302 331  
5 2 0.99930654 2 5 2 1 8 413 420  
5 2 0.99930654 2 5 2 10 1 301 307  
5 2 0.99930654 2 5 5 4 8 416 443  
5 2 0.99930654 2 6 2 10 1 263 314  
5 2 0.99930654 2 9 1 1 3 592 598  
5 2 0.99930654 2 9 1 9 7 692 768  
5 2 0.99930654 2 9 6 2 7 688 710  
5 2 0.99930654 2 9 8 8 3 615 620  
5 2 0.99930654 2 10 2 1 5 500 523  
4 2 1 1 2 0 2 9 911 961  
4 2 1 1 5 2 10 0 288 617  
4 2 1 1 5 9 1 0 15 350  
4 2 1 1 6 0 1 10 841 885  
4 2 1 1 8 0 8 10 805 837  
4 2 1 1 9 6 2 0 398 742  
4 2 1 1 9 8 0 1 293 324  
4 2 1 1 9 0 10 10 820 893  
4 2 1 1 10 7 1 0 428 631  
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4 2 1 1 0 2 10 1 280 288 
4 2 1 1 0 5 3 8 419 429 
4 2 1 2 1 1 3 0 89 356 
4 2 1 2 1 1 7 0 177 410 
4 2 1 2 1 1 9 0 46 553 
4 2 1 2 1 2 7 0 573 822 
4 2 1 2 1 2 0 10 818 822 
4 2 1 2 1 3 8 0 291 679 
4 2 1 2 1 4 4 0 229 370 
4 2 1 2 1 4 0 7 704 711 
4 2 1 2 1 4 0 8 403 425 
4 2 1 2 1 5 3 0 460 636 
4 2 1 2 1 5 0 10 824 880 
4 2 1 2 1 6 5 0 347 759 
4 2 1 2 1 6 8 0 506 559 
4 2 1 2 1 6 0 4 453 459 
4 2 1 2 1 6 0 5 506 525 
4 2 1 2 1 7 4 0 344 628 
4 2 1 2 1 7 9 0 464 673 
4 2 1 2 1 7 0 1 339 344 
4 2 1 2 1 7 0 3 588 628 
4 2 1 2 1 7 0 4 464 483 
4 2 1 2 1 7 0 7 656 673 
4 2 1 2 1 8 0 1 311 340 
4 2 1 2 1 10 0 4 447 458 
4 2 1 2 1 0 1 7 695 756 
4 2 1 2 1 0 3 6 356 365 
4 2 1 2 1 0 3 7 636 704 
4 2 1 2 1 0 4 6 353 370 
4 2 1 2 1 0 7 3 573 588 
4 2 1 2 1 0 7 4 447 483 
4 2 1 2 1 0 7 7 656 757 
4 2 1 2 1 0 8 1 266 291 
4 2 1 2 1 0 9 3 553 568 
4 2 1 2 1 0 9 4 453 464 
4 2 1 2 1 0 9 10 818 869 
4 2 1 2 1 0 10 8 403 425 
4 2 1 2 2 6 6 0 143 629 
4 2 1 2 2 6 0 3 610 629 
4 2 1 2 2 8 0 7 646 647 
4 2 1 2 2 10 6 0 105 639 
4 2 1 2 2 0 4 3 536 626 
4 2 1 2 2 0 9 10 809 813 
4 2 1 2 3 1 0 7 634 708 
4 2 1 2 4 1 2 0 334 681 
4 2 1 2 4 1 10 0 5 179 
4 2 1 2 4 1 0 7 681 772 
4 2 1 2 4 2 5 0 69 200 
4 2 1 2 4 2 6 0 38 76 
4 2 1 2 4 3 0 1 278 336 
4 2 1 2 4 3 0 3 571 624 
4 2 1 2 4 4 3 0 90 137 
4 2 1 2 4 5 5 0 211 254 
4 2 1 2 4 5 10 0 223 859 
4 2 1 2 4 5 0 3 541 595 
4 2 1 2 4 7 6 0 308 548 
4 2 1 2 4 7 0 1 275 308 
4 2 1 2 4 10 4 0 433 882 
4 2 1 2 4 0 4 1 275 337 
4 2 1 2 4 0 5 3 583 624 
4 2 1 2 4 0 7 1 265 336 
4 2 1 2 4 0 10 10 800 859 
4 2 1 2 5 1 2 0 391 672 
4 2 1 2 5 1 5 0 252 530 
4 2 1 2 5 1 0 1 302 331 
4 2 1 2 5 1 0 3 563 619 
4 2 1 2 5 2 8 0 91 326 
4 2 1 2 5 2 10 0 301 307 
4 2 1 2 5 2 0 4 478 491 
4 2 1 2 5 2 0 8 413 420 
4 2 1 2 5 3 10 0 412 540 
4 2 1 2 5 3 0 5 526 534 
4 2 1 2 5 5 4 0 416 443 
4 2 1 2 5 5 8 0 713 761 
4 2 1 2 5 5 0 8 416 443 
4 2 1 2 5 6 5 0 555 867 
4 2 1 2 5 6 0 3 555 590 
4 2 1 2 5 7 0 6 364 388 
4 2 1 2 5 7 0 7 709 771 
4 2 1 2 5 8 0 5 498 503 
4 2 1 2 5 9 0 6 386 400 
4 2 1 2 5 0 1 1 302 331 
4 2 1 2 5 0 1 7 649 771 
4 2 1 2 5 0 1 8 413 420 
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4 2 1 2 5 0 2 3 552 590 
4 2 1 2 5 0 2 7 670 672 
4 2 1 2 5 0 4 4 465 475 
4 2 1 2 5 0 4 8 416 443 
4 2 1 2 5 0 6 3 544 619 
4 2 1 2 5 0 7 7 668 709 
4 2 1 2 5 0 8 5 498 520 
4 2 1 2 5 0 8 7 633 761 
4 2 1 2 5 0 8 10 793 857 
4 2 1 2 5 0 9 5 518 534 
4 2 1 2 5 0 10 1 301 307 
4 2 1 2 5 0 10 3 540 577 
4 2 1 2 6 1 6 0 737 948 
4 2 1 2 6 1 8 0 221 537 
4 2 1 2 6 2 10 0 263 314 
4 2 1 2 6 4 0 7 677 693 
4 2 1 2 6 6 1 0 333 705 
4 2 1 2 6 6 0 7 637 705 
4 2 1 2 6 0 2 5 521 522 
4 2 1 2 6 0 4 9 901 954 
4 2 1 2 6 0 6 1 271 281 
4 2 1 2 6 0 9 10 794 881 
4 2 1 2 6 0 10 1 263 314 
4 2 1 2 7 1 5 0 88 575 
4 2 1 2 7 2 9 0 752 890 
4 2 1 2 7 5 0 3 569 603 
4 2 1 2 7 6 1 0 662 879 
4 2 1 2 7 10 10 0 316 423 
4 2 1 2 7 10 0 10 791 808 
4 2 1 2 7 0 10 1 259 316 
4 2 1 2 8 2 0 10 799 891 
4 2 1 2 8 4 4 0 11 26 
4 2 1 2 8 6 2 0 226 451 
4 2 1 2 8 6 7 0 454 616 
4 2 1 2 8 6 0 4 451 454 
4 2 1 2 8 6 0 7 645 760 
4 2 1 2 8 7 4 0 8 504 
4 2 1 2 8 0 4 7 690 760 
4 2 1 2 9 1 4 0 382 435 
4 2 1 2 9 1 9 0 692 768 
4 2 1 2 9 1 10 0 172 514 
4 2 1 2 9 1 0 5 514 515 
4 2 1 2 9 1 0 6 354 382 
4 2 1 2 9 2 3 0 358 576 
4 2 1 2 9 2 4 0 274 401 
4 2 1 2 9 2 8 0 351 731 
4 2 1 2 9 2 0 7 665 766 
4 2 1 2 9 3 0 6 378 392 
4 2 1 2 9 5 1 0 714 823 
4 2 1 2 9 5 10 0 203 664 
4 2 1 2 9 5 0 3 558 612 
4 2 1 2 9 5 0 5 507 531 
4 2 1 2 9 5 0 7 664 777 
4 2 1 2 9 5 0 10 823 860 
4 2 1 2 9 6 2 0 688 710 
4 2 1 2 9 6 10 0 148 482 
4 2 1 2 9 7 1 0 683 732 
4 2 1 2 9 8 7 0 492 862 
4 2 1 2 9 8 0 3 615 620 
4 2 1 2 9 9 1 0 485 699 
4 2 1 2 9 9 0 7 676 699 
4 2 1 2 9 10 3 0 218 493 
4 2 1 2 9 0 1 2 714 732 
4 2 1 2 9 0 1 3 592 598 
4 2 1 2 9 0 1 7 683 699 
4 2 1 2 9 0 2 9 921 936 
4 2 1 2 9 0 3 3 539 576 
4 2 1 2 9 0 4 6 382 401 
4 2 1 2 9 0 6 6 378 387 
4 2 1 2 9 0 7 7 665 778 
4 2 1 2 9 0 8 7 666 777 
4 2 1 2 10 2 1 0 500 523 
4 2 1 2 10 2 0 5 500 523 
4 2 1 2 10 8 4 0 481 863 
4 2 1 2 10 0 1 5 500 523 
4 2 1 2 10 0 3 7 669 785 
4 2 1 2 10 0 4 9 898 907 
4 2 1 2 10 0 8 3 599 632 
4 2 1 2 0 1 1 3 592 598 
4 2 1 2 0 1 5 5 524 530 
4 2 1 2 0 1 6 2 737 743 
4 2 1 2 0 1 8 5 515 517 
4 2 1 2 0 1 8 6 354 395 
4 2 1 2 0 1 9 7 692 768 
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4 2 1 2 0 2 1 5 500 523 
4 2 1 2 0 2 1 8 413 420 
4 2 1 2 0 2 1 10 799 821 
4 2 1 2 0 2 4 1 274 315 
4 2 1 2 0 2 6 1 257 281 
4 2 1 2 0 2 8 2 729 731 
4 2 1 2 0 2 8 3 535 599 
4 2 1 2 0 2 9 2 725 752 
4 2 1 2 0 2 9 10 818 890 
4 2 1 2 0 3 4 5 512 526 
4 2 1 2 0 3 6 1 271 287 
4 2 1 2 0 4 10 8 403 425 
4 2 1 2 0 5 1 10 811 823 
4 2 1 2 0 5 4 8 416 443 
4 2 1 2 0 5 6 10 824 860 
4 2 1 2 0 5 7 3 541 603 
4 2 1 2 0 5 8 7 761 777 
4 2 1 2 0 5 9 5 509 531 
4 2 1 2 0 5 10 10 803 859 
4 2 1 2 0 6 1 3 570 610 
4 2 1 2 0 6 1 7 662 705 
4 2 1 2 0 6 2 10 795 858 
4 2 1 2 0 6 9 9 925 958 
4 2 1 2 0 6 9 10 794 796 
4 2 1 2 0 7 1 7 683 771 
4 2 1 2 0 7 2 6 364 369 
4 2 1 2 0 7 4 1 275 344 
4 2 1 2 0 7 6 10 792 819 
4 2 1 2 0 7 7 3 588 608 
4 2 1 2 0 7 7 7 656 709 
4 2 1 2 0 7 8 10 793 839 
4 2 1 2 0 7 9 7 673 780 
4 2 1 2 0 8 7 4 455 492 
4 2 1 2 0 8 7 10 844 862 
4 2 1 2 0 9 1 7 657 699 
4 2 1 2 0 10 4 8 426 433 
4 2 1 2 0 10 10 4 471 477 
4 2 0.99999958 0 1 4 10 8 403 425 
4 2 0.99999958 0 3 2 10 10 806 830 
4 2 0.99999958 0 5 1 1 1 302 331 
4 2 0.99999958 0 5 2 1 8 413 420 
4 2 0.99999958 0 5 6 9 1 297 303 
4 2 0.99999958 0 6 2 10 1 263 314 
4 2 0.99999958 0 9 1 1 3 592 598 
4 2 0.99999958 0 9 1 9 7 692 768 
4 2 0.99999958 0 9 6 2 7 688 710 
4 2 0.99999958 0 9 8 8 3 615 620 
4 2 0.99999958 0 9 9 10 10 820 828 
4 2 0.99999958 0 10 2 1 5 500 523 
3 2 1 1 1 0 7 0 163 606 
3 2 1 1 1 0 8 0 691 930 
3 2 1 1 1 0 10 0 283 781 
3 2 1 1 1 0 0 7 691 781 
3 2 1 1 1 0 0 9 930 950 
3 2 1 1 2 2 0 0 280 961 
3 2 1 1 2 0 2 0 911 961 
3 2 1 1 2 0 0 9 911 961 
3 2 1 1 3 2 0 0 117 806 
3 2 1 1 3 5 0 0 130 419 
3 2 1 1 3 0 10 0 556 806 
3 2 1 1 3 0 0 8 406 419 
3 2 1 1 4 2 0 0 51 587 
3 2 1 1 4 0 3 0 51 429 
3 2 1 1 4 0 0 1 286 342 
3 2 1 1 5 2 0 0 288 617 
3 2 1 1 5 3 0 0 237 385 
3 2 1 1 5 5 0 0 306 439 
3 2 1 1 5 6 0 0 303 383 
3 2 1 1 5 9 0 0 15 350 
3 2 1 1 5 0 9 0 303 738 
3 2 1 1 5 0 0 7 769 787 
3 2 1 1 5 0 0 8 409 439 
3 2 1 1 6 7 0 0 231 841 
3 2 1 1 6 10 0 0 261 885 
3 2 1 1 6 0 1 0 841 885 
3 2 1 1 7 4 0 0 118 906 
3 2 1 1 8 1 0 0 35 883 
3 2 1 1 8 0 5 0 35 887 
3 2 1 1 8 0 8 0 805 837 
3 2 1 1 8 0 0 2 749 750 
3 2 1 1 9 5 0 0 330 376 
3 2 1 1 9 7 0 0 204 922 
3 2 1 1 9 0 5 0 324 877 
3 2 1 1 9 0 7 0 201 397 
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3 2 1 1 9 0 9 0 402 922 
3 2 1 1 9 0 0 9 922 923 
3 2 1 1 10 3 0 0 140 396 
3 2 1 1 10 7 0 0 428 631 
3 2 1 1 10 0 3 0 396 411 
3 2 1 1 0 1 2 0 883 911 
3 2 1 1 0 1 5 0 35 877 
3 2 1 1 0 1 6 0 406 923 
3 2 1 1 0 1 0 8 406 427 
3 2 1 1 0 1 0 10 877 883 
3 2 1 1 0 2 0 1 280 288 
3 2 1 1 0 2 0 3 587 617 
3 2 1 1 0 2 0 10 805 806 
3 2 1 1 0 3 3 0 147 396 
3 2 1 1 0 3 0 6 385 396 
3 2 1 1 0 4 6 0 551 784 
3 2 1 1 0 4 7 0 118 163 
3 2 1 1 0 4 0 6 393 402 
3 2 1 1 0 4 0 7 784 787 
3 2 1 1 0 4 0 9 906 930 
3 2 1 1 0 5 4 0 330 439 
3 2 1 1 0 5 5 0 306 753 
3 2 1 1 0 6 2 0 398 742 
3 2 1 1 0 6 3 0 383 875 
3 2 1 1 0 6 0 6 383 398 
3 2 1 1 0 7 10 0 204 231 
3 2 1 1 0 8 3 0 411 865 
3 2 1 1 0 8 0 1 293 324 
3 2 1 1 0 9 1 0 15 350 
3 2 1 1 0 10 0 10 885 887 
3 2 1 1 0 0 1 6 350 393 
3 2 1 1 0 0 1 9 906 947 
3 2 1 1 0 0 1 10 841 885 
3 2 1 1 0 0 2 9 911 961 
3 2 1 1 0 0 3 10 865 875 
3 2 1 1 0 0 5 10 877 887 
3 2 1 1 0 0 6 7 769 784 
3 2 1 1 0 0 8 6 349 371 
3 2 1 1 0 0 8 7 691 786 
3 2 1 1 0 0 8 10 805 837 
3 2 1 1 0 0 9 1 261 303 
3 2 1 1 0 0 10 3 556 617 
3 2 1 1 0 0 10 8 409 427 
3 2 1 2 2 5 0 0 62 119 
3 2 1 2 2 0 0 2 715 724 
3 2 1 2 2 0 0 8 421 426 
3 2 1 2 3 0 3 0 24 634 
3 2 1 2 3 0 9 0 23 925 
3 2 1 2 3 0 0 1 313 317 
3 2 1 2 3 0 0 5 495 524 
3 2 1 2 4 6 0 0 161 407 
3 2 1 2 4 0 0 7 681 772 
3 2 1 2 4 0 0 8 407 433 
3 2 1 2 5 4 0 0 520 552 
3 2 1 2 5 8 0 0 498 503 
3 2 1 2 5 9 0 0 386 400 
3 2 1 2 5 0 0 2 713 717 
3 2 1 2 5 0 0 9 847 848 
3 2 1 2 6 3 0 0 225 271 
3 2 1 2 6 5 0 0 811 957 
3 2 1 2 6 9 0 0 657 901 
3 2 1 2 6 10 0 0 238 521 
3 2 1 2 6 0 3 0 235 637 
3 2 1 2 6 0 5 0 27 677 
3 2 1 2 6 0 7 0 131 225 
3 2 1 2 6 0 10 0 263 314 
3 2 1 2 6 0 0 5 521 522 
3 2 1 2 7 3 0 0 852 908 
3 2 1 2 7 7 0 0 96 457 
3 2 1 2 7 0 7 0 603 900 
3 2 1 2 7 0 0 2 736 752 
3 2 1 2 8 3 0 0 138 600 
3 2 1 2 8 0 5 0 193 273 
3 2 1 2 8 0 10 0 600 726 
3 2 1 2 8 0 0 4 451 454 
3 2 1 2 9 0 0 8 417 435 
3 2 1 2 10 7 0 0 663 792 
3 2 1 2 10 8 0 0 481 863 
3 2 1 2 10 9 0 0 466 669 
3 2 1 2 10 10 0 0 424 907 
3 2 1 2 10 0 3 0 669 785 
3 2 1 2 10 0 6 0 287 792 
3 2 1 2 10 0 0 4 466 481 
3 2 1 2 10 0 0 9 898 907 
Page | E57  
3 2 1 2 0 1 0 4 469 475 
3 2 1 2 0 2 0 5 500 523 
3 2 1 2 0 2 0 8 413 420 
3 2 1 2 0 2 0 9 847 921 
3 2 1 2 0 3 1 0 171 717 
3 2 1 2 0 3 2 0 194 727 
3 2 1 2 0 3 5 0 421 624 
3 2 1 2 0 3 0 2 717 727 
3 2 1 2 0 3 0 7 640 679 
3 2 1 2 0 3 0 8 412 421 
3 2 1 2 0 3 0 10 852 869 
3 2 1 2 0 4 1 0 436 693 
3 2 1 2 0 4 2 0 224 552 
3 2 1 2 0 4 0 3 552 586 
3 2 1 2 0 4 0 10 800 809 
3 2 1 2 0 5 0 2 713 714 
3 2 1 2 0 5 0 4 460 486 
3 2 1 2 0 5 0 9 915 957 
3 2 1 2 0 6 7 0 454 616 
3 2 1 2 0 6 0 2 728 736 
3 2 1 2 0 7 3 0 6 80 
3 2 1 2 0 7 5 0 468 663 
3 2 1 2 0 7 0 2 726 732 
3 2 1 2 0 7 0 8 422 446 
3 2 1 2 0 8 2 0 340 646 
3 2 1 2 0 8 5 0 583 746 
3 2 1 2 0 8 10 0 584 647 
3 2 1 2 0 8 0 1 311 340 
3 2 1 2 0 8 0 2 735 746 
3 2 1 2 0 9 2 0 154 386 
3 2 1 2 0 9 3 0 494 669 
3 2 1 2 0 9 4 0 381 901 
3 2 1 2 0 9 5 0 193 466 
3 2 1 2 0 9 9 0 676 723 
3 2 1 2 0 9 10 0 317 828 
3 2 1 2 0 9 0 1 266 317 
3 2 1 2 0 9 0 4 466 485 
3 2 1 2 0 9 0 9 901 939 
3 2 1 2 0 9 0 10 828 892 
3 2 1 2 0 10 2 0 521 791 
3 2 1 2 0 10 0 5 495 521 
3 2 1 2 0 10 0 9 907 962 
3 2 1 2 0 0 1 9 939 946 
3 2 1 2 0 0 2 3 552 590 
3 2 1 2 0 0 2 4 451 478 
3 2 1 2 0 0 3 1 285 309 
3 2 1 2 0 0 3 3 539 576 
3 2 1 2 0 0 3 4 460 493 
3 2 1 2 0 0 3 5 494 507 
3 2 1 2 0 0 3 8 404 407 
3 2 1 2 0 0 3 9 847 962 
3 2 1 2 0 0 4 10 863 882 
3 2 1 2 0 0 5 1 273 332 
3 2 1 2 0 0 5 5 524 530 
3 2 1 2 0 0 5 6 347 375 
3 2 1 2 0 0 5 10 807 867 
3 2 1 2 0 0 6 2 737 743 
3 2 1 2 0 0 6 4 456 473 
3 2 1 2 0 0 6 6 378 387 
3 2 1 2 0 0 6 9 846 948 
3 2 1 2 0 0 7 6 392 400 
3 2 1 2 0 0 8 4 469 472 
3 2 1 2 0 0 8 9 908 915 
3 2 1 2 0 0 9 1 256 297 
3 2 1 2 0 0 9 3 553 568 
3 2 1 0 1 1 7 0 177 410 
3 2 1 0 1 1 9 0 46 553 
3 2 1 0 1 1 0 7 685 691 
3 2 1 0 1 2 7 0 573 822 
3 2 1 0 1 2 0 10 818 822 
3 2 1 0 1 3 8 0 291 679 
3 2 1 0 1 3 10 0 283 593 
3 2 1 0 1 3 0 1 283 291 
3 2 1 0 1 4 4 0 229 370 
3 2 1 0 1 4 8 0 711 930 
3 2 1 0 1 4 0 6 370 393 
3 2 1 0 1 4 0 7 704 711 
3 2 1 0 1 4 0 8 403 425 
3 2 1 0 1 5 3 0 460 636 
3 2 1 0 1 5 0 10 824 880 
3 2 1 0 1 6 5 0 347 759 
3 2 1 0 1 6 8 0 506 559 
3 2 1 0 1 6 0 4 453 459 
3 2 1 0 1 6 0 5 506 525 
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3 2 1 0 1 7 4 0 344 628 
3 2 1 0 1 7 9 0 464 673 
3 2 1 0 1 7 0 1 339 344 
3 2 1 0 1 7 0 3 588 628 
3 2 1 0 1 7 0 4 464 483 
3 2 1 0 1 7 0 7 656 673 
3 2 1 0 1 8 0 1 311 340 
3 2 1 0 1 10 7 0 447 606 
3 2 1 0 1 10 0 4 447 458 
3 2 1 0 1 0 1 7 695 756 
3 2 1 0 1 0 3 6 356 365 
3 2 1 0 1 0 3 7 636 704 
3 2 1 0 1 0 4 6 353 370 
3 2 1 0 1 0 7 4 447 483 
3 2 1 0 1 0 7 7 656 757 
3 2 1 0 1 0 8 1 266 291 
3 2 1 0 1 0 9 3 553 568 
3 2 1 0 1 0 9 4 453 464 
3 2 1 0 1 0 9 10 818 869 
3 2 1 0 1 0 10 1 283 327 
3 2 1 0 1 0 10 7 653 781 
3 2 1 0 1 0 10 8 403 425 
3 2 1 0 2 1 2 0 715 911 
3 2 1 0 2 2 10 0 104 280 
3 2 1 0 2 6 6 0 143 629 
3 2 1 0 2 6 0 3 610 629 
3 2 1 0 2 7 8 0 371 839 
3 2 1 0 2 8 0 7 646 647 
3 2 1 0 2 10 6 0 105 639 
3 2 1 0 2 0 2 9 911 961 
3 2 1 0 2 0 4 3 536 626 
3 2 1 0 2 0 9 10 809 813 
3 2 1 0 2 0 10 1 280 292 
3 2 1 0 3 1 0 7 634 708 
3 2 1 0 3 2 10 0 806 830 
3 2 1 0 3 2 0 10 806 830 
3 2 1 0 3 0 10 10 806 830 
3 2 1 0 4 1 2 0 334 681 
3 2 1 0 4 1 10 0 5 179 
3 2 1 0 4 1 0 7 681 772 
3 2 1 0 4 2 5 0 69 200 
3 2 1 0 4 2 6 0 38 76 
3 2 1 0 4 3 0 1 278 336 
3 2 1 0 4 3 0 3 571 624 
3 2 1 0 4 4 3 0 90 137 
3 2 1 0 4 5 5 0 211 254 
3 2 1 0 4 5 10 0 223 859 
3 2 1 0 4 5 0 3 541 595 
3 2 1 0 4 7 6 0 308 548 
3 2 1 0 4 10 4 0 433 882 
3 2 1 0 4 0 3 8 407 429 
3 2 1 0 4 0 4 1 275 337 
3 2 1 0 4 0 5 3 583 624 
3 2 1 0 4 0 7 1 265 336 
3 2 1 0 4 0 10 1 278 286 
3 2 1 0 4 0 10 10 800 859 
3 2 1 0 5 1 2 0 391 672 
3 2 1 0 5 1 5 0 252 530 
3 2 1 0 5 1 0 1 302 331 
3 2 1 0 5 1 0 3 563 619 
3 2 1 0 5 2 8 0 91 326 
3 2 1 0 5 2 0 4 478 491 
3 2 1 0 5 2 0 8 413 420 
3 2 1 0 5 3 10 0 412 540 
3 2 1 0 5 3 0 5 526 534 
3 2 1 0 5 3 0 6 366 385 
3 2 1 0 5 4 2 0 552 787 
3 2 1 0 5 4 0 3 551 552 
3 2 1 0 5 5 8 0 713 761 
3 2 1 0 5 5 0 1 285 306 
3 2 1 0 5 6 3 0 61 383 
3 2 1 0 5 6 5 0 555 867 
3 2 1 0 5 6 0 1 297 303 
3 2 1 0 5 6 0 3 555 590 
3 2 1 0 5 7 1 0 77 771 
3 2 1 0 5 7 0 6 364 388 
3 2 1 0 5 7 0 7 709 771 
3 2 1 0 5 8 6 0 503 769 
3 2 1 0 5 8 0 5 498 503 
3 2 1 0 5 9 1 0 15 350 
3 2 1 0 5 10 3 0 191 585 
3 2 1 0 5 10 0 3 544 585 
3 2 1 0 5 0 1 1 302 331 
3 2 1 0 5 0 1 7 649 771 
Page | E59  
3 2 1 0 5 0 1 8 413 420 
3 2 1 0 5 0 2 3 552 590 
3 2 1 0 5 0 3 1 285 325 
3 2 1 0 5 0 4 4 465 475 
3 2 1 0 5 0 7 7 668 709 
3 2 1 0 5 0 8 5 498 520 
3 2 1 0 5 0 8 7 633 761 
3 2 1 0 5 0 8 10 793 857 
3 2 1 0 5 0 9 1 297 303 
3 2 1 0 5 0 9 5 518 534 
3 2 1 0 5 0 10 8 409 412 
3 2 1 0 6 1 6 0 737 948 
3 2 1 0 6 1 8 0 221 537 
3 2 1 0 6 2 10 0 263 314 
3 2 1 0 6 4 0 7 677 693 
3 2 1 0 6 6 1 0 333 705 
3 2 1 0 6 6 3 0 637 875 
3 2 1 0 6 6 0 7 637 705 
3 2 1 0 6 6 0 10 794 875 
3 2 1 0 6 10 1 0 238 885 
3 2 1 0 6 0 2 5 521 522 
3 2 1 0 6 0 4 9 901 954 
3 2 1 0 6 0 6 1 271 281 
3 2 1 0 6 0 9 10 794 881 
3 2 1 0 6 0 10 1 263 314 
3 2 1 0 7 1 5 0 88 575 
3 2 1 0 7 2 9 0 752 890 
3 2 1 0 7 5 0 3 569 603 
3 2 1 0 7 6 1 0 662 879 
3 2 1 0 7 10 10 0 316 423 
3 2 1 0 7 10 0 10 791 808 
3 2 1 0 7 0 10 1 259 316 
3 2 1 0 8 1 2 0 114 883 
3 2 1 0 8 2 8 0 12 805 
3 2 1 0 8 3 3 0 138 147 
3 2 1 0 8 4 1 0 436 750 
3 2 1 0 8 4 4 0 11 26 
3 2 1 0 8 4 0 2 747 750 
3 2 1 0 8 6 2 0 226 451 
3 2 1 0 8 6 7 0 454 616 
3 2 1 0 8 6 0 4 451 454 
3 2 1 0 8 6 0 7 645 760 
3 2 1 0 8 7 4 0 8 504 
3 2 1 0 8 7 6 0 749 819 
3 2 1 0 8 7 0 2 726 749 
3 2 1 0 8 8 8 0 550 837 
3 2 1 0 8 0 4 7 690 760 
3 2 1 0 8 0 8 10 805 837 
3 2 1 0 9 1 4 0 382 435 
3 2 1 0 9 1 7 0 397 778 
3 2 1 0 9 1 9 0 692 768 
3 2 1 0 9 1 0 5 514 515 
3 2 1 0 9 1 0 8 427 435 
3 2 1 0 9 1 0 9 923 936 
3 2 1 0 9 1 0 10 877 884 
3 2 1 0 9 2 3 0 358 576 
3 2 1 0 9 2 4 0 274 401 
3 2 1 0 9 2 7 0 201 665 
3 2 1 0 9 2 8 0 351 731 
3 2 1 0 9 2 0 7 665 766 
3 2 1 0 9 3 0 6 378 392 
3 2 1 0 9 4 0 6 359 402 
3 2 1 0 9 5 1 0 714 823 
3 2 1 0 9 5 3 0 376 507 
3 2 1 0 9 5 4 0 330 558 
3 2 1 0 9 5 10 0 203 664 
3 2 1 0 9 5 0 3 558 612 
3 2 1 0 9 5 0 5 507 531 
3 2 1 0 9 5 0 7 664 777 
3 2 1 0 9 5 0 10 823 860 
3 2 1 0 9 6 10 0 148 482 
3 2 1 0 9 7 1 0 683 732 
3 2 1 0 9 7 9 0 780 922 
3 2 1 0 9 8 5 0 324 746 
3 2 1 0 9 8 7 0 492 862 
3 2 1 0 9 8 0 1 293 324 
3 2 1 0 9 8 0 3 615 620 
3 2 1 0 9 8 0 10 862 893 
3 2 1 0 9 9 1 0 485 699 
3 2 1 0 9 9 10 0 820 828 
3 2 1 0 9 9 0 7 676 699 
3 2 1 0 9 9 0 10 820 828 
3 2 1 0 9 10 3 0 218 493 
3 2 1 0 9 0 1 2 714 732 
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3 2 1 0 9 0 1 3 592 598 
3 2 1 0 9 0 1 7 683 699 
3 2 1 0 9 0 2 2 727 742 
3 2 1 0 9 0 2 6 368 398 
3 2 1 0 9 0 2 9 921 936 
3 2 1 0 9 0 3 3 539 576 
3 2 1 0 9 0 3 6 358 376 
3 2 1 0 9 0 4 1 274 330 
3 2 1 0 9 0 4 6 382 401 
3 2 1 0 9 0 6 6 378 387 
3 2 1 0 9 0 7 6 392 397 
3 2 1 0 9 0 7 7 665 778 
3 2 1 0 10 2 1 0 500 523 
3 2 1 0 10 2 0 5 500 523 
3 2 1 0 10 3 4 0 140 512 
3 2 1 0 10 6 1 0 570 947 
3 2 1 0 10 7 1 0 428 631 
3 2 1 0 10 8 4 0 481 863 
3 2 1 0 10 9 5 0 431 466 
3 2 1 0 10 0 1 3 570 631 
3 2 1 0 10 0 1 5 500 523 
3 2 1 0 10 0 3 7 669 785 
3 2 1 0 10 0 4 9 898 907 
3 2 1 0 10 0 8 3 599 632 
3 2 1 0 0 1 1 3 592 598 
3 2 1 0 0 1 2 9 911 936 
3 2 1 0 0 1 4 9 898 950 
3 2 1 0 0 1 5 5 524 530 
3 2 1 0 0 1 6 2 737 743 
3 2 1 0 0 1 6 9 923 948 
3 2 1 0 0 1 8 5 515 517 
3 2 1 0 0 1 8 6 354 395 
3 2 1 0 0 1 8 7 633 691 
3 2 1 0 0 1 9 7 692 768 
3 2 1 0 0 2 1 5 500 523 
3 2 1 0 0 2 1 8 413 420 
3 2 1 0 0 2 1 10 799 821 
3 2 1 0 0 2 2 9 921 961 
3 2 1 0 0 2 4 1 274 315 
3 2 1 0 0 2 6 1 257 281 
3 2 1 0 0 2 8 2 729 731 
3 2 1 0 0 2 8 3 535 599 
3 2 1 0 0 2 9 2 725 752 
3 2 1 0 0 2 9 10 818 890 
3 2 1 0 0 2 10 10 806 830 
3 2 1 0 0 3 4 5 512 526 
3 2 1 0 0 3 6 1 271 287 
3 2 1 0 0 3 6 6 378 385 
3 2 1 0 0 3 10 1 278 283 
3 2 1 0 0 4 3 1 309 325 
3 2 1 0 0 5 1 10 811 823 
3 2 1 0 0 5 3 8 419 429 
3 2 1 0 0 5 6 10 824 860 
3 2 1 0 0 5 7 3 541 603 
3 2 1 0 0 5 8 7 761 777 
3 2 1 0 0 5 9 5 509 531 
3 2 1 0 0 5 10 10 803 859 
3 2 1 0 0 6 1 3 570 610 
3 2 1 0 0 6 1 7 662 705 
3 2 1 0 0 6 1 9 946 947 
3 2 1 0 0 6 2 2 728 742 
3 2 1 0 0 6 2 10 795 858 
3 2 1 0 0 6 9 1 297 303 
3 2 1 0 0 6 9 9 925 958 
3 2 1 0 0 6 9 10 794 796 
3 2 1 0 0 7 1 7 683 771 
3 2 1 0 0 7 2 6 364 369 
3 2 1 0 0 7 4 1 275 344 
3 2 1 0 0 7 6 10 792 819 
3 2 1 0 0 7 7 3 588 608 
3 2 1 0 0 7 7 7 656 709 
3 2 1 0 0 7 8 10 793 839 
3 2 1 0 0 7 9 7 673 780 
3 2 1 0 0 7 9 9 848 922 
3 2 1 0 0 8 2 1 293 340 
3 2 1 0 0 8 7 4 455 492 
3 2 1 0 0 8 7 10 844 862 
3 2 1 0 0 9 1 7 657 699 
3 2 1 0 0 9 10 1 286 317 
3 2 1 0 0 9 10 10 820 828 
3 2 1 0 0 10 4 8 426 433 
3 2 1 0 0 10 9 1 256 261 
3 2 1 0 0 10 10 4 471 477 
2 2 1 1 7 0 0 0 118 906 
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2 2 1 0 1 9 0 0 266 781 
2 2 1 0 2 5 0 0 62 119 
2 2 1 0 2 0 0 2 715 724 
2 2 1 0 2 0 0 8 421 426 
2 2 1 0 3 5 0 0 130 419 
2 2 1 0 3 10 0 0 495 556 
2 2 1 0 3 0 1 0 130 495 
2 2 1 0 3 0 5 0 117 524 
2 2 1 0 3 0 6 0 202 406 
2 2 1 0 3 0 9 0 23 925 
2 2 1 0 3 0 0 1 313 317 
2 2 1 0 3 0 0 3 535 556 
2 2 1 0 3 0 0 5 495 524 
2 2 1 0 3 0 0 8 406 419 
2 2 1 0 3 0 0 10 806 830 
2 2 1 0 4 6 0 0 161 407 
2 2 1 0 5 0 0 9 847 848 
2 2 1 0 6 3 0 0 225 271 
2 2 1 0 6 9 0 0 657 901 
2 2 1 0 6 0 5 0 27 677 
2 2 1 0 6 0 7 0 131 225 
2 2 1 0 6 0 0 5 521 522 
2 2 1 0 7 3 0 0 852 908 
2 2 1 0 7 7 0 0 96 457 
2 2 1 0 7 0 0 2 736 752 
2 2 1 0 8 5 0 0 132 269 
2 2 1 0 8 8 0 0 550 837 
2 2 1 0 8 0 0 4 451 454 
2 2 1 0 9 4 0 0 359 402 
2 2 1 0 10 6 0 0 570 947 
2 2 1 0 10 0 6 0 287 792 
2 2 1 0 10 0 0 4 466 481 
2 2 1 0 0 1 0 4 469 475 
2 2 1 0 0 2 0 5 500 523 
2 2 1 0 0 2 0 8 413 420 
2 2 1 0 0 3 1 0 171 717 
2 2 1 0 0 3 2 0 194 727 
2 2 1 0 0 3 5 0 421 624 
2 2 1 0 0 3 0 2 717 727 
2 2 1 0 0 3 0 7 640 679 
2 2 1 0 0 3 0 8 412 421 
2 2 1 0 0 3 0 10 852 869 
2 2 1 0 0 4 7 0 118 163 
2 2 1 0 0 4 0 10 800 809 
2 2 1 0 0 5 0 4 460 486 
2 2 1 0 0 5 0 6 372 376 
2 2 1 0 0 5 0 9 915 957 
2 2 1 0 0 6 7 0 454 616 
2 2 1 0 0 7 3 0 6 80 
2 2 1 0 0 7 0 9 848 922 
2 2 1 0 0 8 3 0 411 865 
2 2 1 0 0 8 0 2 735 746 
2 2 1 0 0 9 2 0 154 386 
2 2 1 0 0 9 3 0 494 669 
2 2 1 0 0 9 4 0 381 901 
2 2 1 0 0 9 9 0 676 723 
2 2 1 0 0 9 0 4 466 485 
2 2 1 0 0 9 0 9 901 939 
2 2 1 0 0 10 2 0 521 791 
2 2 1 0 0 10 0 5 495 521 
2 2 1 0 0 10 0 9 907 962 
2 2 1 0 0 0 2 3 552 590 
2 2 1 0 0 0 2 4 451 478 
2 2 1 0 0 0 3 4 460 493 
2 2 1 0 0 0 3 9 847 962 
2 2 1 0 0 0 4 10 863 882 
2 2 1 0 0 0 5 2 746 753 
2 2 1 0 0 0 5 5 524 530 
2 2 1 0 0 0 5 6 347 375 
2 2 1 0 0 0 5 8 421 431 
2 2 1 0 0 0 6 4 456 473 
2 2 1 0 0 0 6 8 406 422 
2 2 1 0 0 0 8 4 469 472 
2 2 1 0 0 0 9 6 366 402 
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Appendix E6: COMPLETE FINGERPRINT ANALYSIS OF THE FINAL EXIT ORDERED BY PROBABILITY 
 
Matches 
 
Samples 
 
Probability   
Split   Bead IDs 1 2 3 4 5 
2 77 0 2 1 0 0 0 13 32 46 56 80 89 125 142 177 187 194 195 229 266 291 311 327 339 340 344 347 
2 76 0 2 9 0 0 0 34 83 102 148 150 169 172 198 203 209 213 218 256 264 274 296 351 354 358 359 368 
2 83 0 2 0 1 0 0 2 5 7 13 23 32 46 56 88 89 98 100 114 131 150 169 172 177 179 187 195 
2 69 0.0000001 2 5 0 0 0 43 61 91 107 133 191 252 285 297 301 302 307 326 331 364 366 386 388 391 400 404 
3 18 0.00000015 2 9 1 0 0 150 169 172 296 354 382 435 514 515 539 592 598 614 692 768 778 884 936    
2 68 0.0000003 2 0 2 0 0 3 12 27 38 43 69 71 76 91 103 104 125 133 135 157 160 180 197 198 200 202 
2 22 0.00000485 0 9 1 0 0 150 169 172 296 354 382 397 427 435 514 515 539 592 598 614 692 768 778 877 884 923 
3 16 0.0000051 2 9 0 0 7 650 664 665 666 676 683 688 692 699 700 710 766 768 777 778 780      
3 15 0.0000326 2 5 1 0 0 252 302 331 391 404 475 510 528 530 563 619 633 649 672 857       
2 61 0.00005223 2 0 0 0 7 633 634 636 637 639 640 645 646 647 649 650 653 654 656 657 662 663 664 665 666 668 
3 14 0.00018655 2 1 0 0 7 636 653 656 673 679 685 687 695 704 711 756 757 759 776        
3 14 0.00018655 2 9 0 8 0 34 83 351 354 359 389 417 515 614 615 620 666 731 777        
3 14 0.00018655 2 0 1 0 7 633 634 649 654 672 681 685 690 692 708 768 772 778 785        
2 59 0.00019647 2 0 0 8 0 12 34 83 91 103 180 221 266 268 291 326 351 354 359 389 395 417 424 446 469 472 
3 13 0.00099931 2 1 1 0 0 13 32 46 56 89 177 187 195 356 410 553 685 743         
2 56 0.00124251 2 0 6 0 0 22 60 61 67 143 148 161 213 214 226 259 297 333 347 407 451 453 454 459 465 472 
3 7 0.0015603 0 0 2 10 1 263 280 288 301 307 314 327               
2 54 0.00386314 2 0 0 1 0 3 13 62 71 150 157 171 238 296 302 319 328 331 333 339 346 413 420 436 459 485 
2 17 0.00430046 0 9 0 0 7 650 664 665 666 676 683 688 692 699 700 710 766 768 777 778 780 786     
3 12 0.00495671 2 1 6 0 0 347 453 459 506 525 554 559 568 728 759 795 958          
3 12 0.00495671 2 1 7 0 0 80 339 344 369 446 464 483 588 628 656 673 814          
3 12 0.00495671 2 5 2 0 0 43 91 133 301 307 326 413 420 478 491 821 847          
3 12 0.00495671 2 9 2 0 0 198 209 274 351 358 368 401 576 665 731 766 921          
3 12 0.00495671 2 9 5 0 0 83 203 417 507 531 558 612 664 714 777 823 860          
3 12 0.00495671 2 0 1 1 0 13 150 296 302 319 328 331 528 592 598 649 894          
3 12 0.00495671 2 0 1 8 0 221 354 395 469 515 517 537 563 614 632 633 857          
2 52 0.01109328 2 4 0 0 0 3 5 6 7 38 58 69 76 78 90 103 136 137 161 179 200 211 219 223 245 254 
2 16 0.01413298 0 1 1 0 0 13 32 46 56 89 177 187 195 356 410 501 553 685 691 743 950      
2 16 0.01413298 0 1 0 0 7 636 653 656 673 679 685 687 691 695 704 711 756 757 759 776 781      
2 51 0.01823055 2 0 0 0 3 535 536 537 539 540 541 544 548 550 552 553 554 555 558 559 563 568 569 570 571 573 
4 5 0.02015554 2 9 0 9 7 650 676 692 768 780                 
4 5 0.02015554 2 0 1 1 1 296 302 319 328 331                 
4 5 0.02015554 2 0 2 10 1 263 301 307 314 327                 
3 11 0.02253171 2 1 0 9 0 46 453 464 509 553 568 673 735 818 869 958           
3 11 0.02253171 2 5 0 1 0 302 331 413 420 491 528 578 649 717 771 821           
3 11 0.02253171 2 9 0 1 0 150 296 485 592 598 683 699 714 732 823 946           
3 11 0.02253171 2 9 0 0 6 351 354 358 359 368 378 382 387 389 392 401           
3 11 0.02253171 2 0 2 1 0 3 71 157 413 420 491 500 523 756 799 821           
3 11 0.02253171 2 0 2 0 1 257 263 274 276 281 301 307 314 315 326 327           
3 11 0.02253171 2 0 6 9 0 67 214 297 453 518 568 650 794 796 925 958           
3 11 0.02253171 2 0 0 8 3 535 537 550 559 563 571 599 614 615 620 632           
2 15 0.04343585 0 5 1 0 0 252 302 331 391 404 475 510 528 530 563 619 633 649 672 857       
2 15 0.04343585 0 9 0 8 0 34 83 351 354 359 389 417 515 614 615 620 666 731 777 786       
2 15 0.04343585 0 9 0 0 6 351 354 358 359 368 376 378 382 387 389 392 397 398 401 402       
2 15 0.04343585 0 0 1 0 7 633 634 649 654 672 681 685 690 691 692 708 768 772 778 785       
2 15 0.04343585 0 0 0 10 1 259 263 269 278 280 283 286 288 292 301 307 314 316 317 327       
2 48 0.07042222 2 0 7 0 0 6 8 52 80 96 219 264 268 275 292 308 313 339 344 364 369 388 422 446 456 457 
2 48 0.07042222 2 0 0 9 0 10 23 46 52 67 78 100 119 214 245 250 256 297 366 453 464 486 502 509 518 531 
3 10 0.09175675 2 1 0 7 0 177 311 410 447 483 573 588 656 757 822            
3 10 0.09175675 2 1 0 8 0 266 291 446 506 559 679 687 711 729 880            
3 10 0.09175675 2 1 0 10 0 32 327 372 403 425 554 586 593 653 814            
3 10 0.09175675 2 5 6 0 0 61 297 465 518 555 590 670 796 858 867            
3 10 0.09175675 2 5 0 8 0 91 326 498 520 563 633 713 761 793 857            
3 10 0.09175675 2 0 1 2 0 56 114 334 391 522 654 672 681 715 936            
3 10 0.09175675 2 0 1 0 3 537 539 553 563 575 592 598 614 619 632            
3 10 0.09175675 2 0 2 8 0 12 91 103 180 326 351 535 599 729 731            
3 10 0.09175675 2 0 6 2 0 226 451 525 590 670 688 710 728 795 858            
3 10 0.09175675 2 0 6 0 7 637 645 650 662 670 688 705 710 759 760            
3 10 0.09175675 2 0 0 1 7 649 657 662 683 693 695 699 705 756 771            
3 10 0.09175675 2 0 0 10 1 259 263 278 292 301 307 314 316 317 327            
2 47 0.10466423 2 0 0 10 0 5 32 104 148 172 179 203 223 259 263 278 292 301 307 314 316 317 327 372 403 412 
2 14 0.12235477 0 5 2 0 0 43 91 133 288 301 307 326 413 420 478 491 617 821 847        
2 14 0.12235477 0 5 0 1 0 15 77 302 331 350 413 420 491 528 578 649 717 771 821        
2 14 0.12235477 0 9 5 0 0 83 203 330 376 417 507 531 558 612 664 714 777 823 860        
2 45 0.2081044 2 0 0 4 0 8 11 26 58 98 125 136 229 274 275 315 337 344 353 370 381 382 388 401 416 426 
2 45 0.2081044 2 0 0 0 1 256 257 259 263 264 265 266 268 271 273 274 275 276 278 281 285 287 291 292 296 297 
3 5 0.21190326 0 9 0 9 7 650 676 692 768 780                 
3 5 0.21190326 0 0 1 1 1 296 302 319 328 331                 
4 3 0.220039 0 5 2 10 1 288 301 307                   
4 3 0.220039 0 5 5 4 8 416 439 443                   
2 44 0.27516937 2 0 5 0 0 58 62 83 119 132 203 211 223 254 285 372 416 417 443 460 486 507 509 531 541 558 
2 44 0.27516937 2 0 0 2 0 56 96 114 135 154 194 197 209 219 224 226 276 313 334 340 364 368 369 386 391 451 
2 44 0.27516937 2 0 0 0 10 791 792 793 794 795 796 798 799 800 803 807 808 809 811 813 814 818 819 821 822 823 
2 13 0.30368808 0 9 2 0 0 198 201 209 274 351 358 368 401 576 665 731 766 921         
2 13 0.30368808 0 0 1 8 0 221 354 395 469 515 517 537 563 614 632 633 691 857         
2 13 0.30368808 0 0 2 0 1 257 263 274 276 280 281 288 301 307 314 315 326 327         
4 4 0.30386886 2 5 1 1 0 302 331 528 649                  
4 4 0.30386886 2 5 2 1 0 413 420 491 821                  
4 4 0.30386886 2 9 1 1 0 150 296 592 598                  
4 4 0.30386886 2 9 1 0 3 539 592 598 614                  
4 4 0.30386886 2 9 2 0 6 351 358 368 401                  
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2 77 0 2 1 0 0 0 353 356 365 369 370 372 403 410 425 446 447 453 458 459 460 464 473 483 506 509 525 
2 76 0 2 9 0 0 0 378 382 387 389 392 401 417 435 468 482 485 492 493 507 514 515 531 539 558 576 592 
2 83 0 2 0 1 0 0 221 242 252 296 302 319 328 331 334 354 356 382 391 395 404 410 435 469 475 510 514 
2 69 0.0000001 2 5 0 0 0 412 413 416 420 422 443 465 475 478 486 491 498 503 510 518 520 526 528 530 534 540 
3 18 0.00000015 2 9 1 0 0                      
2 68 0.0000003 2 0 2 0 0 209 235 253 257 263 274 276 281 301 307 314 315 326 327 351 358 368 401 413 420 478 
2 22 0.00000485 0 9 1 0 0 936                     
3 16 0.0000051 2 9 0 0 7                      
3 15 0.0000326 2 5 1 0 0                      
2 61 0.00005223 2 0 0 0 7 669 670 672 673 676 677 679 681 683 685 687 688 690 692 693 695 699 700 704 705 708 
3 14 0.00018655 2 1 0 0 7                      
3 14 0.00018655 2 9 0 8 0                      
3 14 0.00018655 2 0 1 0 7                      
2 59 0.00019647 2 0 0 8 0 498 506 515 517 520 535 537 550 559 563 571 599 614 615 620 632 633 666 679 687 711 
3 13 0.00099931 2 1 1 0 0                      
2 56 0.00124251 2 0 6 0 0 482 506 518 525 554 555 559 568 570 590 610 616 629 637 645 650 662 670 688 705 710 
3 7 0.0015603 0 0 2 10 1                      
2 54 0.00386314 2 0 0 1 0 491 495 500 523 528 569 570 578 592 595 598 610 649 657 662 683 693 695 699 705 714 
2 17 0.00430046 0 9 0 0 7                      
3 12 0.00495671 2 1 6 0 0                      
3 12 0.00495671 2 1 7 0 0                      
3 12 0.00495671 2 5 2 0 0                      
3 12 0.00495671 2 9 2 0 0                      
3 12 0.00495671 2 9 5 0 0                      
3 12 0.00495671 2 0 1 1 0                      
3 12 0.00495671 2 0 1 8 0                      
2 52 0.01109328 2 4 0 0 0 265 275 278 308 334 336 337 346 375 381 407 433 477 502 541 548 571 583 595 624 681 
2 16 0.01413298 0 1 1 0 0                      
2 16 0.01413298 0 1 0 0 7                      
2 51 0.01823055 2 0 0 0 3 575 576 577 578 579 583 584 586 588 590 592 593 595 598 599 600 603 608 610 612 614 
4 5 0.02015554 2 9 0 9 7                      
4 5 0.02015554 2 0 1 1 1                      
4 5 0.02015554 2 0 2 10 1                      
3 11 0.02253171 2 1 0 9 0                      
3 11 0.02253171 2 5 0 1 0                      
3 11 0.02253171 2 9 0 1 0                      
3 11 0.02253171 2 9 0 0 6                      
3 11 0.02253171 2 0 2 1 0                      
3 11 0.02253171 2 0 2 0 1                      
3 11 0.02253171 2 0 6 9 0                      
3 11 0.02253171 2 0 0 8 3                      
2 15 0.04343585 0 5 1 0 0                      
2 15 0.04343585 0 9 0 8 0                      
2 15 0.04343585 0 9 0 0 6                      
2 15 0.04343585 0 0 1 0 7                      
2 15 0.04343585 0 0 0 10 1                      
2 48 0.07042222 2 0 7 0 0 464 468 483 504 548 577 588 608 628 656 663 666 673 683 700 709 726 732 771 780 792 
2 48 0.07042222 2 0 0 9 0 534 553 568 640 650 673 676 692 723 725 735 752 768 780 794 796 798 809 813 818 848 
3 10 0.09175675 2 1 0 7 0                      
3 10 0.09175675 2 1 0 8 0                      
3 10 0.09175675 2 1 0 10 0                      
3 10 0.09175675 2 5 6 0 0                      
3 10 0.09175675 2 5 0 8 0                      
3 10 0.09175675 2 0 1 2 0                      
3 10 0.09175675 2 0 1 0 3                      
3 10 0.09175675 2 0 2 8 0                      
3 10 0.09175675 2 0 6 2 0                      
3 10 0.09175675 2 0 6 0 7                      
3 10 0.09175675 2 0 0 1 7                      
3 10 0.09175675 2 0 0 10 1                      
2 47 0.10466423 2 0 0 10 0 423 425 457 471 477 482 514 540 554 577 579 584 586 593 600 647 653 664 708 726 800 
2 14 0.12235477 0 5 2 0 0                      
2 14 0.12235477 0 5 0 1 0                      
2 14 0.12235477 0 9 5 0 0                      
2 45 0.2081044 2 0 0 4 0 433 435 443 465 475 481 489 504 512 526 536 558 626 628 690 736 760 776 863 882 898 
2 45 0.2081044 2 0 0 0 1 301 302 307 308 309 311 313 314 315 316 317 319 326 327 328 331 332 333 334 336 337 
3 5 0.21190326 0 9 0 9 7                      
3 5 0.21190326 0 0 1 1 1                      
4 3 0.220039 0 5 2 10 1                      
4 3 0.220039 0 5 5 4 8                      
2 44 0.27516937 2 0 5 0 0 569 578 595 603 612 636 664 713 714 757 761 776 777 803 807 811 823 824 859 860 880 
2 44 0.27516937 2 0 0 2 0 478 521 522 525 552 590 646 654 670 672 681 688 700 710 715 727 728 791 795 858 921 
2 44 0.27516937 2 0 0 0 10 824 828 830 839 844 852 857 858 859 860 862 863 867 869 879 880 881 882 884 890 891 
2 13 0.30368808 0 9 2 0 0                      
2 13 0.30368808 0 0 1 8 0                      
2 13 0.30368808 0 0 2 0 1                      
4 4 0.30386886 2 5 1 1 0                      
4 4 0.30386886 2 5 2 1 0                      
4 4 0.30386886 2 9 1 1 0                      
4 4 0.30386886 2 9 1 0 3                      
4 4 0.30386886 2 9 2 0 6                      
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2 77 0 2 1 0 0 0 553 554 559 568 573 586 588 593 628 636 653 656 673 679 685 687 695 704 711 728 729 
2 76 0 2 9 0 0 0 598 612 614 615 620 650 664 665 666 676 683 688 692 699 700 710 714 727 731 732 746 
2 83 0 2 0 1 0 0 515 517 522 524 528 530 537 539 553 563 575 592 598 614 619 632 633 634 649 654 672 
2 69 0.0000001 2 5 0 0 0 544 552 555 563 577 578 590 619 633 640 649 668 670 672 709 713 717 761 771 793 796 
3 18 0.00000015 2 9 1 0 0                      
2 68 0.0000003 2 0 2 0 0 489 491 500 523 535 573 576 599 626 665 725 729 731 752 756 762 766 799 818 821 822 
2 22 0.00000485 0 9 1 0 0                      
3 16 0.0000051 2 9 0 0 7                      
3 15 0.0000326 2 5 1 0 0                      
2 61 0.00005223 2 0 0 0 7 709 710 711 712 756 757 759 760 761 762 766 768 771 772 776 777 778 780 785   
3 14 0.00018655 2 1 0 0 7                      
3 14 0.00018655 2 9 0 8 0                      
3 14 0.00018655 2 0 1 0 7                      
2 59 0.00019647 2 0 0 8 0 712 713 724 729 731 739 747 761 777 793 808 839 857 880 892 908 915     
3 13 0.00099931 2 1 1 0 0                      
2 56 0.00124251 2 0 6 0 0 728 736 759 760 794 795 796 858 867 879 925 946 954 958        
3 7 0.0015603 0 0 2 10 1                      
2 54 0.00386314 2 0 0 1 0 717 732 756 771 799 811 821 823 879 894 939 946          
2 17 0.00430046 0 9 0 0 7                      
3 12 0.00495671 2 1 6 0 0                      
3 12 0.00495671 2 1 7 0 0                      
3 12 0.00495671 2 5 2 0 0                      
3 12 0.00495671 2 9 2 0 0                      
3 12 0.00495671 2 9 5 0 0                      
3 12 0.00495671 2 0 1 1 0                      
3 12 0.00495671 2 0 1 8 0                      
2 52 0.01109328 2 4 0 0 0 723 772 798 800 844 859 882 892 894 915            
2 16 0.01413298 0 1 1 0 0                      
2 16 0.01413298 0 1 0 0 7                      
2 51 0.01823055 2 0 0 0 3 615 616 619 620 624 626 628 629 632             
4 5 0.02015554 2 9 0 9 7                      
4 5 0.02015554 2 0 1 1 1                      
4 5 0.02015554 2 0 2 10 1                      
3 11 0.02253171 2 1 0 9 0                      
3 11 0.02253171 2 5 0 1 0                      
3 11 0.02253171 2 9 0 1 0                      
3 11 0.02253171 2 9 0 0 6                      
3 11 0.02253171 2 0 2 1 0                      
3 11 0.02253171 2 0 2 0 1                      
3 11 0.02253171 2 0 6 9 0                      
3 11 0.02253171 2 0 0 8 3                      
2 15 0.04343585 0 5 1 0 0                      
2 15 0.04343585 0 9 0 8 0                      
2 15 0.04343585 0 9 0 0 6                      
2 15 0.04343585 0 0 1 0 7                      
2 15 0.04343585 0 0 0 10 1                      
2 48 0.07042222 2 0 7 0 0 793 798 814 819 839 848                
2 48 0.07042222 2 0 0 9 0 869 881 890 925 935 958                
3 10 0.09175675 2 1 0 7 0                      
3 10 0.09175675 2 1 0 8 0                      
3 10 0.09175675 2 1 0 10 0                      
3 10 0.09175675 2 5 6 0 0                      
3 10 0.09175675 2 5 0 8 0                      
3 10 0.09175675 2 0 1 2 0                      
3 10 0.09175675 2 0 1 0 3                      
3 10 0.09175675 2 0 2 8 0                      
3 10 0.09175675 2 0 6 2 0                      
3 10 0.09175675 2 0 6 0 7                      
3 10 0.09175675 2 0 0 1 7                      
3 10 0.09175675 2 0 0 10 1                      
2 47 0.10466423 2 0 0 10 0 803 814 828 830 859                 
2 14 0.12235477 0 5 2 0 0                      
2 14 0.12235477 0 5 0 1 0                      
2 14 0.12235477 0 9 5 0 0                      
2 45 0.2081044 2 0 0 4 0 901 907 954                   
2 45 0.2081044 2 0 0 0 1 339 340 344                   
3 5 0.21190326 0 9 0 9 7                      
3 5 0.21190326 0 0 1 1 1                      
4 3 0.220039 0 5 2 10 1                      
4 3 0.220039 0 5 5 4 8                      
2 44 0.27516937 2 0 5 0 0 915 957                    
2 44 0.27516937 2 0 0 2 0 936 957                    
2 44 0.27516937 2 0 0 0 10 892 894                    
2 13 0.30368808 0 9 2 0 0                      
2 13 0.30368808 0 0 1 8 0                      
2 13 0.30368808 0 0 2 0 1                      
4 4 0.30386886 2 5 1 1 0                      
4 4 0.30386886 2 5 2 1 0                      
4 4 0.30386886 2 9 1 1 0                      
4 4 0.30386886 2 9 1 0 3                      
4 4 0.30386886 2 9 2 0 6                      
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2 77 0 2 1 0 0 0 735 743 756 757 759 776 795 814 818 822 824 869 880 958       2 76 0 2 9 0 0 0 766 768 777 778 780 823 828 860 862 884 921 936 946        
2 83 0 2 0 1 0 0 681 685 690 692 708 715 722 737 743 768 772 778 785 857 884 894 898 900 936 948 
2 69 0.0000001 2 5 0 0 0 821 847 848 857 858 867               
3 18 0.00000015 2 9 1 0 0                     
2 68 0.0000003 2 0 2 0 0 830 847 890 891 921                
2 22 0.00000485 0 9 1 0 0                     
3 16 0.0000051 2 9 0 0 7                     
3 15 0.0000326 2 5 1 0 0                     
2 61 0.00005223 2 0 0 0 7                     
3 14 0.00018655 2 1 0 0 7                     
3 14 0.00018655 2 9 0 8 0                     
3 14 0.00018655 2 0 1 0 7                     
2 59 0.00019647 2 0 0 8 0                     
3 13 0.00099931 2 1 1 0 0                     
2 56 0.00124251 2 0 6 0 0                     
3 7 0.0015603 0 0 2 10 1                     
2 54 0.00386314 2 0 0 1 0                     
2 17 0.00430046 0 9 0 0 7                     
3 12 0.00495671 2 1 6 0 0                     
3 12 0.00495671 2 1 7 0 0                     
3 12 0.00495671 2 5 2 0 0                     
3 12 0.00495671 2 9 2 0 0                     
3 12 0.00495671 2 9 5 0 0                     
3 12 0.00495671 2 0 1 1 0                     
3 12 0.00495671 2 0 1 8 0                     
2 52 0.01109328 2 4 0 0 0                     
2 16 0.01413298 0 1 1 0 0                     
2 16 0.01413298 0 1 0 0 7                     
2 51 0.01823055 2 0 0 0 3                     
4 5 0.02015554 2 9 0 9 7                     
4 5 0.02015554 2 0 1 1 1                     
4 5 0.02015554 2 0 2 10 1                     
3 11 0.02253171 2 1 0 9 0                     
3 11 0.02253171 2 5 0 1 0                     
3 11 0.02253171 2 9 0 1 0                     
3 11 0.02253171 2 9 0 0 6                     
3 11 0.02253171 2 0 2 1 0                     
3 11 0.02253171 2 0 2 0 1                     
3 11 0.02253171 2 0 6 9 0                     
3 11 0.02253171 2 0 0 8 3                     
2 15 0.04343585 0 5 1 0 0                     
2 15 0.04343585 0 9 0 8 0                     
2 15 0.04343585 0 9 0 0 6                     
2 15 0.04343585 0 0 1 0 7                     
2 15 0.04343585 0 0 0 10 1                     
2 48 0.07042222 2 0 7 0 0                     
2 48 0.07042222 2 0 0 9 0                     
3 10 0.09175675 2 1 0 7 0                     
3 10 0.09175675 2 1 0 8 0                     
3 10 0.09175675 2 1 0 10 0                     
3 10 0.09175675 2 5 6 0 0                     
3 10 0.09175675 2 5 0 8 0                     
3 10 0.09175675 2 0 1 2 0                     
3 10 0.09175675 2 0 1 0 3                     
3 10 0.09175675 2 0 2 8 0                     
3 10 0.09175675 2 0 6 2 0                     
3 10 0.09175675 2 0 6 0 7                     
3 10 0.09175675 2 0 0 1 7                     
3 10 0.09175675 2 0 0 10 1                     
2 47 0.10466423 2 0 0 10 0                     
2 14 0.12235477 0 5 2 0 0                     
2 14 0.12235477 0 5 0 1 0                     
2 14 0.12235477 0 9 5 0 0                     
2 45 0.2081044 2 0 0 4 0                     
2 45 0.2081044 2 0 0 0 1                     
3 5 0.21190326 0 9 0 9 7                     
3 5 0.21190326 0 0 1 1 1                     
4 3 0.220039 0 5 2 10 1                     
4 3 0.220039 0 5 5 4 8                     
2 44 0.27516937 2 0 5 0 0                     
2 44 0.27516937 2 0 0 2 0                     
2 44 0.27516937 2 0 0 0 10                     
2 13 0.30368808 0 9 2 0 0                     
2 13 0.30368808 0 0 1 8 0                     
2 13 0.30368808 0 0 2 0 1                     
4 4 0.30386886 2 5 1 1 0                     
4 4 0.30386886 2 5 2 1 0                     
4 4 0.30386886 2 9 1 1 0                     
4 4 0.30386886 2 9 1 0 3                     
4 4 0.30386886 2 9 2 0 6                     
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4 4 0.30386886 2 9 7 0 7 666 683 700 780                  4 4 0.30386886 2 9 0 8 6 351 354 359 389                  
4 4 0.30386886 2 0 1 8 3 537 563 614 632                  
4 4 0.30386886 2 0 3 10 3 540 579 593 600                  
3 9 0.31096464 2 1 0 0 3 553 554 559 568 573 586 588 593 628             
3 9 0.31096464 2 5 0 2 0 364 386 391 478 552 590 670 672 858             
3 9 0.31096464 2 5 0 0 3 540 544 552 555 563 577 578 590 619             
3 9 0.31096464 2 5 0 0 5 498 503 510 518 520 526 528 530 534             
3 9 0.31096464 2 5 0 0 7 633 640 649 668 670 672 709 761 771             
3 9 0.31096464 2 9 0 0 3 539 558 576 592 598 612 614 615 620             
3 9 0.31096464 2 0 1 3 0 89 169 356 404 539 634 772 785 884             
3 9 0.31096464 2 0 1 7 0 2 131 177 242 410 510 722 778 900             
3 9 0.31096464 2 0 6 0 3 554 555 559 568 570 590 610 616 629             
3 9 0.31096464 2 0 7 0 7 656 663 666 673 683 700 709 771 780             
3 9 0.31096464 2 0 0 9 10 794 796 798 809 813 818 869 881 890             
2 39 0.50109449 2 8 0 0 0 2 8 11 12 26 52 70 99 100 114 132 138 193 226 242 257 273 276 315 436 451 
2 39 0.50109449 2 0 0 3 0 6 24 60 61 80 89 90 99 137 138 169 191 218 235 285 309 356 358 365 404 407 
2 39 0.50109449 2 0 0 6 0 7 38 43 50 70 76 105 132 143 161 195 202 257 271 281 287 308 378 387 422 456 
2 38 0.50760048 2 2 0 0 0 10 50 60 62 67 104 105 119 143 154 157 160 171 253 292 309 328 332 421 426 455 
2 38 0.50760048 2 0 0 5 0 22 27 69 88 102 107 142 160 187 193 198 200 211 213 252 254 273 332 347 375 421 
2 37 0.51474779 2 0 10 0 0 102 105 107 191 218 238 245 256 265 316 332 346 365 387 423 424 426 433 447 458 471 
2 37 0.51474779 2 0 0 7 0 2 131 133 177 225 242 253 264 265 311 336 392 400 410 447 454 455 483 492 510 541 
2 12 0.61303025 0 1 6 0 0 347 453 459 506 525 554 559 568 728 759 795 958          
2 12 0.61303025 0 1 7 0 0 80 339 344 369 446 464 483 588 628 656 673 814          
2 12 0.61303025 0 1 0 7 0 163 177 311 410 447 483 573 588 606 656 757 822          
2 12 0.61303025 0 1 0 8 0 266 291 446 506 559 679 687 691 711 729 880 930          
2 12 0.61303025 0 1 0 10 0 32 283 327 372 403 425 554 586 593 653 781 814          
2 12 0.61303025 0 5 6 0 0 61 297 303 383 465 518 555 590 670 796 858 867          
2 12 0.61303025 0 5 0 0 3 540 544 551 552 555 563 577 578 585 590 617 619          
2 12 0.61303025 0 0 1 1 0 13 150 296 302 319 328 331 528 592 598 649 894          
2 12 0.61303025 0 0 1 2 0 56 114 334 391 522 654 672 681 715 883 911 936          
2 12 0.61303025 0 0 6 2 0 226 398 451 525 590 670 688 710 728 742 795 858          
2 12 0.61303025 0 0 6 9 0 67 214 297 303 453 518 568 650 794 796 925 958          
2 33 0.62731421 2 6 0 0 0 27 71 98 131 197 221 225 235 238 263 268 271 281 314 333 472 521 522 537 637 657 
2 33 0.62731421 2 0 3 0 0 24 138 171 194 225 271 278 287 291 336 366 378 392 412 421 473 512 526 534 536 540 
2 32 0.69435517 2 0 4 0 0 11 26 70 78 90 99 137 142 224 229 273 309 337 359 370 375 403 425 436 520 552 
3 8 0.73183986 2 1 4 0 0 142 229 370 403 425 586 704 711              
3 8 0.73183986 2 1 5 0 0 372 460 509 636 757 776 824 880              
3 8 0.73183986 2 1 0 0 4 447 453 458 459 460 464 473 483              
3 8 0.73183986 2 4 5 0 0 58 211 223 254 541 595 859 915              
3 8 0.73183986 2 5 7 0 0 364 388 422 577 709 771 793 848              
3 8 0.73183986 2 5 0 9 0 297 366 486 518 534 640 796 848              
3 8 0.73183986 2 9 0 2 0 209 368 688 700 710 727 921 936              
3 8 0.73183986 2 9 0 3 0 169 218 358 493 507 539 576 884              
3 8 0.73183986 2 0 1 0 5 510 514 515 517 522 524 528 530              
3 8 0.73183986 2 0 5 0 10 803 807 811 823 824 859 860 880              
3 8 0.73183986 2 0 6 1 0 333 459 570 610 662 705 879 946              
3 8 0.73183986 2 0 7 0 1 264 268 275 292 308 313 339 344              
3 8 0.73183986 2 0 0 2 7 646 654 670 672 681 688 700 710              
3 8 0.73183986 2 0 0 8 7 633 666 679 687 711 712 761 777              
3 8 0.73183986 2 0 0 10 3 540 554 577 579 584 586 593 600              
2 31 0.77722135 2 7 0 0 0 22 88 96 180 214 224 250 259 316 319 395 423 457 569 575 584 603 654 662 736 752 
2 30 0.86445525 2 0 0 0 4 447 451 453 454 455 456 457 458 459 460 464 465 466 468 469 471 472 473 475 477 478 
3 4 0.90236622 0 1 0 8 7 679 687 691 711                  
3 4 0.90236622 0 5 1 1 0 302 331 528 649                  
3 4 0.90236622 0 5 2 1 0 413 420 491 821                  
3 4 0.90236622 0 5 2 10 0 288 301 307 617                  
3 4 0.90236622 0 5 2 0 1 288 301 307 326                  
3 4 0.90236622 0 5 6 9 0 297 303 518 796                  
3 4 0.90236622 0 9 1 1 0 150 296 592 598                  
3 4 0.90236622 0 9 1 0 3 539 592 598 614                  
3 4 0.90236622 0 9 2 0 6 351 358 368 401                  
3 4 0.90236622 0 9 6 2 0 398 688 710 742                  
3 4 0.90236622 0 9 6 0 7 650 688 710 786                  
3 4 0.90236622 0 9 7 0 7 666 683 700 780                  
3 4 0.90236622 0 9 0 8 6 351 354 359 389                  
3 4 0.90236622 0 0 1 8 3 537 563 614 632                  
3 4 0.90236622 0 0 3 10 3 540 579 593 600                  
2 11 0.9061659 0 1 4 0 0 142 163 229 370 393 403 425 586 704 711 930           
2 11 0.9061659 0 1 0 9 0 46 453 464 509 553 568 673 735 818 869 958           
2 11 0.9061659 0 5 0 8 0 91 326 349 498 520 563 633 713 761 793 857           
2 11 0.9061659 0 5 0 0 1 285 288 297 301 302 303 306 307 325 326 331           
2 11 0.9061659 0 5 0 0 7 633 640 649 668 670 672 709 761 769 771 787           
2 11 0.9061659 0 9 0 1 0 150 296 485 592 598 683 699 714 732 823 946           
2 11 0.9061659 0 9 0 2 0 209 293 368 398 688 700 710 727 742 921 936           
2 11 0.9061659 0 9 0 10 0 148 172 203 204 427 482 514 664 820 828 893           
2 11 0.9061659 0 0 2 1 0 3 71 157 413 420 491 500 523 756 799 821           
2 11 0.9061659 0 0 2 8 0 12 91 103 180 326 351 535 599 729 731 805           
2 11 0.9061659 0 0 2 10 0 104 263 280 288 301 307 314 327 617 806 830           
2 11 0.9061659 0 0 6 0 7 637 645 650 662 670 688 705 710 759 760 786           
2 11 0.9061659 0 0 0 8 3 535 537 550 559 563 571 599 614 615 620 632           
2 29 0.9373832 2 0 8 0 0 10 34 50 136 250 311 340 353 455 481 492 498 502 503 550 583 584 615 620 646 647 
2 28 0.98103458 2 0 0 0 6 346 347 351 353 354 356 358 359 364 365 366 368 369 370 372 375 378 381 382 386 387 
3 7 0.98518164 2 1 2 0 0 125 327 573 729 756 818 822               
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4 4 0.30386886 2 9 0 8 6                   4 4 0.30386886 2 0 1 8 3                   
4 4 0.30386886 2 0 3 10 3                   
3 9 0.31096464 2 1 0 0 3                   
3 9 0.31096464 2 5 0 2 0                   
3 9 0.31096464 2 5 0 0 3                   
3 9 0.31096464 2 5 0 0 5                   
3 9 0.31096464 2 5 0 0 7                   
3 9 0.31096464 2 9 0 0 3                   
3 9 0.31096464 2 0 1 3 0                   
3 9 0.31096464 2 0 1 7 0                   
3 9 0.31096464 2 0 6 0 3                   
3 9 0.31096464 2 0 7 0 7                   
3 9 0.31096464 2 0 0 9 10                   
2 39 0.50109449 2 8 0 0 0                   
2 39 0.50109449 2 0 0 3 0 454 494 504 517 550 600 616 645 690 722 725 726 747 760 799 819 891 939 
2 39 0.50109449 2 0 0 6 0 460 493 494 507 539 576 634 636 637 669 704 772 785 847 852 884 891 962 
2 38 0.50760048 2 2 0 0 0 473 503 544 548 619 629 639 645 685 737 743 766 792 819 824 846 860 948 
2 38 0.50760048 2 0 0 5 0 456 469 471 536 608 610 626 629 639 646 647 715 724 809 813 839 962  
2 37 0.51474779 2 0 10 0 0 458 466 468 524 530 555 575 583 612 624 663 677 746 759 762 807 867  
2 37 0.51474779 2 0 0 7 0 477 493 495 521 544 639 653 668 687 695 791 808 813 882 907 962   
2 12 0.61303025 0 1 6 0 0 573 588 603 608 616 656 665 668 709 722 757 778 822 844 862 900   
2 12 0.61303025 0 1 7 0 0                   
2 12 0.61303025 0 1 0 7 0                   
2 12 0.61303025 0 1 0 8 0                   
2 12 0.61303025 0 1 0 10 0                   
2 12 0.61303025 0 5 6 0 0                   
2 12 0.61303025 0 5 0 0 3                   
2 12 0.61303025 0 0 1 1 0                   
2 12 0.61303025 0 0 1 2 0                   
2 12 0.61303025 0 0 6 2 0                   
2 12 0.61303025 0 0 6 9 0                   
2 33 0.62731421 2 6 0 0 0                   
2 33 0.62731421 2 0 3 0 0 677 693 705 737 794 811 881 901 935 948 954 957       
2 32 0.69435517 2 0 4 0 0 571 579 593 600 624 640 679 717 727 852 869 908       
3 8 0.73183986 2 1 4 0 0 586 677 693 704 711 724 739 747 800 809 935        
3 8 0.73183986 2 1 5 0 0                   
3 8 0.73183986 2 1 0 0 4                   
3 8 0.73183986 2 4 5 0 0                   
3 8 0.73183986 2 5 7 0 0                   
3 8 0.73183986 2 5 0 9 0                   
3 8 0.73183986 2 9 0 2 0                   
3 8 0.73183986 2 9 0 3 0                   
3 8 0.73183986 2 0 1 0 5                   
3 8 0.73183986 2 0 5 0 10                   
3 8 0.73183986 2 0 6 1 0                   
3 8 0.73183986 2 0 7 0 1                   
3 8 0.73183986 2 0 0 2 7                   
3 8 0.73183986 2 0 0 8 7                   
3 8 0.73183986 2 0 0 10 3                   
2 31 0.77722135 2 7 0 0 0                   
2 30 0.86445525 2 0 0 0 4 762 791 803 808 846 852 879 890 900 908         
3 4 0.90236622 0 1 0 8 7 481 482 483 485 486 489 491 492 493          
3 4 0.90236622 0 5 1 1 0                   
3 4 0.90236622 0 5 2 1 0                   
3 4 0.90236622 0 5 2 10 0                   
3 4 0.90236622 0 5 2 0 1                   
3 4 0.90236622 0 5 6 9 0                   
3 4 0.90236622 0 9 1 1 0                   
3 4 0.90236622 0 9 1 0 3                   
3 4 0.90236622 0 9 2 0 6                   
3 4 0.90236622 0 9 6 2 0                   
3 4 0.90236622 0 9 6 0 7                   
3 4 0.90236622 0 9 7 0 7                   
3 4 0.90236622 0 9 0 8 6                   
3 4 0.90236622 0 0 1 8 3                   
3 4 0.90236622 0 0 3 10 3                   
2 11 0.9061659 0 1 4 0 0                   
2 11 0.9061659 0 1 0 9 0                   
2 11 0.9061659 0 5 0 8 0                   
2 11 0.9061659 0 5 0 0 1                   
2 11 0.9061659 0 5 0 0 7                   
2 11 0.9061659 0 9 0 1 0                   
2 11 0.9061659 0 9 0 2 0                   
2 11 0.9061659 0 9 0 10 0                   
2 11 0.9061659 0 0 2 1 0                   
2 11 0.9061659 0 0 2 8 0                   
2 11 0.9061659 0 0 2 10 0                   
2 11 0.9061659 0 0 6 0 7                   
2 11 0.9061659 0 0 0 8 3                   
2 29 0.9373832 2 0 8 0 0                   
2 28 0.98103458 2 0 0 0 6 712 735 746 844 846 862 863 881           
3 7 0.98518164 2 1 2 0 0 388 389 391 392 395 400 401            
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3 7 0.98518164 2 1 0 2 0           3 7 0.98518164 2 1 0 3 0 80 89 356 365 460 636 704    
3 7 0.98518164 2 1 0 4 0 125 229 344 353 370 628 776    
3 7 0.98518164 2 1 0 0 1 266 291 311 327 339 340 344    
3 7 0.98518164 2 1 0 0 6 347 353 356 365 369 370 372    
3 7 0.98518164 2 1 0 0 10 795 814 818 822 824 869 880    
3 7 0.98518164 2 2 10 0 0 105 332 426 471 639 813 962    
3 7 0.98518164 2 4 1 0 0 5 7 179 334 681 772 894    
3 7 0.98518164 2 4 0 4 0 58 136 275 337 381 433 882    
3 7 0.98518164 2 4 0 5 0 69 200 211 254 375 583 624    
3 7 0.98518164 2 4 0 10 0 5 179 223 278 477 800 859    
3 7 0.98518164 2 4 0 0 1 265 275 278 308 334 336 337    
3 7 0.98518164 2 4 0 0 10 798 800 844 859 882 892 894    
3 7 0.98518164 2 5 3 0 0 366 412 526 534 540 640 717    
3 7 0.98518164 2 5 5 0 0 285 416 443 486 578 713 761    
3 7 0.98518164 2 5 0 0 1 285 297 301 302 307 326 331    
3 7 0.98518164 2 5 0 0 8 404 412 413 416 420 422 443    
3 7 0.98518164 2 6 1 0 0 98 131 221 522 537 737 948    
3 7 0.98518164 2 6 2 0 0 27 71 197 235 263 281 314    
3 7 0.98518164 2 6 0 1 0 71 238 333 657 693 705 811    
3 7 0.98518164 2 8 1 0 0 2 100 114 242 517 690 722    
3 7 0.98518164 2 8 2 0 0 12 257 276 315 725 799 891    
3 7 0.98518164 2 8 4 0 0 11 26 70 99 273 436 747    
3 7 0.98518164 2 8 0 4 0 8 11 26 315 504 690 760    
3 7 0.98518164 2 9 6 0 0 148 213 482 650 688 710 946    
3 7 0.98518164 2 9 7 0 0 264 468 666 683 700 732 780    
3 7 0.98518164 2 9 0 9 0 256 531 650 676 692 768 780    
3 7 0.98518164 2 9 0 10 0 148 172 203 482 514 664 828    
3 7 0.98518164 2 0 1 6 0 7 195 619 685 737 743 948    
3 7 0.98518164 2 0 2 2 0 135 197 209 276 368 478 921    
3 7 0.98518164 2 0 2 6 0 38 43 76 202 257 281 766    
3 7 0.98518164 2 0 2 10 0 104 263 301 307 314 327 830    
3 7 0.98518164 2 0 2 0 10 799 818 821 822 830 890 891    
3 7 0.98518164 2 0 3 0 3 536 540 571 579 593 600 624    
3 7 0.98518164 2 0 5 1 0 62 569 578 595 714 811 823    
3 7 0.98518164 2 0 5 8 0 83 417 713 761 777 880 915    
3 7 0.98518164 2 0 5 0 3 541 558 569 578 595 603 612    
3 7 0.98518164 2 0 6 0 4 451 453 454 459 465 472 482    
3 7 0.98518164 2 0 0 1 1 296 302 319 328 331 333 339    
3 7 0.98518164 2 0 0 1 3 569 570 578 592 595 598 610    
3 7 0.98518164 2 0 0 3 7 634 636 637 669 704 772 785    
3 7 0.98518164 2 0 0 9 7 640 650 673 676 692 768 780    
4 3 0.99371495 2 1 1 6 0 195 685 743        
4 3 0.99371495 2 1 4 10 0 403 425 586        
4 3 0.99371495 2 1 5 0 7 636 757 776        
4 3 0.99371495 2 1 6 2 0 525 728 795        
4 3 0.99371495 2 1 6 9 0 453 568 958        
4 3 0.99371495 2 1 6 0 3 554 559 568        
4 3 0.99371495 2 1 7 7 0 483 588 656        
4 3 0.99371495 2 1 10 0 7 653 687 695        
4 3 0.99371495 2 1 0 8 7 679 687 711        
4 3 0.99371495 2 1 0 10 3 554 586 593        
4 3 0.99371495 2 5 1 8 0 563 633 857        
4 3 0.99371495 2 5 1 0 5 510 528 530        
4 3 0.99371495 2 5 1 0 7 633 649 672        
4 3 0.99371495 2 5 2 0 1 301 307 326        
4 3 0.99371495 2 5 3 9 0 366 534 640        
4 3 0.99371495 2 5 6 2 0 590 670 858        
4 3 0.99371495 2 5 6 9 0 297 518 796        
4 3 0.99371495 2 5 6 0 10 796 858 867        
4 3 0.99371495 2 5 0 2 6 364 386 391        
4 3 0.99371495 2 6 2 0 1 263 281 314        
4 3 0.99371495 2 6 0 1 7 657 693 705        
4 3 0.99371495 2 8 1 7 0 2 242 722        
4 3 0.99371495 2 8 2 0 1 257 276 315        
4 3 0.99371495 2 9 1 3 0 169 539 884        
4 3 0.99371495 2 9 1 8 0 354 515 614        
4 3 0.99371495 2 9 1 0 7 692 768 778        
4 3 0.99371495 2 9 2 2 0 209 368 921        
4 3 0.99371495 2 9 5 8 0 83 417 777        
4 3 0.99371495 2 9 6 0 7 650 688 710        
4 3 0.99371495 2 9 8 8 0 34 615 620        
4 3 0.99371495 2 9 0 2 7 688 700 710        
4 3 0.99371495 2 9 0 8 3 614 615 620        
4 3 0.99371495 2 0 1 2 7 654 672 681        
4 3 0.99371495 2 0 1 3 7 634 772 785        
4 3 0.99371495 2 0 4 8 2 724 739 747        
4 3 0.99371495 2 0 5 1 3 569 578 595        
4 3 0.99371495 2 0 6 2 7 670 688 710        
4 3 0.99371495 2 0 8 8 3 550 615 620        
2 10 0.99651754 0 1 0 0 3 553 554 559 568 573 586 588 593 606 628 
2 10 0.99651754 0 5 0 2 0 364 386 391 478 552 590 670 672 787 858 
2 10 0.99651754 0 5 0 9 0 297 303 366 486 518 534 640 738 796 848 
2 10 0.99651754 0 5 0 0 6 349 350 364 366 383 385 386 388 391 400 
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2 10 0.99651754 0 9 6 0 0 148 213 398 482 650 688 710 742 786 946            2 10 0.99651754 0 0 1 3 0 89 169 356 404 501 539 634 772 785 884            
2 10 0.99651754 0 0 1 7 0 2 131 177 242 397 410 510 722 778 900            
2 10 0.99651754 0 0 1 0 3 537 539 553 563 575 592 598 614 619 632            
2 10 0.99651754 0 0 0 1 7 649 657 662 683 693 695 699 705 756 771            
2 10 0.99651754 0 0 0 8 7 633 666 679 687 691 711 712 761 777 786            
2 10 0.99651754 0 0 0 10 3 540 554 556 577 579 584 586 593 600 617            
2 27 0.99700221 2 0 0 0 5 494 495 498 500 502 503 504 506 507 509 510 512 514 515 517 518 520 521 522 523 524 
                       525 526 528 530 531 534 
5 2 0.99930654 2 1 4 10 8 403 425                    
5 2 0.99930654 2 5 1 1 1 302 331                    
5 2 0.99930654 2 5 2 1 8 413 420                    
5 2 0.99930654 2 5 2 10 1 301 307                    
5 2 0.99930654 2 5 5 4 8 416 443                    
5 2 0.99930654 2 6 2 10 1 263 314                    
5 2 0.99930654 2 9 1 1 3 592 598                    
5 2 0.99930654 2 9 1 9 7 692 768                    
5 2 0.99930654 2 9 6 2 7 688 710                    
5 2 0.99930654 2 9 8 8 3 615 620                    
5 2 0.99930654 2 10 2 1 5 500 523                    
3 6 0.99999524 2 1 3 0 0 194 291 473 593 679 869                
3 6 0.99999524 2 1 10 0 0 365 447 458 653 687 695                
3 6 0.99999524 2 2 0 6 0 50 105 143 456 629 639                
3 6 0.99999524 2 4 2 0 0 3 38 69 76 103 200                
3 6 0.99999524 2 4 4 0 0 78 90 137 337 375 800                
3 6 0.99999524 2 4 7 0 0 6 219 275 308 548 798                
3 6 0.99999524 2 4 10 0 0 245 265 346 433 477 882                
3 6 0.99999524 2 4 0 6 0 7 38 76 161 308 548                
3 6 0.99999524 2 4 0 0 3 541 548 571 583 595 624                
3 6 0.99999524 2 5 0 4 0 388 416 443 465 475 526                
3 6 0.99999524 2 5 0 0 6 364 366 386 388 391 400                
3 6 0.99999524 2 5 0 0 10 793 796 821 857 858 867                
3 6 0.99999524 2 6 6 0 0 333 472 637 705 794 954                
3 6 0.99999524 2 6 0 0 1 263 268 271 281 314 333                
3 6 0.99999524 2 7 1 0 0 88 319 395 575 654 900                
3 6 0.99999524 2 7 6 0 0 22 214 259 662 736 879                
3 6 0.99999524 2 7 0 10 0 259 316 423 457 584 803                
3 6 0.99999524 2 7 0 0 10 791 803 808 852 879 890                
3 6 0.99999524 2 8 6 0 0 226 451 454 616 645 760                
3 6 0.99999524 2 9 8 0 0 34 492 615 620 746 862                
3 6 0.99999524 2 9 0 5 0 102 198 213 468 612 746                
3 6 0.99999524 2 9 0 7 0 264 392 492 665 778 862                
3 6 0.99999524 2 0 1 4 0 98 382 435 475 690 898                
3 6 0.99999524 2 0 1 5 0 88 187 252 524 530 575                
3 6 0.99999524 2 0 1 9 0 23 46 100 553 692 768                
3 6 0.99999524 2 0 1 10 0 5 32 172 179 514 708                
3 6 0.99999524 2 0 1 0 1 296 302 319 328 331 334                
3 6 0.99999524 2 0 2 4 0 125 274 315 401 489 626                
3 6 0.99999524 2 0 2 5 0 27 69 160 198 200 762                
3 6 0.99999524 2 0 3 10 0 278 412 540 579 593 600                
3 6 0.99999524 2 0 4 8 0 359 520 711 724 739 747                
3 6 0.99999524 2 0 5 10 0 203 223 372 664 803 859                
3 6 0.99999524 2 0 5 0 7 636 664 757 761 776 777                
3 6 0.99999524 2 0 6 5 0 22 213 347 555 759 867                
3 6 0.99999524 2 0 6 0 10 794 795 796 858 867 879                
3 6 0.99999524 2 0 7 2 0 96 219 313 364 369 700                
3 6 0.99999524 2 0 7 4 0 8 275 344 388 504 628                
3 6 0.99999524 2 0 7 6 0 308 422 456 548 792 819                
3 6 0.99999524 2 0 7 7 0 264 483 588 608 656 709                
3 6 0.99999524 2 0 7 9 0 52 464 673 780 798 848                
3 6 0.99999524 2 0 7 0 10 792 793 798 814 819 839                
3 6 0.99999524 2 0 8 8 0 34 498 550 615 620 712                
3 6 0.99999524 2 0 0 1 10 799 811 821 823 879 894                
3 6 0.99999524 2 0 0 4 6 353 370 381 382 388 401                
3 6 0.99999524 2 0 0 7 3 541 573 588 603 608 616                
3 6 0.99999524 2 0 0 7 7 656 665 668 709 757 778                
3 6 0.99999524 2 0 0 8 2 713 724 729 731 739 747                
3 6 0.99999524 2 0 0 8 10 793 808 839 857 880 892                
3 6 0.99999524 2 0 0 10 10 800 803 814 828 830 859                
2 9 0.99999821 0 1 5 0 0 372 460 509 636 753 757 776 824 880             
2 9 0.99999821 0 4 5 0 0 58 211 223 254 429 541 595 859 915             
2 9 0.99999821 0 4 0 0 1 265 275 278 286 308 334 336 337 342             
2 9 0.99999821 0 5 3 0 0 237 366 385 412 526 534 540 640 717             
2 9 0.99999821 0 5 5 0 0 285 306 416 439 443 486 578 713 761             
2 9 0.99999821 0 5 7 0 0 77 364 388 422 577 709 771 793 848             
2 9 0.99999821 0 5 0 0 5 498 503 510 518 520 526 528 530 534             
2 9 0.99999821 0 5 0 0 8 404 409 412 413 416 420 422 439 443             
2 9 0.99999821 0 6 0 1 0 71 238 333 657 693 705 811 841 885             
2 9 0.99999821 0 8 1 0 0 2 35 100 114 242 517 690 722 883             
2 9 0.99999821 0 9 7 0 0 204 264 468 666 683 700 732 780 922             
2 9 0.99999821 0 9 8 0 0 34 293 324 492 615 620 746 862 893             
2 9 0.99999821 0 9 0 3 0 169 218 358 376 493 507 539 576 884             
2 9 0.99999821 0 9 0 9 0 256 402 531 650 676 692 768 780 922             
2 9 0.99999821 0 9 0 0 3 539 558 576 592 598 612 614 615 620             
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2 9 0.99999821 0 0 1 6 0 7 195 406 619 685 737 743 923 948           2 9 0.99999821 0 0 1 0 5 501 510 514 515 517 522 524 528 530           
2 9 0.99999821 0 0 2 0 10 799 805 806 818 821 822 830 890 891           
2 9 0.99999821 0 0 6 1 0 333 459 570 610 662 705 879 946 947           
2 9 0.99999821 0 0 6 0 3 554 555 559 568 570 590 610 616 629           
2 9 0.99999821 0 0 7 0 1 264 268 275 292 308 313 339 342 344           
2 9 0.99999821 0 0 7 0 7 656 663 666 673 683 700 709 771 780           
2 9 0.99999821 0 0 0 2 7 646 654 670 672 681 688 700 710 787           
2 9 0.99999821 0 0 0 9 10 794 796 798 809 813 818 869 881 890           
2 9 0.99999821 0 0 0 10 10 800 803 806 814 820 828 830 859 893           
4 2 0.99999958 0 1 4 10 8 403 425                  
4 2 0.99999958 0 3 2 10 10 806 830                  
4 2 0.99999958 0 5 1 1 1 302 331                  
4 2 0.99999958 0 5 2 1 8 413 420                  
4 2 0.99999958 0 5 6 9 1 297 303                  
4 2 0.99999958 0 6 2 10 1 263 314                  
4 2 0.99999958 0 9 1 1 3 592 598                  
4 2 0.99999958 0 9 1 9 7 692 768                  
4 2 0.99999958 0 9 6 2 7 688 710                  
4 2 0.99999958 0 9 8 8 3 615 620                  
4 2 0.99999958 0 9 9 10 10 820 828                  
4 2 0.99999958 0 10 2 1 5 500 523                  
3 3 1 1 1 1 0 0 501 691 950                 
3 3 1 1 1 4 0 0 163 393 930                 
3 2 1 1 1 0 7 0 163 606                  
3 2 1 1 1 0 8 0 691 930                  
3 2 1 1 1 0 10 0 283 781                  
3 2 1 1 1 0 0 7 691 781                  
3 2 1 1 1 0 0 9 930 950                  
2 10 1 1 1 0 0 0 163 283 393 501 606 691 753 781 930 950          
3 2 1 1 2 2 0 0 280 961                  
4 2 1 1 2 0 2 9 911 961                  
3 2 1 1 2 0 2 0 911 961                  
3 2 1 1 2 0 0 9 911 961                  
2 5 1 1 2 0 0 0 280 371 865 911 961               
3 2 1 1 3 2 0 0 117 806                  
3 2 1 1 3 5 0 0 130 419                  
3 2 1 1 3 0 10 0 556 806                  
3 2 1 1 3 0 0 8 406 419                  
2 6 1 1 3 0 0 0 117 130 406 419 556 806              
3 2 1 1 4 2 0 0 51 587                  
3 2 1 1 4 0 3 0 51 429                  
3 2 1 1 4 0 0 1 286 342                  
2 6 1 1 4 0 0 0 51 286 342 429 587 784              
4 2 1 1 5 2 10 0 288 617                  
3 2 1 1 5 2 0 0 288 617                  
3 2 1 1 5 3 0 0 237 385                  
3 4 1 1 5 4 0 0 325 409 551 787                
3 2 1 1 5 5 0 0 306 439                  
3 2 1 1 5 6 0 0 303 383                  
4 2 1 1 5 9 1 0 15 350                  
3 2 1 1 5 9 0 0 15 350                  
3 3 1 1 5 10 0 0 349 585 738                 
3 3 1 1 5 0 1 0 15 77 350                 
3 3 1 1 5 0 3 0 325 383 585                 
3 3 1 1 5 0 6 0 385 551 769                 
3 2 1 1 5 0 9 0 303 738                  
3 3 1 1 5 0 10 0 288 409 617                 
3 4 1 1 5 0 0 1 288 303 306 325                
3 3 1 1 5 0 0 3 551 585 617                 
3 4 1 1 5 0 0 6 349 350 383 385                
3 2 1 1 5 0 0 7 769 787                  
3 2 1 1 5 0 0 8 409 439                  
2 19 1 1 5 0 0 0 15 77 237 288 303 306 325 349 350 383 385 409 439 551 585 617 738 769 787 
3 2 1 1 6 7 0 0 231 841                  
3 2 1 1 6 10 0 0 261 885                  
4 2 1 1 6 0 1 10 841 885                  
3 2 1 1 6 0 1 0 841 885                  
3 3 1 1 6 0 0 10 841 875 885                 
2 6 1 1 6 0 0 0 231 248 261 841 875 885              
3 2 1 1 7 4 0 0 118 906                  
2 2 1 1 7 0 0 0 118 906                  
3 2 1 1 8 1 0 0 35 883                  
3 2 1 1 8 0 5 0 35 887                  
4 2 1 1 8 0 8 10 805 837                  
3 2 1 1 8 0 8 0 805 837                  
3 2 1 1 8 0 0 2 749 750                  
3 4 1 1 8 0 0 10 805 837 883 887                
2 9 1 1 8 0 0 0 35 147 269 749 750 805 837 883 887           
3 4 1 1 9 1 0 0 397 427 877 923                
3 2 1 1 9 5 0 0 330 376                  
4 2 1 1 9 6 2 0 398 742                  
3 3 1 1 9 6 0 0 398 742 786                 
3 2 1 1 9 7 0 0 204 922                  
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4 2 1 1 9 8 0 1 293 324                3 3 1 1 9 8 0 0 293 324 893               
3 3 1 1 9 0 2 0 293 398 742               
3 2 1 1 9 0 5 0 324 877                
3 2 1 1 9 0 7 0 201 397                
3 2 1 1 9 0 9 0 402 922                
4 2 1 1 9 0 10 10 820 893                
3 4 1 1 9 0 10 0 204 427 820 893              
3 3 1 1 9 0 0 1 293 324 330               
3 4 1 1 9 0 0 6 376 397 398 402              
3 2 1 1 9 0 0 9 922 923                
3 3 1 1 9 0 0 10 820 877 893               
2 17 1 1 9 0 0 0 201 204 293 324 330 376 397 398 402 427 742 786 820 877 893 922 923 
3 2 1 1 10 3 0 0 140 396                
4 2 1 1 10 7 1 0 428 631                
3 2 1 1 10 7 0 0 428 631                
3 3 1 1 10 0 1 0 428 631 947               
3 2 1 1 10 0 3 0 396 411                
3 3 1 1 10 0 0 8 411 428 431               
2 8 1 1 10 0 0 0 140 165 396 411 428 431 631 947          
3 2 1 1 0 1 2 0 883 911                
3 2 1 1 0 1 5 0 35 877                
3 2 1 1 0 1 6 0 406 923                
3 2 1 1 0 1 0 8 406 427                
3 3 1 1 0 1 0 9 911 923 950               
3 2 1 1 0 1 0 10 877 883                
2 11 1 1 0 1 0 0 35 397 406 427 501 691 877 883 911 923 950       
4 2 1 1 0 2 10 1 280 288                
3 4 1 1 0 2 10 0 280 288 617 806              
3 2 1 1 0 2 0 1 280 288                
3 2 1 1 0 2 0 3 587 617                
3 2 1 1 0 2 0 10 805 806                
2 10 1 1 0 2 0 0 51 117 201 280 288 587 617 805 806 961        
3 2 1 1 0 3 3 0 147 396                
3 2 1 1 0 3 0 6 385 396                
2 6 1 1 0 3 0 0 140 147 237 283 385 396            
3 3 1 1 0 4 1 0 393 750 906               
3 2 1 1 0 4 6 0 551 784                
3 2 1 1 0 4 7 0 118 163                
3 2 1 1 0 4 0 6 393 402                
3 2 1 1 0 4 0 7 784 787                
3 2 1 1 0 4 0 9 906 930                
2 12 1 1 0 4 0 0 118 163 325 393 402 409 551 750 784 787 906 930      
4 2 1 1 0 5 3 8 419 429                
3 3 1 1 0 5 3 0 376 419 429               
3 2 1 1 0 5 4 0 330 439                
3 2 1 1 0 5 5 0 306 753                
3 3 1 1 0 5 0 1 269 306 330               
3 3 1 1 0 5 0 8 419 429 439               
2 10 1 1 0 5 0 0 130 248 269 306 330 376 419 429 439 753        
3 2 1 1 0 6 2 0 398 742                
3 2 1 1 0 6 3 0 383 875                
3 2 1 1 0 6 0 6 383 398                
2 7 1 1 0 6 0 0 303 383 398 742 786 875 947           
3 4 1 1 0 7 1 0 77 428 631 841              
3 2 1 1 0 7 10 0 204 231                
2 10 1 1 0 7 0 0 77 204 231 342 371 428 631 749 841 922        
3 2 1 1 0 8 3 0 411 865                
3 2 1 1 0 8 0 1 293 324                
3 3 1 1 0 8 0 10 837 865 893               
2 7 1 1 0 8 0 0 293 324 411 769 837 865 893           
3 2 1 1 0 9 1 0 15 350                
3 3 1 1 0 9 10 0 286 781 820               
2 6 1 1 0 9 0 0 15 286 350 431 781 820            
3 3 1 1 0 10 9 0 165 261 738               
3 3 1 1 0 10 0 3 556 585 606               
3 2 1 1 0 10 0 10 885 887                
2 9 1 1 0 10 0 0 165 261 349 556 585 606 738 885 887         
3 2 1 1 0 0 1 6 350 393                
3 2 1 1 0 0 1 9 906 947                
3 2 1 1 0 0 1 10 841 885                
2 12 1 1 0 0 1 0 15 77 130 350 393 428 631 750 841 885 906 947      
3 2 1 1 0 0 2 9 911 961                
2 7 1 1 0 0 2 0 293 398 742 787 883 911 961           
3 3 1 1 0 0 3 6 376 383 396               
3 3 1 1 0 0 3 8 411 419 429               
3 2 1 1 0 0 3 10 865 875                
2 13 1 1 0 0 3 0 51 147 325 376 383 396 411 419 429 501 585 865 875     
2 4 1 1 0 0 4 0 140 330 439 950              
3 3 1 1 0 0 5 1 306 324 342               
3 2 1 1 0 0 5 10 877 887                
2 9 1 1 0 0 5 0 35 117 306 324 342 431 753 877 887         
3 2 1 1 0 0 6 7 769 784                
2 7 1 1 0 0 6 0 385 406 551 749 769 784 923           
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2 6 1 1 0 0 7 0 118 163 201 237 397 606          3 2 1 1 0 0 8 6 349 371              
3 2 1 1 0 0 8 7 691 786              
3 2 1 1 0 0 8 10 805 837              
2 8 1 1 0 0 8 0 248 349 371 691 786 805 837 930        
3 2 1 1 0 0 9 1 261 303              
2 7 1 1 0 0 9 0 165 261 303 402 587 738 922         
3 5 1 1 0 0 10 1 269 280 283 286 288           
3 2 1 1 0 0 10 3 556 617              
3 2 1 1 0 0 10 8 409 427              
3 3 1 1 0 0 10 10 806 820 893             
2 15 1 1 0 0 10 0 204 231 269 280 283 286 288 409 427 556 617 781 806 820 893 
2 13 1 1 0 0 0 1 261 269 280 283 286 288 293 303 306 324 325 330 342   
2 5 1 1 0 0 0 2 738 742 749 750 753           
2 7 1 1 0 0 0 3 551 556 585 587 606 617 631         
2 11 1 1 0 0 0 6 349 350 371 376 383 385 393 396 397 398 402     
2 6 1 1 0 0 0 7 691 769 781 784 786 787          
2 9 1 1 0 0 0 8 406 409 411 419 427 428 429 431 439       
2 8 1 1 0 0 0 9 906 911 922 923 930 947 950 961        
2 12 1 1 0 0 0 10 805 806 820 837 841 865 875 877 883 885 887 893    
4 2 1 2 1 1 3 0 89 356              
4 2 1 2 1 1 7 0 177 410              
4 2 1 2 1 1 9 0 46 553              
4 2 1 2 1 2 7 0 573 822              
4 2 1 2 1 2 0 10 818 822              
4 2 1 2 1 3 8 0 291 679              
4 2 1 2 1 4 4 0 229 370              
4 2 1 2 1 4 0 7 704 711              
4 2 1 2 1 4 0 8 403 425              
4 2 1 2 1 5 3 0 460 636              
4 2 1 2 1 5 0 10 824 880              
4 2 1 2 1 6 5 0 347 759              
4 2 1 2 1 6 8 0 506 559              
4 2 1 2 1 6 0 4 453 459              
4 2 1 2 1 6 0 5 506 525              
4 2 1 2 1 7 4 0 344 628              
4 2 1 2 1 7 9 0 464 673              
4 2 1 2 1 7 0 1 339 344              
4 2 1 2 1 7 0 3 588 628              
4 2 1 2 1 7 0 4 464 483              
4 2 1 2 1 7 0 7 656 673              
4 2 1 2 1 8 0 1 311 340              
3 4 1 2 1 8 0 0 311 340 353 735            
4 2 1 2 1 10 0 4 447 458              
4 2 1 2 1 0 1 7 695 756              
3 5 1 2 1 0 1 0 13 339 459 695 756           
4 2 1 2 1 0 3 6 356 365              
4 2 1 2 1 0 3 7 636 704              
4 2 1 2 1 0 4 6 353 370              
3 5 1 2 1 0 5 0 142 187 347 458 759           
3 5 1 2 1 0 6 0 195 473 685 743 824           
4 2 1 2 1 0 7 3 573 588              
4 2 1 2 1 0 7 4 447 483              
4 2 1 2 1 0 7 7 656 757              
4 2 1 2 1 0 8 1 266 291              
4 2 1 2 1 0 9 3 553 568              
4 2 1 2 1 0 9 4 453 464              
4 2 1 2 1 0 9 10 818 869              
4 2 1 2 1 0 10 8 403 425              
3 4 1 2 1 0 0 2 728 729 735 743            
3 3 1 2 1 0 0 5 506 509 525             
3 4 1 2 1 0 0 8 403 410 425 446            
3 3 1 2 2 1 0 0 328 469 715             
3 5 1 2 2 2 0 0 104 157 160 253 626           
3 3 1 2 2 3 0 0 171 421 536             
3 3 1 2 2 4 0 0 309 724 809             
3 2 1 2 2 5 0 0 62 119              
4 2 1 2 2 6 6 0 143 629              
4 2 1 2 2 6 0 3 610 629              
3 5 1 2 2 6 0 0 60 67 143 610 629           
3 4 1 2 2 7 0 0 292 456 608 839            
4 2 1 2 2 8 0 7 646 647              
3 5 1 2 2 8 0 0 10 50 455 646 647           
4 2 1 2 2 10 6 0 105 639              
3 5 1 2 2 0 1 0 62 157 171 328 610           
3 3 1 2 2 0 2 0 154 646 715             
3 3 1 2 2 0 3 0 60 309 962             
4 2 1 2 2 0 4 3 536 626              
3 3 1 2 2 0 4 0 426 536 626             
3 3 1 2 2 0 5 0 160 332 421             
3 3 1 2 2 0 7 0 253 455 608             
3 3 1 2 2 0 8 0 469 724 839             
4 2 1 2 2 0 9 10 809 813              
3 5 1 2 2 0 9 0 10 67 119 809 813           
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3 4 1 2 2 0 10 0 104 292 471 647            3 4 1 2 2 0 0 1 292 309 328 332            
3 2 1 2 2 0 0 2 715 724              
3 5 1 2 2 0 0 3 536 608 610 626 629           
3 4 1 2 2 0 0 4 455 456 469 471            
3 3 1 2 2 0 0 7 639 646 647             
3 2 1 2 2 0 0 8 421 426              
3 3 1 2 2 0 0 10 809 813 839             
4 2 1 2 3 1 0 7 634 708              
3 4 1 2 3 1 0 0 23 524 634 708            
3 4 1 2 3 2 0 0 202 489 535 830            
3 2 1 2 3 0 3 0 24 634              
3 3 1 2 3 0 8 0 535 712 739             
3 2 1 2 3 0 9 0 23 925              
3 3 1 2 3 0 10 0 317 708 830             
3 2 1 2 3 0 0 1 313 317              
3 2 1 2 3 0 0 5 495 524              
3 3 1 2 3 0 0 7 634 708 712             
2 15 1 2 3 0 0 0 23 24 202 313 317 489 495 524 535 634 708 712 739 830 925 
4 2 1 2 4 1 2 0 334 681              
4 2 1 2 4 1 10 0 5 179              
4 2 1 2 4 1 0 7 681 772              
4 2 1 2 4 2 5 0 69 200              
4 2 1 2 4 2 6 0 38 76              
4 2 1 2 4 3 0 1 278 336              
4 2 1 2 4 3 0 3 571 624              
3 4 1 2 4 3 0 0 278 336 571 624            
4 2 1 2 4 4 3 0 90 137              
4 2 1 2 4 5 5 0 211 254              
4 2 1 2 4 5 10 0 223 859              
4 2 1 2 4 5 0 3 541 595              
3 2 1 2 4 6 0 0 161 407              
4 2 1 2 4 7 6 0 308 548              
4 2 1 2 4 7 0 1 275 308              
3 4 1 2 4 8 0 0 136 502 583 844            
3 3 1 2 4 9 0 0 381 723 892             
4 2 1 2 4 10 4 0 433 882              
3 4 1 2 4 0 1 0 3 346 595 894            
3 3 1 2 4 0 2 0 219 334 681             
3 5 1 2 4 0 3 0 6 90 137 407 772           
4 2 1 2 4 0 4 1 275 337              
4 2 1 2 4 0 5 3 583 624              
4 2 1 2 4 0 7 1 265 336              
3 4 1 2 4 0 7 0 265 336 541 844            
3 4 1 2 4 0 8 0 103 571 892 915            
3 5 1 2 4 0 9 0 78 245 502 723 798           
4 2 1 2 4 0 10 10 800 859              
3 3 1 2 4 0 0 6 346 375 381             
3 2 1 2 4 0 0 7 681 772              
3 2 1 2 4 0 0 8 407 433              
4 2 1 2 5 1 2 0 391 672              
4 2 1 2 5 1 5 0 252 530              
4 2 1 2 5 1 0 1 302 331              
4 2 1 2 5 1 0 3 563 619              
4 2 1 2 5 2 8 0 91 326              
4 2 1 2 5 2 10 0 301 307              
4 2 1 2 5 2 0 4 478 491              
4 2 1 2 5 2 0 8 413 420              
4 2 1 2 5 3 10 0 412 540              
4 2 1 2 5 3 0 5 526 534              
3 2 1 2 5 4 0 0 520 552              
4 2 1 2 5 5 4 0 416 443              
4 2 1 2 5 5 8 0 713 761              
4 2 1 2 5 5 0 8 416 443              
4 2 1 2 5 6 5 0 555 867              
4 2 1 2 5 6 0 3 555 590              
4 2 1 2 5 7 0 6 364 388              
4 2 1 2 5 7 0 7 709 771              
4 2 1 2 5 8 0 5 498 503              
3 2 1 2 5 8 0 0 498 503              
4 2 1 2 5 9 0 6 386 400              
3 2 1 2 5 9 0 0 386 400              
3 4 1 2 5 10 0 0 107 191 544 668            
4 2 1 2 5 0 1 1 302 331              
4 2 1 2 5 0 1 7 649 771              
4 2 1 2 5 0 1 8 413 420              
4 2 1 2 5 0 2 3 552 590              
4 2 1 2 5 0 2 7 670 672              
3 5 1 2 5 0 3 0 61 191 285 404 847           
4 2 1 2 5 0 4 4 465 475              
4 2 1 2 5 0 4 8 416 443              
3 5 1 2 5 0 5 0 107 252 530 555 867           
4 2 1 2 5 0 6 3 544 619              
3 5 1 2 5 0 6 0 43 422 503 544 619           
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4 2 1 2 5 0 7 7 668 709    3 5 1 2 5 0 7 0 133 400 510 668 709 
4 2 1 2 5 0 8 5 498 520    
4 2 1 2 5 0 8 7 633 761    
4 2 1 2 5 0 8 10 793 857    
4 2 1 2 5 0 9 5 518 534    
4 2 1 2 5 0 10 1 301 307    
4 2 1 2 5 0 10 3 540 577    
3 5 1 2 5 0 10 0 301 307 412 540 577 
3 2 1 2 5 0 0 2 713 717    
3 5 1 2 5 0 0 4 465 475 478 486 491 
3 2 1 2 5 0 0 9 847 848    
4 2 1 2 6 1 6 0 737 948    
4 2 1 2 6 1 8 0 221 537    
4 2 1 2 6 2 10 0 263 314    
3 2 1 2 6 3 0 0 225 271    
4 2 1 2 6 4 0 7 677 693    
3 3 1 2 6 4 0 0 677 693 935   
3 2 1 2 6 5 0 0 811 957    
4 2 1 2 6 6 1 0 333 705    
4 2 1 2 6 6 0 7 637 705    
3 2 1 2 6 9 0 0 657 901    
3 2 1 2 6 10 0 0 238 521    
4 2 1 2 6 0 2 5 521 522    
3 4 1 2 6 0 2 0 197 521 522 957  
3 2 1 2 6 0 3 0 235 637    
4 2 1 2 6 0 4 9 901 954    
3 3 1 2 6 0 4 0 98 901 954   
3 2 1 2 6 0 5 0 27 677    
4 2 1 2 6 0 6 1 271 281    
3 4 1 2 6 0 6 0 271 281 737 948  
3 2 1 2 6 0 7 0 131 225    
3 4 1 2 6 0 8 0 221 268 472 537  
4 2 1 2 6 0 9 10 794 881    
3 3 1 2 6 0 9 0 794 881 935   
4 2 1 2 6 0 10 1 263 314    
3 2 1 2 6 0 10 0 263 314    
3 2 1 2 6 0 0 5 521 522    
3 5 1 2 6 0 0 7 637 657 677 693 705 
3 5 1 2 6 0 0 9 901 935 948 954 957 
3 3 1 2 6 0 0 10 794 811 881   
4 2 1 2 7 1 5 0 88 575    
4 2 1 2 7 2 9 0 752 890    
3 4 1 2 7 2 0 0 180 752 762 890  
3 2 1 2 7 3 0 0 852 908    
4 2 1 2 7 5 0 3 569 603    
3 3 1 2 7 5 0 0 569 603 803   
4 2 1 2 7 6 1 0 662 879    
3 2 1 2 7 7 0 0 96 457    
3 3 1 2 7 8 0 0 250 584 846   
4 2 1 2 7 10 10 0 316 423    
4 2 1 2 7 10 0 10 791 808    
3 4 1 2 7 10 0 0 316 423 791 808  
3 4 1 2 7 0 1 0 319 569 662 879  
3 4 1 2 7 0 2 0 96 224 654 791  
3 4 1 2 7 0 5 0 22 88 575 762  
3 2 1 2 7 0 7 0 603 900    
3 4 1 2 7 0 8 0 180 395 808 908  
3 4 1 2 7 0 9 0 214 250 752 890  
4 2 1 2 7 0 10 1 259 316    
3 3 1 2 7 0 0 1 259 316 319   
3 2 1 2 7 0 0 2 736 752    
3 4 1 2 7 0 0 3 569 575 584 603  
3 3 1 2 7 0 0 7 654 662 762   
3 3 1 2 7 0 0 9 846 900 908   
4 2 1 2 8 2 0 10 799 891    
3 2 1 2 8 3 0 0 138 600    
4 2 1 2 8 4 4 0 11 26    
4 2 1 2 8 6 2 0 226 451    
4 2 1 2 8 6 7 0 454 616    
4 2 1 2 8 6 0 4 451 454    
4 2 1 2 8 6 0 7 645 760    
4 2 1 2 8 7 4 0 8 504    
3 5 1 2 8 7 0 0 8 52 504 726 819 
3 3 1 2 8 9 0 0 193 494 939   
3 3 1 2 8 0 1 0 436 799 939   
3 4 1 2 8 0 2 0 114 226 276 451  
3 4 1 2 8 0 3 0 99 138 494 891  
4 2 1 2 8 0 4 7 690 760    
3 2 1 2 8 0 5 0 193 273    
3 5 1 2 8 0 6 0 70 132 257 645 819 
3 5 1 2 8 0 7 0 2 242 454 616 722 
3 4 1 2 8 0 8 0 12 517 550 747  
3 3 1 2 8 0 9 0 52 100 725   
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3 2 1 2 8 0 10 0 600 726                   3 4 1 2 8 0 0 1 257 273 276 315                 
3 4 1 2 8 0 0 2 722 725 726 747                 
3 3 1 2 8 0 0 3 550 600 616                  
3 2 1 2 8 0 0 4 451 454                   
3 3 1 2 8 0 0 5 494 504 517                  
3 3 1 2 8 0 0 7 645 690 760                  
3 3 1 2 8 0 0 10 799 819 891                  
4 2 1 2 9 1 4 0 382 435                   
4 2 1 2 9 1 9 0 692 768                   
4 2 1 2 9 1 10 0 172 514                   
4 2 1 2 9 1 0 5 514 515                   
4 2 1 2 9 1 0 6 354 382                   
4 2 1 2 9 2 3 0 358 576                   
4 2 1 2 9 2 4 0 274 401                   
4 2 1 2 9 2 8 0 351 731                   
4 2 1 2 9 2 0 7 665 766                   
4 2 1 2 9 3 0 6 378 392                   
3 3 1 2 9 3 0 0 378 392 727                  
4 2 1 2 9 5 1 0 714 823                   
4 2 1 2 9 5 10 0 203 664                   
4 2 1 2 9 5 0 3 558 612                   
4 2 1 2 9 5 0 5 507 531                   
4 2 1 2 9 5 0 7 664 777                   
4 2 1 2 9 5 0 10 823 860                   
4 2 1 2 9 6 2 0 688 710                   
4 2 1 2 9 6 10 0 148 482                   
4 2 1 2 9 7 1 0 683 732                   
4 2 1 2 9 8 7 0 492 862                   
4 2 1 2 9 8 0 3 615 620                   
4 2 1 2 9 9 1 0 485 699                   
4 2 1 2 9 9 0 7 676 699                   
3 5 1 2 9 9 0 0 389 485 676 699 828                
4 2 1 2 9 10 3 0 218 493                   
3 5 1 2 9 10 0 0 102 218 256 387 493                
4 2 1 2 9 0 1 2 714 732                   
4 2 1 2 9 0 1 3 592 598                   
4 2 1 2 9 0 1 7 683 699                   
4 2 1 2 9 0 2 9 921 936                   
4 2 1 2 9 0 3 3 539 576                   
4 2 1 2 9 0 4 6 382 401                   
3 5 1 2 9 0 4 0 274 382 401 435 558                
4 2 1 2 9 0 6 6 378 387                   
3 4 1 2 9 0 6 0 378 387 766 860                 
4 2 1 2 9 0 7 7 665 778                   
4 2 1 2 9 0 8 7 666 777                   
3 4 1 2 9 0 0 1 256 264 274 296                 
3 5 1 2 9 0 0 2 714 727 731 732 746                
3 5 1 2 9 0 0 4 468 482 485 492 493                
3 4 1 2 9 0 0 5 507 514 515 531                 
3 2 1 2 9 0 0 8 417 435                   
3 3 1 2 9 0 0 9 921 936 946                  
3 5 1 2 9 0 0 10 823 828 860 862 884                
3 3 1 2 10 1 0 0 632 785 898                  
4 2 1 2 10 2 1 0 500 523                   
4 2 1 2 10 2 0 5 500 523                   
3 4 1 2 10 2 0 0 135 500 523 599                 
3 3 1 2 10 3 0 0 287 512 579                  
3 2 1 2 10 7 0 0 663 792                   
4 2 1 2 10 8 4 0 481 863                   
3 2 1 2 10 8 0 0 481 863                   
3 2 1 2 10 9 0 0 466 669                   
3 2 1 2 10 10 0 0 424 907                   
4 2 1 2 10 0 1 5 500 523                   
3 3 1 2 10 0 1 0 500 523 570                  
4 2 1 2 10 0 3 7 669 785                   
3 2 1 2 10 0 3 0 669 785                   
4 2 1 2 10 0 4 9 898 907                   
3 5 1 2 10 0 4 0 481 512 863 898 907                
3 3 1 2 10 0 5 0 466 663 807                  
3 2 1 2 10 0 6 0 287 792                   
4 2 1 2 10 0 8 3 599 632                   
3 3 1 2 10 0 8 0 424 599 632                  
3 4 1 2 10 0 0 3 570 579 599 632                 
3 2 1 2 10 0 0 4 466 481                   
3 3 1 2 10 0 0 5 500 512 523                  
3 3 1 2 10 0 0 7 663 669 785                  
3 2 1 2 10 0 0 9 898 907                   
3 3 1 2 10 0 0 10 792 807 863                  
2 20 1 2 10 0 0 0 135 287 424 466 481 500 512 523 570 579 599 632 663 669 785 792 807 863 898 907 
4 2 1 2 0 1 1 3 592 598                   
4 2 1 2 0 1 5 5 524 530                   
4 2 1 2 0 1 6 2 737 743                   
4 2 1 2 0 1 8 5 515 517                   
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4 2 1 2 0 1 8 6 354 395    4 2 1 2 0 1 9 7 692 768    
3 4 1 2 0 1 0 2 715 722 737 743  
3 2 1 2 0 1 0 4 469 475    
3 5 1 2 0 1 0 6 354 356 382 391 395 
3 3 1 2 0 1 0 8 404 410 435   
3 4 1 2 0 1 0 9 898 900 936 948  
3 3 1 2 0 1 0 10 857 884 894   
4 2 1 2 0 2 1 5 500 523    
4 2 1 2 0 2 1 8 413 420    
4 2 1 2 0 2 1 10 799 821    
3 5 1 2 0 2 3 0 235 358 576 847 891 
4 2 1 2 0 2 4 1 274 315    
4 2 1 2 0 2 6 1 257 281    
3 5 1 2 0 2 7 0 133 253 573 665 822 
4 2 1 2 0 2 8 2 729 731    
4 2 1 2 0 2 8 3 535 599    
4 2 1 2 0 2 9 2 725 752    
4 2 1 2 0 2 9 10 818 890    
3 4 1 2 0 2 9 0 725 752 818 890  
3 4 1 2 0 2 0 2 725 729 731 752  
3 5 1 2 0 2 0 3 535 573 576 599 626 
3 3 1 2 0 2 0 4 478 489 491   
3 2 1 2 0 2 0 5 500 523    
3 4 1 2 0 2 0 6 351 358 368 401  
3 4 1 2 0 2 0 7 665 756 762 766  
3 2 1 2 0 2 0 8 413 420    
3 2 1 2 0 2 0 9 847 921    
3 2 1 2 0 3 1 0 171 717    
3 2 1 2 0 3 2 0 194 727    
3 3 1 2 0 3 3 0 24 138 852   
4 2 1 2 0 3 4 5 512 526    
3 3 1 2 0 3 4 0 512 526 536   
3 2 1 2 0 3 5 0 421 624    
4 2 1 2 0 3 6 1 271 287    
3 4 1 2 0 3 6 0 271 287 378 473  
3 3 1 2 0 3 7 0 225 336 392   
3 4 1 2 0 3 8 0 291 571 679 908  
3 4 1 2 0 3 9 0 366 534 640 869  
3 5 1 2 0 3 0 1 271 278 287 291 336 
3 2 1 2 0 3 0 2 717 727    
3 3 1 2 0 3 0 5 512 526 534   
3 3 1 2 0 3 0 6 366 378 392   
3 2 1 2 0 3 0 7 640 679    
3 2 1 2 0 3 0 8 412 421    
3 2 1 2 0 3 0 10 852 869    
3 2 1 2 0 4 1 0 436 693    
3 2 1 2 0 4 2 0 224 552    
3 5 1 2 0 4 3 0 90 99 137 309 704 
3 5 1 2 0 4 4 0 11 26 229 337 370 
3 4 1 2 0 4 5 0 142 273 375 677  
3 3 1 2 0 4 9 0 78 809 935   
4 2 1 2 0 4 10 8 403 425    
3 4 1 2 0 4 10 0 403 425 586 800  
3 3 1 2 0 4 0 1 273 309 337   
3 3 1 2 0 4 0 2 724 739 747   
3 2 1 2 0 4 0 3 552 586    
3 3 1 2 0 4 0 6 359 370 375   
3 4 1 2 0 4 0 7 677 693 704 711  
3 3 1 2 0 4 0 8 403 425 436   
3 2 1 2 0 4 0 10 800 809    
4 2 1 2 0 5 1 10 811 823    
3 4 1 2 0 5 3 0 285 460 507 636  
4 2 1 2 0 5 4 8 416 443    
3 5 1 2 0 5 4 0 58 416 443 558 776 
3 4 1 2 0 5 5 0 211 254 612 807  
4 2 1 2 0 5 6 10 824 860    
3 3 1 2 0 5 6 0 132 824 860   
4 2 1 2 0 5 7 3 541 603    
3 3 1 2 0 5 7 0 541 603 757   
4 2 1 2 0 5 8 7 761 777    
4 2 1 2 0 5 9 5 509 531    
3 4 1 2 0 5 9 0 119 486 509 531  
4 2 1 2 0 5 10 10 803 859    
3 2 1 2 0 5 0 2 713 714    
3 2 1 2 0 5 0 4 460 486    
3 3 1 2 0 5 0 5 507 509 531   
3 3 1 2 0 5 0 8 416 417 443   
3 2 1 2 0 5 0 9 915 957    
4 2 1 2 0 6 1 3 570 610    
4 2 1 2 0 6 1 7 662 705    
4 2 1 2 0 6 2 10 795 858    
3 4 1 2 0 6 3 0 60 61 407 637  
3 4 1 2 0 6 4 0 465 736 760 954  
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3 4 1 2 0 6 6 0 143 161 629 645                 3 2 1 2 0 6 7 0 454 616                   
3 3 1 2 0 6 8 0 472 506 559                  
4 2 1 2 0 6 9 9 925 958                   
4 2 1 2 0 6 9 10 794 796                   
3 4 1 2 0 6 10 0 148 259 482 554                 
3 3 1 2 0 6 0 1 259 297 333                  
3 2 1 2 0 6 0 2 728 736                   
3 3 1 2 0 6 0 5 506 518 525                  
3 4 1 2 0 6 0 9 925 946 954 958                 
4 2 1 2 0 7 1 7 683 771                   
3 4 1 2 0 7 1 0 339 683 732 771                 
4 2 1 2 0 7 2 6 364 369                   
3 2 1 2 0 7 3 0 6 80                   
4 2 1 2 0 7 4 1 275 344                   
3 2 1 2 0 7 5 0 468 663                   
4 2 1 2 0 7 6 10 792 819                   
4 2 1 2 0 7 7 3 588 608                   
4 2 1 2 0 7 7 7 656 709                   
4 2 1 2 0 7 8 10 793 839                   
3 5 1 2 0 7 8 0 268 446 666 793 839                
4 2 1 2 0 7 9 7 673 780                   
3 5 1 2 0 7 10 0 292 457 577 726 814                
3 2 1 2 0 7 0 2 726 732                   
3 5 1 2 0 7 0 3 548 577 588 608 628                
3 5 1 2 0 7 0 4 456 457 464 468 483                
3 3 1 2 0 7 0 6 364 369 388                  
3 2 1 2 0 7 0 8 422 446                   
3 2 1 2 0 8 2 0 340 646                   
3 4 1 2 0 8 4 0 136 353 481 863                 
3 2 1 2 0 8 5 0 583 746                   
3 3 1 2 0 8 6 0 50 503 846                  
4 2 1 2 0 8 7 4 455 492                   
4 2 1 2 0 8 7 10 844 862                   
3 5 1 2 0 8 7 0 311 455 492 844 862                
3 5 1 2 0 8 9 0 10 250 502 735 881                
3 2 1 2 0 8 10 0 584 647                   
3 2 1 2 0 8 0 1 311 340                   
3 2 1 2 0 8 0 2 735 746                   
3 5 1 2 0 8 0 3 550 583 584 615 620                
3 3 1 2 0 8 0 4 455 481 492                  
3 3 1 2 0 8 0 5 498 502 503                  
3 3 1 2 0 8 0 7 646 647 712                  
3 4 1 2 0 8 0 10 844 862 863 881                 
4 2 1 2 0 9 1 7 657 699                   
3 4 1 2 0 9 1 0 485 657 699 939                 
3 2 1 2 0 9 2 0 154 386                   
3 2 1 2 0 9 3 0 494 669                   
3 2 1 2 0 9 4 0 381 901                   
3 2 1 2 0 9 5 0 193 466                   
3 3 1 2 0 9 8 0 266 389 892                  
3 2 1 2 0 9 9 0 676 723                   
3 2 1 2 0 9 10 0 317 828                   
3 2 1 2 0 9 0 1 266 317                   
3 2 1 2 0 9 0 4 466 485                   
3 4 1 2 0 9 0 6 381 386 389 400                 
3 4 1 2 0 9 0 7 657 669 676 699                 
3 2 1 2 0 9 0 9 901 939                   
3 2 1 2 0 9 0 10 828 892                   
2 20 1 2 0 9 0 0 154 193 266 317 381 386 389 400 466 485 494 657 669 676 699 723 828 892 901 939 
3 4 1 2 0 10 1 0 238 346 495 695                 
3 2 1 2 0 10 2 0 521 791                   
3 5 1 2 0 10 3 0 191 218 365 493 962                
4 2 1 2 0 10 4 8 426 433                   
3 4 1 2 0 10 4 0 426 433 882 907                 
3 4 1 2 0 10 5 0 102 107 332 458                 
3 4 1 2 0 10 6 0 105 387 544 639                 
3 3 1 2 0 10 7 0 265 447 668                  
3 3 1 2 0 10 8 0 424 687 808                  
3 3 1 2 0 10 9 0 245 256 813                  
4 2 1 2 0 10 10 4 471 477                   
3 5 1 2 0 10 10 0 316 423 471 477 653                
3 4 1 2 0 10 0 1 256 265 316 332                 
3 5 1 2 0 10 0 4 447 458 471 477 493                
3 2 1 2 0 10 0 5 495 521                   
3 3 1 2 0 10 0 6 346 365 387                  
3 5 1 2 0 10 0 7 639 653 668 687 695                
3 4 1 2 0 10 0 8 423 424 426 433                 
3 2 1 2 0 10 0 9 907 962                   
3 4 1 2 0 10 0 10 791 808 813 882                 
3 3 1 2 0 0 1 2 714 717 732                  
3 3 1 2 0 0 1 4 459 485 491                  
3 4 1 2 0 0 1 5 495 500 523 528                 
3 3 1 2 0 0 1 8 413 420 436                  
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3 2 1 2 0 0 1 9 939 946                    3 4 1 2 0 0 2 1 276 313 334 340                  
3 3 1 2 0 0 2 2 715 727 728                   
3 2 1 2 0 0 2 3 552 590                    
3 2 1 2 0 0 2 4 451 478                    
3 3 1 2 0 0 2 5 521 522 525                   
3 5 1 2 0 0 2 6 364 368 369 386 391                 
3 3 1 2 0 0 2 9 921 936 957                   
3 3 1 2 0 0 2 10 791 795 858                   
3 2 1 2 0 0 3 1 285 309                    
3 2 1 2 0 0 3 3 539 576                    
3 2 1 2 0 0 3 4 460 493                    
3 2 1 2 0 0 3 5 494 507                    
3 3 1 2 0 0 3 6 356 358 365                   
3 2 1 2 0 0 3 8 404 407                    
3 2 1 2 0 0 3 9 847 962                    
3 3 1 2 0 0 3 10 852 884 891                   
3 5 1 2 0 0 4 1 274 275 315 337 344                 
3 4 1 2 0 0 4 3 536 558 626 628                  
3 4 1 2 0 0 4 4 465 475 481 489                  
3 3 1 2 0 0 4 5 504 512 526                   
3 3 1 2 0 0 4 7 690 760 776                   
3 5 1 2 0 0 4 8 416 426 433 435 443                 
3 4 1 2 0 0 4 9 898 901 907 954                  
3 2 1 2 0 0 4 10 863 882                    
3 2 1 2 0 0 5 1 273 332                    
3 5 1 2 0 0 5 3 555 575 583 612 624                 
3 3 1 2 0 0 5 4 458 466 468                   
3 2 1 2 0 0 5 5 524 530                    
3 2 1 2 0 0 5 6 347 375                    
3 4 1 2 0 0 5 7 663 677 759 762                  
3 2 1 2 0 0 5 10 807 867                    
3 5 1 2 0 0 6 1 257 271 281 287 308                 
3 2 1 2 0 0 6 2 737 743                    
3 4 1 2 0 0 6 3 544 548 619 629                  
3 2 1 2 0 0 6 4 456 473                    
3 2 1 2 0 0 6 6 378 387                    
3 4 1 2 0 0 6 7 639 645 685 766                  
3 2 1 2 0 0 6 9 846 948                    
3 4 1 2 0 0 6 10 792 819 824 860                  
3 4 1 2 0 0 7 1 264 265 311 336                  
3 5 1 2 0 0 7 4 447 454 455 483 492                 
3 2 1 2 0 0 7 6 392 400                    
3 3 1 2 0 0 7 10 822 844 862                   
3 4 1 2 0 0 8 1 266 268 291 326                  
3 2 1 2 0 0 8 4 469 472                    
3 5 1 2 0 0 8 5 498 506 515 517 520                 
3 5 1 2 0 0 8 6 351 354 359 389 395                 
3 3 1 2 0 0 8 8 417 424 446                   
3 2 1 2 0 0 8 9 908 915                    
3 2 1 2 0 0 9 1 256 297                    
3 4 1 2 0 0 9 2 723 725 735 752                  
3 2 1 2 0 0 9 3 553 568                    
3 3 1 2 0 0 9 4 453 464 486                   
3 5 1 2 0 0 9 5 502 509 518 531 534                 
3 4 1 2 0 0 9 9 848 925 935 958                  
3 4 1 2 0 0 10 4 457 471 477 482                  
3 4 1 2 0 0 10 7 647 653 664 708                  
3 4 1 2 0 0 10 8 403 412 423 425                  
2 22 1 2 0 0 0 2 713 714 715 717 722 723 724 725 726 727 728 729 731 732 735 736 737 739 743 746 747 
                            752 
2 20 1 2 0 0 0 8 403 404 407 410 412 413 416 417 420 421 422 423 424 425 426 433 435 436 443 446  
2 20 1 2 0 0 0 9 846 847 848 898 900 901 907 908 915 921 925 935 936 939 946 948 954 957 958 962  
3 3 1 0 1 1 3 0 89 356 501                   
3 3 1 0 1 1 6 0 195 685 743                   
3 2 1 0 1 1 7 0 177 410                    
3 2 1 0 1 1 9 0 46 553                    
3 2 1 0 1 1 0 7 685 691                    
3 2 1 0 1 2 7 0 573 822                    
3 2 1 0 1 2 0 10 818 822                    
2 7 1 0 1 2 0 0 125 327 573 729 756 818 822               
3 2 1 0 1 3 8 0 291 679                    
3 2 1 0 1 3 10 0 283 593                    
3 2 1 0 1 3 0 1 283 291                    
2 7 1 0 1 3 0 0 194 283 291 473 593 679 869               
3 2 1 0 1 4 4 0 229 370                    
3 2 1 0 1 4 8 0 711 930                    
3 3 1 0 1 4 10 0 403 425 586                   
3 2 1 0 1 4 0 6 370 393                    
3 2 1 0 1 4 0 7 704 711                    
3 2 1 0 1 4 0 8 403 425                    
3 2 1 0 1 5 3 0 460 636                    
3 3 1 0 1 5 0 7 636 757 776                   
3 2 1 0 1 5 0 10 824 880                    
Page | E79  
3 3 1 0 1 6 2 0 525 728 795      3 2 1 0 1 6 5 0 347 759       
3 2 1 0 1 6 8 0 506 559       
3 3 1 0 1 6 9 0 453 568 958      
3 3 1 0 1 6 0 3 554 559 568      
3 2 1 0 1 6 0 4 453 459       
3 2 1 0 1 6 0 5 506 525       
3 2 1 0 1 7 4 0 344 628       
3 3 1 0 1 7 7 0 483 588 656      
3 2 1 0 1 7 9 0 464 673       
3 2 1 0 1 7 0 1 339 344       
3 2 1 0 1 7 0 3 588 628       
3 2 1 0 1 7 0 4 464 483       
3 2 1 0 1 7 0 7 656 673       
3 2 1 0 1 8 0 1 311 340       
2 4 1 0 1 8 0 0 311 340 353 735     
2 2 1 0 1 9 0 0 266 781       
3 2 1 0 1 10 7 0 447 606       
3 2 1 0 1 10 0 4 447 458       
3 3 1 0 1 10 0 7 653 687 695      
2 7 1 0 1 10 0 0 365 447 458 606 653 687 695  
3 2 1 0 1 0 1 7 695 756       
2 6 1 0 1 0 1 0 13 339 393 459 695 756   
2 7 1 0 1 0 2 0 56 194 340 369 525 728 795  
3 2 1 0 1 0 3 6 356 365       
3 2 1 0 1 0 3 7 636 704       
2 8 1 0 1 0 3 0 80 89 356 365 460 501 636 704 
3 2 1 0 1 0 4 6 353 370       
2 8 1 0 1 0 4 0 125 229 344 353 370 628 776 950 
2 6 1 0 1 0 5 0 142 187 347 458 753 759   
2 5 1 0 1 0 6 0 195 473 685 743 824    
3 3 1 0 1 0 7 3 573 588 606      
3 2 1 0 1 0 7 4 447 483       
3 2 1 0 1 0 7 7 656 757       
3 2 1 0 1 0 8 1 266 291       
3 2 1 0 1 0 9 3 553 568       
3 2 1 0 1 0 9 4 453 464       
3 2 1 0 1 0 9 10 818 869       
3 2 1 0 1 0 10 1 283 327       
3 3 1 0 1 0 10 3 554 586 593      
3 2 1 0 1 0 10 7 653 781       
3 2 1 0 1 0 10 8 403 425       
2 8 1 0 1 0 0 1 266 283 291 311 327 339 340 344 
2 5 1 0 1 0 0 2 728 729 735 743 753    
2 8 1 0 1 0 0 4 447 453 458 459 460 464 473 483 
2 4 1 0 1 0 0 5 501 506 509 525     
2 8 1 0 1 0 0 6 347 353 356 365 369 370 372 393 
2 4 1 0 1 0 0 8 403 410 425 446     
2 3 1 0 1 0 0 9 930 950 958      
2 7 1 0 1 0 0 10 795 814 818 822 824 869 880  
3 2 1 0 2 1 2 0 715 911       
2 4 1 0 2 1 0 0 328 469 715 911     
3 2 1 0 2 2 10 0 104 280       
2 7 1 0 2 2 0 0 104 157 160 253 280 626 961  
2 3 1 0 2 3 0 0 171 421 536      
2 3 1 0 2 4 0 0 309 724 809      
2 2 1 0 2 5 0 0 62 119       
3 2 1 0 2 6 6 0 143 629       
3 2 1 0 2 6 0 3 610 629       
2 5 1 0 2 6 0 0 60 67 143 610 629    
3 2 1 0 2 7 8 0 371 839       
2 5 1 0 2 7 0 0 292 371 456 608 839    
3 2 1 0 2 8 0 7 646 647       
2 6 1 0 2 8 0 0 10 50 455 646 647 865   
3 2 1 0 2 10 6 0 105 639       
2 7 1 0 2 10 0 0 105 332 426 471 639 813 962  
2 5 1 0 2 0 1 0 62 157 171 328 610    
3 2 1 0 2 0 2 9 911 961       
2 5 1 0 2 0 2 0 154 646 715 911 961    
2 4 1 0 2 0 3 0 60 309 865 962     
3 2 1 0 2 0 4 3 536 626       
2 3 1 0 2 0 4 0 426 536 626      
2 3 1 0 2 0 5 0 160 332 421      
2 6 1 0 2 0 6 0 50 105 143 456 629 639   
2 3 1 0 2 0 7 0 253 455 608      
2 4 1 0 2 0 8 0 371 469 724 839     
3 2 1 0 2 0 9 10 809 813       
2 5 1 0 2 0 9 0 10 67 119 809 813    
3 2 1 0 2 0 10 1 280 292       
2 5 1 0 2 0 10 0 104 280 292 471 647    
2 5 1 0 2 0 0 1 280 292 309 328 332    
2 2 1 0 2 0 0 2 715 724       
2 5 1 0 2 0 0 3 536 608 610 626 629    
2 4 1 0 2 0 0 4 455 456 469 471     
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2 3 1 0 2 0 0 7 639 646 647      2 2 1 0 2 0 0 8 421 426       
2 3 1 0 2 0 0 9 911 961 962      
2 4 1 0 2 0 0 10 809 813 839 865     
3 2 1 0 3 1 0 7 634 708       
2 5 1 0 3 1 0 0 23 406 524 634 708    
3 2 1 0 3 2 10 0 806 830       
3 2 1 0 3 2 0 10 806 830       
2 6 1 0 3 2 0 0 117 202 489 535 806 830   
2 2 1 0 3 5 0 0 130 419       
2 2 1 0 3 10 0 0 495 556       
2 2 1 0 3 0 1 0 130 495       
2 3 1 0 3 0 3 0 24 419 634      
2 2 1 0 3 0 5 0 117 524       
2 2 1 0 3 0 6 0 202 406       
2 3 1 0 3 0 8 0 535 712 739      
2 2 1 0 3 0 9 0 23 925       
3 2 1 0 3 0 10 10 806 830       
2 5 1 0 3 0 10 0 317 556 708 806 830    
2 2 1 0 3 0 0 1 313 317       
2 2 1 0 3 0 0 3 535 556       
2 2 1 0 3 0 0 5 495 524       
2 3 1 0 3 0 0 7 634 708 712      
2 2 1 0 3 0 0 8 406 419       
2 2 1 0 3 0 0 10 806 830       
3 2 1 0 4 1 2 0 334 681       
3 2 1 0 4 1 10 0 5 179       
3 2 1 0 4 1 0 7 681 772       
2 7 1 0 4 1 0 0 5 7 179 334 681 772 894  
3 2 1 0 4 2 5 0 69 200       
3 2 1 0 4 2 6 0 38 76       
2 8 1 0 4 2 0 0 3 38 51 69 76 103 200 587 
3 2 1 0 4 3 0 1 278 336       
3 2 1 0 4 3 0 3 571 624       
2 4 1 0 4 3 0 0 278 336 571 624     
3 2 1 0 4 4 3 0 90 137       
2 7 1 0 4 4 0 0 78 90 137 337 375 784 800  
3 2 1 0 4 5 5 0 211 254       
3 2 1 0 4 5 10 0 223 859       
3 2 1 0 4 5 0 3 541 595       
2 2 1 0 4 6 0 0 161 407       
3 2 1 0 4 7 6 0 308 548       
3 3 1 0 4 7 0 1 275 308 342      
2 7 1 0 4 7 0 0 6 219 275 308 342 548 798  
2 4 1 0 4 8 0 0 136 502 583 844     
2 4 1 0 4 9 0 0 286 381 723 892     
3 2 1 0 4 10 4 0 433 882       
2 6 1 0 4 10 0 0 245 265 346 433 477 882   
2 4 1 0 4 0 1 0 3 346 595 894     
2 3 1 0 4 0 2 0 219 334 681      
3 2 1 0 4 0 3 8 407 429       
2 7 1 0 4 0 3 0 6 51 90 137 407 429 772  
3 2 1 0 4 0 4 1 275 337       
2 7 1 0 4 0 4 0 58 136 275 337 381 433 882  
3 2 1 0 4 0 5 3 583 624       
2 8 1 0 4 0 5 0 69 200 211 254 342 375 583 624 
2 7 1 0 4 0 6 0 7 38 76 161 308 548 784  
3 2 1 0 4 0 7 1 265 336       
2 4 1 0 4 0 7 0 265 336 541 844     
2 4 1 0 4 0 8 0 103 571 892 915     
2 6 1 0 4 0 9 0 78 245 502 587 723 798   
3 2 1 0 4 0 10 1 278 286       
3 2 1 0 4 0 10 10 800 859       
2 8 1 0 4 0 10 0 5 179 223 278 286 477 800 859 
2 7 1 0 4 0 0 3 541 548 571 583 587 595 624  
2 3 1 0 4 0 0 6 346 375 381      
2 3 1 0 4 0 0 7 681 772 784      
2 3 1 0 4 0 0 8 407 429 433      
2 7 1 0 4 0 0 10 798 800 844 859 882 892 894  
3 2 1 0 5 1 2 0 391 672       
3 2 1 0 5 1 5 0 252 530       
3 3 1 0 5 1 8 0 563 633 857      
3 2 1 0 5 1 0 1 302 331       
3 2 1 0 5 1 0 3 563 619       
3 3 1 0 5 1 0 5 510 528 530      
3 3 1 0 5 1 0 7 633 649 672      
3 2 1 0 5 2 8 0 91 326       
3 2 1 0 5 2 0 4 478 491       
3 2 1 0 5 2 0 8 413 420       
3 3 1 0 5 3 9 0 366 534 640      
3 2 1 0 5 3 10 0 412 540       
3 2 1 0 5 3 0 5 526 534       
3 2 1 0 5 3 0 6 366 385       
3 2 1 0 5 4 2 0 552 787       
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3 2 1 0 5 4 0 3 551 552       2 6 1 0 5 4 0 0 325 409 520 551 552 787   
3 3 1 0 5 5 4 0 416 439 443      
3 2 1 0 5 5 8 0 713 761       
3 2 1 0 5 5 0 1 285 306       
3 3 1 0 5 5 0 8 416 439 443      
3 3 1 0 5 6 2 0 590 670 858      
3 2 1 0 5 6 3 0 61 383       
3 2 1 0 5 6 5 0 555 867       
3 2 1 0 5 6 0 1 297 303       
3 2 1 0 5 6 0 3 555 590       
3 3 1 0 5 6 0 10 796 858 867      
3 2 1 0 5 7 1 0 77 771       
3 2 1 0 5 7 0 6 364 388       
3 2 1 0 5 7 0 7 709 771       
3 2 1 0 5 8 6 0 503 769       
3 2 1 0 5 8 0 5 498 503       
2 3 1 0 5 8 0 0 498 503 769      
3 2 1 0 5 9 1 0 15 350       
3 3 1 0 5 9 0 6 350 386 400      
2 4 1 0 5 9 0 0 15 350 386 400     
3 2 1 0 5 10 3 0 191 585       
3 2 1 0 5 10 0 3 544 585       
2 7 1 0 5 10 0 0 107 191 349 544 585 668 738  
3 2 1 0 5 0 1 1 302 331       
3 2 1 0 5 0 1 7 649 771       
3 2 1 0 5 0 1 8 413 420       
3 2 1 0 5 0 2 3 552 590       
3 3 1 0 5 0 2 6 364 386 391      
3 3 1 0 5 0 2 7 670 672 787      
3 2 1 0 5 0 3 1 285 325       
2 8 1 0 5 0 3 0 61 191 285 325 383 404 585 847 
3 2 1 0 5 0 4 4 465 475       
3 3 1 0 5 0 4 8 416 439 443      
2 7 1 0 5 0 4 0 388 416 439 443 465 475 526  
2 6 1 0 5 0 5 0 107 252 306 530 555 867   
3 3 1 0 5 0 6 3 544 551 619      
2 8 1 0 5 0 6 0 43 385 422 503 544 551 619 769 
3 2 1 0 5 0 7 7 668 709       
2 6 1 0 5 0 7 0 133 237 400 510 668 709   
3 2 1 0 5 0 8 5 498 520       
3 2 1 0 5 0 8 7 633 761       
3 2 1 0 5 0 8 10 793 857       
3 2 1 0 5 0 9 1 297 303       
3 2 1 0 5 0 9 5 518 534       
3 3 1 0 5 0 10 1 288 301 307      
3 3 1 0 5 0 10 3 540 577 617      
3 2 1 0 5 0 10 8 409 412       
2 8 1 0 5 0 10 0 288 301 307 409 412 540 577 617 
2 3 1 0 5 0 0 2 713 717 738      
2 5 1 0 5 0 0 4 465 475 478 486 491    
2 2 1 0 5 0 0 9 847 848       
2 6 1 0 5 0 0 10 793 796 821 857 858 867   
3 2 1 0 6 1 6 0 737 948       
3 2 1 0 6 1 8 0 221 537       
2 7 1 0 6 1 0 0 98 131 221 522 537 737 948  
3 2 1 0 6 2 10 0 263 314       
3 3 1 0 6 2 0 1 263 281 314      
2 7 1 0 6 2 0 0 27 71 197 235 263 281 314  
2 2 1 0 6 3 0 0 225 271       
3 2 1 0 6 4 0 7 677 693       
2 3 1 0 6 4 0 0 677 693 935      
2 3 1 0 6 5 0 0 248 811 957      
3 2 1 0 6 6 1 0 333 705       
3 2 1 0 6 6 3 0 637 875       
3 2 1 0 6 6 0 7 637 705       
3 2 1 0 6 6 0 10 794 875       
2 7 1 0 6 6 0 0 333 472 637 705 794 875 954  
2 3 1 0 6 7 0 0 231 268 841      
2 2 1 0 6 9 0 0 657 901       
3 2 1 0 6 10 1 0 238 885       
2 4 1 0 6 10 0 0 238 261 521 885     
3 3 1 0 6 0 1 7 657 693 705      
3 3 1 0 6 0 1 10 811 841 885      
3 2 1 0 6 0 2 5 521 522       
2 4 1 0 6 0 2 0 197 521 522 957     
2 3 1 0 6 0 3 0 235 637 875      
3 2 1 0 6 0 4 9 901 954       
2 3 1 0 6 0 4 0 98 901 954      
2 2 1 0 6 0 5 0 27 677       
3 2 1 0 6 0 6 1 271 281       
2 4 1 0 6 0 6 0 271 281 737 948     
2 2 1 0 6 0 7 0 131 225       
2 5 1 0 6 0 8 0 221 248 268 472 537    
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3 2 1 0 6 0 9 10 794 881       2 4 1 0 6 0 9 0 261 794 881 935     
3 2 1 0 6 0 10 1 263 314       
2 3 1 0 6 0 10 0 231 263 314      
2 7 1 0 6 0 0 1 261 263 268 271 281 314 333  
2 2 1 0 6 0 0 5 521 522       
2 5 1 0 6 0 0 7 637 657 677 693 705    
2 5 1 0 6 0 0 9 901 935 948 954 957    
2 6 1 0 6 0 0 10 794 811 841 875 881 885   
3 2 1 0 7 1 5 0 88 575       
2 6 1 0 7 1 0 0 88 319 395 575 654 900   
3 2 1 0 7 2 9 0 752 890       
2 4 1 0 7 2 0 0 180 752 762 890     
2 2 1 0 7 3 0 0 852 908       
2 3 1 0 7 4 0 0 118 224 906      
3 2 1 0 7 5 0 3 569 603       
2 3 1 0 7 5 0 0 569 603 803      
3 2 1 0 7 6 1 0 662 879       
2 6 1 0 7 6 0 0 22 214 259 662 736 879   
2 2 1 0 7 7 0 0 96 457       
2 3 1 0 7 8 0 0 250 584 846      
3 2 1 0 7 10 10 0 316 423       
3 2 1 0 7 10 0 10 791 808       
2 4 1 0 7 10 0 0 316 423 791 808     
2 5 1 0 7 0 1 0 319 569 662 879 906    
2 4 1 0 7 0 2 0 96 224 654 791     
2 4 1 0 7 0 5 0 22 88 575 762     
2 3 1 0 7 0 7 0 118 603 900      
2 4 1 0 7 0 8 0 180 395 808 908     
2 4 1 0 7 0 9 0 214 250 752 890     
3 2 1 0 7 0 10 1 259 316       
2 6 1 0 7 0 10 0 259 316 423 457 584 803   
2 3 1 0 7 0 0 1 259 316 319      
2 2 1 0 7 0 0 2 736 752       
2 4 1 0 7 0 0 3 569 575 584 603     
2 3 1 0 7 0 0 7 654 662 762      
2 4 1 0 7 0 0 9 846 900 906 908     
2 6 1 0 7 0 0 10 791 803 808 852 879 890   
3 2 1 0 8 1 2 0 114 883       
3 3 1 0 8 1 7 0 2 242 722      
3 2 1 0 8 2 8 0 12 805       
3 3 1 0 8 2 0 1 257 276 315      
3 3 1 0 8 2 0 10 799 805 891      
2 8 1 0 8 2 0 0 12 257 276 315 725 799 805 891 
3 2 1 0 8 3 3 0 138 147       
2 3 1 0 8 3 0 0 138 147 600      
3 2 1 0 8 4 1 0 436 750       
3 2 1 0 8 4 4 0 11 26       
3 2 1 0 8 4 0 2 747 750       
2 8 1 0 8 4 0 0 11 26 70 99 273 436 747 750 
2 2 1 0 8 5 0 0 132 269       
3 2 1 0 8 6 2 0 226 451       
3 2 1 0 8 6 7 0 454 616       
3 2 1 0 8 6 0 4 451 454       
3 2 1 0 8 6 0 7 645 760       
2 6 1 0 8 6 0 0 226 451 454 616 645 760   
3 2 1 0 8 7 4 0 8 504       
3 2 1 0 8 7 6 0 749 819       
3 2 1 0 8 7 0 2 726 749       
2 6 1 0 8 7 0 0 8 52 504 726 749 819   
3 2 1 0 8 8 8 0 550 837       
2 2 1 0 8 8 0 0 550 837       
2 3 1 0 8 9 0 0 193 494 939      
2 4 1 0 8 0 1 0 436 750 799 939     
2 5 1 0 8 0 2 0 114 226 276 451 883    
2 5 1 0 8 0 3 0 99 138 147 494 891    
3 2 1 0 8 0 4 7 690 760       
2 7 1 0 8 0 4 0 8 11 26 315 504 690 760  
2 4 1 0 8 0 5 0 35 193 273 887     
2 6 1 0 8 0 6 0 70 132 257 645 749 819   
2 5 1 0 8 0 7 0 2 242 454 616 722    
3 2 1 0 8 0 8 10 805 837       
2 6 1 0 8 0 8 0 12 517 550 747 805 837   
2 3 1 0 8 0 9 0 52 100 725      
2 3 1 0 8 0 10 0 269 600 726      
2 5 1 0 8 0 0 1 257 269 273 276 315    
2 6 1 0 8 0 0 2 722 725 726 747 749 750   
2 3 1 0 8 0 0 3 550 600 616      
2 2 1 0 8 0 0 4 451 454       
2 3 1 0 8 0 0 5 494 504 517      
2 3 1 0 8 0 0 7 645 690 760      
2 7 1 0 8 0 0 10 799 805 819 837 883 887 891  
3 3 1 0 9 1 3 0 169 539 884      
3 2 1 0 9 1 4 0 382 435       
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3 2 1 0 9 1 7 0 397 778       3 3 1 0 9 1 8 0 354 515 614      
3 2 1 0 9 1 9 0 692 768       
3 3 1 0 9 1 10 0 172 427 514      
3 2 1 0 9 1 0 5 514 515       
3 3 1 0 9 1 0 6 354 382 397      
3 3 1 0 9 1 0 7 692 768 778      
3 2 1 0 9 1 0 8 427 435       
3 2 1 0 9 1 0 9 923 936       
3 2 1 0 9 1 0 10 877 884       
3 3 1 0 9 2 2 0 209 368 921      
3 2 1 0 9 2 3 0 358 576       
3 2 1 0 9 2 4 0 274 401       
3 2 1 0 9 2 7 0 201 665       
3 2 1 0 9 2 8 0 351 731       
3 2 1 0 9 2 0 7 665 766       
3 2 1 0 9 3 0 6 378 392       
2 3 1 0 9 3 0 0 378 392 727      
3 2 1 0 9 4 0 6 359 402       
2 2 1 0 9 4 0 0 359 402       
3 2 1 0 9 5 1 0 714 823       
3 2 1 0 9 5 3 0 376 507       
3 2 1 0 9 5 4 0 330 558       
3 3 1 0 9 5 8 0 83 417 777      
3 2 1 0 9 5 10 0 203 664       
3 2 1 0 9 5 0 3 558 612       
3 2 1 0 9 5 0 5 507 531       
3 2 1 0 9 5 0 7 664 777       
3 2 1 0 9 5 0 10 823 860       
3 2 1 0 9 6 10 0 148 482       
3 2 1 0 9 7 1 0 683 732       
3 2 1 0 9 7 9 0 780 922       
3 2 1 0 9 8 5 0 324 746       
3 2 1 0 9 8 7 0 492 862       
3 3 1 0 9 8 8 0 34 615 620      
3 2 1 0 9 8 0 1 293 324       
3 2 1 0 9 8 0 3 615 620       
3 2 1 0 9 8 0 10 862 893       
3 2 1 0 9 9 1 0 485 699       
3 2 1 0 9 9 10 0 820 828       
3 2 1 0 9 9 0 7 676 699       
3 2 1 0 9 9 0 10 820 828       
2 6 1 0 9 9 0 0 389 485 676 699 820 828   
3 2 1 0 9 10 3 0 218 493       
2 5 1 0 9 10 0 0 102 218 256 387 493    
3 2 1 0 9 0 1 2 714 732       
3 2 1 0 9 0 1 3 592 598       
3 2 1 0 9 0 1 7 683 699       
3 2 1 0 9 0 2 2 727 742       
3 2 1 0 9 0 2 6 368 398       
3 3 1 0 9 0 2 7 688 700 710      
3 2 1 0 9 0 2 9 921 936       
3 2 1 0 9 0 3 3 539 576       
3 2 1 0 9 0 3 6 358 376       
3 2 1 0 9 0 4 1 274 330       
3 2 1 0 9 0 4 6 382 401       
2 6 1 0 9 0 4 0 274 330 382 401 435 558   
2 8 1 0 9 0 5 0 102 198 213 324 468 612 746 877 
3 2 1 0 9 0 6 6 378 387       
2 5 1 0 9 0 6 0 378 387 766 860 923    
3 2 1 0 9 0 7 6 392 397       
3 2 1 0 9 0 7 7 665 778       
2 8 1 0 9 0 7 0 201 264 392 397 492 665 778 862 
3 3 1 0 9 0 8 3 614 615 620      
3 3 1 0 9 0 8 7 666 777 786      
3 3 1 0 9 0 10 10 820 828 893      
2 7 1 0 9 0 0 1 256 264 274 293 296 324 330  
2 6 1 0 9 0 0 2 714 727 731 732 742 746   
2 5 1 0 9 0 0 4 468 482 485 492 493    
2 4 1 0 9 0 0 5 507 514 515 531     
2 3 1 0 9 0 0 8 417 427 435      
2 5 1 0 9 0 0 9 921 922 923 936 946    
2 8 1 0 9 0 0 10 820 823 828 860 862 877 884 893 
2 3 1 0 10 1 0 0 632 785 898      
3 2 1 0 10 2 1 0 500 523       
3 2 1 0 10 2 0 5 500 523       
2 4 1 0 10 2 0 0 135 500 523 599     
3 2 1 0 10 3 4 0 140 512       
2 5 1 0 10 3 0 0 140 287 396 512 579    
3 2 1 0 10 6 1 0 570 947       
2 2 1 0 10 6 0 0 570 947       
3 2 1 0 10 7 1 0 428 631       
2 4 1 0 10 7 0 0 428 631 663 792     
3 2 1 0 10 8 4 0 481 863       
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2 3 1 0 10 8 0 0 411 481 863      3 2 1 0 10 9 5 0 431 466       
2 3 1 0 10 9 0 0 431 466 669      
2 3 1 0 10 10 0 0 165 424 907      
3 2 1 0 10 0 1 3 570 631       
3 2 1 0 10 0 1 5 500 523       
2 6 1 0 10 0 1 0 428 500 523 570 631 947   
3 2 1 0 10 0 3 7 669 785       
2 4 1 0 10 0 3 0 396 411 669 785     
3 2 1 0 10 0 4 9 898 907       
2 6 1 0 10 0 4 0 140 481 512 863 898 907   
2 4 1 0 10 0 5 0 431 466 663 807     
2 2 1 0 10 0 6 0 287 792       
3 2 1 0 10 0 8 3 599 632       
2 3 1 0 10 0 8 0 424 599 632      
2 5 1 0 10 0 0 3 570 579 599 631 632    
2 2 1 0 10 0 0 4 466 481       
2 3 1 0 10 0 0 5 500 512 523      
2 3 1 0 10 0 0 7 663 669 785      
2 4 1 0 10 0 0 8 411 424 428 431     
2 3 1 0 10 0 0 9 898 907 947      
2 3 1 0 10 0 0 10 792 807 863      
3 2 1 0 0 1 1 3 592 598       
3 3 1 0 0 1 2 7 654 672 681      
3 2 1 0 0 1 2 9 911 936       
3 3 1 0 0 1 3 7 634 772 785      
3 2 1 0 0 1 4 9 898 950       
2 7 1 0 0 1 4 0 98 382 435 475 690 898 950  
3 2 1 0 0 1 5 5 524 530       
2 8 1 0 0 1 5 0 35 88 187 252 524 530 575 877 
3 2 1 0 0 1 6 2 737 743       
3 2 1 0 0 1 6 9 923 948       
3 2 1 0 0 1 8 5 515 517       
3 2 1 0 0 1 8 6 354 395       
3 2 1 0 0 1 8 7 633 691       
3 2 1 0 0 1 9 7 692 768       
2 6 1 0 0 1 9 0 23 46 100 553 692 768   
2 7 1 0 0 1 10 0 5 32 172 179 427 514 708  
2 6 1 0 0 1 0 1 296 302 319 328 331 334   
2 4 1 0 0 1 0 2 715 722 737 743     
2 2 1 0 0 1 0 4 469 475       
2 6 1 0 0 1 0 6 354 356 382 391 395 397   
2 5 1 0 0 1 0 8 404 406 410 427 435    
2 7 1 0 0 1 0 9 898 900 911 923 936 948 950  
2 5 1 0 0 1 0 10 857 877 883 884 894    
3 2 1 0 0 2 1 5 500 523       
3 2 1 0 0 2 1 8 413 420       
3 2 1 0 0 2 1 10 799 821       
3 2 1 0 0 2 2 9 921 961       
2 8 1 0 0 2 2 0 135 197 209 276 368 478 921 961 
2 6 1 0 0 2 3 0 51 235 358 576 847 891   
3 2 1 0 0 2 4 1 274 315       
2 6 1 0 0 2 4 0 125 274 315 401 489 626   
2 7 1 0 0 2 5 0 27 69 117 160 198 200 762  
3 2 1 0 0 2 6 1 257 281       
2 7 1 0 0 2 6 0 38 43 76 202 257 281 766  
2 6 1 0 0 2 7 0 133 201 253 573 665 822   
3 2 1 0 0 2 8 2 729 731       
3 2 1 0 0 2 8 3 535 599       
3 2 1 0 0 2 9 2 725 752       
3 2 1 0 0 2 9 10 818 890       
2 5 1 0 0 2 9 0 587 725 752 818 890    
3 2 1 0 0 2 10 10 806 830       
2 4 1 0 0 2 0 2 725 729 731 752     
2 7 1 0 0 2 0 3 535 573 576 587 599 617 626  
2 3 1 0 0 2 0 4 478 489 491      
2 2 1 0 0 2 0 5 500 523       
2 4 1 0 0 2 0 6 351 358 368 401     
2 4 1 0 0 2 0 7 665 756 762 766     
2 2 1 0 0 2 0 8 413 420       
2 3 1 0 0 2 0 9 847 921 961      
2 2 1 0 0 3 1 0 171 717       
2 2 1 0 0 3 2 0 194 727       
2 5 1 0 0 3 3 0 24 138 147 396 852    
3 2 1 0 0 3 4 5 512 526       
2 4 1 0 0 3 4 0 140 512 526 536     
2 2 1 0 0 3 5 0 421 624       
3 2 1 0 0 3 6 1 271 287       
3 2 1 0 0 3 6 6 378 385       
2 5 1 0 0 3 6 0 271 287 378 385 473    
2 4 1 0 0 3 7 0 225 237 336 392     
2 4 1 0 0 3 8 0 291 571 679 908     
2 4 1 0 0 3 9 0 366 534 640 869     
3 2 1 0 0 3 10 1 278 283       
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2 7 1 0 0 3 10 0 278 283 412 540 579 593 600  2 6 1 0 0 3 0 1 271 278 283 287 291 336   
2 2 1 0 0 3 0 2 717 727       
2 7 1 0 0 3 0 3 536 540 571 579 593 600 624  
2 3 1 0 0 3 0 5 512 526 534      
2 5 1 0 0 3 0 6 366 378 385 392 396    
2 2 1 0 0 3 0 7 640 679       
2 2 1 0 0 3 0 8 412 421       
2 2 1 0 0 3 0 10 852 869       
2 5 1 0 0 4 1 0 393 436 693 750 906    
2 3 1 0 0 4 2 0 224 552 787      
3 2 1 0 0 4 3 1 309 325       
2 6 1 0 0 4 3 0 90 99 137 309 325 704   
2 5 1 0 0 4 4 0 11 26 229 337 370    
2 4 1 0 0 4 5 0 142 273 375 677     
2 3 1 0 0 4 6 0 70 551 784      
2 2 1 0 0 4 7 0 118 163       
3 3 1 0 0 4 8 2 724 739 747      
2 7 1 0 0 4 8 0 359 520 711 724 739 747 930  
2 4 1 0 0 4 9 0 78 402 809 935     
3 3 1 0 0 4 10 8 403 409 425      
2 5 1 0 0 4 10 0 403 409 425 586 800    
2 4 1 0 0 4 0 1 273 309 325 337     
2 4 1 0 0 4 0 2 724 739 747 750     
2 3 1 0 0 4 0 3 551 552 586      
2 5 1 0 0 4 0 6 359 370 375 393 402    
2 6 1 0 0 4 0 7 677 693 704 711 784 787   
2 4 1 0 0 4 0 8 403 409 425 436     
2 3 1 0 0 4 0 9 906 930 935      
2 2 1 0 0 4 0 10 800 809       
3 3 1 0 0 5 1 3 569 578 595      
3 2 1 0 0 5 1 10 811 823       
2 8 1 0 0 5 1 0 62 130 569 578 595 714 811 823 
3 2 1 0 0 5 3 8 419 429       
2 7 1 0 0 5 3 0 285 376 419 429 460 507 636  
3 3 1 0 0 5 4 8 416 439 443      
2 7 1 0 0 5 4 0 58 330 416 439 443 558 776  
2 6 1 0 0 5 5 0 211 254 306 612 753 807   
3 2 1 0 0 5 6 10 824 860       
2 3 1 0 0 5 6 0 132 824 860      
3 2 1 0 0 5 7 3 541 603       
2 3 1 0 0 5 7 0 541 603 757      
3 2 1 0 0 5 8 7 761 777       
2 8 1 0 0 5 8 0 83 248 417 713 761 777 880 915 
3 2 1 0 0 5 9 5 509 531       
2 4 1 0 0 5 9 0 119 486 509 531     
3 2 1 0 0 5 10 10 803 859       
2 7 1 0 0 5 10 0 203 223 269 372 664 803 859  
2 4 1 0 0 5 0 1 269 285 306 330     
2 3 1 0 0 5 0 2 713 714 753      
2 7 1 0 0 5 0 3 541 558 569 578 595 603 612  
2 2 1 0 0 5 0 4 460 486       
2 3 1 0 0 5 0 5 507 509 531      
2 2 1 0 0 5 0 6 372 376       
2 6 1 0 0 5 0 7 636 664 757 761 776 777   
2 6 1 0 0 5 0 8 416 417 419 429 439 443   
2 2 1 0 0 5 0 9 915 957       
2 8 1 0 0 5 0 10 803 807 811 823 824 859 860 880 
3 2 1 0 0 6 1 3 570 610       
3 2 1 0 0 6 1 7 662 705       
3 2 1 0 0 6 1 9 946 947       
3 2 1 0 0 6 2 2 728 742       
3 3 1 0 0 6 2 7 670 688 710      
3 2 1 0 0 6 2 10 795 858       
2 6 1 0 0 6 3 0 60 61 383 407 637 875   
2 4 1 0 0 6 4 0 465 736 760 954     
2 6 1 0 0 6 5 0 22 213 347 555 759 867   
2 4 1 0 0 6 6 0 143 161 629 645     
2 2 1 0 0 6 7 0 454 616       
2 4 1 0 0 6 8 0 472 506 559 786     
3 2 1 0 0 6 9 1 297 303       
3 2 1 0 0 6 9 9 925 958       
3 2 1 0 0 6 9 10 794 796       
2 4 1 0 0 6 10 0 148 259 482 554     
2 4 1 0 0 6 0 1 259 297 303 333     
2 3 1 0 0 6 0 2 728 736 742      
2 7 1 0 0 6 0 4 451 453 454 459 465 472 482  
2 3 1 0 0 6 0 5 506 518 525      
2 3 1 0 0 6 0 6 347 383 398      
2 5 1 0 0 6 0 9 925 946 947 954 958    
2 7 1 0 0 6 0 10 794 795 796 858 867 875 879  
3 2 1 0 0 7 1 7 683 771       
2 8 1 0 0 7 1 0 77 339 428 631 683 732 771 841 
3 2 1 0 0 7 2 6 364 369       
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2 6 1 0 0 7 2 0 96 219 313 364 369 700  2 2 1 0 0 7 3 0 6 80      
3 2 1 0 0 7 4 1 275 344      
2 6 1 0 0 7 4 0 8 275 344 388 504 628  
2 3 1 0 0 7 5 0 342 468 663     
3 2 1 0 0 7 6 10 792 819      
2 7 1 0 0 7 6 0 308 422 456 548 749 792 819 
3 2 1 0 0 7 7 3 588 608      
3 2 1 0 0 7 7 7 656 709      
2 6 1 0 0 7 7 0 264 483 588 608 656 709  
3 2 1 0 0 7 8 10 793 839      
2 6 1 0 0 7 8 0 268 371 446 666 793 839  
3 2 1 0 0 7 9 7 673 780      
3 2 1 0 0 7 9 9 848 922      
2 7 1 0 0 7 9 0 52 464 673 780 798 848 922 
2 7 1 0 0 7 10 0 204 231 292 457 577 726 814 
2 3 1 0 0 7 0 2 726 732 749     
2 6 1 0 0 7 0 3 548 577 588 608 628 631  
2 5 1 0 0 7 0 4 456 457 464 468 483   
2 4 1 0 0 7 0 6 364 369 371 388    
2 3 1 0 0 7 0 8 422 428 446     
2 2 1 0 0 7 0 9 848 922      
2 7 1 0 0 7 0 10 792 793 798 814 819 839 841 
3 2 1 0 0 8 2 1 293 340      
2 3 1 0 0 8 2 0 293 340 646     
2 2 1 0 0 8 3 0 411 865      
2 4 1 0 0 8 4 0 136 353 481 863    
2 3 1 0 0 8 5 0 324 583 746     
2 4 1 0 0 8 6 0 50 503 769 846    
3 2 1 0 0 8 7 4 455 492      
3 2 1 0 0 8 7 10 844 862      
2 5 1 0 0 8 7 0 311 455 492 844 862   
3 3 1 0 0 8 8 3 550 615 620     
2 7 1 0 0 8 8 0 34 498 550 615 620 712 837 
2 5 1 0 0 8 9 0 10 250 502 735 881   
2 3 1 0 0 8 10 0 584 647 893     
2 4 1 0 0 8 0 1 293 311 324 340    
2 2 1 0 0 8 0 2 735 746      
2 5 1 0 0 8 0 3 550 583 584 615 620   
2 3 1 0 0 8 0 4 455 481 492     
2 3 1 0 0 8 0 5 498 502 503     
2 4 1 0 0 8 0 7 646 647 712 769    
2 7 1 0 0 8 0 10 837 844 862 863 865 881 893 
3 2 1 0 0 9 1 7 657 699      
2 6 1 0 0 9 1 0 15 350 485 657 699 939  
2 2 1 0 0 9 2 0 154 386      
2 2 1 0 0 9 3 0 494 669      
2 2 1 0 0 9 4 0 381 901      
2 3 1 0 0 9 5 0 193 431 466     
2 3 1 0 0 9 8 0 266 389 892     
2 2 1 0 0 9 9 0 676 723      
3 2 1 0 0 9 10 1 286 317      
3 2 1 0 0 9 10 10 820 828      
2 5 1 0 0 9 10 0 286 317 781 820 828   
2 3 1 0 0 9 0 1 266 286 317     
2 2 1 0 0 9 0 4 466 485      
2 5 1 0 0 9 0 6 350 381 386 389 400   
2 5 1 0 0 9 0 7 657 669 676 699 781   
2 2 1 0 0 9 0 9 901 939      
2 3 1 0 0 9 0 10 820 828 892     
2 5 1 0 0 10 1 0 238 346 495 695 885   
2 2 1 0 0 10 2 0 521 791      
2 6 1 0 0 10 3 0 191 218 365 493 585 962  
3 2 1 0 0 10 4 8 426 433      
2 4 1 0 0 10 4 0 426 433 882 907    
2 5 1 0 0 10 5 0 102 107 332 458 887   
2 4 1 0 0 10 6 0 105 387 544 639    
2 4 1 0 0 10 7 0 265 447 606 668    
2 4 1 0 0 10 8 0 349 424 687 808    
3 2 1 0 0 10 9 1 256 261      
2 6 1 0 0 10 9 0 165 245 256 261 738 813  
3 2 1 0 0 10 10 4 471 477      
2 6 1 0 0 10 10 0 316 423 471 477 556 653  
2 5 1 0 0 10 0 1 256 261 265 316 332   
2 4 1 0 0 10 0 3 544 556 585 606    
2 5 1 0 0 10 0 4 447 458 471 477 493   
2 2 1 0 0 10 0 5 495 521      
2 4 1 0 0 10 0 6 346 349 365 387    
2 5 1 0 0 10 0 7 639 653 668 687 695   
2 4 1 0 0 10 0 8 423 424 426 433    
2 2 1 0 0 10 0 9 907 962      
2 6 1 0 0 10 0 10 791 808 813 882 885 887  
2 7 1 0 0 0 1 1 296 302 319 328 331 333 339 
2 4 1 0 0 0 1 2 714 717 732 750    
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2 8 1 0 0 0 1 3 569 570 578 592 595 598 610 631 
2 3 1 0 0 0 1 4 459 485 491      
2 4 1 0 0 0 1 5 495 500 523 528     
2 3 1 0 0 0 1 6 346 350 393      
2 4 1 0 0 0 1 8 413 420 428 436     
2 4 1 0 0 0 1 9 906 939 946 947     
2 8 1 0 0 0 1 10 799 811 821 823 841 879 885 894 
2 5 1 0 0 0 2 1 276 293 313 334 340    
2 4 1 0 0 0 2 2 715 727 728 742     
2 2 1 0 0 0 2 3 552 590       
2 2 1 0 0 0 2 4 451 478       
2 3 1 0 0 0 2 5 521 522 525      
2 6 1 0 0 0 2 6 364 368 369 386 391 398   
2 5 1 0 0 0 2 9 911 921 936 957 961    
2 4 1 0 0 0 2 10 791 795 858 883     
2 3 1 0 0 0 3 1 285 309 325      
2 3 1 0 0 0 3 3 539 576 585      
2 2 1 0 0 0 3 4 460 493       
2 3 1 0 0 0 3 5 494 501 507      
2 6 1 0 0 0 3 6 356 358 365 376 383 396   
2 7 1 0 0 0 3 7 634 636 637 669 704 772 785  
2 5 1 0 0 0 3 8 404 407 411 419 429    
2 2 1 0 0 0 3 9 847 962       
2 5 1 0 0 0 3 10 852 865 875 884 891    
2 6 1 0 0 0 4 1 274 275 315 330 337 344   
2 4 1 0 0 0 4 3 536 558 626 628     
2 4 1 0 0 0 4 4 465 475 481 489     
2 3 1 0 0 0 4 5 504 512 526      
2 6 1 0 0 0 4 6 353 370 381 382 388 401   
2 3 1 0 0 0 4 7 690 760 776      
2 6 1 0 0 0 4 8 416 426 433 435 439 443   
2 5 1 0 0 0 4 9 898 901 907 950 954    
2 2 1 0 0 0 4 10 863 882       
2 5 1 0 0 0 5 1 273 306 324 332 342    
2 2 1 0 0 0 5 2 746 753       
2 5 1 0 0 0 5 3 555 575 583 612 624    
2 3 1 0 0 0 5 4 458 466 468      
2 2 1 0 0 0 5 5 524 530       
2 2 1 0 0 0 5 6 347 375       
2 4 1 0 0 0 5 7 663 677 759 762     
2 2 1 0 0 0 5 8 421 431       
2 4 1 0 0 0 5 10 807 867 877 887     
2 5 1 0 0 0 6 1 257 271 281 287 308    
2 3 1 0 0 0 6 2 737 743 749      
2 5 1 0 0 0 6 3 544 548 551 619 629    
2 2 1 0 0 0 6 4 456 473       
2 3 1 0 0 0 6 6 378 385 387      
2 6 1 0 0 0 6 7 639 645 685 766 769 784   
2 2 1 0 0 0 6 8 406 422       
2 3 1 0 0 0 6 9 846 923 948      
2 4 1 0 0 0 6 10 792 819 824 860     
2 4 1 0 0 0 7 1 264 265 311 336     
2 7 1 0 0 0 7 3 541 573 588 603 606 608 616  
2 5 1 0 0 0 7 4 447 454 455 483 492    
2 3 1 0 0 0 7 6 392 397 400      
2 6 1 0 0 0 7 7 656 665 668 709 757 778   
2 3 1 0 0 0 7 10 822 844 862      
2 4 1 0 0 0 8 1 266 268 291 326     
2 6 1 0 0 0 8 2 713 724 729 731 739 747   
2 2 1 0 0 0 8 4 469 472       
2 5 1 0 0 0 8 5 498 506 515 517 520    
2 7 1 0 0 0 8 6 349 351 354 359 371 389 395  
2 3 1 0 0 0 8 8 417 424 446      
2 3 1 0 0 0 8 9 908 915 930      
2 8 1 0 0 0 8 10 793 805 808 837 839 857 880 892 
2 4 1 0 0 0 9 1 256 261 297 303     
2 5 1 0 0 0 9 2 723 725 735 738 752    
2 3 1 0 0 0 9 3 553 568 587      
2 3 1 0 0 0 9 4 453 464 486      
2 5 1 0 0 0 9 5 502 509 518 531 534    
2 2 1 0 0 0 9 6 366 402       
2 7 1 0 0 0 9 7 640 650 673 676 692 768 780  
2 5 1 0 0 0 9 9 848 922 925 935 958    
2 4 1 0 0 0 10 4 457 471 477 482     
2 5 1 0 0 0 10 7 647 653 664 708 781    
2 6 1 0 0 0 10 8 403 409 412 423 425 427   
 
